Tax-ID-1	Gene-ID-1	HIV-product-accession.version	HIV-product-name	Interaction-short-phrase	Tax-ID-2	Gene-ID-2	Human-product-accession.version	Human-product-name	PubMed-ID	last-update-timestamp	GeneRIF-text
11676	155348	NP_705926.1	retropepsin	cleaves	9606	2	NP_000005.2	alpha-2-macroglobulin precursor	1724156,7524416,7690356	2007-11-07 17:29	The cleavage site of alpha 2-Macroglobulin by HIV-1 protease is the Phe684-Tyr685 bond
11676	155871	NP_057853.1	Tat	inhibits	9606	2	NP_000005.2	alpha-2-macroglobulin precursor	11100124	2007-11-07 17:30	Binding of HIV-1 Tat to LRP inhibits neuronal binding, uptake and degradation of physiological ligands for LRP, including alpha2-macroglobulin, apolipoprotein E4, amyloid precursor and amyloid beta-protein
11676	156110	NP_057857.2	Nef	downregulates	9606	19	NP_005493.2	ATP-binding cassette sub-family A member 1	17076584	2007-11-07 17:31	HIV-1 Nef interacts with ABCA1 and induces downregulation and redistribution of ABCA1 to the plasma membrane
11676	155030	NP_579876.2	matrix	interacts with	9606	58	NP_001091.1	actin, alpha skeletal muscle	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155348	NP_705926.1	retropepsin	cleaves	9606	58	NP_001091.1	actin, alpha skeletal muscle	1540415	2007-11-07 17:29	Actin, one of the most abundant proteins of the cell, is hydrolyzed by the human immunodeficiency virus type 1 (HIV-1) protease during acute infection of cultured human T lymphocytes
11676	155348	NP_705926.1	retropepsin	cleaves	9606	58	NP_001091.1	actin, alpha skeletal muscle	1540415,1907279,1991513,8997639	2007-11-07 17:29	HIV-1 protease cleaves actin in vitro at amino acid residues 66-67, 94-95, and 126-127
11676	155348	NP_705927.1	reverse transcriptase	co-localizes with	9606	58	NP_001091.1	actin, alpha skeletal muscle	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155871	NP_057853.1	Tat	induces rearrangement of	9606	58	NP_001091.1	actin, alpha skeletal muscle	14694110	2007-11-07 17:28	HIV-1 Tat induces actin cytoskeletal rearrangements through p21-activated kinase 1 (PAK1) and downstream activation of the endothelial NADPH oxidase, an effect that is lost by introduction of mutations into the Tat cysteine-rich or basic domains
11676	155871	NP_057853.1	Tat	downregulates	9606	58	NP_001091.1	actin, alpha skeletal muscle	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	58	NP_001091.1	actin, alpha skeletal muscle	10556093	2007-11-07 17:31	The interaction of the long cytoplasmic tail of HIV-1 gp41 with the carboxy-terminal regulatory domain of p115-RhoGEF inhibits p115-mediated actin stress fiber formation and activation of serum response factor (SRF)
11676	155030	NP_579876.2	matrix	interacts with	9606	59	NP_001604.1	actin, aortic smooth muscle	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155348	NP_705926.1	retropepsin	cleaves	9606	59	NP_001604.1	actin, aortic smooth muscle	1540415	2007-11-07 17:29	Actin, one of the most abundant proteins of the cell, is hydrolyzed by the human immunodeficiency virus type 1 (HIV-1) protease during acute infection of cultured human T lymphocytes
11676	155348	NP_705926.1	retropepsin	cleaves	9606	59	NP_001604.1	actin, aortic smooth muscle	1540415,1907279,1991513,8997639	2007-11-07 17:29	HIV-1 protease cleaves actin in vitro at amino acid residues 66-67, 94-95, and 126-127
11676	155348	NP_705927.1	reverse transcriptase	co-localizes with	9606	59	NP_001604.1	actin, aortic smooth muscle	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155871	NP_057853.1	Tat	induces rearrangement of	9606	59	NP_001604.1	actin, aortic smooth muscle	14694110	2007-11-07 17:28	HIV-1 Tat induces actin cytoskeletal rearrangements through p21-activated kinase 1 (PAK1) and downstream activation of the endothelial NADPH oxidase, an effect that is lost by introduction of mutations into the Tat cysteine-rich or basic domains
11676	155871	NP_057853.1	Tat	downregulates	9606	59	NP_001604.1	actin, aortic smooth muscle	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	59	NP_001604.1	actin, aortic smooth muscle	10556093	2007-11-07 17:31	The interaction of the long cytoplasmic tail of HIV-1 gp41 with the carboxy-terminal regulatory domain of p115-RhoGEF inhibits p115-mediated actin stress fiber formation and activation of serum response factor (SRF)
11676	155030	NP_579876.2	matrix	interacts with	9606	60	NP_001092.1	actin, cytoplasmic 1	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155030	NP_579881.1	nucleocapsid	binds	9606	60	NP_001092.1	actin, cytoplasmic 1	8661406,8892894,9971772,10049817,10074138,11709093,12009869	2007-11-07 17:29	Mature HIV-1 Nucleocapsid, as well as the nucleocapsid domain of the HIV-1 Gag polyprotein, binds filamentous actin resulting in incorporation of actin into virus particles and enhancement of cell motility
11676	155348	NP_705926.1	retropepsin	cleaves	9606	60	NP_001092.1	actin, cytoplasmic 1	1540415	2007-11-07 17:29	Actin, one of the most abundant proteins of the cell, is hydrolyzed by the human immunodeficiency virus type 1 (HIV-1) protease during acute infection of cultured human T lymphocytes
11676	155348	NP_705926.1	retropepsin	cleaves	9606	60	NP_001092.1	actin, cytoplasmic 1	1540415,1907279,1991513,8997639	2007-11-07 17:29	HIV-1 protease cleaves actin in vitro at amino acid residues 66-67, 94-95, and 126-127
11676	155348	NP_705927.1	reverse transcriptase	binds	9606	60	NP_001092.1	actin, cytoplasmic 1	7535922	2007-11-07 17:29	Eukaryotic beta-actin binds to either the large subunit (p66) of HIV-1 reverse transcriptase or to the HIV-1 Pol precursor polyprotein in vitro; this interaction is believed to be important for the secretion of HIV-1 virions
11676	155348	NP_705927.1	reverse transcriptase	co-localizes with	9606	60	NP_001092.1	actin, cytoplasmic 1	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155871	NP_057853.1	Tat	induces rearrangement of	9606	60	NP_001092.1	actin, cytoplasmic 1	14694110	2007-11-07 17:28	HIV-1 Tat induces actin cytoskeletal rearrangements through p21-activated kinase 1 (PAK1) and downstream activation of the endothelial NADPH oxidase, an effect that is lost by introduction of mutations into the Tat cysteine-rich or basic domains
11676	155871	NP_057853.1	Tat	upregulates	9606	60	NP_001092.1	actin, cytoplasmic 1	15710247	2007-11-07 17:28	Upregulation of actin, heat shock protein 90 and mitochondrial single-stranded DNA binding protein, and downregulation of lactate dehydrogenase are identified in human astrocytes expressing Tat
11676	155871	NP_057853.1	Tat	downregulates	9606	60	NP_001092.1	actin, cytoplasmic 1	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155908	NP_057854.1	Rev	associates with	9606	60	NP_001092.1	actin, cytoplasmic 1	9150887	2007-11-07 17:29	Rev plays an important role in the compartmentation of translation by directing RRE-containing mRNAs to the beta-actin to form the perinuclear clusters at which the synthesis of viral structural proteins begins
11676	155908	NP_057854.1	Rev	associates with	9606	60	NP_001092.1	actin, cytoplasmic 1	10792467,11238447	2007-11-07 17:29	beta actin is involved in the Rev-dependent nuclear export of unspliced and incompletely spliced HIV-1 mRNA
11676	155908	NP_057854.1	Rev	associates with	9606	60	NP_001092.1	actin, cytoplasmic 1	11238447	2007-11-07 17:29	during Rev-mediated nuclear export of HIV-1 mRNA, actin binds to eukaryotic initiation factor 5A (eIF-5A), a protein that interacts directly with Rev and facilitates the nuclear export process
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	60	NP_001092.1	actin, cytoplasmic 1	10556093	2007-11-07 17:31	The interaction of the long cytoplasmic tail of HIV-1 gp41 with the carboxy-terminal regulatory domain of p115-RhoGEF inhibits p115-mediated actin stress fiber formation and activation of serum response factor (SRF)
11676	156110	NP_057857.2	Nef	associates with	9606	60	NP_001092.1	actin, cytoplasmic 1	9288906	2007-11-07 17:28	N-terminal myristoylated, but not unmyristoylated, HIV-1 Nef associates with actin in human B and T lymphocytes forming a high-molecular-mass complex of 150-300 kDa that influences the subcellular localization of Nef
11676	156110	NP_057857.2	Nef	induces rearrangement of	9606	60	NP_001092.1	actin, cytoplasmic 1	14597672	2007-11-07 17:28	HIV-1 Nef induces rearrangement of actin microfilaments in dendritic cells, leading to uropod and ruffle formation, as well as the recruitment of T cells with a pronounced focal polarization of F-actin toward the DC/T cell contact sites
11676	156110	NP_057857.2	Nef	interacts with	9606	60	NP_001092.1	actin, cytoplasmic 1	15140972,16091223	2007-11-07 17:28	Disruption of the actin cytoskeleton by treatment with CytD and LatB complements the infectivity defect of HIV-1 virions lacking Nef, suggesting Nef interacts with actin to enhance virion infectivity
11676	156110	NP_057857.2	Nef	interacts with	9606	60	NP_001092.1	actin, cytoplasmic 1	15371598	2007-11-07 17:28	Assays with phage-displayed Nef from HIV-1 NL4-3 have been used to identify a series of guanidine alkaloid-based inhibitors of Nef interactions with p53, actin, and p56(lck)
11676	155030	NP_579876.2	matrix	interacts with	9606	70	NP_005150.1	actin, alpha cardiac muscle 1 proprotein	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155348	NP_705926.1	retropepsin	cleaves	9606	70	NP_005150.1	actin, alpha cardiac muscle 1 proprotein	1540415	2007-11-07 17:29	Actin, one of the most abundant proteins of the cell, is hydrolyzed by the human immunodeficiency virus type 1 (HIV-1) protease during acute infection of cultured human T lymphocytes
11676	155348	NP_705926.1	retropepsin	cleaves	9606	70	NP_005150.1	actin, alpha cardiac muscle 1 proprotein	1540415,1907279,1991513,8997639	2007-11-07 17:29	HIV-1 protease cleaves actin in vitro at amino acid residues 66-67, 94-95, and 126-127
11676	155348	NP_705927.1	reverse transcriptase	co-localizes with	9606	70	NP_005150.1	actin, alpha cardiac muscle 1 proprotein	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155871	NP_057853.1	Tat	induces rearrangement of	9606	70	NP_005150.1	actin, alpha cardiac muscle 1 proprotein	14694110	2007-11-07 17:28	HIV-1 Tat induces actin cytoskeletal rearrangements through p21-activated kinase 1 (PAK1) and downstream activation of the endothelial NADPH oxidase, an effect that is lost by introduction of mutations into the Tat cysteine-rich or basic domains
11676	155871	NP_057853.1	Tat	downregulates	9606	70	NP_005150.1	actin, alpha cardiac muscle 1 proprotein	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	70	NP_005150.1	actin, alpha cardiac muscle 1 proprotein	10556093	2007-11-07 17:31	The interaction of the long cytoplasmic tail of HIV-1 gp41 with the carboxy-terminal regulatory domain of p115-RhoGEF inhibits p115-mediated actin stress fiber formation and activation of serum response factor (SRF)
11676	155030	NP_579876.2	matrix	interacts with	9606	71	NP_001605.1	actin, cytoplasmic 2	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155030	NP_579881.1	nucleocapsid	binds	9606	71	NP_001605.1	actin, cytoplasmic 2	8661406,8892894,9971772,10049817,10074138,11709093,12009869	2007-11-07 17:29	Mature HIV-1 Nucleocapsid, as well as the nucleocapsid domain of the HIV-1 Gag polyprotein, binds filamentous actin resulting in incorporation of actin into virus particles and enhancement of cell motility
11676	155348	NP_705926.1	retropepsin	cleaves	9606	71	NP_001605.1	actin, cytoplasmic 2	1540415	2007-11-07 17:29	Actin, one of the most abundant proteins of the cell, is hydrolyzed by the human immunodeficiency virus type 1 (HIV-1) protease during acute infection of cultured human T lymphocytes
11676	155348	NP_705926.1	retropepsin	cleaves	9606	71	NP_001605.1	actin, cytoplasmic 2	1540415,1907279,1991513,8997639	2007-11-07 17:29	HIV-1 protease cleaves actin in vitro at amino acid residues 66-67, 94-95, and 126-127
11676	155348	NP_705927.1	reverse transcriptase	co-localizes with	9606	71	NP_001605.1	actin, cytoplasmic 2	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155807	NP_057852.2	Vpr	enhances polymerization of	9606	71	NP_001605.1	actin, cytoplasmic 2	9199338,10713718	2007-11-07 17:27	HIV-1 Vpr-expressing Jurkat T cell clones showed a significant increase in G-actin polymerization to filamentous actin (F-actin), indicating a role of Vpr in microfilament system assembly.  Vpr also causes disruption of the actin cytoskeleton in yeast.
11676	155871	NP_057853.1	Tat	induces rearrangement of	9606	71	NP_001605.1	actin, cytoplasmic 2	14694110	2007-11-07 17:28	HIV-1 Tat induces actin cytoskeletal rearrangements through p21-activated kinase 1 (PAK1) and downstream activation of the endothelial NADPH oxidase, an effect that is lost by introduction of mutations into the Tat cysteine-rich or basic domains
11676	155871	NP_057853.1	Tat	downregulates	9606	71	NP_001605.1	actin, cytoplasmic 2	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	71	NP_001605.1	actin, cytoplasmic 2	10556093	2007-11-07 17:31	The interaction of the long cytoplasmic tail of HIV-1 gp41 with the carboxy-terminal regulatory domain of p115-RhoGEF inhibits p115-mediated actin stress fiber formation and activation of serum response factor (SRF)
11676	156110	NP_057857.2	Nef	associates with	9606	71	NP_001605.1	actin, cytoplasmic 2	9288906	2007-11-07 17:28	N-terminal myristoylated, but not unmyristoylated, HIV-1 Nef associates with actin in human B and T lymphocytes forming a high-molecular-mass complex of 150-300 kDa that influences the subcellular localization of Nef
11676	156110	NP_057857.2	Nef	induces rearrangement of	9606	71	NP_001605.1	actin, cytoplasmic 2	14597672	2007-11-07 17:28	HIV-1 Nef induces rearrangement of actin microfilaments in dendritic cells, leading to uropod and ruffle formation, as well as the recruitment of T cells with a pronounced focal polarization of F-actin toward the DC/T cell contact sites
11676	155030	NP_579876.2	matrix	interacts with	9606	72	NP_001606.1	actin, gamma-enteric smooth muscle propeptide	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155348	NP_705926.1	retropepsin	cleaves	9606	72	NP_001606.1	actin, gamma-enteric smooth muscle propeptide	1540415	2007-11-07 17:29	Actin, one of the most abundant proteins of the cell, is hydrolyzed by the human immunodeficiency virus type 1 (HIV-1) protease during acute infection of cultured human T lymphocytes
11676	155348	NP_705926.1	retropepsin	cleaves	9606	72	NP_001606.1	actin, gamma-enteric smooth muscle propeptide	1540415,1907279,1991513,8997639	2007-11-07 17:29	HIV-1 protease cleaves actin in vitro at amino acid residues 66-67, 94-95, and 126-127
11676	155348	NP_705927.1	reverse transcriptase	co-localizes with	9606	72	NP_001606.1	actin, gamma-enteric smooth muscle propeptide	9841925	2007-11-07 17:29	The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules)
11676	155871	NP_057853.1	Tat	induces rearrangement of	9606	72	NP_001606.1	actin, gamma-enteric smooth muscle propeptide	14694110	2007-11-07 17:28	HIV-1 Tat induces actin cytoskeletal rearrangements through p21-activated kinase 1 (PAK1) and downstream activation of the endothelial NADPH oxidase, an effect that is lost by introduction of mutations into the Tat cysteine-rich or basic domains
11676	155871	NP_057853.1	Tat	downregulates	9606	72	NP_001606.1	actin, gamma-enteric smooth muscle propeptide	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	72	NP_001606.1	actin, gamma-enteric smooth muscle propeptide	10556093	2007-11-07 17:31	The interaction of the long cytoplasmic tail of HIV-1 gp41 with the carboxy-terminal regulatory domain of p115-RhoGEF inhibits p115-mediated actin stress fiber formation and activation of serum response factor (SRF)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	81	NP_004915.2	alpha-actinin-4	10556093	2007-11-07 17:31	The interaction of the long cytoplasmic tail of HIV-1 gp41 with the carboxy-terminal regulatory domain of p115-RhoGEF inhibits p115-mediated actin stress fiber formation and activation of serum response factor (SRF)
11676	155348	NP_705926.1	retropepsin	cleaves	9606	87	NP_001093.1	alpha-actinin-1 isoform b	1991513,8997639	2007-11-07 17:29	Alpha-actinin is cleaved in vitro by HIV-1 protease at amino acid residues 166-167 and 471-472
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	100	NP_000013.2	adenosine deaminase	9103436,9330696,10899322,11278278	2007-11-07 17:27	HIV-1 gp120 inhibits adenosine deaminase (ADA) binding to CD26 (dipeptidyl-peptidase 4) in both CD4+ and CD4- cells; this effect requires the interaction of gp120 with CD4 or CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	103	NP_001102.2	double-stranded RNA-specific adenosine deaminase isoform a	9103436,9330696,10899322,11278278	2007-11-07 17:31	HIV-1 gp120 inhibits adenosine deaminase (ADA) binding to CD26 (dipeptidyl-peptidase 4) in both CD4+ and CD4- cells; this effect requires the interaction of gp120 with CD4 or CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	104	NP_001103.1	double-stranded RNA-specific editase 1 isoform 1	9103436,9330696,10899322,11278278	2007-11-07 17:31	HIV-1 gp120 inhibits adenosine deaminase (ADA) binding to CD26 (dipeptidyl-peptidase 4) in both CD4+ and CD4- cells; this effect requires the interaction of gp120 with CD4 or CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	105	NP_061172.1	double-stranded RNA-specific editase B2	9103436,9330696,10899322,11278278	2007-11-07 17:31	HIV-1 gp120 inhibits adenosine deaminase (ADA) binding to CD26 (dipeptidyl-peptidase 4) in both CD4+ and CD4- cells; this effect requires the interaction of gp120 with CD4 or CXCR4
11676	155871	NP_057853.1	Tat	inhibits	9606	107	NP_066939.1	adenylate cyclase type 1	11299302	2007-11-07 17:29	HIV-1 Tat inhibits adenylyl cyclase activity in microglia and astrocyte cultures from neonatal rat brain, suggesting that Tat inhibition of cAMP synthesis may contribute to neuronal degeneration and cell death associated with HIV infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	107	NP_066939.1	adenylate cyclase type 1	10808179	2007-11-07 17:31	The addition of HIV-1 gp120 with TNF-alpha to human B-cells stimulates cAMP production in a dose-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	107	NP_066939.1	adenylate cyclase type 1	10089566,10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	156110	NP_057857.2	Nef	activates	9606	107	NP_066939.1	adenylate cyclase type 1	11884542	2007-11-07 17:28	HIV-1 induces the upregulation of complement factor C3 in astrocytes and neurons through signaling pathways that involve protein kinase C and adenylate cyclase activation, which is an effect that may contribute to the pathogenesis of AIDS in the brain
11676	155871	NP_057853.1	Tat	inhibits	9606	108	NP_065433.2	adenylate cyclase type 2	11299302	2007-11-07 17:29	HIV-1 Tat inhibits adenylyl cyclase activity in microglia and astrocyte cultures from neonatal rat brain, suggesting that Tat inhibition of cAMP synthesis may contribute to neuronal degeneration and cell death associated with HIV infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	108	NP_065433.2	adenylate cyclase type 2	10808179	2007-11-07 17:31	The addition of HIV-1 gp120 with TNF-alpha to human B-cells stimulates cAMP production in a dose-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	108	NP_065433.2	adenylate cyclase type 2	10089566,10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	156110	NP_057857.2	Nef	activates	9606	108	NP_065433.2	adenylate cyclase type 2	11884542	2007-11-07 17:28	HIV-1 induces the upregulation of complement factor C3 in astrocytes and neurons through signaling pathways that involve protein kinase C and adenylate cyclase activation, which is an effect that may contribute to the pathogenesis of AIDS in the brain
11676	155871	NP_057853.1	Tat	inhibits	9606	109	NP_004027.1	adenylate cyclase 3	11299302	2007-11-07 17:29	HIV-1 Tat inhibits adenylyl cyclase activity in microglia and astrocyte cultures from neonatal rat brain, suggesting that Tat inhibition of cAMP synthesis may contribute to neuronal degeneration and cell death associated with HIV infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	109	NP_004027.1	adenylate cyclase 3	10808179	2007-11-07 17:31	The addition of HIV-1 gp120 with TNF-alpha to human B-cells stimulates cAMP production in a dose-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	109	NP_004027.1	adenylate cyclase 3	10089566,10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	156110	NP_057857.2	Nef	activates	9606	109	NP_004027.1	adenylate cyclase 3	11884542	2007-11-07 17:28	HIV-1 induces the upregulation of complement factor C3 in astrocytes and neurons through signaling pathways that involve protein kinase C and adenylate cyclase activation, which is an effect that may contribute to the pathogenesis of AIDS in the brain
11676	155871	NP_057853.1	Tat	inhibits	9606	111	NP_899200.1	adenylate cyclase type 5	11299302	2007-11-07 17:29	HIV-1 Tat inhibits adenylyl cyclase activity in microglia and astrocyte cultures from neonatal rat brain, suggesting that Tat inhibition of cAMP synthesis may contribute to neuronal degeneration and cell death associated with HIV infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	111	NP_899200.1	adenylate cyclase type 5	10808179	2007-11-07 17:31	The addition of HIV-1 gp120 with TNF-alpha to human B-cells stimulates cAMP production in a dose-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	111	NP_899200.1	adenylate cyclase type 5	10089566,10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	156110	NP_057857.2	Nef	activates	9606	111	NP_899200.1	adenylate cyclase type 5	11884542	2007-11-07 17:28	HIV-1 induces the upregulation of complement factor C3 in astrocytes and neurons through signaling pathways that involve protein kinase C and adenylate cyclase activation, which is an effect that may contribute to the pathogenesis of AIDS in the brain
11676	155871	NP_057853.1	Tat	inhibits	9606	112	NP_056085.1	adenylate cyclase type 6 isoform a	11299302	2007-11-07 17:29	HIV-1 Tat inhibits adenylyl cyclase activity in microglia and astrocyte cultures from neonatal rat brain, suggesting that Tat inhibition of cAMP synthesis may contribute to neuronal degeneration and cell death associated with HIV infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	112	NP_056085.1	adenylate cyclase type 6 isoform a	10808179	2007-11-07 17:31	The addition of HIV-1 gp120 with TNF-alpha to human B-cells stimulates cAMP production in a dose-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	112	NP_056085.1	adenylate cyclase type 6 isoform a	10089566,10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	156110	NP_057857.2	Nef	activates	9606	112	NP_056085.1	adenylate cyclase type 6 isoform a	11884542	2007-11-07 17:28	HIV-1 induces the upregulation of complement factor C3 in astrocytes and neurons through signaling pathways that involve protein kinase C and adenylate cyclase activation, which is an effect that may contribute to the pathogenesis of AIDS in the brain
11676	155871	NP_057853.1	Tat	inhibits	9606	113	NP_001105.1	adenylate cyclase type 7	11299302	2007-11-07 17:29	HIV-1 Tat inhibits adenylyl cyclase activity in microglia and astrocyte cultures from neonatal rat brain, suggesting that Tat inhibition of cAMP synthesis may contribute to neuronal degeneration and cell death associated with HIV infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	113	NP_001105.1	adenylate cyclase type 7	10808179	2007-11-07 17:31	The addition of HIV-1 gp120 with TNF-alpha to human B-cells stimulates cAMP production in a dose-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	113	NP_001105.1	adenylate cyclase type 7	10089566,10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	156110	NP_057857.2	Nef	activates	9606	113	NP_001105.1	adenylate cyclase type 7	11884542	2007-11-07 17:28	HIV-1 induces the upregulation of complement factor C3 in astrocytes and neurons through signaling pathways that involve protein kinase C and adenylate cyclase activation, which is an effect that may contribute to the pathogenesis of AIDS in the brain
11676	155871	NP_057853.1	Tat	inhibits	9606	114	NP_001106.1	adenylate cyclase type 8	11299302	2007-11-07 17:29	HIV-1 Tat inhibits adenylyl cyclase activity in microglia and astrocyte cultures from neonatal rat brain, suggesting that Tat inhibition of cAMP synthesis may contribute to neuronal degeneration and cell death associated with HIV infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	114	NP_001106.1	adenylate cyclase type 8	10808179	2007-11-07 17:31	The addition of HIV-1 gp120 with TNF-alpha to human B-cells stimulates cAMP production in a dose-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	114	NP_001106.1	adenylate cyclase type 8	10089566,10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	156110	NP_057857.2	Nef	activates	9606	114	NP_001106.1	adenylate cyclase type 8	11884542	2007-11-07 17:28	HIV-1 induces the upregulation of complement factor C3 in astrocytes and neurons through signaling pathways that involve protein kinase C and adenylate cyclase activation, which is an effect that may contribute to the pathogenesis of AIDS in the brain
11676	155871	NP_057853.1	Tat	inhibits	9606	115	NP_001107.2	adenylate cyclase type 9	11299302	2007-11-07 17:29	HIV-1 Tat inhibits adenylyl cyclase activity in microglia and astrocyte cultures from neonatal rat brain, suggesting that Tat inhibition of cAMP synthesis may contribute to neuronal degeneration and cell death associated with HIV infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	115	NP_001107.2	adenylate cyclase type 9	10808179	2007-11-07 17:31	The addition of HIV-1 gp120 with TNF-alpha to human B-cells stimulates cAMP production in a dose-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	115	NP_001107.2	adenylate cyclase type 9	10089566,10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	156110	NP_057857.2	Nef	activates	9606	115	NP_001107.2	adenylate cyclase type 9	11884542	2007-11-07 17:28	HIV-1 induces the upregulation of complement factor C3 in astrocytes and neurons through signaling pathways that involve protein kinase C and adenylate cyclase activation, which is an effect that may contribute to the pathogenesis of AIDS in the brain
11676	155871	NP_057853.1	Tat	inhibited by	9606	135	NP_000666.2	adenosine receptor A2a	15351206	2007-11-07 17:28	Activation of adenosine A2a receptor with CGS 21680 inhibits Tat-induced increases of intracellular calcium and this inhibition is dependent on protein phosphatase activity in monocytes
11676	155348	NP_705926.1	retropepsin	induces cleavage of	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	12404116	2007-11-07 17:29	HIV-1 protease directly cleaves and activates procaspase 8 in T cells, which is associated with cleavage of BID, mitochondrial release of cytochrome c, activation of the downstream caspases 9 and 3, and cleavage of DFF and PARP
11676	155348	NP_705926.1	retropepsin	cleaves	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	15781132	2007-11-07 17:29	Inhibition of HIV-1 protease by saquinavir and leu3.a blocks PARP cleavage and protects cells from apoptosis and necrosis
11676	155348	NP_705928.1	integrase	requires	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	11070027,11248084	2007-11-07 17:29	PARP has been described as a requirement for efficient HIV-1 integration, however a conflicting report indicates it is not essential for efficient lentivirus integration
11676	155807	NP_057852.2	Vpr	induces cleavage of	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	15650754	2007-11-07 17:28	HIV-1 Vpr induces apoptosis and the cleavage of ADPRT in a manner that is signaled through the DNA damage signaling protein ataxia telangiectasia Rad3-related protein (ATR)
11676	155807	NP_057852.2	Vpr	recruits	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	16429131	2007-11-07 17:29	Recruitment of PARP-1 by HIV-1 Vpr-glucocorticoid receptor (GR) complex prevents its nuclear localization, which is necessary for Vpr to suppress NF-kappaB
11676	155871	NP_057853.1	Tat	regulates	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	8491200	2007-11-07 17:30	The poly(A) site in the HIV-1 5'-LTR is occluded in a Tat-dependent manner, suggesting a role for Tat in regulating this nucleotide signal
11676	155871	NP_057853.1	Tat	modified by	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	10405328	2007-11-07 17:30	Poly(ADP-ribose) polymerase modifies HIV-1 Tat with poly(ADP-ribose), suggesting a role for this enzyme in the regulation of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	stimulates	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	10405328	2007-11-07 17:30	Purified recombinant HIV-1 Tat protein stimulates poly(ADP-ribose) polymerase in a dose dependent manner
11676	155871	NP_057853.1	Tat	induces cleavage of	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	10799874	2007-11-07 17:28	HIV-1 Tat induces the cleavage of PARP and activation of apoptosis through a p56lck dependent mechanism
11676	155871	NP_057853.1	Tat	induces cleavage of	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	11509621	2007-11-07 17:28	Treatment of primary human microvascular endothelial cells of lung origin with HIV-1 Tat caused cleavage of poly(A/DP)-ribose polymerase as a result of caspase activation
11676	155871	NP_057853.1	Tat	regulated by	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	15498776	2007-11-07 17:29	PARP1 negatively regulates HIV-1 transcription by directly competing with Tat-P-TEFb complex for binding to TAR RNA
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces cleavage of	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	9548463,15103018	2007-11-07 17:27	Contact of CD4+ T cells with HIV-1 infected or HIV-1 gp120-expressing cells induces PARP hydrolysis, which leads to the cleavage of 116 kDa PARP into two fragments
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	15103018	2007-11-07 17:31	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	156110	NP_057857.2	Nef	induces cleavage of	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	11123279	2007-11-07 17:28	HIV-1 Nef enhances apoptosis in CD4+ T lymphoblastoid cell lines through mechanisms that include the cleavage of the caspase target poly(ADP-ribose) polymerase
11676	156110	NP_057857.2	Nef	induces cleavage of	9606	142	NP_001609.1	poly (ADP-ribose) polymerase family, member 1	15767427	2007-11-07 17:28	Expression of HIV-1 Nef in human brain microvascular endothelial cells induces the cleavage of PARP protein, which is involved in DNA repair
11676	155348	NP_705926.1	retropepsin	induces cleavage of	9606	143	NP_006428.2	poly	12404116	2007-11-07 17:29	HIV-1 protease directly cleaves and activates procaspase 8 in T cells, which is associated with cleavage of BID, mitochondrial release of cytochrome c, activation of the downstream caspases 9 and 3, and cleavage of DFF and PARP
11676	155348	NP_705926.1	retropepsin	cleaves	9606	143	NP_006428.2	poly	15781132	2007-11-07 17:29	Inhibition of HIV-1 protease by saquinavir and leu3.a blocks PARP cleavage and protects cells from apoptosis and necrosis
11676	155030	NP_057850.1	Pr55(Gag)	binds	9606	160	NP_055018.2	AP-2 complex subunit alpha-1 isoform 1	16139856	2007-11-07 17:29	HIV-1 Gag binds to AP-2, and this binding is dependent on tyrosine residue 132 and valine residue 135 at the matrix-capsid junction in the Gag polyprotein
11676	155871	NP_057853.1	Tat	interacts with	9606	160	NP_055018.2	AP-2 complex subunit alpha-1 isoform 1	15020715	2007-11-07 17:28	HIV-1 Tat enters T cells by using clathrin/AP2-mediated endocytosis followed by low-pH-induced and Hsp90-assisted endosomal translocation, which leads to cell responses that are induced from the cytosol
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	160	NP_055018.2	AP-2 complex subunit alpha-1 isoform 1	9882340	2007-11-07 17:30	The cytoplasmic domain (residues 707-856) of HIV-1 gp41 interacts with whole clathrin-associated AP-1 and AP-2 adaptor complexes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	160	NP_055018.2	AP-2 complex subunit alpha-1 isoform 1	17108326	2007-11-07 17:31	Two independent motifs, a membrane proximal conserved GYxxO motif (residues 711-715) and a C-terminal dileucine motif (residues 855-856), of the HIV-1 gp41 protein mediate endocytosis through interaction with the clathrin adaptor AP-2
11676	155030	NP_057850.1	Pr55(Gag)	binds	9606	161	NP_036437.1	AP-2 complex subunit alpha-2	16139856	2007-11-07 17:29	HIV-1 Gag binds to AP-2, and this binding is dependent on tyrosine residue 132 and valine residue 135 at the matrix-capsid junction in the Gag polyprotein
11676	155871	NP_057853.1	Tat	interacts with	9606	161	NP_036437.1	AP-2 complex subunit alpha-2	15020715	2007-11-07 17:28	HIV-1 Tat enters T cells by using clathrin/AP2-mediated endocytosis followed by low-pH-induced and Hsp90-assisted endosomal translocation, which leads to cell responses that are induced from the cytosol
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	161	NP_036437.1	AP-2 complex subunit alpha-2	9882340	2007-11-07 17:30	The cytoplasmic domain (residues 707-856) of HIV-1 gp41 interacts with whole clathrin-associated AP-1 and AP-2 adaptor complexes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	161	NP_036437.1	AP-2 complex subunit alpha-2	17108326	2007-11-07 17:31	Two independent motifs, a membrane proximal conserved GYxxO motif (residues 711-715) and a C-terminal dileucine motif (residues 855-856), of the HIV-1 gp41 protein mediate endocytosis through interaction with the clathrin adaptor AP-2
11676	156110	NP_057857.2	Nef	interacts with	9606	162	NP_001118.2	adaptor-related protein complex 1 beta 1 subunit isoform a	9736718,9811606,9811611,11463741,12486136,12836198,15681409	2007-11-07 17:29	A leucine-based motif near the C-terminus of HIV-1 Nef interacts with AP-1 complexes; residues 164 and 165 in Nef are required for the interaction with AP-1
11676	156110	NP_057857.2	Nef	binds	9606	162	NP_001118.2	adaptor-related protein complex 1 beta 1 subunit isoform a	12486136,15681409,16253302	2007-11-07 17:29	The dileucine motif (residues 164-165) in HIV-1 Nef is required for binding to AP-1 complexes and stabilizing their association with membranes
11676	156110	NP_057857.2	Nef	stabilizes	9606	162	NP_001118.2	adaptor-related protein complex 1 beta 1 subunit isoform a	16253302	2007-11-07 17:29	HIV-1 Nef stabilizes AP-1 complexes on endosomal membranes after ADP-ribosylation factor-1 (ARF1) -dependent attachment
11676	155030	NP_057850.1	Pr55(Gag)	binds	9606	163	NP_001273.1	AP-2 complex subunit beta isoform b	16139856	2007-11-07 17:29	HIV-1 Gag binds to AP-2, and this binding is dependent on tyrosine residue 132 and valine residue 135 at the matrix-capsid junction in the Gag polyprotein
11676	155871	NP_057853.1	Tat	interacts with	9606	163	NP_001273.1	AP-2 complex subunit beta isoform b	15020715	2007-11-07 17:28	HIV-1 Tat enters T cells by using clathrin/AP2-mediated endocytosis followed by low-pH-induced and Hsp90-assisted endosomal translocation, which leads to cell responses that are induced from the cytosol
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	163	NP_001273.1	AP-2 complex subunit beta isoform b	9882340	2007-11-07 17:30	The cytoplasmic domain (residues 707-856) of HIV-1 gp41 interacts with whole clathrin-associated AP-1 and AP-2 adaptor complexes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	163	NP_001273.1	AP-2 complex subunit beta isoform b	17108326	2007-11-07 17:31	Two independent motifs, a membrane proximal conserved GYxxO motif (residues 711-715) and a C-terminal dileucine motif (residues 855-856), of the HIV-1 gp41 protein mediate endocytosis through interaction with the clathrin adaptor AP-2
11676	156110	NP_057857.2	Nef	co-localizes with	9606	163	NP_001273.1	AP-2 complex subunit beta isoform b	9384576	2007-11-07 17:28	HIV-1 Nef co-localizes with the beta subunit of the adaptor protein complexes (AP-2) in human T cells; Nef residues 174-179 are required for the co-localization of Nef with the beta subunit
11676	156110	NP_057857.2	Nef	binds	9606	163	NP_001273.1	AP-2 complex subunit beta isoform b	9811611,11463741	2007-11-07 17:28	A dileucine-motif-containing segment of Nef binds directly to the beta subunit of the clathrin adaptor complexes AP-2, which are responsible for recruiting sorted proteins into clathrin coated pits
11676	156110	NP_057857.2	Nef	co-localizes with	9606	163	NP_001273.1	AP-2 complex subunit beta isoform b	11285224	2007-11-07 17:28	In cells expressing an HIV-1 Nef-green fluorescent protein (GFP) fusion, CD28 co-localizes with the AP-2 clathrin adaptor and Nef-GFP
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	164	NP_001119.3	AP-1 complex subunit gamma-1 isoform b	9882340,11222723	2007-11-07 17:30	The cytoplasmic domain (residues 707-856) of HIV-1 gp41 interacts with whole clathrin-associated AP-1 and AP-2 adaptor complexes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	164	NP_001119.3	AP-1 complex subunit gamma-1 isoform b	11222723	2007-11-07 17:30	The highly conserved C-terminal dileucine motif (residues 851-856) in the cytosolic domain of HIV-1 gp41 interacts with clathrin-associated AP-1 adaptor complexes
11676	156110	NP_057857.2	Nef	binds	9606	164	NP_001119.3	AP-1 complex subunit gamma-1 isoform b	12486136,15681409,16253302	2007-11-07 17:28	HIV-1 Nef stabilizes the association of AP-1 with membranes; the dileucine residues (164-165) in Nef are required for Nef binding and stabilization of the AP-1 complexes
11676	156110	NP_057857.2	Nef	stabilizes	9606	164	NP_001119.3	AP-1 complex subunit gamma-1 isoform b	16253302	2007-11-07 17:29	HIV-1 Nef stabilizes AP-1 complexes on endosomal membranes after ADP-ribosylation factor-1 (ARF1) -dependent attachment
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	187	NP_005152.1	apelin receptor	9653051,9736741	2007-11-07 17:28	Macrophage-tropic HIV-1 can use CCR2b, and to a lesser extent CCR3, STRL33, and APJ, to infect cells; the V1/2 region of HIV-1 gp120 plays a more important role in governing the use of CCR2b, CCR3, STRL33, and APJ than for CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	187	NP_005152.1	apelin receptor	11040134	2007-11-07 17:31	APJ, a seven transmembrane domain G-protein-coupled receptor, functions as a coreceptor for gp120 from some HIV-1 strains; a natural peptide ligand for APJ, apelin-13, efficiently blocks APJ coreceptor activity
11676	155807	NP_057852.2	Vpr	inhibits	9606	207	NP_005154.2	RAC-alpha serine/threonine-protein kinase	15616007	2007-11-07 17:28	HIV-1 Vpr inhibits Akt-induced cytoplasmic translocation of Foxo3a, a subtype of the forkhead transcription factors
11676	155871	NP_057853.1	Tat	activates	9606	207	NP_005154.2	RAC-alpha serine/threonine-protein kinase	9394803,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates AKT kinase through activation of PI3 kinase, resulting in the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	activates	9606	207	NP_005154.2	RAC-alpha serine/threonine-protein kinase	11156964	2007-11-07 17:28	HIV-1 Tat downregulates CREB transcription factor expression in PC12 neuronal cells through activation of a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway
11676	155871	NP_057853.1	Tat	upregulates	9606	207	NP_005154.2	RAC-alpha serine/threonine-protein kinase	11994280	2007-11-07 17:29	HIV-1 Tat upregulates several anti-apoptotic genes, including AKT-1, AKT-2, BCL2, BCL-XL, and insulin-like growth factor I in vincristine-treated Kaposi's sarcoma cells
11676	155871	NP_057853.1	Tat	activates	9606	207	NP_005154.2	RAC-alpha serine/threonine-protein kinase	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	207	NP_005154.2	RAC-alpha serine/threonine-protein kinase	10869418	2007-11-07 17:31	Fractalkine (CX3CL1) protects hippocampal neurons from the neurotoxicity induced by the HIV-1 envelope protein gp120, and neuronal CX(3)CR1 receptors and Akt activation are responsible for the neuroprotective effects of fractalkine
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	decreases phosphorylation of	9606	207	NP_005154.2	RAC-alpha serine/threonine-protein kinase	11208609	2007-11-07 17:30	HIV-1 gp120 downregulates expression of c-Myc, Max, and 14-3-3epsilon proteins, and decreases phosphorylation of ATP-dependent tyrosine kinases (Akt) at Ser-473 in human mesangial cells (HMC)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	207	NP_005154.2	RAC-alpha serine/threonine-protein kinase	15689238	2007-11-07 17:30	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	207	NP_005154.2	RAC-alpha serine/threonine-protein kinase	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	207	NP_005154.2	RAC-alpha serine/threonine-protein kinase	16841089	2007-11-07 17:31	HIV-1 gp120 induced cell death is inhibited by a CCR5-mediated neuroprotective pathway that involves protein kinase Akt/PKB as an essential component and can be triggered by the CCR5 agonists MIP-1beta and RANTES
11676	155807	NP_057852.2	Vpr	inhibits	9606	208	NP_001617.1	RAC-beta serine/threonine-protein kinase	15616007	2007-11-07 17:28	HIV-1 Vpr inhibits Akt-induced cytoplasmic translocation of Foxo3a, a subtype of the forkhead transcription factors
11676	155871	NP_057853.1	Tat	activates	9606	208	NP_001617.1	RAC-beta serine/threonine-protein kinase	9394803,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates AKT kinase through activation of PI3 kinase, resulting in the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	activates	9606	208	NP_001617.1	RAC-beta serine/threonine-protein kinase	11156964	2007-11-07 17:28	HIV-1 Tat downregulates CREB transcription factor expression in PC12 neuronal cells through activation of a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway
11676	155871	NP_057853.1	Tat	upregulates	9606	208	NP_001617.1	RAC-beta serine/threonine-protein kinase	11994280	2007-11-07 17:28	HIV-1 Tat upregulates several anti-apoptotic genes, including AKT-1, AKT-2, BCL2, BCL-XL, and insulin-like growth factor I in vincristine-treated Kaposi's sarcoma cells
11676	155871	NP_057853.1	Tat	activates	9606	208	NP_001617.1	RAC-beta serine/threonine-protein kinase	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	208	NP_001617.1	RAC-beta serine/threonine-protein kinase	10869418	2007-11-07 17:31	Fractalkine (CX3CL1) protects hippocampal neurons from the neurotoxicity induced by the HIV-1 envelope protein gp120, and neuronal CX(3)CR1 receptors and Akt activation are responsible for the neuroprotective effects of fractalkine
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	decreases phosphorylation of	9606	208	NP_001617.1	RAC-beta serine/threonine-protein kinase	11208609	2007-11-07 17:30	HIV-1 gp120 downregulates expression of c-Myc, Max, and 14-3-3epsilon proteins, and decreases phosphorylation of ATP-dependent tyrosine kinases (Akt) at Ser-473 in human mesangial cells (HMC)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	208	NP_001617.1	RAC-beta serine/threonine-protein kinase	15689238	2007-11-07 17:30	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	208	NP_001617.1	RAC-beta serine/threonine-protein kinase	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	208	NP_001617.1	RAC-beta serine/threonine-protein kinase	16841089	2007-11-07 17:31	HIV-1 gp120 induced cell death is inhibited by a CCR5-mediated neuroprotective pathway that involves protein kinase Akt/PKB as an essential component and can be triggered by the CCR5 agonists MIP-1beta and RANTES
11676	155871	NP_057853.1	Tat	induces release of	9606	213	NP_000468.1	serum albumin preproprotein	10780709,11145723	2007-11-07 17:27	HIV-1 Tat induces a dose-dependent flux of albumin through endothelial cell monolayers, an effect involving Tat activation of the VEGF receptor type 2 and MAP kinase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	213	NP_000468.1	serum albumin preproprotein	1810199	2007-11-07 17:30	Inhibition of HIV-1 binding to CD4 by suramin is reversed by human albumin, suggesting that only free suramin has antiviral properties
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	213	NP_000468.1	serum albumin preproprotein	8605586,10086322,10580404,12007569	2007-11-07 17:30	The negatively charged succinylated and aconitylated albumins bind to the V3 loop (amino acids 296-330) and the C-terminal part of HIV-1 gp120 and do not interact directly with the HIV chemokine receptors CXCR4 and CCR5
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	213	NP_000468.1	serum albumin preproprotein	9168236	2007-11-07 17:27	The inhibition of HIV-1 gp120 binding to cells by succinylated human serum albumin is reversed by heparin
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibited by	9606	213	NP_000468.1	serum albumin preproprotein	7576927	2007-11-07 17:31	The lysis of erythrocytes induced by the amino-terminal peptide (residues 519-541) of HIV-1 gp41 is blocked by anti-(518-541) IgG, dextran sulfate, and anionic albumins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	213	NP_000468.1	serum albumin preproprotein	8312056	2007-11-07 17:31	N-terminal gp41 peptide binds as an alpha helix (residues 519-536) to fatty acid sites on human serum albumin (HSA)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	240	NP_000689.1	arachidonate 5-lipoxygenase	9639560,12354292	2007-11-07 17:30	HIV-1 gp120 increases the intracellular concentrations of prostaglandin E2 and leukotriene B4 by upregulating the activity and expression of the arachidonate-metabolizing enzymes prostaglandin H synthase and 5-lipoxygenase, respectively
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	248	NP_001622.1	intestinal alkaline phosphatase precursor	1321014	2007-11-07 17:30	Cells exposed in vitro to HIV-1 gp120 show a defect in inositol polyphosphate-mediated signal transduction resulting from the downregulation of inositol (1,3,4,5)P4 5-phosphomonoesterase (PME) by gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	249	NP_000469.3	alkaline phosphatase, tissue-nonspecific isozyme isoform 1 precursor	1321014	2007-11-07 17:30	Cells exposed in vitro to HIV-1 gp120 show a defect in inositol polyphosphate-mediated signal transduction resulting from the downregulation of inositol (1,3,4,5)P4 5-phosphomonoesterase (PME) by gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	250	NP_001623.3	alkaline phosphatase, placental type preproprotein	1321014	2007-11-07 17:30	Cells exposed in vitro to HIV-1 gp120 show a defect in inositol polyphosphate-mediated signal transduction resulting from the downregulation of inositol (1,3,4,5)P4 5-phosphomonoesterase (PME) by gp120
11676	155908	NP_057854.1	Rev	requires	9606	262	NP_001625.2	S-adenosylmethionine decarboxylase proenzyme isoform 1 precursor	16941339	2007-11-07 17:31	Inhibition of S-adenosylmethionine decarboxylase, a key enzyme in polyamine biosynthesis, compromises hypusine modification and activation of eukaryotic initiation factor 5A (eIF-5A), a cellular cofactor of HIV-1 Rev, and inhibits Rev function
11676	155807	NP_057852.2	Vpr	binds	9606	291	NP_001142.2	ADP/ATP translocase 1	10620603,11181702,11193032,12750393,12750404,15142377,15638722,15725353,15817944,15832179,16120388,16354571,16429131	2007-11-07 17:27	HIV-1 Vpr (amino acids 71-96) induces mitochondrial membrane permeabilization and apoptosis via a specific binding interaction with the adenine nucleotide translocator (amino acids 104-116)
11676	155807	NP_057852.2	Vpr	binds	9606	291	NP_001142.2	ADP/ATP translocase 1	10620603,11175251,11181702,11193032,16354571,16492162,16511342	2007-11-07 17:27	Interaction of HIV-1 Vpr with human adenine nucleotide translocator (ANT) is presumed based on a specific binding interaction between Vpr and rat ANT
11676	155807	NP_057852.2	Vpr	binds	9606	291	NP_001142.2	ADP/ATP translocase 1	16492162	2007-11-07 17:31	HIV-1 Vpr peptides 27-51 and 71-82 bind to adenine nucleotide translocator (ANT) in a region encompassing the first ANT intermembrane space loop and part of its second and third transmembrane helices
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	302	NP_001002858.1	annexin A2 isoform 1	16501079,16940516	2007-11-07 17:31	Annexin 2 (Anx2) interacts with HIV-1 Gag by coimmunoprecipitation in transfected cells and in a cell-free system; Anx2 co-localizes with Gag and CD63 in intracellular vesicles of HIV-1 infected macrophages
11676	155030	NP_057850.1	Pr55(Gag)	interacts with	9606	302	NP_001002858.1	annexin A2 isoform 1	16501079	2007-11-07 17:31	Anx2 depletion by siRNA is associated with decreased infectivity of HIV-1 and aberrant HIV-1 Gag processing, indicating an interaction of Anx2 with Gag
11676	155871	NP_057853.1	Tat	downregulates	9606	302	NP_004030.1	annexin A2 isoform 2	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	317	NP_037361.1	apoptotic protease-activating factor 1 isoform a	15103018	2007-11-07 17:30	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155807	NP_057852.2	Vpr	downregulates	9606	329	NP_001157.1	baculoviral IAP repeat-containing protein 2	17158886	2007-11-07 17:31	HIV-1 Vpr-(52-96)-induced apoptosis is mediated through downregulation of Bcl2 and c-IAP1 genes
11676	155871	NP_057853.1	Tat	upregulates	9606	330	NP_001156.1	baculoviral IAP repeat-containing protein 3	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the expression of many proteins, including MIHC, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155807	NP_057852.2	Vpr	upregulates	9606	332	NP_001159.2	baculoviral IAP repeat-containing protein 5 isoform 1	12510154	2007-11-07 17:28	HIV-1 Vpr upregulates survivin expression by transactivating the survivin promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	competes with	9606	335	NP_000030.1	apolipoprotein A-I preproprotein	12608057	2007-11-07 17:30	Apolipoprotein A-1 competes with CD4 receptor binding to HIV-1 gp120 in human lymphocytes
11676	156110	NP_057857.2	Nef	inhibits	9606	335	NP_000030.1	apolipoprotein A-I preproprotein	17076584	2007-11-07 17:31	HIV-1 Nef impairs cholesterol efflux from macrophages and inhibits internalization of apolipoprotein A1 from the plasma membrane
11676	155871	NP_057853.1	Tat	inhibits	9606	348	NP_000032.1	apolipoprotein E precursor	11100124,16697650	2007-11-07 17:30	Binding of HIV-1 Tat to LRP inhibits neuronal binding, uptake and degradation of physiological ligands for LRP, including alpha2-macroglobulin, apolipoprotein E4, amyloid precursor and amyloid beta-protein
11676	155871	NP_057853.1	Tat	inhibited by	9606	348	NP_000032.1	apolipoprotein E precursor	15264223	2007-11-07 17:28	The antioxidant properties of human lipidated apoE3 protects neurons from Tat-induced toxicity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	348	NP_000032.1	apolipoprotein E precursor	16697650	2007-11-07 17:31	HIV-1 gp120 causes increased neurotoxicity in human neuronal cultures with the ApoE4 allele
11676	155030	NP_057850.1	Pr55(Gag)	binds	9606	350	NP_000033.1	apolipoprotein H precursor	8989432	2007-11-07 17:29	Binding of apolipoprotein H to HIV-1 Gag protein p18 as well as to the Gag p55 polyprotein has been demonstrated in vitro
11676	155348	NP_705926.1	retropepsin	cleaves	9606	351	NP_000475.1	amyloid beta A4 protein isoform a precursor	1907279	2007-11-07 17:29	HIV-1 protease cleaves amyloid protein precursor at amino acid sites 200-201, 229-230, and 535-536
11676	155871	NP_057853.1	Tat	inhibits	9606	351	NP_000475.1	amyloid beta A4 protein isoform a precursor	11100124	2007-11-07 17:30	Binding of HIV-1 Tat to LRP inhibits neuronal binding, uptake and degradation of physiological ligands for LRP, including alpha2-macroglobulin, apolipoprotein E4, amyloid precursor and amyloid beta-protein
11676	155871	NP_057853.1	Tat	upregulates	9606	351	NP_000475.1	amyloid beta A4 protein isoform a precursor	15668537,15668546	2007-11-07 17:28	HIV-1 Tat treatment results in a 125% increase in soluble amyloid beta (Abeta) in brain cultures
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	351	NP_000475.1	amyloid beta A4 protein isoform a precursor	7699335,8624131	2007-11-07 17:30	Transgenic (tg) mice overexpressing both human amyloid precursor proteins and HIV-1 gp120 at moderate levels show significantly less neuronal loss, synapto-dendritic degeneration, and gliosis than singly tg mice expressing gp120 alone
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	downregulates	9606	351	NP_000475.1	amyloid beta A4 protein isoform a precursor	10527458	2007-11-07 17:31	A putative immunosuppressive domain (amino acids 583-599) of HIV-1 gp41 downregulates the interleukin 1beta- (IL-1beta) induced elevation of the secreted form of APP (sAPP alpha)
11676	155871	NP_057853.1	Tat	upregulates	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	7539892,9971775,10671224,11909874,15843521	2007-11-07 17:27	HIV-1 Tat sensitizes T cells to CD95 mediated apoptosis through the upregulation of CD95 ligand and caspase 8
11676	155871	NP_057853.1	Tat	upregulates	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	9223324,9268734	2007-11-07 17:27	HIV-1 Tat activates B and T cells and upregulates expression of Fas (CD95) in these cells
11676	155945	NP_057855.1	Vpu	interacts with	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	9847311	2007-11-07 17:27	Increased susceptibility of HIV-infected cells to Fas killing has been mapped to the HIV-1 vpu gene
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	8780394,10625668	2007-11-07 17:30	The calmodulin-binding domains in HIV-1 gp160 are involved in Fas-mediated apoptosis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	8976184,9002959,9226175,9247148,9475352	2007-11-07 17:30	Antibodies reactive to a domain within the V3 region of HIV-1 gp120 are effective cross-linkers of Fas and increase apoptosis in peripheral T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	9002959,9226175,9247148,10799864,15936090	2007-11-07 17:31	Apoptosis induced by HIV-1 gp120/CD4 cross-linking in Th1 clones is inhibited by anti-CD95 or anti-CD95L neutralizing monoclonal antibodies, as well as by a specific interleukin-1 beta converting enzyme (ICE) inhibitor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	9226175,10072505	2007-11-07 17:31	Binding of HIV-1 gp120 to CD4 downregulates Bcl-2 protein in CD4+ T lymphocytes and facilitates Fas/Fas-ligand triggered apoptosis; addition of IL-2 rescues CD4+ T cells from CD4/gp120-induced Bcl-2 downmodulation and apoptosis induction
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	9263011,10505674	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	9475352,15818415,15972662	2007-11-07 17:28	Preincubation of T cells with HIV-1 gp120 accelerates the apoptosis observed during CD2-pathway stimulation of the T cells; this process is mediated by Fas/Fas ligand interaction and related to an increased induction of Fas ligand mRNA by gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	11208609	2007-11-07 17:30	At high concentrations, HIV-1 gp120 enhances expression of Fas and FasL and promotes apoptosis in human mesangial cells (HMC)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	14739941	2007-11-07 17:30	HIV-1 gp120-mediated CD4 engagement is involved in the induction of susceptibility of primary human T lymphocytes to CD95-mediated apoptosis through ezrin phosphorylation and ezrin-to-CD95 association
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	relocalizes	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	15972662	2007-11-07 17:30	CXCR4-tropic and CXCR4/CCR5 dual-tropic HIV-1 gp120 induce the relocalization of cytoplasmic CD95 to the cellular plasma membrane and a 23% increase in CD95-mediated apoptosis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	156110	NP_057857.2	Nef	upregulates	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	9920849	2007-11-07 17:27	HIV-1 Nef sensitizes CD4+ T lymphoid cells to apoptosis by upregulating the expression of both Fas and Fas ligand, an effect that requires the PxxP motif (amino acids 72-75) in the core region of Nef
11676	156110	NP_057857.2	Nef	inhibits	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	11177389,11298454,11323689	2007-11-07 17:27	HIV-1 Nef inhibits Fas-mediated apoptosis by binding to and inactivating the catalytic activity of ASK1, as well as through the downregulation of caspase-3 and caspase-8
11676	156110	NP_057857.2	Nef	inhibits	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	11298454	2007-11-07 17:27	Amino acid 106 of HIV-1 Nef is important for the inhibition of Fas-mediated apoptosis resulting from the interaction of Nef with ASK1
11676	156110	NP_057857.2	Nef	upregulates	9606	355	NP_000034.1	tumor necrosis factor receptor superfamily member 6 isoform 1 precursor	15858021	2007-11-07 17:28	In a murine model of AIDS, CD4C/HIV transgenic (Tg) mice expressing HIV-1 Nef, it has been shown that Nef upregulates expression of Fas and FasL in CD4+ and CD8+ cells from the Tg mouse
11676	155871	NP_057853.1	Tat	upregulates	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	7539892,9971775,10671224,11909874,15843521,16155003	2007-11-07 17:27	HIV-1 Tat sensitizes T cells to CD95 mediated apoptosis through the upregulation of CD95 ligand and caspase 8
11676	155871	NP_057853.1	Tat	upregulates	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	10671224,11909874	2007-11-07 17:27	HIV-1 Tat upregulates FasL expression by enhancing Egr-dependent and NF-kappaB mediated transactivation of the FasL promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	17118988	2007-11-07 17:31	HIV-1 Tat has a synergistic effect on Cryptosporidium parvum-induced cholangiocyte apoptosis via a paracrine-mediated, FasL-dependent mechanism
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	9002959,9226175,9247148,10799864,15936090	2007-11-07 17:27	Apoptosis induced by HIV-1 gp120/CD4 cross-linking in Th1 clones is inhibited by anti-CD95 or anti-CD95L neutralizing monoclonal antibodies, as well as by a specific interleukin-1 beta converting enzyme (ICE) inhibitor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	9226175,10072505	2007-11-07 17:31	Binding of HIV-1 gp120 to CD4 downregulates Bcl-2 protein in CD4+ T lymphocytes and facilitates Fas/Fas-ligand triggered apoptosis; addition of IL-2 rescues CD4+ T cells from CD4/gp120-induced Bcl-2 downmodulation and apoptosis induction
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	9475352,10799864	2007-11-07 17:28	Preincubation of T cells with HIV-1 gp120 accelerates the apoptosis observed during CD2-pathway stimulation of the T cells; this process is mediated by Fas/Fas ligand interaction and related to an increased induction of Fas ligand mRNA by gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	9672636,9801169,15936090	2007-11-07 17:27	Depletion of CD4 and CD8 T cells by HIV-1 gp120 is mediated by Fas ligand
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	11208609	2007-11-07 17:30	At high concentrations, HIV-1 gp120 enhances expression of Fas and FasL and promotes apoptosis in human mesangial cells (HMC)
11676	156110	NP_057857.2	Nef	upregulates	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	9920849,10224289,15078178	2007-11-07 17:27	HIV-1 Nef sensitizes CD4+ T lymphoid cells to apoptosis by upregulating the expression of both Fas and Fas ligand, an effect that requires the PxxP motif (amino acids 72-75) in the core region of Nef
11676	156110	NP_057857.2	Nef	upregulates	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	10224289	2007-11-07 17:27	Upregulation of Fas ligand by HIV-1 Nef is mediated through a direct interaction of Nef with the T cell Receptor zeta chain and binding of Nef to the Nef-associated kinase (NAK/p62)
11676	156110	NP_057857.2	Nef	upregulates	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	12884192	2007-11-07 17:27	HIV-1 Nef upregulates Fas ligand expression in gene-transfected hepatic cells from rat liver allografts
11676	156110	NP_057857.2	Nef	upregulates	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	15858021	2007-11-07 17:28	Increased expression of Fas ligand was observed in CD4(+) and CD8(+) T cells from Transgenic (Tg) mice expressing HIV-1 Nef compared to that of non-Tg mice
11676	156110	NP_057857.2	Nef	upregulates	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	15928037	2007-11-07 17:28	Experiments using a dominant-negative isoform of p38 MAPK, p38 siRNA, and inhibitors of p38 activation indicate that p38 is required for HIV-1 Nef-induced Fas ligand upregulation
11676	156110	NP_057857.2	Nef	upregulates	9606	356	NP_000630.1	tumor necrosis factor ligand superfamily member 6	15928037	2007-11-07 17:28	The PxxP domain of HIV-1 Nef is required for upregulation of Fas ligand transcription and p38 MAPK activation by Nef
11676	156110	NP_057857.2	Nef	binds	9606	375	NP_001649.1	ADP-ribosylation factor 1	15202998	2007-11-07 17:28	Nef binds GTPase ARF1 directly via residues E154 and E155 and recruits the GTPase to endosomal membranes
11676	155030	NP_057850.1	Pr55(Gag)	inhibited by	9606	382	NP_001654.1	ADP-ribosylation factor 6	15465916	2007-11-07 17:29	Overexpression of an active form of Arf6 (Arf6/Q67L), which induces the formation of PI(4,5)P2-enriched endosomal structures, severely reduces HIV-1 Gag virus production by redirecting Gag to PI(4,5)P2-enriched vesicles
11676	156110	NP_057857.2	Nef	regulated by	9606	382	NP_001654.1	ADP-ribosylation factor 6	12526811,14617802	2007-11-07 17:28	HIV-1 Nef-mediated downregulation of MHC-I has been reported to be regulated by ARF6, however a separate report indicates the apparent Arf6 dependency of Nef-mediated MHC class I down-modulation is due to nonspecific perturbations in membrane traffic
11676	156110	NP_057857.2	Nef	activates	9606	382	NP_001654.1	ADP-ribosylation factor 6	12526811,15638726	2007-11-07 17:27	The interaction of HIV-1 Nef and phosphatidylinositol-3-kinase (PI3K) activates the expression of ADP-ribosylation factor 6 (ARF6) in human melanoma cells
11676	155807	NP_057852.2	Vpr	upregulates	9606	387	NP_001655.1	transforming protein RhoA precursor	10713718	2007-11-07 17:27	HIV-1 Vpr-expressing Jurkat T cell clones showed a significant upregulation of RhoA expression
11676	155871	NP_057853.1	Tat	activates	9606	387	NP_001655.1	transforming protein RhoA precursor	16105876	2007-11-07 17:29	HIV-1 Tat exerts several pleiotropic effects by interacting with different cellular receptors, including integrin alpha(v)beta3, which triggers the activation of focal adhesion kinase, RhoA and pp60src
11676	155807	NP_057852.2	Vpr	upregulates	9606	388	NP_004031.1	rho-related GTP-binding protein RhoB precursor	10713718	2007-11-07 17:27	HIV-1 Vpr-expressing Jurkat T cell clones showed a significant upregulation of RhoB expression
11676	155807	NP_057852.2	Vpr	upregulates	9606	391	NP_001656.2	rho-related GTP-binding protein RhoG precursor	10713718	2007-11-07 17:27	HIV-1 Vpr-expressing Jurkat T cell clones showed a significant upregulation of RhoG expression
11676	155807	NP_057852.2	Vpr	upregulates	9606	396	NP_004300.1	rho GDP-dissociation inhibitor 1 isoform a	10713718	2007-11-07 17:27	HIV-1 Vpr-expressing Jurkat T cell clones showed a significant upregulation of Rho GDI expression
11676	155871	NP_057853.1	Tat	downregulates	9606	396	NP_004300.1	rho GDP-dissociation inhibitor 1 isoform a	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155807	NP_057852.2	Vpr	activates	9606	466	NP_005162.1	cyclic AMP-dependent transcription factor ATF-1	12444143	2007-11-07 17:27	HIV-1 Vpr activation of activating protein 1-regulated promoters is linked to Vpr regulation of IL-12, CD44, Toll-like receptor 4, indolamine 2,3-dioxygenase, macrophage receptor with collagenous structure, and thrombospondin 1
11676	155807	NP_057852.2	Vpr	activates	9606	466	NP_005162.1	cyclic AMP-dependent transcription factor ATF-1	12444143	2007-11-07 17:27	HIV-1 Vpr potentiates the trans-activation, but not the trans-repression, properties of the glucocorticoid receptor on activating protein 1-regulated simple promoters
11676	156110	NP_057857.2	Nef	upregulates	9606	467	NP_001665.1	cyclic AMP-dependent transcription factor ATF-3 isoform 1	11810028	2007-11-07 17:28	Expression of activating transcription factor 3 (ATF-3) is upregulated by HIV-1 Nef in HeLa cells
11676	155945	NP_057855.1	Vpu	stabilizes	9606	468	NP_001666.2	cyclic AMP-dependent transcription factor ATF-4	14561767	2007-11-07 17:29	HIV-1 Vpu is a strong competitive inhibitor of beta-TrCP and impairs the degradation of SCF-beta-TrCP substrates such as IKBalpha, ATF4 and beta-catenin
11676	155348	NP_705928.1	integrase	interacts with	9606	472	NP_000042.3	serine-protein kinase ATM isoform 1	11158303	2007-11-07 17:29	ATM is proposed to play a role in the prevention of HIV-1 Integrase mediated cell killing
11676	155807	NP_057852.2	Vpr	activates	9606	472	NP_000042.3	serine-protein kinase ATM isoform 1	16983346	2007-11-07 17:31	HIV-1 Vpr activates ATM, a DNA double-strand break kinase that is required for cell response to DNA damage and for genome stability
11676	155908	NP_057854.1	Rev	stimulated by	9606	472	NP_000042.3	serine-protein kinase ATM isoform 1	16474151	2007-11-07 17:29	Ataxia-telangiectasia-mutated (ATM) kinase enhances HIV-1 replication by stimulating the action of the HIV-1 Rev viral posttranscriptional regulator
11676	155348	NP_705928.1	integrase	interacts with	9606	545	NP_001175.1	ataxia telangiectasia and Rad3 related protein	12679521	2007-11-07 17:29	ATR kinase is hypothesized to be required for successful completion of the HIV-1 viral DNA integration process, suggesting a functional interaction with HIV-1 Integrase
11676	155807	NP_057852.2	Vpr	activates	9606	545	NP_001175.1	ataxia telangiectasia and Rad3 related protein	12738771,15485898,15650754,16306615,16354571,16956949,17140287	2007-11-07 17:30	HIV-1 Vpr activates ATR, resulting in phosphorylation of Chk1 and activation of the ATR-mediated DNA damage response
11676	155807	NP_057852.2	Vpr	interacts with	9606	545	NP_001175.1	ataxia telangiectasia and Rad3 related protein	15650754	2007-11-07 17:28	HIV-1 Vpr induces phosphorylation of BRCA1 at serine 1423 in an ATR-dependent manner
11676	155807	NP_057852.2	Vpr	interacts with	9606	545	NP_001175.1	ataxia telangiectasia and Rad3 related protein	16956949	2007-11-07 17:31	HIV-1 Vpr induces phosphorylation of replication protein A (RPA32) at serine 4 and 8 in an ATR-dependent manner
11676	155807	NP_057852.2	Vpr	activates	9606	545	NP_001175.1	ataxia telangiectasia and Rad3 related protein	17140287	2007-11-07 17:31	HIV-1 Vpr-induced apoptosis is mediated via Bax, downstream of ATR activation
11676	155871	NP_057853.1	Tat	downregulates	9606	567	NP_004039.1	beta-2-microglobulin precursor	9751712,10199391	2007-11-07 17:28	HIV-1 Tat represses transcription of the beta 2-microglobulin (B2M) promoter, thereby downregulating B2M expression, suggesting a mechanism by which HIV-1 could prevent cell surface expression of the MHC class I complex and avoid immune detection
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	572	NP_004313.1	bcl2 antagonist of cell death	11994280	2007-11-07 17:28	HIV-1 Tat enhances phosphorylation of BAD in vincristine-treated Kaposi's sarcoma cells, an effect that contributes to the anti-apoptotic effect of Tat in these cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	decreases phosphorylation of	9606	572	NP_004313.1	bcl2 antagonist of cell death	11739707	2007-11-07 17:30	Treatment of CD4+ cells with HIV-1 gp160 causes intracellular calcium increase followed by the release of cytochrome c from mitochondria; association of BAD with Bcl-xL is observed, and a portion of BAD is dephosphorylated after gp160 induction
11676	156110	NP_057857.2	Nef	induces phosphorylation of	9606	572	NP_004313.1	bcl2 antagonist of cell death	11689886,15078178,16445909	2007-11-07 17:28	HIV-1 Nef-associated p21-activated kinase (PAK), which is activated by Nef, phosphorylates BCL2-antagonist of cell death (BAD) leading to induction of anti-apoptotic signals
11676	155871	NP_057853.1	Tat	upregulates	9606	573	NP_004314.4	BCL2-associated athanogene isoform 1L	11994280	2007-11-07 17:28	HIV-1 Tat upregulates the expression of BAG-1 in Kaposi's sarcoma cells
11676	155807	NP_057852.2	Vpr	downregulates	9606	581	NP_004315.1	apoptosis regulator BAX isoform beta	9449720	2007-11-07 17:27	Constitutive expression of HIV-1 Vpr in Jurkat cells resulted in downregulation of Bax, suggesting Vpr is a negative regulator of apoptosis
11676	155807	NP_057852.2	Vpr	enhanced by	9606	581	NP_004315.1	apoptosis regulator BAX isoform beta	10620603,11175251	2007-11-07 17:27	HIV-1 Vpr induction of mitochondrial membrane permeabilization through binding to adenine nucleotide translocator (ANT) is enhanced by Bax
11676	155807	NP_057852.2	Vpr	upregulates	9606	581	NP_004315.1	apoptosis regulator BAX isoform beta	11437653,17140287	2007-11-07 17:27	Mice transgenic for the HIV-1 vpr gene have enhanced apoptotic death of T lymphocytes with up-regulation of Bax suggesting the involvement of Bax in the apoptotic processes
11676	155807	NP_057852.2	Vpr	mediated by	9606	581	NP_004315.1	apoptosis regulator BAX isoform beta	17140287	2007-11-07 17:31	HIV-1 Vpr-induced apoptosis is mediated via Bax, downstream of ATR activation
11676	155871	NP_057853.1	Tat	upregulates	9606	581	NP_004315.1	apoptosis regulator BAX isoform beta	8760290,15555592	2007-11-07 17:30	Expression of HIV-1 Tat in hematopoietic cells results in downregulation of Bcl-2 and upregulation of Bax, resulting in the induction of apoptosis
11676	155871	NP_057853.1	Tat	upregulates	9606	581	NP_004315.1	apoptosis regulator BAX isoform beta	11994280	2007-11-07 17:28	HIV-1 Tat upregulates the expression of BAX in Kaposi's sarcoma cells
11676	155871	NP_057853.1	Tat	interacts with	9606	581	NP_004315.1	apoptosis regulator BAX isoform beta	16235026	2007-11-07 17:29	Tumor protein p73 interferes with Tat-mediated apoptosis by preventing the up-regulation of Bax and down-regulation of Bcl-2 proteins in astrocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	581	NP_620116.1	apoptosis regulator BAX isoform alpha	10942389,11602639,15033690	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	581	NP_620116.1	apoptosis regulator BAX isoform alpha	11602639,15033690	2007-11-07 17:31	Syncytial apoptosis mediated by the fusion of cells expressing HIV-1 gp120 with cells expressing the CD4/CXCR4 receptor/coreceptor complex causes phosphorylation of p53 on serine 15 and Bax upregulation
11676	155871	NP_057853.1	Tat	downregulates	9606	595	NP_444284.1	G1/S-specific cyclin-D1	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat downregulates the expression of many proteins, including Cyclin PRAD1, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	595	NP_444284.1	G1/S-specific cyclin-D1	16436505	2007-11-07 17:29	Treatment of human endothelial cells with HIV-1 Tat significantly upregulates Cyclin D1
11676	156110	NP_057857.2	Nef	upregulates	9606	595	NP_444284.1	G1/S-specific cyclin-D1	12241561	2007-11-07 17:28	HIV-1 Nef is implicated in the upregulation of Cyclin D1 in infected podocytes and may be involved in the pathogenesis of HIV-associated nephropathy
11676	155348	NP_705926.1	retropepsin	downregulates	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	8790371,9561195	2007-11-07 17:29	HIV-1 protease depletes infected cells of bcl-2, leading to oxidative stress-dependent activation of NF kappa B, a cellular factor required for HIV transcription, and ultimately to cell death
11676	155348	NP_705926.1	retropepsin	cleaves	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	8790371	2007-11-07 17:29	Purified bcl-2 is cleaved by HIV-1 protease between phenylalanine 112 and alanine 113
11676	155807	NP_057852.2	Vpr	upregulates	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	9449720,11437653,15353294,15832179	2007-11-07 17:28	Constitutive expression of HIV-1 Vpr in Jurkat cells or transgenic mice resulted in upregulation of Bcl-2, providing evidence for the role of Vpr in the regulation of apoptosis during HIV-1 replication
11676	155807	NP_057852.2	Vpr	inhibited by	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	10620603,11175251,11181702,12095993,12096338,12404120,15832179,16120388	2007-11-07 17:27	Bcl-2 inhibits or reduces HIV-1 Vpr mediated cytotoxicity, induction of mitochondrial membrane permeabilization and apoptosis
11676	155807	NP_057852.2	Vpr	downregulates	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	17158886	2007-11-07 17:31	HIV-1 Vpr-(52-96)-induced apoptosis is mediated through downregulation of Bcl2 and c-IAP1 genes
11676	155871	NP_057853.1	Tat	upregulates	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	7579350,8402618,9031086,10329560,11914580,11994280,12167335	2007-11-07 17:30	HIV-1 Tat upregulates Bcl-2 expression in a variety of cell types (PBMC, MDM, Jurkat, HeLa, etc.), an effect that is linked to the ability of Tat to inhibit apoptosis
11676	155871	NP_057853.1	Tat	downregulates	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	8760290,15179054	2007-11-07 17:30	Expression of HIV-1 Tat in hematopoietic cells results in downregulation of Bcl-2 and induction of apoptosis
11676	155871	NP_057853.1	Tat	downregulates	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	15093750	2007-11-07 17:28	Tat-expressing EBV-positive B cells show downregulation of Bcl-2, and in serum starvation conditions display the Retinoblastoma (Rb) hyper-phosphorylated form, progress throughout the cell cycle, and retain the ability to grow in small clumps
11676	155871	NP_057853.1	Tat	interacts with	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	16181427	2007-11-07 17:29	A fusion protein between HIV-1 Tat and a Bcl-2 construct with the loop domain deleted (TAT-Bcl-2Deltaloop) binds to neural cell and rat brain mitochondria to increase the survival of cortical neurons
11676	155871	NP_057853.1	Tat	interacts with	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	16235026	2007-11-07 17:29	Tumor protein p73 interferes with Tat-mediated apoptosis by preventing the up-regulation of Bax and down-regulation of Bcl-2 proteins in astrocytes
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	downregulates	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	9226228	2007-11-07 17:31	HIV-1 gp160-induced apoptosis is affected in part by the release of TNF-alpha and is associated with attenuated Bcl-2 mRNA expression
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	9226175,10072505	2007-11-07 17:27	Binding of HIV-1 gp120 to CD4 downregulates Bcl-2 protein in CD4+ T lymphocytes and facilitates Fas/Fas-ligand triggered apoptosis; addition of IL-2 rescues CD4+ T cells from CD4/gp120-induced Bcl-2 downmodulation and apoptosis induction
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	10072505	2007-11-07 17:31	Binding of HIV-1 envelope protein gp120 to CD4 downregulates Bcl-2 expression; this effect is inhibited by gp17/GCDFP-15, which blocks the ability of CD4 to interact with gp120, leading to moderate up-regulation of Bcl-2
11676	156110	NP_057857.2	Nef	downregulates	9606	596	NP_000624.2	apoptosis regulator Bcl-2 alpha isoform	11123279	2007-11-07 17:28	HIV-1 Nef enhances apoptosis in CD4+ human lymphoblastoid cell lines through mechanisms that include the downregulation of the anti-apoptotic proteins Bcl-2 and Bcl-XL
11676	155945	NP_057855.1	Vpu	downregulates	9606	597	NP_004040.1	bcl-2-related protein A1 isoform 1	11696595	2007-11-07 17:27	Levels of A1/Bfl-1 are reduced in T cells as a result of HIV-1 Vpu-mediated inhibition of NF-kappa B activation
11676	155807	NP_057852.2	Vpr	relocalizes	9606	598	NP_612815.1	bcl-2-like protein 1 isoform 1	10713718	2007-11-07 17:27	Expression of HIV-1 Vpr causes redistribution of Bcl-X protein into an organized, network-like manner to form filamentous structures
11676	155807	NP_057852.2	Vpr	downregulates	9606	598	NP_612815.1	bcl-2-like protein 1 isoform 1	11437653	2007-11-07 17:27	HIV-1 Vpr downregulated Bcl-X expression in transgenic mice suggesting a role in Vpr mediated apoptosis of T lymphocytes
11676	155871	NP_057853.1	Tat	upregulates	9606	598	NP_612815.1	bcl-2-like protein 1 isoform 1	11994280	2007-11-07 17:28	HIV-1 Tat upregulates several anti-apoptotic genes, including AKT-1, AKT-2, BCL2, BCL-XL, and insulin-like growth factor I in vincristine-treated Kaposi's sarcoma cells
11676	155945	NP_057855.1	Vpu	downregulates	9606	598	NP_612815.1	bcl-2-like protein 1 isoform 1	11696595	2007-11-07 17:27	Levels of Bcl-xL are reduced in T cells as a result of HIV-1 Vpu-mediated inhibition of NF-kappa B activation
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	598	NP_612815.1	bcl-2-like protein 1 isoform 1	11739707	2007-11-07 17:30	Treatment of CD4+ cells with HIV-1 gp160 causes intracellular calcium increase followed by the release of cytochrome c from mitochondria; association of BAD with Bcl-xL is observed, and a portion of BAD is dephosphorylated after gp160 induction
11676	156110	NP_057857.2	Nef	downregulates	9606	598	NP_612815.1	bcl-2-like protein 1 isoform 1	11123279	2007-11-07 17:28	HIV-1 Nef enhances apoptosis in CD4+ human lymphoblastoid cell lines through mechanisms that include the downregulation of the anti-apoptotic proteins Bcl-2 and Bcl-XL
11676	156110	NP_057857.2	Nef	upregulates	9606	598	NP_612815.1	bcl-2-like protein 1 isoform 1	15459189	2007-11-07 17:28	HIV-1 Nef suppresses apoptosis of TF-1 macrophages by upregulating mitochondrial anti-apoptosis protein Bcl-XL expression; cell survival and Bcl-XL induction by Nef are dependent on the Erk/MAPK pathway, but independent of PI3K and Akt activation
11676	155871	NP_057853.1	Tat	upregulates	9606	604	NP_001697.2	B-cell lymphoma 6 protein isoform 1	11994280	2007-11-07 17:28	HIV-1 Tat upregulates the expression of BCL-6 in Kaposi's sarcoma cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	627	NP_001700.2	brain-derived neurotrophic factor isoform a preproprotein	9878821	2007-11-07 17:31	Co-exposure of human fetal neurons to brain-derived neurotrophic factor (BDNF) and HIV-1 gp120 leads to a dose-dependent increase in BDNF-induced somatostatin (SRIF) production
11676	155348	NP_705926.1	retropepsin	induces cleavage of	9606	637	NP_932070.1	BH3-interacting domain death agonist isoform 1	12404116	2007-11-07 17:29	HIV-1 protease directly cleaves and activates procaspase 8 in T cells which is associated with cleavage of BID, mitochondrial release of cytochrome c, activation of the downstream caspases 9 and 3, and cleavage of DFF and PARP
11676	155871	NP_057853.1	Tat	upregulates	9606	649	NP_001190.1	bone morphogenetic protein 1 isoform 1 precursor	15857508	2007-11-07 17:29	BMP-1 is upregulated in human epithelial cells by HIV-1 Tat treatment
11676	155871	NP_057853.1	Tat	upregulates	9606	650	NP_001191.1	bone morphogenetic protein 2 preproprotein	15857508	2007-11-07 17:28	BMP-2 is upregulated by HIV-1 Tat treatment in human epithelial cells
11676	155871	NP_057853.1	Tat	downregulates	9606	659	NP_001195.2	bone morphogenetic protein receptor type-2 precursor	16282533	2007-11-07 17:29	HIV-1 Tat decreases the transcriptional levels of bone morphogenetic protein receptor-2 (BMPR2) in the macrophage cell line U937
11676	155871	NP_057853.1	Tat	downregulates	9606	659	NP_001195.2	bone morphogenetic protein receptor type-2 precursor	16615932	2007-11-07 17:31	HIV-1 Tat interaction with cyclin T1 is required for the repression of mannose receptor (MR) and bone morphogenetic protein receptor-2 (BMPR2) promoters
11676	155871	NP_057853.1	Tat	activates	9606	661	NP_001713.2	DNA-directed RNA polymerase III subunit RPC4	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155807	NP_057852.2	Vpr	relocalizes	9606	672	NP_009225.1	breast cancer type 1 susceptibility protein isoform 1	15485898,16983346	2007-11-07 17:28	HIV-1 Vpr expression in HeLa cells induces formation of nuclear foci containing H2AFX and BRCA1
11676	155807	NP_057852.2	Vpr	induces phosphorylation of	9606	672	NP_009225.1	breast cancer type 1 susceptibility protein isoform 1	15650754	2007-11-07 17:28	HIV-1 Vpr induces phosphorylation of BRCA1 at serine 1423 in an ATR-dependent manner
11676	155807	NP_057852.2	Vpr	stimulates	9606	672	NP_009225.1	breast cancer type 1 susceptibility protein isoform 1	16983346	2007-11-07 17:31	HIV-1 Vpr stimulates the focus formation of Rad51 and BRCA1, which are involved in repair of DNA double-strand breaks (DSBs) by homologous recombination (HR)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	regulated by	9606	682	NP_001719.2	basigin isoform 1 precursor	12925876	2007-11-07 17:30	The functional interaction between CD98 and CD147 is involved in the regulation of HIV-1 gp160-mediated cell fusion
11676	155871	NP_057853.1	Tat	enhanced by	9606	687	NP_001197.1	Krueppel-like factor 9	8257632	2007-11-07 17:30	BTEB enhances HIV-1 Tat transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	binds	9606	708	NP_001203.1	complement component 1 Q subcomponent-binding protein, mitochondrial precursor	7778269	2007-11-07 17:30	Using a yeast two-hybrid system, the splicing factor SF2-associated protein p32 has been shown to bind to the basic domain of HIV-1 Tat (amino acids 47-59), suggesting a role for p32 in mediating the biological activity of Tat during HIV-1 replication
11676	155871	NP_057853.1	Tat	binds	9606	708	NP_001203.1	complement component 1 Q subcomponent-binding protein, mitochondrial precursor	16537587	2007-11-07 17:31	Splicing factor SF2-associated protein p32 preferentially binds acetylated HIV-1 Tat and co-localizes with Tat in HIV-1 infected cells
11676	155908	NP_057854.1	Rev	binds	9606	708	NP_001203.1	complement component 1 Q subcomponent-binding protein, mitochondrial precursor	8189522,8626563	2007-11-07 17:29	p32 binds to the basic domain of HIV-1 Rev (amino acids 35-50)
11676	155908	NP_057854.1	Rev	inhibits	9606	708	NP_001203.1	complement component 1 Q subcomponent-binding protein, mitochondrial precursor	8626563,12833064	2007-11-07 17:29	Rev binding to p32 is associated with the function of Rev in inhibiting the splicing of HIV-1 mRNA by splicing factors ASF/SF2
11676	155908	NP_057854.1	Rev	binds	9606	708	NP_001203.1	complement component 1 Q subcomponent-binding protein, mitochondrial precursor	8626563	2007-11-07 17:29	Rev bridges the association of p32 with RRE RNA
11676	155908	NP_057854.1	Rev	binds	9606	708	NP_001203.1	complement component 1 Q subcomponent-binding protein, mitochondrial precursor	12833064	2007-11-07 17:30	Human p32 protein relieves a post-transcriptional block to HIV-1 replication in murine cells by restoring HIV-1 Rev function
11676	155348	NP_705926.1	retropepsin	cleaves	9606	710	NP_000053.2	plasma protease C1 inhibitor precursor	15325085	2007-11-07 17:29	HIV-1 protease directly cleaves complement component 1 inhibitor precursor between amino acid residues Leu-32 and Phe-33 in the N-terminal region of C1-inhibitor
11676	155871	NP_057853.1	Tat	upregulates	9606	710	NP_000053.2	plasma protease C1 inhibitor precursor	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the expression of many proteins, including Plasma protease (C1) inhibitor, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	712	NP_057075.1	complement C1q subcomponent subunit A precursor	1875953,9443108	2007-11-07 17:30	Fibronectin, which is present in submandibular saliva, binds to HIV-1 gp120/160 and enhances the interaction of C1q with gp120/160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	712	NP_057075.1	complement C1q subcomponent subunit A precursor	1875953,7507842,7642209,12396016	2007-11-07 17:30	Free C1q binds to HIV-1 gp120; digestion of the C1q stem portion with collagenase completely eliminates its binding to recombinant gp120, suggesting that the collagen-like stem region of C1q participates in the binding to gp120
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	712	NP_057075.1	complement C1q subcomponent subunit A precursor	1744579,9052718,9223728,9444979,9780209	2007-11-07 17:31	HIV-1 gp41 (amino acid residues 561-575, 591-605 and 601-620) binds to complement C1q and activates the C1 complex in a dose- and time-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	712	NP_057075.1	complement C1q subcomponent subunit A precursor	1744579,7507842,7739575,8245486,8252810,9052718,9223728,9444979,10504397,11318594,12396016	2007-11-07 17:27	Three sites (amino acids 526-538, 590-613 and 625-655) of the cell-external part of HIV-1 gp41 bind both HIV-1 gp120 and C1q
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	712	NP_057075.1	complement C1q subcomponent subunit A precursor	7739575	2007-11-07 17:31	The interaction between C1q and HIV-gp41 is dependent upon the presence of calcium; calcium can not be replaced by larger cations such as strontium, barium, lead or smaller ions such as magnesium and manganese
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	713	NP_000482.3	complement C1q subcomponent subunit B precursor	1875953,9443108	2007-11-07 17:30	Fibronectin, which is present in submandibular saliva, binds to HIV-1 gp120/160 and enhances the interaction of C1q with gp120/160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	713	NP_000482.3	complement C1q subcomponent subunit B precursor	1875953,7507842,7642209,12396016	2007-11-07 17:30	Free C1q binds to HIV-1 gp120; digestion of the C1q stem portion with collagenase completely eliminates its binding to recombinant gp120, suggesting that the collagen-like stem region of C1q participates in the binding to gp120
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	713	NP_000482.3	complement C1q subcomponent subunit B precursor	1744579,9780209	2007-11-07 17:31	HIV-1 gp41 (amino acid residues 561-575, 591-605 and 601-620) binds to complement C1q and activates the C1 complex in a dose- and time-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	713	NP_000482.3	complement C1q subcomponent subunit B precursor	1744579,7507842,7739575,8245486,8252810,10504397,11318594,12396016	2007-11-07 17:27	Three sites (amino acids 526-538, 590-613 and 625-655) of the cell-external part of HIV-1 gp41 bind both HIV-1 gp120 and C1q
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	713	NP_000482.3	complement C1q subcomponent subunit B precursor	7739575	2007-11-07 17:31	The interaction between C1q and HIV-gp41 is dependent upon the presence of calcium; calcium can not be replaced by larger cations such as strontium, barium, lead or smaller ions such as magnesium and manganese
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	714	NP_758957.2	complement C1q subcomponent subunit C precursor	1875953,9443108	2007-11-07 17:30	Fibronectin, which is present in submandibular saliva, binds to HIV-1 gp120/160 and enhances the interaction of C1q with gp120/160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	714	NP_758957.2	complement C1q subcomponent subunit C precursor	1875953,7507842,7590886,7642209,12396016	2007-11-07 17:30	Free C1q binds to HIV-1 gp120; digestion of the C1q stem portion with collagenase completely eliminates its binding to recombinant gp120, suggesting that the collagen-like stem region of C1q participates in the binding to gp120
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	714	NP_758957.2	complement C1q subcomponent subunit C precursor	1744579	2007-11-07 17:31	HIV-1 gp41 (amino acid residues 561-575, 591-605 and 601-620) binds to complement C1q and activates the C1 complex in a dose- and time-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	714	NP_758957.2	complement C1q subcomponent subunit C precursor	1744579,7507842,7739575,8245486,8252810,10504397,11318594,12396016	2007-11-07 17:27	Three sites (amino acids 526-538, 590-613 and 625-655) of the cell-external part of HIV-1 gp41 bind both HIV-1 gp120 and C1q
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	714	NP_758957.2	complement C1q subcomponent subunit C precursor	7739575	2007-11-07 17:31	The interaction between C1q and HIV-gp41 is dependent upon the presence of calcium; calcium can not be replaced by larger cations such as strontium, barium, lead or smaller ions such as magnesium and manganese
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulates	9606	718	NP_000055.2	complement C3 precursor	8471312,9544576	2007-11-07 17:30	Complement component 3 (C3) production is upregulated by HIV-1 gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	718	NP_000055.2	complement C3 precursor	7535292	2007-11-07 17:27	Inhibition of DAF or use of factor H depleted sera significantly increases C3 deposition on recombinant HIV-1 gp120 coated CD4 cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	718	NP_000055.2	complement C3 precursor	7590866,8630395	2007-11-07 17:27	Amino acid residues 100-129, 161-190, 231-250, 301-328, 410-449, and 470-499 of HIV-1 gp120 are involved in its binding to C3
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	718	NP_000055.2	complement C3 precursor	7590866,7642209,7893437,7911492	2007-11-07 17:27	Complement proteins C4, C3d, C5b-9, and properdin bind to HIV-1 gp120-coated CD4+ T cells of healthy individuals when incubated in autologous serum
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	718	NP_000055.2	complement C3 precursor	7893437	2007-11-07 17:31	Preincubation of HIV-1 gp41 with either factor H or properdin, and of HIV-1 gp120 with C3b or C4b affect the interaction between HIV-1 gp41 and gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaves	9606	718	NP_000055.2	complement C3 precursor	8471312	2007-11-07 17:31	Complexes of recombinant HIV-1 gp120 with anti-HIV-1 antibodies cleave C3 and present generated C3 fragments on the cell surface
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	718	NP_000055.2	complement C3 precursor	8630395	2007-11-07 17:31	A synthetic peptide covering positions 233-251 of the HIV-1 gp120 protein binds to complement proteins C3, C4, C5, C9, and properdin
11676	156110	NP_057857.2	Nef	upregulates	9606	718	NP_000055.2	complement C3 precursor	11884542	2007-11-07 17:28	HIV-1 induces the upregulation of complement factor C3 in astrocytes and neurons through signaling pathways that involve protein kinase C and adenylate cyclase activation, which is an effect that may contribute to the pathogenesis of AIDS in the brain
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	721	NP_001002029	complement C4-B preproprotein	7590866	2007-11-07 17:27	Amino acid residues 410-449 of HIV-1 gp120 are involved in its binding to C4b
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	721	NP_001002029	complement C4-B preproprotein	7642209,7893437,7911492	2007-11-07 17:27	Complement proteins C4, C3d, C5b-9, and properdin bind to HIV-1 gp120-coated CD4+ T cells of healthy individuals when incubated in autologous serum
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	721	NP_001002029	complement C4-B preproprotein	7893437	2007-11-07 17:31	Preincubation of HIV-1 gp41 with either factor H or properdin, and of HIV-1 gp120 with C3b or C4b affect the interaction between HIV-1 gp41 and gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	721	NP_001002029	complement C4-B preproprotein	8630395	2007-11-07 17:30	A synthetic peptide covering positions 233-251 of the HIV-1 gp120 protein binds to complement proteins C3, C4, C5, C9, and properdin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	727	NP_001726.2	complement C5 preproprotein	7911492	2007-11-07 17:27	Complement proteins C4, C3d, C5b-9, and properdin bind to HIV-1 gp120-coated CD4+ T cells of healthy individuals when incubated in autologous serum
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	727	NP_001726.2	complement C5 preproprotein	8630395	2007-11-07 17:30	A synthetic peptide covering positions 233-251 of the HIV-1 gp120 protein binds to complement proteins C3, C4, C5, C9, and properdin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	728	NP_001727.1	C5a anaphylatoxin chemotactic receptor	2541200	2007-11-07 17:29	Interaction of HIV-1 gp120 with CD4 is sufficient to trigger a marked reduction in C5a Receptor and a modest reduction in FMLP Receptor on monocytes
11676	156110	NP_057857.2	Nef	upregulates	9606	728	NP_001727.1	C5a anaphylatoxin chemotactic receptor	10597774	2007-11-07 17:28	Stable expression of HIV-1 Nef induces the upregulated expression of CD88 (complement receptor C5a)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	735	NP_001728.1	complement component C9 precursor	8630395	2007-11-07 17:30	A synthetic peptide covering positions 233-251 of the HIV-1 gp120 protein binds to complement proteins C3, C4, C5, C9, and properdin
11676	155030	NP_579876.2	matrix	binds	9606	801	NP_008819.1	calmodulin isoform 1	11054265	2007-11-07 17:28	Calmodulin binds to both HIV-1 Gag and Matrix proteins through an extended calmodulin-binding domain in Matrix (amino acids 11-46)
11676	155348	NP_705926.1	retropepsin	cleaves	9606	801	NP_008819.1	calmodulin isoform 1	1872871,2062825	2007-11-07 17:29	Calcium-depleted calmodulin can be cleaved at phe65-pro66 and met71-met72 by HIV-1 protease
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	801	NP_008819.1	calmodulin isoform 1	8226798,8573130,8780394,9362478,9658102,16229872	2007-11-07 17:29	The carboxyl-terminal domains (residues 768-788 and 826-854) of HIV-1 gp160 bind to calmodulin (CaM)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	801	NP_008819.1	calmodulin isoform 1	8780394,8862395,9658102,10625668,16229872	2007-11-07 17:30	The calmodulin-binding domains in HIV-1 gp160 are involved in Fas-mediated apoptosis
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	801	NP_008819.1	calmodulin isoform 1	8226798,8312049,11072229	2007-11-07 17:31	The carboxyl terminus (amino acid residues 768-788 and 828-855) of HIV-1 gp41 binds efficiently to purified calmodulin (CaM) and inhibits in vitro CaM-mediated stimulation of phosphodiesterase activity
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibited by	9606	801	NP_008819.1	calmodulin isoform 1	9282777	2007-11-07 17:31	The fusion between CD4+ human cells and cells stably expressing HIV-1 gp41 and gp120 is inhibited by calmodulin
11676	156110	NP_057857.2	Nef	interacts with	9606	801	NP_008819.1	calmodulin isoform 1	9096366	2007-11-07 17:28	HIV-1 Nef induces interleukin 10 expression through an interaction with the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway
11676	156110	NP_057857.2	Nef	interacts with	9606	801	NP_008819.1	calmodulin isoform 1	11847276	2007-11-07 17:28	Fluorescence spectroscopy analyses indicate the myristoylated N-terminal eight amino acids of HIV-1 Nef directly interact with calcium bound calmodulin
11676	156110	NP_057857.2	Nef	binds	9606	801	NP_008819.1	calmodulin isoform 1	15632291	2007-11-07 17:28	Interaction of HIV-1 Nef with calmodulin has been shown by coimmunoprecipitation analyses with lysates from NIH3T3 cells expressing Nef; a myristoylated 20 amino-acid peptide of Nef binds to calmodulin with higher affinity than the nonmyristoylated form
11676	156110	NP_057857.2	Nef	requires	9606	801	NP_008819.1	calmodulin isoform 1	17046994	2007-11-07 17:31	HIV-1 Nef-induced CCL-2/MCP-1 upregulation in astrocytes depends on the myristoylation moiety (residues 2-3) of Nef and requires functional calmodulin
11676	155030	NP_579876.2	matrix	binds	9606	805	NP_001734.1	calmodulin	11054265	2007-11-07 17:28	Calmodulin binds to both HIV-1 Gag and Matrix proteins through an extended calmodulin-binding domain in Matrix (amino acids 11-46)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	805	NP_001734.1	calmodulin	8226798,8573130,8780394,9362478,9658102,16229872	2007-11-07 17:29	The carboxyl-terminal domains (residues 768-788 and 826-854) of HIV-1 gp160 bind to calmodulin (CaM)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	805	NP_001734.1	calmodulin	8780394,8862395,9658102,10625668,16229872	2007-11-07 17:30	The calmodulin-binding domains in HIV-1 gp160 are involved in Fas-mediated apoptosis
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	805	NP_001734.1	calmodulin	8226798,8312049,11072229	2007-11-07 17:31	The carboxyl terminus (amino acid residues 768-788 and 828-855) of HIV-1 gp41 binds efficiently to purified calmodulin (CaM) and inhibits in vitro CaM-mediated stimulation of phosphodiesterase activity
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibited by	9606	805	NP_001734.1	calmodulin	9282777	2007-11-07 17:31	The fusion between CD4+ human cells and cells stably expressing HIV-1 gp41 and gp120 is inhibited by calmodulin
11676	156110	NP_057857.2	Nef	interacts with	9606	805	NP_001734.1	calmodulin	9096366	2007-11-07 17:28	HIV-1 Nef induces interleukin 10 expression through an interaction with the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway
11676	156110	NP_057857.2	Nef	interacts with	9606	805	NP_001734.1	calmodulin	11847276	2007-11-07 17:28	Fluorescence spectroscopy analyses indicate the myristoylated N-terminal eight amino acids of HIV-1 Nef directly interact with calcium bound calmodulin
11676	156110	NP_057857.2	Nef	requires	9606	805	NP_001734.1	calmodulin	17046994	2007-11-07 17:31	HIV-1 Nef-induced CCL-2/MCP-1 upregulation in astrocytes depends on the myristoylation moiety (residues 2-3) of Nef and requires functional calmodulin
11676	155030	NP_579876.2	matrix	binds	9606	808	NP_005175.2	calmodulin	11054265	2007-11-07 17:28	Calmodulin binds to both HIV-1 Gag and Matrix proteins through an extended calmodulin-binding domain in Matrix (amino acids 11-46)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	808	NP_005175.2	calmodulin	8226798,8573130,8780394,9362478,9658102,16229872	2007-11-07 17:29	The carboxyl-terminal domains (residues 768-788 and 826-854) of HIV-1 gp160 bind to calmodulin (CaM)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	808	NP_005175.2	calmodulin	8780394,8862395,9658102,10625668,16229872	2007-11-07 17:30	The calmodulin-binding domains in HIV-1 gp160 are involved in Fas-mediated apoptosis
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	808	NP_005175.2	calmodulin	8226798,8312049,11072229	2007-11-07 17:31	The carboxyl terminus (amino acid residues 768-788 and 828-855) of HIV-1 gp41 binds efficiently to purified calmodulin (CaM) and inhibits in vitro CaM-mediated stimulation of phosphodiesterase activity
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibited by	9606	808	NP_005175.2	calmodulin	9256481	2007-11-07 17:31	The fusion between CD4+ human cells and cells stably expressing HIV-1 gp41 and gp120 is inhibited by calmodulin
11676	156110	NP_057857.2	Nef	interacts with	9606	808	NP_005175.2	calmodulin	9096366	2007-11-07 17:28	HIV-1 Nef induces interleukin 10 expression through an interaction with the calcium/calmodulin-dependent phosphodiesterase signal transduction pathway
11676	156110	NP_057857.2	Nef	interacts with	9606	808	NP_005175.2	calmodulin	11847276	2007-11-07 17:28	Fluorescence spectroscopy analyses indicate the myristoylated N-terminal eight amino acids of HIV-1 Nef directly interact with calcium bound calmodulin
11676	156110	NP_057857.2	Nef	requires	9606	808	NP_005175.2	calmodulin	17046994	2007-11-07 17:31	HIV-1 Nef-induced CCL-2/MCP-1 upregulation in astrocytes depends on the myristoylation moiety (residues 2-3) of Nef and requires functional calmodulin
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	811	NP_004334.1	calreticulin precursor	8550632	2007-11-07 17:30	The ubiquitous eukaryotic protein calreticulin binds to newly synthesized HIV-1 gp160, suggesting that calreticulin might act as a chaperone
11676	155871	NP_057853.1	Tat	inhibits	9606	815	NP_057065.2	calcium/calmodulin-dependent protein kinase type II subunit alpha isoform 1	11751951	2007-11-07 17:30	HIV-1 Tat inhibits the activation of CAMKII elicited via LFA-1 in NK cells, providing evidence that Tat inhibits NK cell activation which might contribute to the impairment of natural immunity in HIV-1 infection
11676	155871	NP_057853.1	Tat	inhibits	9606	815	NP_057065.2	calcium/calmodulin-dependent protein kinase type II subunit alpha isoform 1	11867691	2007-11-07 17:30	HIV-1 Tat inhibits the activation of CAMKII elicited via beta (3) integrin
11676	155871	NP_057853.1	Tat	inhibits	9606	816	NP_001211.3	calcium/calmodulin-dependent protein kinase type II subunit beta isoform 1	11751951	2007-11-07 17:30	HIV-1 Tat inhibits the activation of CAMKII elicited via LFA-1 in NK cells, providing evidence that Tat inhibits NK cell activation which might contribute to the impairment of natural immunity in HIV-1 infection
11676	155871	NP_057853.1	Tat	inhibits	9606	816	NP_001211.3	calcium/calmodulin-dependent protein kinase type II subunit beta isoform 1	11867691	2007-11-07 17:30	HIV-1 Tat inhibits the activation of CAMKII elicited via beta (3) integrin
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	821	NP_001737.1	calnexin precursor	8550632,8790377,10873786,11054427	2007-11-07 17:30	The molecular chaperone calnexin binds to newly synthesized HIV-1 gp160; nonglycosylated gp160 is not associated with calnexin, suggesting a requirement for N-linked oligosaccharides on the newly synthesized protein for binding to occur
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	associates with	9606	821	NP_001737.1	calnexin precursor	10873786	2007-11-07 17:31	The signal-sequence-retained form of HIV-1 gp120 is associated with calnexin in the endoplasmic reticulum (ER), while the signal-sequence-cleaved form is disassociated from calnexin and undergoes folding to associate with the CD4 cellular receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	823	NP_005177.2	calpain-1 catalytic subunit	8954122	2007-11-07 17:27	Activation of the Ca(2+)-dependent protease, calpain, is involved in cytotoxic effects mediated by HIV-1 gp120 in neuroblastoma cultures
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	824	NP_001739.1	calpain 2, large subunit	8954122	2007-11-07 17:27	Activation of the Ca(2+)-dependent protease, calpain, is involved in cytotoxic effects mediated by HIV-1 gp120 in neuroblastoma cultures
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	825	NP_000061.1	calpain-3 isoform a	8954122	2007-11-07 17:27	Activation of the Ca(2+)-dependent protease, calpain, is involved in cytotoxic effects mediated by HIV-1 gp120 in neuroblastoma cultures
11676	155807	NP_057852.2	Vpr	activates	9606	834	NP_150634.1	caspase-1 isoform alpha precursor	10438581,10708425,11437653	2007-11-07 17:27	HIV-1 Vpr-induced apoptosis involves activation of caspases and the involvement of caspase 1 is suggested based on studies with mice transgenic for the HIV-1 vpr gene
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	834	NP_150634.1	caspase-1 isoform alpha precursor	9002959,9548463	2007-11-07 17:27	Apoptosis induced by HIV-1 gp120/CD4 cross-linking in Th1 clones is inhibited by anti-CD95 or anti-CD95L neutralizing monoclonal antibodies, as well as by a specific interleukin-1 beta converting enzyme (ICE) inhibitor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	834	NP_150634.1	caspase-1 isoform alpha precursor	15749123	2007-11-07 17:30	Up-regulation of apoptosis genes such as caspase 1, NALP1, and TNF receptor-associated factor 5 are induced by HIV-gp120/ethanol in human neurons
11676	155348	NP_705926.1	retropepsin	activates	9606	836	NP_004337.2	caspase-3 preproprotein	12404116	2007-11-07 17:29	HIV-1 protease directly cleaves and activates procaspase 8 in T cells which is associated with cleavage of BID, mitochondrial release of cytochrome c, activation of the downstream caspases 9 and 3, and cleavage of DFF and PARP
11676	155807	NP_057852.2	Vpr	activates	9606	836	NP_004337.2	caspase-3 preproprotein	10438581,10708425,12095993,12750393,12750404,15578977,15725353,16120388,16338743,16511342,16520893	2007-11-07 17:27	Through activation of the caspase 9 pathway, HIV-1 Vpr also activates caspase 3
11676	155807	NP_057852.2	Vpr	activates	9606	836	NP_004337.2	caspase-3 preproprotein	16480911,17140287	2007-11-07 17:31	HIV-1 Vpr increases the activity of caspase-3 and caspase-9, but not of caspase-8 in human HeLa cells; Vpr-induced apoptosis can be inhibited by inhibitors of caspase-3 and caspase-9, but not by inhibitors of caspase-8
11676	155807	NP_057852.2	Vpr	activates	9606	836	NP_004337.2	caspase-3 preproprotein	16520893	2007-11-07 17:31	Overproduction of EEF2 blocks HIV-1 Vpr-induced cell death both in fission yeast and human cells, suppresses caspase 9 and caspase 3-mediated apoptosis induced by Vpr, and reduces cytochrome c release induced by Vpr
11676	155807	NP_057852.2	Vpr	activates	9606	836	NP_004337.2	caspase-3 preproprotein	17140287	2007-11-07 17:31	HIV-1 Vpr-induced apoptosis through caspase activation and Smac release from mitochondria is dependent on G2 cell cycle arrest , but is lost in cells synchronized in G1/S
11676	155871	NP_057853.1	Tat	activates	9606	836	NP_004337.2	caspase-3 preproprotein	9878167,10602513,10799874,11509621,15204919	2007-11-07 17:28	HIV-1 Tat induces apoptosis through activation of caspase-3
11676	155871	NP_057853.1	Tat	downregulates	9606	836	NP_004337.2	caspase-3 preproprotein	15179054	2007-11-07 17:28	A p53 fusion protein with the HIV-1 Tat basic domain at its N terminus activates the expression of p21and downregulates the levels of caspase-3 and Bcl-2
11676	155945	NP_057855.1	Vpu	activates	9606	836	NP_004337.2	caspase-3 preproprotein	11696595	2007-11-07 17:27	Levels of active caspase-3 are elevated in T cells as a result of HIV-1 Vpu-mediated inhibition of NF-kappa B activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	836	NP_004337.2	caspase-3 preproprotein	9548463,10430052	2007-11-07 17:27	The cytolytic process that takes place between primary uninfected CD4+ T cells and HIV-1 infected or HIV-1 gp120-expressing cells requires the activity of caspases such as ICE and CPP32
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	836	NP_004337.2	caspase-3 preproprotein	10704341,10942389,11141237,11462036,12019321,12190962,14555204,14993250,16111829	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	836	NP_004337.2	caspase-3 preproprotein	11462036	2007-11-07 17:31	The interaction of cell-associated HIV-1 gp120 with CXCR4-expressing target cells triggers apoptotic processes by activating caspase-9 and -3
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	836	NP_004337.2	caspase-3 preproprotein	16897667	2007-11-07 17:31	Signal transducer and activator of transcription factor 1 (STAT1) partially regulates HIV-1 gp120/HCV E2-induced caspase 3 activity
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	836	NP_004337.2	caspase-3 preproprotein	16330530	2007-11-07 17:31	HIV-1 gp41-dependent apoptosis involves caspase-3-dependent mitochondrial depolarization and reactive oxygen species production; HIV-1 gp41-induced mitochondrial depolarization is inhibited by the protease inhibitor nelfinavir
11676	156110	NP_057857.2	Nef	activates	9606	836	NP_004337.2	caspase-3 preproprotein	11123279	2007-11-07 17:27	Stable expression of HIV-1 Nef in CEM T cells activates caspase-3 and enhances apoptosis through mechanisms unrelated to Fas
11676	156110	NP_057857.2	Nef	inactivates	9606	836	NP_004337.2	caspase-3 preproprotein	11177389	2007-11-07 17:27	Stable expression of HIV-1 Nef in Jurkat T cells confers resistance to Fas-mediated apoptosis through inactivation of caspase-3 and caspase-8
11676	156110	NP_057857.2	Nef	requires	9606	836	NP_004337.2	caspase-3 preproprotein	15767427	2007-11-07 17:28	Microarray and Western blot analyses have shown HIV-1 Nef-induced apoptosis in human brain microvascular endothelial cells requires the involvement of caspase-3 and caspase-9
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	839	NP_001217.2	caspase-6 isoform alpha preproprotein	15103018	2007-11-07 17:30	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155348	NP_705926.1	retropepsin	activates	9606	841	NP_001219.2	caspase-8 isoform A precursor	12404116	2007-11-07 17:29	HIV-1 protease directly cleaves and activates procaspase 8 in T cells, which is associated with cleavage of BID, mitochondrial release of cytochrome c, activation of the downstream caspases 9 and 3, and cleavage of DFF and PARP
11676	155807	NP_057852.2	Vpr	activates	9606	841	NP_001219.2	caspase-8 isoform A precursor	10438581,10708425,11000244,12095993,12096338,12750393,12750404,15142380,15578977	2007-11-07 17:27	HIV-1 Vpr induces apoptosis through caspase activation and caspase 8 has been specifically demonstrated in one study to be activated during this process, however in other studies it was not activated
11676	155871	NP_057853.1	Tat	upregulates	9606	841	NP_001219.2	caspase-8 isoform A precursor	9878167,9971775	2007-11-07 17:28	HIV-1 Tat induces apoptosis and increases sensitivity to apoptotic signals by upregulating FLICE/Caspase-8
11676	156110	NP_057857.2	Nef	inactivates	9606	841	NP_001219.2	caspase-8 isoform A precursor	11177389	2007-11-07 17:27	Stable expression of HIV-1 Nef in Jurkat T cells confers resistance to Fas-mediated apoptosis through inactivation of caspase-3 and caspase-8
11676	155348	NP_705926.1	retropepsin	activates	9606	842	NP_001220.2	caspase-9 isoform alpha preproprotein	12404116	2007-11-07 17:29	HIV-1 protease directly cleaves and activates procaspase 8 in T cells which is associated with cleavage of BID, mitochondrial release of cytochrome c, activation of the downstream caspases 9 and 3, and cleavage of DFF and PARP
11676	155807	NP_057852.2	Vpr	activates	9606	842	NP_001220.2	caspase-9 isoform alpha preproprotein	10438581,10708425,12095993,12096338,15578977,15725353,16120388,16480911,16511342,16520893	2007-11-07 17:27	HIV-1 Vpr induces apoptosis through activation of caspase 9 as well as by increasing the overall expression level of caspase 9
11676	155807	NP_057852.2	Vpr	activates	9606	842	NP_001220.2	caspase-9 isoform alpha preproprotein	16520893	2007-11-07 17:31	Overproduction of EEF2 blocks HIV-1 Vpr-induced cell death both in fission yeast and human cells, suppresses caspase 9 and caspase 3-mediated apoptosis induced by Vpr, and reduces cytochrome c release induced by Vpr
11676	155807	NP_057852.2	Vpr	activates	9606	842	NP_001220.2	caspase-9 isoform alpha preproprotein	17140287	2007-11-07 17:31	HIV-1 Vpr-induced apoptosis through caspase activation and Smac release from mitochondria is dependent on G2 cell cycle arrest , but is lost in cells synchronized in G1/S
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	842	NP_001220.2	caspase-9 isoform alpha preproprotein	11462036	2007-11-07 17:31	The interaction of cell-associated HIV-1 gp120 with CXCR4-expressing target cells triggers apoptotic processes by activating caspase-9 and -3
11676	156110	NP_057857.2	Nef	upregulates	9606	842	NP_001220.2	caspase-9 isoform alpha preproprotein	15767427	2007-11-07 17:28	Microarray analyses have shown HIV-1 Nef-induced upregulation of caspase-9 in primary human brain microvascular endothelial cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibited by	9606	847	NP_001743.1	catalase	14975589	2007-11-07 17:30	Free radical scavengers such as superoxide dismutase (SOD), dimethylthiourea (DMTU) and catalase attenuate morphine and gp160-induced human monocyte apoptosis
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	857	NP_001744.2	caveolin-1 isoform alpha	15539149,17197700	2007-11-07 17:31	HIV-1 gp41 forms a stable complex with caveolin-1 through its amino-acid residues 623-631 in HIV-infected cells; antibodies to the caveolin-1 binding domain in gp41 inhibit virus infectivity
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	857	NP_001744.2	caveolin-1 isoform alpha	17197700	2007-11-07 17:31	Amino acid residues 61-101 of caveolin 1 are involved in the binding of caveolin 1 to the N36(L8)C34 domain of gp41
11676	156110	NP_057857.2	Nef	induces phosphorylation of	9606	867	NP_005179.2	E3 ubiquitin-protein ligase CBL	15892963	2007-11-07 17:28	HIV-1 Nef enhances the phosphorylation of c-Cbl in CD4+ T cells, an effect that requires the Src tyrosine kinase Lck
11676	156110	NP_057857.2	Nef	induces complex with	9606	867	NP_005179.2	E3 ubiquitin-protein ligase CBL	16356860	2007-11-07 17:29	In the presence of Nef, lipid raft Cdc42 is activated and forms a ternary complex between the c-Cbl-interacting protein p85Cool-1/betaPix and c-Cbl, displacing UbcH7 from rafts
11676	155871	NP_057853.1	Tat	interacts with	9606	890	NP_001228.1	cyclin-A2	15050687	2007-11-07 17:28	When expressed in astrocytes, neurons, and non-glial 293T cells, HIV-1 Tat interacts with a number of cell cycle-related proteins including cyclin A, cyclin B, cyclin D3, Cdk2, Cdk4, Cdk1/Cdc2, cdc6, p27, p53, p63, hdlg, and PCNA
11676	155807	NP_057852.2	Vpr	inactivates	9606	891	NP_114172.1	G2/mitotic-specific cyclin-B1	7474080,7474100,7494303,7666531,9094673,10958988	2007-11-07 17:28	HIV-1 Vpr inactivates the cdc2-cyclin B kinase complex by inhibiting the dephosphorylation of cdc2 tyrosine 15, leading to arrest in the G2 phase of the cell cycle
11676	155807	NP_057852.2	Vpr	inactivates	9606	891	NP_114172.1	G2/mitotic-specific cyclin-B1	7474100,11531413,15265780	2007-11-07 17:28	HIV-1 Vpr inactivates the cdc2-cyclin B kinase complex by inactivating cdc25C, the phosphatase that dephosphorylates and activates cdc2
11676	155807	NP_057852.2	Vpr	inactivates	9606	891	NP_114172.1	G2/mitotic-specific cyclin-B1	7494303	2007-11-07 17:28	Inactivation of the cdc2-cyclin B kinase complex and arrest in the G2 phase of the cell cycle has been mapped to the C-terminus of HIV-1 Vpr, including amino acids 73, 80 and 84-96
11676	155807	NP_057852.2	Vpr	inactivates	9606	891	NP_114172.1	G2/mitotic-specific cyclin-B1	9520381	2007-11-07 17:28	The human Vpr interacting protein (hVIP/MOV34) is a likely cellular cofactor for HIV-1 Vpr inactivation of the cdc2-cyclin B kinase complex and induction of cell cycle arrest
11676	155807	NP_057852.2	Vpr	inhibits	9606	891	NP_114172.1	G2/mitotic-specific cyclin-B1	9560267	2007-11-07 17:28	Data suggests that HIV-1 Vpr transactivation of the HIV-LTR promoter occurs through the inhibition of p300-associated cdc2-cyclin B kinase complex activity which enhances transcriptional activation by Rel A and p300
11676	155807	NP_057852.2	Vpr	induces release of	9606	891	NP_114172.1	G2/mitotic-specific cyclin-B1	11691994	2007-11-07 17:28	Rupture of HIV-1 Vpr-induced nuclear envelope herniations produces transient loss of the subcellular compartmentalization of Wee1, Cdc25C, cyclin B1, and presumably other soluble cellular components, resulting in their release into the cytoplasm
11676	155807	NP_057852.2	Vpr	inactivates	9606	891	NP_114172.1	G2/mitotic-specific cyclin-B1	11878934	2007-11-07 17:28	Inactivation of the cdc2-cyclin B kinase complex by HIV-1 Vpr leads to the activation of Poly(A) polymerase
11676	155871	NP_057853.1	Tat	upregulates	9606	891	NP_114172.1	G2/mitotic-specific cyclin-B1	16751065	2007-11-07 17:31	HIV-1 Tat induces a constitutive overexpression of cyclin B1 protein in human rhabdomyosarcoma cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces accumulation of	9606	891	NP_114172.1	G2/mitotic-specific cyclin-B1	8524869	2007-11-07 17:30	Cell-cell contact between T cells expressing HIV-1 gp120/gp41 and other T cells expressing CD4 receptors leads to the rapid accumulation of cyclin B and tyrosine-hyperphosphorylated p34cdc2 (cdk1) kinase, indicative of cell cycle arrest at G2 phase
11676	155871	NP_057853.1	Tat	interacts with	9606	892	NP_005181.2	cyclin-C isoform a	9121429	2007-11-07 17:28	HIV-1 Tat interacts with the RNA polymerase II holoenzyme, which includes cyclin c, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	896	NP_001751.1	G1/S-specific cyclin-D3 isoform 2	15050687	2007-11-07 17:28	When expressed in astrocytes, neurons, and non-glial 293T cells, HIV-1 Tat interacts with a number of cell cycle-related proteins including cyclin A, cyclin B, cyclin D3, Cdk2, Cdk4, Cdk1/Cdc2, cdc6, p27, p53, p63, hdlg, and PCNA
11676	155871	NP_057853.1	Tat	activates	9606	898	NP_001229.1	G1/S-specific cyclin-E1 isoform 1	9223324	2007-11-07 17:27	HIV-1 Tat induces Cyclin E-associated cdk activity in lymphocytes, indicating Tat drives cells to the late G1 phase of the cell cycle
11676	155871	NP_057853.1	Tat	downregulates	9606	898	NP_001229.1	G1/S-specific cyclin-E1 isoform 1	9525916	2007-11-07 17:28	HIV-1 Tat induces a G1 arrest in cells of glial origin, leading to a downregulation of cyclin E-Cdk2 kinase activity and phosphorylation of Rb
11676	155871	NP_057853.1	Tat	stimulated by	9606	898	NP_001229.1	G1/S-specific cyclin-E1 isoform 1	12114499	2007-11-07 17:30	Cdk2/cyclin E stimulates Tat-dependent HIV-1 transcription
11676	155871	NP_057853.1	Tat	binds	9606	898	NP_001229.1	G1/S-specific cyclin-E1 isoform 1	16289656	2007-11-07 17:29	HIV-1 Tat 41/44 peptide TAALS from the core domain of Tat inhibits Tat-mediated HIV-1 gene expression and replication by binding the Cdk2/Cyclin E complex and inhibiting the phosphorylation of serine 5 of RNAPII
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	898	NP_001229.1	G1/S-specific cyclin-E1 isoform 1	9453249	2007-11-07 17:28	The V3 loop of HIV-1 gp120 induces G1 arrest in IL-2-dependent cell cycle progression by reducing cyclin E expression and phosphorylation of retinoblastoma protein (pRb)
11676	156110	NP_057857.2	Nef	downregulates	9606	898	NP_001229.1	G1/S-specific cyclin-E1 isoform 1	15343382	2007-11-07 17:28	HIV-1 Nef induces the downregulation of cyclin E expression in podocytes
11676	155807	NP_057852.2	Vpr	enhanced by	9606	902	NP_001230.1	cyclin-H	12379213	2007-11-07 17:28	As a component of the TFIIH transcription complex, cyclin H enhances the synergistic activation of glucocorticoid receptor by HIV-1 Vpr and p300
11676	155807	NP_057852.2	Vpr	inhibited by	9606	902	NP_001230.1	cyclin-H	12379213	2007-11-07 17:28	As a component of the TFIIH transcription complex, cyclin H inhibits HIV-1 Vpr cell cycle-arresting function
11676	155871	NP_057853.1	Tat	binds	9606	902	NP_001230.1	cyclin-H	8628270,8934526,9184228,9334327,9765201	2007-11-07 17:28	Amino acids 1-48 of HIV-1 Tat, which includes the Tat activation domain, mediate the binding of Tat to CAK and the TFIIH complex through a direct interaction with CDK7 and possibly other TFIIH subunits, including p62 and ERCC3
11676	155871	NP_057853.1	Tat	interacts with	9606	902	NP_001230.1	cyclin-H	8849451,8934526,9054383,9121429	2007-11-07 17:28	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIH, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	requires	9606	902	NP_001230.1	cyclin-H	8934526,9184228,9334327	2007-11-07 17:28	CAK/TFIIH is required for HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	902	NP_001230.1	cyclin-H	8934526,9184228,9311822,9334327,9570510,9651670,10438593,10866664,14569024	2007-11-07 17:28	Interaction of HIV-1 Tat with TFIIH stimulates phosphorylation of Ser-5 of the RNA polymerase II C-terminal domain (CTD), which in turn also stimulates co-transcriptional capping of HIV-1 mRNA
11676	155871	NP_057853.1	Tat	synergizes with	9606	902	NP_001230.1	cyclin-H	8934526	2007-11-07 17:28	TFIIH synergizes with HIV-1 Tat to induce transcription elongation from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	binds	9606	902	NP_001230.1	cyclin-H	9311822,10639311,12049628	2007-11-07 17:28	TFIIH subunits CDK7 and cyclin H have been identified as two components associated with the Tat-associated CTD kinase (TTK) that binds to HIV-1 Tat
11676	155871	NP_057853.1	Tat	interacts with	9606	902	NP_001230.1	cyclin-H	9651670,10066804,10082552,10866664,14569024	2007-11-07 17:28	TFIIH interacts with HIV-1 Tat as a component of the HIV-1 transcription preinitiation complex, but is released from the elongation complex which includes P-TEFb
11676	155807	NP_057852.2	Vpr	binds	9606	904	NP_001231.2	cyclin-T1	10931842,15142377	2007-11-07 17:28	HIV-1 Vpr binds to cyclin T1 (amino acids 300-479) in a ternary complex of HIV-1 Tat, Vpr, Cyclin T1, and CDK9, and enhances Tat transactivation of the viral LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	904	NP_001231.2	cyclin-T1	7853496,8676484,9570510,9649438,9651670,9696809,10066804,10077579,10082552,10329125,10364292,10438593,10536359,10617616,10866664,10958691,11112772,11547919,12052871,14569024	2007-11-07 17:27	During HIV-1 Tat mediated transactivation of the HIV-1 LTR promoter, Tat stimulates the phosphorylation of the C-terminal domain (CTD) of RNA polymerase II by P-TEFb, leading to transcription elongation
11676	155871	NP_057853.1	Tat	binds	9606	904	NP_001231.2	cyclin-T1	7853496,8676484,9356449,9491887,9651670,9765201,9832504,9843510,9990016,10077579,10329125,10364292,10364329,10384302,10465067,11080476,11504720,12753906	2007-11-07 17:27	The N-terminus (amino acids 1-48, including activation domain) of HIV-1 Tat binds to P-TEFb through a direct interaction with the N-terminus (amino acids 1-290) of cyclin T1 during Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	recruits	9606	904	NP_001231.2	cyclin-T1	8676484,9491887,9649438,9696809,9843510,10329125,10364329,10384302,10393900,10467404,11504720	2007-11-07 17:27	HIV-1 Tat recruits P-TEFb to the HIV-1 Transcription Activation Response (TAR) RNA during Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	complexes with	9606	904	NP_001231.2	cyclin-T1	8849451,9649438,9765201,10393184,10454543,10913173,10964778,11780068	2007-11-07 17:27	Tat-SF1 is a required cofactor for HIV-1 Tat activity that complexes with P-TEFb and Tat, and stimulates Tat-mediated activation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	requires	9606	904	NP_001231.2	cyclin-T1	9334325,9334326,9557739,10082552,10377393,10393900,10913173	2007-11-07 17:27	P-TEFb is required for HIV-1 Tat-mediated transcriptional activation
11676	155871	NP_057853.1	Tat	regulated by	9606	904	NP_001231.2	cyclin-T1	9356449,9811724,11689614,11739686,12368300,12588988,12727882,14984439,15139295,15183343,15473004,15638724,15719065,16035254,16146763,16838299	2007-11-07 17:27	The up and downregulation of expression of CDK9 and cyclin T1 or sequestration of cyclin T1 in infected cells may regulate HIV-1 latency by up or downregulating HIV-1 Tat transcriptional activation
11676	155871	NP_057853.1	Tat	enhanced by	9606	904	NP_001231.2	cyclin-T1	9651670,10049833,10329125,10944537,10958691,11549886,14972556,15994812,16764723,16838299	2007-11-07 17:27	The interaction of HIV-1 Tat with HIV-1 Transcription Activation Response (TAR) RNA is enhanced by the interaction of Tat with P-TEFb, and TAR RNA also enhances the interaction between Tat and cyclin T1
11676	155871	NP_057853.1	Tat	binds	9606	904	NP_001231.2	cyclin-T1	9832504,9843510,9990016,10077579,10329125,10329126,10364329	2007-11-07 17:27	Amino acids 260-263 of cyclin T1 are critical for HIV-1 Tat-mediated transcriptional activation, and mediate the species specificity of cyclin T1 and P-TEFb binding to Tat
11676	155871	NP_057853.1	Tat	interacts with	9606	904	NP_001231.2	cyclin-T1	10066804,17168834	2007-11-07 17:27	P-TEFb interacts with HIV-1 Tat as part of both the HIV-1 transcription preinitiation and elongation complexes
11676	155871	NP_057853.1	Tat	binds	9606	904	NP_001231.2	cyclin-T1	10545121,11080476,12486002,12887902	2007-11-07 17:27	Acetylation of HIV-1 Tat by cellular histone acetyltransferases regulates the binding of Tat to P-TEFb
11676	155871	NP_057853.1	Tat	stimulates	9606	904	NP_001231.2	cyclin-T1	10617616	2007-11-07 17:27	Hsp70 and Hsp90/Cdc37 stabilize CDK9 as well as the assembly of an active P-TEFb complex which is stimulated by HIV-1 Tat during HIV-1 transcriptional activation
11676	155871	NP_057853.1	Tat	binds	9606	904	NP_001231.2	cyclin-T1	10661406,11118314	2007-11-07 17:27	HIV-1 Tat competes with CIITA for the binding to P-TEFb, leading to the downregulation of MHC class II gene expression
11676	155871	NP_057853.1	Tat	interacts with	9606	904	NP_001231.2	cyclin-T1	10671520,12944466	2007-11-07 17:27	The human I-mfa domain-containing protein (HIC) interacts with both P-TEFb and HIV-1 Tat, and modulates Tat transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	904	NP_001231.2	cyclin-T1	10757782,11112772,11809800	2007-11-07 17:27	HIV-1 Tat stimulates the phosphorylation of SPT5 by P-TEFb during transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	regulated by	9606	904	NP_001231.2	cyclin-T1	10913173,10958691	2007-11-07 17:27	P-TEFb regulates HIV-1 Tat-mediated activation of transcription through two built-in autoinhibitory mechanisms, autophosphorylation of CDK9 and cyclin T1 binding to the transcription elongation factor Tat-SF1
11676	155871	NP_057853.1	Tat	recruited by	9606	904	NP_001231.2	cyclin-T1	11282025,14972556,15994812,16838299,17168834	2007-11-07 17:27	Cyclin T1 is capable of recruiting CDK9 and HIV-1 Tat to splicing factor-rich nuclear speckle regions, suggesting nuclear speckles are a site of P-TEFb and Tat function
11676	155871	NP_057853.1	Tat	complexes with	9606	904	NP_001231.2	cyclin-T1	11704662	2007-11-07 17:27	The p160 nuclear receptor co-activator GRIP1 binds to the N-terminal region of HIV-1 Tat, bridging HIV-1 LTR promoter-bound factors to the Tat-P-TEFb complex and enhancing the transactivating activity of Tat
11676	155871	NP_057853.1	Tat	cooperates with	9606	904	NP_001231.2	cyclin-T1	11730934	2007-11-07 17:27	P-TEFb, Puralpha and HIV-1 Tat cooperate to activate the TNFalpha promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	904	NP_001231.2	cyclin-T1	12588988,12727882	2007-11-07 17:27	The growth factor granulin and the promyelocytic leukemia (PML) protein regulate HIV-1 Tat-mediated transcriptional activation by competing with the Tat interaction with cyclin T1/P-TEFb
11676	155871	NP_057853.1	Tat	binds	9606	904	NP_001231.2	cyclin-T1	12832472	2007-11-07 17:27	MAQ1 and 7SK RNA interact with P-TEFb and compete with the binding of HIV-1 Tat to cyclin T1, suggesting the TAR RNA/Tat lentivirus system evolved to subvert the cellular 7SK RNA/MAQ1 system
11676	155871	NP_057853.1	Tat	stimulates	9606	904	NP_001231.2	cyclin-T1	14569024	2007-11-07 17:27	HIV-1 Tat-mediated stimulation of RNA polymerase II C-terminal domain phosphorylation by P-TEFb leads to stimulation of co-transcriptional capping of HIV-1 mRNA
11676	155871	NP_057853.1	Tat	complexes with	9606	904	NP_001231.2	cyclin-T1	15498776	2007-11-07 17:29	PARP1 negatively regulates HIV-1 transcription by directly competing with Tat-P-TEFb complex for binding to TAR RNA
11676	155871	NP_057853.1	Tat	complexes with	9606	904	NP_001231.2	cyclin-T1	15905409	2007-11-07 17:28	SKIP is required for Tat transactivation in vivo and stimulates HIV-1 transcription elongation by associating with CycT1:CDK9 (P-TEFb) and Tat:P-TEFb complexes both in nuclear extracts and in recombinant Tat:P-TEFb:TAR RNA complexes in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	904	NP_001231.2	cyclin-T1	16439541	2007-11-07 17:29	Expression of human cyclin T1 in transgenic mice is sufficient to support HIV-1 Tat-mediated transactivation in primary mouse CD4 T lymphocytes and monocytes/macrophages and increases in vitro and in vivo HIV-1 production
11676	155871	NP_057853.1	Tat	interacts with	9606	904	NP_001231.2	cyclin-T1	16615932	2007-11-07 17:31	HIV-1 Tat interaction with cyclin T1 is required for the repression of mannose receptor (MR) and bone morphogenetic protein receptor-2 (BMPR2) promoters
11676	155871	NP_057853.1	Tat	interacts with	9606	904	NP_001231.2	cyclin-T1	16781761	2007-11-07 17:31	IL-10 inhibits HIV-1 gene expression in an HIV-1 Tat-dependent manner by downregulating cyclin T1 expression through the induction of proteasome-mediated proteolysis in human macrophages
11676	155871	NP_057853.1	Tat	requires	9606	904	NP_001231.2	cyclin-T1	17014716	2007-11-07 17:31	Cyclin T1-P-TEFb is important for prostratin stimulation of HIV-1 virus expression in the presence of functional Tat
11676	155871	NP_057853.1	Tat	inhibited by	9606	905	NP_001232.1	cyclin-T2 isoform a	10049833,10465067	2007-11-07 17:27	Cyclin T2 competes with cyclin T1 for binding to CDK9 and can thereby inhibit HIV-1 Tat activity
11676	155871	NP_057853.1	Tat	binds	9606	905	NP_001232.1	cyclin-T2 isoform a	10329126,10364329	2007-11-07 17:27	Amino acids 260-263 of cyclin T1 are critical for HIV-1 Tat-mediated transcriptional activation, and site-directed mutations in this region of cyclin T2 (asparagine to cysteine at residue 260) allow it to bind Tat and stimulate transcription
11676	156110	NP_057857.2	Nef	downregulates	9606	909	NP_001754.2	T-cell surface glycoprotein CD1a precursor	15262497,16454711,17077296	2007-11-07 17:28	CD1a molecules are downregulated by and co-localized with Nef in CD1a-transfected cells; this co-localization is dependent upon the CD1a cytoplasmic tail from amino acid position 325 to 327
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	912	NP_001757.1	antigen-presenting glycoprotein CD1d precursor	15790518	2007-11-07 17:31	CD1d surface expression on human cell lines is downregulated after infection with M-tropic HIV, T-tropic HIV, or after exposure to HIV gp120 in vitro
11676	156110	NP_057857.2	Nef	downregulates	9606	912	NP_001757.1	antigen-presenting glycoprotein CD1d precursor	15916790,16385629,16454711	2007-11-07 17:28	Nef-induced downregulation of CD1d is observed when cells are co-expressing Nef and CD1d, and six amino acids (300-305) in the cytoplasmic tail of CD1d are required for the downregulation by Nef
11676	156110	NP_057857.2	Nef	downregulates	9606	912	NP_001757.1	antigen-presenting glycoprotein CD1d precursor	16385629,16454711	2007-11-07 17:29	HIV-1 Nef downregulates the expression of the non-classical MHC-I like CD1d molecule by increasing internalization of CD1d molecules from the cell surface and retaining CD1d in the trans-Golgi-network (TGN)
11676	156110	NP_057857.2	Nef	downregulates	9606	912	NP_001757.1	antigen-presenting glycoprotein CD1d precursor	16385629,16454711	2007-11-07 17:29	HIV-1 Nef-mediated downregulation of CD1d requires a tyrosine-based motif in the CD1d cytoplasmic tail and four Nef amino acid motifs (EEEE65, PxxP75, DD165, and LL175), which are known to be involved in the downregulation of MHC-I and CD4
11676	155030	NP_579880.1	capsid	interacts with	9606	914	NP_001758.1	CD2 molecule	1385321,2111780,7517794,8809126,9743208,10722370	2007-11-07 17:29	Synthetic peptides corresponding to amino acids 218-238 of HIV-1 Capsid have been shown to inhibit in a dose dependent manner the induction of a specific antibody response to the sheep red cell (SRC) antigen
11676	155030	NP_579880.1	capsid	interacts with	9606	914	NP_001758.1	CD2 molecule	7517794	2007-11-07 17:29	Peptides corresponding to amino acids 218-238 of HIV-1 Capsid inhibited anti-CD3-induced lymphoproliferation but did not directly affect anti-CD2 activation
11676	155030	NP_579880.1	capsid	interacts with	9606	914	NP_001758.1	CD2 molecule	8809126,9743208	2007-11-07 17:29	Interferon-gamma can counteract the inhibitory effect of HIV-1 Capsid based peptides on antibody response to SRC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	914	NP_001758.1	CD2 molecule	7589092	2007-11-07 17:30	Molecular interactions of CD2 with LFA-3 and CD28 with B7-1 in conjunction with TCR occupancy prevent T cells from programmed apoptosis mediated by binding of CD4 to HIV-1 gp120, resulting in increased levels of IL-2 and IL-4 secretion from the T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	914	NP_001758.1	CD2 molecule	9475352	2007-11-07 17:31	Preincubation of T cells with HIV-1 gp120 accelerates the apoptosis observed during CD2-pathway stimulation of the T cells; this process is mediated by Fas/Fas ligand interaction and related to an increased induction of Fas ligand mRNA by gp120
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	914	NP_001758.1	CD2 molecule	1832084	2007-11-07 17:31	HIV-1 gp41 peptide (amino acids 581-597) inhibits lymphoproliferation stimulated via the T-cell-activation molecules CD3, CD2, and CD28, as well as via direct stimulation mediated by phorbol ester combined with ionomycin
11676	155030	NP_579880.1	capsid	inhibits	9606	915	NP_000723.1	T-cell surface glycoprotein CD3 delta chain isoform A precursor	1385321,2111780,7517794,8809126,9743208,10722370	2007-11-07 17:29	Synthetic peptides corresponding to amino acids 218-238 of HIV-1 Capsid have been shown to inhibit in a dose dependent manner the induction of a specific antibody response to the sheep red cell (SRC) antigen through the T3-Ti complex
11676	155030	NP_579880.1	capsid	inhibits	9606	915	NP_000723.1	T-cell surface glycoprotein CD3 delta chain isoform A precursor	7517794	2007-11-07 17:29	Peptides corresponding to amino acids 218-238 of HIV-1 Capsid inhibited anti-CD3-induced lymphoproliferation but did not directly affect anti-CD2 activation
11676	155030	NP_579880.1	capsid	interacts with	9606	915	NP_000723.1	T-cell surface glycoprotein CD3 delta chain isoform A precursor	8809126,9743208	2007-11-07 17:29	Interferon-gamma can counteract the inhibitory effect of HIV-1 Capsid based peptides on antibody response to SRC
11676	155871	NP_057853.1	Tat	interacts with	9606	915	NP_000723.1	T-cell surface glycoprotein CD3 delta chain isoform A precursor	9045614,9510190,17001685	2007-11-07 17:28	HIV-1 Tat interacts with CD3 and CD28 to co-stimulate IL-2 and IL-8 expression
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	915	NP_000723.1	T-cell surface glycoprotein CD3 delta chain isoform A precursor	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	915	NP_000723.1	T-cell surface glycoprotein CD3 delta chain isoform A precursor	7506554,8125527,8145026	2007-11-07 17:29	Binding of HIV-1 gp120 to the CD4 receptor molecule results in co-stimulation of CD3-induced T cell activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	915	NP_000723.1	T-cell surface glycoprotein CD3 delta chain isoform A precursor	7539755	2007-11-07 17:27	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	915	NP_000723.1	T-cell surface glycoprotein CD3 delta chain isoform A precursor	7774645	2007-11-07 17:30	HIV-1 gp120 inhibits CD3-induced Lck activation and cellular tyrosine phosphorylation, particularly of phosphoinositide-specific phospholipase C-gamma-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	915	NP_000723.1	T-cell surface glycoprotein CD3 delta chain isoform A precursor	9263011	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	915	NP_000723.1	T-cell surface glycoprotein CD3 delta chain isoform A precursor	1832084	2007-11-07 17:31	HIV-1 gp41 peptide (amino acids 581-597) inhibits lymphoproliferation stimulated via the T-cell-activation molecules CD3, CD2, and CD28, as well as via direct stimulation mediated by phorbol ester combined with ionomycin
11676	156110	NP_057857.2	Nef	downregulates	9606	915	NP_000723.1	T-cell surface glycoprotein CD3 delta chain isoform A precursor	16777597	2007-11-07 17:31	HIV-1 nef alleles from the great majority of primate lentiviruses, including HIV-2, downregulate TCR-CD3 from infected T cells and thereby block their responsiveness to activation
11676	155030	NP_579880.1	capsid	interacts with	9606	916	NP_000724.1	T-cell surface glycoprotein CD3 epsilon chain precursor	1385321,2111780,7517794,8809126,9743208,10722370	2007-11-07 17:29	Synthetic peptides corresponding to amino acids 218-238 of HIV-1 Capsid have been shown to inhibit in a dose dependent manner the induction of a specific antibody response to the sheep red cell (SRC) antigen through the T3-Ti complex
11676	155030	NP_579880.1	capsid	inhibits	9606	916	NP_000724.1	T-cell surface glycoprotein CD3 epsilon chain precursor	7517794	2007-11-07 17:29	Peptides corresponding to amino acids 218-238 of HIV-1 Capsid inhibited anti-CD3-induced lymphoproliferation but did not directly affect anti-CD2 activation
11676	155030	NP_579880.1	capsid	interacts with	9606	916	NP_000724.1	T-cell surface glycoprotein CD3 epsilon chain precursor	8809126,9743208	2007-11-07 17:29	Interferon-gamma can counteract the inhibitory effect of HIV-1 Capsid based peptides on antibody response to SRC
11676	155871	NP_057853.1	Tat	interacts with	9606	916	NP_000724.1	T-cell surface glycoprotein CD3 epsilon chain precursor	9045614,9510190,17001685	2007-11-07 17:28	HIV-1 Tat interacts with CD3 and CD28 to co-stimulate IL-2 and IL-8 expression
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	916	NP_000724.1	T-cell surface glycoprotein CD3 epsilon chain precursor	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	916	NP_000724.1	T-cell surface glycoprotein CD3 epsilon chain precursor	7506554,8125527,8145026	2007-11-07 17:29	Binding of HIV-1 gp120 to the CD4 receptor molecule results in co-stimulation of CD3-induced T cell activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	916	NP_000724.1	T-cell surface glycoprotein CD3 epsilon chain precursor	7539755	2007-11-07 17:27	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	916	NP_000724.1	T-cell surface glycoprotein CD3 epsilon chain precursor	7774645	2007-11-07 17:30	HIV-1 gp120 inhibits CD3-induced Lck activation and cellular tyrosine phosphorylation, particularly of phosphoinositide-specific phospholipase C-gamma-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	916	NP_000724.1	T-cell surface glycoprotein CD3 epsilon chain precursor	9263011	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	916	NP_000724.1	T-cell surface glycoprotein CD3 epsilon chain precursor	1832084	2007-11-07 17:31	HIV-1 gp41 peptide (amino acids 581-597) inhibits lymphoproliferation stimulated via the T-cell-activation molecules CD3, CD2, and CD28, as well as via direct stimulation mediated by phorbol ester combined with ionomycin
11676	156110	NP_057857.2	Nef	downregulates	9606	916	NP_000724.1	T-cell surface glycoprotein CD3 epsilon chain precursor	16777597	2007-11-07 17:31	HIV-1 nef alleles from the great majority of primate lentiviruses, including HIV-2, downregulate TCR-CD3 from infected T cells and thereby block their responsiveness to activation
11676	155030	NP_579880.1	capsid	interacts with	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	1385321,2111780,7517794,8809126,9743208,10722370	2007-11-07 17:29	Synthetic peptides corresponding to amino acids 218-238 of HIV-1 Capsid have been shown to inhibit in a dose dependent manner the induction of a specific antibody response to the sheep red cell (SRC) antigen through the T3-Ti complex
11676	155030	NP_579880.1	capsid	inhibits	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	7517794	2007-11-07 17:29	Peptides corresponding to amino acids 218-238 of HIV-1 Capsid inhibited anti-CD3-induced lymphoproliferation but did not directly affect anti-CD2 activation
11676	155030	NP_579880.1	capsid	interacts with	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	8809126,9743208	2007-11-07 17:29	Interferon-gamma can counteract the inhibitory effect of HIV-1 Capsid based peptides on antibody response to SRC
11676	155871	NP_057853.1	Tat	interacts with	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	9045614,9510190,17001685	2007-11-07 17:28	HIV-1 Tat interacts with CD3 and CD28 to co-stimulate IL-2 and IL-8 expression
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	7506554,8125527,8145026	2007-11-07 17:29	Binding of HIV-1 gp120 to the CD4 receptor molecule results in co-stimulation of CD3-induced T cell activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	7539755	2007-11-07 17:27	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	7774645	2007-11-07 17:30	HIV-1 gp120 inhibits CD3-induced Lck activation and cellular tyrosine phosphorylation, particularly of phosphoinositide-specific phospholipase C-gamma-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	9263011	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	decreases phosphorylation of	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	1832084,2139676	2007-11-07 17:30	A synthetic peptide containing residues 581-597 from HIV-1 gp41 inhibits protein kinase C (pkC)-mediated phosphorylation of the CD3 gamma-chain in intact cells and directly inhibits partially purified pkC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	1832084	2007-11-07 17:31	HIV-1 gp41 peptide (amino acids 581-597) inhibits lymphoproliferation stimulated via the T-cell-activation molecules CD3, CD2, and CD28, as well as via direct stimulation mediated by phorbol ester combined with ionomycin
11676	156110	NP_057857.2	Nef	downregulates	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	11298321,15638726	2007-11-07 17:28	Expression of HIV-1 Tat and/or HIV-1 Nef in the absence of HIV-1 Rev leads to downregulation of CD3-gamma gene transcripts and TCR/CD3 surface density
11676	156110	NP_057857.2	Nef	downregulates	9606	917	NP_000064.1	T-cell surface glycoprotein CD3 gamma chain precursor	16777597	2007-11-07 17:31	HIV-1 nef alleles from the great majority of primate lentiviruses, including HIV-2, downregulate TCR-CD3 from infected T cells and thereby block their responsiveness to activation
11676	155030	NP_579880.1	capsid	interacts with	9606	919	NP_000725.1	T-cell surface glycoprotein CD3 zeta chain isoform 2 precursor	1385321,2111780,7517794,8809126,9743208,10722370	2007-11-07 17:29	Synthetic peptides corresponding to amino acids 218-238 of HIV-1 Capsid have been shown to inhibit in a dose dependent manner the induction of a specific antibody response to the sheep red cell (SRC) antigen through the T3-Ti complex
11676	155030	NP_579880.1	capsid	inhibits	9606	919	NP_000725.1	T-cell surface glycoprotein CD3 zeta chain isoform 2 precursor	7517794	2007-11-07 17:29	Peptides corresponding to amino acids 218-238 of HIV-1 Capsid inhibited anti-CD3-induced lymphoproliferation but did not directly affect anti-CD2 activation
11676	155030	NP_579880.1	capsid	interacts with	9606	919	NP_000725.1	T-cell surface glycoprotein CD3 zeta chain isoform 2 precursor	8809126,9743208	2007-11-07 17:29	Interferon-gamma can counteract the inhibitory effect of HIV-1 Capsid based peptides on antibody response to SRC
11676	155871	NP_057853.1	Tat	interacts with	9606	919	NP_932170.1	T-cell surface glycoprotein CD3 zeta chain isoform 1 precursor	9045614,9510190,17001685	2007-11-07 17:28	HIV-1 Tat interacts with CD3 and CD28 to co-stimulate IL-2 and IL-8 expression
11676	156110	NP_057857.2	Nef	interacts with	9606	919	NP_932170.1	T-cell surface glycoprotein CD3 zeta chain isoform 1 precursor	10224289,11463741,12734410	2007-11-07 17:28	HIV-1 Nef directly interacts with TCR-zeta; this interaction is mediated through amino acids 73-82 in Nef and is required for HIV-mediated upregulation of Fas ligand expression
11676	156110	NP_057857.2	Nef	Interacts with	9606	919	NP_932170.1	T-cell surface glycoprotein CD3 zeta chain isoform 1 precursor	11525746,12734410,16454711	2007-11-07 17:28	An HIV-1 Nef isoform (R-Nef) efficiently interacts with signaling molecules of the T cell receptor (TCR) in primary T cells, including TCR-zeta, Lck, and Vav; the PxxP motif in Nef is involved in the interactions
11676	156110	NP_057857.2	Nef	Upregulates	9606	919	NP_932170.1	T-cell surface glycoprotein CD3 zeta chain isoform 1 precursor	15186530,16454711	2007-11-07 17:28	HIV-1 Nef increases the association of the src family tyrosine kinase, Lck, and TCRzeta with rafts in human T cells, suggesting Nef primes resting T cells for activation by increasing the levels of signaling molecules within rafts
11676	155459	NP_057851.1	Vif	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8924209	2007-11-07 17:27	Vif plays an important role in promoting HIV-1 binding to CD4
11676	155807	NP_057852.2	Vpr	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11024150,16354571	2007-11-07 17:27	HIV-1 Vpr downregulates the expression of surface CD4 receptors in Jurkat T cells
11676	155871	NP_057853.1	Tat	upregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2845147,16354571,17001685	2007-11-07 17:28	HIV-1 Tat upregulates mRNA expression and cell surface levels of CD4 antigen in Jurkat cells
11676	155945	NP_057855.1	Vpu	degrades	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1433512,7778293,7853484,8091666,8091684,8230446,8289353,8350411,8510209,8551619,8709227,8806575,8887470,9049413,9151836,9622505,10375528,15929700	2007-11-07 17:27	The C-terminal domain of HIV-1 Vpu (amino acids 76-81) interacts with the cytoplasmic domain of CD4 (amino acids 402-425) and causes the rapid degradation of CD4 in the endoplasmic reticulum
11676	155945	NP_057855.1	Vpu	regulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1727486,7961587	2007-11-07 17:27	HIV-1 Vpu regulates the formation of intracellular HIV-1 gp160-CD4 complexes and liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum
11676	155945	NP_057855.1	Vpu	degrades	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8139011,8659106,9185604,11024464,12954211	2007-11-07 17:27	Phosphorylation of HIV-1 Vpu on two serine phosphoacceptor sites (amino acids 52 and 56) by casein kinase 2 is required for Vpu-mediated degradation of CD4 in the endoplasmic reticulum
11676	155945	NP_057855.1	Vpu	degrades	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9499087,9660940,14561767,15099523,15279589,16354571,17121803	2007-11-07 17:27	HIV-1 Vpu mediated degradation of CD4 requires the function of proteasomes and results from the formation of a ternary complex between beta-TrCP, Vpu and CD4 which connects CD4 to the endoplasmic reticulum degradation pathway
11676	155945	NP_057855.1	Vpu	inhibited by	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	10559275	2007-11-07 17:27	Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity, possibly by disrupting the oligomeric structure of Vpu
11676	155945	NP_057855.1	Vpu	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	12746459,12842621,17121803	2007-11-07 17:29	Downregulation of CD4 from the surface of HIV-1 infected cells by HIV-1 Vpu increases viral infectivity
11676	155945	NP_057855.1	Vpu	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	15975620	2007-11-07 17:28	A simian-human immunodeficiency virus (SHIVtm) with a scrambled amino acid sequence in the transmembrane domain of HIV-1 Vpu fails to downregulate cell surface expression of CD4
11676	155945	NP_057855.1	Vpu	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	17121803	2007-11-07 17:31	Co-expression of HIV-1 Vpu with beta-TrCP2 induces degradation of total cellular CD4 content; Vpu-mediated CD4 down-modulation is inhibited by double silencing of beta-TrCP1 and beta-TrCP2
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1501294,8151300	2007-11-07 17:30	Dimeric HIV-1 gp160 binds to two CD4 molecules
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1501294,1520872,1677023,1678778,1697332,1727486,1727497,1979339,1984054,1985202,2104682,2111957,2187500,2190605,2214026,2523711,2538547,2545918,2558687,7504739,7576930,7688827,7853478,7903106,8091666,8151300,8151301,8178478,8438588,8560759,8635586,8661396,8661397,8738430,8862276,8882662,8896248,9269777,9360974,9499113,10606089,10873786,11333908,11414813,14646564,15033690,15977243,17083721	2007-11-07 17:29	HIV-1 glycoprotein gp160 binds to both cell surface receptor and soluble CD4 and the interaction of gp160 with CD4 results in virus-cell and cell-cell fusion
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1501294,8151300	2007-11-07 17:30	HIV-1 gp160 molecules exist predominantly as a dimer, but higher forms corresponding to trimers and tetramers are also observed; multiple CD4 molecules bind to the gp160 oligomers
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1535787,1548763,9989602	2007-11-07 17:31	Interaction of HIV-1 gp160 with CD4 increases p56lck autophosphorylation and kinase activity
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	complexes with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1727486,7961587,8091666	2007-11-07 17:31	Coexpression of HIV-1 gp160 and human CD4 in HeLa cells severely impairs HIV-1 gp120 production due to the formation of intracellular gp160-CD4 complexes; this CD4-mediated inhibition of gp160 processing is alleviated by coexpression of Vpu
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	complexes with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1727486,2111957,2214026,8409933,8661397	2007-11-07 17:29	Newly synthesized CD4 and HIV-1 gp160 form a complex prior to transport from the endoplasmic reticulum (ER)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7917519,17083721	2007-11-07 17:31	ICAM-1 promotes HIV-1 gp160-mediated syncytium formation, and the ICAM-1 contrareceptor LFA-1 attenuates the syncytium-inhibiting activity of virus-neutralizing monoclonal antibodies and soluble CD4
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8178478,8661397,16873261	2007-11-07 17:30	A complete disappearance of surface CD4 preceding single-cell death occurs in cell clones expressing gp160, in which a complex between CD4 and gp160 is formed and then accumulates intracellularly
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8661396	2007-11-07 17:27	Amino acid residues 257, 368, 370, and 457 of HIV-1 gp160 are critical for both cell surface and intracellular interaction between gp160 and CD4
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8661397	2007-11-07 17:27	Interaction of the anchoring domain of HIV-1 gp160 with the endoplasmic reticulum membrane is responsible for gp160-mediated cell surface downregulation of CD4
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9269777,9344703	2007-11-07 17:30	HIV-1 gp160 alone or CD4/gp160 cross-linking induces tyrosine phosphorylation of intracellular substrates p59fyn, zap 70, and p95vav and also leads to ras activation
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9443108	2007-11-07 17:31	HIV-1 gp160 and gp120 specifically recognize the C-terminal heparin-binding domain of fibronectin (Fn) and this binding inhibits the interaction of gp160/gp120 with soluble CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1279195,1280382,1281202,1348943,1352879,1354681,1356673,1370558,1373203,1373549,1374095,1376134,1376135,1378510,1381203,1381399,1382339,1388715,1402655,1438278,1457207,1465431,1472279,1493050,1500858,1501286,1503822,1512692,1543562,1546447,1548744,1548769,1549584,1563094,1567578,1569213,1588493,1599754,1602552,1614536,1627247,1636088,1685857,1690236,1691226,1691563,1693676,1696539,1698804,1698964,1701782,1702163,1702842,1703212,1706342,1709701,1710248,1711033,1713252,1717587,1717717,1720590,1720631,1721822,1722676,1727475,1727487,1730924,1732513,1736938,1738091,1742075,1810199,1832782,1845049,1870202,1870209,1871120,1889086,1899141,1910691,1931229,1959561,1967269,1967280,1970124,1971526,1977427,1978941,1979910,1983967,1985197,1991970,1995942,2006155,2018763,2040664,2045792,2059359,2068099,2076345,2078013,2078408,2078409,2082620,2103853,2107024,2111957,2115689,2125484,2136376,2171457,2182910,2187500,2190096,2190605,2198840,2212945,2243375,2251501,2261984,2324685,2325207,2335819,2341717,2363051,2364018,237459	2007-11-07 17:29	HIV-1 envelope glycoprotein gp120 binds to the cell surface receptor CD4 or soluble CD4; the carbohydrates present on gp120 are necessary for CD4 binding during HIV-1 entry
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1279195,1280382,1370558,1374095,1376134,1376135,1380099,1382339,1543562,1548744,1588493,1690236,1702163,1703212,1710248,1717717,1720590,1722676,1724568,1888898,2068099,2136376,2324685,2431105,2431482,2432599,2436231,2437327,2438696,2441727,2446880,2462895,2482055,2821115,2833917,2986290,2986291,2990682,3006256,3018753,3023102,3027168,3038935,3304356,3466790,3484980,3495568,3497054,3652531,7529290,7529735,7533854,7543586,7544051,7545244,7546903,7562439,7592573,7594524,7615007,7685405,7686944,7687306,7689324,7690418,7690724,7692037,7769687,7935503,8139010,8212576,8331723,8363802,8417177,8455141,8460995,8497077,8551569,8568275,8575195,8615015,8627160,8627264,8627711,8663408,8760413,8827217,8892926,8973529,8995609,9000083,9037057,9264287,9641677,9658072,9739096,9862697,10558884,11413335,11413337,11533181,11734627,12072528,12134256,12208966,12477867,12487827,12502824,12584309,12597360,12646791,12646921,12719580,12768015,14505925,14557624,14585209,14659896,15016849,15090827,15168796,15183057,15279588,15308718,153	2007-11-07 17:30	Monoclonal antibodies (MAbs) to defined peptide epitopes or N-linked glycans in HIV-1 gp120 inhibit the binding of gp120 to CD4 and exhibit neutralizing activities against HIV-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1280382,1281202,1348943,1373203,1563094,1567578,1599754,1605591,1627247,1639820,1674549,1687500,1690832,1693676,1713252,1727475,1727487,1870209,1871120,1977427,2007979,2015114,2078408,2190604,2190605,2341717,2538505,2549987,2550671,2829022,2829023,7592573,7618285,7687306,7690418,7693970,7734186,7904348,7904656,8139010,8363802,8419649,8464887,8510207,8663408,8827217,8906988,9658072,11533181,11827520,12943795	2007-11-07 17:29	Soluble CD4 can bind to HIV-1 gp120 and block HIV-1 infectivity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	requires	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1281202,1348943,1370558,1370739,1376135,1380099,1457207,1501286,1527858,1546447,1548744,1548769,1602552,1622897,1627247,1636088,1706342,1709701,1720627,1721822,1742075,1845049,1870202,1899141,1910691,1985197,1995942,2109100,2374593,2830667,2995487,3001934,3016552,3095663,3257102,6096719,7592573,7618285,7688827,7707502,7737288,7754236,7897356,8129620,8160267,8280475,8331723,8361381,8437234,8510207,8551601,8560767,8726523,8806567,8891109,8892926,9349472,12406507,12885233,17084877	2007-11-07 17:30	A high affinity interaction between the HIV-1 glycoprotein gp120/gp41 complex and the cellular receptor CD4 is necessary for both virus-cell and cell-cell fusion; the V3 region (amino acids 301-336) of gp120 and gp41 amino terminus are involved in fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1310988,1979339,2851650,8801439	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1352879,1354681,1354808,1376134,1382339,1489581,1551875,1592430,1711118,1717587,1931230,2062847,3682024,7494500,7616571,7692087,7737288,7831801,8102473,8356059,8419649,8460995,8615021,8649438,8811198,8827218,8977179,10557278,11311058,11413337,15665647,16611063,16736946	2007-11-07 17:29	Synthetic peptides as agonists of the HIV-1 envelope glycoprotein gp120 or CD4 receptor block the binding of gp120 and CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1356673,1402655,2198840,2543930,2846691,7541827,7914230,8168144,8356059,8575195,8801439,9186786,16829607,16855325,17180012	2007-11-07 17:30	HIV-1 envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Antigens
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1356673,1388715,2468713,7589092,7615007,7913036,8552983,8575195,8801439,9002959,9036944,9043947,9123823,9269777,9344703,9548463,9604776,9637477,10202115,10623764,16829607	2007-11-07 17:29	HIV-1 gp120 suppresses T and B cell activation and the expression of cytolytic activities through its interaction with CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1370558,1493050,1549584,1698804,2076345,2111957,2136376,2536098,8122371,8160267,8416385,8627264,15183057	2007-11-07 17:29	Removal of the N-linked sugars on HIV-1 gp120 by endoglycosidase H treatment results in deglycosylated proteins that are unable to bind to CD4, suggesting that glycosylation contributes to the ability of gp120 to bind to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1373203,1378510,1381201,1381399,1438278,1503822,1614536,1690236,1691226,1698911,1701782,1702842,1706342,1757107,1888898,1977427,1983967,2040664,2078408,2198840,2461565,2482055,2537355,2555159,2571187,3029227,3260352,7506554,7544051,7592573,7685405,7686944,7690724,7769687,7904351,8196669,8363802,8464887,8497074,8615032,8827217,9739096,12477840,12943795,14505925,14592765,15168796,15321703,15650196,15893666,16106369,16426633,16616288,17158233	2007-11-07 17:29	Anti-CD4 antibodies are capable of neutralizing HIV-1 strains or blocking the binding of HIV-1 envelope glycoprotein gp120 and cell surface receptor CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1373549,12885233	2007-11-07 17:30	Amino acid residues (102-126) and (425-452) of HIV-1 gp120 contribute to the binding site for CD4 and are expected to be juxtaposed in the folded gp120 chain
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulated by	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1374095,2190096	2007-11-07 17:30	Expression of a soluble CD4 mutant molecule lacking transmembrane and cytoplasmic domains blocks secretion of HIV-1 gp120 and surface expression of HIV-1 gp120 and gp41 from the endoplasmic reticulum
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1380260,15936090	2007-11-07 17:30	Pretreatment of HIV-1 infected cells with TNF alpha augments syncytia formation mediated by the interaction of HIV-1 gp120 with cell surface CD4 molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1381203,15936090	2007-11-07 17:30	Interaction of HIV-1 gp120 with cell-associated CD4 leads to the induction of IFN alpha; preincubation of cells with anti-CD4 or the presence of soluble CD4 during incubation inhibits IFN alpha induction
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1402655,7589091,7754236,7913036,8547064,8801439,9344703,9604776,16829607	2007-11-07 17:30	Crosslinking of HIV-1 gp120 on human CD4+ T cells followed by signaling through the TCR results in activation-induced apoptosis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1457205	2007-11-07 17:30	LFA-1 adhesion molecules are not involved in the early stages of cell membrane fusion mediated by the interaction of gp120 with CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1465431,1713692,1888898,1889086,1967269,1978941,12033937	2007-11-07 17:29	Amino acid residues 42-49 and 54-57 in the V1 region of CD4 are involved in the interaction of CD4 with both HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1491632,1535086,1622897,2040625,7545243,7774645,7821926,8862276,9473011,9621091,10941932,16873261,16886061	2007-11-07 17:30	HIV-1 gp120 induces the dissociation of p56lck from CD4 and the downregulation of CD4 from the cellular surface
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1537337	2007-11-07 17:30	A 287 residue variant of HIV-1 gp120 (ENV59) missing 197 amino acids binds to CD4 with high affinity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1551875,1931230,1971526	2007-11-07 17:30	A CD4 peptide (amino acids 74-95) inhibits the binding of gp120 to CD4+ human lymphoblastic leukemia (CEM) cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1567578,2243375	2007-11-07 17:29	Changes in two hydrophobic regions (Thr-257 and Trp-427) and two hydrophilic regions (Asp-368, Glu-370, and Asp-457) of HIV-1 gp120 result in significant reductions in CD4 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1691226,1701782,1730924,1732513,2018763,2078013,2103853,2198840,2402498,2453925,2461565,2479005,2482055,2541915,2559777,3260352,3261864,8411350,8986758,10779509,12033937,16331979	2007-11-07 17:30	The first two domains (amino acid residues 1-177) of human CD4 bind effectively to HIV-1 gp120, and most residues interacting with gp120 lie within amino acids 21-64; the COOH-terminal half of the molecule is not necessary
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1691563,7521897,7537501,7576913,8043225,8102473,9451022,9918507,15797855	2007-11-07 17:30	Several polyanionic anti-HIV compounds, including dextran sulfate, pentosan polysulfate, heparin, aurintricarboxylic acid (ATA), suramin, and Evans blue, interact with HIV-1 gp120 to block the binding of gp120 to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1711033,1889086,2549633,2555159,8075984,11535811	2007-11-07 17:29	HIV-1 gp120 and class II MHC binding sites of CD4 are distinct and can be separated
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1721822,1910691,2339113	2007-11-07 17:29	The N-terminal region of HIV-1 gp120 contains conserved residues (amino acids 56-62 and 108-116) critical for binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1721822,1910691,1977427,2187500	2007-11-07 17:30	Through binding to cell surface CD4, both HIV-1 gp120 and gp160 inhibit syncytia formation between HIV-1-infected cells and CD4+ cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1732513	2007-11-07 17:30	Mutation of two basic amino acids Lys46 and Arg59 in CD4 dramatically disrupts its ability to bind HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1738091	2007-11-07 17:30	Two disulfide bonds linking cysteine residues at positions 378 and 445 and positions 385 and 418 in the carboxyl terminus of HIV-1 gp120 contribute to CD4 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1757107	2007-11-07 17:31	Antibodies to LFA-3 block the early stages of HIV-1 infection by cell-free virus following HIV-1 gp120 binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1763044	2007-11-07 17:30	Cleavage of HIV-1 gp120 with trypsin at residue 432 destroys CD4 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1810199	2007-11-07 17:30	Inhibition of HIV-1 binding to CD4 by suramin is reversed by human albumin, suggesting that only free suramin has antiviral properties
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1896455,1995942,2006155,2251501,7515973,7678271,7693970,7904348,7904656,8437224,8627160,8906988,12719560	2007-11-07 17:30	Binding of recombinant soluble CD4 (sCD4), the purified V1 domain of sCD4, or neutralizing antibodies to the HIV-1 surface glycoprotein gp120 on virions results in rapid dissociation of gp120 from its complex with the transmembrane glycoprotein gp41
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1918997,8801439,9604776	2007-11-07 17:30	HIV-1 gp120 stimulates monocytes to release TNF-alpha, IL-1 beta, IL-6, and granulocyte-macrophage-CSF, and this effect can be blocked with soluble CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1970444	2007-11-07 17:29	12-O-tetradecanoylphorbol-13-acetate (TPA) down-modulates the expression of CD4, which is essential for syncytia formation through interaction with the HIV-1 envelope protein gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1970444	2007-11-07 17:29	Downmodulation of the interaction between HIV-1 gp120 and CD4 by TPA is blocked by protein kinase C (PKC) inhibitors, suggesting PKC may play an important role in HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1970444,7906314	2007-11-07 17:30	Phorbol myristate acetate (PMA) pretreatment of CD4+ cells prevents subsequent HIV-1 gp120-induced downregulation of CD4 receptor molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2015114	2007-11-07 17:30	Cleavage at position R315 of HIV-1 gp120 by thrombin is enhanced by soluble CD4 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2045792,2475780	2007-11-07 17:29	A single amino-acid change (cysteine 402 or tryptophan 432) in HIV-1 gp120 can abrogate CD4 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2107024	2007-11-07 17:30	Chimpanzee CD4 molecules bearing the human amino acid at position 87 support syncytium formation, while human CD4 molecules bearing the chimpanzee residue at position 87 do not; HIV-1 gp120 binding to CD4 is not affected by the substitution at position 87
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2115689	2007-11-07 17:29	Small molecules, termed N-carbomethoxycarbonyl-prolyl-phenylalanyl benzyl esters (CPFs), block the binding of gp120 to CD4, but do not interfere with the binding of CD4 to class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2182910	2007-11-07 17:29	HIV-1 gp120 with substitution of cysteines 296, 331, 418 or 445 on fails to bind to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2335819,2538547,7832633,8129620,8160267,8419650,8438588,12438611	2007-11-07 17:29	HIV-1 gp120/160 deglycosylated by Endo H and Endo F still binds to CD4, indicating that the carbohydrates of gp120/160 do not play a significant role in the in vitro binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2402498	2007-11-07 17:29	Mutations at four locations (amino acids 29, 59-64, 77-81, and 85) outside the antigen-complementarity-determining region (CDR2)-like sequence of CD4 markedly affect HIV-1 gp120 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2441877,2482055,2550679,2558637,2559777,12477867,16315040	2007-11-07 17:29	Amino acid sequences 397-439 in HIV-1 gp120 are directly involved in the binding of gp120 to the CD4 receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2550679	2007-11-07 17:29	Deletion analysis shows that amino acid regions 82-95, 386-389, 424-432, and 487-499 constitute a part of the HIV-1 gp120 binding region to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2842778	2007-11-07 17:30	95- and 25-kDa peptides derived from the disulfide bond reduction of HIV-1 gp120 bind to human CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	3259291	2007-11-07 17:30	A specific interaction between CD4 and HIV-1 gp120 is required for phosphorylation of CD4, which could involve protein kinase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7506554,7774645,7914230,8125527,9043947,9344703	2007-11-07 17:29	Binding of HIV-1 gp120 to the CD4 receptor molecule results in co-stimulation of CD3-induced T cell activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7522245,9036944,9123823	2007-11-07 17:30	Binding of HIV-1 gp120 to CD4 receptor induces p56lck activation and zeta-chain (TCR) associated protein kinase 70kDa desensitization independent of TCR tyrosine phosphorylation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7541827	2007-11-07 17:31	The binding of HIV-1 gp120 to CD4 molecules on T cells interrupts the sequential cascade of intercellular interactions involving antigen/MHC class II-TCR/CD4, CD40L-CD40, and B71-CD28
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7589091,7589092,7897355,7897356,7906657,8105835,8738430,8806567,8891109,11397808	2007-11-07 17:29	Expression of the HIV-1 envelope gene in CD4+ T cell lines and binding of HIV-1 gp120 to CD4 is sufficient for the induction of apoptosis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7774645,7874384,8437234,10758170	2007-11-07 17:29	Calcium ions are required for cell fusion mediated by interactions between CD4 and HIV-1 gp120/gp41; EDTA and EGTA block cell fusion in culture media containing calcium ions
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7821926,7867080	2007-11-07 17:30	Apoptosis of CD4+ lymphocytes induced by HIV-1 gp120 cross-linking to CD4 is inhibited by IL-12
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7903479	2007-11-07 17:29	CD26 (dipeptidyl peptidase IV) cleaves the highly conserved V3 loop of HIV-1 gp120 and functions as a cofactor for entry of HIV-1 in CD4+ human cells; coexpression of human CD4 and CD26 in murine NIH 3T3 cells renders them permissive to HIV-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8331723,8497077	2007-11-07 17:29	Mutants with amino acid changes in the V1/V2 region (residues 131-196) of the HIV-1 gp120 are able to bind CD4 but are deficient in syncytium formation and/or virus entry
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8369162	2007-11-07 17:29	Combinations of CD4-based molecules and antibodies to HIV-1 gp120 and/or gp41 inhibit cell fusion formation mediated by the interaction of CD4 to gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8411350	2007-11-07 17:29	Cells expressing a chimeric molecule consisting of the first 177 residues of CD4 attached to residues from the hinge, transmembrane, and cytoplasmic domains of CD8 are susceptible to fusion with cells expressing HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8419649	2007-11-07 17:29	The third complementarity-determining region (CDR3; residues 79-96) within domain 1 of the human CD4 molecule plays a critical role in membrane fusion mediated by the interaction of CD4 with HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8464887	2007-11-07 17:29	Release of neurotoxins from monocytes through HIV-1 gp120 stimulation involves CD4 receptors; toxin production can be inhibited either by a monoclonal antibody to the CD4-binding region of gp120 or by soluble CD4 receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleavage induced by	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8474162	2007-11-07 17:29	Following incubation with a soluble form of CD4, gp120 of highly purified HIV-1 preparations is cleaved without addition of exogenous proteinase, yielding two proteins of 50 and 70 kDa; this cleavage likely occurs in the gp120 V3 loop
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8599832	2007-11-07 17:27	IL-16 induces rapid translocation of PKC from the cytosol to the membrane in CD4+ cells; PKC inhibitors completely block IL-16-induced lymphocyte migration as well as the motile response induced by HIV-1 gp120 and anti-CD4 antibody binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8605026,8948487,12769725,12930892,12970437,14967033,15016894,15051887,15109676,15113923,15180540,15180541,15194768,15258189,15321703,15577644,15729334,15778371,15807900,15857997,15956589,15996703,16002156,16103167,16185162,16309726,16515489	2007-11-07 17:27	Small molecules exhibit strong anti-HIV-1 activity by binding specifically to both HIV-1 gp120 and/or cell surface receptors (CD4, CCR5, CXCR4) and prevent gp120/CD4/CCR5 and gp120/CD4/CXCR4 complex formation and cell-cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8629022,8805353,8849450,9499113,9499115,9600268,9601645,9614108,9632631,9653051,9658081,9696823,9721247,9770524,9780207,10074122,10329539,10358157,10364484,10371171,10393974,10430052,10446313,10482576,10559349,10582593,10590121,10600606,10738970,10816381,10875613,11024154,11069996,11086073,11201791,11264367,11265761,11287575,11333905,11356967,11397808,11413305,11489906,11504923,11602639,11752220,11799176,11861874,11876757,11877445,11878912,11884536,11931835,11967288,12120995,12163558,12368322,12402167,12429712,12429730,12502809,12614324,12634405,12713058,12832058,12845769,12857973,12864967,12871111,12873765,12953261,12960231,12963807,14576059,14592831,14990703,15014135,15018709,15113900,15113923,15215692,15258189,15585836,15737612,15748209,15784911,15890935,15990565,16046522,16047221,16103167,16174727,16188969,16227248,16886053,16886061,17121788,17144914,17187670	2007-11-07 17:30	CXCR4, a 45kDa cellular membrane protein, interacts with the cell surface HIV-1 gp120-CD4 complex and acts as a coreceptor to preferentially support T cell line-tropic HIV-1 Env-mediated cell fusion and HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8648738	2007-11-07 17:30	HIV-1 gp120-CD4 interaction is necessary to repress HIV-1 long terminal repeat-dependent luciferase activity; the cytoplasmic domain of CD4 is found to be required for this effect to occur
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8674119,8805353,8898753,8906795,8906796,8976200,9420225,9445013,9525683,9576954,9632396,9653051,9870313,10393974,10446313,10590121,10623731,10644351,10738970,10774549,10816381,10888615,11024154,11069996,11118070,11201791,11238869,11264367,11265761,11312658,11356961,11356967,11397808,11413305,11489906,11504923,11861874,11876757,11877445,11878912,11884536,11906183,11967288,12120995,12163558,12368322,12392548,12429712,12429730,12441808,12610158,12634405,12692222,12845769,12857973,12871111,12873765,12887918,12960231,12963807,14512572,14517611,14592765,14967033,14990703,15018709,15113926,15194768,15215692,15258189,15321703,15767435,15767436,15784911,15807900,15857992,15890935,15956589,15964018,15983047,16002156,16103167,16282475,16300985,16753228,16775320,16817962,17035237,17121788	2007-11-07 17:29	The CCR5 chemokine receptor is required for the entry of macrophage-tropic HIV-1 into target cells; the HIV-1 gp120-CD4 complex binds CCR5, which inhibits the binding of the natural CCR5 ligands macrophage inflammatory protein (MIP)-1alpha and MIP-1beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8707350,11290759	2007-11-07 17:27	CD4 downregulation by the treatment of macrophages with HIV-1 gp120 is mediated through the induction of endogenous TNF-alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8887682	2007-11-07 17:30	Binding of HIV-1 gp120 to CD4 molecules in cells results in the association of Lck and Raf-1, which is abolished by preincubation of the virus with soluble CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9002959,9226175,9548463,10505674,15719026	2007-11-07 17:27	Apoptosis induced by HIV-1 gp120/CD4 cross-linking in Th1 clones is inhibited by anti-CD95 or anti-CD95L neutralizing monoclonal antibodies, as well as by a specific interleukin-1 beta converting enzyme (ICE) inhibitor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9261346,9334377,11333905,12887918,15857992,16777164,16796521,16817962,17053352	2007-11-07 17:28	Antibodies to specific epitopes of HIV-1 gp120 block the interaction of CCR5 with the gp120/CD4 complex, suggesting that a CD4-mediated conformational change in gp120 is required for subsequent binding to CCR5
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9263011	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9377118	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9417096,9573233	2007-11-07 17:31	CD4-expressing human T cell lines induce significant and rapid conformational changes in gp120-gp41 from T cell-tropic HIV-1 strains, and little conformational changes in gp120-gp41 from macrophage-tropic HIV-1 strains
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9443108	2007-11-07 17:31	HIV-1 gp120 specifically recognizes the C-terminal heparin-binding domain of fibronectin (Fn) and this binding inhibits the interaction of gp120 with soluble CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9525894,9600078,10213312,10213313,10233996,10589997,11070895,11201791	2007-11-07 17:31	Glycolipids such as galactosylceramides, sulfogalactoceramides, globotriosylceramide, and gangliosides play an important role as HIV-1 fusion cofactors following the interaction of CD4 and HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9548463	2007-11-07 17:27	Contact of CD4+ T cells with HIV-1 infected or HIV-1 gp120-expressing cells induces PARP hydrolysis, which leads to the cleavage of 116 kDa PARP into two fragments
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9621091	2007-11-07 17:30	CD4-p56Lck interaction is required for HIV-1 gp120-induced nuclear translocation of NF-kappaB in HeLa cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9637477	2007-11-07 17:30	The inhibition of IL-2R expression and proliferation induced by the interaction of CD4 with HIV-1 envelope glycoprotein gp120 is correlated with the inhibition of expression and activation of Janus kinase JAK3
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9724097	2007-11-07 17:31	Gross cystic disease fluid protein-15 (GCDFP-15) binds to CD4, a T-cell co-receptor involved in antigen recognition, thereby inhibiting the ability of the receptor to interact with the HIV-1 envelope protein gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	10089882	2007-11-07 17:31	The chemokine receptor CCR5 is posttranslationally modified by sulfation of its N-terminal tyrosines; sulfated tyrosines contribute to the binding of CCR5 to MIP-1 alpha, MIP-1 beta, and HIV-1 gp120/CD4 complexes and to the ability of HIV-1 to enter cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	10581250	2007-11-07 17:31	The interaction between exposed cyclophilin A (CypA) and cell surface heparans represents the initial step of HIV-1 attachment and is a necessary step for HIV-1 gp120 binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	10593874	2007-11-07 17:31	CD38 expression blocks lymphocyte susceptibility to HIV-1 infection by inhibiting HIV-1 gp120/CD4-dependent viral binding to target cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	10779509	2007-11-07 17:31	Human C" beta strand (amino acids 42-47) of CD4, particularly Phe-43, plays a crucial role in HIV-1 coreceptor function as well as in HIV-1 gp120-CD4 binding capacity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	10941932	2007-11-07 17:31	T-tropic HIV-1 gp120s are capable of priming phorbol ester (PMA) induced co-down-modulation of gp120 complexes with tailless CD4 by interacting with CXCR4, whereas M-tropic gp120 are not, even in the presence of CCR5
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11069996,11327825	2007-11-07 17:31	Antibodies to specific epitopes of the CCR5 or CXCR4 chemokine receptors inhibit the entry of M-tropic, T-tropic, or dual-tropic HIV-1 into target cells by blocking the interaction of the receptors with the HIV-1 gp120/CD4 complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11352665	2007-11-07 17:30	The level of HIV-1 gp120-mediated syncytium formation and infectivity is enhanced in the presence of neuraminidase (NA) and involves the interaction between gp120, CD4, and chemokine coreceptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11453640,15033567	2007-11-07 17:31	A fusion protein between HIV-1 gp120 hepatitis B surface antigen (HBsAg) is capable of spontaneous assembly into virus-like particles and exhibits high affinity binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11602639,15719026	2007-11-07 17:31	Syncytial apoptosis mediated by the fusion of cells expressing HIV-1 gp120 with cells expressing the CD4/CXCR4 receptor/coreceptor complex causes phosphorylation of p53 on serine 15 and Bax upregulation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11704677,12008044	2007-11-07 17:31	The physiological levels of cell-surface CD4 interfere with HIV-1 replication in T cells by a mechanism that inhibits HIV-1 gp120 envelope incorporation into viral membranes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11711593	2007-11-07 17:31	The cis expression of DC-SIGN on multiple lymphoid cell lines enables more efficient entry and replication of CXCR4-tropic and CCR5/CXCR4 dual-tropic HIV-1 through its binding to the HIV-1 gp120-CD4-CXCR4 complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	relocalizes	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11799176	2007-11-07 17:31	Adsorption of multivalent gp120-containing HIV-1 virion particles into CD4+ T lymphocytes results in segregation of CD4 and CXCR4 into distinct lipid microdomains
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11804554	2007-11-07 17:31	CD4(+)CD45RO(+) cells display high HIV-1 gp120-binding capacity, whereas CD4(+)CD45RO(-) cells show undetectable HIV-1 gp120 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	12083833	2007-11-07 17:31	HIV-1 gp120 interacts with CD4 and alphavbeta3 in peripheral blood monocyte-derived macrophages; neutralizing antibodies against the alphavbeta3 integrin interfere with the coprecipitation of alphavbeta3 with an anti-gp120 antibody
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	12145207,15719026	2007-11-07 17:30	Cell-cell contact between T cells expressing HIV-1 gp120/gp41 and other T cells expressing CD4 receptors leads to the rapid accumulation of cyclin B and tyrosine-hyperphosphorylated p34cdc2 (cdk1) kinase, indicative of cell cycle arrest at G2 phase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	12191776	2007-11-07 17:31	Expression of the human CD4 receptor in murine T-cells is sufficient for syncytia formation with HIV-1 envelope expressing cells and entry of MLV/HIV pseudotyped retroviral vectors, suggesting that the murine CXCR4 is a functional coreceptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	12218051,12218052,14592831	2007-11-07 17:31	Protein-disulfide isomerase (PDI) cleaves disulfide bonds in recombinant HIV-1 envelope glycoprotein gp120, and gp120 bound to the surface receptor CD4 undergoes a disulfide reduction that is prevented by PDI inhibitors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	12707350,14585219	2007-11-07 17:31	Retrocyclin binds to soluble CD4 and HIV-1 gp120, colocalizes with CD4, CXCR4, and CCR5, and inhibits replication of CCR5-tropic and CXCR4-tropic strains of HIV-1 in human cells, presumably through inhibition of gp120-CD4 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	12787886	2007-11-07 17:30	The fusion of insulin-like growth factor I (IGF I) with stromal cell-derived factor I or alpha1 proteinase inhibitor has the capacity to compete with the binding of HIV-1 gp120 to CD4 receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	14739941,15719026	2007-11-07 17:30	HIV-1 gp120-mediated CD4 engagement is involved in the induction of susceptibility of primary human T lymphocytes to CD95-mediated apoptosis through ezrin phosphorylation and ezrin-to-CD95 association
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	15572157,15613479	2007-11-07 17:30	Griffithsin isolated from an aqueous extract of the red alga Griffithsia species blocks CD4-dependent HIV-1 gp120 binding to receptor-expressing cells and binds to viral coat glycoproteins (gp120, gp41, and gp160) in a glycosylation-dependent manner
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	15778371	2007-11-07 17:30	Galectin-1, a dimeric beta-galactoside-binding protein, promotes infection with CCR5-tropic, CXCR4-tropic, and CCR5/CXCR4 dual-tropic HIV-1 variants by facilitating attachment of HIV-1 gp120 to CD4 at the cell surface
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	16148047	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4+-permissive cells increases the level of acetylated alpha-tubulin in a CD4-dependent manner; overexpression of Histone Deacetylase 6 (HDAC6) inhibits the acetylation of alpha-tubulin and prevents HIV-1-cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	16507315	2007-11-07 17:31	The ability of thioredoxin, a protein disulfide isomerase (PDI), to reduce the disulfide bond in CD4 is enhanced in the presence of HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	16963439	2007-11-07 17:31	The V3 domain of HIV-1 gp120 induces associations between CD4 and CCR5 receptors in cholesterol-rich microenvironments
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	17005819	2007-11-07 17:31	Bile salt-stimulated lipase (BSSL), a Lewis X (LeX)-containing glycoprotein found in human milk, binds to DC-SIGN and inhibits the interaction of gp120 with CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	requires	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	17121788	2007-11-07 17:31	HIV-1 gp120-induced Ca(2+) fluxing is CD4 dependent and coreceptor specific, and is mediated by the CCR5 and CXCR4 coreceptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	17132727	2007-11-07 17:31	Alpha-defensins inhibit the binding of HIV-1 gp120 to CD4 through interaction with the D1 domain of CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	17151103	2007-11-07 17:31	Co-expression of CD4 and DC-SIGN in Raji cells promotes internalization and intracellular retention of HIV-1 through interaction with HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	17151103	2007-11-07 17:31	Expression of CD4 on Raji B cells strongly inhibits DC-SIGN-mediated HIV-1 transmission to T cells, presumably through interaction with HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	17158233	2007-11-07 17:31	CCR5- or CXCR4-tropic HIV-1 induce Indoleamine 2,3-dioxygenase (IDO) in plasmacytoid dendritic cells and this induction is inhibited by the blockade of gp120/CD4 interactions with antibodies to CD4
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7688299	2007-11-07 17:30	The HIV-1 transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro; soluble CD4 can block the transglutaminase-catalyzed incorporation of the polyamine spermidine into HIV-1 gp41
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	complexes with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8882662,10776787,12525600,14505910,14624372,14640682,15161081,15258189,15308751,15542675,17010381	2007-11-07 17:31	HIV-1 gp120 and gp41 form a transitional complex with the CD4 receptor and CCR5/CXCR4 coreceptors during virus-cell and cell-cell membrane fusion
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11861835	2007-11-07 17:31	A truncated cytoplasmic domain of 27 amino acids in HIV-1 gp41 can expose highly conserved domains involved in both HIV-1 coreceptor and CD4 binding
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	1565858,2014052,3118220,7902127,7903128,8437228,15638726,16454711	2007-11-07 17:28	HIV-1 Nef downregulates CD4 molecules from the cell surface of T, B, peripheral blood mononuclear and monocyte/macrophage cell lines as well as non-lymphoid cell lines
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	2014052	2007-11-07 17:28	CD4 downregulation by HIV-1 Nef is independent of the level of CD4 mRNA expressed in cells and of the level of CD4 serine phosphorylation
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7769669,15854903	2007-11-07 17:28	Mutational analysis of HIV-1 Nef shows that a membrane targeting domain (residues 2-7) and a conserved glutamic acid-rich segment (residues 60-71) are required for CD4 downregulation but not for viral infectivity enhancement
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7831289,8124721,8151774,11463741,15854903	2007-11-07 17:28	A dileucine motif in the CD4 cytoplasmic domain is required for its downregulation by HIV-1 Nef; cysteine residues in the cytoplasmic domain of CD4 are essential for the binding of Lck but are not required for Nef-induced downregulation
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7831289,7871751,8035515,8151774,10208934,16354571,16454711	2007-11-07 17:28	HIV-1 Nef-mediated downregulation of CD4 is induced by an accelerated dissociation of the T-cell tyrosine kinase Lck and CD4, and a decrease in the half-life of CD4
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7975260	2007-11-07 17:28	CEM cells stably transfected with a replication-defective provirus of HIV-1 that has a rev-splicing mutation and expresses an intact nef gene have markedly reduced cell surface expression of CD4
11676	156110	NP_057857.2	Nef	degrades	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7982906,10199403,11264386	2007-11-07 17:28	HIV-1 Nef-induced CD4 degradation is regulated by a highly conserved diacidic-based motif in Nef that acts as a lysosomal targeting signal through the binding of beta-COP in endosomes
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	7983750	2007-11-07 17:28	HIV-1 Nef downregulates cell surface expression of CD4 in CEM Nef+ cells by promoting the accumulation of CD4 in an acidic early endosome
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8057354,11578695	2007-11-07 17:28	Deletion of the 19 N-terminal amino acids, including the myristoylation signal from HIV-1 Nef inhibits both MHC-I and CD4 downregulation while preserving most CTL, T-helper and B-cell epitopes
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8262036,16454711	2007-11-07 17:28	In adult HIV-1 Nef transgenic mice, CD4 downregulation is found in CD4- and CD8-double positive thymocytes; co-localization of CD4 with a Golgi-specific marker indicates Nef interferes with CD4 intracellular trafficking
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8331733	2007-11-07 17:28	Nef from primary isolates of HIV-1 suppresses surface CD4 expression in human and mouse T cells
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8437228	2007-11-07 17:28	Transduction of the HIV-1 nef gene into murine cells expressing human, chimpanzee, or murine CD4 induces cell surface downregulation of all three molecules; the cytoplasmic domain of CD4 is required for its downregulation by Nef
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8516299	2007-11-07 17:28	CD4 is downregulated by nef alleles isolated from peripheral blood leukocytes of HIV-1-infected individuals; Nef proteins with point mutations at positions Gly2, Asp36, Cys122, and Val148 exhibit different levels of CD4 downregulation
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8599214	2007-11-07 17:28	HIV-1 Nef mutants C142A and K158A/E160G exhibit a temperature-dependent ability to downregulate CD4
11676	156110	NP_057857.2	Nef	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8599229	2007-11-07 17:28	Yeast two-hybrid assays show that a nearly complete HIV-1 Nef protein is required for binding to the CD4 cytoplasmic domain (residues 394-416), and the dileucine motif in CD4 (residues 413-414) is essential for this direct interaction
11676	156110	NP_057857.2	Nef	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8599760,11264384	2007-11-07 17:28	Solution NMR spectroscopy studies show a 13 amino acid peptide (residues 407-419) derived from the CD4 cytoplasmic domain binds directly to HIV-1 Nef in a manner that involves amino acid residues 57-59, 95-97, 106, and 110 in Nef
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8709227	2007-11-07 17:28	HIV-1 Nef downregulates CD4 rapidly during the early phase of virus infection, whereas HIV-1 Vpu and Env function late in the infection; in primary cells, down-modulation of CD4 has a stronger dependence on Nef function for reducing cell surface CD4
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	8871625	2007-11-07 17:28	A dileucine motif in the cytoplasmic domain of CD4 is involved in the association of CD4 with the tyrosine kinase Lck and the downregulation of CD4 by HIV-1 Nef, however Nef does not induce dissociation of Lck from CD4 in acutely HIV-infected cells
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9049297,9473011,12734410,12836198,14965316,15078178,16091223,16310238,16354571,16454711,16476977,16684552,16873261,17042973,17077296	2007-11-07 17:28	HIV-1 Nef downregulates CD4 expression on the surface of Jurkat cells and blocks the CD3 signaling pathway; mutations at amino acids 174 and 175 reduce the ability of Nef to downregulate CD4 expression
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9052838,9811606,9811611	2007-11-07 17:28	A dileucine motif in Nef is required for CD4 downregulation and for interaction with clathrin adaptor complexes AP-1 and AP-2, which are responsible for recruiting sorted proteins into clathrin-coated pits
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9168885	2007-11-07 17:28	An isoleucine residue at position 410 and two leucine residues at positions 413 and 414 in CD4 are required for HIV-1 Nef-mediated CD4 downregulation in cells
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9168885	2007-11-07 17:28	Two distinct regions within HIV-1 Nef, amino acid residues 96-144 and 175-186, are required for CD4 downregulation in cells
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	9923610	2007-11-07 17:28	Overexpression of Nef-associated factor 1, Naf1, increases cell surface CD4 expression; HIV-1 Nef suppresses this activity of Naf1 to downregulate CD4 expression
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	10375525,10375528	2007-11-07 17:28	High levels of CD4 on the surface of an HIV-1 producing cell block viral infectivity by interfering with incorporation of HIV-1 envelope into the virion; HIV-1 Nef and Vpu inhibit this block by downregulating CD4 from the cell surface
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	10451539,11581379,11932428,12816953,12842621,17083721	2007-11-07 17:28	CD4 downregulation by HIV-1 Nef enhances the efficiency of HIV-1 replication in both activated human primary T lymphocytes and lymphoid tissues; Nef-induced CD4 downregulation correlates with severe depletion of CD4+ T cells in lymphoid tissues
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	10684310,12525647	2007-11-07 17:28	The functional ability of HIV-1 Nef to downregulate CD4, but not MHC class I, is associated with Nef-mediated enhancement of HIV-1 pathogenicity in severe combined immunodeficiency (SCID) mice implanted with human fetal thymus and liver
11676	156110	NP_057857.2	Nef	modulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11396948,14557639	2007-11-07 17:28	Different levels of CD4 modulation are induced by different HIV-1 Nef proteins derived from HIV-1 infected adults and children
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11438519	2007-11-07 17:28	HIV-1 Nef downregulates CD4 in Jurkat cells in a concentration-dependent manner
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11602785	2007-11-07 17:28	The HIV-1 Nef mutant F12-HIVNef, containing three rare amino acid substitutions, G(140)E, V(153)L and E(177)G, represses Nef-induced accelerated rates of CD4 internalization and p62NAK activation
11676	156110	NP_057857.2	Nef	binds	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	11922627	2007-11-07 17:28	The presence of an alpha-helix in CD4, which extends from residues Gln403 to Arg406, promotes the binding of CD4 to HIV-1 Nef
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	13679604	2007-11-07 17:28	A dileucine motif in the cytoplasmic tail of CD4 is not required for HIV-1 Nef binding in insect cells, but is essential for Nef-induced CD4 downregulation
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	14670336	2007-11-07 17:28	Expression of HIV-1 Nef in human monocyte-derived dendritic cells using an adenovirus based delivery system decreases CD4 levels, but has no effect on class I MHC
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	15166428	2007-11-07 17:28	The Nef protein from the primary virus isolate HIV-1 KS2 lacks two glutamic acid residues (EE154-5) and has a decreased ability to downregulate CD4
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	15166429	2007-11-07 17:28	HIV-1 expressing Nef proteins defective in CD4 downregulation activity retain wild-type levels of infectivity in single-round assays, but exhibit delayed replication kinetics and lower titers compared to the wild-type virus in monocyte-derived macrophages
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	15194762	2007-11-07 17:28	HIV-1 group N and group O Nef alleles only weakly downregulate CD4, CD28, and class I and II MHC molecules
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	15202998	2007-11-07 17:28	HIV-1 Nef forms a ternary complex with ARF1 and beta-COP in endosomes, which facilitates Nef-induced downregulation and transport of CD4 to acidic late-endosomal compartments
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	15494497	2007-11-07 17:28	PMA treatment of T cells expressing HIV-1 Nef, which downregulates CD4, restores cell surface CD4 up to 35%; mutations in the phosphorylation sites of the CD4 cytoplasmic tail (Ser408 and Ser415) abolish this effect of PMA
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	15722538	2007-11-07 17:28	Experiments using both a recombinant HIV-1 Integrase-defective virus and a diketo acid Integrase inhibitor demonstrate that HIV-1 Nef expressed from extrachromosomal DNA (E-DNA) downregulates CD4 surface expression on primary CD4(+) T lymphocytes
11676	156110	NP_057857.2	Nef	interacts with	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	15956605	2007-11-07 17:28	Bioluminescence resonance energy transfer (BRET) and co-immunoprecipitation assays have been used to demonstrate the interaction of HIV-1 Nef and CD4 in intact human cells
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	16116206	2007-11-07 17:28	HIV-1 Nef-mediated CD4 downregulation is profoundly inhibited by the synergistic effect of Eps15DIII, a dominant negative mutant of Eps involved in endocytosis and RNA interference of AP-2 expression
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	16365153,16439540	2007-11-07 17:29	HIV-1 Nef induces drastic and moderate downregulation of CD4 and MHC-I in resting CD4(+) T lymphocytes, respectively, but markedly upregulates cell surface levels of the MHC-II invariant chain CD74
11676	156110	NP_057857.2	Nef	downregulates	9606	920	NP_000607.1	T-cell surface glycoprotein CD4 precursor	16979207	2007-11-07 17:31	CD4 and MHC-1 downregulation are highly conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable
11676	156110	NP_057857.2	Nef	downregulates	9606	925	NP_001759.3	T-cell surface glycoprotein CD8 alpha chain isoform 1 precursor	11251883,16354571,16454711	2007-11-07 17:28	HIV-inoculated and HIV-1 Nef-treated human peripheral blood lymphocytes downregulate cell surface CD8, and this down-modulation could inhibit anti-HIV cytotoxicity associated with cytotoxic T-cell function
11676	156110	NP_057857.2	Nef	co-localizes with	9606	926	NP_742097.1	CD8b antigen isoform 1 precursor	16103193	2007-11-07 17:28	Co-localization of HIV-1 Nef and CD8beta is revealed by staining assays in 293T cells expressing both proteins
11676	156110	NP_057857.2	Nef	downregulates	9606	926	NP_742097.1	CD8b antigen isoform 1 precursor	16103193	2007-11-07 17:28	Downregulation of CD8beta by HIV-1 Nef requires an intact AP-2 complex
11676	156110	NP_057857.2	Nef	downregulates	9606	926	NP_742097.1	CD8b antigen isoform 1 precursor	16103193	2007-11-07 17:28	HIV-1 Nef downregulates surface expression of the beta-chain of the CD8 receptor by accelerated endocytosis; amino acid positions 57 to 58 and 174 to 175 in Nef are involved in the downmodulation
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	928	NP_001760.1	CD9 antigen	16735575,16940516	2007-11-07 17:31	HIV-1 Gag proteins co-localize with tetraspanins CD9, CD81, and CD82 in CD63-enriched microdomains
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	928	NP_001760.1	CD9 antigen	17015697	2007-11-07 17:31	Overexpression of CD81 and CD9 renders cells less susceptible to HIV-1 gp120/gp41-mediated syncytia formation; antibodies raised against CD9 and CD81 enhance syncytia formation
11676	156110	NP_057857.2	Nef	upregulates	9606	929	NP_000582.1	monocyte differentiation antigen CD14 precursor	12414752	2007-11-07 17:28	HIV-1 Nef enhances membrane-bound (m) CD14 expression on monocytes but does not induce the release of soluble CD14 into the culture supernatants of PBMC; the upregulation of mCD14 expression does not involve endogenously produced IL-10
11676	156110	NP_057857.2	Nef	upregulates	9606	933	NP_001762.1	CD22 molecule	12853962	2007-11-07 17:28	B lymphocytes exposed to supernatants from HIV-1 Nef-expressing macrophages have upregulated expression of receptors CD22, CD54, and CD58
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	939	NP_001233.1	CD27 antigen precursor	9263011	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155807	NP_057852.2	Vpr	downregulates	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	17023015	2007-11-07 17:31	HIV-1 Vpr significantly downregulates CD28 expression in infected T cells
11676	155871	NP_057853.1	Tat	interacts with	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	9045614,9510190	2007-11-07 17:28	HIV-1 Tat interacts with CD3 and CD28 to co-stimulate IL-2 and IL-8 expression
11676	155871	NP_057853.1	Tat	inhibited by	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	12077252	2007-11-07 17:28	Recruitment of phosphatidylinositol 3-kinase to CD28 inhibits HIV-1 Tat-mediated transcription
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	8450224,9328113	2007-11-07 17:30	Antibodies against cell surface molecules LFA-1, ICAM-1, HLA-DR, and CD28 inhibit the HIV-1 gp160-induced B cell differentiation response; gp160 also induces IL-6R and CD23 molecule expression on B cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	7541827	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4 molecules on T cells interrupts the sequential cascade of intercellular interactions involving antigen/MHC class II-TCR/CD4, CD40L-CD40, and B71-CD28
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	7589092	2007-11-07 17:27	Molecular interactions of CD2 with LFA-3 and CD28 with B7-1 in conjunction with TCR occupancy prevent T cells from programmed apoptosis mediated by binding of CD4 to HIV-1 gp120, resulting in increased levels of IL-2 and IL-4 secretion from the T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	8706326	2007-11-07 17:30	In the presence of HIV-1 gp120, stimulation through the CD28 pathway partially restores IL-2 and IFN-gamma production by T cell lines in response to anti-CD3 antibodies
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	1832084	2007-11-07 17:31	HIV-1 gp41 peptide (amino acids 581-597) inhibits lymphoproliferation stimulated via the T-cell-activation molecules CD3, CD2, and CD28, as well as via direct stimulation mediated by phorbol ester combined with ionomycin
11676	156110	NP_057857.2	Nef	upregulates	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	10618429	2007-11-07 17:28	HIV-1 Nef upregulates IL-2 secretion and HIV-1 transcription in T cells stimulated via CD3 or CD28
11676	156110	NP_057857.2	Nef	downregulates	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	11285224,12836198,15078178,16454711	2007-11-07 17:28	Amino acid residues 57-59 in HIV-1 Nef interact with the cytoplasmic domain at positions 185-193 of CD28, resulting in CD28 downregulation by endocytosis via the AP-2 pathway
11676	156110	NP_057857.2	Nef	co-localizes with	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	11285224	2007-11-07 17:28	CD28 co-localizes with the AP-2 clathrin adaptor and an HIV-1 Nef-GFP fusion protein
11676	156110	NP_057857.2	Nef	downregulates	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	11285224,12734410,16091223,16354571,16454711	2007-11-07 17:28	HIV-1 Nef downregulates CD28, a major co-stimulatory receptor that mediates effective T-cell activation, by accelerating CD28 endocytosis via the AP-2 pathway
11676	156110	NP_057857.2	Nef	downregulates	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	12836198	2007-11-07 17:28	HIV-1 Nef directly interacts with clathrin adaptor complexes (AP) to downregulate numerous cellular proteins, including CD4, MHC-I, LIGHT, DC-SIGN, CD28 and MHC-II, by misrouting them to the endosomal degradation compartment or the trans Golgi-network
11676	156110	NP_057857.2	Nef	downregulates	9606	940	NP_006130.1	T-cell-specific surface glycoprotein CD28 precursor	15194762	2007-11-07 17:28	HIV-1 group N and group O Nef alleles only weakly downregulate CD4, CD28, and class I and II MHC molecules
11676	155807	NP_057852.2	Vpr	downregulates	9606	941	NP_005182.1	T-lymphocyte activation antigen CD80 precursor	15611322	2007-11-07 17:28	HIV-1 Vpr downregulates the expression of several immunologically important molecules including CD40, CD80, CD83, and CD86 co-stimulatory molecules on monocyte-derived macrophage (MDM) and monocyte-derived dendritic cells (MDDC)
11676	155807	NP_057852.2	Vpr	downregulates	9606	941	NP_005182.1	T-lymphocyte activation antigen CD80 precursor	15956545	2007-11-07 17:28	HIV-1 Vpr inhibits the expression of co-stimulatory molecules including CD80, CD83, and CD86 at the transcriptional level without altering normal cellular transcription during dendritic cell maturation
11676	155871	NP_057853.1	Tat	upregulates	9606	941	NP_005182.1	T-lymphocyte activation antigen CD80 precursor	11751963	2007-11-07 17:27	HIV-1 Tat upregulates the expression of MHC and co-stimulatory molecules CD40, CD80, CD83 and CD86 in monocyte-derived dendritic cells, thereby driving T cell-mediated immune responses
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	941	NP_005182.1	T-lymphocyte activation antigen CD80 precursor	7541827	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4 molecules on T cells interrupts the sequential cascade of intercellular interactions involving antigen/MHC class II-TCR/CD4, CD40L-CD40, and B71-CD28
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	941	NP_005182.1	T-lymphocyte activation antigen CD80 precursor	7589092	2007-11-07 17:27	Molecular interactions of CD2 with LFA-3 and CD28 with B7-1 in conjunction with TCR occupancy prevent T cells from programmed apoptosis mediated by binding of CD4 to HIV-1 gp120, resulting in increased levels of IL-2 and IL-4 secretion from the T cells
11676	156110	NP_057857.2	Nef	interacts with	9606	941	NP_005182.1	T-lymphocyte activation antigen CD80 precursor	8086129	2007-11-07 17:31	HIV-1 Nef-induced B-cell differentiation response is suppressed by monoclonal antibodies to cell surface molecule B7, indicating an interaction between Nef and B7
11676	156110	NP_057857.2	Nef	binds	9606	941	NP_005182.1	T-lymphocyte activation antigen CD80 precursor	16177101	2007-11-07 17:28	HIV-1 Nef co-localizes with MHC class I (MHCI), CD80, and CD86 in intracellular compartments by staining assays, and binds to both human CD80 and CD86 using yeast two-hybrid assays
11676	156110	NP_057857.2	Nef	downregulates	9606	941	NP_005182.1	T-lymphocyte activation antigen CD80 precursor	16177101,16272310,16454711,17077296	2007-11-07 17:28	HIV-1 Nef downregulates the co-stimulatory molecule CD80 from the cell surface in the human monocytic U937 cell line as well as in mouse macrophages and dendritic cells
11676	155807	NP_057852.2	Vpr	downregulates	9606	942	NP_787058.3	T-lymphocyte activation antigen CD86 isoform 1	15611322	2007-11-07 17:29	HIV-1 Vpr downregulates the expression of several immunologically important molecules including CD40, CD80, CD83, and CD86 co-stimulatory molecules on monocyte-derived macrophage (MDM) and monocyte-derived dendritic cells (MDDC)
11676	155807	NP_057852.2	Vpr	downregulates	9606	942	NP_787058.3	T-lymphocyte activation antigen CD86 isoform 1	15956545	2007-11-07 17:29	HIV-1 Vpr inhibits the expression of co-stimulatory molecules including CD80, CD83, and CD86 at the transcriptional level without altering normal cellular transcription during dendritic cell maturation
11676	155871	NP_057853.1	Tat	upregulates	9606	942	NP_787058.3	T-lymphocyte activation antigen CD86 isoform 1	11751963	2007-11-07 17:27	HIV-1 Tat upregulates the expression of MHC and co-stimulatory molecules CD40, CD80, CD83 and CD86 in monocyte-derived dendritic cells, thereby driving T cell-mediated immune responses
11676	156110	NP_057857.2	Nef	binds	9606	942	NP_787058.3	T-lymphocyte activation antigen CD86 isoform 1	16177101	2007-11-07 17:28	HIV-1 Nef co-localizes with MHC class I (MHCI), CD80, and CD86 in intracellular compartments by staining assays, and binds to both human CD80 and CD86 using yeast two-hybrid assays
11676	156110	NP_057857.2	Nef	downregulates	9606	942	NP_787058.3	T-lymphocyte activation antigen CD86 isoform 1	16177101,16272310,17077296	2007-11-07 17:28	HIV-1 Nef downregulates CD86 from the cell surface in the human monocytic U937 cell line as well as in mouse macrophages and dendritic cells
11676	155807	NP_057852.2	Vpr	downregulates	9606	945	NP_001763.2	CD33 antigen (gp67)	15611322	2007-11-07 17:28	HIV-1 Vpr downregulates CD33 expression in PBMC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	952	NP_001766.2	ADP-ribosyl cyclase 1	7539755,9263011	2007-11-07 17:27	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	952	NP_001766.2	ADP-ribosyl cyclase 1	9263011	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	952	NP_001766.2	ADP-ribosyl cyclase 1	10593874,12551845	2007-11-07 17:31	CD38 expression blocks lymphocyte susceptibility to HIV-1 infection by inhibiting HIV-1 gp120/CD4-dependent viral binding to target cells
11676	155807	NP_057852.2	Vpr	downregulates	9606	958	NP_001241.1	tumor necrosis factor receptor superfamily member 5 isoform 1 precursor	15611322	2007-11-07 17:28	HIV-1 Vpr downregulates the expression of several immunologically important molecules including CD40, CD80, CD83, and CD86 co-stimulatory molecules on monocyte-derived macrophage (MDM) and monocyte-derived dendritic cells (MDDC)
11676	155871	NP_057853.1	Tat	upregulates	9606	958	NP_001241.1	tumor necrosis factor receptor superfamily member 5 isoform 1 precursor	11751963	2007-11-07 17:27	HIV-1 Tat upregulates the expression of MHC and co-stimulatory molecules CD40, CD80, CD83 and CD86 in monocyte-derived dendritic cells, thereby driving T cell-mediated immune responses
11676	155945	NP_057855.1	Vpu	upregulates	9606	958	NP_001241.1	tumor necrosis factor receptor superfamily member 5 isoform 1 precursor	15078922	2007-11-07 17:29	HIV-1 Vpu upregulates CD40 expression, which enhances efficient expression of VCAM-1 in endothelial cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	958	NP_001241.1	tumor necrosis factor receptor superfamily member 5 isoform 1 precursor	7541827	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4 molecules on T cells interrupts the sequential cascade of intercellular interactions involving antigen/MHC class II-TCR/CD4, CD40L-CD40, and B71-CD28
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	958	NP_001241.1	tumor necrosis factor receptor superfamily member 5 isoform 1 precursor	11087201	2007-11-07 17:30	HIV-1 gp120-induced reduction of IL-12 parallels IL-10 induction and inhibits translocation of CD40 to the surface of monocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	958	NP_001241.1	tumor necrosis factor receptor superfamily member 5 isoform 1 precursor	15749123	2007-11-07 17:30	Upregulation of apoptosis genes such as NCK-associated protein 1, PTB domain adaptor protein CED-6, and TNF receptor superfamily 5 are induced by HIV-1 gp120 in human neurons
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	959	NP_000065.1	CD40 ligand	7541827,12960257,14764743	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4 molecules on T cells interrupts the sequential cascade of intercellular interactions involving antigen/MHC class II-TCR/CD4, CD40L-CD40, and B71-CD28
11676	156110	NP_057857.2	Nef	inhibits	9606	959	NP_000065.1	CD40 ligand	16429138	2007-11-07 17:31	HIV-1 Nef suppresses immunoglobulin class-switch DNA recombination by inducing IkappaBalpha and SOCS proteins, which block CD154, IL-4 and IL-10 cytokine signaling via NF-kappaB and STAT transcription factors
11676	155807	NP_057852.2	Vpr	downregulates	9606	960	NP_000601.3	CD44 antigen isoform 1 precursor	12444143	2007-11-07 17:27	HIV-1 Vpr potentiates the suppression of CD44 by glucocorticoids via the glucocorticoid receptor pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	965	NP_001770.1	lymphocyte function-associated antigen 3 isoform 1	1757107	2007-11-07 17:30	Antibodies to LFA-3 block the early stages of HIV-1 infection by cell-free virus following HIV-1 gp120 binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	965	NP_001770.1	lymphocyte function-associated antigen 3 isoform 1	7589092	2007-11-07 17:27	Molecular interactions of CD2 with LFA-3 and CD28 with B7-1 in conjunction with TCR occupancy prevent T cells from programmed apoptosis mediated by binding of CD4 to HIV-1 gp120, resulting in increased levels of IL-2 and IL-4 secretion from the T cells
11676	156110	NP_057857.2	Nef	upregulates	9606	965	NP_001770.1	lymphocyte function-associated antigen 3 isoform 1	12853962	2007-11-07 17:28	B lymphocytes exposed to supernatants from HIV-1 Nef-expressing macrophages have upregulated expression of receptors CD22, CD54, and CD58
11676	155030	NP_579876.2	matrix	co-localizes with	9606	966	NP_000602.1	CD59 glycoprotein preproprotein	10708443	2007-11-07 17:28	HIV-1 Matrix co-localizes with CD59 in lipid rafts, the site of virus particle budding from cells, and CD59 is incorporated into virus particles as a result of this process
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	966	NP_000602.1	CD59 glycoprotein preproprotein	7539755,9263011	2007-11-07 17:27	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	966	NP_000602.1	CD59 glycoprotein preproprotein	8887350	2007-11-07 17:30	The complement regulatory proteins CD55 (DAF) and CD59 (HRF20) exist on HIV-1 virions, along with HIV-1 gp120 molecules, suggesting an interaction between these proteins and gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	966	NP_000602.1	CD59 glycoprotein preproprotein	9263011	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	downregulates	9606	966	NP_000602.1	CD59 glycoprotein preproprotein	10786997	2007-11-07 17:31	A peptide corresponding to the amino acids 598-613 of HIV-1 gp41, as well as recombinant gp41 protein, markedly reduce CD59 levels in a dose dependent manner in human neuronal and glial cells
11676	155030	NP_579880.1	capsid	co-localizes with	9606	967	NP_001771.1	CD63 antigen isoform A	12230470	2007-11-07 17:29	In human macrophages, HIV-1 Capsid (p24) co-localizes with MHC II (HLA-DR), CD63, and Lamp1 in MHC II compartments
11676	155807	NP_057852.2	Vpr	activates	9606	969	NP_001772.1	early activation antigen CD69	16103171	2007-11-07 17:28	Human endothelial cell (EC)-stimulated virus-producing cells (p24(high) T cells) are activated to sometimes express CD69 (but not CD25, HLA-DR, VLA-1, or effector cytokines) in the presence of HIV-1 Vpr
11676	155871	NP_057853.1	Tat	upregulates	9606	969	NP_001772.1	early activation antigen CD69	10480634	2007-11-07 17:27	HIV-1 Tat binds to a cell surface receptor and activates a cell surface-mediated signal pathway in K562 cells, leading to the activation of NF-kappa B and the induction of CD69
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	969	NP_001772.1	early activation antigen CD69	8528739	2007-11-07 17:30	HIV-1 gp120 significantly inhibits CD69 expression in phytohemagglutinin-stimulated T cells in vitro and may also affect T-cell activation in vivo
11676	156110	NP_057857.2	Nef	downregulates	9606	969	NP_001772.1	early activation antigen CD69	9049297	2007-11-07 17:28	HIV-1 Nef blocks a receptor-proximal event in CD3 signaling by downregulating CD69 expression on the cell surface; mutations at amino acid residues P72, P75, R105 and R106 in Nef disrupts the ability of Nef to block CD3 signaling
11676	156110	NP_057857.2	Nef	downregulates	9606	969	NP_001772.1	early activation antigen CD69	11438519	2007-11-07 17:28	HIV-1 Nef downregulates CD69 in Jurkat cells in a concentration-dependent manner
11676	156110	NP_057857.2	Nef	upregulates	9606	972	NP_004346.1	HLA class II histocompatibility antigen gamma chain isoform b	11593029,12970439,16454711	2007-11-07 17:28	Upregulation of Ii expression by Nef at the cell surface impairs mature MHC class II antigen presentation
11676	156110	NP_057857.2	Nef	upregulates	9606	972	NP_004346.1	HLA class II histocompatibility antigen gamma chain isoform b	15194762,16454711	2007-11-07 17:28	HIV-1 group N and group O Nef alleles upregulate surface expression of invariant chain (Ii) associated with immature major histocompatibility complex (MHC) class II
11676	156110	NP_057857.2	Nef	upregulates	9606	972	NP_004346.1	HLA class II histocompatibility antigen gamma chain isoform b	16365153,16454711	2007-11-07 17:29	HIV-1 Nef induces drastic and moderate downregulation of CD4 and MHC-I in resting CD4(+) T lymphocytes, respectively, but markedly upregulates cell surface levels of the MHC-II invariant chain CD74
11676	156110	NP_057857.2	Nef	upregulates	9606	972	NP_004346.1	HLA class II histocompatibility antigen gamma chain isoform b	16439540	2007-11-07 17:29	Substitution of HIV-1 Nef acidic residue E160 with uncharged residues impairs the ability of Nef to upregulate the expression of DC-SIGN and the invariant chain of MHC class II at the cell surface
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	974	NP_000617.1	B-cell antigen receptor complex-associated protein beta chain isoform 1 precursor	10808179	2007-11-07 17:31	HIV-1 gp120 downregulates CD79B from the surface of dual-positive CD79b/CD20 B cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	974	NP_000617.1	B-cell antigen receptor complex-associated protein beta chain isoform 1 precursor	12482395	2007-11-07 17:31	SDF-1alpha reverses gp120-induced downregulation of CD79b in CD40- and IL-4-activated purified HIV-1 seronegative human peripheral blood B cells
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	975	NP_004347.1	CD81 antigen	16533950,16682056,16735575,16940516	2007-11-07 17:31	HIV-1 Gag proteins co-localize with CD63 and CD81 in intracellular exosomes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	975	NP_004347.1	CD81 antigen	17015697	2007-11-07 17:31	Overexpression of CD81 and CD9 renders cells less susceptible to HIV-1 gp120/gp41-mediated syncytia formation; antibodies raised against CD9 and CD81 enhance syncytia formation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	977	NP_004348.2	CD151 antigen	12775420	2007-11-07 17:31	Downregulation of guanine nucleotide-releasing protein, CD151/PETA-3, neuronatin, neuroendocrine differentiation factor, mitochondria 16s rRNA, and signal recognition particle is observed in HIV-1 infected and HIV-1 gp120-treated astrocytes
11676	155807	NP_057852.2	Vpr	inactivates	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	7474080,7474100,7494303,7666531,9094673,10958988,15142377,15265780,15578977,15725353,15780175,15817944,16354571	2007-11-07 17:28	HIV-1 Vpr inactivates the cdc2-cyclin B kinase complex by inhibiting the dephosphorylation of cdc2 tyrosine 15, leading to arrest in the G2 phase of the cell cycle
11676	155807	NP_057852.2	Vpr	inactivates	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	7474100,11531413,15142377,15265780,15578977,15725353,16354571	2007-11-07 17:28	HIV-1 Vpr inactivates the cdc2-cyclin B kinase complex by inactivating cdc25C, the phosphatase that dephosphorylates and activates cdc2
11676	155807	NP_057852.2	Vpr	inactivates	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	7494303	2007-11-07 17:28	Inactivation of the cdc2-cyclin B kinase complex and arrest in the G2 phase of the cell cycle has been mapped to the C-terminus of HIV-1 Vpr, including amino acids 73, 80 and 84-96
11676	155807	NP_057852.2	Vpr	activates	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	9188632,12525641,16354571	2007-11-07 17:28	Accumulation of the hypophosphorylated or active form of cdc2 kinase is not required for HIV-1 Vpr-induced apoptosis, however one report indicates cdc2 is activated in Vpr-induced apoptotic cells
11676	155807	NP_057852.2	Vpr	inactivates	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	9520381	2007-11-07 17:28	The human Vpr interacting protein (hVIP/MOV34) is a likely cellular cofactor for HIV-1 Vpr inactivation of the cdc2-cyclin B kinase complex and induction of cell cycle arrest
11676	155807	NP_057852.2	Vpr	inhibits	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	9560267	2007-11-07 17:28	Data suggests that HIV-1 Vpr transactivation of the HIV-LTR promoter occurs through the inhibition of p300-associated cdc2-cyclin B kinase complex activity which enhances transcriptional activation by Rel A and p300
11676	155807	NP_057852.2	Vpr	inactivates	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	11878934	2007-11-07 17:28	Inactivation of the cdc2-cyclin B kinase complex by HIV-1 Vpr leads to the activation of Poly(A) polymerase
11676	155871	NP_057853.1	Tat	enhances	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	7716549	2007-11-07 17:30	Cdc2 activity is enhanced by HIV-1 Tat expression in Jurkat T cells and is associated with Tat-induced apoptosis
11676	155871	NP_057853.1	Tat	interacts with	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	15050687	2007-11-07 17:28	When expressed in astrocytes, neurons, and non-glial 293T cells, HIV-1 Tat interacts with a number of cell cycle-related proteins including cyclin A, cyclin B, cyclin D3, Cdk2, Cdk4, Cdk1/Cdc2, cdc6, p27, p53, p63, hdlg, and PCNA
11676	155908	NP_057854.1	Rev	phosphorylated by	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	8806671	2007-11-07 17:29	cdc2 has been shown to phosphorylate Rev in vitro
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces accumulation of	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	8524869	2007-11-07 17:30	Cell-cell contact between T cells expressing HIV-1 gp120/gp41 and other T cells expressing CD4 receptors leads to the rapid accumulation of cyclin B and tyrosine-hyperphosphorylated p34cdc2 (cdk1) kinase, indicative of cell cycle arrest at G2 phase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	983	NP_001777.1	cell division control protein 2 homolog isoform 1	17011204	2007-11-07 17:31	In cultured neurons, HIV-1 gp120 increases transcription factor E2F1 levels in the nucleus, stimulates its transcriptional activity, and enhances the expression of the E2F1 target proteins Cdc2 and Puma
11676	155871	NP_057853.1	Tat	interacts with	9606	990	NP_001245.1	cell division control protein 6 homolog	15050687	2007-11-07 17:28	When expressed in astrocytes, neurons, and non-glial 293T cells, HIV-1 Tat interacts with a number of cell cycle-related proteins including cyclin A, cyclin B, cyclin D3, Cdk2, Cdk4, Cdk1/Cdc2, cdc6, p27, p53, p63, hdlg, and PCNA
11676	155871	NP_057853.1	Tat	downregulates	9606	991	NP_001246.2	cell division cycle protein 20 homolog	16751065	2007-11-07 17:31	The DNA repair gene DNA-PKcs and cell cycle-related genes Cdc20, Cdc25C, KIF2C and CTS1 are downregulated in HIV-1 Tat-expressing human rhabdomyosarcoma cells
11676	155807	NP_057852.2	Vpr	inactivates	9606	995	NP_001781.1	cell division cycle 25C protein isoform a	7474100,11531413,14972559,15142382,15265780,15638722	2007-11-07 17:28	HIV-1 Vpr inactivates the cdc2-cyclin B kinase complex by inactivating cdc25C, the phosphatase that dephosphorylates and activates cdc2
11676	155807	NP_057852.2	Vpr	inactivates	9606	995	NP_001781.1	cell division cycle 25C protein isoform a	7494303	2007-11-07 17:28	Inactivation of the cdc2-cyclin B kinase complex through Cdc25c and arrest in the G2 phase of the cell cycle has been mapped to the C-terminus of HIV-1 Vpr, including amino acids 73, 80 and 84-96
11676	155807	NP_057852.2	Vpr	inactivates	9606	995	NP_001781.1	cell division cycle 25C protein isoform a	9520381	2007-11-07 17:28	The human Vpr interacting protein (hVIP/MOV34) is a likely cellular cofactor for HIV-1 Vpr inactivation of the cdc2-cyclin B kinase complex through Cdc25c and induction of cell cycle arrest
11676	155807	NP_057852.2	Vpr	induces release of	9606	995	NP_001781.1	cell division cycle 25C protein isoform a	11691994	2007-11-07 17:28	Rupture of HIV-1 Vpr-induced nuclear envelope herniations produces transient loss of the subcellular compartmentalization of Wee1, Cdc25C, cyclin B1, and presumably other soluble cellular components, resulting in their release into the cytoplasm
11676	155807	NP_057852.2	Vpr	binds	9606	995	NP_001781.1	cell division cycle 25C protein isoform a	14972559	2007-11-07 17:28	A minimal domain between amino acids 334 and 379 of Cdc25c, upstream of its catalytic site, is sufficient to bind HIV-1 Vpr; mutation at residue E352 of Cdc25c greatly reduces binding of Vpr to Cdc25c
11676	155807	NP_057852.2	Vpr	binds	9606	995	NP_001781.1	cell division cycle 25C protein isoform a	14972559	2007-11-07 17:28	Binding of Cdc25c to HIV-1 Vpr is required for Vpr-mediated G2 arrest in HeLa cells
11676	155807	NP_057852.2	Vpr	complexes with	9606	995	NP_001781.1	cell division cycle 25C protein isoform a	15708996	2007-11-07 17:28	HIV-1 Vpr forms a triple complex with 14-3-3 eta and Cdc25C and thereby promotes cell cycle arrest at the G(2)/M phase by facilitating association of 14-3-3 and Cdc25C
11676	155871	NP_057853.1	Tat	downregulates	9606	995	NP_001781.1	cell division cycle 25C protein isoform a	16751065	2007-11-07 17:31	The DNA repair gene DNA-PKcs and cell cycle-related genes Cdc20, Cdc25C, KIF2C and CTS1 are downregulated in HIV-1 Tat-expressing human rhabdomyosarcoma cells
11676	156110	NP_057857.2	Nef	interacts with	9606	998	NP_001782.1	cell division control protein 42 homolog isoform 1	8994833,10713183,16356860	2007-11-07 17:28	The activation of Nef-associated kinase (NAK; also known as p21-activated kinase 1 or PAK1) by HIV-1 Nef is via the small GTPases Cdc42 and Rac1, suggesting an interaction between Nef and these GTPases
11676	156110	NP_057857.2	Nef	upregulates	9606	998	NP_001782.1	cell division control protein 42 homolog isoform 1	10366564,14597672	2007-11-07 17:27	HIV-1 Nef treatment upregulates active CDC42 levels in dendritic cells
11676	156110	NP_057857.2	Nef	inhibits	9606	998	NP_001782.1	cell division control protein 42 homolog isoform 1	16687395	2007-11-07 17:31	HIV-1 Nef inhibits the concomitant activation of the actin organizer N-Wasp by interfering with the translocation of N-Wasp to the cell periphery and blocks morphological changes induced by the known N-Wasp regulators Rac1 and Cdc42
11676	155807	NP_057852.2	Vpr	upregulates	9606	999	NP_004351.1	cadherin-1 preproprotein	10713718	2007-11-07 17:27	HIV-1 Vpr-expressing Jurkat T cell clones showed upregulated expression of cadherin, suggesting a role of Vpr in modulating the cell adhesion process
11676	155871	NP_057853.1	Tat	enhances	9606	1017	NP_001789.2	cell division protein kinase 2 isoform 1	7716549	2007-11-07 17:30	Cdk2 activity is enhanced by HIV-1 Tat expression in Jurkat T cells and is associated with Tat-induced apoptosis
11676	155871	NP_057853.1	Tat	activates	9606	1017	NP_001789.2	cell division protein kinase 2 isoform 1	9223324	2007-11-07 17:27	HIV-1 Tat induces Cyclin E-associated cdk activity in lymphocytes, indicating Tat drives cells to the late G1 phase of the cell cycle
11676	155871	NP_057853.1	Tat	stimulated by	9606	1017	NP_001789.2	cell division protein kinase 2 isoform 1	9311822,10639311,12049628,12114499	2007-11-07 17:30	Cdk2/cyclin E stimulates Tat-dependent HIV-1 transcription
11676	155871	NP_057853.1	Tat	activates	9606	1017	NP_001789.2	cell division protein kinase 2 isoform 1	9311822,10639311,12049628,12114499	2007-11-07 17:30	HIV-1 Tat induces Cdk2 to phosphorylate the RNA Polymerase C-terminal domain
11676	155871	NP_057853.1	Tat	downregulates	9606	1017	NP_001789.2	cell division protein kinase 2 isoform 1	9525916	2007-11-07 17:28	HIV-1 Tat induces a G1 arrest in cells of glial origin, leading to a downregulation of cyclin E-Cdk2 kinase activity and phosphorylation of Rb
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	1017	NP_001789.2	cell division protein kinase 2 isoform 1	12114499,17083724	2007-11-07 17:30	Cdk2 phosphorylates HIV-1 Tat
11676	155871	NP_057853.1	Tat	interacts with	9606	1017	NP_001789.2	cell division protein kinase 2 isoform 1	12114499	2007-11-07 17:30	Tat-mediated phosphorylation of RNA Polymerase C-terminal domain involves dynamic interactions of Cdk2 with Tat amino acids 15-24 and 36-49 and requires cysteine 22 in the activation domain of Tat and amino acids 42-72 of Tat
11676	155871	NP_057853.1	Tat	interacts with	9606	1017	NP_001789.2	cell division protein kinase 2 isoform 1	15050687	2007-11-07 17:28	When expressed in astrocytes, neurons, and non-glial 293T cells, HIV-1 Tat interacts with a number of cell cycle-related proteins including cyclin A, cyclin B, cyclin D3, Cdk2, Cdk4, Cdk1/Cdc2, cdc6, p27, p53, p63, hdlg, and PCNA
11676	155871	NP_057853.1	Tat	binds	9606	1017	NP_001789.2	cell division protein kinase 2 isoform 1	16289656	2007-11-07 17:29	HIV-1 Tat 41/44 peptide TAALS from the core domain of Tat inhibits Tat-mediated HIV-1 gene expression and replication by binding the Cdk2/Cyclin E complex and inhibiting the phosphorylation of serine 5 of RNAPII
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	1017	NP_001789.2	cell division protein kinase 2 isoform 1	17083724	2007-11-07 17:31	Amino acid residues serine 16 and 46 of HIV-1 Tat are phosphorylated by CDK2; mutation of these two residues reduces HIV-1 transcription in cells
11676	155871	NP_057853.1	Tat	requires	9606	1019	NP_000066.1	cell division protein kinase 4	10639311	2007-11-07 17:28	Cell cycle progression through G1 phase, and in particular the activity of the G1-specific CDK4, is required for HIV-1 Tat transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	1019	NP_000066.1	cell division protein kinase 4	15050687	2007-11-07 17:28	When expressed in astrocytes, neurons, and non-glial 293T cells, HIV-1 Tat interacts with a number of cell cycle-related proteins including cyclin A, cyclin B, cyclin D3, Cdk2, Cdk4, Cdk1/Cdc2, cdc6, p27, p53, p63, hdlg, and PCNA
11676	155871	NP_057853.1	Tat	downregulates	9606	1020	NP_004926.1	cell division protein kinase 5 isoform 1	12491158	2007-11-07 17:28	HIV-1 Tat downregulates the expression of p35, a neuron-specific activator of cdk5, and also binds to Puralpha, which associates with cdk5, leading to deregulation of neuronal differentiation and survival
11676	155807	NP_057852.2	Vpr	enhanced by	9606	1022	NP_001790.1	cell division protein kinase 7	12379213	2007-11-07 17:28	As a component of the TFIIH transcription complex, CDK7 enhances the synergistic activation of glucocorticoid receptor by HIV-1 Vpr and p300
11676	155807	NP_057852.2	Vpr	inhibited by	9606	1022	NP_001790.1	cell division protein kinase 7	12379213	2007-11-07 17:28	As a component of the TFIIH transcription complex, CDK7 inhibits HIV-1 Vpr cell cycle-arresting function
11676	155871	NP_057853.1	Tat	binds	9606	1022	NP_001790.1	cell division protein kinase 7	8628270,8934526,9184228,9334327,9765201	2007-11-07 17:28	Amino acids 1-48 of HIV-1 Tat, which includes the Tat activation domain, mediate the binding of Tat to CAK and the TFIIH complex through a direct interaction with CDK7 and possibly other TFIIH subunits, including p62 and ERCC3
11676	155871	NP_057853.1	Tat	interacts with	9606	1022	NP_001790.1	cell division protein kinase 7	8849451,8934526,9054383,9121429	2007-11-07 17:29	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIH, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	requires	9606	1022	NP_001790.1	cell division protein kinase 7	8934526,9184228,9334327	2007-11-07 17:28	CAK/TFIIH is required for HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	1022	NP_001790.1	cell division protein kinase 7	8934526,9184228,9311822,9334327,9570510,9651670,10438593,10866664,14569024	2007-11-07 17:28	Interaction of HIV-1 Tat with TFIIH stimulates phosphorylation of Ser-5 of the RNA polymerase II C-terminal domain (CTD), which in turn also stimulates co-transcriptional capping of HIV-1 mRNA
11676	155871	NP_057853.1	Tat	synergizes with	9606	1022	NP_001790.1	cell division protein kinase 7	8934526	2007-11-07 17:28	TFIIH synergizes with HIV-1 Tat to induce transcription elongation from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	binds	9606	1022	NP_001790.1	cell division protein kinase 7	9311822,10639311,12049628	2007-11-07 17:28	TFIIH subunits CDK7 and cyclin H have been identified as two components associated with the Tat-associated CTD kinase (TTK) that binds to HIV-1 Tat
11676	155871	NP_057853.1	Tat	interacts with	9606	1022	NP_001790.1	cell division protein kinase 7	9651670,10066804,10082552,10866664,14569024	2007-11-07 17:28	TFIIH interacts with HIV-1 Tat as a component of the HIV-1 transcription preinitiation complex, but is released from the elongation complex which includes P-TEFb
11676	155871	NP_057853.1	Tat	interacts with	9606	1022	NP_001790.1	cell division protein kinase 7	12049628	2007-11-07 17:28	Phosphorylation of CDK7 by CDK2 is involved in the interaction of HIV-1 Tat with CDK7 and subsequent activation of HIV-1 transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	1024	NP_001251.1	cell division protein kinase 8	9121429	2007-11-07 17:28	HIV-1 Tat interacts with the RNA polymerase II holoenzyme, which includes CDK8, during Tat-mediated transactivation of the HIV-1 LTR
11676	155807	NP_057852.2	Vpr	interacts with	9606	1025	NP_001252.1	cell division protein kinase 9	10931842	2007-11-07 17:28	HIV-1 Vpr interacts with CDK9 through binding to HIV-1 Tat and cyclin T1 in a ternary complex, Tat-Vpr-Cyclin T1-CDK9, and enhances Tat transactivation of the viral LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	1025	NP_001252.1	cell division protein kinase 9	7853496,8676484,9570510,9649438,9651670,9696809,10066804,10077579,10082552,10329125,10364292,10438593,10536359,10617616,10866664,10958691,11112772,11547919,12052871,14569024,15994812,16838299	2007-11-07 17:27	During HIV-1 Tat mediated transactivation of the HIV-1 LTR promoter, Tat stimulates the phosphorylation of the C-terminal domain (CTD) of RNA polymerase II by P-TEFb, leading to transcription elongation
11676	155871	NP_057853.1	Tat	binds	9606	1025	NP_001252.1	cell division protein kinase 9	7853496,8676484,9356449,9491887,9651670,9765201,9832504,9843510,9990016,10077579,10329125,10364292,10364329,10384302,10465067,11080476,11504720,12753906,14984439,15139295,15183343,15473004,15638724,15719065,16035254,16146763	2007-11-07 17:27	The N-terminus (amino acids 1-48, including activation domain) of HIV-1 Tat binds to P-TEFb through a direct interaction with the N-terminus (amino acids 1-290) of cyclin T1 during Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	recruits	9606	1025	NP_001252.1	cell division protein kinase 9	8676484,9491887,9649438,9696809,9843510,10329125,10364329,10384302,10393900,10467404,11504720,15994812,16838299	2007-11-07 17:27	HIV-1 Tat recruits P-TEFb to the HIV-1 Transcription Activation Response (TAR) RNA during Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	complexes with	9606	1025	NP_001252.1	cell division protein kinase 9	8849451,9649438,9765201,10393184,10454543,10913173,10964778,11780068	2007-11-07 17:27	Tat-SF1 is a required cofactor for HIV-1 Tat activity that complexes with P-TEFb and Tat, and stimulates Tat-mediated activation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	requires	9606	1025	NP_001252.1	cell division protein kinase 9	9334325,9334326,9557739,10082552,10377393,10393900,10913173	2007-11-07 17:27	P-TEFb is required for HIV-1 Tat-mediated transcriptional activation
11676	155871	NP_057853.1	Tat	regulated by	9606	1025	NP_001252.1	cell division protein kinase 9	9356449,9811724,11689614,11739686,12368300,12588988,12727882	2007-11-07 17:27	The up and downregulation of expression of CDK9 and cyclin T1 or sequestration of cyclin T1 in infected cells may regulate HIV-1 latency by up or downregulating HIV-1 Tat transcriptional activation
11676	155871	NP_057853.1	Tat	enhanced by	9606	1025	NP_001252.1	cell division protein kinase 9	9651670,10049833,10329125,10944537,10958691,11549886	2007-11-07 17:27	The interaction of HIV-1 Tat with HIV-1 Transcription Activation Response (TAR) RNA is enhanced by the interaction of Tat with P-TEFb, and TAR RNA also enhances the interaction between Tat and cyclin T1
11676	155871	NP_057853.1	Tat	binds	9606	1025	NP_001252.1	cell division protein kinase 9	9832504,9843510,9990016,10077579,10329125,10329126,10364329	2007-11-07 17:27	Amino acids 260-263 of cyclin T1 are critical for HIV-1 Tat-mediated transcriptional activation, and mediate the species specificity of cyclin T1 and P-TEFb binding to Tat
11676	155871	NP_057853.1	Tat	inhibited by	9606	1025	NP_001252.1	cell division protein kinase 9	10064603,11152495	2007-11-07 17:27	Overexpression of CDK9 or CDK9 mutants inhibits HIV-1 Tat transcriptional activation
11676	155871	NP_057853.1	Tat	interacts with	9606	1025	NP_001252.1	cell division protein kinase 9	10066804	2007-11-07 17:27	P-TEFb interacts with HIV-1 Tat as part of both the HIV-1 transcription preinitiation and elongation complexes
11676	155871	NP_057853.1	Tat	binds	9606	1025	NP_001252.1	cell division protein kinase 9	10545121,11080476,12486002,12887902	2007-11-07 17:27	Acetylation of HIV-1 Tat by cellular histone acetyltransferases regulates the binding of Tat to P-TEFb
11676	155871	NP_057853.1	Tat	stimulates	9606	1025	NP_001252.1	cell division protein kinase 9	10617616	2007-11-07 17:27	Hsp70 and Hsp90/Cdc37 stabilize CDK9 as well as the assembly of an active P-TEFb complex which is stimulated by HIV-1 Tat during HIV-1 transcriptional activation
11676	155871	NP_057853.1	Tat	binds	9606	1025	NP_001252.1	cell division protein kinase 9	10661406,11118314	2007-11-07 17:27	HIV-1 Tat competes with CIITA for the binding to P-TEFb, leading to the downregulation of MHC class II gene expression
11676	155871	NP_057853.1	Tat	interacts with	9606	1025	NP_001252.1	cell division protein kinase 9	10671520,12944466	2007-11-07 17:27	The human I-mfa domain-containing protein (HIC) interacts with both P-TEFb and HIV-1 Tat, and modulates Tat transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	1025	NP_001252.1	cell division protein kinase 9	10757782,11112772,11809800	2007-11-07 17:27	HIV-1 Tat stimulates the phosphorylation of SPT5 by P-TEFb during transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	regulated by	9606	1025	NP_001252.1	cell division protein kinase 9	10913173,10958691,16838299	2007-11-07 17:27	P-TEFb regulates HIV-1 Tat-mediated activation of transcription through two built-in autoinhibitory mechanisms, autophosphorylation of CDK9 and cyclin T1 binding to the transcription elongation factor Tat-SF1
11676	155871	NP_057853.1	Tat	recruited by	9606	1025	NP_001252.1	cell division protein kinase 9	11282025	2007-11-07 17:27	Cyclin T1 is capable of recruiting CDK9 and HIV-1 Tat to splicing factor-rich nuclear speckle regions, suggesting nuclear speckles are a site of P-TEFb and Tat function
11676	155871	NP_057853.1	Tat	activates	9606	1025	NP_001252.1	cell division protein kinase 9	11572868	2007-11-07 17:27	TFIIH inhibits the phosphorylation of CDK9 in the HIV-1 transcription preinitiation complex, while HIV-1 Tat stimulates CDK9 autophosphorylation to activate transcription elongation
11676	155871	NP_057853.1	Tat	complexes with	9606	1025	NP_001252.1	cell division protein kinase 9	11704662	2007-11-07 17:27	The p160 nuclear receptor co-activator GRIP1 binds to the N-terminal region of HIV-1 Tat, bridging HIV-1 LTR promoter-bound factors to the Tat-P-TEFb complex and enhancing the transactivating activity of Tat
11676	155871	NP_057853.1	Tat	cooperates with	9606	1025	NP_001252.1	cell division protein kinase 9	11730934	2007-11-07 17:27	P-TEFb, Puralpha and HIV-1 Tat cooperate to activate the TNFalpha promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	1025	NP_001252.1	cell division protein kinase 9	12588988,12727882	2007-11-07 17:27	The growth factor granulin and the promyelocytic leukemia (PML) protein regulate HIV-1 Tat-mediated transcriptional activation by competing with the Tat interaction with cyclin T1/P-TEFb
11676	155871	NP_057853.1	Tat	binds	9606	1025	NP_001252.1	cell division protein kinase 9	12832472	2007-11-07 17:27	MAQ1 and 7SK RNA interact with P-TEFb and compete with the binding of HIV-1 Tat to cyclin T1, suggesting the TAR RNA/Tat lentivirus system evolved to subvert the cellular 7SK RNA/MAQ1 system
11676	155871	NP_057853.1	Tat	stimulates	9606	1025	NP_001252.1	cell division protein kinase 9	14569024,16838299	2007-11-07 17:27	HIV-1 Tat-mediated stimulation of RNA polymerase II C-terminal domain phosphorylation by P-TEFb leads to stimulation of co-transcriptional capping of HIV-1 mRNA
11676	155871	NP_057853.1	Tat	complexes with	9606	1025	NP_001252.1	cell division protein kinase 9	15498776	2007-11-07 17:29	PARP1 negatively regulates HIV-1 transcription by directly competing with Tat-P-TEFb complex for binding to TAR RNA
11676	155871	NP_057853.1	Tat	activates	9606	1025	NP_001252.1	cell division protein kinase 9	15564463	2007-11-07 17:28	HIV-1 Tat-induced kinase activity of P-TEFb is highly sensitive to flavopiridol, a CDK inhibitor. P-TEFb-mediated phosphorylation of RNAP II CTD, SPT5, and Tat-SF1 during HIV-1 transcription elongation is also highly sensitive to flavopiridol
11676	155871	NP_057853.1	Tat	complexes with	9606	1025	NP_001252.1	cell division protein kinase 9	15905409	2007-11-07 17:28	SKIP is required for Tat transactivation in vivo and stimulates HIV-1 transcription elongation by associating with CycT1:CDK9 (P-TEFb) and Tat:P-TEFb complexes both in nuclear extracts and in recombinant Tat:P-TEFb:TAR RNA complexes in vitro
11676	155871	NP_057853.1	Tat	complexes with	9606	1025	NP_001252.1	cell division protein kinase 9	16103164	2007-11-07 17:28	Cdk9, the catalytic subunit of P-TEFb, is ubiquitinated by Skp1/Cul1/F-box protein E3 ubiquitin ligase Skp2, which facilitates the formation of the RNA-protein complex between P-TEFb, Tat, and TAR, thereby enhancing Tat transactivation
11676	156110	NP_057857.2	Nef	upregulates	9606	1025	NP_001252.1	cell division protein kinase 9	11420046	2007-11-07 17:28	CDK9 mRNA and kinase activity are upregulated in HIV-1 Nef-expressing human T cell lines
11676	156110	NP_057857.2	Nef	interacts with	9606	1025	NP_001252.1	cell division protein kinase 9	16179353	2007-11-07 17:29	HIV-1 Nef interacts with Hsp40, leading to increased Hsp40 translocation to the nucleus of infected cells and facilitation of viral gene expression by complex formation of Hsp40 with the cdk9-associated transcription complex
11676	155807	NP_057852.2	Vpr	activates	9606	1026	NP_000380.1	cyclin-dependent kinase inhibitor 1	12573582,15302882	2007-11-07 17:28	Activation of p21/Waf1/Cip1 by HIV-1 Vpr appears to be dependent upon p53
11676	155807	NP_057852.2	Vpr	activates	9606	1026	NP_000380.1	cyclin-dependent kinase inhibitor 1	12573582,15142382	2007-11-07 17:28	HIV-1 Vpr activates the expression and transcription of the cyclin-dependent kinase inhibitor p21/Waf1/Cip1, an inhibitor of the G1 and G2/M phase transitions in T lymphoid and myeloid cells
11676	155807	NP_057852.2	Vpr	upregulates	9606	1026	NP_000380.1	cyclin-dependent kinase inhibitor 1	15302882	2007-11-07 17:28	HIV-1 Vpr activates promoter activity of p21/Cip1/Waf1 through the GC-rich region located between nucleotides -84 and -74 in a manner that requires cooperativity of Sp1, which binds to the DNA sequence spanning -84 to -74
11676	155807	NP_057852.2	Vpr	interacts with	9606	1026	NP_000380.1	cyclin-dependent kinase inhibitor 1	15302882	2007-11-07 17:28	Results from GST pull-down assays show the association of Vpr with p53 in extracts containing Sp1, suggesting the physical interaction of Vpr with Sp1 and p53 could modulate transcriptional activity of p21
11676	155871	NP_057853.1	Tat	activates	9606	1026	NP_000380.1	cyclin-dependent kinase inhibitor 1	15179054	2007-11-07 17:28	A p53 fusion protein with the HIV-1 Tat basic domain at its N terminus activates the expression of p21and downregulates the levels of caspase-3 and Bcl-2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	1026	NP_000380.1	cyclin-dependent kinase inhibitor 1	16554660	2007-11-07 17:31	HIV-1 gp120 induces NF-kappaB activation and increases p21(cip1/waf1) and p27(kip1) protein levels in human mesangial cells
11676	155871	NP_057853.1	Tat	interacts with	9606	1027	NP_004055.1	cyclin-dependent kinase inhibitor 1B	15050687	2007-11-07 17:28	When expressed in astrocytes, neurons, and non-glial 293T cells, HIV-1 Tat interacts with a number of cell cycle-related proteins including cyclin A, cyclin B, cyclin D3, Cdk2, Cdk4, Cdk1/Cdc2, cdc6, p27, p53, p63, hdlg, and PCNA
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	1027	NP_004055.1	cyclin-dependent kinase inhibitor 1B	16554660	2007-11-07 17:31	HIV-1 gp120 induces NF-kappaB activation and increases p21(cip1/waf1) and p27(kip1) protein levels in human mesangial cells
11676	155807	NP_057852.2	Vpr	activates	9606	1051	NP_005185.2	CCAAT/enhancer-binding protein beta	10775602	2007-11-07 17:27	HIV-1 Vpr activates NF-IL-6 resulting in an increase in IL-8 expression and IL-8 promoter activity and also increases transcription of NF-IL-6 enhancer-containing viral promoters
11676	155807	NP_057852.2	Vpr	activates	9606	1051	NP_005185.2	CCAAT/enhancer-binding protein beta	10775602	2007-11-07 17:27	Upregulation of IL-6, IL-10, TNFalpha, and gamma interferon is linked to HIV-1 Vpr activation of NF-IL-6
11676	155871	NP_057853.1	Tat	activates	9606	1051	NP_005185.2	CCAAT/enhancer-binding protein beta	8113688,9169458	2007-11-07 17:29	HIV-1 Tat upregulates IL-6 expression by transactivating the IL-6 promoter, an effect mediated through enhancement of CAAT enhancer-binding protein (C/EBP; nuclear factor-IL-6) DNA binding activity
11676	155871	NP_057853.1	Tat	binds	9606	1051	NP_005185.2	CCAAT/enhancer-binding protein beta	9169458	2007-11-07 17:29	HIV-1 Tat induces an increase in C/EBPbeta binding activity through a direct binding interaction between Tat and C/EBPbeta that is mediated through the N-terminal, cysteine rich, and core regions of Tat (amino acids 1-47)
11676	155871	NP_057853.1	Tat	activates	9606	1051	NP_005185.2	CCAAT/enhancer-binding protein beta	12167619	2007-11-07 17:29	HIV-1 Tat induces iNOS in human astroglia through the activation of NF-kappaB and C/EBPbeta, an effect that may participate in the pathogenesis of HIV-associated dementia
11676	155871	NP_057853.1	Tat	modulated by	9606	1051	NP_005185.2	CCAAT/enhancer-binding protein beta	12202226,16511829,17031851	2007-11-07 17:29	Interaction between TGF-beta signaling proteins Smad-3 and Smad-4, and C/EBPbeta modulates basal and HIV-1 Tat-mediated transcription of the HIV-1 LTR promoter in astrocytes
11676	155871	NP_057853.1	Tat	interacts with	9606	1051	NP_005185.2	CCAAT/enhancer-binding protein beta	15710476	2007-11-07 17:28	Interaction of C/EBPbeta and HIV-1 Tat stimulates MCP-1 transcription in astrocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	1056	NP_001798.1	carboxyl ester lipase precursor	17005819	2007-11-07 17:31	Bile salt-stimulated lipase (BSSL) isolated from human milk binds to DC-SIGN, preventing HIV-1 gp120 from interacting with this receptor
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	1068	NP_004057.1	centrin-1	16101678	2007-11-07 17:29	Studies using a combined approach of immunofluorescence detection of Gag protein and in situ hybridization detection of viral genomic RNA indicate Gag co-localizes with Psi+ RNA in the perinuclear region and also co-localizes with centrins
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	1069	NP_004335.1	centrin-2	16101678	2007-11-07 17:29	Studies using a combined approach of immunofluorescence detection of Gag protein and in situ hybridization detection of viral genomic RNA indicate Gag co-localizes with Psi+ RNA in the perinuclear region and also co-localizes with centrins
11676	155807	NP_057852.2	Vpr	induces accumulation of	9606	1069	NP_004335.1	centrin-2	14767062	2007-11-07 17:28	HIV-1 Vpr-expressing HeLa cells stained with centriole markers pericentrin, gamma-tubulin, and Cen2 contain multiple pairs of centrioles scattered in the perinuclear region, indicating Vpr causes the accumulation of multiple centrosome-like structures
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	1070	NP_004356.2	centrin-3	16101678	2007-11-07 17:29	Studies using a combined approach of immunofluorescence detection of Gag protein and in situ hybridization detection of viral genomic RNA indicate Gag co-localizes with Psi+ RNA in the perinuclear region and also co-localizes with centrins
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	1072	NP_005498.1	cofilin-1	8892894	2007-11-07 17:29	The cytoskeletal proteins ezrin, moesin, and cofilin are incorporated into HIV-1 particles, presumably through their interaction with actin which binds to the nucleocapsid domain of HIV-1 Gag
11676	155871	NP_057853.1	Tat	downregulates	9606	1072	NP_005498.1	cofilin-1	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155871	NP_057853.1	Tat	downregulates	9606	1073	NP_068733.1	cofilin-2	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155807	NP_057852.2	Vpr	activates	9606	1111	NP_001265.1	CHK1 checkpoint homolog	12738771,16306615	2007-11-07 17:30	HIV-1 Vpr activates ATR, resulting in phosphorylation of Chk1 and activation of the ATR-mediated DNA damage response
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1134	NP_000070.1	acetylcholine receptor subunit alpha isoform b precursor	1397297	2007-11-07 17:30	HIV-1 gp120 binds to nicotinic acetylcholine receptors in muscle cells and neurons
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1140	NP_000738.2	acetylcholine receptor subunit beta precursor	1397297	2007-11-07 17:30	HIV-1 gp120 binds to nicotinic acetylcholine receptors in muscle cells and neurons
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1141	NP_000739.1	neuronal acetylcholine receptor subunit beta-2 precursor	1397297	2007-11-07 17:30	HIV-1 gp120 binds to nicotinic acetylcholine receptors in muscle cells and neurons
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	1147	NP_001269.3	inhibitor of nuclear factor kappa-B kinase subunit alpha	11959143	2007-11-07 17:31	HIV-1 gp120/CD4 interaction-induced NF-kappaB activation stimulates the hyperphosphorylation of IkappaB-alpha by IkappaB kinases (IKKs)
11676	156110	NP_057857.2	Nef	induces phosphorylation of	9606	1147	NP_001269.3	inhibitor of nuclear factor kappa-B kinase subunit alpha	17182689	2007-11-07 17:31	HIV-1 Nef myristoylation is required for the rapid and transient phosphorylation of the alpha- and beta- subunits of the Ikappa-B kinase complex and activation of JNK, ERK1/2 and p38 MAPK family members
11676	155030	NP_057850.1	Pr55(Gag)	binds	9606	1173	NP_004059.2	AP-2 complex subunit mu isoform a	16139856	2007-11-07 17:29	HIV-1 Gag binds to AP-2, and this binding is dependent on tyrosine residue 132 and valine residue 135 at the matrix-capsid junction in the Gag polyprotein
11676	155871	NP_057853.1	Tat	interacts with	9606	1173	NP_004059.2	AP-2 complex subunit mu isoform a	15020715	2007-11-07 17:28	HIV-1 Tat enters T cells by using clathrin/AP2-mediated endocytosis followed by low-pH-induced and Hsp90-assisted endosomal translocation, which leads to cell responses that are induced from the cytosol
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	1173	NP_004059.2	AP-2 complex subunit mu isoform a	9400603,9882340,11222723,17108326	2007-11-07 17:27	Two tyrosine-based endocytic signals (residues 704-710 and 760-766) in the cytosolic tail (gp41) of the HIV-1 envelope glycoprotein (Env) complex interact with members of the adaptor medium chain family, AP-1 mu1, AP-2 mu2 and AP-3 mu3A
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	1173	NP_004059.2	AP-2 complex subunit mu isoform a	17108326	2007-11-07 17:31	Two independent motifs, a membrane proximal conserved GYxxO motif (residues 711-715) and a C-terminal dileucine motif (residues 855-856), of the HIV-1 gp41 protein mediate endocytosis through interaction with the clathrin adaptor AP-2
11676	156110	NP_057857.2	Nef	requires	9606	1173	NP_004059.2	AP-2 complex subunit mu isoform a	15611114,16116206	2007-11-07 17:28	Nef-mediated CD4 downregulation is inhibited by RNA interference of AP-2 expression, indicating that Nef-mediated CD4 downregulation requires AP-2
11676	156110	NP_057857.2	Nef	Requires	9606	1173	NP_004059.2	AP-2 complex subunit mu isoform a	16103193	2007-11-07 17:28	Using RNA interference analyses, the downregulation of CD8beta by Nef requires an intact mu subunit of the AP-2 complex
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	1174	NP_001274.1	AP-1 complex subunit sigma-1A	9882340,11222723	2007-11-07 17:30	The cytoplasmic domain (residues 707-856) of HIV-1 gp41 interacts with whole clathrin-associated AP-1 and AP-2 adaptor complexes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	1174	NP_001274.1	AP-1 complex subunit sigma-1A	11222723	2007-11-07 17:30	The highly conserved C-terminal dileucine motif (residues 851-856) in the cytosolic domain of HIV-1 gp41 interacts with clathrin-associated AP-1 adaptor complexes
11676	156110	NP_057857.2	Nef	interacts with	9606	1174	NP_001274.1	AP-1 complex subunit sigma-1A	9736718,9811606,9811611,11463741,12486136,12836198,15681409	2007-11-07 17:29	A leucine-based motif near the C-terminus of HIV-1 Nef interacts with AP-1 complexes; residues 164 and 165 in Nef are required for the interaction with AP-1
11676	156110	NP_057857.2	Nef	binds	9606	1174	NP_001274.1	AP-1 complex subunit sigma-1A	12486136,15681409,16253302	2007-11-07 17:29	The dileucine motif (residues 164-165) in HIV-1 Nef is required for binding to AP-1 complexes and stabilizing their association with membranes
11676	156110	NP_057857.2	Nef	stabilizes	9606	1174	NP_001274.1	AP-1 complex subunit sigma-1A	16253302	2007-11-07 17:29	HIV-1 Nef stabilizes AP-1 complexes on endosomal membranes after ADP-ribosylation factor-1 (ARF1) -dependent attachment
11676	155030	NP_057850.1	Pr55(Gag)	binds	9606	1175	NP_004060.2	AP-2 complex subunit sigma isoform AP17	16139856	2007-11-07 17:29	HIV-1 Gag binds to AP-2, and this binding is dependent on tyrosine residue 132 and valine residue 135 at the matrix-capsid junction in the Gag polyprotein
11676	155871	NP_057853.1	Tat	interacts with	9606	1175	NP_004060.2	AP-2 complex subunit sigma isoform AP17	15020715	2007-11-07 17:28	HIV-1 Tat enters T cells by using clathrin/AP2-mediated endocytosis followed by low-pH-induced and Hsp90-assisted endosomal translocation, which leads to cell responses that are induced from the cytosol
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	1175	NP_004060.2	AP-2 complex subunit sigma isoform AP17	9882340,17108326	2007-11-07 17:30	The cytoplasmic domain (residues 707-856) of HIV-1 gp41 interacts with whole clathrin-associated AP-1 and AP-2 adaptor complexes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	1175	NP_004060.2	AP-2 complex subunit sigma isoform AP17	17108326	2007-11-07 17:31	Two independent motifs, a membrane proximal conserved GYxxO motif (residues 711-715) and a C-terminal dileucine motif (residues 855-856), of the HIV-1 gp41 protein mediate endocytosis through interaction with the clathrin adaptor AP-2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1179	NP_001276.2	calcium-activated chloride channel regulator 1 precursor	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	156110	NP_057857.2	Nef	interacts with	9606	1213	NP_004850.1	clathrin heavy chain 1	9314527	2007-11-07 17:28	HIV-1 Nef induces the formation of clathrin-coated pits in the presence of CD4 in human lymphocytes by interacting with components of the clathrin-coated surface domain
11676	155871	NP_057853.1	Tat	modulates	9606	1230	NP_001286.1	C-C chemokine receptor type 1	10094132	2007-11-07 17:29	HIV-1 Tat protein modulates CCR1 and CCR3 mRNA expression in blood-brain barrier cultures, suggesting HIV-induced molecules can manipulate the surface receptor expression of the blood-brain barrier for their preferential entry into brain
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	associates with	9606	1230	NP_001286.1	C-C chemokine receptor type 1	11804551,15053339	2007-11-07 17:31	HIV-1 gp120 from CXCR4-tropic subtype E viruses isolated in Thailand associates with and uses at least one of the following coreceptors for virus entry: CCR8, CCR1, CCR2b, or CX3CR1
11676	155871	NP_057853.1	Tat	upregulates	9606	1232	NP_001828.1	C-C chemokine receptor type 3 isoform 1	9765440,9789057,10094132,11120849,11149986,11396683,15857508	2007-11-07 17:28	HIV-1 Tat upregulates CCR3 expression on monocytes/macrophages, Fc epsilonRI+ cells and blood brain barrier cultures, and acts as a potent chemoattractant, indicating a role for Tat in HIV-1 pathogenesis and in promoting HIV-1 infectivity
11676	155871	NP_057853.1	Tat	binds	9606	1232	NP_001828.1	C-C chemokine receptor type 3 isoform 1	9789057	2007-11-07 17:28	HIV-1 Tat binds to CCR3 and displaces MCP-3 from this beta-chemokine receptor, an effect mediated by Tat amino acids 24-51
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1232	NP_001828.1	C-C chemokine receptor type 3 isoform 1	8674119,10590105,10877489,11115360,15053339,15194768,15992849,16470129,16712896	2007-11-07 17:27	HIV-1 gp120 utilization of CCR3 as a coreceptor facilitates infection by a more restricted subset of primary viruses, and binding of the CCR3 ligand, eotaxin, inhibits infection by these isolates
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1232	NP_001828.1	C-C chemokine receptor type 3 isoform 1	8674119,9359702,9653051,9736741,15053339,17041228	2007-11-07 17:27	Utilization of CCR3 and CCR5 as coreceptors of HIV-1 binding/fusion depends upon the sequence of the third variable (V3) region of the HIV-1 gp120 exterior envelope glycoprotein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1232	NP_001828.1	C-C chemokine receptor type 3 isoform 1	9636210,9736741	2007-11-07 17:28	Macrophage-tropic HIV-1 can use CCR2b, and to a lesser extent CCR3, STRL33, and APJ, to infect cells; the V1/2 region of HIV-1 gp120 plays a more important role in governing the use of CCR2b, CCR3, STRL33, and APJ than for CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1232	NP_001828.1	C-C chemokine receptor type 3 isoform 1	16631222	2007-11-07 17:31	The coreceptor-binding site in HIV-1 gp120 is centered around an anti-parallel beta-sheet structure "bridging sheet domain"; mutations in and adjacent to this domain affect the use of coreceptors CCR3 and CCR8 by gp120 for virus entry
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1232	NP_001828.1	C-C chemokine receptor type 3 isoform 1	16904155	2007-11-07 17:31	HIV-1 isolates showing CCR3 tropism are particularly efficient in using CMKLR1/ChemR23 as a co-receptor; some HIV-2 and SIV isolates also use CMKLR1/ChemR23
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1232	NP_001828.1	C-C chemokine receptor type 3 isoform 1	17041228	2007-11-07 17:31	Amino acid N356 in conserved region 3 of HIV-1 gp120 and amino acids R440 and N448 in conserved region 4 of gp120 are three amino-acid determinants for CCR3 use as a coreceptor for HIV-1 entry into cells
11676	155871	NP_057853.1	Tat	upregulated by	9606	1233	NP_005499.1	C-C chemokine receptor type 4	15857508	2007-11-07 17:28	CCR4 is upregulated by HIV-1 Tat treatment in human epithelial cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1233	NP_005499.1	C-C chemokine receptor type 4	12429730	2007-11-07 17:31	An envelope-mediated fusion assay demonstrates low HIV-1 gp120 use of CCR4 as a coreceptor for some primary HIV-1 isolates; treatment of PBMC with CCL22 causes down-modulation of endogenous CCR4 but has no significant effect on HIV-1 entry
11676	155871	NP_057853.1	Tat	upregulates	9606	1234	NP_000570.1	C-C chemokine receptor type 5	9765440,10453044,15586413,15629079,16179731	2007-11-07 17:28	HIV-1 Tat upregulates CCR5 expression on monocytes/macrophages but not on lymphocytes, indicating a role for Tat in HIV-1 pathogenesis and in promoting the infection of monocytes/macrophages.
11676	155871	NP_057853.1	Tat	upregulates	9606	1234	NP_000570.1	C-C chemokine receptor type 5	10602409	2007-11-07 17:29	HIV-1 Tat is associated with upregulation of CCR5 and MIP-1alpha expression in nodular lesions found in HIV encephalopathy and progressive multifocal leukoencephalopathy (PML), indicating a role for Tat in HIV-1 pathogenesis
11676	155871	NP_057853.1	Tat	downregulates	9606	1234	NP_000570.1	C-C chemokine receptor type 5	10751368,16179731	2007-11-07 17:28	Results from the treatment of microglia with HIV-1 Tat suggest downregulation of CCR5 mRNA expression by HIV-1 Tat, however this was deemed to not be significant
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	8674119,8805353,8898753,8906795,8906796,8976200,8995603,9020356,9031325,9184207,9188565,9261346,9261451,9334377,9353123,9359702,9362541,9420225,9420238,9445013,9525683,9576751,9576954,9632396,9636210,9653051,9870313,9882290,9882373,9890944,9971818,10029247,10089882,10200301,10229873,10339592,10357469,10370370,10393974,10413516,10438870,10446313,10449282,10477718,10482572,10487781,10497246,10505675,10527688,10544150,10555208,10559284,10562492,10574939,10585143,10590105,10590121,10602038,10606089,10623731,10644351,10725362,10738970,10775626,10816381,10820198,10823934,10826481,10877489,10882583,10888615,10888639,10938094,10961858,10970739,11005830,11023526,11024154,11069996,11086073,11115360,11118070,11134270,11162839,11238869,11263244,11264346,11264367,11265761,11290759,11312658,11313374,11336643,11342415,11356961,11356967,11397808,11413305,11414813,11427892,11429110,11464139,11468147,11485305,11489906,11517394,11529558,11596075,11602715,11679153,11689632,11698270,11709091,11861850,11861874,11876757,11877445	2007-11-07 17:27	The CCR5 chemokine receptor is required for the entry of macrophage-tropic HIV-1 into target cells; the HIV-1 gp120-CD4 complex binds CCR5, which inhibits the binding of the natural CCR5 ligands macrophage inflammatory protein (MIP)-1alpha and MIP-1beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	8898753,8976200,9031325,9359702,9420238,9576751,9653051,10393974,10644351,10775626,10820198,10882583,11162839,11313374,11427892,11877445,12689409,12692222,12871111,12873764,12873765,12963807,14990703,15279544,15992849,17053352	2007-11-07 17:27	The binding of HIV-1 gp120 to CCR5 and entry of macrophage-tropic HIV-1 isolates into cells is blocked by CCR5 antagonists or the chemokine RANTES, which interacts with CCR5
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	1234	NP_000570.1	C-C chemokine receptor type 5	9184207,9188565,9334377,11414813,12873764,15258189,16300985	2007-11-07 17:28	HIV-1-induced cell fusion is mediated by multiple regions within both the viral gp120 protein and the CCR5 coreceptor; dual-tropic virus isolates are less tolerant to changes in CCR5 than macrophage-tropic strains that have more restricted coreceptor use
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1234	NP_000570.1	C-C chemokine receptor type 5	9184207,9261451,9632396,9653051,9870313,9971818,10200301,10357469,10482572,10544150,10562492,11069996,11153675,11861850,12163614,12202222,12368322,12408990,12490404,12610158,15857992,15890935,15964018,15983047,16378977,16476981,16721558,16966601,17101166	2007-11-07 17:28	The specific amino acids 298-329 in the V3 loop of HIV-1 gp120 that determine cellular tropism also regulate chemokine coreceptor (CCR5 or CXCR4) preference for cell entry by the virus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	1234	NP_000570.1	C-C chemokine receptor type 5	9261346,9334377,11264346,12477875,12887918,16672549,16702010,16817962,17053352	2007-11-07 17:28	Antibodies to specific epitopes of HIV-1 gp120 block the interaction of CCR5 with the gp120/CD4 complex, suggesting that a CD4-mediated conformational change in gp120 is required for subsequent binding to CCR5
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	1234	NP_000570.1	C-C chemokine receptor type 5	9353123,12857973,12960231	2007-11-07 17:28	The HIV-1 envelope protein gp120 from macrophage-tropic HIV and SIV induces a signal through CCR5 on CD4+ T cells and macrophages, and this gp120-mediated signal transduction induces chemotaxis of T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	9362541,11698270,12857973,12960231	2007-11-07 17:28	Engagement of the CCR5 and CXCR4 receptors by HIV-1 gp120 induces tyrosine phosphorylation of the protein tyrosine kinase Pyk2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	9420225,9445013,9525683,9653051,9882373,9890944,10574939,10823934,10938094,11356961,12183462	2007-11-07 17:31	The amino-terminal residues (amino acids 1-25) and three extracellular loops (amino acids 88-102, 168-194, 261-277) of the CCR5 coreceptor are highly involved in its binding to gp120 from macrophage-tropic HIV-1 strains and in CCR5-mediated HIV-1 entry
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	9632396,10602038,10801487,10826481,10888615,10970739,11278567,15113926,16157597	2007-11-07 17:31	In addition to the V3 loop of HIV-1 gp120, some conserved amino acid residues (117-123, 207, 419-422, and 438-441) are also involved in CCR5 chemokine receptor binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	1234	NP_000570.1	C-C chemokine receptor type 5	9653130,11413305,11414813	2007-11-07 17:31	HIV-1 gp120 from a T-cell-tropic virus causes CD4-dependent antagonism of CXCR4 response to SDF-1alpha, whereas gp120 from macrophage-tropic viruses causes CD4-dependent antagonism of CCR5 response to MIP-1alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	10089882,10497246,12169668,12183462	2007-11-07 17:31	The chemokine receptor CCR5 is posttranslationally modified by sulfation of its N-terminal tyrosines; sulfated tyrosines contribute to the binding of CCR5 to MIP-1 alpha, MIP-1 beta, and HIV-1 gp120/CD4 complexes and to the ability of HIV-1 to enter cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	10339592,10438870,10482561,11238869	2007-11-07 17:31	An adapted primary HIV-1 isolate, ADA, is able to replicate in CD4-negative cells expressing human CCR5; the gp120 glycoprotein of the adapted virus binds CCR5 directly, without prior interaction with CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	1234	NP_000570.1	C-C chemokine receptor type 5	10438703,11342415	2007-11-07 17:31	A synthetic peptide corresponding to amino acid residues 414-434 of HIV-1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	10477718	2007-11-07 17:31	Chemokines such as MCP-3 and MCP-2 that can compete with high affinity for MIP-1beta binding to CCR5 can also compete for monomeric HIV-1 gp120 binding to CCR5, although with variable potencies
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	10725362	2007-11-07 17:31	Anti-CCR5 monoclonal antibodies efficiently prevent HIV-1 infection by inducing receptor dimerization, but not by interfering with HIV-1 gp120 binding to CCR5
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1234	NP_000570.1	C-C chemokine receptor type 5	10758170,12857973,12960231	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1234	NP_000570.1	C-C chemokine receptor type 5	11023526	2007-11-07 17:31	N-formyl-methionyl-leucylphenyl-alanine binding to formyl peptide receptor (FPR) results in significant attenuation of cell responses to CCR5 ligands and in inhibition of HIV-1 gp120-mediated fusion and infection of cells expressing CD4, CCR5, and FPR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	1234	NP_000570.1	C-C chemokine receptor type 5	11069996,11134270,11264346,15321703,17147503	2007-11-07 17:31	Antibodies to specific epitopes of the CCR5 or CXCR4 chemokine receptors inhibit the entry of M-tropic, T-tropic, or dual-tropic HIV-1 into target cells by blocking the interaction of the receptors with the HIV-1 gp120/CD4 complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1234	NP_000570.1	C-C chemokine receptor type 5	11278567,11356952,11390601,11529558,11679153,11689632,11709091,11711617,12368322,15767436	2007-11-07 17:31	V1, V2, and V3 domains and N-linked glycosylation sites of HIV-1 gp120 confer coreceptor tropism; loss of an N-linked glycosylation site within V3 has a major influence on the virus switching from CCR5 to CXCR4 tropism in a V3 charge-dependent manner
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	11336643	2007-11-07 17:31	AGP inhibits the binding of the HIV-1 gp120 consensus V3 domain (V3Cs) and macrophage inflammatory protein-1beta (MIP-1beta) to CCR5 on human monocyte-derived macrophages (MDM)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	11468147,11698270,12857973,12960231	2007-11-07 17:31	CCR5 and CXCR4 coreceptor engagement by HIV-1 gp120 in primary macrophages activates 2 members of the mitogen-activated protein kinase (MAPK) superfamily, c-Jun amino-terminal kinase and p38 MAPK
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	1234	NP_000570.1	C-C chemokine receptor type 5	12551992,12960231	2007-11-07 17:31	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1234	NP_000570.1	C-C chemokine receptor type 5	15972662	2007-11-07 17:30	HIV-1 gp120 interactions with CXCR4 and CCR5 lead to the cross-desensitization of CCR6 and CCR7; this gp120-induced inhibition is strictly dependent on CXCR4 or CCR5 and lipid rafts but not on CD4 or V(H)3-expressing BCR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1234	NP_000570.1	C-C chemokine receptor type 5	16375941	2007-11-07 17:31	HIV-1 gp120 and gp41-mediated virus-cell fusion is more dependent on viral core maturation for viruses bearing CXCR4-tropic gp120 than for those bearing CCR5-tropic gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	1234	NP_000570.1	C-C chemokine receptor type 5	16621960	2007-11-07 17:31	Stimulation of human monocyte-derived macrophages with HIV-1 gp120 results in the CCR5-mediated activation of Lyn and the concomitant Lyn-dependent activation of the mitogen-activated protein (MAP) kinase ERK-1/2, which leads to production of TNF-alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	16631222	2007-11-07 17:31	The coreceptor-binding site in HIV-1 gp120 is centered around an anti-parallel beta-sheet structure "bridging sheet domain"; mutations in and adjacent to this domain have greater impact on CXCR4-mediated fusion than on CCR5-mediated fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	1234	NP_000570.1	C-C chemokine receptor type 5	16841089	2007-11-07 17:31	HIV-1 gp120 induced cell death is inhibited by a CCR5-mediated neuroprotective pathway that involves protein kinase Akt/PKB as an essential component and can be triggered by the CCR5 agonists MIP-1beta and RANTES
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	1234	NP_000570.1	C-C chemokine receptor type 5	16841089	2007-11-07 17:31	HIV-1 gp120-induced neuronal cell death involves p38 mitogen-activated protein kinase; both HIV-1 coreceptors, CCR5 and CXCR4, can mediate HIV-1 gp120-induced neurotoxicity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1234	NP_000570.1	C-C chemokine receptor type 5	16963439	2007-11-07 17:31	The V3 domain of HIV-1 gp120 induces associations between CD4 and CCR5 receptors in cholesterol-rich microenvironments
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	1234	NP_000570.1	C-C chemokine receptor type 5	17121788	2007-11-07 17:31	HIV-1 gp120-induced Ca(2+) fluxing is CD4 dependent and coreceptor specific, and is mediated by the CCR5 and CXCR4 coreceptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1234	NP_000570.1	C-C chemokine receptor type 5	17210123	2007-11-07 17:31	A peptide fragment corresponding to the loop between the fifth and sixth transmembrane regions of the CCR5 receptor (amino acids 222-240) can inhibit HIV-1 infection of MT-4 cells, suggesting this region of CCR5 is involved with HIV-1 gp120 binding
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	1234	NP_000570.1	C-C chemokine receptor type 5	9256481	2007-11-07 17:31	RANTES, MIP-1beta, and anti-CD4 antibodies inhibit CCR5-dependent cell-cell fusion mediated by HIV-1 gp120 and gp41 from macrophage-tropic isolates
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	1234	NP_000570.1	C-C chemokine receptor type 5	10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	induces phosphorylation of	9606	1234	NP_000570.1	C-C chemokine receptor type 5	10872839	2007-11-07 17:30	HIV-1 gp41 activates innate host immune cells through FPRL1, and the activation of FPRL1 by gp41 further induces the phosphorylation of the chemokine receptor CCR5
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	complexes with	9606	1234	NP_000570.1	C-C chemokine receptor type 5	12871111,14505910,14694113,15047829,15258189,15308751,15479838	2007-11-07 17:31	HIV-1 gp120 and gp41 form a transitional complex with the CD4 receptor and CCR5/CXCR4 coreceptors during virus-cell and cell-cell membrane fusion
11676	156110	NP_057857.2	Nef	downregulates	9606	1234	NP_000570.1	C-C chemokine receptor type 5	15854903	2007-11-07 17:29	HIV-1 Nef downregulates cell-surface levels of CCR5 in CHO cells expressing human CCR5; the Nef-induced downregulation of CCR5 is as efficient as the downregulation induced by the natural beta-chemokine ligand RANTES
11676	156110	NP_057857.2	Nef	downregulates	9606	1234	NP_000570.1	C-C chemokine receptor type 5	15854903	2007-11-07 17:28	SH3 (PxxP motif) and PACS (E4) interaction surfaces as well as the myristoylation site (G2) in HIV-1 Nef are required for Nef-mediated downregulation of CCR5
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	1235	NP_004358.2	C-C chemokine receptor type 6	15972662	2007-11-07 17:30	HIV-1 gp120 interactions with CXCR4 and CCR5 lead to the cross-desensitization of CCR6 and CCR7; this gp120-induced inhibition is strictly dependent on CXCR4 or CCR5 and lipid rafts but not on CD4 or V(H)3-expressing BCR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	1236	NP_001829.1	C-C chemokine receptor type 7 precursor	15972662	2007-11-07 17:31	HIV-1 gp120 interactions with CXCR4 and CCR5 lead to the cross-desensitization of CCR6 and CCR7; this gp120-induced inhibition is strictly dependent on CXCR4 or CCR5 and lipid rafts but not on CD4 or V(H)3-expressing BCR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	1236	NP_001829.1	C-C chemokine receptor type 7 precursor	16278001	2007-11-07 17:31	Stimulated HIV-1 infected CD4+ cells induce plasmacytoid dendritic cell (PDC) activation and maturation in a manner that is inhibited by antibodies to HIV-1 gp120; markers for PDC migration (CCR7) are enhanced during this process
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	associates with	9606	1237	NP_005192.1	C-C chemokine receptor type 8	11804551,15053339,15992849,16631222	2007-11-07 17:31	HIV-1 gp120 from CXCR4-tropic subtype E viruses isolated in Thailand associates with and uses at least one of the following coreceptors for virus entry: CCR8, CCR1, CCR2b, or CX3CR1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1237	NP_005192.1	C-C chemokine receptor type 8	16631222	2007-11-07 17:31	The coreceptor-binding site in HIV-1 gp120 is centered around an anti-parallel beta-sheet structure "bridging sheet domain"; mutations in and adjacent to this domain affect the use of coreceptors CCR3 and CCR8 by gp120 for virus entry
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1238	NP_001287.2	chemokine-binding protein 2	16014924	2007-11-07 17:30	A promiscuous CC chemokine receptor, D6, can function as a coreceptor for various primary dual-tropic isolates of HIV-1 and HIV-2 through binding to the viral gp120 protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1240	NP_004063.1	chemokine receptor-like 1 isoform b	16904155	2007-11-07 17:31	HIV-1 isolates showing CCR3 tropism are particularly efficient in using CMKLR1/ChemR23 as a co-receptor; some HIV-2 and SIV isolates also use CMKLR1/ChemR23
11676	155871	NP_057853.1	Tat	activates	9606	1267	NP_149124.3	2',3'-cyclic-nucleotide 3'-phosphodiesterase	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	upregulates	9606	1277	NP_000079.2	collagen alpha-1(I) chain preproprotein	1409674,11311202	2007-11-07 17:29	HIV-1 Tat upregulates the steady-state RNA levels for fibronectin and types I and III collagen in glioblastoma cells and salivary gland cell lines
11676	155871	NP_057853.1	Tat	inhibits	9606	1277	NP_000079.2	collagen alpha-1(I) chain preproprotein	8552450	2007-11-07 17:29	HIV-1 Tat, through its basic domain (amino acids 46-60), inhibits the adhesion of collagen I to the neuroblastoma cell line GI-CA-N, suggesting a role for Tat in the neurologic dysfunction and destruction of the CNS observed in infants infected with HIV-1
11676	155871	NP_057853.1	Tat	upregulates	9606	1278	NP_000080.2	collagen alpha-2(I) chain precursor	1409674,11311202	2007-11-07 17:29	HIV-1 Tat upregulates the steady-state RNA levels for fibronectin and types I and III collagen in glioblastoma cells and salivary gland cell lines
11676	155871	NP_057853.1	Tat	inhibits	9606	1278	NP_000080.2	collagen alpha-2(I) chain precursor	8552450	2007-11-07 17:29	HIV-1 Tat, through its basic domain (amino acids 46-60), inhibits the adhesion of collagen I to the neuroblastoma cell line GI-CA-N, suggesting a role for Tat in the neurologic dysfunction and destruction of the CNS observed in infants infected with HIV-1
11676	155871	NP_057853.1	Tat	upregulates	9606	1281	NP_000081.1	collagen alpha-1(III) chain preproprotein	1409674,11311202	2007-11-07 17:29	HIV-1 Tat upregulates the steady-state RNA levels for fibronectin and types I and III collagen in glioblastoma cells and salivary gland cell lines
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	1282	NP_001836.1	alpha 1 type IV collagen preproprotein	7495302	2007-11-07 17:31	HIV-1 gp160 and serum-free macrophage supernatant (MSP) enhance synthesis of type IV collagen by mesangial cells; anti-TGF-beta antibodies attenuate this gp160/MSP-induced collagen synthesis
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	1284	NP_001837.2	collagen alpha-2(IV) chain preproprotein	7495302	2007-11-07 17:31	HIV-1 gp160 and serum-free macrophage supernatant (MSP) enhance synthesis of type IV collagen by mesangial cells; anti-TGF-beta antibodies attenuate this gp160/MSP-induced collagen synthesis
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	1285	NP_000082.2	collagen alpha-3(IV) chain isoform 1 precursor	7495302	2007-11-07 17:31	HIV-1 gp160 and serum-free macrophage supernatant (MSP) enhance synthesis of type IV collagen by mesangial cells; anti-TGF-beta antibodies attenuate this gp160/MSP-induced collagen synthesis
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	1286	NP_000083.3	collagen alpha-4(IV) chain precursor	7495302	2007-11-07 17:31	HIV-1 gp160 and serum-free macrophage supernatant (MSP) enhance synthesis of type IV collagen by mesangial cells; anti-TGF-beta antibodies attenuate this gp160/MSP-induced collagen synthesis
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	1287	NP_000486.1	collagen alpha-5(IV) chain isoform 1 precursor	7495302	2007-11-07 17:31	HIV-1 gp160 and serum-free macrophage supernatant (MSP) enhance synthesis of type IV collagen by mesangial cells; anti-TGF-beta antibodies attenuate this gp160/MSP-induced collagen synthesis
11676	156110	NP_057857.2	Nef	binds	9606	1315	NP_057535.1	coatomer subunit beta	7982906,9017839,10199403,11264386,11463741	2007-11-07 17:28	Binding of HIV-1 Nef to Beta-COP has been demonstrated by yeast two-hybrid and coimmunoprecipitation experiments and may be involved in the downregulation of CD4 by Nef
11676	156110	NP_057857.2	Nef	co-localizes with	9606	1315	NP_057535.1	coatomer subunit beta	15202998	2007-11-07 17:28	Co-localization of HIV-1 Nef, ARF1, and Beta-COP in early endosomes depends on Nef residues at E154 and E155; this co-localization is required for the downregulation and transport of CD4 to acidic late-endosomal compartments
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1366	NP_001298.2	claudin 7	16368003	2007-11-07 17:31	HIV-1 virions expressing claudin-7 on their envelopes show a much higher infectivity for 293T CD4(-) cells than parental HIV-1 with no CLDN-7, suggesting an interaction with gp160 or gp120
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	palmitoylated by	9606	1374	NP_001867.2	carnitine O-palmitoyltransferase 1, liver isoform isoform 1	11095714	2007-11-07 17:31	HIV-1 envelope glycoprotein (gp160) contains two palmitoylated cysteine residues C764 and C837; removal of both palmitoylation sites results in the formation of virus with low levels of gp160 incorporation, as well as a decrease in viral infectivity
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	palmitoylated by	9606	1375	NP_004368.1	carnitine O-palmitoyltransferase 1, muscle isoform isoform a	11095714	2007-11-07 17:31	HIV-1 envelope glycoprotein (gp160) contains two palmitoylated cysteine residues C764 and C837; removal of both palmitoylation sites results in the formation of virus with low levels of gp160 incorporation, as well as a decrease in viral infectivity
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	palmitoylated by	9606	1376	NP_000089.1	carnitine O-palmitoyltransferase 2, mitochondrial precursor	11095714	2007-11-07 17:31	HIV-1 envelope glycoprotein (gp160) contains two palmitoylated cysteine residues C764 and C837; removal of both palmitoylation sites results in the formation of virus with low levels of gp160 incorporation, as well as a decrease in viral infectivity
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	1380	NP_001006659.1	complement receptor type 2 isoform 1 precursor	15603708	2007-11-07 17:31	The activation of mitogen-activated protein kinases (MAPKs, including ERK, JNK, and p38MAPK) is induced by incubation of HIV-1 gp160 with CD4+complement receptor type 2 (CR2)+ cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1380	NP_001006659.1	complement receptor type 2 isoform 1 precursor	8474169	2007-11-07 17:29	HIV-1 particles (gp120/gp41) bind to MT-2 (CD4+ CR2+) and Raji-3 (CD4- CR2+) cells but not to CEM (CD4+ CR2-) cells, suggesting that the virus binds to CR2 independently of CD4
11676	155871	NP_057853.1	Tat	activates	9606	1385	NP_004370.1	cyclic AMP-responsive element-binding protein 1 isoform A	9558095	2007-11-07 17:29	Extracellular HIV-1 Tat protein induces the rapid Ser-133 phosphorylation and activation of CREB transcription factor in lymphoid cells through a signal cascade involving the MAPK pathway
11676	155871	NP_057853.1	Tat	downregulates	9606	1385	NP_004370.1	cyclic AMP-responsive element-binding protein 1 isoform A	11156964	2007-11-07 17:28	HIV-1 Tat protein downregulates the Ser-133 phosphorylation, activation, and expression of CREB transcription factor in PC12 neuronal cells through sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	1385	NP_004370.1	cyclic AMP-responsive element-binding protein 1 isoform A	16339753	2007-11-07 17:29	HIV-1 Tat increases both CREB phosphorylation and DNA binding by 7- to 10-fold within 2 hrs after stimulation in hematopoietic progenitor cells
11676	155871	NP_057853.1	Tat	activates	9606	1385	NP_004370.1	cyclic AMP-responsive element-binding protein 1 isoform A	16920714	2007-11-07 17:31	HIV-1 Tat upregulates IL-10 synthesis by ERK MAPK-dependent CREB-1 transcription factor activation through Ser(133) phosphorylation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	1386	NP_001871.2	cyclic AMP-dependent transcription factor ATF-2	16179804	2007-11-07 17:31	HIV-1 gp120 and p300 synergistically increase TGF-beta, ATF-2 and activating protein-1 (AP-1) expression leading to tubular cell apoptosis; in addition, HIV-1 gp120 treatment causes phosphorylation of Smad2 and downregulation of c-Jun
11676	155807	NP_057852.2	Vpr	binds	9606	1387	NP_004371.2	CREB-binding protein isoform a	12208951,12634356,12642036,12788643,15142377,15725353	2007-11-07 17:27	HIV-1 Vpr binds directly to the CBP co-activator to induce transcription of the HIV-1 LTR and glucocorticoid-responsive promoters
11676	155871	NP_057853.1	Tat	regulated by	9606	1387	NP_004371.2	CREB-binding protein isoform a	9733868,9811832,10607594,11080476,11931765	2007-11-07 17:30	Acetylation of HIV-1 Tat by the p300/CBP complex at Lys50 regulates Tat binding to cyclin T1 and HIV-1 TAR RNA, as well as Tat-mediated transactivation of the HIV-1 LTR promoter, by allowing Tat to dissociate from TAR RNA
11676	155871	NP_057853.1	Tat	binds	9606	1387	NP_004371.2	CREB-binding protein isoform a	9733868,9811832,11080476,15139295,15183343,15473004,15638724,16035254,16046164,16146763	2007-11-07 17:30	HIV-1 Tat binds to the minimal histone acetyltransferase domain of the CBP/p300 complex (amino acids 1253-1710 of p300) and E1a binding domain (amino acids 1542-1710) of p300, an effect mediated by the basic domain (amino acids 48-57) of Tat
11676	155871	NP_057853.1	Tat	recruits	9606	1387	NP_004371.2	CREB-binding protein isoform a	9811832,11547919,14657027	2007-11-07 17:30	HIV-1 Tat recruits the CBP/p300 complex, as well as other known cellular acetyltransferases, to the HIV-1 LTR promoter, an effect involved in the acetylation of histones H3 and H4, and HIV-1 transcriptional activation
11676	155871	NP_057853.1	Tat	acetylated by	9606	1387	NP_004371.2	CREB-binding protein isoform a	10607594	2007-11-07 17:30	HIV-1 Tat is acetylated by the p300/CBP complex on Lys50 and Lys51
11676	155871	NP_057853.1	Tat	interacts with	9606	1387	NP_004371.2	CREB-binding protein isoform a	11080476,11739381	2007-11-07 17:30	Binding of HIV-1 Tat to p300 induces a conformational change in the CBP/p300 complex such that it can acquire and bind better to basal transcription factors, indicating Tat helps CBP/p300 recruit new partners to the transcription machinery
11676	155871	NP_057853.1	Tat	induces complex with	9606	1387	NP_004371.2	CREB-binding protein isoform a	11160671	2007-11-07 17:30	HIV-1 Tat induces CBP to complex with NFkappaB p65 and bind to the IL-8 promoter leading to an upregulation of IL-8 expression
11676	155871	NP_057853.1	Tat	regulates	9606	1387	NP_004371.2	CREB-binding protein isoform a	11739381	2007-11-07 17:30	Acetylation of the p50 subunit of NFkappaB by CBP/p300 is regulated by HIV-1 Tat
11676	155871	NP_057853.1	Tat	inhibits	9606	1387	NP_004371.2	CREB-binding protein isoform a	12154097	2007-11-07 17:30	HIV-1 Tat inhibits the histone acetyltransferase and transcriptional activation activities of CBP, an effect mediated by amino acids 86-101 of Tat
11676	155871	NP_057853.1	Tat	regulates	9606	1387	NP_004371.2	CREB-binding protein isoform a	12154097	2007-11-07 17:30	HIV-1 Tat regulates the activity of CBP by inhibiting CBP acetylation of histones, but not CBP acetylation of p53 or MyoD, indicating Tat induces a substrate selectivity for CBP
11676	155871	NP_057853.1	Tat	binds	9606	1387	NP_004371.2	CREB-binding protein isoform a	12549909,14744133	2007-11-07 17:30	The N-terminal 24 amino acids of HIV-1 Tat mediate its binding to the KIX domain (amino acids 589-679) of CBP
11676	155871	NP_057853.1	Tat	activates	9606	1387	NP_004371.2	CREB-binding protein isoform a	16001085	2007-11-07 17:28	HIV-1 Tat induces the polyubiquitination and degradation of Tip60 through p300/CBP-associated E4-type ubiquitin-ligase activity, which results in a dramatic impairment of the Tip60-dependent apoptotic cell response to DNA damage
11676	155871	NP_057853.1	Tat	upregulates	9606	1387	NP_004371.2	CREB-binding protein isoform a	16339753	2007-11-07 17:29	HIV-1 Tat treatment of hematopoietic progenitor cells upregulates CBP gene expression (7- to 9-fold) and protein levels (5- to 7-fold) within 6-12 hrs after stimulation
11676	155871	NP_057853.1	Tat	upregulates	9606	1390	NP_898883.1	cAMP-responsive element modulator isoform v	10660577	2007-11-07 17:28	Treatment of dopaminergic rat PC12 cells with HIV-1 Tat downregulates the expression of tyrosine hydroxylase (TH) by upregulating the expression of the inducible cAMP early repressor which in turn abrogates the transcription activity of the TH promoter
11676	155871	NP_057853.1	Tat	activates	9606	1390	NP_898883.1	cAMP-responsive element modulator isoform v	10853989	2007-11-07 17:30	Extracellular HIV-1 Tat protein activates the inducible cAMP early repressor (ICER) in both the Jurkat cell line and primary peripheral blood mononuclear cells
11676	155807	NP_057852.2	Vpr	activates	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	17158886	2007-11-07 17:31	Treatment of cells with HIV-1 Vpr 52-96 or Vpr 1-45 peptides induces strong activation of p38, ERK and JNK MAPKs and results in phosphorylation of ERK and JNK MAPKs
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	15603708	2007-11-07 17:31	The activation of mitogen-activated protein kinases (MAPKs, including ERK, JNK, and p38MAPK) is induced by incubation of HIV-1 gp160 with CD4+complement receptor type 2 (CR2)+ cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	11468147,11698270,12239168,14660488,15972662,16081599,16111829	2007-11-07 17:31	CCR5 and CXCR4 coreceptor engagement by HIV-1 gp120 in primary macrophages activates 2 members of the mitogen-activated protein kinase (MAPK) superfamily, c-Jun amino-terminal kinase and p38 MAPK
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	12824191	2007-11-07 17:31	HCV-E2 and HIV-1 gp120 act collaboratively to trigger a specific set of downstream signaling pathways that include activation of p38 mitogen-activated protein (MAP) kinase and the tyrosine phosphatase, SHP2, in hepatocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	15642743	2007-11-07 17:31	p38 MAPK-mediated p53 phosphorylation on serine 46 contributes to apoptosis induced by the HIV-1 envelope glycoprotein complex (gp120/gp41)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	15717263	2007-11-07 17:30	Morphine potentiates HIV-1 gp120-induced neuronal apoptosis, which involves activation of the p38 MAPK cellular signaling pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	15972662	2007-11-07 17:30	CXCR4-tropic and CXCR4/CCR5 dual-tropic HIV-1 gp120 induce the cleavage of CD62 ligand by a mechanism dependent on matrix metalloproteinases 1 and 3, CD4, CXCR4, Galpha(i), and p38 MAPK, whereas CCR5-tropic gp120 does not
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	16111829	2007-11-07 17:31	HIV-1 gp120-induced increases in caspase-3 activity, neurite losses and neuronal death are prevented by p38 MAPK, but not c-jun-N-terminal kinase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	16841089	2007-11-07 17:31	HIV-1 gp120-induced neuronal cell death involves p38 mitogen-activated protein kinase; both HIV-1 coreceptors, CCR5 and CXCR4, can mediate HIV-1 gp120-induced neurotoxicity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	16897667	2007-11-07 17:31	STAT1 associates with p38 MAP kinase in a time-dependent manner after HIV-1 gp120/HCV E2 costimulation in human hepatocytes
11676	156110	NP_057857.2	Nef	activates	9606	1432	NP_001306.1	mitogen-activated protein kinase 14 isoform 1	17182689	2007-11-07 17:31	HIV-1 Nef myristoylation is required for the rapid and transient phosphorylation of the alpha- and beta- subunits of the Ikappa-B kinase complex and activation of JNK, ERK1/2 and p38 MAPK family members
11676	156110	NP_057857.2	Nef	inhibits	9606	1436	NP_005202.2	macrophage colony-stimulating factor 1 receptor precursor	15626739	2007-11-07 17:28	HIV-1 Nef inhibits the activation of M-CSF receptor signaling by means of the activation of Hck and the subsequent induction of an aberrant molecular association between Hck and M-CSF receptor complex
11676	155871	NP_057853.1	Tat	upregulates	9606	1437	NP_000749.2	granulocyte-macrophage colony-stimulating factor precursor	7695626,7818827	2007-11-07 17:29	HIV-1 Tat upregulates GM-CSF production in uninfected mononuclear cells and synergizes with PMA+PHA to induce GM-CSF in Raji B-cells and Jurkat T-cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulates	9606	1437	NP_000749.2	granulocyte-macrophage colony-stimulating factor precursor	7642615,8018916	2007-11-07 17:30	The aberrant activation of AP-1 by HIV-1 gp160 in CD4+ T cells is hypothesized to upregulate cytokines containing AP-1 sites (e.g. IL-3 and colony stimulating factor) and lead to T cell unresponsiveness by inhibiting interleukin-2 secretion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	1437	NP_000749.2	granulocyte-macrophage colony-stimulating factor precursor	1918997,15481145	2007-11-07 17:30	HIV-1 gp120 stimulates monocytes to release TNF-alpha, IL-1 beta, IL-6, and granulocyte-macrophage-CSF, and this effect can be blocked with soluble CD4
11676	155871	NP_057853.1	Tat	activates	9606	1445	NP_004374.1	tyrosine-protein kinase CSK	9621077	2007-11-07 17:27	HIV-1 Tat stimulates the tyrosine phosphorylation and activation of c-Src kinase resulting in the activation of the intrinsic kinase activity of c-Src, an effect associated with Tat-induced angiogenesis and Kaposi's sarcoma
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	1457	NP_001886.1	casein kinase II subunit alpha isoform a	9151826	2007-11-07 17:28	CK2 has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155348	NP_705926.1	retropepsin	phosphorylated by	9606	1457	NP_001886.1	casein kinase II subunit alpha isoform a	10964683	2007-11-07 17:29	Purified recombinant HIV-1 protease (rPR) is phosphorylated by casein kinase II, and the activity of rPR is stimulated approximately 2.9-fold as a result of this phosphorylation
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	1457	NP_001886.1	casein kinase II subunit alpha isoform a	9654140	2007-11-07 17:29	Casein kinase II phosphorylates HIV-1 RT p66 and p51 in human cells
11676	155348	NP_705927.1	reverse transcriptase	stimulated by	9606	1457	NP_001886.1	casein kinase II subunit alpha isoform a	9654140,9881639,10549869,10641798,10944435	2007-11-07 17:29	Phosphorylation of HIV-1 RT p66 and p51 by Casein kinase II mediates the stimulation of RNA-dependent DNA polymerase (RDDP) activity in vitro
11676	155908	NP_057854.1	Rev	modulated by	9606	1457	NP_001886.1	casein kinase II subunit alpha isoform a	7794916,9092824,12511551	2007-11-07 17:28	CK2 modulates the interaction of Rev with nucleolar phosphoprotein B23 by phosphorylating B23
11676	155908	NP_057854.1	Rev	phosphorylated by	9606	1457	NP_001886.1	casein kinase II subunit alpha isoform a	8806671,10984616,11827166	2007-11-07 17:28	CK2 phosphorylates Rev on Serine 5 and Serine 8
11676	155908	NP_057854.1	Rev	activates	9606	1457	NP_001886.1	casein kinase II subunit alpha isoform a	9654140,11827166	2007-11-07 17:28	Rev activates CK2, an effect hypothesized to promote HIV-1 replication
11676	155908	NP_057854.1	Rev	phosphorylated by	9606	1457	NP_001886.1	casein kinase II subunit alpha isoform a	10984616,11827166	2007-11-07 17:28	phosphorylation of Rev is dependent on the beta subunit of CK2
11676	155908	NP_057854.1	Rev	binds	9606	1457	NP_001886.1	casein kinase II subunit alpha isoform a	11827166	2007-11-07 17:28	amino acids 35-50 of Rev are involved with electrostatic interactions with CK2 while amino acids 12-24 of Rev are involved with hydrophobic interactions
11676	155945	NP_057855.1	Vpu	phosphorylated by	9606	1457	NP_001886.1	casein kinase II subunit alpha isoform a	1541298,8107101,8548340	2007-11-07 17:28	The HIV-1 Vpu protein is phosphorylated by casein kinase 2 on serine amino acids 52 and 56
11676	155945	NP_057855.1	Vpu	phosphorylated by	9606	1457	NP_001886.1	casein kinase II subunit alpha isoform a	7491787,8139011,8548340,8659106,9185604	2007-11-07 17:28	Phosphorylation of HIV-1 Vpu by casein kinase 2 is required for Vpu-mediated degradation of CD4, regulation of HIV-1 envelope secretion and control of syncytium formation
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	1459	NP_001887.1	casein kinase II subunit alpha'	9151826	2007-11-07 17:28	CK2 has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155348	NP_705926.1	retropepsin	phosphorylated by	9606	1459	NP_001887.1	casein kinase II subunit alpha'	10964683	2007-11-07 17:29	Purified recombinant HIV-1 protease (rPR) is phosphorylated by casein kinase II, and the activity of rPR is stimulated approximately 2.9-fold as a result of this phosphorylation
11676	155908	NP_057854.1	Rev	modulated by	9606	1459	NP_001887.1	casein kinase II subunit alpha'	7794916,9092824,12511551	2007-11-07 17:28	CK2 modulates the interaction of Rev with nucleolar phosphoprotein B23 by phosphorylating B23
11676	155908	NP_057854.1	Rev	phosphorylated by	9606	1459	NP_001887.1	casein kinase II subunit alpha'	8806671,10984616,11827166	2007-11-07 17:28	CK2 phosphorylates Rev on Serine 5 and Serine 8
11676	155908	NP_057854.1	Rev	activates	9606	1459	NP_001887.1	casein kinase II subunit alpha'	9654140,11827166	2007-11-07 17:28	Rev activates CK2, an effect hypothesized to promote HIV-1 replication
11676	155908	NP_057854.1	Rev	phosphorylated by	9606	1459	NP_001887.1	casein kinase II subunit alpha'	10984616,11827166	2007-11-07 17:28	phosphorylation of Rev is dependent on the beta subunit of CK2
11676	155908	NP_057854.1	Rev	binds	9606	1459	NP_001887.1	casein kinase II subunit alpha'	11827166	2007-11-07 17:28	amino acids 35-50 of Rev are involved with electrostatic interactions with CK2 while amino acids 12-24 of Rev are involved with hydrophobic interactions
11676	155945	NP_057855.1	Vpu	phosphorylated by	9606	1459	NP_001887.1	casein kinase II subunit alpha'	1541298,8107101,8548340	2007-11-07 17:28	The HIV-1 Vpu protein is phosphorylated by casein kinase 2 on serine amino acids 52 and 56
11676	155945	NP_057855.1	Vpu	phosphorylated by	9606	1459	NP_001887.1	casein kinase II subunit alpha'	7491787,8139011,8548340,8659106,9185604	2007-11-07 17:28	Phosphorylation of HIV-1 Vpu by casein kinase 2 is required for Vpu-mediated degradation of CD4, regulation of HIV-1 envelope secretion and control of syncytium formation
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	1460	NP_001311.3	casein kinase II subunit beta	9151826	2007-11-07 17:28	CK2 has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155348	NP_705926.1	retropepsin	phosphorylated by	9606	1460	NP_001311.3	casein kinase II subunit beta	10964683	2007-11-07 17:29	Purified recombinant HIV-1 protease (rPR) is phosphorylated by casein kinase II, and the activity of rPR is stimulated approximately 2.9-fold as a result of this phosphorylation
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	1460	NP_001311.3	casein kinase II subunit beta	9654140	2007-11-07 17:29	Casein kinase II phosphorylates HIV-1 RT p66 and p51 in human cells
11676	155348	NP_705927.1	reverse transcriptase	stimulated by	9606	1460	NP_001311.3	casein kinase II subunit beta	9654140,9881639,10549869,10641798,10944435	2007-11-07 17:29	Phosphorylation of HIV-1 RT p66 and p51 by Casein kinase II mediates the stimulation of RNA-dependent DNA polymerase (RDDP) activity in vitro
11676	155908	NP_057854.1	Rev	modulated by	9606	1460	NP_001311.3	casein kinase II subunit beta	7794916,9092824,12511551	2007-11-07 17:27	CK2 modulates the interaction of Rev with nucleolar phosphoprotein B23 by phosphorylating B23
11676	155908	NP_057854.1	Rev	phosphorylated by	9606	1460	NP_001311.3	casein kinase II subunit beta	8806671,10984616,11827166	2007-11-07 17:29	CK2 phosphorylates Rev on Serine 5 and Serine 8
11676	155908	NP_057854.1	Rev	activates	9606	1460	NP_001311.3	casein kinase II subunit beta	9654140,11827166	2007-11-07 17:29	Rev activates CK2, an effect hypothesized to promote HIV-1 replication
11676	155908	NP_057854.1	Rev	phosphorylated by	9606	1460	NP_001311.3	casein kinase II subunit beta	10984616,11827166	2007-11-07 17:29	phosphorylation of Rev is dependent on the beta subunit of CK2
11676	155908	NP_057854.1	Rev	binds	9606	1460	NP_001311.3	casein kinase II subunit beta	11827166	2007-11-07 17:29	amino acids 35-50 of Rev are involved with electrostatic interactions with CK2 while amino acids 12-24 of Rev are involved with hydrophobic interactions
11676	155945	NP_057855.1	Vpu	phosphorylated by	9606	1460	NP_001311.3	casein kinase II subunit beta	1541298,8107101,8548340,12954211	2007-11-07 17:27	The HIV-1 Vpu protein is phosphorylated by casein kinase 2 on serine amino acids 52 and 56
11676	155945	NP_057855.1	Vpu	phosphorylated by	9606	1460	NP_001311.3	casein kinase II subunit beta	7491787,8139011,8548340,8659106,9185604	2007-11-07 17:27	Phosphorylation of HIV-1 Vpu by casein kinase 2 is required for Vpu-mediated degradation of CD4, regulation of HIV-1 envelope secretion and control of syncytium formation
11676	155945	NP_057855.1	Vpu	phosphorylated by	9606	1460	NP_001311.3	casein kinase II subunit beta	12954211	2007-11-07 17:29	The presence of the casein kinase II phosphorylation sites of HIV-1 Vpu enhances CD4(+) T cell loss in a non-human primate model for HIV-1 infection
11676	155807	NP_057852.2	Vpr	upregulates	9606	1493	NP_005205.2	cytotoxic T-lymphocyte protein 4 isoform a precursor	17023015	2007-11-07 17:31	HIV-1 Vpr increases the levels of CTLA4 expression in infected T cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	co-localizes with	9606	1493	NP_005205.2	cytotoxic T-lymphocyte protein 4 isoform a precursor	12060749	2007-11-07 17:30	The envelope glycoprotein (gp160)) of HIV-1 is directed to intracellular CTLA-4-containing granules rather than trafficking constitutively from the Golgi to the cell surface
11676	156110	NP_057857.2	Nef	upregulates	9606	1493	NP_005205.2	cytotoxic T-lymphocyte protein 4 isoform a precursor	10618429	2007-11-07 17:27	HIV-1 Nef expression in Jurkat cells upregulates the level of CTLA4 production in the absence of CD3 and CD28 stimulation
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	1495	NP_001894.2	catenin alpha-1	10420987,11883950	2007-11-07 17:31	HIV-1 gp41 and alpha-catenin co-localize in gp160 and GST-alpha-catenin expressing cells; the leucine zipper-like domain (gp160 residues 791-824) of gp41 interacts strongly with the carboxy terminus (residues 795-906) of alpha-catenin
11676	155945	NP_057855.1	Vpu	stabilizes	9606	1499	NP_001895.1	catenin beta-1	14561767	2007-11-07 17:29	HIV-1 Vpu is a strong competitive inhibitor of beta-TrCP and impairs the degradation of SCF-beta-TrCP substrates such as IKBalpha, ATF4 and beta-catenin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modified by	9606	1509	NP_001900.1	cathepsin D preproprotein	10623764	2007-11-07 17:31	Cathepsin D may induce conformational modification of HIV-1 gp120, allowing direct interaction with the CXCR4 coreceptor and enhancing HIV-1 infectivity and entry into cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	1510	NP_001901.1	cathepsin E isoform a preproprotein	8457383	2007-11-07 17:29	HIV-1 gp120 is processed in its V3 loop by cathepsin E
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	1524	NP_001328.1	CX3C chemokine receptor 1 isoform b	10869418	2007-11-07 17:31	Fractalkine (CX3CL1) protects hippocampal neurons from the neurotoxicity induced by the HIV-1 envelope protein gp120, and neuronal CX(3)CR1 receptors and Akt activation are responsible for the neuroprotective effects of fractalkine
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	associates with	9606	1524	NP_001328.1	CX3C chemokine receptor 1 isoform b	11804551	2007-11-07 17:31	HIV-1 gp120 from CXCR4-tropic subtype E viruses isolated in Thailand associates with and uses at least one of the following coreceptors for virus entry: CCR8, CCR1, CCR2b, or CX3CR1
11676	155030	NP_579880.1	capsid	downregulates	9606	1536	NP_000388.2	cytochrome b-245 heavy chain	1905983	2007-11-07 17:29	HIV-1 Capsid (p24) inhibits interferon gamma induced increases in HLA-DR and cytochrome B heavy chain mRNA levels in the human monocyte-like cell line THP1
11676	155807	NP_057852.2	Vpr	induces release of	9606	1537	NP_001907.2	cytochrome c1, heme protein, mitochondrial	11181702,12095993,12096338,12750393,12750404,16511342	2007-11-07 17:27	HIV-1 Vpr-induced mitochondrial membrane permeabilization and caspase activation results in release of cytochrome c
11676	155030	NP_579876.2	matrix	activates	9606	1594	NP_000776.1	25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial	9282826	2007-11-07 17:28	HIV-1 Matrix activates fructose 1,6-bisphosphatase gene expression by induction of 1alpha-hydroxylase activity
11676	156110	NP_057857.2	Nef	upregulates	9606	1595	NP_000777.1	lanosterol 14-alpha demethylase isoform 1	12824470	2007-11-07 17:28	In Jurkat cells HIV-1 Nef upregulates the expression of the sterol 14-alpha demethylase CYP51 gene, which catalyzes the demethylation of lanosterol during cholesterol biosynthesis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1604	NP_000565.1	complement decay-accelerating factor isoform 1 preproprotein	7535292	2007-11-07 17:27	Inhibition of DAF or use of factor H depleted sera significantly increases C3 deposition on recombinant HIV-1 gp120 coated CD4 cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1604	NP_000565.1	complement decay-accelerating factor isoform 1 preproprotein	8887350	2007-11-07 17:30	The complement regulatory proteins CD55 (DAF) and CD59 (HRF20) exist on HIV-1 virions, along with HIV-1 gp120 molecules, suggesting an interaction between these proteins and gp120
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	1636	NP_000780.1	angiotensin I converting enzyme 1 isoform 1 precursor	1316930	2007-11-07 17:30	HIV-1 gp160-derived peptide p18 presented by H-2Dd class I major histocompatibility complex molecules is processed by angiotensin-1 converting enzyme (ACE) prior to T cell stimulation by the peptide p18
11676	155807	NP_057852.2	Vpr	upregulates	9606	1647	NP_001915.1	growth arrest and DNA damage-inducible protein GADD45 alpha	15650754	2007-11-07 17:28	HIV-1 Vpr upregulates GADD45alpha protein levels in primary CD4+ lymphocytes and SupT1 cells; knockdown of GADD45alpha by GADD45alpha siRNA relieves Vpr-induced apoptosis
11676	155871	NP_057853.1	Tat	enhanced by	9606	1649	NP_004074.2	DNA damage-inducible transcript 3 protein	16511829	2007-11-07 17:31	Expression of Rad51 enhances basal- and HIV-1 Tat-induced transcription of the HIV-1 LTR promoter; this event requires cooperativity from the C/EBP family of transcription factors including C/EBPbeta and C/EBPbeta homologous protein (CHOP)
11676	155908	NP_057854.1	Rev	interacts with	9606	1653	NP_004930.1	ATP-dependent RNA helicase DDX1	15567440	2007-11-07 17:29	DDX1 is capable of binding to HIV-1 RRE RNA in vivo, suggesting an interaction with HIV-1 Rev, however DDX1 alone cannot rescue HIV-1 virion production from a Rev-negative provirus in the absence of Rev
11676	155908	NP_057854.1	Rev	interacts with	9606	1653	NP_004930.1	ATP-dependent RNA helicase DDX1	15567440	2007-11-07 17:28	The RNA helicase DDX1 interacts with HIV-1 Rev through yeast two-hybrid screening and co-immunoprecipitation assays, and DDX1 is required for proper subcellular localization of Rev
11676	155908	NP_057854.1	Rev	relocalized by	9606	1653	NP_004930.1	ATP-dependent RNA helicase DDX1	15892970,16354571	2007-11-07 17:28	Endogenous DDX1 expression in human astrocytes leads to a shift of Rev sub-cellular distribution dominance from nuclear and/or nucleolar to cytoplasmic
11676	155908	NP_057854.1	Rev	relocalized by	9606	1653	NP_004930.1	ATP-dependent RNA helicase DDX1	15892970	2007-11-07 17:28	Overexpression of exogenous DDX1 significantly alters both Rev sub-cellular localization from cytoplasmic to nuclear predominance and concomitantly increases HIV-1 viral production in human astrocytes
11676	155908	NP_057854.1	Rev	exported by	9606	1654	NP_001347.3	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3	15507209,15516266,16354571	2007-11-07 17:28	As part of the HIV-1 Rev-RRE/CRM1 pathway, DDX3, an RNA-dependent ATPase/helicase, locates to nuclear pores and binds CRM1 in order to export Rev and unspliced/partially spliced HIV-1 transcripts to the cytoplasm
11676	155030	NP_057850.1	Pr55(Gag)	interacts with	9606	1660	NP_001348.2	ATP-dependent RNA helicase A	16527808	2007-11-07 17:31	HIV-1 Gag interacts with RNA helicase A (RHA) in an RNA-dependent manner, and RHA binds HIV-1 RNA
11676	155908	NP_057854.1	Rev	interacts with	9606	1660	NP_001348.2	ATP-dependent RNA helicase A	9892698,10951562	2007-11-07 17:27	RNA helicase A is a cofactor that binds to the Rev responsive element (RRE) of HIV-1 mRNA during Rev-mediated nuclear export of mRNA
11676	155908	NP_057854.1	Rev	interacts with	9606	1660	NP_001348.2	ATP-dependent RNA helicase A	9892698	2007-11-07 17:27	it is hypothesized that RNA helicase A is required to release RRE-containing mRNA from spliceosomes before completion of splicing, thus freeing them for nuclear export
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1667	NP_004075.1	neutrophil defensin 1 preproprotein	15620707,17132727	2007-11-07 17:30	Human neutrophil alpha-defensin 4 (HNP4) is more effective than HNP1-3 in protecting human peripheral blood mononuclear cells from infection by both CXCR4- and CCR5-tropic HIV-1 strains, but HNP4 binds to both CD4 and gp120 weaker than does HNP1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	1667	NP_004075.1	neutrophil defensin 1 preproprotein	17132727	2007-11-07 17:31	Alpha-defensins inhibit the binding of HIV-1 gp120 to CD4 through interaction with the D1 domain of CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	1668	NP_005208.1	neutrophil defensin 3 preproprotein	15620707,17132727	2007-11-07 17:31	Alpha-defensins inhibit the binding of HIV-1 gp120 to CD4 through interaction with the D1 domain of CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1668	NP_005208.1	neutrophil defensin 3 preproprotein	17132727	2007-11-07 17:31	Human neutrophil alpha-defensin 4 (HNP4) is more effective than HNP1-3 in protecting human peripheral blood mononuclear cells from infection by both CXCR4- and CCR5-tropic HIV-1 strains, but HNP4 binds to both CD4 and gp120 weaker than does HNP1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1669	NP_001916.1	neutrophil defensin 4 preproprotein	15620707,17132727	2007-11-07 17:30	Human neutrophil alpha-defensin 4 (HNP4) is more effective than HNP1-3 in protecting human peripheral blood mononuclear cells from infection by both CXCR4- and CCR5-tropic HIV-1 strains, but HNP4 binds to both CD4 and gp120 weaker than does HNP1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	1669	NP_001916.1	neutrophil defensin 4 preproprotein	17132727	2007-11-07 17:31	Alpha-defensins inhibit the binding of HIV-1 gp120 to CD4 through interaction with the D1 domain of CD4
11676	155348	NP_705926.1	retropepsin	cleaves	9606	1674	NP_001918.3	desmin	2201025,8424456,8997639	2007-11-07 17:29	HIV-1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein in vitro
11676	155348	NP_705926.1	retropepsin	induces cleavage of	9606	1676	NP_004392.1	DNA fragmentation factor subunit alpha isoform 1	12404116	2007-11-07 17:29	HIV-1 protease directly cleaves and activates procaspase 8 in T cells, which is associated with cleavage of BID, mitochondrial release of cytochrome c, activation of the downstream caspases 9 and 3, and cleavage of DFF and PARP
11676	155348	NP_705926.1	retropepsin	induces cleavage of	9606	1677	NP_004393.1	DNA fragmentation factor subunit beta	12404116	2007-11-07 17:29	HIV-1 protease directly cleaves and activates procaspase 8 in T cells, which is associated with cleavage of BID, mitochondrial release of cytochrome c, activation of the downstream caspases 9 and 3, and cleavage of DFF and PARP
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	1755	NP_004397.1	deleted in malignant brain tumors 1 isoform a precursor	12689412,15242536,16796526	2007-11-07 17:30	Salivary agglutinin (SAG), a high molecular weight glycoprotein (340 kDa), binds to HIV-1 gp120; SAG binding to gp120 is Ca(2+) dependent and specifically inhibits HIV-1 infectivity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	1755	NP_004397.1	deleted in malignant brain tumors 1 isoform a precursor	15242536	2007-11-07 17:30	The interaction of gp340 (SAG) with HIV-1 gp120 is enhanced by prebinding of sCD4 to gp120, suggesting that gp340 inhibitory activity is mediated by blocking access of gp120 to its chemokine coreceptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1755	NP_004397.1	deleted in malignant brain tumors 1 isoform a precursor	16796526	2007-11-07 17:31	A 35KDa purified recombinant N-terminal protein of gp340 (SAG) interacts with the V3 domain of HIV-1 gp120
11676	156110	NP_057857.2	Nef	Interacts with	9606	1794	NP_004937.1	dedicator of cytokinesis protein 2	14737186	2007-11-07 17:28	Interaction of HIV-1 Nef with a protein complex, which includes Rac2, DOCK2, and ELMO1, activates Rac activity in T cells
11676	155871	NP_057853.1	Tat	inhibits	9606	1803	NP_001926.2	dipeptidyl peptidase 4	7912830,8095514,8635502,8852605,8925885,9330689,9374514,9671214,12752434	2007-11-07 17:27	HIV-1 Tat inhibits the enzymatic activity of CD26, thereby suppressing DNA synthesis and IL-1 beta production, stimulating secretion of IL-1 receptor antagonist and TNF-alpha, and causing, at least in part, the immunosuppressive effects of Tat
11676	155871	NP_057853.1	Tat	binds	9606	1803	NP_001926.2	dipeptidyl peptidase 4	7912830,8925885,9374514,12752434	2007-11-07 17:27	The N-terminal nine amino acids of HIV-1 Tat mediate the binding of Tat to CD26
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1803	NP_001926.2	dipeptidyl peptidase 4	7539755,9185130,9263011	2007-11-07 17:27	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1803	NP_001926.2	dipeptidyl peptidase 4	7585218	2007-11-07 17:30	Infection of cells with Macrophage-tropic HIV-1 confers preferential survival to cells with low CD26 levels; the third hypervariable region (V3) of the HIV-1 gp120 envelope protein plays an important role in this selection process
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1803	NP_001926.2	dipeptidyl peptidase 4	7903479,11831694	2007-11-07 17:30	Although CD26 has been described as a cofactor for HIV-1 gp120 mediated entry into cells, no evidence of a CD26-gp120 interaction was observed in vitro by using glutathione S-transferase-tagged HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaved by	9606	1803	NP_001926.2	dipeptidyl peptidase 4	7903479	2007-11-07 17:29	CD26 (dipeptidyl peptidase IV) cleaves the highly conserved V3 loop of HIV-1 gp120 and functions as a cofactor for entry of HIV-1 in CD4+ human cells; coexpression of human CD4 and CD26 in murine NIH 3T3 cells renders them permissive to HIV-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	1803	NP_001926.2	dipeptidyl peptidase 4	8806567,9330699	2007-11-07 17:30	Apoptosis is observed in CD4+ cells expressing the HIV-1 gp120/gp41 complex and with enhanced levels of CD26, but is not detected in cell lines expressing an uncleavable precursor of HIV-1 gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	1803	NP_001926.2	dipeptidyl peptidase 4	9103436,9330696,10899322,11278278	2007-11-07 17:27	HIV-1 gp120 inhibits adenosine deaminase (ADA) binding to CD26 (dipeptidyl-peptidase 4) in both CD4+ and CD4- cells; this effect requires the interaction of gp120 with CD4 or CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	relocalizes	9606	1803	NP_001926.2	dipeptidyl peptidase 4	11278278	2007-11-07 17:31	SDF-1alpha and HIV-1 gp120 induce the appearance of pseudopodia in which CD26 and CXCR4 co-localize
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	1803	NP_001926.2	dipeptidyl peptidase 4	8806567,9330699	2007-11-07 17:30	Apoptosis is observed in CD4+ cells expressing the HIV-1 gp120/gp41 complex and with enhanced levels of CD26, but is not detected in cell lines expressing an uncleavable precursor of HIV-1 gp160
11676	156110	NP_057857.2	Nef	upregulates	9606	1805	NP_001928.2	dermatopontin precursor	11810028	2007-11-07 17:28	HIV-1 Nef-induced upregulation of tyrosine-rich acidic matrix protein (TRAMP) is found in Nef expressing HeLa cells
11676	155871	NP_057853.1	Tat	inhibits	9606	1810	NP_001929.1	protein Dr1	8764062	2007-11-07 17:27	Interaction of HIV-1 Tat with TBP/TFIID competes with negative cofactor Dr1 interaction with TBP, thereby inhibiting Dr1
11676	155871	NP_057853.1	Tat	inhibited by	9606	1869	NP_005216.1	transcription factor E2F1	7474112	2007-11-07 17:29	E2F1 has the ability to suppress basal transcriptional activity of the HIV-1 LTR and to diminish the extent of the Tat-induced activation of this viral promoter
11676	155871	NP_057853.1	Tat	inhibited by	9606	1869	NP_005216.1	transcription factor E2F1	9525916	2007-11-07 17:28	The under-phosphorylated form of Rb that is prevalent in HIV-1 Tat treated glial cells activates HIV-1 transcription, likely through promoting the interaction of Rb with E2F-1 and preventing the inhibition of Tat function associated with E2F-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	1869	NP_005216.1	transcription factor E2F1	17011204	2007-11-07 17:31	In cultured neurons, HIV-1 gp120 increases transcription factor E2F1 levels in the nucleus, stimulates its transcriptional activity, and enhances the expression of the E2F1 target proteins Cdc2 and Puma
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	requires	9606	1869	NP_005216.1	transcription factor E2F1	17011204	2007-11-07 17:31	Transcription factor E2F1 is necessary for neuronal cell death induced by HIV-1 gp120 via neuronal CXCR4
11676	155871	NP_057853.1	Tat	recruits	9606	1874	NP_001941.2	transcription factor E2F4	12055184	2007-11-07 17:29	Binding of HIV-1 Tat to E2F4 is mediated through amino acids 1-49 of Tat and 1-184 of E2F4, allowing Tat to recruit E2F4 to promoter elements to exert its multiple biological activities
11676	155871	NP_057853.1	Tat	upregulates	9606	1906	NP_001946.2	endothelin 1	17197385	2007-11-07 17:31	In HIV-1 Tat-expressing and HIV-infected astrocytes, endothelin-1 (ET-1) is significantly elevated through NF-kappaB (NF-kappaB)-responsive sites in the ET-1 promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	1906	NP_001946.2	endothelin 1	8482849,12151765,15481145,15979050	2007-11-07 17:29	HIV-1 gp120 stimulates the secretion of endothelin-1, as well as TNF-alpha, from human cells in a concentration-dependent manner
11676	156110	NP_057857.2	Nef	inhibits	9606	1906	NP_001946.2	endothelin 1	9453574	2007-11-07 17:28	The activation of extracellular signal-regulated kinase (ERK) by endothelin-1 (ET-1) is inhibited by HIV-1 Nef in human astrocytes; a similar inhibitory action of Nef on ERK activation was observed after direct stimulation of G proteins
11676	155030	NP_579876.2	matrix	binds	9606	1915	NP_001393.1	elongation factor 1-alpha 1	10364286	2007-11-07 17:28	Binding of elongation factor 1-alpha to HIV-1 Gag proteins (Matrix and Nucleocapsid) appears to be mediated by RNA
11676	155030	NP_579876.2	matrix	binds	9606	1915	NP_001393.1	elongation factor 1-alpha 1	10364286	2007-11-07 17:28	Elongation factor 1-alpha binds to HIV-1 Matrix, as well as to HIV-1 Gag and Nucleocapsid and is incorporated into HIV-1 virion membranes
11676	155030	NP_579876.2	matrix	binds	9606	1915	NP_001393.1	elongation factor 1-alpha 1	10364286	2007-11-07 17:28	The basic region of HIV-1 Matrix (amino acids 15-35) mediates binding to amino acids 1-74 of elongation factor 1-alpha
11676	155030	NP_579876.2	matrix	inhibits	9606	1915	NP_001393.1	elongation factor 1-alpha 1	10364286	2007-11-07 17:29	The interaction between HIV-1 Matrix and elongation factor 1-alpha impairs translation in vitro, suggesting a role for this interaction in releasing viral RNA from polysomes, permitting the RNA to be packaged into virions
11676	155348	NP_705928.1	integrase	binds	9606	1915	NP_001393.1	elongation factor 1-alpha 1	11689615	2007-11-07 17:29	Interaction of human EF1alpha with HIV-1 integrase is presumed based on a reported binding interaction between yeast TEF1alpha and integrase
11676	155871	NP_057853.1	Tat	interacts with	9606	1915	NP_001393.1	elongation factor 1-alpha 1	8626763	2007-11-07 17:30	EF-1alpha stimulates the binding of RNA Polymerase II and TRP-185 to HIV-1 TAR RNA, suggesting an interaction between EF-1alpha and HIV-1 Tat
11676	155871	NP_057853.1	Tat	interacts with	9606	1917	NP_001949.1	elongation factor 1-alpha 2	8626763	2007-11-07 17:30	EF-1alpha stimulates the binding of RNA Polymerase II and TRP-185 to HIV-1 TAR RNA, suggesting an interaction between EF-1alpha and HIV-1 Tat
11676	155871	NP_057853.1	Tat	inhibits	9606	1936	NP_115754.2	elongation factor 1-delta isoform 1	9514931	2007-11-07 17:29	The second exon of HIV-1 Tat (amino acids 73-86) binds to EF-1delta (amino acids 144-280), thereby dramatically reducing the efficiency of the translation of cellular, but not viral, mRNA
11676	155807	NP_057852.2	Vpr	inhibited by	9606	1938	NP_001952.1	elongation factor 2	16520893	2007-11-07 17:31	Overproduction of EEF2 blocks HIV-1 Vpr-induced cell death both in fission yeast and human cells, suppresses caspase 9 and caspase 3-mediated apoptosis induced by Vpr, and reduces cytochrome c release induced by Vpr
11676	155871	NP_057853.1	Tat	interacts with	9606	1950	NP_001954.1	epidermal growth factor (beta-urogastrone)	8123596	2007-11-07 17:29	HIV-1 Tat upregulates transcription of the transforming growth factor alpha gene in an epidermal growth factor (EGF)-dependent manner, suggesting an interaction between Tat and EGF
11676	155030	NP_057850.1	Pr55(Gag)	upregulates	9606	1956	NP_005219.2	epidermal growth factor receptor isoform a precursor	15507625	2007-11-07 17:29	Expression of HIV-1 Gag decreases the rate of EGFR downregulation by ESCRT proteins at endosomal membranes, an effect that is dependent on the presence of the TSG101 binding motif (PTAP) within the Gag C-terminal p6 domain
11676	155871	NP_057853.1	Tat	binds	9606	1958	NP_001955.1	early growth response protein 1	11909874	2007-11-07 17:29	HIV-1 Tat binds to Egr-1, an interaction that is mediated through Tat amino acids 30-40
11676	155871	NP_057853.1	Tat	synergizes with	9606	1959	NP_000390.2	early growth response protein 2 isoform a	11909874	2007-11-07 17:29	HIV-1 Tat (through amino acids 30-40) binds to Egr-2 and synergizes with this protein to super induce the FasL promoter
11676	155871	NP_057853.1	Tat	synergizes with	9606	1960	NP_004421.2	early growth response protein 3	11909874	2007-11-07 17:29	HIV-1 Tat (through amino acids 30-40) binds to Egr-3 and synergizes with this protein to super induce the FasL promoter
11676	155871	NP_057853.1	Tat	competes with	9606	1965	NP_004085.1	eukaryotic translation initiation factor 2 subunit 1	9079663,10620360	2007-11-07 17:28	HIV-1 Tat competes with eukaryotic initiation factor 2, a well characterized substrate of PKR, for phosphorylation by activated PKR
11676	155871	NP_057853.1	Tat	interacts with	9606	1965	NP_004085.1	eukaryotic translation initiation factor 2 subunit 1	10648795	2007-11-07 17:29	Eukaryotic translation initiation factor 2 (eIF2) recognizes and binds the TAR secondary structure in HIV-1 RNA, suggesting a role in Tat transactivation of the viral LTR promoter
11676	155871	NP_057853.1	Tat	competes with	9606	1968	NP_001406.1	eukaryotic translation initiation factor 2 subunit 3	9079663,10620360	2007-11-07 17:28	HIV-1 Tat competes with eukaryotic initiation factor 2, a well characterized substrate of PKR, for phosphorylation by activated PKR
11676	155871	NP_057853.1	Tat	interacts with	9606	1968	NP_001406.1	eukaryotic translation initiation factor 2 subunit 3	10648795	2007-11-07 17:29	Eukaryotic translation initiation factor 2 (eIF2) recognizes and binds the TAR secondary structure in HIV-1 RNA, suggesting a role in Tat transactivation of the viral LTR promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	1977	NP_001959.1	eukaryotic translation initiation factor 4E isoform 1	12089333,12775419	2007-11-07 17:30	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155348	NP_705926.1	retropepsin	cleaves	9606	1981	NP_937884.1	eukaryotic translation initiation factor 4 gamma 1 isoform 1	11606767,12054764,12505164,12682023,14610163	2007-11-07 17:29	Purified HIV-1 protease cleaves eIF4GI at positions 678, 681, and 1086 leading to inhibition of protein synthesis directed by capped mRNAs
11676	155908	NP_057854.1	Rev	interacts with	9606	1984	NP_001961.1	eukaryotic translation initiation factor 5A-1 isoform B	7971969,9285095,16354571	2007-11-07 17:29	eIF-5A is a hypusine-containing protein required for Rev-mediated nuclear export of HIV-1 mRNA
11676	155908	NP_057854.1	Rev	binds	9606	1984	NP_001961.1	eukaryotic translation initiation factor 5A-1 isoform B	8253832	2007-11-07 17:29	eIF-5A interacts with the activation domain of Rev (amino acids 75-83)
11676	155908	NP_057854.1	Rev	binds	9606	1984	NP_001961.1	eukaryotic translation initiation factor 5A-1 isoform B	9285100	2007-11-07 17:29	eIF-5A binds Rev Response Element (RRE) RNA, an interaction likely to be involved in its association with Rev during nuclear export
11676	155908	NP_057854.1	Rev	binds	9606	1984	NP_001961.1	eukaryotic translation initiation factor 5A-1 isoform B	9465063,16354571	2007-11-07 17:27	eIF-5A interacts with the ribosomal protein L5 during its Rev nuclear export activity
11676	155908	NP_057854.1	Rev	interacts with	9606	1984	NP_001961.1	eukaryotic translation initiation factor 5A-1 isoform B	10381392,11238447	2007-11-07 17:29	eIF-5A directly interacts with CRM1 and mediates its binding to Rev, an effect that is required for nuclear export of Rev
11676	155908	NP_057854.1	Rev	interacts with	9606	1984	NP_001961.1	eukaryotic translation initiation factor 5A-1 isoform B	11238447	2007-11-07 17:29	eIF-5A interacts with nucleoporins CAN/nup214, nup153, nup98, and nup62 as well as nuclear actin during the nuclear export of Rev
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	1991	NP_001963.1	neutrophil elastase preproprotein	12933574	2007-11-07 17:31	Human leukocyte elastase (HLE) interacts with the fusion motif (residues 491-495) of HIV-1 gp41, suggesting a nonenzymatic receptor function for HLE in the context of HIV-1 entry into cells
11676	156110	NP_057857.2	Nef	induces phosphorylation of	9606	2002	NP_005220.1	ELK1 protein	11726657,15638726	2007-11-07 17:28	Nef increases Elk1 phosphorylation via the activation of the ERK1/2 signaling pathway in primary CD4 T cells
11676	155348	NP_705928.1	integrase	interacts with	9606	2010	NP_000108.1	emerin	16680152,16738646	2007-11-07 17:31	Barrier-to-autointegration factor (BAF) is required for the association of viral cDNA with emerin and for chromatin engagement by viral cDNA before integration, indicating potential interactions between BAF, emerin and HIV-1 integrase
11676	155871	NP_057853.1	Tat	activates	9606	2021	NP_004426.2	endonuclease G, mitochondrial precursor	15204919	2007-11-07 17:28	HIV-1 Tat-induced neurotoxicity is associated with the activation of a pathway involving endonuclease G
11676	155871	NP_057853.1	Tat	inhibits	9606	2023	NP_001419.1	alpha-enolase	9093905	2007-11-07 17:30	MBP-1 suppresses transcription from the HIV-1 LTR promoter, an effect that is inhibited by HIV-1 Tat, suggesting an important role for MBP-1 in the regulation of HIV-1 replication in infected cells
11676	155807	NP_057852.2	Vpr	activates	9606	2033	NP_001420.2	histone acetyltransferase p300	9560267	2007-11-07 17:27	Data suggests that HIV-1 Vpr, Rel A, and p300 act in concert to activate HIV transcription
11676	155807	NP_057852.2	Vpr	binds	9606	2033	NP_001420.2	histone acetyltransferase p300	9560267,12208951,12379213,15142377,15725353	2007-11-07 17:27	HIV-1 Vpr transactivation of HIV transcription and of the glucocorticoid receptor pathway is mediated by direct binding to the p300 co-activator
11676	155807	NP_057852.2	Vpr	activates	9606	2033	NP_001420.2	histone acetyltransferase p300	12208951,12379213,12788643	2007-11-07 17:27	Adenovirus E1A protein represses activation by Vpr by competing for binding to p300, suggesting that p300 is required for activation of HIV transcription by Vpr
11676	155807	NP_057852.2	Vpr	binds	9606	2033	NP_001420.2	histone acetyltransferase p300	12208951	2007-11-07 17:27	The C-terminus of HIV-1 Vpr (amino acids 64-84) mediates the binding of Vpr to p300 (amino acids 2045-2191)
11676	155807	NP_057852.2	Vpr	enhanced by	9606	2033	NP_001420.2	histone acetyltransferase p300	12379213	2007-11-07 17:27	Transcription Factor IIH (TFIIH) and p300 act cooperatively to enhance Vpr effects on glucocorticoid receptor transactivation
11676	155871	NP_057853.1	Tat	complexes with	9606	2033	NP_001420.2	histone acetyltransferase p300	9733796	2007-11-07 17:30	HIV-1 Tat forms a ternary complex with p300 and P/CAF
11676	155871	NP_057853.1	Tat	interacts with	9606	2033	NP_001420.2	histone acetyltransferase p300	9733796,11956210,15611041	2007-11-07 17:30	HIV-1 Tat interaction with p300 and other histone acetyl transferases is preferentially important for Tat-mediated transactivation of integrated, but not unintegrated, HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	regulated by	9606	2033	NP_001420.2	histone acetyltransferase p300	9733868,9811832,10545121,10607594,11080476,11931765,11956210,12887902,15171254	2007-11-07 17:30	Acetylation of HIV-1 Tat by p300 at Lys50 regulates Tat binding to cyclin T1 and HIV-1 TAR RNA, as well as Tat-mediated transactivation of the HIV-1 LTR promoter, by allowing Tat to dissociate from TAR RNA
11676	155871	NP_057853.1	Tat	binds	9606	2033	NP_001420.2	histone acetyltransferase p300	9733868,9811832,11080476	2007-11-07 17:30	HIV-1 Tat binds to the minimal histone acetyltransferase domain (amino acids 1253-1710) and E1a binding domain (amino acids 1542-1710) of p300, an effect mediated by the basic domain (amino acids 48-57) of Tat
11676	155871	NP_057853.1	Tat	recruits	9606	2033	NP_001420.2	histone acetyltransferase p300	9811832,11547919	2007-11-07 17:30	HIV-1 Tat recruits CBP/p300 to the chromosomally integrated HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	acetylated by	9606	2033	NP_001420.2	histone acetyltransferase p300	10545121,10607594,11547919,11956210,12887902,12904943,15171254	2007-11-07 17:30	HIV-1 Tat is acetylated by p300 on Lys50 and Lys51
11676	155871	NP_057853.1	Tat	interacts with	9606	2033	NP_001420.2	histone acetyltransferase p300	11080476,11739381	2007-11-07 17:30	Binding of HIV-1 Tat to p300 induces a conformational change in the CBP/p300 complex such that it can acquire and bind better to basal transcription factors, indicating Tat helps CBP/p300 recruit new partners to the transcription machinery
11676	155871	NP_057853.1	Tat	modulates	9606	2033	NP_001420.2	histone acetyltransferase p300	11689053,15611041	2007-11-07 17:30	HIV-1 Tat interaction with p300 increases the histone acetyl transferase (HAT) activity of p300 on histone H4, indicating Tat modulates HAT activity of co-activators to derepress the HIV-1 chromatin structure and aid in activated transcription
11676	155871	NP_057853.1	Tat	regulates	9606	2033	NP_001420.2	histone acetyltransferase p300	11739381	2007-11-07 17:30	Acetylation of the p50 subunit of NFkappaB by CBP/p300 is regulated by HIV-1 Tat
11676	155871	NP_057853.1	Tat	activates	9606	2033	NP_001420.2	histone acetyltransferase p300	16001085	2007-11-07 17:28	HIV-1 Tat induces the polyubiquitination and degradation of Tip60 through p300/CBP-associated E4-type ubiquitin-ligase activity, which results in a dramatic impairment of the Tip60-dependent apoptotic cell response to DNA damage
11676	155871	NP_057853.1	Tat	regulated by	9606	2033	NP_001420.2	histone acetyltransferase p300	16601680,16687403	2007-11-07 17:31	INI-1 and BRG-1 synergize with the p300 acetyltransferase to activate the HIV promoter; this synergism depends on the acetyltransferase activity of p300 and on HIV-1 Tat amino acids Lys(50) and Lys(51), suggesting a regulation of Tat by these proteins
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	2033	NP_001420.2	histone acetyltransferase p300	16179804	2007-11-07 17:31	HIV-1 gp120 and p300 synergistically increase TGF-beta, ATF-2 and activating protein-1 (AP-1) expression leading to tubular cell apoptosis; in addition, HIV-1 gp120 treatment causes phosphorylation of Smad2 and downregulation of c-Jun
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	enhanced by	9606	2033	NP_001420.2	histone acetyltransferase p300	16179804	2007-11-07 17:31	HIV-1 gp120-induced apoptosis in human proximal renal tubular cells is significantly enhanced by p300, and Smad7 and an anti-TGF-beta antibody inhibit this effect of p300
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	2056	NP_000790.2	erythropoietin precursor	15073510	2007-11-07 17:30	The cytokine erythropoietin (EPO) is clinically used to treat anemia but has also been found to prevent gp120-induced neuronal death
11676	155871	NP_057853.1	Tat	binds	9606	2068	NP_000391.1	TFIIH basal transcription factor complex helicase subunit isoform 1	8628270,8934526,9184228,9334327,9765201	2007-11-07 17:28	Amino acids 1-48 of HIV-1 Tat, which includes the Tat activation domain, mediate the binding of Tat to CAK and the TFIIH complex through a direct interaction with CDK7 and possibly other TFIIH subunits, including p62 and ERCC3
11676	155871	NP_057853.1	Tat	interacts with	9606	2068	NP_000391.1	TFIIH basal transcription factor complex helicase subunit isoform 1	8849451,8934526,9054383,9121429	2007-11-07 17:28	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIH, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	requires	9606	2068	NP_000391.1	TFIIH basal transcription factor complex helicase subunit isoform 1	8934526,9184228,9334327	2007-11-07 17:28	CAK/TFIIH is required for HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	2068	NP_000391.1	TFIIH basal transcription factor complex helicase subunit isoform 1	8934526,9184228,9311822,9334327,9570510,9651670,10438593,10866664,14569024	2007-11-07 17:28	Interaction of HIV-1 Tat with TFIIH stimulates phosphorylation of Ser-5 of the RNA polymerase II C-terminal domain (CTD), which in turn also stimulates co-transcriptional capping of HIV-1 mRNA
11676	155871	NP_057853.1	Tat	synergizes with	9606	2068	NP_000391.1	TFIIH basal transcription factor complex helicase subunit isoform 1	8934526	2007-11-07 17:28	TFIIH synergizes with HIV-1 Tat to induce transcription elongation from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	2068	NP_000391.1	TFIIH basal transcription factor complex helicase subunit isoform 1	9651670,10066804,10082552,10866664,14569024	2007-11-07 17:28	TFIIH interacts with HIV-1 Tat as a component of the HIV-1 transcription preinitiation complex, but is released from the elongation complex which includes P-TEFb
11676	155871	NP_057853.1	Tat	binds	9606	2071	NP_000113.1	TFIIH basal transcription factor complex helicase XPB subunit	8628270,8934526,9184228,9334327,9765201	2007-11-07 17:28	Amino acids 1-48 of HIV-1 Tat, which includes the Tat activation domain, mediate the binding of Tat to CAK and the TFIIH complex through a direct interaction with CDK7 and possibly other TFIIH subunits, including p62 and ERCC3
11676	155871	NP_057853.1	Tat	interacts with	9606	2071	NP_000113.1	TFIIH basal transcription factor complex helicase XPB subunit	8849451,8934526,9054383,9121429	2007-11-07 17:28	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIH, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	requires	9606	2071	NP_000113.1	TFIIH basal transcription factor complex helicase XPB subunit	8934526,9184228,9334327	2007-11-07 17:28	CAK/TFIIH is required for HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	2071	NP_000113.1	TFIIH basal transcription factor complex helicase XPB subunit	8934526,9184228,9311822,9334327,9570510,9651670,10438593,10866664,14569024	2007-11-07 17:28	Interaction of HIV-1 Tat with TFIIH stimulates phosphorylation of Ser-5 of the RNA polymerase II C-terminal domain (CTD), which in turn also stimulates co-transcriptional capping of HIV-1 mRNA
11676	155871	NP_057853.1	Tat	synergizes with	9606	2071	NP_000113.1	TFIIH basal transcription factor complex helicase XPB subunit	8934526	2007-11-07 17:28	TFIIH synergizes with HIV-1 Tat to induce transcription elongation from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	2071	NP_000113.1	TFIIH basal transcription factor complex helicase XPB subunit	9651670,10066804,10082552,10866664,14569024	2007-11-07 17:28	TFIIH interacts with HIV-1 Tat as a component of the HIV-1 transcription preinitiation complex, but is released from the elongation complex which includes P-TEFb
11676	155871	NP_057853.1	Tat	regulated by	9606	2071	NP_000113.1	TFIIH basal transcription factor complex helicase XPB subunit	11572868	2007-11-07 17:28	The XPB (ERCC3) subunit of TFIIH inhibits phosphorylation of CDK9 in the HIV-1 transcription preinitiation and elongation complexes, thereby regulating HIV-1 Tat transactivation of the HIV-1 LTR promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2099	NP_000116.2	estrogen receptor isoform 1	15899520	2007-11-07 17:31	17beta-estradiol (17beta-E2) protects human neuroblastoma cells from cell death elicited by HIV-1 gp120; estrogen receptor antagonists antagonize 17beta-E2-mediated inhibition gp120-induced cell death
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2100	NP_001428.1	estrogen receptor beta isoform 1	15899520	2007-11-07 17:31	17beta-estradiol (17beta-E2) protects human neuroblastoma cells from cell death elicited by HIV-1 gp120; estrogen receptor antagonists antagonize 17beta-E2-mediated inhibition gp120-induced cell death
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaved by	9606	2147	NP_000497.1	prothrombin preproprotein	2015114,8457383,8503188	2007-11-07 17:30	Cleavage at amino acid position R315 of HIV-1 gp120 by thrombin is enhanced by soluble CD4 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activated by	9606	2147	NP_000497.1	prothrombin preproprotein	15109955	2007-11-07 17:31	Thrombin activates HIV-1 gp120/gp41 and enhances virus-cell fusion
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	2185	NP_004094.3	protein-tyrosine kinase 2-beta isoform a	9621077	2007-11-07 17:27	HIV-1 Tat stimulates the tyrosine phosphorylation of RAFTK and its association with paxillin, an effect mediated by the basic (amino acids 46-60) and RGD-containing (amino acids 65-80) domains of Tat and linked to AIDS-related Kaposi's sarcoma
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	2185	NP_004094.3	protein-tyrosine kinase 2-beta isoform a	9362541,10194422,10356363,12628756,12857973,12960231	2007-11-07 17:28	Engagement of the CCR5 and CXCR4 receptors by HIV-1 gp120 induces tyrosine phosphorylation of the protein tyrosine kinase Pyk2
11676	156110	NP_057857.2	Nef	upregulates	9606	2185	NP_775266.1	protein-tyrosine kinase 2-beta isoform a	12354773	2007-11-07 17:28	HIV-1 Nef expression in human T cells upregulates the levels of RAFTK activity through the SDF-1alpha signaling pathway
11676	155030	NP_579876.2	matrix	activates	9606	2203	NP_000498.2	fructose-1,6-bisphosphatase 1	9282826	2007-11-07 17:28	HIV-1 Matrix activates fructose 1,6-bisphosphatase gene expression by induction of a 1alpha-hydroxylase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	2204	NP_001991.1	immunoglobulin alpha Fc receptor isoform a precursor	8145026	2007-11-07 17:30	Preincubation of monocytes with HIV-1 gp120 depresses anti-CD3 antibody-induced T cell stimulation and Fc receptor-mediated phagocytosis
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulates	9606	2208	NP_001993.2	low affinity immunoglobulin epsilon Fc receptor	8450224	2007-11-07 17:30	Antibodies against cell surface molecules LFA-1, ICAM-1, HLA-DR, and CD28 inhibit the HIV-1 gp160-induced B cell differentiation response; gp160 also induces IL-6R and CD23 molecule expression on B cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	2208	NP_001993.2	low affinity immunoglobulin epsilon Fc receptor	11500085	2007-11-07 17:31	CD23 protein membrane expression is upregulated by HIV-1 gp120 and this upregulation induces the production of nitric oxide (NO) and IL-1beta
11676	156110	NP_057857.2	Nef	Induces release of	9606	2208	NP_001993.2	low affinity immunoglobulin epsilon Fc receptor	12853962	2007-11-07 17:28	In macrophages, activation of CD40 or expression of HIV-1 Nef induces the release of sCD23 and sICAM, which mediate effects on T lymphocytes, rendering them permissive to HIV-1 infection
11676	156110	NP_057857.2	Nef	downregulates	9606	2209	NP_000557.1	high affinity immunoglobulin gamma Fc receptor I precursor	9490697	2007-11-07 17:28	HIV-1 Nef downregulates Fc-gamma Receptor I in human monocytes/macrophages
11676	156110	NP_057857.2	Nef	downregulates	9606	2212	NP_067674.2	low affinity immunoglobulin gamma Fc region receptor II-a isoform 2	9490697	2007-11-07 17:28	HIV-1 Nef downregulates Fc-gamma Receptor II in human monocytes/macrophages
11676	156110	NP_057857.2	Nef	downregulates	9606	2213	NP_003992.3	low affinity immunoglobulin gamma Fc region receptor II-b isoform 1	9490697	2007-11-07 17:28	HIV-1 Nef downregulates Fc-gamma Receptor II in human monocytes/macrophages
11676	155871	NP_057853.1	Tat	inhibits	9606	2214	NP_000560.5	low affinity immunoglobulin gamma Fc region receptor III-A isoform a precursor	9743356	2007-11-07 17:27	HIV-1 Tat inhibits the rise in intracellular free calcium concentration in Natural Killer (NK) cells upon cross-linking of the adhesion molecule CD11a and the activation molecule CD16, indicating Tat is involved in the impairment of NK cell function
11676	155871	NP_057853.1	Tat	inhibits	9606	2215	NP_000561.2	low affinity immunoglobulin gamma Fc region receptor III-B precursor	9743356	2007-11-07 17:27	HIV-1 Tat inhibits the rise in intracellular free calcium concentration in Natural Killer (NK) cells upon cross-linking of the adhesion molecule CD11a and the activation molecule CD16, indicating Tat is involved in the impairment of NK cell function
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	2217	NP_004098.1	igG receptor FcRn large subunit p51 precursor	8145026	2007-11-07 17:30	Preincubation of monocytes with HIV-1 gp120 depresses anti-CD3 antibody-induced T cell stimulation and Fc receptor-mediated phagocytosis
11676	155348	NP_705928.1	integrase	stimulates	9606	2237	NP_004102.1	flap endonuclease 1	12065902	2007-11-07 17:29	FEN-1 is stimulated by HIV-1 Integrase and is hypothesized to play a role in the processing of HIV-1 integration intermediates
11676	155871	NP_057853.1	Tat	upregulates	9606	2246	NP_000791.1	heparin-binding growth factor 1 isoform 1 proprotein	7542239,9501919	2007-11-07 17:30	HIV-1 Tat induces the expression and secretion of FGF-1 from primary murine embryonic fibroblasts, an effect that may be relevant to the pathophysiological development of AIDS associated Kaposi's sarcoma
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	2246	NP_000791.1	heparin-binding growth factor 1 isoform 1 proprotein	11245213	2007-11-07 17:31	HIV-1 gp120-induced neurotoxic effects are inhibited by the presence of fibroblast growth factor 1 (FGF1)
11676	155871	NP_057853.1	Tat	synergizes with	9606	2247	NP_001997.4	fibroblast growth factor 2	7935812,10438928,11598182	2007-11-07 17:30	HIV-1 Tat synergizes with bFGF to promote Kaposi's sarcoma, endothelial cell growth and locomotion, and secretion of matrix-metalloproteinase-2
11676	155871	NP_057853.1	Tat	competes with	9606	2247	NP_001997.4	fibroblast growth factor 2	9342064,10397733	2007-11-07 17:30	HIV-1 Tat competes with bFGF for binding to Heparin, an effect mediated by the basic region of Tat (amino acids 49-57)
11676	155871	NP_057853.1	Tat	inhibits	9606	2247	NP_001997.4	fibroblast growth factor 2	11598182	2007-11-07 17:30	HIV-1 Tat inhibits bFGF-induced secretion of tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1 and TIMP-2)
11676	155871	NP_057853.1	Tat	interacts with	9606	2247	NP_001997.4	fibroblast growth factor 2	16436505	2007-11-07 17:29	HIV-1 Tat induces endothelial cells to progress through the G1 phase in response to bFGF, and this process is linked to ERK activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2247	NP_001997.4	fibroblast growth factor 2	11141237	2007-11-07 17:31	HIV-1 gp120-induced apoptosis in cell cultures through binding to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	2247	NP_001997.4	fibroblast growth factor 2	15689238	2007-11-07 17:30	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	2280	NP_000792.1	peptidyl-prolyl cis-trans isomerase FKBP1A	9546659,12181673	2007-11-07 17:29	Macrophage- and T-cell-tropic V3 loop peptides of HIV-1 gp120 bind specifically to the active site of the immunophilins FK506-binding protein (FKBP12), and cyclophilins A and B, and inhibit their peptidyl-prolyl cis-trans isomerase (PPIase) activities
11676	155807	NP_057852.2	Vpr	inhibits	9606	2309	NP_001446.1	forkhead box protein O3	15265780,15616007	2007-11-07 17:28	HIV-1 Vpr inhibits insulin- and Akt-induced cytoplasmic translocation of Foxo3a, a subtype of the forkhead transcription factors
11676	155807	NP_057852.2	Vpr	inhibits	9606	2309	NP_001446.1	forkhead box protein O3	15265780,15708996	2007-11-07 17:28	HIV-1 Vpr inhibits insulin-induced association of 14-3-3 and Foxo3a in HeLa cells
11676	155348	NP_705926.1	retropepsin	cleaves	9606	2316	NP_001447.2	filamin-A isoform 1	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155348	NP_705926.1	retropepsin	cleaves	9606	2317	NP_001448.2	filamin-B isoform 2	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155348	NP_705926.1	retropepsin	cleaves	9606	2318	NP_001449.3	filamin-C isoform a	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155871	NP_057853.1	Tat	activates	9606	2321	NP_002010.1	fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)	9269752	2007-11-07 17:27	The biologic activities of HIV-1 Tat in human monocytes are, at least in part, elicited by Tat activation of VEGFR-1/Flt-1
11676	155871	NP_057853.1	Tat	binds	9606	2321	NP_002010.1	fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)	9269752	2007-11-07 17:27	The mechanism of monocyte activation by HIV-1 Tat involves the binding of Tat to VEGFR-1/Flt-1 and activating signals through this receptor
11676	155871	NP_057853.1	Tat	inhibited by	9606	2321	NP_002010.1	fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)	9269752	2007-11-07 17:27	The soluble form of VEGFR-1 inhibits monocyte polarization and migration induced by HIV-1 Tat
11676	155871	NP_057853.1	Tat	upregulates	9606	2335	NP_002017.1	fibronectin isoform 3 preproprotein	1409674,8599839,11311202	2007-11-07 17:30	HIV-1 Tat upregulates fibronectin expression in salivary gland cell lines, thymic epithelial cells, and glioblastoma cells
11676	155871	NP_057853.1	Tat	competes with	9606	2335	NP_002017.1	fibronectin isoform 3 preproprotein	7690138	2007-11-07 17:30	HIV-1 Tat competes with fibronectin for binding to integrins
11676	155871	NP_057853.1	Tat	modulated by	9606	2335	NP_002017.1	fibronectin isoform 3 preproprotein	9339851,9626063	2007-11-07 17:30	Fibronectin modulates the effects of HIV-1 Tat on endothelial cells and murine Kaposi's sarcoma-like cells
11676	155348	NP_705926.1	retropepsin	cleaves	9606	2335	NP_997647.1	fibronectin isoform 1 preproprotein	1959621,8997639,12119179	2007-11-07 17:29	The cell-associated protein fibronectin (A-chain) is specifically cleaved in vitro by HIV-1 protease
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	2335	NP_997647.1	fibronectin isoform 1 preproprotein	1875953,9443108	2007-11-07 17:31	HIV-1 gp160 and gp120 specifically recognize the C-terminal heparin-binding domain of fibronectin (Fn) and this binding inhibits the interaction of gp160/gp120 with soluble CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	2335	NP_997647.1	fibronectin isoform 1 preproprotein	1875953,8173552	2007-11-07 17:30	Fibronectin, which is present in submandibular saliva, binds to HIV-1 gp120/160 and enhances the interaction of C1q with gp120/160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	2335	NP_997647.1	fibronectin isoform 1 preproprotein	8952048,9443108,10706716	2007-11-07 17:27	HIV-1 gp120 binds to fibronectin (FN) present on the surface of platelets; the specificity of this binding is confirmed by the inhibition obtained by pretreating platelets with anti-FN antibodies
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	2335	NP_997647.1	fibronectin isoform 1 preproprotein	8173552	2007-11-07 17:29	Fibronectin (FN) binds to HIV-1 glycoproteins, including gp41 and gp120; preincubation with antibodies against FN abolishes this binding
11676	156110	NP_057857.2	Nef	upregulates	9606	2335	NP_997647.1	fibronectin isoform 1 preproprotein	10451539,11180285	2007-11-07 17:29	Exogenous HIV-1 Nef upregulates fibronectin (FN) expression in MT4 and H9 T-cell lines
11676	155807	NP_057852.2	Vpr	activates	9606	2353	NP_005243.1	proto-oncogene c-Fos	16243842	2007-11-07 17:29	Synthetic HIV-1 Vpr protein activates AP-1 (Jun/Fos), c-Jun N-terminal kinase (JNK), NF-kappaB, and MKK7 in both U937 cells and primary macrophages.
11676	155871	NP_057853.1	Tat	upregulates	9606	2353	NP_005243.1	proto-oncogene c-Fos	9057648,9129988,11260070,15258149	2007-11-07 17:30	HIV-1 Tat upregulates c-Fos expression and c-Fos protein has been shown to be essential for optimal transactivation of the HIV-1 LTR promoter by Tat
11676	155871	NP_057853.1	Tat	activates	9606	2353	NP_005243.1	proto-oncogene c-Fos	10799874	2007-11-07 17:28	HIV-1 Tat activates the AP-1 complex containing c-fos through a p56lck dependent mechanism
11676	155871	NP_057853.1	Tat	interacts with	9606	2353	NP_005243.1	proto-oncogene c-Fos	15258149	2007-11-07 17:28	HIV-1 Tat contributes to the super-induction of IL-2 promoter activity through transcription factors such as NF-kappaB and AP-1 (c-Jun and c-Fos)
11676	155871	NP_057853.1	Tat	enhances	9606	2353	NP_005243.1	proto-oncogene c-Fos	16690925	2007-11-07 17:31	HIV-1 Tat expression in Jurkat T cells enhances cooperative NFAT/AP-1- but not AP-1-dependent transcription independent of its ability to transactivate the HIV-1 LTR
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	2353	NP_005243.1	proto-oncogene c-Fos	7642615	2007-11-07 17:30	HIV-1 gp160 induces activation of transcription factor, activated protein-1 (AP-1), comprised of Fos and Jun proteins, in CD4 positive T cell lines
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	2353	NP_005243.1	proto-oncogene c-Fos	7957556	2007-11-07 17:29	HIV-1 gp120 and anti-CD4 antibodies induce a specific, significant decrease in the binding activity of NF-AT, NF-kappa B and AP-1, which leads to an inhibition of IL-2 production and cell proliferation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	2353	NP_005243.1	proto-oncogene c-Fos	8621941	2007-11-07 17:30	Binding of heat-inactivated HIV-1 (iHIV-1) or HIV-1 gp120 to infected resting PBMCs is sufficient to activate NF-kappa B and AP-1, to induce cell surface expression of CD25, and to commit cells to produce virus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	2353	NP_005243.1	proto-oncogene c-Fos	10027715,10581001	2007-11-07 17:31	Treatment of cells with HIV-1 gp120 induces increased levels of endogenous c-fos and c-jun mRNA and proteins, an activation of both c-fos and c-jun promoters, and a very rapid stimulation of the MAPK/ERK pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2353	NP_005243.1	proto-oncogene c-Fos	16001969	2007-11-07 17:31	HIV-1 envelope protein gp120 is able to induce COX-2 mRNA and protein in human neuroblastoma cell lines that express CXCR4 and CCR5 but not CD4; gp120 induces COX-2 promoter transcription through NF-kappaB and activating protein-1 (AP-1) sites
11676	156110	NP_057857.2	Nef	downregulates	9606	2353	NP_005243.1	proto-oncogene c-Fos	8151786,8480425	2007-11-07 17:28	HIV-1 Nef inhibits the recruitment of AP-1 DNA binding activity by downregulating the transcription of c-fos in mitogen-stimulated human T cells
11676	156110	NP_057857.2	Nef	activates	9606	2353	NP_005243.1	proto-oncogene c-Fos	10388555,12419805	2007-11-07 17:28	HIV-1 Nef expression in human (THP-1) monocyte-macrophages induces both DNA binding and transcriptional activities of the activator protein-1 (AP-1) transcription factor, c-fos and c-jun; this induction requires the proline-rich PxxP motif of Nef
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	2357	NP_002020.1	fMet-Leu-Phe receptor	2541200	2007-11-07 17:31	Interaction of HIV-1 gp120 with CD4 is sufficient to trigger a marked reduction in C5a Receptor and a modest reduction in FMLP Receptor on monocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	2357	NP_002020.1	fMet-Leu-Phe receptor	11023526	2007-11-07 17:31	N-formyl-methionyl-leucylphenyl-alanine binding to formyl peptide receptor (FPR) results in significant attenuation of cell responses to CCR5 ligands and in inhibition of HIV-1 gp120-mediated fusion and infection of cells expressing CD4, CCR5, and FPR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	2358	NP_001453.1	N-formyl peptide receptor 2	10438703	2007-11-07 17:31	A synthetic peptide corresponding to amino acid residues 414-434 of HIV-1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	2358	NP_001453.1	N-formyl peptide receptor 2	10872839	2007-11-07 17:31	A synthetic peptide domain of the V3 region of HIV-1 gp120 activates the FPRL1 receptor in monocytes and neutrophils and causes reduced response to several chemokines that use multiple cell receptors, including SDF-1alpha and RANTES
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	2358	NP_001453.1	N-formyl peptide receptor 2	10872839,10964542	2007-11-07 17:30	HIV-1 gp41 activates innate host immune cells through FPRL1, and the activation of FPRL1 by gp41 further induces the phosphorylation of the chemokine receptor CCR5
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	2475	NP_004949.1	serine/threonine-protein kinase mTOR	11602639	2007-11-07 17:31	Syncytia arising from the fusion of cells expressing HIV-1 gp120 with cells expressing the CD4/CXCR4 complex causes phosphorylation of p53, which is mediated by the upregulation of mammalian target of FKBP12-rapamycin-associated protein (FRAP)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	2530	NP_004471.3	alpha-(1,6)-fucosyltransferase isoform b	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	decreases phosphorylation of	9606	2534	NP_002028.1	tyrosine-protein kinase Fyn isoform a	9344703	2007-11-07 17:30	Pretreatment of cells with HIV-1 gp160 results in marked inhibition of tyrosine phosphorylation of p59(fyn), PLC-gamma1, ras activation, and TNF-alpha secretion in anti-CD3 mAb activated CD4+ T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	2534	NP_002028.1	tyrosine-protein kinase Fyn isoform a	8671590,8883579,9043947,9269777,9344703	2007-11-07 17:27	Interaction of HIV-1 gp120 with CD4 leads to increased levels of phosphorylation of the src-family Lck and Fyn protein tyrosine kinases and enhancement of their activities
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	2534	NP_002028.1	tyrosine-protein kinase Fyn isoform a	8671590	2007-11-07 17:30	HIV-1 gp120 and gp41-induced cell killing is accompanied by tyrosine phosphorylation and activation of the CD4-associated p56(Lck) kinase, and by activation of a second member of the scr family of protein tyrosine kinases, p59(fyn) kinase
11676	156110	NP_057857.2	Nef	binds	9606	2534	NP_002028.1	tyrosine-protein kinase Fyn isoform a	7588629,10642173,16454711	2007-11-07 17:27	The single amino acid residue number 96 in the SH3 domain of Fyn regulates its affinity and specificity in binding to HIV-1 Nef
11676	156110	NP_057857.2	Nef	binds	9606	2534	NP_002028.1	tyrosine-protein kinase Fyn isoform a	7859737,10544125,14965316,15078178,15638726,16454711	2007-11-07 17:27	HIV-1 Nef binds to the SH3 domain of Fyn through its proline-rich (PXXP) motifs between amino acid residues 65 and 82; this binding enhances viral replication but not down-regulation of CD4
11676	156110	NP_057857.2	Nef	binds	9606	2534	NP_002028.1	tyrosine-protein kinase Fyn isoform a	8681387,9351809,9778343,16454711	2007-11-07 17:27	Crystal structure studies reveal the conserved PXXP sequence motif of HIV-1 Nef is part of a polyproline type II helix that is required for Nef binding to the SH3 domain of Fyn
11676	155871	NP_057853.1	Tat	activates	9606	2539	NP_000393.4	glucose-6-phosphate 1-dehydrogenase isoform a	8356804	2007-11-07 17:29	HIV-1 Tat increases the rate of transcription from the human glucose 6-phosphate dehydrogenase (G6PD) promoter and thereby activates G6PD
11676	155348	NP_705928.1	integrase	interacts with	9606	2547	NP_001460.1	X-ray repair cross-complementing protein 6	10213687,11070027,11158303,11406603	2007-11-07 17:29	DNA-PK, along with Ku70 and Ku80, is proposed to play a role in retroviral DNA integration and protects cells against toxicity induced by HIV-1 Integrase or integration
11676	155348	NP_705928.1	integrase	associates with	9606	2547	NP_001460.1	X-ray repair cross-complementing protein 6	11406603	2007-11-07 17:29	Ku70 associates with viral preintegration complexes containing HIV-1 Integrase
11676	155459	NP_057851.1	Vif	binds	9606	2547	NP_001460.1	X-ray repair cross-complementing protein 6	11158303,11406603,12368356	2007-11-07 17:27	Ku70, which is a component of HIV-1 preintegration complexes, was shown to bind to HIV-1 Vif in a yeast two-hybrid screen of a human lymphocyte cDNA library
11676	155871	NP_057853.1	Tat	interacts with	9606	2547	NP_001460.1	X-ray repair cross-complementing protein 6	8240370	2007-11-07 17:30	Ku protein binds to HIV-1 TAR RNA and is involved in the stimulation of the elongation property of RNA polymerase II as well as the activation of several transcription factors, suggesting a role in HIV-1 gene expression and Tat transactivation
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	2548	NP_000143.2	lysosomal alpha-glucosidase preproprotein	1678778,2825177	2007-11-07 17:30	Inhibitors of alpha-glucosidase inhibit syncytium formation induced by the envelope glycoprotein of HIV-1 and reduce processing of the HIV-1 envelope precursor protein gp160 by glucosidase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	2548	NP_000143.2	lysosomal alpha-glucosidase preproprotein	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	2548	NP_000143.2	lysosomal alpha-glucosidase preproprotein	1704656,2959866	2007-11-07 17:29	Glucosidase inhibitors inhibit the syncytium formation between HIV-infected and CD4-expressing cells and interfere with HIV-1 infectivity, indicating processing of HIV-1 gp120 by glucosidase is important for virus replication
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	glycosylated by	9606	2548	NP_000143.2	lysosomal alpha-glucosidase preproprotein	2076345,2136376,2283726,2355006,2649653,2959866,8218172,12719582,16547752	2007-11-07 17:29	HIV-1 gp120 is extremely heavily glycosylated (31-36 N-linked glycans per molecule) by glucosidase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	2548	NP_000143.2	lysosomal alpha-glucosidase preproprotein	8416962	2007-11-07 17:29	Imino sugar N-butyldeoxynojirimycin (NB-DNJ) inhibits HIV envelope glycoprotein gp120 processing mediated by alpha glucosidase I
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	2548	NP_000143.2	lysosomal alpha-glucosidase preproprotein	8794361,8794362,11752220	2007-11-07 17:30	The alpha-glucosidase inhibitor N-butyldeoxynojirimycin (NB-DNJ) inhibits HIV-1 entry and this inhibition correlates with impaired HIV-1 gp120 shedding and gp41 exposure and with changes in antibody recognition of gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	2548	NP_000143.2	lysosomal alpha-glucosidase preproprotein	12560567	2007-11-07 17:30	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	2548	NP_000143.2	lysosomal alpha-glucosidase preproprotein	1704656,1736542,2829950,3099781,3264072,8093218	2007-11-07 17:31	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	2568	NP_055026.1	gamma-aminobutyric acid receptor subunit pi precursor	12775419	2007-11-07 17:30	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	2595	NP_937784.2	neutral alpha-glucosidase C	1678778,2825177	2007-11-07 17:30	Inhibitors of alpha-glucosidase inhibit syncytium formation induced by the envelope glycoprotein of HIV-1 and reduce processing of the HIV-1 envelope precursor protein gp160 by glucosidase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	2595	NP_937784.2	neutral alpha-glucosidase C	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	2595	NP_937784.2	neutral alpha-glucosidase C	1704656,2959866	2007-11-07 17:29	Glucosidase inhibitors inhibit the syncytium formation between HIV-infected and CD4-expressing cells and interfere with HIV-1 infectivity, indicating processing of HIV-1 gp120 by glucosidase is important for virus replication
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	glycosylated by	9606	2595	NP_937784.2	neutral alpha-glucosidase C	2076345,2136376,2283726,2355006,2649653,2959866,8218172,12719582,16547752	2007-11-07 17:29	HIV-1 gp120 is extremely heavily glycosylated (31-36 N-linked glycans per molecule) by glucosidase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	2595	NP_937784.2	neutral alpha-glucosidase C	8416962	2007-11-07 17:29	Imino sugar N-butyldeoxynojirimycin (NB-DNJ) inhibits HIV envelope glycoprotein gp120 processing mediated by alpha glucosidase I
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	2595	NP_937784.2	neutral alpha-glucosidase C	8794361,8794362,11752220	2007-11-07 17:30	The alpha-glucosidase inhibitor N-butyldeoxynojirimycin (NB-DNJ) inhibits HIV-1 entry and this inhibition correlates with impaired HIV-1 gp120 shedding and gp41 exposure and with changes in antibody recognition of gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	2595	NP_937784.2	neutral alpha-glucosidase C	12560567	2007-11-07 17:30	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	2595	NP_937784.2	neutral alpha-glucosidase C	1704656,1736542,2829950,3099781,3264072,8093218	2007-11-07 17:31	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	2619	NP_002039.1	growth arrest-specific 1	15103018	2007-11-07 17:30	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	156110	NP_057857.2	Nef	binds	9606	2623	NP_002040.1	erythroid transcription factor	12767938	2007-11-07 17:27	Amino acids 19-26 of HIV-1 Nef mediate the binding of Nef to murine GATA-1 and GATA-3 in vitro, suggesting Nef may act as a nuclear regulatory factor through binding to human GATA-1 and GATA-3
11676	155871	NP_057853.1	Tat	synergizes with	9606	2624	NP_116027.2	endothelial transcription factor GATA-2 isoform 1	9517987	2007-11-07 17:29	GATA-2 synergizes with HIV-1 Tat to enhance transcriptional activity from the HIV-1 LTR promoter
11676	156110	NP_057857.2	Nef	binds	9606	2625	NP_002042.1	trans-acting T-cell-specific transcription factor GATA-3 isoform 2	12767938	2007-11-07 17:27	Amino acids 19-26 of HIV-1 Nef mediate the binding of Nef to murine GATA-1 and GATA-3 in vitro, suggesting Nef may act as a nuclear regulatory factor through binding to human GATA-1 and GATA-3
11676	155871	NP_057853.1	Tat	interacts with	9606	2629	NP_000148.2	glucosylceramidase isoform 1 precursor	16223608	2007-11-07 17:28	Glucocerebrosidase fusion proteins with the HIV-1 Tat transduction domain are internalized by cells and localize to endosomes and lysosomes, suggesting a novel strategy for generating therapeutic enzymes for Gaucher disease enzyme replacement therapy
11676	155871	NP_057853.1	Tat	binds	9606	2648	NP_066564.1	GCN5 general control of amino-acid synthesis 5-like 2	11384967,12154097	2007-11-07 17:30	Binding of HIV-1 Tat to hGCN5 is mediated by amino acids 20-48 of Tat (includes cysteine rich, core, and minimal activation domains of Tat) and by amino acids 111-151 (histone acetyltransferase domain) and 389-476 (bromodomain) of hGCN5
11676	155871	NP_057853.1	Tat	acetylated by	9606	2648	NP_066564.1	GCN5 general control of amino-acid synthesis 5-like 2	11384967	2007-11-07 17:30	HIV-1 Tat is acetylated by hGCN5 on lysines 50 and 51
11676	155871	NP_057853.1	Tat	enhanced by	9606	2648	NP_066564.1	GCN5 general control of amino-acid synthesis 5-like 2	11384967,11956210	2007-11-07 17:30	hGCN5 enhances HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	inhibits	9606	2648	NP_066564.1	GCN5 general control of amino-acid synthesis 5-like 2	12154097	2007-11-07 17:30	HIV-1 Tat inhibits the histone acetyltransferase and transcriptional activation activities of hGCN5, an effect mediated by amino acids 86-101 of Tat
11676	155871	NP_057853.1	Tat	recruits	9606	2648	NP_066564.1	GCN5 general control of amino-acid synthesis 5-like 2	14657027	2007-11-07 17:30	HIV-1 Tat recruits hGCN5, as well as other known cellular acetyltransferases, to the HIV-1 LTR promoter, an effect involved in the acetylation of histones H3 and H4, and HIV-1 transcriptional activation
11676	155348	NP_705926.1	retropepsin	cleaves	9606	2670	NP_002046.1	glial fibrillary acidic protein isoform 1	2201025	2007-11-07 17:29	HIV-1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein in vitro
11676	155871	NP_057853.1	Tat	upregulates	9606	2670	NP_002046.1	glial fibrillary acidic protein isoform 1	15519244	2007-11-07 17:28	HIV-1 Tat expression in astrocytes results in a significant increase in glial fibrillary acidic protein (GFAP) expression
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	decreases phosphorylation of	9606	2670	NP_002046.1	glial fibrillary acidic protein isoform 1	7842474,8381971	2007-11-07 17:30	The phosphorylation of the two major cytoskeletal proteins, vimentin and GFAP, which is normally stimulated by isoproterenol, is partially prevented by HIV-1 gp120 in astrocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	2670	NP_002046.1	glial fibrillary acidic protein isoform 1	8318270,15285794	2007-11-07 17:30	Treatment of human brain tissue with HIV-1 gp120 causes astrocyte alterations and/or death observed by decreases in the expression of glial fibrillary acidic protein (GFAP), as well as the diminution of a major protein of 66 kDa
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2670	NP_002046.1	glial fibrillary acidic protein isoform 1	15285794	2007-11-07 17:30	Ascorbate supplementation prevents the deleterious upregulation of iNOS and associated neuronal (MAP2) and astrocytic (GFAP) protein expression and structural changes caused by gp120 in human brain cell cultures
11676	156110	NP_057857.2	Nef	upregulates	9606	2670	NP_002046.1	glial fibrillary acidic protein isoform 1	10597774	2007-11-07 17:28	Nef upregulates the levels of glial fibrillary acidic protein (GFAP) expression in human astrocytes
11676	156110	NP_057857.2	Nef	co-localizes with	9606	2670	NP_002046.1	glial fibrillary acidic protein isoform 1	11519482,17077296	2007-11-07 17:27	HIV-1 Nef co-localizes with the astrocyte-specific cytoskeleton protein GFAP in persistently nef-expressing human astrocytes, suggesting an interaction between Nef and GFAP may contribute to changes in morphology and activation state of astrocytes
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	2683	NP_001488.2	beta-1,4-galactosyltransferase 1	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155871	NP_057853.1	Tat	inhibited by	9606	2688	NP_000506.2	somatotropin isoform 1	14595650	2007-11-07 17:27	Growth hormone (GH) inhibits the induction of p53 expression in neurons by supernatants from HIV-1 Tat-transfected monocytoid cells, indicating GH may have a role in the treatment of HIV-induced neurodegeneration
11676	155871	NP_057853.1	Tat	synergizes with	9606	2736	NP_005261.2	zinc finger protein GLI2	11160734	2007-11-07 17:29	GLI-2 physically interacts with HIV-1 Tat (demonstrated in GST pull-down experiments) and strongly synergizes with Tat during transactivation of the HIV-1 LTR promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2770	NP_002060.4	guanine nucleotide-binding protein G(i) subunit alpha-1	15972662	2007-11-07 17:31	CXCR4-tropic and CXCR4/CCR5 dual-tropic HIV-1 gp120 induce the cleavage of CD62 ligand by a mechanism dependent on matrix metalloproteinases 1 and 3, CD4, CXCR4, Galpha(i), and p38 MAPK, whereas CCR5-tropic gp120 does not
11676	156110	NP_057857.2	Nef	binds	9606	2775	NP_066268.1	guanine nucleotide-binding protein G(o) subunit alpha isoform a	10753665	2007-11-07 17:27	Coimmunoprecipitation experiments indicate HIV-1 Nef binds to non-palmitoylated G(o)alpha, presumably outside caveolin-rich microdomains of the plasma membrane
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	2821	NP_000166.2	glucose-6-phosphate isomerase isoform 2	2547084	2007-11-07 17:29	Glucophosphoisomerase (GPI) can be antagonized by the human immunodeficiency virus (HIV-1) gp120 protein in human and rat neuroblastoma cell lines
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2825	NP_005270.2	probable G-protein coupled receptor 1	10916084	2007-11-07 17:31	Mesangial cells, an important component of the glomerulus, are susceptible to HIV-1 strains for which the viral gp120 protein uses GPR1 as a coreceptor
11676	155871	NP_057853.1	Tat	inhibits	9606	2833	NP_001495.1	C-X-C chemokine receptor type 3 isoform A	14630801	2007-11-07 17:28	HIV-1 Tat can inhibit CXCR3-mediated functions by interfering with the chemotactic activity of IP-10/CXCL10, an effect mediated by Tat amino acids 25-31
11676	156110	NP_057857.2	Nef	interacts with	9606	2833	NP_001495.1	C-X-C chemokine receptor type 3 isoform A	15518810	2007-11-07 17:28	Significant increases in neuronal cell death resulting from HIV-1 Nef-induced upregulation of IP-10 is reduced by an antibody directed against human CXCR3, suggesting an interaction of CXCR3 with Nef
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	2838	NP_005281.1	G-protein coupled receptor 15	11696454,15992849	2007-11-07 17:30	HIV gp120-induced calcium signaling, microtubule loss, and physiological changes on HT-29 cells are inhibited by anti-Bob/GPR15 neutralizing antibodies, suggesting that gp120-induced Bob/GRP15 activation is a plausible cause of HIV enteropathy
11676	155807	NP_057852.2	Vpr	downregulates	9606	2872	NP_060042.2	MAP kinase-interacting serine/threonine-protein kinase 2 isoform 1	16103188	2007-11-07 17:28	HIV-1 Vpr downregulates expression of genes involved in the MEK2-ERK pathway, including MAP2K2 (MEK2) and MKNK2, and overexpression of Vpr decreases phosphorylation of MEK2
11676	155871	NP_057853.1	Tat	modulates	9606	2876	NP_000572.2	glutathione peroxidase 1 isoform 1	9501919,10652368	2007-11-07 17:30	HIV-1 Tat causes a greater than 50% decrease in intracellular reduced glutathione (GSH), leading to the extracellular appearance of acidic FGF-1, an effect that is partially mediated through modulation of GSH biosynthetic enzymes
11676	155871	NP_057853.1	Tat	downregulates	9606	2876	NP_000572.2	glutathione peroxidase 1 isoform 1	11368344,15910762	2007-11-07 17:30	Expression of HIV-1 Tat in HeLa cells downregulates cytoplasmic glutathione peroxidase while upregulating phospholipid hydroperoxide glutathione peroxidase, thereby deregulating intracellular oxidant/antioxidant balance and amplifying UV sensitivity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	2876	NP_000572.2	glutathione peroxidase 1 isoform 1	16871233	2007-11-07 17:31	Antioxidant enzymes such as Cu/Zn-superoxide dismutase (SOD1) and/or glutathione peroxidase (GPx1) protect neuronal cells from HIV-1 gp120-induced programmed cell death
11676	155871	NP_057853.1	Tat	modulates	9606	2877	NP_002074.2	glutathione peroxidase 2	9501919,10652368	2007-11-07 17:30	HIV-1 Tat causes a greater than 50% decrease in intracellular reduced glutathione (GSH), leading to the extracellular appearance of acidic FGF-1, an effect that is partially mediated through modulation of GSH biosynthetic enzymes
11676	155871	NP_057853.1	Tat	downregulates	9606	2877	NP_002074.2	glutathione peroxidase 2	11368344,15910762	2007-11-07 17:30	Expression of HIV-1 Tat in HeLa cells downregulates cytoplasmic glutathione peroxidase while upregulating phospholipid hydroperoxide glutathione peroxidase, thereby deregulating intracellular oxidant/antioxidant balance and amplifying UV sensitivity
11676	155871	NP_057853.1	Tat	modulates	9606	2878	NP_002075.2	glutathione peroxidase 3 precursor	9501919,10652368	2007-11-07 17:30	HIV-1 Tat causes a greater than 50% decrease in intracellular reduced glutathione (GSH), leading to the extracellular appearance of acidic FGF-1, an effect that is partially mediated through modulation of GSH biosynthetic enzymes
11676	155871	NP_057853.1	Tat	downregulates	9606	2878	NP_002075.2	glutathione peroxidase 3 precursor	11368344,15910762	2007-11-07 17:30	Expression of HIV-1 Tat in HeLa cells downregulates cytoplasmic glutathione peroxidase while upregulating phospholipid hydroperoxide glutathione peroxidase, thereby deregulating intracellular oxidant/antioxidant balance and amplifying UV sensitivity
11676	155871	NP_057853.1	Tat	modulates	9606	2879	NP_002076.2	phospholipid hydroperoxide glutathione peroxidase, mitochondrial isoform A precursor	9501919,10652368	2007-11-07 17:30	HIV-1 Tat causes a greater than 50% decrease in intracellular reduced glutathione (GSH), leading to the extracellular appearance of acidic FGF-1, an effect that is partially mediated through modulation of GSH biosynthetic enzymes
11676	155871	NP_057853.1	Tat	downregulates	9606	2879	NP_002076.2	phospholipid hydroperoxide glutathione peroxidase, mitochondrial isoform A precursor	11368344,15910762	2007-11-07 17:30	Expression of HIV-1 Tat in HeLa cells downregulates cytoplasmic glutathione peroxidase while upregulating phospholipid hydroperoxide glutathione peroxidase, thereby deregulating intracellular oxidant/antioxidant balance and amplifying UV sensitivity
11676	155871	NP_057853.1	Tat	modulates	9606	2880	NP_001500.1	epididymal secretory glutathione peroxidase isoform 1 precursor	9501919,10652368	2007-11-07 17:30	HIV-1 Tat causes a greater than 50% decrease in intracellular reduced glutathione (GSH), leading to the extracellular appearance of acidic FGF-1, an effect that is partially mediated through modulation of GSH biosynthetic enzymes
11676	155871	NP_057853.1	Tat	downregulates	9606	2880	NP_001500.1	epididymal secretory glutathione peroxidase isoform 1 precursor	11368344,15910762	2007-11-07 17:30	Expression of HIV-1 Tat in HeLa cells downregulates cytoplasmic glutathione peroxidase while upregulating phospholipid hydroperoxide glutathione peroxidase, thereby deregulating intracellular oxidant/antioxidant balance and amplifying UV sensitivity
11676	155871	NP_057853.1	Tat	modulates	9606	2882	NP_056511.2	glutathione peroxidase 7 precursor	9501919,10652368	2007-11-07 17:30	HIV-1 Tat causes a greater than 50% decrease in intracellular reduced glutathione (GSH), leading to the extracellular appearance of acidic FGF-1, an effect that is partially mediated through modulation of GSH biosynthetic enzymes
11676	155871	NP_057853.1	Tat	downregulates	9606	2882	NP_056511.2	glutathione peroxidase 7 precursor	11368344,15910762	2007-11-07 17:30	Expression of HIV-1 Tat in HeLa cells downregulates cytoplasmic glutathione peroxidase while upregulating phospholipid hydroperoxide glutathione peroxidase, thereby deregulating intracellular oxidant/antioxidant balance and amplifying UV sensitivity
11676	155871	NP_057853.1	Tat	upregulates	9606	2885	NP_002077.1	growth factor receptor-bound protein 2 isoform 1	10906142,11006130	2007-11-07 17:29	Grb3-3, an isoform of Grb2, is upregulated by HIV-1 Tat protein and potentiates HIV-1 LTR promoter activity
11676	155871	NP_057853.1	Tat	recruits	9606	2885	NP_002077.1	growth factor receptor-bound protein 2 isoform 1	16436505	2007-11-07 17:29	HIV-1 Tat-induced small GTPase Ras activation is mediated by tyrosine phosphorylation of Shc and recruitment of Grb2 in human endothelial cells
11676	156110	NP_057857.2	Nef	upregulates	9606	2885	NP_002077.1	growth factor receptor-bound protein 2 isoform 1	10906142,11006130	2007-11-07 17:27	Grb3-3, an isoform of Grb2, is upregulated by HIV-1 Nef protein and potentiates HIV-1 LTR promoter activity
11676	155871	NP_057853.1	Tat	binds	9606	2896	NP_002078.1	granulins precursor	10079180	2007-11-07 17:29	The cysteine rich region of HIV-1 Tat (amino acids 21-37) mediates the binding of Tat to granulin amino acids 206-337 (granulin regions B+A) suggesting a role for granulin growth factors as biologically important extracellular Tat co-factors
11676	155871	NP_057853.1	Tat	inhibited by	9606	2896	NP_002078.1	granulins precursor	12588988,15653695	2007-11-07 17:29	Granulin forms stable complexes with cyclin T1 and HIV-1 Tat and inhibits Tat transactivation of the viral LTR promoter
11676	155871	NP_057853.1	Tat	activates	9606	2902	NP_000823.4	glutamate	7695237,9651389,10197777,11483648,11606043,12414113,12775422,14644469,16697675	2007-11-07 17:27	HIV-1 Tat induces apoptosis of neurons and neurotoxicity through the activation of both NMDA and non-NMDA receptors
11676	155871	NP_057853.1	Tat	upregulates	9606	2902	NP_000823.4	glutamate	12753088,16489129	2007-11-07 17:27	HIV-1 Tat upregulates expression of NMDA receptor 1 in mixed cultures of human neurons and astrocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2902	NP_000823.4	glutamate	8563977,8581564,8724036,8804048,8821747,8822372,8845955,8955056,10448428,15749123	2007-11-07 17:30	HIV-1 gp120-mediated human cell death involves the NMDA receptor complex; antagonists of the NMDA receptor reverse the gp120-mediated effects
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	sensitizes	9606	2902	NP_000823.4	glutamate	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	2902	NP_000823.4	glutamate	10555109	2007-11-07 17:31	HIV-1 gp120 binds to cells expressing epsilon1/zeta1 or epsilon2/zeta1 combined NMDA receptor subunits, but not to cells expressing a single epsilon1, epsilon2, or zeta1 NMDA receptor subunit
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	2902	NP_000823.4	glutamate	16481105	2007-11-07 17:31	HIV-1 gp120 activates NMDA receptor directly and phosphorylates JNK through a gp120-mediated apoptotic pathway in human neuroblastoma cells
11676	155871	NP_057853.1	Tat	activates	9606	2903	NP_000824.1	glutamate	7695237,9651389,10197777,11483648,11606043,12414113,12775422,14644469,16489129,16697675	2007-11-07 17:27	HIV-1 Tat induces apoptosis of neurons and neurotoxicity through the activation of both NMDA and non-NMDA receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2903	NP_000824.1	glutamate	8563977,8581564,8724036,8804048,8821747,8822372,8845955,8955056,10448428,15749123	2007-11-07 17:30	HIV-1 gp120-mediated human cell death involves the NMDA receptor complex; antagonists of the NMDA receptor reverse the gp120-mediated effects
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	sensitizes	9606	2903	NP_000824.1	glutamate	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	2903	NP_000824.1	glutamate	10555109	2007-11-07 17:31	HIV-1 gp120 binds to cells expressing epsilon1/zeta1 or epsilon2/zeta1 combined NMDA receptor subunits, but not to cells expressing a single epsilon1, epsilon2, or zeta1 NMDA receptor subunit
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	2903	NP_000824.1	glutamate	16481105	2007-11-07 17:31	HIV-1 gp120 activates NMDA receptor directly and phosphorylates JNK through a gp120-mediated apoptotic pathway in human neuroblastoma cells
11676	155871	NP_057853.1	Tat	activates	9606	2904	NP_000825.1	N-methyl-D-aspartate receptor subunit 2B precursor	7695237,9651389,10197777,11483648,11606043,12414113,12775422,14644469,16489129,16697675	2007-11-07 17:27	HIV-1 Tat induces apoptosis of neurons and neurotoxicity through the activation of both NMDA and non-NMDA receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2904	NP_000825.1	N-methyl-D-aspartate receptor subunit 2B precursor	8563977,8581564,8724036,8804048,8821747,8822372,8845955,8955056,10448428,15749123	2007-11-07 17:30	HIV-1 gp120-mediated human cell death involves the NMDA receptor complex; antagonists of the NMDA receptor reverse the gp120-mediated effects
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	sensitizes	9606	2904	NP_000825.1	N-methyl-D-aspartate receptor subunit 2B precursor	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	2904	NP_000825.1	N-methyl-D-aspartate receptor subunit 2B precursor	10555109	2007-11-07 17:31	HIV-1 gp120 binds to cells expressing epsilon1/zeta1 or epsilon2/zeta1 combined NMDA receptor subunits, but not to cells expressing a single epsilon1, epsilon2, or zeta1 NMDA receptor subunit
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	2904	NP_000825.1	N-methyl-D-aspartate receptor subunit 2B precursor	16481105	2007-11-07 17:31	HIV-1 gp120 activates NMDA receptor directly and phosphorylates JNK through a gp120-mediated apoptotic pathway in human neuroblastoma cells
11676	155871	NP_057853.1	Tat	activates	9606	2905	NP_000826.2	glutamate	7695237,9651389,10197777,11483648,11606043,12414113,12775422,14644469,16489129,16697675	2007-11-07 17:27	HIV-1 Tat induces apoptosis of neurons and neurotoxicity through the activation of both NMDA and non-NMDA receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2905	NP_000826.2	glutamate	8563977,8581564,8724036,8804048,8821747,8822372,8845955,8955056,10448428,15749123	2007-11-07 17:30	HIV-1 gp120-mediated human cell death involves the NMDA receptor complex; antagonists of the NMDA receptor reverse the gp120-mediated effects
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	sensitizes	9606	2905	NP_000826.2	glutamate	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	2905	NP_000826.2	glutamate	10555109	2007-11-07 17:31	HIV-1 gp120 binds to cells expressing epsilon1/zeta1 or epsilon2/zeta1 combined NMDA receptor subunits, but not to cells expressing a single epsilon1, epsilon2, or zeta1 NMDA receptor subunit
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	2905	NP_000826.2	glutamate	16481105	2007-11-07 17:31	HIV-1 gp120 activates NMDA receptor directly and phosphorylates JNK through a gp120-mediated apoptotic pathway in human neuroblastoma cells
11676	155871	NP_057853.1	Tat	activates	9606	2906	NP_000827.1	N-methyl-D-aspartate receptor subunit 2D precursor	7695237,9651389,10197777,11483648,11606043,12414113,12775422,14644469,16489129,16697675	2007-11-07 17:27	HIV-1 Tat induces apoptosis of neurons and neurotoxicity through the activation of both NMDA and non-NMDA receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2906	NP_000827.1	N-methyl-D-aspartate receptor subunit 2D precursor	8563977,8581564,8724036,8804048,8821747,8822372,8845955,8955056,10448428,15749123	2007-11-07 17:30	HIV-1 gp120-mediated human cell death involves the NMDA receptor complex; antagonists of the NMDA receptor reverse the gp120-mediated effects
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	sensitizes	9606	2906	NP_000827.1	N-methyl-D-aspartate receptor subunit 2D precursor	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	2906	NP_000827.1	N-methyl-D-aspartate receptor subunit 2D precursor	10555109	2007-11-07 17:31	HIV-1 gp120 binds to cells expressing epsilon1/zeta1 or epsilon2/zeta1 combined NMDA receptor subunits, but not to cells expressing a single epsilon1, epsilon2, or zeta1 NMDA receptor subunit
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	2906	NP_000827.1	N-methyl-D-aspartate receptor subunit 2D precursor	16481105	2007-11-07 17:31	HIV-1 gp120 activates NMDA receptor directly and phosphorylates JNK through a gp120-mediated apoptotic pathway in human neuroblastoma cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	2907	NP_000828.1	glutamate	8563977,8581564,8724036,8804048,8821747,8822372,8845955,8955056,10448428,15749123	2007-11-07 17:30	HIV-1 gp120-mediated human cell death involves the NMDA receptor complex; antagonists of the NMDA receptor reverse the gp120-mediated effects
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	sensitizes	9606	2907	NP_000828.1	glutamate	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	2907	NP_000828.1	glutamate	10555109	2007-11-07 17:31	HIV-1 gp120 binds to cells expressing epsilon1/zeta1 or epsilon2/zeta1 combined NMDA receptor subunits, but not to cells expressing a single epsilon1, epsilon2, or zeta1 NMDA receptor subunit
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	2907	NP_000828.1	glutamate	16481105	2007-11-07 17:31	HIV-1 gp120 activates NMDA receptor directly and phosphorylates JNK through a gp120-mediated apoptotic pathway in human neuroblastoma cells
11676	155807	NP_057852.2	Vpr	activates	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	7724608,9874563,10933727,11689055,12208951,12634356,12642036,15142377,15265780,15638722,15725353,15832179,16429131	2007-11-07 17:28	HIV-1 Vpr (amino acids 22-26 and 64-68) binds to and activates glucocorticoid receptor (GR) and transactivates the HIV-1 LTR promoter through the host GR pathway
11676	155807	NP_057852.2	Vpr	complexes with	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	7724608	2007-11-07 17:28	HIV-1 Vpr targets the glucocorticoid receptor type II complex through an interaction with Vpr interacting protein 1 (Rip-1), a 41 kDa cytosolic protein that binds to Vpr and in a complex with the human glucocorticoid receptor
11676	155807	NP_057852.2	Vpr	activates	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	8800208,9874563,10359081,15142377,15265780,15638722,15725353,15832179	2007-11-07 17:28	Specific binding of HIV-1 Vpr (amino acids 15-35) to TFIIB (amino acids 52-55) causes a conformational change in TFIIB and is correlated with the ability of Vpr to stimulate transcription through the glucocorticoid receptor pathway
11676	155807	NP_057852.2	Vpr	activates	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	9334723,16429131	2007-11-07 17:27	Studies suggest effects of HIV-1 Vpr on cytokine expression (IL-2, IL-10, IL-12, TNFalpha and IL-4) and T-cell proliferation may be mediated through activation of the glucocorticoid receptor pathway
11676	155807	NP_057852.2	Vpr	activates	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	9874563	2007-11-07 17:28	HIV-1 Vpr (amino acids 1-35) binds to TFIID, an interaction that is associated with the ability of Vpr to stimulate transcription through the glucocorticoid receptor pathway
11676	155807	NP_057852.2	Vpr	activates	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	9874563	2007-11-07 17:28	HIV-1 Vpr synergistically enhances SRC-1 ligand-activated glucocorticoid receptor activity
11676	155807	NP_057852.2	Vpr	activates	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	12208951	2007-11-07 17:27	HIV-1 Vpr activates transcription of glucocorticoid-responsive promoters by binding directly to p300/CBP co-activators, forming a stable complex with p300 and interacting with ligand-bound glucocorticoid receptor
11676	155807	NP_057852.2	Vpr	activates	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	12237292	2007-11-07 17:28	Interaction of HIV-1 Vpr and hVIP/mov34 may be involved in the activation of glucocorticoid receptor by Vpr
11676	155807	NP_057852.2	Vpr	activates	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	12379213	2007-11-07 17:28	Transcription factors TFIIH, CDK7, Cyclin H, and MAT1 enhance HIV-1 Vpr activation of glucocorticoid receptor
11676	155807	NP_057852.2	Vpr	activates	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	12444143	2007-11-07 17:27	HIV-1 Vpr affects the gene expression of glucocorticoid-regulated genes (IL-12, CD44, Toll-like receptor 4 and indolamine 2,3-dioxygenase, macrophage receptor with collagenous structure, and thrombospondin 1) through activation of the GR pathway
11676	155807	NP_057852.2	Vpr	activates	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	12444143,16429131	2007-11-07 17:27	HIV-1 Vpr potentiates the trans-activation, but not the trans-repression, properties of the glucocorticoid receptor on NF-kappa B and activating protein 1-regulated simple promoters
11676	155807	NP_057852.2	Vpr	interacts with	9606	2908	NP_000167.1	glucocorticoid receptor isoform alpha	15380361	2007-11-07 17:28	HIV-1 Vpr leucine residues mediate Vpr-Glucocorticoid Receptor (GR) interaction and promoter transactivation; mutation at residue L22 results in 8- to 11-fold higher GRE and HIV-1 LTR transactivation, while L42 and L67 mutants showed reduced activation
11676	155871	NP_057853.1	Tat	activates	9606	2911	NP_000829.1	glutamate receptor, metabotropic 1	16489129,16697675	2007-11-07 17:31	HIV-1 Tat upregulates N-methyl-D-aspartate receptor function by activating metabotropic glutamate receptor 1 in human brain noradrenergic neurons
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	2919	NP_001502.1	growth-regulated alpha protein precursor	11390582,12089333,12388718	2007-11-07 17:30	Production of the C-X-C chemokine growth-regulated oncogene alpha (GRO-alpha) is markedly stimulated by CXCR4-tropic HIV-1; HIV-1 gp120 engagement of CXCR4 initiates the stimulation of GRO-alpha production, which is blocked by antibodies to CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	2919	NP_001502.1	growth-regulated alpha protein precursor	16934308	2007-11-07 17:31	In endometrial epithelium-derived cells, gp120 from CCR5-tropic HIV-1 increases the release of monocytes/chemokines-attracting chemokines (IL-8 and GRO) and proinflammatory cytokines (TNF-beta and IL-1alpha)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaved by	9606	2923	NP_005304.3	protein disulfide-isomerase A3 precursor	12218051,12218052,15644496,16182193	2007-11-07 17:30	Protein-disulfide isomerase (PDI) cleaves disulfide bonds in recombinant HIV-1 envelope glycoprotein gp120, and gp120 bound to the surface receptor CD4 undergoes a disulfide reduction that is prevented by PDI inhibitors
11676	155871	NP_057853.1	Tat	activates	9606	2932	NP_002084.2	glycogen synthase kinase-3 beta isoform 1	10428053	2007-11-07 17:29	HIV-1 Tat associates with glycogen synthase kinase-3beta (GSK-3beta) in rat cerebellar granule neurons and increases GSK-3beta activity, suggesting dysregulation of this enzyme could contribute to HIV-induced neuronal apoptosis
11676	155871	NP_057853.1	Tat	downregulates	9606	2934	NP_000168.1	gelsolin isoform a precursor	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155871	NP_057853.1	Tat	modulates	9606	2937	NP_000169.1	glutathione synthetase	9501919,10652368	2007-11-07 17:28	HIV-1 Tat causes a greater than 50% decrease in intracellular reduced glutathione (GSH), leading to the extracellular appearance of acidic FGF-1, an effect that is partially mediated through modulation of GSH biosynthetic enzymes
11676	155871	NP_057853.1	Tat	stabilizes	9606	2957	NP_056943.1	transcription initiation factor IIA subunit 1 isoform 1	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	stabilizes	9606	2958	NP_004483.1	transcription initiation factor IIA subunit 2	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155030	NP_579881.1	nucleocapsid	enhances	9606	2959	NP_001505.1	transcription initiation factor IIB	10704334	2007-11-07 17:29	HIV-1 Nucleocapsid has been shown to bind to the HIV-1 LTR promoter and enhance NF-kappaB, Sp1, and TFIIB-induced HIV-1 LTR-directed RNA transcription
11676	155807	NP_057852.2	Vpr	binds	9606	2959	NP_001505.1	transcription initiation factor IIB	8800208,9874563,10359081,15142377,15265780,15353294	2007-11-07 17:28	Specific binding of HIV-1 Vpr (amino acids 15-35) to TFIIB (amino acids 52-55) causes a conformational change in TFIIB and is correlated with the ability of Vpr to stimulate transcription through the glucocorticoid receptor pathway
11676	155871	NP_057853.1	Tat	inhibited by	9606	2959	NP_001505.1	transcription initiation factor IIB	7608968,9292011	2007-11-07 17:27	Overexpression of TFIIB inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	2959	NP_001505.1	transcription initiation factor IIB	7707527,7707528	2007-11-07 17:27	HIV-1 Tat interacts with a cellular protein, TAP (Tat-associated protein), that functions as a co-activator and bridges Tat to the general transcription machinery via TFIIB
11676	155871	NP_057853.1	Tat	interacts with	9606	2959	NP_001505.1	transcription initiation factor IIB	8849451	2007-11-07 17:27	Transactivation of the HIV-1 LTR by HIV-1 Tat and the cellular cofactor Tat-SF1 is mediated by basal transcription factors, including TFIIB
11676	155871	NP_057853.1	Tat	interacts with	9606	2959	NP_001505.1	transcription initiation factor IIB	9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme complex that supports Tat-mediated transactivation of the HIV-1 LTR in vitro upon addition of TBP and TFIIB
11676	155871	NP_057853.1	Tat	binds	9606	2959	NP_001505.1	transcription initiation factor IIB	9292011	2007-11-07 17:27	The cysteine rich and core domains (amino acids 27-103) of HIV-1 Tat mediate binding to two domains of TFIIB, amino acids 27-103 in the N-terminal domain and the first direct repeat of the C-terminal domain between amino acids 148-163
11676	155871	NP_057853.1	Tat	interacts with	9606	2959	NP_001505.1	transcription initiation factor IIB	9765201	2007-11-07 17:27	HIV-1 Tat directly interacts with TFIIB as demonstrated by Tat-affinity column purification
11676	155871	NP_057853.1	Tat	recruits	9606	2959	NP_001505.1	transcription initiation factor IIB	11080476	2007-11-07 17:27	Binding of HIV-1 Tat to p300 induces a conformational change in the CBP/p300 complex such that it can acquire and bind better to transcription factors such as TBP and TFIIB, indicating Tat helps CBP/p300 recruit new partners to the transcription machinery
11676	155871	NP_057853.1	Tat	interacts with	9606	2960	NP_005504.1	general transcription factor IIE, polypeptide 1 (alpha subunit, 56kD)	8849451,8934526,9054383,9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIE, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	2961	NP_002086.1	transcription initiation factor IIE subunit beta	8849451,8934526,9054383,9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIE, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	requires	9606	2962	NP_002087.1	general transcription factor IIF, polypeptide 1, 74kDa	1559613,9765201,10704353	2007-11-07 17:27	TFIIF is required for both basal and HIV-1 Tat-activated transcription
11676	155871	NP_057853.1	Tat	interacts with	9606	2962	NP_002087.1	general transcription factor IIF, polypeptide 1, 74kDa	8849451,8934526,9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIF, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	synergizes with	9606	2962	NP_002087.1	general transcription factor IIF, polypeptide 1, 74kDa	9765201,10454543	2007-11-07 17:27	TFIIF synergizes with HIV-1 Tat and the cellular co-activator Tat-SF1 during Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	2962	NP_002087.1	general transcription factor IIF, polypeptide 1, 74kDa	10704353	2007-11-07 17:27	HIV-1 Tat stimulates the phosphorylation of TFIIF subunit RAP74 by TAFII250 during Tat-mediated transcription of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	inhibits	9606	2962	NP_002087.1	general transcription factor IIF, polypeptide 1, 74kDa	15723517	2007-11-07 17:28	HIV-1 Tat inhibits the binding of RAP74 amino acids 436-517 to FCP1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	2962	NP_002087.1	general transcription factor IIF, polypeptide 1, 74kDa	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155871	NP_057853.1	Tat	requires	9606	2963	NP_004119.1	general transcription factor IIF subunit 2	1559613,9765201,10704353	2007-11-07 17:27	TFIIF is required for both basal and HIV-1 Tat-activated transcription
11676	155871	NP_057853.1	Tat	interacts with	9606	2963	NP_004119.1	general transcription factor IIF subunit 2	8849451,8934526,9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIF, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	2963	NP_004119.1	general transcription factor IIF subunit 2	9765201	2007-11-07 17:27	HIV-1 Tat directly interacts with the RAP30 subunit of TFIIF as demonstrated by Tat-affinity column purification
11676	155871	NP_057853.1	Tat	synergizes with	9606	2963	NP_004119.1	general transcription factor IIF subunit 2	9765201,10454543	2007-11-07 17:27	TFIIF synergizes with HIV-1 Tat and the cellular co-activator Tat-SF1 during Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	2963	NP_004119.1	general transcription factor IIF subunit 2	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	enhanced by	9606	2965	NP_005307.1	general transcription factor IIH subunit 1	12379213	2007-11-07 17:28	TFIIH enhances the synergistic activation of glucocorticoid receptor by HIV-1 Vpr and p300
11676	155807	NP_057852.2	Vpr	inhibited by	9606	2965	NP_005307.1	general transcription factor IIH subunit 1	12379213	2007-11-07 17:28	TFIIH inhibits HIV-1 Vpr cell cycle-arresting function
11676	155871	NP_057853.1	Tat	binds	9606	2965	NP_005307.1	general transcription factor IIH subunit 1	8628270,8934526,9184228,9334327,9765201	2007-11-07 17:29	Amino acids 1-48 of HIV-1 Tat, which includes the Tat activation domain, mediate the binding of Tat to CAK and the TFIIH complex through a direct interaction with CDK7 and possibly other TFIIH subunits, including p62 and ERCC3
11676	155871	NP_057853.1	Tat	interacts with	9606	2965	NP_005307.1	general transcription factor IIH subunit 1	8849451,8934526,9054383,9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIH, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	requires	9606	2965	NP_005307.1	general transcription factor IIH subunit 1	8934526,9184228,9334327	2007-11-07 17:28	CAK/TFIIH is required for HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	2965	NP_005307.1	general transcription factor IIH subunit 1	8934526,9184228,9311822,9334327,9570510,9651670,10438593,10866664,14569024	2007-11-07 17:27	Interaction of HIV-1 Tat with TFIIH stimulates phosphorylation of Ser-5 of the RNA polymerase II C-terminal domain (CTD), which in turn also stimulates co-transcriptional capping of HIV-1 mRNA
11676	155871	NP_057853.1	Tat	synergizes with	9606	2965	NP_005307.1	general transcription factor IIH subunit 1	8934526	2007-11-07 17:27	TFIIH synergizes with HIV-1 Tat to induce transcription elongation from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	2965	NP_005307.1	general transcription factor IIH subunit 1	9651670,10066804,10082552,10866664,14569024	2007-11-07 17:28	TFIIH interacts with HIV-1 Tat as a component of the HIV-1 transcription preinitiation complex, but is released from the elongation complex which includes P-TEFb
11676	155871	NP_057853.1	Tat	binds	9606	2966	NP_001506.1	general transcription factor IIH subunit 2	8628270,8934526,9184228,9334327,9765201	2007-11-07 17:28	Amino acids 1-48 of HIV-1 Tat, which includes the Tat activation domain, mediate the binding of Tat to CAK and the TFIIH complex through a direct interaction with CDK7 and possibly other TFIIH subunits, including p62 and ERCC3
11676	155871	NP_057853.1	Tat	interacts with	9606	2966	NP_001506.1	general transcription factor IIH subunit 2	8849451,8934526,9054383,9121429	2007-11-07 17:28	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIH, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	requires	9606	2966	NP_001506.1	general transcription factor IIH subunit 2	8934526,9184228,9334327	2007-11-07 17:28	CAK/TFIIH is required for HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	2966	NP_001506.1	general transcription factor IIH subunit 2	8934526,9184228,9311822,9334327,9570510,9651670,10438593,10866664,14569024	2007-11-07 17:28	Interaction of HIV-1 Tat with TFIIH stimulates phosphorylation of Ser-5 of the RNA polymerase II C-terminal domain (CTD), which in turn also stimulates co-transcriptional capping of HIV-1 mRNA
11676	155871	NP_057853.1	Tat	synergizes with	9606	2966	NP_001506.1	general transcription factor IIH subunit 2	8934526	2007-11-07 17:28	TFIIH synergizes with HIV-1 Tat to induce transcription elongation from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	2966	NP_001506.1	general transcription factor IIH subunit 2	9651670,10066804,10082552,10866664,14569024	2007-11-07 17:28	TFIIH interacts with HIV-1 Tat as a component of the HIV-1 transcription preinitiation complex, but is released from the elongation complex which includes P-TEFb
11676	155871	NP_057853.1	Tat	binds	9606	2967	NP_001507.2	general transcription factor IIH subunit 3	8628270,8934526,9184228,9334327,9765201	2007-11-07 17:28	Amino acids 1-48 of HIV-1 Tat, which includes the Tat activation domain, mediate the binding of Tat to CAK and the TFIIH complex through a direct interaction with CDK7 and possibly other TFIIH subunits, including p62 and ERCC3
11676	155871	NP_057853.1	Tat	interacts with	9606	2967	NP_001507.2	general transcription factor IIH subunit 3	8849451,8934526,9054383,9121429	2007-11-07 17:28	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIH, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	requires	9606	2967	NP_001507.2	general transcription factor IIH subunit 3	8934526,9184228,9334327	2007-11-07 17:28	CAK/TFIIH is required for HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	2967	NP_001507.2	general transcription factor IIH subunit 3	8934526,9184228,9311822,9334327,9570510,9651670,10438593,10866664,14569024	2007-11-07 17:28	Interaction of HIV-1 Tat with TFIIH stimulates phosphorylation of Ser-5 of the RNA polymerase II C-terminal domain (CTD), which in turn also stimulates co-transcriptional capping of HIV-1 mRNA
11676	155871	NP_057853.1	Tat	synergizes with	9606	2967	NP_001507.2	general transcription factor IIH subunit 3	8934526	2007-11-07 17:28	TFIIH synergizes with HIV-1 Tat to induce transcription elongation from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	2967	NP_001507.2	general transcription factor IIH subunit 3	9651670,10066804,10082552,10866664,14569024	2007-11-07 17:28	TFIIH interacts with HIV-1 Tat as a component of the HIV-1 transcription preinitiation complex, but is released from the elongation complex which includes P-TEFb
11676	155871	NP_057853.1	Tat	binds	9606	2968	NP_001508.1	general transcription factor IIH subunit 4	8628270,8934526,9184228,9334327,9765201	2007-11-07 17:28	Amino acids 1-48 of HIV-1 Tat, which includes the Tat activation domain, mediate the binding of Tat to CAK and the TFIIH complex through a direct interaction with CDK7 and possibly other TFIIH subunits, including p62 and ERCC3
11676	155871	NP_057853.1	Tat	interacts with	9606	2968	NP_001508.1	general transcription factor IIH subunit 4	8849451,8934526,9054383,9121429	2007-11-07 17:28	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIH, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	requires	9606	2968	NP_001508.1	general transcription factor IIH subunit 4	8934526,9184228,9334327	2007-11-07 17:28	CAK/TFIIH is required for HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	2968	NP_001508.1	general transcription factor IIH subunit 4	8934526,9184228,9311822,9334327,9570510,9651670,10438593,10866664,14569024	2007-11-07 17:28	Interaction of HIV-1 Tat with TFIIH stimulates phosphorylation of Ser-5 of the RNA polymerase II C-terminal domain (CTD), which in turn also stimulates co-transcriptional capping of HIV-1 mRNA
11676	155871	NP_057853.1	Tat	synergizes with	9606	2968	NP_001508.1	general transcription factor IIH subunit 4	8934526	2007-11-07 17:28	TFIIH synergizes with HIV-1 Tat to induce transcription elongation from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	2968	NP_001508.1	general transcription factor IIH subunit 4	9651670,10066804,10082552,10866664,14569024	2007-11-07 17:28	TFIIH interacts with HIV-1 Tat as a component of the HIV-1 transcription preinitiation complex, but is released from the elongation complex which includes P-TEFb
11676	155871	NP_057853.1	Tat	activates	9606	2975	NP_001511.2	general transcription factor 3C polypeptide 1	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	activates	9606	2976	NP_001512.1	general transcription factor 3C polypeptide 2	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	downregulates	9606	2993	NP_002090.2	glycophorin-A precursor	16179731	2007-11-07 17:29	HIV-1 Tat suppresses butyric acid (BA)-induced erythroid differentiation in K562 cells by decreasing glycophorin-A expression
11676	156110	NP_057857.2	Nef	upregulates	9606	3001	NP_006135.1	granzyme A precursor	7912927	2007-11-07 17:28	Downregulation of cell-surface CD4 induced by HIV-1 Nef prevents monoclonal antibodies against CD4 from blocking the presentation of serine esterase tryptase in human monocytoid and CD4+ lymphoid cells
11676	155871	NP_057853.1	Tat	binds	9606	3012	NP_066390.1	histone H2A type 1-B/E	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	3013	NP_066409.1	histone H2A type 1-D	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155807	NP_057852.2	Vpr	induces phosphorylation of	9606	3014	NP_002096.1	histone H2A.x	15485898	2007-11-07 17:28	HIV-1 Vpr expression in HeLa cells and human primary CD4+ lymphocytes induces phosphorylation of H2AFX and formation of nuclear foci containing H2AFX and BRCA1
11676	155871	NP_057853.1	Tat	binds	9606	3014	NP_002096.1	histone H2A.x	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	3015	NP_002097.1	histone H2A.Z	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	3017	NP_066407.1	histone H2B type 1-D	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	3018	NP_066406.1	histone H2B type 1-B	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	3020	NP_002098.1	histone H3.3	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	3021	NP_005315.1	histone H3.3	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155459	NP_057851.1	Vif	inhibits	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	11278465,12600646	2007-11-07 17:27	Vif binds specifically to the Src homology 3 domain of Hck, represses the kinase activity of Hck, and suppresses negative effects of Hck on HIV-1 replication
11676	156110	NP_057857.2	Nef	binds	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	7588629,7859737,9705913,10544125,11463741,15078178,15638726,16454711	2007-11-07 17:27	The PXXP motif (65-82) and C-terminal proline residues 147 and 150 of HIV-1 Nef interacts with the SH3 domain of Hck; the single amino acid residue 96 in the Hck SH3 domain determines its high affinity in binding to Nef
11676	156110	NP_057857.2	Nef	binds	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	8599760,9778343,10547288	2007-11-07 17:27	Structure analyses reveal that an RT loop region (residues 90-108) in the Hck SH3 domain binds to the PXXP motif (residues 69-78) of HIV-1 Nef; proline residues substituted by alanine in the PXXP motif abolish its binding to Hck
11676	156110	NP_057857.2	Nef	activates	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	9024665,9218412,10642173,16849330	2007-11-07 17:27	The Interaction of HIV-1 Nef with the SH3 domain of Hck regulates the effects of Nef on Hck tyrosine kinase activation
11676	156110	NP_057857.2	Nef	binds	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	9656992	2007-11-07 17:27	Hck binds to HIV-1 subtype B and E Nef proteins with equal affinity, but has weaker binding to HIV-2 subtype A Nef and no binding to HIV-2 subtype B Nef
11676	156110	NP_057857.2	Nef	binds	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	10364375,12033791	2007-11-07 17:27	The interaction of SIV Nef with human Hck is not mediated via conserved proline-rich motifs, which are known to mediate HIV-1 Nef binding to the Hck SH3 domain; instead, SIV Nef binds the Hck SH2 domain
11676	156110	NP_057857.2	Nef	requires	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	10388555	2007-11-07 17:27	Induction of AP-1 by HIV-1 Nef is a specific feature of human and murine macrophage cell lines that requires signal transduction events involving Hck and MAPK
11676	156110	NP_057857.2	Nef	binds	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	10574946	2007-11-07 17:27	HIV-1 Nef increases the amount of intracellular stored Ca2+ in myelomonocytic cells through binding to Hck
11676	156110	NP_057857.2	Nef	activates	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	11328823,12734410	2007-11-07 17:28	HIV-1 Nef activates endogenous Hck in the granulocyte-macrophage colony-stimulating factor-dependent human myeloid cell line, TF-1, resulting in TF-1 cytokine-independence and Stat 3 activation
11676	156110	NP_057857.2	Nef	binds	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	11448168,12076760	2007-11-07 17:27	Peptides derived from the Hck SH3 domain with high affinity binding to HIV-1 Nef inhibit SH3-dependent Nef functions, such as association with PAK2 and induction of NFAT
11676	156110	NP_057857.2	Nef	interacts with	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	11500821,16454711	2007-11-07 17:27	A dominant-negative mutant protein derived from Hck, (composed of the N-terminal region, SH2, and SH3 domains) interacts with HIV-1 Nef and inhibits Nef-induced downregulation of MHC class I
11676	156110	NP_057857.2	Nef	interacts with	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	11533201	2007-11-07 17:27	Mutation of the PXXP motif in HIV-1 Nef abolishes the interaction of Nef with Hck in transgenic mice, resulting in the delayed development of an AIDS-like disease in the mice
11676	156110	NP_057857.2	Nef	activates	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	11976726	2007-11-07 17:27	SH3-dependent activation of Hck by HIV-1 Nef binding or by SH2-kinase linker mutation does not modulate tail tyrosine phosphorylation in vivo
11676	156110	NP_057857.2	Nef	activates	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	15491611	2007-11-07 17:28	HIV-1 Nef alleles (HIV-1 SF2, LAI and Consensus) bind and activate Hck, while HIV-1 ELI Nef fails to bind to the Hck SH3 domain in vitro and does not cooperate with Hck in fibroblast transformation
11676	156110	NP_057857.2	Nef	activates	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	15491611	2007-11-07 17:28	Molecular modeling has identified three residues in the core region of Nef from HIV-1 SF2 (Ala83, His116, and Tyr120) that are required for Hck recruitment and activation
11676	156110	NP_057857.2	Nef	activates	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	15595833	2007-11-07 17:28	In Rat-2 fibroblasts co-expressing Hck and a Nef fusion protein with the hormone-binding domain of estrogen receptor (Nef-ER), 4-hydroxytamoxifen treatment induces Nef-ER oligomerization, leading to Hck kinase activation and cellular transformation
11676	156110	NP_057857.2	Nef	Inhibits	9606	3055	NP_002101.2	tyrosine-protein kinase HCK isoform a	15626739	2007-11-07 17:28	HIV-1 Nef-induced aberrant molecular formation between Hck and M-CSF receptor inhibits M-CSF bioactivities in monocytes/macrophages
11676	155871	NP_057853.1	Tat	inhibited by	9606	3065	NP_004955.2	histone deacetylase 1	8289393,9371597,10888618,11940654,16838299	2007-11-07 17:30	YY1 and LSF transcription factors cooperatively recruit histone deacetylase 1 (HDAC1) to the HIV-1 LTR promoter, thereby inhibiting transcription and Tat activation of the promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3075	NP_000177.2	complement factor H isoform a precursor	7535292	2007-11-07 17:27	Inhibition of DAF or use of factor H depleted sera significantly increases C3 deposition on recombinant HIV-1 gp120 coated CD4 cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3075	NP_000177.2	complement factor H isoform a precursor	7576914	2007-11-07 17:27	Direct interaction of complement factor H with the C1 domain (amino acids 105-119) of HIV-1 gp120 is found in sera from AIDS patients
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	3075	NP_000177.2	complement factor H isoform a precursor	7492444,7590866,7893437	2007-11-07 17:27	Four areas in HIV-1 gp41 (aa 561-585, 587-605, 615-635, 651-675) interact with human factor H
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	3075	NP_000177.2	complement factor H isoform a precursor	7893437	2007-11-07 17:27	Preincubation of HIV-1 gp41 with either factor H or properdin, and of HIV-1 gp120 with C3b or C4b affect the interaction between HIV-1 gp41 and gp120
11676	156110	NP_057857.2	Nef	downregulates	9606	3077	NP_000401.1	hereditary hemochromatosis protein isoform 1 precursor	16043695	2007-11-07 17:28	HIV-1 Nef downregulates the macrophage-expressed MHC 1b protein HFE by rerouting HFE to a perinuclear structure that overlaps the trans-Golgi network, causing a 90% reduction of surface HFE
11676	156110	NP_057857.2	Nef	downregulates	9606	3077	NP_000401.1	hereditary hemochromatosis protein isoform 1 precursor	16043695	2007-11-07 17:28	Myristoylation of HIV-1 Nef at position 2 and the PxxP proline-rich motif of Nef at positions 62-65 are required for Nef-induced downregulation of HFE; amino acid residue Y282 in HFE is involved in the downregulation by Nef
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3082	NP_000592.3	hepatocyte growth factor isoform 1 preproprotein	16554660	2007-11-07 17:31	Scatter factor (SF) attenuates the apoptosis induced by high-doses of HIV-1 gp120 in human mesangial cells (HMC)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3094	NP_005331.1	histidine triad nucleotide-binding protein 1	12775419	2007-11-07 17:30	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155871	NP_057853.1	Tat	enhanced by	9606	3096	NP_002105.2	zinc finger protein 40	1727488,8289330	2007-11-07 17:30	PRDII-BF1 activates HIV-1 gene expression and an antisense PRDII-BF1 construct inhibits Tat-induced HIV-1 gene expression, suggesting a role for PRDII-BF1 in enhancing Tat transactivation of the HIV-1 LTR promoter
11676	155030	NP_057850.1	Pr55(Gag)	binds	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	17116886	2007-11-07 17:31	The HIV-1 Gag 20-28 epitope binds strongly to HLA-A3 molecules and forms very stable complexes
11676	155348	NP_789740.1	Pol	binds	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	17116886	2007-11-07 17:31	The HIV-1 Pol 325-333 epitope binds strongly to HLA-A3 molecules and forms very stable complexes
11676	155871	NP_057853.1	Tat	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	7621073,8493575,9751712,9840288	2007-11-07 17:27	HIV-1 Tat represses the MHC class I gene promoter by binding to and repressing TAFII250, a component of the general transcription factor TFIID, suggesting a mechanism for HIV-1 to downregulate MHC class I expression and avoid immune surveillance
11676	155871	NP_057853.1	Tat	upregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	11751963,14595379	2007-11-07 17:27	HIV-1 Tat upregulates MHC class I in monocyte-derived dendritic cells and CD8(+) T cells, thereby driving T cell-mediated immune responses
11676	155945	NP_057855.1	Vpu	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	9104816	2007-11-07 17:27	Using antibodies specific to MHC class I A, B, and C molecules (clone W6/32), HIV-1 Vpu protein has been shown to downregulate the expression of MHC class I molecules on the surface of HIV-1 infected cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	1316930,10799863	2007-11-07 17:30	HIV-1 gp160-derived peptide p18 presented by H-2Dd class I major histocompatibility complex molecules is processed by angiotensin-1 converting enzyme (ACE) prior to T cell stimulation by the peptide p18
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	17116886	2007-11-07 17:31	Epitope Env37-46 from HIV-1 gp160 binds strongly to HLA-A3 molecules and forms very stable complexes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	2789433,8671651,8877415,9120272,10546855,11932387	2007-11-07 17:31	Conformational changes in HIV-1 gp120, including an enhanced expression of the V3 loop of gp120 and of epitopes that are exposed upon CD4 binding, are consistent with the formation of a multimolecular complex between HLA class I and gp120/160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	7539755,9263011,12427289	2007-11-07 17:27	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	7913356,8084338,9373217	2007-11-07 17:30	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	8612235,12734410,15638726,16091223,16272310,16979207,16987968,17077296	2007-11-07 17:28	HIV-1 Nef downregulates the expression of MHC-I at the surface of lymphoid, monocytic and epithelial cells, causing MHC-I molecules to be rapidly internalized, accumulated in endosomal vesicles and degraded
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	9052838,9586638	2007-11-07 17:28	Interaction of HIV-1 Nef with the mu subunit of AP adaptor complexes requires the recognition of tyrosine-based sorting signals, which likely facilitates the connection between MHC I and the clathrin-dependent sorting machinery during MHC I downregulation
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	9123874	2007-11-07 17:28	Downregulation of MHC-I by HIV-1 Nef decreases the incorporation of MHC-I molecules into virions, but does not decrease virion infectivity
11676	156110	NP_057857.2	Nef	binds	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	9582271,10366557,10982373,11463741,12414957,12836198,14965316,15078178,16454711	2007-11-07 17:28	Four glutamic acids from position 62 to 65 in the SH3 domain of HIV-1 Nef bind to the cytoplasmic tail at position 320Y of MHC-I, and are required for the Nef-mediated downregulation of MHC-I from the cell surface
11676	156110	NP_057857.2	Nef	modulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	9971776,12502873,15078178	2007-11-07 17:28	Two distinct regions of HIV-1 Nef modulate MHC-I cell surface expression: an N-terminal alpha-helix (residues 17-26) and a proline-rich motif (residues 75-78)
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	10403641	2007-11-07 17:28	HIV-1 selectively downregulates HLA-A and HLA-B but does not significantly affect HLA-C or HLA-E, which allows HIV-infected cells to avoid NK cell-mediated lysis; this effect is likely mediated by the HIV-1 Nef protein
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	10684310,15078178	2007-11-07 17:28	A methionine residue at amino acid 20 in the alpha-helix domain of HIV-1 Nef is required for the ability of Nef to downregulate MHC-I expression but not for the downregulation of CD4
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	10707087	2007-11-07 17:28	HIV-1 Nef-induced downregulation of MHC-I expression and MHC-I targeting to the trans-Golgi network (TGN) require the binding of Nef to PACS-1, a molecule that controls the TGN localization of the cellular protein furin
11676	156110	NP_057857.2	Nef	inhibits	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	11289809,12584329	2007-11-07 17:27	Expression of HIV-1 Nef in human T cells inhibits HLA-A2 transport to the cell surface
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	11289809,12526811	2007-11-07 17:28	HIV-1 Nef downregulates expression of MHC-I by blocking transport of MHC-I molecules to the cell surface through a mechanism that requires phosphoinositide 3-kinase (PI 3-kinase) activity
11676	156110	NP_057857.2	Nef	modulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	11396948,14557639	2007-11-07 17:28	Different levels of MHC-I modulation are induced by different HIV-1 Nef proteins derived from HIV-1 infected adults and children
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	11438519	2007-11-07 17:28	HIV-1 Nef downregulates MHC-I in Jurkat cells in a concentration-dependent manner
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	11500821	2007-11-07 17:28	A dominant-negative mutant protein derived from Hck, (composed of the N-terminal region, SH2, and SH3 domains) interacts with HIV-1 Nef and inhibits Nef-induced downregulation of MHC class I
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	11578695,16454711	2007-11-07 17:28	Deletion of the 19 N-terminal amino acids including the myristoylation signal from HIV-1 Nef inhibits both MHC-I and CD4 downregulation while preserving most CTL, T-helper and B-cell epitopes
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	11602047	2007-11-07 17:28	Downregulation of major histocompatibility class I on human dendritic cells by HIV-1 Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	12097566,15611225	2007-11-07 17:28	HIV-1 Nef-mediated downregulation of HLA class I suppresses the cytolytic activity of HIV-1-specific cytotoxic T-lymphocyte (CTL) clones
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	12482663,12884192	2007-11-07 17:28	HIV-1 Nef downregulates human MHC-I more efficiently than murine MHC-I molecules in HeLa cells, and Nef does not function efficiently in murine endothelial cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	14557639,16354571,16454711,16684552	2007-11-07 17:28	HIV-1 Nef alleles derived from perinatally infected children efficiently downregulate both CD4 and MHC-I in HeLa-CD4+ cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	15194762	2007-11-07 17:28	HIV-1 group N and group O Nef alleles only weakly downregulate CD4, CD28, and class I and II MHC molecules
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	15262497	2007-11-07 17:28	HIV-1 Nef has been observed to downregulate HLA-A2 on immature dendritic cells from two donors
11676	156110	NP_057857.2	Nef	binds	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	15569716,15653685	2007-11-07 17:28	HIV-1 Nef disrupts antigen presentation by binding to MHC-I (HLA-A2) hypophosphorylated cytoplasmic tails in the endoplasmic reticulum; this Nef-MHC-I complex migrates normally into the Golgi apparatus but subsequently fails to arrive at the cell surface
11676	156110	NP_057857.2	Nef	inhibits	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	15569716	2007-11-07 17:28	The ability of HIV-1 Nef to disrupt MHC-I trafficking and inhibit antigen presentation is regulated by the expression of the mu1 subunit of adaptor protein (AP) AP-1A, a cellular protein complex implicated in TGN to endolysosomal pathways
11676	156110	NP_057857.2	Nef	inhibits	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	15596859	2007-11-07 17:28	The N-terminal alpha helix (17-26), polyproline (72-78), acidic (62-65), and oligomerization (123) domains of HIV-1 Nef are required for Nef-mediated disruption of the transport of HLA-A2 to the cell surface and for Nef to coprecipitate with HLA-A2
11676	156110	NP_057857.2	Nef	co-localizes with	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	15854903	2007-11-07 17:28	PxxP motifs in HIV-1 Nef induce the accumulation of CCR5 in a perinuclear compartment where both molecules co-localize with MHC-1
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	15878340	2007-11-07 17:28	The HIV-1 Nef mutant NefAAAA, which cannot interact with the endosomal sorting protein PACS-1, increases the number of cells containing long and stable tubules, which allows the internalization of MHC-1 into the tubules from the cell surface
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	16000390,16091223	2007-11-07 17:28	Macrophage-tropic HIV-1 Nef downregulates expression of HLA-A2 on the surface of productively infected macrophages; point mutations in Nef at prolines P74 or P80 abrogate the downregulation of HLA-A2
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	16365153	2007-11-07 17:29	HIV-1 Nef induces drastic and moderate downregulation of CD4 and MHC-I in resting CD4(+) T lymphocytes, respectively, but markedly upregulates cell surface levels of the MHC-II invariant chain CD74
11676	156110	NP_057857.2	Nef	downregulates	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	16847125	2007-11-07 17:31	Mutation of amino acid P78 in HIV-1 Nef affects downregulation of MHC-I molecules from the cell surface, but does not interfere with Nef binding to Src homology 3 (SH3) domains
11676	156110	NP_057857.2	Nef	binds	9606	3105	NP_002107.3	HLA class I histocompatibility antigen, A-1 alpha chain precursor	17116886	2007-11-07 17:31	The HIV-1 Nef 73-82 epitope binds strongly to HLA-A3 molecules and forms very stable complexes
11676	155871	NP_057853.1	Tat	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	7621073,8493575,9751712,9840288	2007-11-07 17:27	HIV-1 Tat represses the MHC class I gene promoter by binding to and repressing TAFII250, a component of the general transcription factor TFIID, suggesting a mechanism for HIV-1 to downregulate MHC class I expression and avoid immune surveillance
11676	155871	NP_057853.1	Tat	upregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	11751963,14595379	2007-11-07 17:27	HIV-1 Tat upregulates MHC class I in monocyte-derived dendritic cells and CD8(+) T cells, thereby driving T cell-mediated immune responses
11676	155945	NP_057855.1	Vpu	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	9104816	2007-11-07 17:27	Using antibodies specific to MHC class I A, B, and C molecules (clone W6/32), HIV-1 Vpu protein has been shown to downregulate the expression of MHC class I molecules on the surface of HIV-1 infected cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	1316930,10799863	2007-11-07 17:30	HIV-1 gp160-derived peptide p18 presented by H-2Dd class I major histocompatibility complex molecules is processed by angiotensin-1 converting enzyme (ACE) prior to T cell stimulation by the peptide p18
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	2789433,8671651,8877415,9120272,10546855,11932387	2007-11-07 17:31	Conformational changes in HIV-1 gp120, including an enhanced expression of the V3 loop of gp120 and of epitopes that are exposed upon CD4 binding, are consistent with the formation of a multimolecular complex between HLA class I and gp120/160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	7539755,9263011,12427289	2007-11-07 17:27	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	7913356,9373217	2007-11-07 17:31	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	8612235,12734410,15638726,16091223,16272310	2007-11-07 17:29	HIV-1 Nef downregulates the expression of MHC-I at the surface of lymphoid, monocytic and epithelial cells, causing MHC-I molecules to be rapidly internalized, accumulated in endosomal vesicles and degraded
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	9052838,9586638	2007-11-07 17:29	Interaction of HIV-1 Nef with the mu subunit of AP adaptor complexes requires the recognition of tyrosine-based sorting signals, which likely facilitates the connection between MHC I and the clathrin-dependent sorting machinery
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	9123874	2007-11-07 17:29	Downregulation of MHC-I by Nef decreases the incorporation of MHC-I molecules into virions, but does not decrease virion infectivity
11676	156110	NP_057857.2	Nef	binds	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	9582271,10366557,10982373,11463741,12414957,12836198,14965316,15078178	2007-11-07 17:29	Four glutamic acids from position 62 to 65 in the SH3 domain of HIV-1 Nef bind to the cytoplasmic tail at position 320Y of MHC-I, and are required for the Nef-mediated downregulation of MHC-I from the cell surface
11676	156110	NP_057857.2	Nef	modulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	9971776,12502873,15078178	2007-11-07 17:29	Two distinct regions of HIV-1 Nef modulate MHC-I expression on cell surface: an N-terminal alpha-helix (residues 17-26) and a proline-rich motif (residues 75-78)
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	10403641	2007-11-07 17:29	HIV-1 selectively downregulates HLA-A and HLA-B but does not significantly affect HLA-C or HLA-E, which allows HIV-infected cells to avoid NK cell-mediated lysis
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	10684310,15078178	2007-11-07 17:29	A methionine residue at amino acid 20 in the alpha-helix domain is required for the ability of HIV-1 Nef to downregulate MHC-I expression but not for the downregulation of CD4
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	10707087	2007-11-07 17:29	HIV-1 Nef-induced downregulation of MHC-I expression and MHC-I targeting to the trans-Golgi network (TGN) require the binding of Nef to PACS-1, a molecule that controls the TGN localization of the cellular protein furin
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	11289809,12526811	2007-11-07 17:29	HIV-1 Nef downregulates expression of MHC-I by blocking transport of MHC-I molecules to the cell surface through a mechanism that requires phosphoinositide 3-kinase (PI 3-kinase) activity
11676	156110	NP_057857.2	Nef	modulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	11396948,14557639	2007-11-07 17:29	Different levels of the modulation of MHC-1 are induced by different Nef proteins derived from HIV-1 infected adults and children
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	11438519	2007-11-07 17:29	HIV-1 Nef-mediated cellular phenotypes, including MHC-1 and CD4 downregulation, are differentially expressed as a function of intracellular Nef concentrations
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	11500821	2007-11-07 17:29	A dominant-negative mutant protein derived from Hck, (composed of the N-terminal region, SH2, and SH3 domains) interacts with HIV-1 Nef and inhibits Nef-induced downregulation of MHC class I
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	11578695	2007-11-07 17:29	Deletion of the 19 N-terminal amino acids including the myristoylation signal from HIV-1 Nef inhibits both MHC-I and CD4 downregulation while preserving most CTL, T-helper and B-cell epitopes
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	11602047	2007-11-07 17:29	Downregulation of major histocompatibility class I on human dendritic cells by HIV-1 Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	12097566,15611225	2007-11-07 17:29	HIV-1-specific CTL clones are suppressed to kill primary CD4(+) T cells infected with a Nef-positive HIV-1 strain (NL-432) but efficiently lysed CD4(+) T cells infected with a nef-mutant NL-M20A
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	12482663,12884192	2007-11-07 17:29	HIV-1 Nef downregulates human MHC-I more efficiently than murine MHC-I molecules in HeLa cells, and Nef does not function efficiently in murine endothelial cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	14557639,17077296	2007-11-07 17:29	HIV-1 Nef alleles derived from perinatally infected children efficiently downregulate both CD4 and MHC-I in HeLa-CD4+ cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	15194762	2007-11-07 17:29	HIV-1 group N or O Nef alleles only weakly downregulate CD4, CD28, and class I and II MHC molecules
11676	156110	NP_057857.2	Nef	co-localizes with	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	15854903	2007-11-07 17:29	PxxP motifs in HIV-1 Nef induce the accumulation of CCR5 in a perinuclear compartment where both molecules co-localize with MHC-1
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	15878340	2007-11-07 17:29	HIV-1 Nef mutant NefAAAA, which cannot interact with the endosomal sorting protein PACS-1, increases the number of cells containing long and stable tubules, which allows the internalization of MHC-1 into the tubules from the cell surface
11676	156110	NP_057857.2	Nef	downregulates	9606	3106	NP_005505.2	HLA class I histocompatibility antigen, B-8 alpha chain precursor	16365153	2007-11-07 17:29	HIV-1 Nef induces drastic and moderate downregulation of CD4 and MHC-I in resting CD4(+) T lymphocytes, respectively, but markedly upregulates cell surface levels of the MHC-II invariant chain CD74
11676	155871	NP_057853.1	Tat	downregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	7621073,8493575,9751712,9840288	2007-11-07 17:27	HIV-1 Tat represses the MHC class I gene promoter by binding to and repressing TAFII250, a component of the general transcription factor TFIID, suggesting a mechanism for HIV-1 to downregulate MHC class I expression and avoid immune surveillance
11676	155871	NP_057853.1	Tat	upregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	11751963,14595379	2007-11-07 17:27	HIV-1 Tat upregulates MHC class I in monocyte-derived dendritic cells and CD8(+) T cells, thereby driving T cell-mediated immune responses
11676	155945	NP_057855.1	Vpu	downregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	9104816	2007-11-07 17:27	Using antibodies specific to MHC class I A, B, and C molecules (clone W6/32), HIV-1 Vpu protein has been shown to downregulate the expression of MHC class I molecules on the surface of HIV-1 infected cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	1316930,10799863	2007-11-07 17:30	HIV-1 gp160-derived peptide p18 presented by H-2Dd class I major histocompatibility complex molecules is processed by angiotensin-1 converting enzyme (ACE) prior to T cell stimulation by the peptide p18
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	2789433,8671651,8877415,9120272,10546855,11932387	2007-11-07 17:31	Conformational changes in HIV-1 gp120, including an enhanced expression of the V3 loop of gp120 and of epitopes that are exposed upon CD4 binding, are consistent with the formation of a multimolecular complex between HLA class I and gp120/160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	7539755,9263011,12427289	2007-11-07 17:27	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	7677956,10546855	2007-11-07 17:30	A highly conserved region of HIV-1 gp120 (amino acids 376 to 383) is recognized by an HLA-C molecule, Cw4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	15316337	2007-11-07 17:30	The presence of HLA-C and HLA-E molecules on HIV-infected cells facilitates evasion of NK-mediated killing of anti-gp120-coated HIV-infected cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	7913356,9373217,9698101	2007-11-07 17:31	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	8084338,9698101	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	8612235,12734410,15638726,16091223,16272310	2007-11-07 17:29	HIV-1 Nef downregulates the expression of MHC-I at the surface of lymphoid, monocytic and epithelial cells, causing MHC-I molecules to be rapidly internalized, accumulated in endosomal vesicles and degraded
11676	156110	NP_057857.2	Nef	downregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	9052838,9586638	2007-11-07 17:29	Interaction of HIV-1 Nef with the mu subunit of AP adaptor complexes requires the recognition of tyrosine-based sorting signals, which likely facilitates the connection between MHC I and the clathrin-dependent sorting machinery
11676	156110	NP_057857.2	Nef	binds	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	9582271,10366557,10982373,11463741,12414957,12836198,14965316,15078178	2007-11-07 17:29	Four glutamic acids from position 62 to 65 in the SH3 domain of HIV-1 Nef bind to the cytoplasmic tail at position 320Y of MHC-I, and are required for the Nef-mediated downregulation of MHC-I from the cell surface
11676	156110	NP_057857.2	Nef	downregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	10684310,15078178	2007-11-07 17:29	A methionine residue at amino acid 20 in the alpha-helix domain is required for the ability of HIV-1 Nef to downregulate MHC-I expression but not for the downregulation of CD4
11676	156110	NP_057857.2	Nef	downregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	10707087	2007-11-07 17:29	HIV-1 Nef-induced downregulation of MHC-I expression and MHC-I targeting to the trans-Golgi network (TGN) require the binding of Nef to PACS-1, a molecule that controls the TGN localization of the cellular protein furin
11676	156110	NP_057857.2	Nef	downregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	11289809,12526811	2007-11-07 17:29	HIV-1 Nef downregulates expression of MHC-I by blocking transport of MHC-I molecules to the cell surface through a mechanism that requires phosphoinositide 3-kinase (PI 3-kinase) activity
11676	156110	NP_057857.2	Nef	downregulates	9606	3107	NP_002108.4	HLA class I histocompatibility antigen, Cw-1 alpha chain precursor	11578695	2007-11-07 17:29	Deletion of the 19 N-terminal amino acids including the myristoylation signal from HIV-1 Nef inhibits both MHC-I and CD4 downregulation while preserving most CTL, T-helper and B-cell epitopes
11676	155871	NP_057853.1	Tat	downregulates	9606	3108	NP_006111.2	HLA class II histocompatibility antigen, DM alpha chain precursor	10661406,11118314	2007-11-07 17:28	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3108	NP_006111.2	HLA class II histocompatibility antigen, DM alpha chain precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3108	NP_006111.2	HLA class II histocompatibility antigen, DM alpha chain precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3108	NP_006111.2	HLA class II histocompatibility antigen, DM alpha chain precursor	2543930,2846691,7541827,8168144,12427289	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3108	NP_006111.2	HLA class II histocompatibility antigen, DM alpha chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3108	NP_006111.2	HLA class II histocompatibility antigen, DM alpha chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3108	NP_006111.2	HLA class II histocompatibility antigen, DM alpha chain precursor	10729169	2007-11-07 17:30	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155871	NP_057853.1	Tat	downregulates	9606	3109	NP_002109.1	HLA class II histocompatibility antigen, DM beta chain precursor	10661406,11118314	2007-11-07 17:28	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3109	NP_002109.1	HLA class II histocompatibility antigen, DM beta chain precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3109	NP_002109.1	HLA class II histocompatibility antigen, DM beta chain precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3109	NP_002109.1	HLA class II histocompatibility antigen, DM beta chain precursor	2543930,2846691,7541827,8168144,12427289	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3109	NP_002109.1	HLA class II histocompatibility antigen, DM beta chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3109	NP_002109.1	HLA class II histocompatibility antigen, DM beta chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3109	NP_002109.1	HLA class II histocompatibility antigen, DM beta chain precursor	10729169	2007-11-07 17:30	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155871	NP_057853.1	Tat	downregulates	9606	3111	NP_002110.1	HLA class II histocompatibility antigen, DO alpha chain precursor	10661406,11118314	2007-11-07 17:28	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3111	NP_002110.1	HLA class II histocompatibility antigen, DO alpha chain precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3111	NP_002110.1	HLA class II histocompatibility antigen, DO alpha chain precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3111	NP_002110.1	HLA class II histocompatibility antigen, DO alpha chain precursor	2543930,2846691,7541827,8168144,12427289	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3111	NP_002110.1	HLA class II histocompatibility antigen, DO alpha chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3111	NP_002110.1	HLA class II histocompatibility antigen, DO alpha chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3111	NP_002110.1	HLA class II histocompatibility antigen, DO alpha chain precursor	10729169	2007-11-07 17:30	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155871	NP_057853.1	Tat	downregulates	9606	3112	NP_002111.1	HLA class II histocompatibility antigen, DO beta chain precursor	10661406,11118314	2007-11-07 17:28	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3112	NP_002111.1	HLA class II histocompatibility antigen, DO beta chain precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3112	NP_002111.1	HLA class II histocompatibility antigen, DO beta chain precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3112	NP_002111.1	HLA class II histocompatibility antigen, DO beta chain precursor	2543930,2846691,7541827,8168144,12427289	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3112	NP_002111.1	HLA class II histocompatibility antigen, DO beta chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3112	NP_002111.1	HLA class II histocompatibility antigen, DO beta chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3112	NP_002111.1	HLA class II histocompatibility antigen, DO beta chain precursor	10729169	2007-11-07 17:30	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155871	NP_057853.1	Tat	downregulates	9606	3113	NP_291032.2	HLA class II histocompatibility antigen, DP alpha 1 chain precursor	10661406,11118314	2007-11-07 17:28	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3113	NP_291032.2	HLA class II histocompatibility antigen, DP alpha 1 chain precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3113	NP_291032.2	HLA class II histocompatibility antigen, DP alpha 1 chain precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3113	NP_291032.2	HLA class II histocompatibility antigen, DP alpha 1 chain precursor	2543930,2846691,7541827,8168144,12427289	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3113	NP_291032.2	HLA class II histocompatibility antigen, DP alpha 1 chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3113	NP_291032.2	HLA class II histocompatibility antigen, DP alpha 1 chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3113	NP_291032.2	HLA class II histocompatibility antigen, DP alpha 1 chain precursor	10729169	2007-11-07 17:31	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155871	NP_057853.1	Tat	downregulates	9606	3115	NP_002112.3	HLA class II histocompatibility antigen, DP beta 1 chain precursor	10661406,11118314	2007-11-07 17:28	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3115	NP_002112.3	HLA class II histocompatibility antigen, DP beta 1 chain precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3115	NP_002112.3	HLA class II histocompatibility antigen, DP beta 1 chain precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3115	NP_002112.3	HLA class II histocompatibility antigen, DP beta 1 chain precursor	2543930,2846691,7541827,8168144,8356059,12427289	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3115	NP_002112.3	HLA class II histocompatibility antigen, DP beta 1 chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3115	NP_002112.3	HLA class II histocompatibility antigen, DP beta 1 chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3115	NP_002112.3	HLA class II histocompatibility antigen, DP beta 1 chain precursor	10729169	2007-11-07 17:30	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155871	NP_057853.1	Tat	downregulates	9606	3117	NP_002113.2	HLA class II histocompatibility antigen, DQ alpha 1 chain precursor	10661406,11118314	2007-11-07 17:28	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3117	NP_002113.2	HLA class II histocompatibility antigen, DQ alpha 1 chain precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3117	NP_002113.2	HLA class II histocompatibility antigen, DQ alpha 1 chain precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3117	NP_002113.2	HLA class II histocompatibility antigen, DQ alpha 1 chain precursor	2543930,2846691,7541827,8168144,12427289	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3117	NP_002113.2	HLA class II histocompatibility antigen, DQ alpha 1 chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3117	NP_002113.2	HLA class II histocompatibility antigen, DQ alpha 1 chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3117	NP_002113.2	HLA class II histocompatibility antigen, DQ alpha 1 chain precursor	10729169	2007-11-07 17:31	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155871	NP_057853.1	Tat	downregulates	9606	3118	NP_064440.1	HLA class II histocompatibility antigen, DQ alpha 2 chain precursor	10661406,11118314	2007-11-07 17:28	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3118	NP_064440.1	HLA class II histocompatibility antigen, DQ alpha 2 chain precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3118	NP_064440.1	HLA class II histocompatibility antigen, DQ alpha 2 chain precursor	1869305,1967269,1978941,7512597	2007-11-07 17:30	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3118	NP_064440.1	HLA class II histocompatibility antigen, DQ alpha 2 chain precursor	2543930,2846691,7541827,8168144,12427289	2007-11-07 17:31	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3118	NP_064440.1	HLA class II histocompatibility antigen, DQ alpha 2 chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3118	NP_064440.1	HLA class II histocompatibility antigen, DQ alpha 2 chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3118	NP_064440.1	HLA class II histocompatibility antigen, DQ alpha 2 chain precursor	10729169	2007-11-07 17:31	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155871	NP_057853.1	Tat	downregulates	9606	3119	NP_002114.2	major histocompatibility complex, class II, DQ beta 1 precursor	10661406,11118314	2007-11-07 17:28	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3119	NP_002114.2	major histocompatibility complex, class II, DQ beta 1 precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3119	NP_002114.2	major histocompatibility complex, class II, DQ beta 1 precursor	1978941	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3119	NP_002114.2	major histocompatibility complex, class II, DQ beta 1 precursor	2543930,2846691,7541827	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3119	NP_002114.2	major histocompatibility complex, class II, DQ beta 1 precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3119	NP_002114.2	major histocompatibility complex, class II, DQ beta 1 precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3119	NP_002114.2	major histocompatibility complex, class II, DQ beta 1 precursor	10729169	2007-11-07 17:31	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155871	NP_057853.1	Tat	downregulates	9606	3120	NP_872355.1	major histocompatibility complex, class II, DQ beta 2	10661406,11118314	2007-11-07 17:28	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3120	NP_872355.1	major histocompatibility complex, class II, DQ beta 2	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3120	NP_872355.1	major histocompatibility complex, class II, DQ beta 2	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3120	NP_872355.1	major histocompatibility complex, class II, DQ beta 2	2543930,2846691,7541827,8168144,12427289	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3120	NP_872355.1	major histocompatibility complex, class II, DQ beta 2	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3120	NP_872355.1	major histocompatibility complex, class II, DQ beta 2	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3120	NP_872355.1	major histocompatibility complex, class II, DQ beta 2	10729169	2007-11-07 17:31	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155030	NP_057850.1	Pr55(Gag)	relocalizes	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	12202216	2007-11-07 17:29	HIV-1 Gag expression is able to induce HLA-DR cell-surface localization in H78-C10.0 cells
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	12230470	2007-11-07 17:29	In human macrophages, HIV-1 Gag proteins co-localize with MHC II (HLA-DR), CD63, and Lamp1 in MHC II compartments
11676	155030	NP_057850.1	Pr55(Gag)	relocalized by	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	16973583	2007-11-07 17:31	Human Leukocyte Antigen DR (HLA-DR), Major Histocompatibility Complex class II molecules (MHC-II) induce a relocation of Gag to late endosomal/multivesicular bodies (LE/MVB) and increase the accumulation of viral particles assembling intracellularly
11676	155030	NP_579880.1	capsid	downregulates	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	1905983	2007-11-07 17:29	HIV-1 Capsid (p24) inhibits interferon gamma induced increases in HLA-DR and cytochrome B heavy chain mRNA levels in the human monocyte-like cell line THP1
11676	155871	NP_057853.1	Tat	downregulates	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	10661406,11118314	2007-11-07 17:27	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155871	NP_057853.1	Tat	upregulates	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	11751963	2007-11-07 17:27	HIV-1 Tat upregulates HLA-DR expression in monocyte-derived dendritic cells and T cells, thereby driving T cell-mediated immune responses and activation
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	8450224	2007-11-07 17:30	Antibodies against cell surface molecules LFA-1, ICAM-1, HLA-DR, and CD28 inhibit the HIV-1 gp160-induced B cell differentiation response; gp160 also induces IL-6R and CD23 molecule expression on B cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	1970352,7645219,12427289	2007-11-07 17:29	Genetic variability in HIV-1 gp120 affects its interactions with HLA-DR molecules and T cell receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	2543930,2846691,7541827,7734415,8168144	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	15784911	2007-11-07 17:31	CD4+ T cells infected with CCR5-tropic HIV-1 have significantly higher levels of activation-marker expression (e.g. CD25, CD71 and HLA-DR) than CD4+ T lymphocytes infected with CXCR4-tropic HIV-1
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	10729169	2007-11-07 17:31	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	156110	NP_057857.2	Nef	inhibits	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	11593029,12836198,15078178	2007-11-07 17:28	HIV-1 Nef expression inhibits MHC II presentation of viral antigens in infected antigen-presenting cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	12970439,16091223,16354571,16454711	2007-11-07 17:28	Expression of patient-derived HIV-1 nef alleles downregulates MHC-II cell surface expression in activated CD4+ T cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3122	NP_061984.2	HLA class II histocompatibility antigen, DR alpha chain precursor	15194762,16454711	2007-11-07 17:28	HIV-1 group N and group O Nef alleles only weakly downregulate CD4, CD28, and class I and II MHC molecules
11676	155030	NP_057850.1	Pr55(Gag)	relocalizes	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	12202216	2007-11-07 17:29	HIV-1 Gag expression is able to induce HLA-DR cell-surface localization in H78-C10.0 cells
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	12230470	2007-11-07 17:29	In human macrophages, HIV-1 Gag proteins co-localize with MHC II (HLA-DR), CD63, and Lamp1 in MHC II compartments
11676	155030	NP_057850.1	Pr55(Gag)	relocalized by	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	16973583	2007-11-07 17:30	Human Leukocyte Antigen DR (HLA-DR), Major Histocompatibility Complex class II molecules (MHC-II) induce a relocation of Gag to late endosomal/multivesicular bodies (LE/MVB) and increase the accumulation of viral particles assembling intracellularly
11676	155030	NP_579880.1	capsid	downregulates	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	1905983	2007-11-07 17:29	HIV-1 Capsid (p24) inhibits interferon gamma induced increases in HLA-DR and cytochrome B heavy chain mRNA levels in the human monocyte-like cell line THP1
11676	155871	NP_057853.1	Tat	upregulates	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	9223324,11751963	2007-11-07 17:27	HIV-1 Tat upregulates HLA-DR expression in monocyte-derived dendritic cells and T cells, thereby driving T cell-mediated immune responses and activation
11676	155871	NP_057853.1	Tat	downregulates	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	10661406,11118314	2007-11-07 17:27	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	8450224	2007-11-07 17:30	Antibodies against cell surface molecules LFA-1, ICAM-1, HLA-DR, and CD28 inhibit the HIV-1 gp160-induced B cell differentiation response; gp160 also induces IL-6R and CD23 molecule expression on B cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	1970352,7642208,7645219,12427289	2007-11-07 17:29	Genetic variability in HIV-1 gp120 affects its interactions with HLA-DR molecules and T cell receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	2543930,2846691,7541827,7734415,8168144	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	15784911	2007-11-07 17:31	CD4+ T cells infected with CCR5-tropic HIV-1 have significantly higher levels of activation-marker expression (e.g. CD25, CD71 and HLA-DR) than CD4+ T lymphocytes infected with CXCR4-tropic HIV-1
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	10729169	2007-11-07 17:30	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	156110	NP_057857.2	Nef	interacts with	9606	3123	NP_002115.1	major histocompatibility complex, class II, DR beta 1 precursor	8086129	2007-11-07 17:27	Monoclonal antibodies to the cell surface molecule human lymphocyte antigen-DR inhibit the Nef-induced B-cell differentiation response, suggesting an interaction between Nef and human lymphocyte antigen-DR
11676	155030	NP_057850.1	Pr55(Gag)	relocalizes	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	12202216	2007-11-07 17:29	HIV-1 Gag expression is able to induce HLA-DR cell-surface localization in H78-C10.0 cells
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	12230470	2007-11-07 17:29	In human macrophages, HIV-1 Gag proteins co-localize with MHC II (HLA-DR), CD63, and Lamp1 in MHC II compartments
11676	155030	NP_057850.1	Pr55(Gag)	relocalized by	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	16973583	2007-11-07 17:31	Human Leukocyte Antigen DR (HLA-DR), Major Histocompatibility Complex class II molecules (MHC-II) induce a relocation of Gag to late endosomal/multivesicular bodies (LE/MVB) and increase the accumulation of viral particles assembling intracellularly
11676	155030	NP_579880.1	capsid	downregulates	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	1905983	2007-11-07 17:29	HIV-1 Capsid (p24) inhibits interferon gamma induced increases in HLA-DR and cytochrome B heavy chain mRNA levels in the human monocyte-like cell line THP1
11676	155871	NP_057853.1	Tat	upregulates	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	9223324,11751963	2007-11-07 17:27	HIV-1 Tat upregulates HLA-DR expression in monocyte-derived dendritic cells and T cells, thereby driving T cell-mediated immune responses and activation
11676	155871	NP_057853.1	Tat	downregulates	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	10661406,11118314	2007-11-07 17:27	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	8450224	2007-11-07 17:30	Antibodies against cell surface molecules LFA-1, ICAM-1, HLA-DR, and CD28 inhibit the HIV-1 gp160-induced B cell differentiation response; gp160 also induces IL-6R and CD23 molecule expression on B cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	1970352,7645219,12427289	2007-11-07 17:29	Genetic variability in HIV-1 gp120 affects its interactions with HLA-DR molecules and T cell receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	2543930,2846691,7541827,7734415,8168144	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	15784911	2007-11-07 17:31	CD4+ T cells infected with CCR5-tropic HIV-1 have significantly higher levels of activation-marker expression (e.g. CD25, CD71 and HLA-DR) than CD4+ T lymphocytes infected with CXCR4-tropic HIV-1
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3125	NP_072049.2	major histocompatibility complex, class II, DR beta 3 precursor	10729169	2007-11-07 17:30	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155030	NP_057850.1	Pr55(Gag)	relocalizes	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	12202216	2007-11-07 17:29	HIV-1 Gag expression is able to induce HLA-DR cell-surface localization in H78-C10.0 cells
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	12230470	2007-11-07 17:29	In human macrophages, HIV-1 Gag proteins co-localize with MHC II (HLA-DR), CD63, and Lamp1 in MHC II compartments
11676	155030	NP_057850.1	Pr55(Gag)	relocalized by	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	16973583	2007-11-07 17:31	Human Leukocyte Antigen DR (HLA-DR), Major Histocompatibility Complex class II molecules (MHC-II) induce a relocation of Gag to late endosomal/multivesicular bodies (LE/MVB) and increase the accumulation of viral particles assembling intracellularly
11676	155030	NP_579880.1	capsid	downregulates	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	1905983	2007-11-07 17:29	HIV-1 Capsid (p24) inhibits interferon gamma induced increases in HLA-DR and cytochrome B heavy chain mRNA levels in the human monocyte-like cell line THP1
11676	155871	NP_057853.1	Tat	upregulates	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	9223324,11751963	2007-11-07 17:27	HIV-1 Tat upregulates HLA-DR expression in monocyte-derived dendritic cells and T cells, thereby driving T cell-mediated immune responses and activation
11676	155871	NP_057853.1	Tat	downregulates	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	10661406,11118314	2007-11-07 17:27	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	8450224	2007-11-07 17:30	Antibodies against cell surface molecules LFA-1, ICAM-1, HLA-DR, and CD28 inhibit the HIV-1 gp160-induced B cell differentiation response; gp160 also induces IL-6R and CD23 molecule expression on B cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	1970352,7645219,12427289	2007-11-07 17:29	Genetic variability in HIV-1 gp120 affects its interactions with HLA-DR molecules and T cell receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	2543930,2846691,7541827,7734415,8168144	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	15784911	2007-11-07 17:31	CD4+ T cells infected with CCR5-tropic HIV-1 have significantly higher levels of activation-marker expression (e.g. CD25, CD71 and HLA-DR) than CD4+ T lymphocytes infected with CXCR4-tropic HIV-1
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3126	NP_068818.4	major histocompatibility complex, class II, DR beta 4 precursor	10729169	2007-11-07 17:30	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155030	NP_057850.1	Pr55(Gag)	relocalizes	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	12202216	2007-11-07 17:29	HIV-1 Gag expression is able to induce HLA-DR cell-surface localization in H78-C10.0 cells
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	12230470	2007-11-07 17:29	In human macrophages, HIV-1 Gag proteins co-localize with MHC II (HLA-DR), CD63, and Lamp1 in MHC II compartments
11676	155030	NP_057850.1	Pr55(Gag)	relocalized by	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	16973583	2007-11-07 17:31	Human Leukocyte Antigen DR (HLA-DR), Major Histocompatibility Complex class II molecules (MHC-II) induce a relocation of Gag to late endosomal/multivesicular bodies (LE/MVB) and increase the accumulation of viral particles assembling intracellularly
11676	155030	NP_579880.1	capsid	downregulates	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	1905983	2007-11-07 17:29	HIV-1 Capsid (p24) inhibits interferon gamma induced increases in HLA-DR and cytochrome B heavy chain mRNA levels in the human monocyte-like cell line THP1
11676	155871	NP_057853.1	Tat	upregulates	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	9223324,11751963	2007-11-07 17:27	HIV-1 Tat upregulates HLA-DR expression in monocyte-derived dendritic cells and T cells, thereby driving T cell-mediated immune responses and activation
11676	155871	NP_057853.1	Tat	downregulates	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	10661406,11118314	2007-11-07 17:27	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	associates with	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	3489470,7602119,8376762,9079699	2007-11-07 17:31	Processing of HIV-1 gp160 to gp120 and gp41 is necessary for the association of HIV-1 envelope glycoproteins with class II MHC
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	8450224	2007-11-07 17:30	Antibodies against cell surface molecules LFA-1, ICAM-1, HLA-DR, and CD28 inhibit the HIV-1 gp160-induced B cell differentiation response; gp160 also induces IL-6R and CD23 molecule expression on B cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	1869305,1967269,1978941,7512597	2007-11-07 17:29	Amino acid residues 42-49 in the V1 region of CD4 are involved in the interaction between HIV-1 gp120 and class II major histocompatibility complex molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	1970352,7645219,12427289	2007-11-07 17:29	Genetic variability in HIV-1 gp120 affects its interactions with HLA-DR molecules and T cell receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	2543930,2846691,7541827,7734415,8168144	2007-11-07 17:30	HIV envelope protein gp120 can specifically inhibit CD4-dependent class II MHC-restricted T cell response to Ag
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	15784911	2007-11-07 17:31	CD4+ T cells infected with CCR5-tropic HIV-1 have significantly higher levels of activation-marker expression (e.g. CD25, CD71 and HLA-DR) than CD4+ T lymphocytes infected with CXCR4-tropic HIV-1
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	incorporates	9606	3127	NP_002116.2	major histocompatibility complex, class II, DR beta 5 precursor	10729169	2007-11-07 17:30	A 43-amino-acid sequence between amino acids 708 and 750 in the HIV-1 gp41(TM) cytoplasmic tail is required for efficient incorporation of HLA class II proteins into virions
11676	155871	NP_057853.1	Tat	downregulates	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	7621073,8493575,9751712,9840288	2007-11-07 17:29	HIV-1 Tat represses the MHC class I gene promoter by binding to and repressing TAFII250, a component of the general transcription factor TFIID, suggesting a mechanism for HIV-1 to downregulate MHC class I expression and avoid immune surveillance
11676	155871	NP_057853.1	Tat	upregulates	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	11751963,14595379	2007-11-07 17:27	HIV-1 Tat upregulates MHC class I in monocyte-derived dendritic cells and CD8(+) T cells, thereby driving T cell-mediated immune responses
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	1316930,10799863	2007-11-07 17:31	HIV-1 gp160-derived peptide p18 presented by H-2Dd class I major histocompatibility complex molecules is processed by angiotensin-1 converting enzyme (ACE) prior to T cell stimulation by the peptide p18
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	2789433,8671651,8877415,9120272,10546855,11932387	2007-11-07 17:31	Conformational changes in HIV-1 gp120, including an enhanced expression of the V3 loop of gp120 and of epitopes that are exposed upon CD4 binding, are consistent with the formation of a multimolecular complex between HLA class I and gp120/160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	7539755,9263011,12427289	2007-11-07 17:31	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	15316337	2007-11-07 17:30	The presence of HLA-C and HLA-E molecules on HIV-infected cells facilitates evasion of NK-mediated killing of anti-gp120-coated HIV-infected cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	7913356,9373217	2007-11-07 17:31	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	8612235,12734410,15638726,16091223,16272310	2007-11-07 17:29	HIV-1 Nef downregulates the expression of MHC-I at the surface of lymphoid, monocytic and epithelial cells, causing MHC-I molecules to be rapidly internalized, accumulated in endosomal vesicles and degraded
11676	156110	NP_057857.2	Nef	downregulates	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	9052838,9586638	2007-11-07 17:29	Interaction of HIV-1 Nef with the mu subunit of AP adaptor complexes requires the recognition of tyrosine-based sorting signals, which likely facilitates the connection between MHC I and the clathrin-dependent sorting machinery
11676	156110	NP_057857.2	Nef	binds	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	9582271,10366557,10982373,11463741,12414957,12836198,14965316,15078178	2007-11-07 17:29	Four glutamic acids from position 62 to 65 in the SH3 domain of HIV-1 Nef bind to the cytoplasmic tail at position 320Y of MHC-I, and are required for the Nef-mediated downregulation of MHC-I from the cell surface
11676	156110	NP_057857.2	Nef	downregulates	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	10684310,15078178	2007-11-07 17:29	A methionine residue at amino acid 20 in the alpha-helix domain is required for the ability of HIV-1 Nef to downregulate MHC-I expression but not for the downregulation of CD4
11676	156110	NP_057857.2	Nef	downregulates	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	10707087	2007-11-07 17:29	HIV-1 Nef-induced downregulation of MHC-I expression and MHC-I targeting to the trans-Golgi network (TGN) require the binding of Nef to PACS-1, a molecule that controls the TGN localization of the cellular protein furin
11676	156110	NP_057857.2	Nef	downregulates	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	11289809,12526811	2007-11-07 17:29	HIV-1 Nef downregulates expression of MHC-I by blocking transport of MHC-I molecules to the cell surface through a mechanism that requires phosphoinositide 3-kinase (PI 3-kinase) activity
11676	156110	NP_057857.2	Nef	downregulates	9606	3133	NP_005507.3	HLA class I histocompatibility antigen, alpha chain E precursor	11578695	2007-11-07 17:29	Deletion of the 19 N-terminal amino acids including the myristoylation signal from HIV-1 Nef inhibits both MHC-I and CD4 downregulation while preserving most CTL, T-helper and B-cell epitopes
11676	155871	NP_057853.1	Tat	downregulates	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	7621073,8493575,9751712,9840288	2007-11-07 17:27	HIV-1 Tat represses the MHC class I gene promoter by binding to and repressing TAFII250, a component of the general transcription factor TFIID, suggesting a mechanism for HIV-1 to downregulate MHC class I expression and avoid immune surveillance
11676	155871	NP_057853.1	Tat	upregulates	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	11751963,14595379	2007-11-07 17:27	HIV-1 Tat upregulates MHC class I in monocyte-derived dendritic cells and CD8(+) T cells, thereby driving T cell-mediated immune responses
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	1316930,10799863	2007-11-07 17:31	HIV-1 gp160-derived peptide p18 presented by H-2Dd class I major histocompatibility complex molecules is processed by angiotensin-1 converting enzyme (ACE) prior to T cell stimulation by the peptide p18
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	2789433,8671651,8877415,9120272,10546855,11932387	2007-11-07 17:31	Conformational changes in HIV-1 gp120, including an enhanced expression of the V3 loop of gp120 and of epitopes that are exposed upon CD4 binding, are consistent with the formation of a multimolecular complex between HLA class I and gp120/160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	7539755,9263011,12427289	2007-11-07 17:31	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	7913356,9373217	2007-11-07 17:31	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	8612235,12734410,15638726,16091223,16272310	2007-11-07 17:29	HIV-1 Nef downregulates the expression of MHC-I at the surface of lymphoid, monocytic and epithelial cells, causing MHC-I molecules to be rapidly internalized, accumulated in endosomal vesicles and degraded
11676	156110	NP_057857.2	Nef	downregulates	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	9052838,9586638	2007-11-07 17:29	Interaction of HIV-1 Nef with the mu subunit of AP adaptor complexes requires the recognition of tyrosine-based sorting signals, which likely facilitates the connection between MHC I and the clathrin-dependent sorting machinery
11676	156110	NP_057857.2	Nef	binds	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	9582271,10366557,10982373,11463741,12414957,12836198,14965316,15078178	2007-11-07 17:29	Four glutamic acids from position 62 to 65 in the SH3 domain of HIV-1 Nef bind to the cytoplasmic tail at position 320Y of MHC-I, and are required for the Nef-mediated downregulation of MHC-I from the cell surface
11676	156110	NP_057857.2	Nef	downregulates	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	10684310,15078178	2007-11-07 17:29	A methionine residue at amino acid 20 in the alpha-helix domain is required for the ability of HIV-1 Nef to downregulate MHC-I expression but not for the downregulation of CD4
11676	156110	NP_057857.2	Nef	downregulates	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	10707087	2007-11-07 17:29	HIV-1 Nef-induced downregulation of MHC-I expression and MHC-I targeting to the trans-Golgi network (TGN) require the binding of Nef to PACS-1, a molecule that controls the TGN localization of the cellular protein furin
11676	156110	NP_057857.2	Nef	downregulates	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	11289809,12526811	2007-11-07 17:29	HIV-1 Nef downregulates expression of MHC-I by blocking transport of MHC-I molecules to the cell surface through a mechanism that requires phosphoinositide 3-kinase (PI 3-kinase) activity
11676	156110	NP_057857.2	Nef	downregulates	9606	3134	NP_061823.1	major histocompatibility complex, class I, F precursor	11578695	2007-11-07 17:29	Deletion of the 19 N-terminal amino acids including the myristoylation signal from HIV-1 Nef inhibits both MHC-I and CD4 downregulation while preserving most CTL, T-helper and B-cell epitopes
11676	155871	NP_057853.1	Tat	downregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	7621073,8493575,9751712,9840288	2007-11-07 17:27	HIV-1 Tat represses the MHC class I gene promoter by binding to and repressing TAFII250, a component of the general transcription factor TFIID, suggesting a mechanism for HIV-1 to downregulate MHC class I expression and avoid immune surveillance
11676	155871	NP_057853.1	Tat	upregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	11751963,14595379	2007-11-07 17:27	HIV-1 Tat upregulates MHC class I in monocyte-derived dendritic cells and CD8(+) T cells, thereby driving T cell-mediated immune responses
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	1316930,10799863	2007-11-07 17:30	HIV-1 gp160-derived peptide p18 presented by H-2Dd class I major histocompatibility complex molecules is processed by angiotensin-1 converting enzyme (ACE) prior to T cell stimulation by the peptide p18
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	2789433,8671651,8877415,9120272,10546855,11932387	2007-11-07 17:31	Conformational changes in HIV-1 gp120, including an enhanced expression of the V3 loop of gp120 and of epitopes that are exposed upon CD4 binding, are consistent with the formation of a multimolecular complex between HLA class I and gp120/160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	7539755,9263011,12427289	2007-11-07 17:31	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	7913356,9373217	2007-11-07 17:31	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 can selectively enhance MHC class I and II expression on human B cells, but does not increase expression of other cell surface antigens such as CD21 and CD54 (ICAM-1)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	8084338	2007-11-07 17:31	Soluble HIV-1 gp41 enhancement effects on MHC class I and II antigen expression can be inhibited by soluble gp41-binding proteins of 45, 49 and 62 kD from human B cells
11676	156110	NP_057857.2	Nef	downregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	8612235,12734410,15638726,16091223,16272310	2007-11-07 17:29	HIV-1 Nef downregulates the expression of MHC-I at the surface of lymphoid, monocytic and epithelial cells, causing MHC-I molecules to be rapidly internalized, accumulated in endosomal vesicles and degraded
11676	156110	NP_057857.2	Nef	downregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	9052838,9586638	2007-11-07 17:29	Interaction of HIV-1 Nef with the mu subunit of AP adaptor complexes requires the recognition of tyrosine-based sorting signals, which likely facilitates the connection between MHC I and the clathrin-dependent sorting machinery
11676	156110	NP_057857.2	Nef	binds	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	9582271,10366557,10982373,11463741,12414957,12836198,14965316,15078178	2007-11-07 17:29	Four glutamic acids from position 62 to 65 in the SH3 domain of HIV-1 Nef bind to the cytoplasmic tail at position 320Y of MHC-I, and are required for the Nef-mediated downregulation of MHC-I from the cell surface
11676	156110	NP_057857.2	Nef	downregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	10684310,15078178	2007-11-07 17:29	A methionine residue at amino acid 20 in the alpha-helix domain is required for the ability of HIV-1 Nef to downregulate MHC-I expression but not for the downregulation of CD4
11676	156110	NP_057857.2	Nef	downregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	10707087	2007-11-07 17:29	HIV-1 Nef-induced downregulation of MHC-I expression and MHC-I targeting to the trans-Golgi network (TGN) require the binding of Nef to PACS-1, a molecule that controls the TGN localization of the cellular protein furin
11676	156110	NP_057857.2	Nef	downregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	11289809,12526811	2007-11-07 17:29	HIV-1 Nef downregulates expression of MHC-I by blocking transport of MHC-I molecules to the cell surface through a mechanism that requires phosphoinositide 3-kinase (PI 3-kinase) activity
11676	156110	NP_057857.2	Nef	downregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	11578695	2007-11-07 17:29	Deletion of the 19 N-terminal amino acids including the myristoylation signal from HIV-1 Nef inhibits both MHC-I and CD4 downregulation while preserving most CTL, T-helper and B-cell epitopes
11676	156110	NP_057857.2	Nef	downregulates	9606	3135	NP_002118.1	HLA class I histocompatibility antigen, alpha chain G precursor	15556689	2007-11-07 17:28	HLA-G, which is mainly expressed in placental tissues and in thymic epithelial cells, resists Nef-induced cell surface downregulation as a result of its short intracytoplasmic domain
11676	156110	NP_057857.2	Nef	Modulates	9606	3156	NP_000850.1	3-hydroxy-3-methylglutaryl-Coenzyme A reductase isoform 1	16014965	2007-11-07 17:28	HIV-1 Nef modulates expression of 3-hydroxy-3-methylglutaryl-Coenzyme A reductase (HMGCR) in Jurkat cells
11676	155348	NP_705928.1	integrase	stimulated by	9606	3159	NP_002122.1	high mobility group protein HMG-I/HMG-Y isoform b	9038339,9188609,10074149,11069991,15875659,16075307,16403635	2007-11-07 17:29	HMG I(Y) is a component of the HIV-1 preintegration complex and stimulates integration by promoting formation of active HIV-1 Integrase-cDNA complexes
11676	155030	NP_579876.2	matrix	associates with	9606	3159	NP_665906.1	high mobility group protein HMG-I/HMG-Y isoform a	9188609	2007-11-07 17:28	HIV-1 Matrix associates with HMG I(Y) which is present in the HIV-1 preintegration complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3163	NP_002125.3	heme oxygenase 2	12775419	2007-11-07 17:31	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155807	NP_057852.2	Vpr	downregulates	9606	3164	NP_002126.2	nuclear receptor subfamily 4 group A member 1	14751250	2007-11-07 17:28	HIV-1 Vpr downregulates expression of the gene coding for growth factor-inducible nuclear protein N10 in PHA-stimulated PBMC
11676	155908	NP_057854.1	Rev	interacts with	9606	3178	NP_002127.1	heterogeneous nuclear ribonucleoprotein A1 isoform a	8883365	2007-11-07 17:27	hnRNP A1 binds to cis-acting repressive (CRS) sequences in HIV-1 RNA suggesting a role for this binding in influencing Rev function
11676	155908	NP_057854.1	Rev	stimulates	9606	3178	NP_002127.1	heterogeneous nuclear ribonucleoprotein A1 isoform a	9925777	2007-11-07 17:27	hnRNP A1 binds to an instability (INS) element in the p17gag gene of HIV-1 RNA causing synergistic stimulation of Rev-dependent nuclear export of unspliced HIV-1 mRNA
11676	155908	NP_057854.1	Rev	modulated by	9606	3178	NP_002127.1	heterogeneous nuclear ribonucleoprotein A1 isoform a	12419255,12458794	2007-11-07 17:27	hnRNP A1 modulates Rev expression by controlling HIV-1 mRNA splicing
11676	155908	NP_057854.1	Rev	interacts with	9606	3190	NP_002131.2	heterogeneous nuclear ribonucleoprotein K isoform a	12370808	2007-11-07 17:27	hnRNP K forms a complex with Sam68 and HIV-1 RRE RNA and inhibits Sam68-mediated, RRE-dependent gene expression suggesting a possible interaction with Rev
11676	155871	NP_057853.1	Tat	activates	9606	3265	NP_005334.1	GTPase HRas isoform 1	16436505	2007-11-07 17:31	HIV-1 Tat activates Ras activity and induces ERK phosphorylation through its arginine-glycine-aspartic (RGD) region in endothelial cells; Tat-induced Ras activation is mediated by tyrosine phosphorylation of Shc and recruitment of Grb2
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	3265	NP_005334.1	GTPase HRas isoform 1	9269777,9344703	2007-11-07 17:30	HIV-1 gp160 alone or CD4/gp160 cross-linking induces tyrosine phosphorylation of intracellular substrates p59fyn, zap 70, and p95vav and also leads to ras activation
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inactivates	9606	3265	NP_005334.1	GTPase HRas isoform 1	9344703	2007-11-07 17:31	Pretreatment of cells with HIV-1 gp160 results in marked inhibition of tyrosine phosphorylation of p59(fyn), PLC-gamma1, ras activation, and TNF-alpha secretion in anti-CD3 mAb activated CD4+ T cells
11676	156110	NP_057857.2	Nef	synergizes with	9606	3265	NP_005334.1	GTPase HRas isoform 1	10748182,11958689	2007-11-07 17:27	In HIV-1 Nef-expressing cells, phorbol 12-myristate 13-acetate treatment results in a 100-fold increase in NFAT-directed gene expression, indicating that Nef and the Ras/MAPK pathway synergistically activate NFAT activity
11676	156110	NP_057857.2	Nef	activates	9606	3265	NP_005334.1	GTPase HRas isoform 1	11958689	2007-11-07 17:27	HIV-1 Nef activates signal transduction pathways from Ras to mitogen-activated protein kinase cascades leading to induction of HIV-1 from latency
11676	155871	NP_057853.1	Tat	activates	9606	3266	NP_853510.1	GTPase ERas precursor	16436505	2007-11-07 17:29	HIV-1 Tat activates the small GTPases Ras and Rac and the mitogen-activated protein kinase ERK when expressed in human endothelial cells; this effect is mediated through the arginine-glycine-aspartic (RGD) region of Tat
11676	155871	NP_057853.1	Tat	activates	9606	3266	NP_853510.1	GTPase ERas precursor	16436505	2007-11-07 17:29	HIV-1 Tat induces ERK phosphorylation by the activation of the small GTPase Ras, but not the small GTPase Rac, in human endothelial cells
11676	155871	NP_057853.1	Tat	activates	9606	3266	NP_853510.1	GTPase ERas precursor	16436505	2007-11-07 17:29	HIV-1 Tat-induced small GTPase Ras activation is mediated by tyrosine phosphorylation of Shc and recruitment of Grb2 in human endothelial cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	3266	NP_853510.1	GTPase ERas precursor	9269777,9344703	2007-11-07 17:30	HIV-1 gp160 alone or CD4/gp160 cross-linking induces tyrosine phosphorylation of intracellular substrates p59fyn, zap 70, and p95vav and also leads to ras activation
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inactivates	9606	3266	NP_853510.1	GTPase ERas precursor	9344703	2007-11-07 17:31	Pretreatment of cells with HIV-1 gp160 results in marked inhibition of tyrosine phosphorylation of p59(fyn), PLC-gamma1, ras activation, and TNF-alpha secretion in anti-CD3 mAb activated CD4+ T cells
11676	155908	NP_057854.1	Rev	binds	9606	3267	NP_004495.2	arf-GAP domain and FG repeats-containing protein 1 isoform 2	7634337,7637788,8633082,8943370	2007-11-07 17:27	hRIP/Rab is a nucleoporin like protein that binds to the activation domain of HIV-1 Rev (amino acids 75-83) and acts as a cofactor for Rev-mediated nuclear export of HIV-1 mRNA
11676	155908	NP_057854.1	Rev	binds	9606	3267	NP_004495.2	arf-GAP domain and FG repeats-containing protein 1 isoform 2	10358091,14554087,16354571	2007-11-07 17:27	hRIP/Rab is known to interact with CRM1 (exportin 1) as part of its cofactor involvement with Rev-mediated nuclear export of HIV-1 mRNA
11676	155908	NP_057854.1	Rev	requires	9606	3267	NP_004495.2	arf-GAP domain and FG repeats-containing protein 1 isoform 2	14701878,16354571	2007-11-07 17:28	hRIP is an essential cellular HIV-1 Rev cofactor; abolishing hRIP activity with a dominant-negative mutant or RNA interference causes Rev-directed mRNAs to mislocalize and aberrantly accumulate at the nuclear periphery
11676	155908	NP_057854.1	Rev	binds	9606	3267	NP_004495.2	arf-GAP domain and FG repeats-containing protein 1 isoform 2	15749819	2007-11-07 17:28	Depletion of endogenous HIV-1 Rev binding protein (hRIP) by RNA interference results in the loss of viral replication in human cell lines and primary macrophages; virus production is restored to wild-type levels after reintroduction of hRIP protein
11676	155908	NP_057854.1	Rev	binds	9606	3268	NP_006067.3	arf-GAP domain and FG repeats-containing protein 2	7568168,9303539	2007-11-07 17:27	RAB-R is a proposed cellular cofactor for Rev function through a binding interaction with the Rev activation domain (amino acids 75-83)
11676	155908	NP_057854.1	Rev	binds	9606	3268	NP_006067.3	arf-GAP domain and FG repeats-containing protein 2	7568168,9303539	2007-11-07 17:27	The proposed interaction of RAB-R with Rev is based on its similarity to HIV-1 Rev binding protein (hRip/RAB)
11676	155807	NP_057852.2	Vpr	upregulates	9606	3297	NP_005517.1	heat shock factor protein 1	14751250	2007-11-07 17:28	HIV-1 Vpr upregulates heat shock transcription factor 1 (HSF1) in PHA-stimulated PBMC
11676	155807	NP_057852.2	Vpr	downregulates	9606	3300	NP_006727.2	dnaJ homolog subfamily B member 2 isoform b	14751250	2007-11-07 17:28	HIV-1 Vpr downregulates DNAJ protein homolog HSJ1 in PHA-stimulated PBMC
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3303	NP_005336.2	heat shock 70kDa protein 1A	11932435	2007-11-07 17:29	Hsp70 co-sediments with HIV-1 capsid protein in sucrose density gradients, providing evidence that it is specifically incorporated into HIV-1 virions through an interaction with HIV-1 Gag proteins
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3303	NP_005336.2	heat shock 70kDa protein 1A	11932435	2007-11-07 17:29	Hsp70 is incorporated into HIV-1 virions through an interaction with HIV-1 Gag
11676	155030	NP_579876.2	matrix	stimulated by	9606	3303	NP_005336.2	heat shock 70kDa protein 1A	10964507	2007-11-07 17:28	Hsp70 facilitates nuclear import of HIV-1 preintegration complexes by stimulating the binding of HIV-1 Matrix to karyopherin alpha
11676	155807	NP_057852.2	Vpr	competes with	9606	3303	NP_005336.2	heat shock 70kDa protein 1A	10964507	2007-11-07 17:28	HIV-1 Vpr competes with Hsp70 for binding to karyopherin alpha
11676	155807	NP_057852.2	Vpr	binds	9606	3303	NP_005336.2	heat shock 70kDa protein 1A	15142379,15331702	2007-11-07 17:31	HIV-1 Vpr binds to Hsp70 in coimmunoprecipitation assays
11676	155807	NP_057852.2	Vpr	inhibited by	9606	3303	NP_005336.2	heat shock 70kDa protein 1A	15142379,15166037,15817944,15832179	2007-11-07 17:28	Hsp70, a heat-shock protein contributing to cellular stress responses, inhibits nuclear translocation of HIV-1 Vpr; Hsp70 stimulates HIV-1 nuclear import and replication in macrophages in the absence of Vpr.
11676	155807	NP_057852.2	Vpr	inhibited by	9606	3303	NP_005336.2	heat shock 70kDa protein 1A	15142379,15331702,15638722,15780175,15817944,15832179	2007-11-07 17:28	Overexpression of Heat shock protein 70 (Hsp70) in yeast and mammalian cells inhibits HIV-1 Vpr-induced cell cycle G2 arrest, and suppression of Hsp70 expression by RNAi increases Vpr-dependent apoptosis
11676	155871	NP_057853.1	Tat	regulated by	9606	3303	NP_005336.2	heat shock 70kDa protein 1A	10617616	2007-11-07 17:28	Hsp70 and Hsp90 and Cdc37 regulate the stabilization and folding of CDK9 as well as the assembly of an active CDK9/cyclin T1 complex responsible for P-TEFb-mediated HIV-1 Tat transactivation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3303	NP_005336.2	heat shock 70kDa protein 1A	7906708	2007-11-07 17:29	The exposure of permissive CD4+ cells to HIV-1 gp120 increases the synthesis and nuclear translocation of 70kDa heat shock protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3303	NP_005336.2	heat shock 70kDa protein 1A	12832005	2007-11-07 17:30	Over expression of hsp70 with a herpes viral amplicon vector protects cultured hippocampal rat neurons from gp120 neurotoxicity
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3304	NP_005337.1	heat shock 70kDa protein 1B	11932435	2007-11-07 17:29	Hsp70 co-sediments with HIV-1 capsid protein in sucrose density gradients, providing evidence that it is specifically incorporated into HIV-1 virions through an interaction with HIV-1 Gag proteins
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3304	NP_005337.1	heat shock 70kDa protein 1B	11932435	2007-11-07 17:29	Hsp70 is incorporated into HIV-1 virions through an interaction with HIV-1 Gag
11676	155030	NP_579876.2	matrix	stimulated by	9606	3304	NP_005337.1	heat shock 70kDa protein 1B	10964507	2007-11-07 17:28	Hsp70 facilitates nuclear import of HIV-1 preintegration complexes by stimulating the binding of HIV-1 Matrix to karyopherin alpha
11676	155807	NP_057852.2	Vpr	competes with	9606	3304	NP_005337.1	heat shock 70kDa protein 1B	10964507	2007-11-07 17:28	HIV-1 Vpr competes with Hsp70 for binding to karyopherin alpha
11676	155871	NP_057853.1	Tat	regulated by	9606	3304	NP_005337.1	heat shock 70kDa protein 1B	10617616	2007-11-07 17:28	Hsp70 and Hsp90 and Cdc37 regulate the stabilization and folding of CDK9 as well as the assembly of an active CDK9/cyclin T1 complex responsible for P-TEFb-mediated HIV-1 Tat transactivation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3304	NP_005337.1	heat shock 70kDa protein 1B	7906708	2007-11-07 17:29	The exposure of permissive CD4+ cells to HIV-1 gp120 increases the synthesis and nuclear translocation of 70kDa heat shock protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3304	NP_005337.1	heat shock 70kDa protein 1B	12832005	2007-11-07 17:30	Over expression of hsp70 with a herpes viral amplicon vector protects cultured hippocampal rat neurons from gp120 neurotoxicity
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3306	NP_068814.2	heat shock-related 70 kDa protein 2	11932435	2007-11-07 17:29	Hsp70 co-sediments with HIV-1 capsid protein in sucrose density gradients, providing evidence that it is specifically incorporated into HIV-1 virions through an interaction with HIV-1 Gag proteins
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3306	NP_068814.2	heat shock-related 70 kDa protein 2	11932435	2007-11-07 17:29	Hsp70 is incorporated into HIV-1 virions through an interaction with HIV-1 Gag
11676	155030	NP_579876.2	matrix	stimulated by	9606	3306	NP_068814.2	heat shock-related 70 kDa protein 2	10964507	2007-11-07 17:28	Hsp70 facilitates nuclear import of HIV-1 preintegration complexes by stimulating the binding of HIV-1 Matrix to karyopherin alpha
11676	155807	NP_057852.2	Vpr	competes with	9606	3306	NP_068814.2	heat shock-related 70 kDa protein 2	10964507	2007-11-07 17:28	HIV-1 Vpr competes with Hsp70 for binding to karyopherin alpha
11676	155871	NP_057853.1	Tat	regulated by	9606	3306	NP_068814.2	heat shock-related 70 kDa protein 2	10617616	2007-11-07 17:28	Hsp70 and Hsp90 and Cdc37 regulate the stabilization and folding of CDK9 as well as the assembly of an active CDK9/cyclin T1 complex responsible for P-TEFb-mediated HIV-1 Tat transactivation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3306	NP_068814.2	heat shock-related 70 kDa protein 2	7906708	2007-11-07 17:29	The exposure of permissive CD4+ cells to HIV-1 gp120 increases the synthesis and nuclear translocation of 70kDa heat shock protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3306	NP_068814.2	heat shock-related 70 kDa protein 2	12832005	2007-11-07 17:30	Over expression of hsp70 with a herpes viral amplicon vector protects cultured hippocampal rat neurons from gp120 neurotoxicity
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3308	NP_002145.3	heat shock 70 kDa protein 4	11932435	2007-11-07 17:29	Hsp70 co-sediments with HIV-1 capsid protein in sucrose density gradients, providing evidence that it is specifically incorporated into HIV-1 virions through an interaction with HIV-1 Gag proteins
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3308	NP_002145.3	heat shock 70 kDa protein 4	11932435	2007-11-07 17:29	Hsp70 is incorporated into HIV-1 virions through an interaction with HIV-1 Gag
11676	155030	NP_579876.2	matrix	stimulated by	9606	3308	NP_002145.3	heat shock 70 kDa protein 4	10964507	2007-11-07 17:28	Hsp70 facilitates nuclear import of HIV-1 preintegration complexes by stimulating the binding of HIV-1 Matrix to karyopherin alpha
11676	155807	NP_057852.2	Vpr	competes with	9606	3308	NP_002145.3	heat shock 70 kDa protein 4	10964507	2007-11-07 17:28	HIV-1 Vpr competes with Hsp70 for binding to karyopherin alpha
11676	155871	NP_057853.1	Tat	regulated by	9606	3308	NP_002145.3	heat shock 70 kDa protein 4	10617616	2007-11-07 17:28	Hsp70 and Hsp90 and Cdc37 regulate the stabilization and folding of CDK9 as well as the assembly of an active CDK9/cyclin T1 complex responsible for P-TEFb-mediated HIV-1 Tat transactivation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3308	NP_002145.3	heat shock 70 kDa protein 4	7906708	2007-11-07 17:29	The exposure of permissive CD4+ cells to HIV-1 gp120 increases the synthesis and nuclear translocation of 70kDa heat shock protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3308	NP_002145.3	heat shock 70 kDa protein 4	12832005	2007-11-07 17:30	Over expression of hsp70 with a herpes viral amplicon vector protects cultured hippocampal rat neurons from gp120 neurotoxicity
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3309	NP_005338.1	78 kDa glucose-regulated protein	11932435	2007-11-07 17:29	Hsp70 co-sediments with HIV-1 capsid protein in sucrose density gradients, providing evidence that it is specifically incorporated into HIV-1 virions through an interaction with HIV-1 Gag proteins
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3309	NP_005338.1	78 kDa glucose-regulated protein	11932435	2007-11-07 17:29	Hsp70 is incorporated into HIV-1 virions through an interaction with HIV-1 Gag
11676	155030	NP_579876.2	matrix	stimulated by	9606	3309	NP_005338.1	78 kDa glucose-regulated protein	10964507	2007-11-07 17:28	Hsp70 facilitates nuclear import of HIV-1 preintegration complexes by stimulating the binding of HIV-1 Matrix to karyopherin alpha
11676	155807	NP_057852.2	Vpr	competes with	9606	3309	NP_005338.1	78 kDa glucose-regulated protein	10964507	2007-11-07 17:28	HIV-1 Vpr competes with Hsp70 for binding to karyopherin alpha
11676	155871	NP_057853.1	Tat	regulated by	9606	3309	NP_005338.1	78 kDa glucose-regulated protein	10617616	2007-11-07 17:28	Hsp70 and Hsp90 and Cdc37 regulate the stabilization and folding of CDK9 as well as the assembly of an active CDK9/cyclin T1 complex responsible for P-TEFb-mediated HIV-1 Tat transactivation
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3309	NP_005338.1	78 kDa glucose-regulated protein	1900540,10514465	2007-11-07 17:30	Newly synthesized HIV-1 gp160 interacts with GRP78-BiP in pulse-chase experiments; the interaction sites of gp160 with BiP include residues 115-132, 484-490, 602-616, 676-690, and 776-807
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3309	NP_005338.1	78 kDa glucose-regulated protein	7906708	2007-11-07 17:29	The exposure of permissive CD4+ cells to HIV-1 gp120 increases the synthesis and nuclear translocation of 70kDa heat shock protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3309	NP_005338.1	78 kDa glucose-regulated protein	12832005	2007-11-07 17:30	Over expression of hsp70 with a herpes viral amplicon vector protects cultured hippocampal rat neurons from gp120 neurotoxicity
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3310	NP_002146.2	heat shock 70 kDa protein 6	11932435	2007-11-07 17:29	Hsp70 co-sediments with HIV-1 capsid protein in sucrose density gradients, providing evidence that it is specifically incorporated into HIV-1 virions through an interaction with HIV-1 Gag proteins
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3310	NP_002146.2	heat shock 70 kDa protein 6	11932435	2007-11-07 17:29	Hsp70 is incorporated into HIV-1 virions through an interaction with HIV-1 Gag
11676	155030	NP_579876.2	matrix	stimulated by	9606	3310	NP_002146.2	heat shock 70 kDa protein 6	10964507	2007-11-07 17:28	Hsp70 facilitates nuclear import of HIV-1 preintegration complexes by stimulating the binding of HIV-1 Matrix to karyopherin alpha
11676	155807	NP_057852.2	Vpr	competes with	9606	3310	NP_002146.2	heat shock 70 kDa protein 6	10964507	2007-11-07 17:28	HIV-1 Vpr competes with Hsp70 for binding to karyopherin alpha
11676	155871	NP_057853.1	Tat	regulated by	9606	3310	NP_002146.2	heat shock 70 kDa protein 6	10617616	2007-11-07 17:28	Hsp70 and Hsp90 and Cdc37 regulate the stabilization and folding of CDK9 as well as the assembly of an active CDK9/cyclin T1 complex responsible for P-TEFb-mediated HIV-1 Tat transactivation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3310	NP_002146.2	heat shock 70 kDa protein 6	7906708	2007-11-07 17:29	The exposure of permissive CD4+ cells to HIV-1 gp120 increases the synthesis and nuclear translocation of 70kDa heat shock protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3310	NP_002146.2	heat shock 70 kDa protein 6	12832005	2007-11-07 17:30	Over expression of hsp70 with a herpes viral amplicon vector protects cultured hippocampal rat neurons from gp120 neurotoxicity
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3312	NP_006588.1	heat shock cognate 71 kDa protein isoform 1	11932435	2007-11-07 17:29	Hsc70 is specifically incorporated into HIV-1 virions, similar to Hsp70 which is incorporated into virions through an interaction with HIV-1 Gag
11676	155030	NP_579876.2	matrix	stimulated by	9606	3312	NP_006588.1	heat shock cognate 71 kDa protein isoform 1	10964507	2007-11-07 17:28	Hsp70 facilitates nuclear import of HIV-1 preintegration complexes by stimulating the binding of HIV-1 Matrix to karyopherin alpha
11676	155807	NP_057852.2	Vpr	competes with	9606	3312	NP_006588.1	heat shock cognate 71 kDa protein isoform 1	10964507	2007-11-07 17:28	HIV-1 Vpr competes with Hsp70 for binding to karyopherin alpha
11676	155871	NP_057853.1	Tat	regulated by	9606	3312	NP_006588.1	heat shock cognate 71 kDa protein isoform 1	10617616	2007-11-07 17:28	Hsp70 and Hsp90 and Cdc37 regulate the stabilization and folding of CDK9 as well as the assembly of an active CDK9/cyclin T1 complex responsible for P-TEFb-mediated HIV-1 Tat transactivation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3312	NP_006588.1	heat shock cognate 71 kDa protein isoform 1	7906708	2007-11-07 17:29	The exposure of permissive CD4+ cells to HIV-1 gp120 increases the synthesis and nuclear translocation of 70kDa heat shock protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3312	NP_006588.1	heat shock cognate 71 kDa protein isoform 1	12832005	2007-11-07 17:30	Over expression of hsp70 with a herpes viral amplicon vector protects cultured hippocampal rat neurons from gp120 neurotoxicity
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3313	NP_004125.3	stress-70 protein, mitochondrial precursor	11932435	2007-11-07 17:29	Hsp70 co-sediments with HIV-1 capsid protein in sucrose density gradients, providing evidence that it is specifically incorporated into HIV-1 virions through an interaction with HIV-1 Gag proteins
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3313	NP_004125.3	stress-70 protein, mitochondrial precursor	11932435	2007-11-07 17:29	Hsp70 is incorporated into HIV-1 virions through an interaction with HIV-1 Gag
11676	155030	NP_579876.2	matrix	stimulated by	9606	3313	NP_004125.3	stress-70 protein, mitochondrial precursor	10964507	2007-11-07 17:28	Hsp70 facilitates nuclear import of HIV-1 preintegration complexes by stimulating the binding of HIV-1 Matrix to karyopherin alpha
11676	155807	NP_057852.2	Vpr	competes with	9606	3313	NP_004125.3	stress-70 protein, mitochondrial precursor	10964507	2007-11-07 17:28	HIV-1 Vpr competes with Hsp70 for binding to karyopherin alpha
11676	155871	NP_057853.1	Tat	regulated by	9606	3313	NP_004125.3	stress-70 protein, mitochondrial precursor	10617616	2007-11-07 17:28	Hsp70 and Hsp90 and Cdc37 regulate the stabilization and folding of CDK9 as well as the assembly of an active CDK9/cyclin T1 complex responsible for P-TEFb-mediated HIV-1 Tat transactivation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3313	NP_004125.3	stress-70 protein, mitochondrial precursor	7906708	2007-11-07 17:29	The exposure of permissive CD4+ cells to HIV-1 gp120 increases the synthesis and nuclear translocation of 70kDa heat shock protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3313	NP_004125.3	stress-70 protein, mitochondrial precursor	12832005	2007-11-07 17:30	Over expression of hsp70 with a herpes viral amplicon vector protects cultured hippocampal rat neurons from gp120 neurotoxicity
11676	155871	NP_057853.1	Tat	regulated by	9606	3320	NP_005339.2	heat shock protein 90kDa alpha (cytosolic), class A member 1 isoform 2	10617616	2007-11-07 17:28	Hsp70 and Hsp90 and Cdc37 regulate the stabilization and folding of CDK9 as well as the assembly of an active CDK9/cyclin T1 complex responsible for P-TEFb-mediated HIV-1 Tat transactivation
11676	155871	NP_057853.1	Tat	requires	9606	3320	NP_005339.2	heat shock protein 90kDa alpha (cytosolic), class A member 1 isoform 2	15020715	2007-11-07 17:28	Hsp90 chaperone activity is required for HIV-1 Tat transport through the endosome membrane
11676	155871	NP_057853.1	Tat	upregulates	9606	3320	NP_005339.2	heat shock protein 90kDa alpha (cytosolic), class A member 1 isoform 2	15710247	2007-11-07 17:28	Upregulation of actin, heat shock protein 90 and mitochondrial single-stranded DNA binding protein, and downregulation of lactate dehydrogenase are identified in human astrocytes expressing Tat
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3329	NP_002147.2	60 kDa heat shock protein, mitochondrial	11932435	2007-11-07 17:29	Hsp60 is specifically incorporated into HIV-1 virions, similar to Hsp70 which is incorporated into virions through an interaction with HIV-1 Gag
11676	155348	NP_705928.1	integrase	stimulated by	9606	3329	NP_002147.2	60 kDa heat shock protein, mitochondrial	11689615,15875659,16075307	2007-11-07 17:29	HSP60 binds to the catalytic core domain (amino acids 48-212) of HIV-1 integrase (IN), stabilizing the IN active form and reducing thermal denaturation of the enzyme, thereby stimulating IN activity
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	3329	NP_002147.2	60 kDa heat shock protein, mitochondrial	10499815	2007-11-07 17:31	HIV-1 gp41 binds to heat-shock protein hsp60 through its extracellular domain (Env amino acids 539-684)
11676	155348	NP_705928.1	integrase	interacts with	9606	3336	NP_002148.1	10 kDa heat shock protein, mitochondrial	11689615	2007-11-07 17:29	HSP10 interacts with HIV-1 integrase, which is a substrate for the hHSP60-HSP10 complex
11676	156110	NP_057857.2	Nef	interacts with	9606	3337	NP_006136.1	dnaJ homolog subfamily B member 1	16179353	2007-11-07 17:29	HIV-1 Nef interacts with Hsp40, leading to increased Hsp40 translocation to the nucleus of infected cells and facilitation of viral gene expression by complex formation of Hsp40 with the cdk9-associated transcription complex
11676	156110	NP_057857.2	Nef	Upregulates	9606	3337	NP_006136.1	dnaJ homolog subfamily B member 1	16179353	2007-11-07 17:28	HIV-1 Subtype C Nef upregulates the expression of Hsp40 in HIV-1 infected CEM cells and enhances the increased translocation of Hsp40 into the nucleus
11676	156110	NP_057857.2	Nef	Interacts with	9606	3337	NP_006136.1	dnaJ homolog subfamily B member 1	16179353	2007-11-07 17:28	HIV-1 subtype C Nef interacts with Hsp40 in immunoprecipitation and immunofluorescence staining experiments
11676	155871	NP_057853.1	Tat	interacts with	9606	3339	NP_005520.3	heparan sulfate proteoglycan 2	15567441	2007-11-07 17:28	Perlecan mediates Tat uptake and is required for HIV-1 LTR-directed transactivation in the human colon carcinoma cell line, WiDr.
11676	155030	NP_579876.2	matrix	co-localizes with	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	7794538	2007-11-07 17:28	ICAM-1 co-localizes with HIV-1 Matrix at sites of cell-to-cell membrane contact and is incorporated into virus particles
11676	155871	NP_057853.1	Tat	interacts with	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	8568270	2007-11-07 17:30	Treatment of monocytes with HIV-1 Tat increases their adhesion to endothelial monolayers, an effect that is inhibited by anti-ICAM-1 Abs, suggesting an interaction between Tat and ICAM-1
11676	155871	NP_057853.1	Tat	upregulates	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	9269771,9792375,10477700,10602408,14550782	2007-11-07 17:30	HIV-1 Tat upregulates the expression of ICAM-1 in endothelial cells and astrocytes, an effect that is in part regulated by NF-kappa B and may be associated with AIDS-related Kaposi's sarcoma
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	7917519,17083721	2007-11-07 17:31	ICAM-1 promotes HIV-1 gp160-mediated syncytium formation, and the ICAM-1 contrareceptor LFA-1 attenuates the syncytium-inhibiting activity of virus-neutralizing monoclonal antibodies and soluble CD4
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	8450224	2007-11-07 17:30	Antibodies against cell surface molecules LFA-1, ICAM-1, HLA-DR, and CD28 inhibit the HIV-1 gp160-induced B cell differentiation response; gp160 also induces IL-6R and CD23 molecule expression on B cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	7904170	2007-11-07 17:29	Cells treated with monoclonal antibodies to ICAM-1 and LFA-1 adhesion molecules show an impaired release of IFN after HIV-1 gp120 stimulation, suggesting a crucial role of cell-to-cell interactions in the process leading to IFN production
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	8558011,11896203,12775419,14581566,14691297	2007-11-07 17:30	HIV-1 gp120 enhances the expression of ICAM-1 in primary human astrocytes, glioma, and endothelial cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	8558011	2007-11-07 17:31	HIV-1 gp120-mediated ICAM-1 expression has functional significance, as it enhances the ability of monocytic cells to bind to gp120-stimulated human astrocytes in an ICAM-1/beta 2 integrin-dependent fashion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	incorporates	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	9865497,15208262	2007-11-07 17:31	Treatment of cells with IFN reduces HIV-1 gp120 incorporation, as well as HIV-1 envelope-mediated incorporation of ICAM-1, into virions resulting in viruses that exhibit a significantly decreased ability to become bound to CD4+ target cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	11517385,14581566,14691297	2007-11-07 17:31	HIV-1 gp120 activates human brain microvascular endothelial cells (HBMEC) via CD4 in upregulating ICAM-1 and VCAM-1 expression, IL-6 secretion and increased monocyte transmigration across monolayers
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	15183063	2007-11-07 17:30	Infectivity of an HIV-1 Matrix mutant that carries a suboptimal amount of HIV-1 gp120/41 is restored to a certain degree by the presence of ICAM-1 when infection is performed in cells expressing an activated form of its natural counter-ligand, LFA-1
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	7913356,17083721	2007-11-07 17:30	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	156110	NP_057857.2	Nef	interacts with	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	8086129	2007-11-07 17:27	Monoclonal antibodies to the cell surface molecule intracellular adhesion molecule (ICAM)-1 inhibit the Nef-induced B-cell differentiation response, suggesting an interaction between Nef and ICAM-1
11676	156110	NP_057857.2	Nef	Induces release of	9606	3383	NP_000192.1	intercellular adhesion molecule 1 precursor	12853962,16272310	2007-11-07 17:28	Expression of HIV-1 Nef in macrophages induces the release of sICAM, which upregulates the expression of co-stimulatory receptors on B lymphocytes
11676	155871	NP_057853.1	Tat	upregulates	9606	3397	NP_002156.2	DNA-binding protein inhibitor ID-1 isoform a	15361847	2007-11-07 17:28	HIV-1 Tat upregulates nerve growth factor (NGF)-induced ID1 expression in PC12 neuronal cells through a pathway that involves phosphorylation of Stat5a
11676	155871	NP_057853.1	Tat	upregulates	9606	3428	NP_005522.2	gamma-interferon-inducible protein 16	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including IFI16, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	3429	NP_005523.3	interferon alpha-inducible protein 27 isoform 2	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including IFI27, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	3430	NP_005524.1	interferon-induced 35 kDa protein	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including IFI35, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	3431	NP_004500.2	SP110 nuclear body protein isoform a	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including IFI41, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	3437	NP_001540.2	interferon-induced protein with tetratricopeptide repeats 3	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including IFIT4, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155030	NP_057850.1	Pr55(Gag)	inhibited by	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	2014240,9181467	2007-11-07 17:29	Interferon alpha inhibits the release of HIV-1 Gag/capsid proteins from infected cells by inducing changes in posttranslational modifications of Gag proteins
11676	155348	NP_705927.1	reverse transcriptase	inhibited by	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	8438572	2007-11-07 17:29	IFN-alpha interferes with the initiation of HIV-1 reverse transcription resulting in a significant reduction in the relative levels of HIV-1 proviral DNA
11676	155459	NP_057851.1	Vif	inhibited by	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	16418394	2007-11-07 17:29	IFN-alpha enhances APOBEC3G expression and inhibits suppression of APOBEC3G by HIV-1 Vif
11676	155871	NP_057853.1	Tat	interacts with	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	1708818	2007-11-07 17:29	HIV-1 Tat enhances translation of the interferon-inducible enzymes 2-5A synthetase and dsRNA-dependent protein kinase, suggesting interaction of Tat with interferons during HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	7532202	2007-11-07 17:29	IFN treatment significantly reduces HIV-1 mRNA levels from a Tat defective provirus, suggesting Tat can overcome the inhibitory effects of IFN on HIV-1 replication
11676	155871	NP_057853.1	Tat	upregulates	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	9520456,16375755	2007-11-07 17:29	HIV-1 Tat upregulates IFN-alpha secretion by macrophages, an effect that augments MIP-1alpha and MIP-1beta secretion and induces immunosuppression of uninfected T cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulated by	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	9343822	2007-11-07 17:31	IFN-alpha treated effector clones (gp120+CD8+ HPB-ALL/HIV) simultaneously downregulate CD8 expression and upregulate expression of both major histocompatibility antigen complex class I (MHC-I) and HIV-1 gp120/gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	1381203,7526537,7904170,8345204,15481145,16278001,17180012	2007-11-07 17:30	Interaction of HIV-1 gp120 with cell-associated CD4 leads to the induction of IFN alpha; preincubation of cells with anti-CD4 or the presence of soluble CD4 during incubation inhibits IFN alpha induction
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	1905933,7583919,17180012	2007-11-07 17:30	HIV-1 gp41 or gp120 synthetic peptides induce the production of interleukin (IL)-1 and tumor necrosis factor (TNF); in contrast, gp41 or gp120 synthetic peptides are able to depress the production of interferon (IFN)-alpha, IFN-gamma, and IL-2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	enhanced by	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	2552026	2007-11-07 17:29	HIV-1 gp120-specific cell mediated cytotoxicity (CMC) is enhanced by IL-2 or the combination of IL-2 and IFN-alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	7511078,7815507,8764000,9108403,9225992,9658081,12089333,15481145,16160188	2007-11-07 17:27	Cytokines induced in vitro by HIV-1 gp120 in normal peripheral blood mononuclear cells (PBMC) include interferon-alpha (IFN-alpha) and IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-10, IL-1 alpha and IL-1 beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	8661419	2007-11-07 17:30	Sulfate containing galactolipids such as sulfatides on responder cells may be part of the HIV-1 gp120-membrane complex that initiates the induction of interferon (IFN)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	9865497	2007-11-07 17:31	Treatment of cells with IFN reduces HIV-1 gp120 incorporation, as well as HIV-1 envelope-mediated incorporation of ICAM-1, into virions resulting in viruses that exhibit a significantly decreased ability to become bound to CD4+ target cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3439	NP_076918.1	interferon alpha-1/13 precursor	7913356	2007-11-07 17:30	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155348	NP_705927.1	reverse transcriptase	inhibited by	9606	3440	NP_000596.2	interferon alpha-2 precursor	8438572	2007-11-07 17:29	IFN-alpha interferes with the initiation of HIV-1 reverse transcription resulting in a significant reduction in the relative levels of HIV-1 proviral DNA
11676	155459	NP_057851.1	Vif	inhibited by	9606	3440	NP_000596.2	interferon alpha-2 precursor	16418394	2007-11-07 17:29	IFN-alpha enhances APOBEC3G expression and inhibits suppression of APOBEC3G by HIV-1 Vif
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulated by	9606	3440	NP_000596.2	interferon alpha-2 precursor	9343822	2007-11-07 17:31	IFN-alpha treated effector clones (gp120+CD8+ HPB-ALL/HIV) simultaneously downregulate CD8 expression and upregulate expression of both major histocompatibility antigen complex class I (MHC-I) and HIV-1 gp120/gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3440	NP_000596.2	interferon alpha-2 precursor	1381203,7526537,7904170,8345204,15481145,16278001,17180012	2007-11-07 17:30	Interaction of HIV-1 gp120 with cell-associated CD4 leads to the induction of IFN alpha; preincubation of cells with anti-CD4 or the presence of soluble CD4 during incubation inhibits IFN alpha induction
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3440	NP_000596.2	interferon alpha-2 precursor	1905933,7583919	2007-11-07 17:30	HIV-1 gp41 or gp120 synthetic peptides induce the production of interleukin (IL)-1 and tumor necrosis factor (TNF); in contrast, gp41 or gp120 synthetic peptides are able to depress the production of interferon (IFN)-alpha, IFN-gamma, and IL-2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	enhanced by	9606	3440	NP_000596.2	interferon alpha-2 precursor	2552026	2007-11-07 17:29	HIV-1 gp120-specific cell mediated cytotoxicity (CMC) is enhanced by IL-2 or the combination of IL-2 and IFN-alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3440	NP_000596.2	interferon alpha-2 precursor	7511078,7815507,8764000,9108403,9225992,9658081,12089333,15481145,16160188	2007-11-07 17:27	Cytokines induced in vitro by HIV-1 gp120 in normal peripheral blood mononuclear cells (PBMC) include interferon-alpha (IFN-alpha) and IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-10, IL-1 alpha and IL-1 beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3440	NP_000596.2	interferon alpha-2 precursor	8661419	2007-11-07 17:27	Sulfate containing galactolipids such as sulfatides on responder cells may be part of the HIV-1 gp120-membrane complex that initiates the induction of interferon (IFN)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3440	NP_000596.2	interferon alpha-2 precursor	9865497	2007-11-07 17:31	Treatment of cells with IFN reduces HIV-1 gp120 incorporation, as well as HIV-1 envelope-mediated incorporation of ICAM-1, into virions resulting in viruses that exhibit a significantly decreased ability to become bound to CD4+ target cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3440	NP_000596.2	interferon alpha-2 precursor	7913356	2007-11-07 17:30	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155348	NP_705927.1	reverse transcriptase	inhibited by	9606	3444	NP_066401.2	interferon alpha-7 precursor	8438572	2007-11-07 17:29	IFN-alpha interferes with the initiation of HIV-1 reverse transcription resulting in a significant reduction in the relative levels of HIV-1 proviral DNA
11676	155459	NP_057851.1	Vif	inhibited by	9606	3444	NP_066401.2	interferon alpha-7 precursor	16418394	2007-11-07 17:29	IFN-alpha enhances APOBEC3G expression and inhibits suppression of APOBEC3G by HIV-1 Vif
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulated by	9606	3444	NP_066401.2	interferon alpha-7 precursor	9343822	2007-11-07 17:31	IFN-alpha treated effector clones (gp120+CD8+ HPB-ALL/HIV) simultaneously downregulate CD8 expression and upregulate expression of both major histocompatibility antigen complex class I (MHC-I) and HIV-1 gp120/gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3444	NP_066401.2	interferon alpha-7 precursor	1381203,7526537,7904170,8345204,15481145,16278001,17180012	2007-11-07 17:30	Interaction of HIV-1 gp120 with cell-associated CD4 leads to the induction of IFN alpha; preincubation of cells with anti-CD4 or the presence of soluble CD4 during incubation inhibits IFN alpha induction
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3444	NP_066401.2	interferon alpha-7 precursor	1905933,7583919	2007-11-07 17:30	HIV-1 gp41 or gp120 synthetic peptides induce the production of interleukin (IL)-1 and tumor necrosis factor (TNF); in contrast, gp41 or gp120 synthetic peptides are able to depress the production of interferon (IFN)-alpha, IFN-gamma, and IL-2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	enhanced by	9606	3444	NP_066401.2	interferon alpha-7 precursor	2552026	2007-11-07 17:29	HIV-1 gp120-specific cell mediated cytotoxicity (CMC) is enhanced by IL-2 or the combination of IL-2 and IFN-alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3444	NP_066401.2	interferon alpha-7 precursor	7511078,7815507,8764000,9108403,9225992,9658081,12089333,15481145,16160188	2007-11-07 17:27	Cytokines induced in vitro by HIV-1 gp120 in normal peripheral blood mononuclear cells (PBMC) include interferon-alpha (IFN-alpha) and IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-10, IL-1 alpha and IL-1 beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3444	NP_066401.2	interferon alpha-7 precursor	8661419	2007-11-07 17:30	Sulfate containing galactolipids such as sulfatides on responder cells may be part of the HIV-1 gp120-membrane complex that initiates the induction of interferon (IFN)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3444	NP_066401.2	interferon alpha-7 precursor	9865497	2007-11-07 17:31	Treatment of cells with IFN reduces HIV-1 gp120 incorporation, as well as HIV-1 envelope-mediated incorporation of ICAM-1, into virions resulting in viruses that exhibit a significantly decreased ability to become bound to CD4+ target cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3444	NP_066401.2	interferon alpha-7 precursor	7913356	2007-11-07 17:30	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155348	NP_705927.1	reverse transcriptase	inhibited by	9606	3449	NP_002164.1	interferon alpha-16 precursor	8438572	2007-11-07 17:29	IFN-alpha interferes with the initiation of HIV-1 reverse transcription resulting in a significant reduction in the relative levels of HIV-1 proviral DNA
11676	155459	NP_057851.1	Vif	inhibited by	9606	3449	NP_002164.1	interferon alpha-16 precursor	16418394	2007-11-07 17:29	IFN-alpha enhances APOBEC3G expression and inhibits suppression of APOBEC3G by HIV-1 Vif
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulated by	9606	3449	NP_002164.1	interferon alpha-16 precursor	9343822	2007-11-07 17:31	IFN-alpha treated effector clones (gp120+CD8+ HPB-ALL/HIV) simultaneously downregulate CD8 expression and upregulate expression of both major histocompatibility antigen complex class I (MHC-I) and HIV-1 gp120/gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3449	NP_002164.1	interferon alpha-16 precursor	1381203,7526537,7904170,8345204,15481145,16278001,17180012	2007-11-07 17:30	Interaction of HIV-1 gp120 with cell-associated CD4 leads to the induction of IFN alpha; preincubation of cells with anti-CD4 or the presence of soluble CD4 during incubation inhibits IFN alpha induction
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3449	NP_002164.1	interferon alpha-16 precursor	1905933,7583919	2007-11-07 17:30	HIV-1 gp41 or gp120 synthetic peptides induce the production of interleukin (IL)-1 and tumor necrosis factor (TNF); in contrast, gp41 or gp120 synthetic peptides are able to depress the production of interferon (IFN)-alpha, IFN-gamma, and IL-2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	enhanced by	9606	3449	NP_002164.1	interferon alpha-16 precursor	2552026	2007-11-07 17:29	HIV-1 gp120-specific cell mediated cytotoxicity (CMC) is enhanced by IL-2 or the combination of IL-2 and IFN-alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3449	NP_002164.1	interferon alpha-16 precursor	7511078,7815507,8764000,9108403,9225992,9658081,12089333,15481145,16160188	2007-11-07 17:27	Cytokines induced in vitro by HIV-1 gp120 in normal peripheral blood mononuclear cells (PBMC) include interferon-alpha (IFN-alpha) and IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-10, IL-1 alpha and IL-1 beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3449	NP_002164.1	interferon alpha-16 precursor	8661419	2007-11-07 17:30	Sulfate containing galactolipids such as sulfatides on responder cells may be part of the HIV-1 gp120-membrane complex that initiates the induction of interferon (IFN)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3449	NP_002164.1	interferon alpha-16 precursor	9865497	2007-11-07 17:31	Treatment of cells with IFN reduces HIV-1 gp120 incorporation, as well as HIV-1 envelope-mediated incorporation of ICAM-1, into virions resulting in viruses that exhibit a significantly decreased ability to become bound to CD4+ target cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3449	NP_002164.1	interferon alpha-16 precursor	7913356	2007-11-07 17:30	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3454	NP_000620.2	interferon alpha/beta receptor 1 precursor	9225992	2007-11-07 17:27	Seven-day cultured macrophages treated with HIV-1 gp120 exhibit higher levels of type I IFN receptors than that of 1-day cultured monocytes
11676	155871	NP_057853.1	Tat	interacts with	9606	3456	NP_002167.1	interferon beta precursor	1708818	2007-11-07 17:29	HIV-1 Tat enhances translation of the interferon-inducible enzymes 2-5A synthetase and dsRNA-dependent protein kinase, suggesting interaction of Tat with interferons during HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	3456	NP_002167.1	interferon beta precursor	7532202,16375755	2007-11-07 17:29	IFN treatment significantly reduces HIV-1 mRNA levels from a Tat defective provirus, suggesting Tat can overcome the inhibitory effects of IFN on HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibited by	9606	3456	NP_002167.1	interferon beta precursor	9713311	2007-11-07 17:29	IFN beta is an effective inhibitor of HIV-1 Tat-stimulated growth, migration and morphogenesis of an endothelial cell line in vitro and of angiogenesis in vivo
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3456	NP_002167.1	interferon beta precursor	8083608,8107259,9225992,15481145	2007-11-07 17:27	HIV-1 (possibly through the HIV-1 gp120 protein) induces low levels of IFN-beta in macrophages, and the IFN-beta plays an effective role in restriction of virus replication
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3456	NP_002167.1	interferon beta precursor	8661419	2007-11-07 17:30	Sulfate containing galactolipids such as sulfatides on responder cells may be part of the HIV-1 gp120-membrane complex that initiates the induction of interferon (IFN)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulates	9606	3456	NP_002167.1	interferon beta precursor	12089333	2007-11-07 17:31	HIV-1 gp120 modulates expression of the cytokines IL1beta, IL3, IL6, IL10, IL13, IL15, IFNbeta2A, IFNgamma, IFNomega, TNFalpha, VEGF, VEGF B, and LIF in PBMCs and MDMs
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3456	NP_002167.1	interferon beta precursor	7913356	2007-11-07 17:30	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibited by	9606	3456	NP_002167.1	interferon beta precursor	10482360,10963806	2007-11-07 17:31	IFN-beta inhibits the binding of soluble gp41 to T, B and monocyte cell lines
11676	156110	NP_057857.2	Nef	upregulates	9606	3456	NP_002167.1	interferon beta precursor	17182689	2007-11-07 17:31	HIV-1 Nef myristoylation is required for the activation of IRF-3, leading to the synthesis of IFNbeta in monocytes-derived-macrophages
11676	155030	NP_579876.2	matrix	binds	9606	3458	NP_000610.2	interferon gamma precursor	2514776,8065455,8619916,8679287	2007-11-07 17:28	HIV-1 Matrix and interferon gamma are structurally similar and have been found to bind in vitro
11676	155030	NP_579876.2	matrix	upregulates	9606	3458	NP_000610.2	interferon gamma precursor	12105273,12542496,16427155	2007-11-07 17:28	HIV-1 Matrix enhances the cytokine-induced production of interferon gamma
11676	155030	NP_579880.1	capsid	inhibits	9606	3458	NP_000610.2	interferon gamma precursor	1905983	2007-11-07 17:29	HIV-1 Capsid (p24) inhibits interferon gamma induced increases in HLA-DR and cytochrome B heavy chain mRNA levels in the human monocyte-like cell line THP1
11676	155030	NP_579880.1	capsid	inhibited by	9606	3458	NP_000610.2	interferon gamma precursor	8809126,9743208	2007-11-07 17:29	Interferon-gamma can counteract the inhibitory effect of HIV-1 Capsid based peptides on antibody response to Sheep Red Cell Antigen
11676	155348	NP_705927.1	reverse transcriptase	degraded by	9606	3458	NP_000610.2	interferon gamma precursor	10358150	2007-11-07 17:29	Up-regulation of LMP7 by IFN-gamma enhances proteasomal degradation of HIV-1 RT and presentation of the VIYQYMDDL epitope derived from HIV-1 RT
11676	155807	NP_057852.2	Vpr	upregulates	9606	3458	NP_000610.2	interferon gamma precursor	10775602	2007-11-07 17:27	Expression of HIV-1 Vpr in U937 cells upregulates gamma interferon expression
11676	155807	NP_057852.2	Vpr	downregulates	9606	3458	NP_000610.2	interferon gamma precursor	17023015	2007-11-07 17:31	HIV-1 Vpr inhibits interferon gamma secretion in infected T cells
11676	155871	NP_057853.1	Tat	inhibited by	9606	3458	NP_000610.2	interferon gamma precursor	1400376	2007-11-07 17:29	IFN-gamma inhibits the transactivation of the HIV-1 LTR promoter by HIV-1 Tat
11676	155871	NP_057853.1	Tat	interacts with	9606	3458	NP_000610.2	interferon gamma precursor	1708818	2007-11-07 17:29	HIV-1 Tat enhances translation of the interferon-inducible enzymes 2-5A synthetase and dsRNA-dependent protein kinase, suggesting interaction of Tat with interferons during HIV-1 replication
11676	155871	NP_057853.1	Tat	upregulates	9606	3458	NP_000610.2	interferon gamma precursor	7818827	2007-11-07 17:29	HIV-1 Tat upregulates IFN-gamma expression by uninfected mononuclear cells
11676	155871	NP_057853.1	Tat	inhibits	9606	3458	NP_000610.2	interferon gamma precursor	8760410	2007-11-07 17:29	HIV-1 Tat inhibits IFN-gamma induced iNOS activity in a murine macrophage cell line
11676	155871	NP_057853.1	Tat	interacts with	9606	3458	NP_000610.2	interferon gamma precursor	9916748	2007-11-07 17:29	IFN-gamma interacts with HIV-1 Tat to induce endothelial cells to proliferate and invade the extracellular matrix by upregulating the receptors for Tat (integrins alpha-5-beta-1 and alpha-v-beta-3), suggesting Tat and IFN-gamma play major roles in AIDS-KS
11676	155871	NP_057853.1	Tat	synergizes with	9606	3458	NP_000610.2	interferon gamma precursor	10438928,16375755	2007-11-07 17:29	IL-1beta, TNF-alpha, and IFN-gamma synergize with HIV-1 Tat to promote in nude mice the development of angioproliferative Kaposi's sarcoma-like lesions
11676	155871	NP_057853.1	Tat	synergizes with	9606	3458	NP_000610.2	interferon gamma precursor	10446807	2007-11-07 17:27	HIV-1 Tat synergizes with IFN-gamma to induce iNOS activity in purified rat microglial cultures
11676	155871	NP_057853.1	Tat	downregulates	9606	3458	NP_000610.2	interferon gamma precursor	11751951	2007-11-07 17:29	HIV-1 Tat inhibits IFN-gamma release by NK cells upon contact with dendritic cells
11676	155871	NP_057853.1	Tat	interacts with	9606	3458	NP_000610.2	interferon gamma precursor	14602571	2007-11-07 17:29	HIV-1 Tat interacts with IFN-gamma, which upregulates the Tat receptor VEGFR2/KDR, to produce cytotoxicity in human brain microvascular endothelial cells
11676	155871	NP_057853.1	Tat	induces release of	9606	3458	NP_000610.2	interferon gamma precursor	15737643,16375755	2007-11-07 17:29	HIV-1 Tat acts as a co-stimulatory molecule that affects viral replication by modulating host immune response through induction of T-bet expression and IFN-gamma secretion
11676	155871	NP_057853.1	Tat	induces release of	9606	3458	NP_000610.2	interferon gamma precursor	16014948	2007-11-07 17:28	HIV-1 Tat delivered by CyaA from Bordetella pertussis induces a Th1-polarized immune response and HIV-Tat-specific gamma interferon-producing CD8(+) T cells are generated after vaccination with CyaA-E5-Tat in a CD4(+) T-cell-independent manner
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	downregulates	9606	3458	NP_000610.2	interferon gamma precursor	7523014,9712080	2007-11-07 17:27	Pretreatment of CD4+ cells with HIV-1 gp160 significantly reduces PHA-induced secretion of IFN-gamma and IL-2 but augments IL-4 production
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3458	NP_000610.2	interferon gamma precursor	1905933,7583919,9534962	2007-11-07 17:30	HIV-1 gp41 or gp120 synthetic peptides induce the production of interleukin (IL)-1 and tumor necrosis factor (TNF); in contrast, gp41 or gp120 synthetic peptides are able to depress the production of interferon (IFN)-alpha, IFN-gamma, and IL-2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3458	NP_000610.2	interferon gamma precursor	7511078,7815507,8764000,9108403,9225992,9658081,12089333,15481145,16160188	2007-11-07 17:31	Cytokines induced in vitro by HIV-1 gp120 in normal peripheral blood mononuclear cells (PBMC) include interferon-alpha (IFN-alpha) and IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-10, IL-1 alpha and IL-1 beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	3458	NP_000610.2	interferon gamma precursor	7511078,7526537,7904170,8345204,8537091,12089333,15936090,17180012	2007-11-07 17:29	Treatment of cells with HIV-1 gp120 induces the release of IFN gamma
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3458	NP_000610.2	interferon gamma precursor	7941321	2007-11-07 17:27	Treatment of human colonic epithelial cells with recombinant gamma-interferon (rlFN gamma) induces a dose-dependent inhibition of Galactosyl ceramide (GalCer) expression on the cell surface; GalCer is a receptor for HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3458	NP_000610.2	interferon gamma precursor	8188658	2007-11-07 17:27	IFN-gamma and gp120-induced activation of Na+/H+ exchange appears to be mediated through activation of tyrosine kinase (TK), because TK inhibitors block the action of IFN-gamma and gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3458	NP_000610.2	interferon gamma precursor	8648753	2007-11-07 17:30	Secretion of IL-12 is found in macrophages primed with gamma interferon (IFN-gamma) and subsequently treated with gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3458	NP_000610.2	interferon gamma precursor	8661419	2007-11-07 17:30	Sulfate containing galactolipids such as sulfatides on responder cells may be part of the HIV-1 gp120-membrane complex that initiates the induction of interferon (IFN)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3458	NP_000610.2	interferon gamma precursor	8706326	2007-11-07 17:30	In the presence of HIV-1 gp120, stimulation through the CD28 pathway partially restores IL-2 and IFN-gamma production by T cell lines in response to anti-CD3 antibodies
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3458	NP_000610.2	interferon gamma precursor	8706326	2007-11-07 17:30	Secretion of IL-2 and IFN-gamma stimulated with anti-CD3 antibodies is inhibited by HIV-1 gp120 in T cell lines
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3458	NP_000610.2	interferon gamma precursor	10933622,15936090	2007-11-07 17:30	HIV-1 gp120 inhibits natural killer (NK) cell natural cytotoxicity and this inhibition also affects the production of the proinflammatory cytokine interferon-gamma (IFN-gamma); the inhibitory activity of gp120 can be prevented by coincubation with VIP
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3458	NP_000610.2	interferon gamma precursor	12975380,15320903,15936090	2007-11-07 17:31	Induction of the receptor activator of cytokine nuclear factor kappa B ligand (RANKL) is mediated by HIV-1 gp120; the gp120-mediated induction of RANKL is blocked by interferon-gamma
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3458	NP_000610.2	interferon gamma precursor	2452186	2007-11-07 17:30	IFN-gamma production in mononuclear leukocytes from an HIV-1-seropositive man is induced by different concentrations of a recombinant HIV-1 envelope glycoprotein gp41 and gp120 fragment
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	3458	NP_000610.2	interferon gamma precursor	8247028	2007-11-07 17:31	PWM, LPS, IFN-gamma and IL-6 can increase HIV-1 gp41 binding to human B cells
11676	156110	NP_057857.2	Nef	upregulates	9606	3458	NP_000610.2	interferon gamma precursor	8102828,8769094	2007-11-07 17:27	HIV-1 Nef has superantigen properties in that it binds to MHC class II antigens and activates T cells, causing T cell proliferation and production of the T helper 1 cytokines IL-2 and IFN-gamma
11676	156110	NP_057857.2	Nef	downregulates	9606	3458	NP_000610.2	interferon gamma precursor	8598486,8765022,15638726	2007-11-07 17:27	Upon T cell activation, HIV-1 Nef expression downregulates both IL-2 and IFN-gamma production in a dose-dependent manner
11676	156110	NP_057857.2	Nef	upregulates	9606	3458	NP_000610.2	interferon gamma precursor	10388525	2007-11-07 17:27	PBMC proliferation induced by exogenous HIV-1 Nef is associated with upregulation of interferon-gamma (IFN-gamma)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3460	NP_005525.2	interferon gamma receptor 2 precursor	15103018	2007-11-07 17:30	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulates	9606	3467	NP_002168.1	interferon omega-1 precursor	12089333	2007-11-07 17:31	HIV-1 gp120 modulates expression of the cytokines IL1beta, IL3, IL6, IL10, IL13, IL15, IFNbeta2A, IFNgamma, IFNomega, TNFalpha, VEGF, VEGF B, and LIF in PBMCs and MDMs
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3467	NP_002168.1	interferon omega-1 precursor	7913356	2007-11-07 17:30	HIV-1 gp41 selectively enhances MHC class I, ICAM-1, IFN-alpha, IFN-beta, and IFN-omega expression in H9 cells
11676	155871	NP_057853.1	Tat	inhibited by	9606	3479	NP_000609.1	insulin-like growth factor 1 isoform 4 preproprotein	10381171	2007-11-07 17:29	Insulin-like growth factor 1 (IGF-1) inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	upregulates	9606	3479	NP_000609.1	insulin-like growth factor 1 isoform 4 preproprotein	11994280	2007-11-07 17:28	HIV-1 Tat upregulates several anti-apoptotic genes, including AKT-1, AKT-2, BCL2, BCL-XL, and insulin-like growth factor I in vincristine-treated Kaposi's sarcoma cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3479	NP_000609.1	insulin-like growth factor 1 isoform 4 preproprotein	12787886	2007-11-07 17:30	The fusion of insulin-like growth factor I (IGF I) with stromal cell-derived factor I or alpha1 proteinase inhibitor has the capacity to compete with the binding of HIV-1 gp120 to CD4 receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3480	NP_000866.1	insulin-like growth factor 1 receptor precursor	15103018	2007-11-07 17:31	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155871	NP_057853.1	Tat	binds	9606	3487	NP_001543.2	insulin-like growth factor-binding protein 4 precursor	7778269	2007-11-07 17:30	Using a yeast two-hybrid system, HIV-1 Tat has been shown to bind the human insulin-like growth factor binding protein 4, suggesting a role for this protein in mediating the biological activity of Tat during HIV-1 replication
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	3551	NP_001547.1	inhibitor of nuclear factor kappa-B kinase subunit beta	11959143	2007-11-07 17:31	HIV-1 gp120/CD4 interaction-induced NF-kappaB activation stimulates the hyperphosphorylation of IkappaB-alpha by IkappaB kinases (IKKs)
11676	156110	NP_057857.2	Nef	induces phosphorylation of	9606	3551	NP_001547.1	inhibitor of nuclear factor kappa-B kinase subunit beta	17182689	2007-11-07 17:31	HIV-1 Nef myristoylation is required for the rapid and transient phosphorylation of the alpha- and beta- subunits of the Ikappa-B kinase complex and activation of JNK, ERK1/2 and p38 MAPK family members
11676	155871	NP_057853.1	Tat	upregulates	9606	3552	NP_000566.3	interleukin-1 alpha proprotein	7494249,7526541,7695626,7818827,16375755	2007-11-07 17:29	HIV-1 Tat upregulates IL-1beta expression in a variety of cell types, including primary blood mononuclear cells (PBMCs), Jurkat and microglia
11676	155871	NP_057853.1	Tat	downregulates	9606	3552	NP_000566.3	interleukin-1 alpha proprotein	7695626	2007-11-07 17:29	HIV-1 Tat downregulates IL-1alpha expression in Raji cells
11676	155871	NP_057853.1	Tat	downregulates	9606	3552	NP_000566.3	interleukin-1 alpha proprotein	16792821	2007-11-07 17:31	IL-1 stimulated NO production and iNOS mRNA expression are down-regulated by pretreatment with HIV-1 Tat-SOD fusion proteins in cultured chondrocytes
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulates	9606	3552	NP_000566.3	interleukin-1 alpha proprotein	1993354,7706435,8892361,8938574	2007-11-07 17:31	IL-1 and TNF-alpha production are induced by the treatment of cells with HIV-1 gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3552	NP_000566.3	interleukin-1 alpha proprotein	2536171,8764000,9185130,15481145,16934308	2007-11-07 17:29	HIV-1 gp120 increases the levels of prostaglandin E2 (PGE2) and IL-1 in human cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3552	NP_000566.3	interleukin-1 alpha proprotein	7511078,7815507,8764000,9108403,9225992,9658081,12089333,15481145,16160188	2007-11-07 17:31	Cytokines induced in vitro by HIV-1 gp120 in normal peripheral blood mononuclear cells (PBMC) include interferon-alpha (IFN-alpha) and IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-10, IL-1 alpha and IL-1 beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3552	NP_000566.3	interleukin-1 alpha proprotein	8458986	2007-11-07 17:29	Addition of HIV-1 gp120 to IL-1 treated human granulocytes or monocytes results in a slower movement that is chemokinetic (loss of directionality or random) in nature
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3552	NP_000566.3	interleukin-1 alpha proprotein	1548758,1905933,7561697,7706435	2007-11-07 17:30	HIV-1 gp41 or gp120 synthetic peptides induce the production of interleukin (IL)-1 and tumor necrosis factor (TNF); in contrast, gp41 or gp120 synthetic peptides are able to depress the production of interferon (IFN)-alpha, IFN-gamma, and IL-2
11676	155030	NP_057850.1	Pr55(Gag)	upregulated by	9606	3553	NP_000567.1	interleukin-1 beta proprotein	15748898	2007-11-07 17:29	Stimulation of HIV-1 infected human adipocytes by TNF-alpha and IL-1beta increases the levels of HIV-1 Gag production
11676	155348	NP_705926.1	retropepsin	cleaves	9606	3553	NP_000567.1	interleukin-1 beta proprotein	1907279	2007-11-07 17:29	HIV-1 protease cleaves pro-interleukin 1 beta (pro-IL-1 beta) in vitro at amino acid positions 23-24 and 98-99
11676	155871	NP_057853.1	Tat	upregulates	9606	3553	NP_000567.1	interleukin-1 beta proprotein	7494249,7526541,7818827,9378998,10358063,10964543,15194470,16375755	2007-11-07 17:29	HIV-1 Tat upregulates IL-1beta expression in a variety of cell types, including macrophages, astrocytes, microglial cells, and primary blood mononuclear cells (PBMCs)
11676	155871	NP_057853.1	Tat	downregulates	9606	3553	NP_000567.1	interleukin-1 beta proprotein	8852605	2007-11-07 17:27	HIV-1 Tat downregulates IL-1beta expression in U937 cells through the inhibition of CD26
11676	155871	NP_057853.1	Tat	synergizes with	9606	3553	NP_000567.1	interleukin-1 beta proprotein	10438928	2007-11-07 17:29	IL-1beta, TNF-alpha, and IFN-gamma synergize with HIV-1 Tat to promote in nude mice the development of angioproliferative Kaposi's sarcoma-like lesions
11676	155871	NP_057853.1	Tat	downregulates	9606	3553	NP_000567.1	interleukin-1 beta proprotein	16792821	2007-11-07 17:31	IL-1 stimulated NO production and iNOS mRNA expression are down-regulated by pretreatment with HIV-1 Tat-SOD fusion proteins in cultured chondrocytes
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulates	9606	3553	NP_000567.1	interleukin-1 beta proprotein	1993354,7706435,8892361,8939574	2007-11-07 17:31	IL-1 and TNF-alpha production are induced by the treatment of cells with HIV-1 gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3553	NP_000567.1	interleukin-1 beta proprotein	1918997,2536171,8764000,9185130,15481145	2007-11-07 17:29	HIV-1 gp120 increases the levels of prostaglandin E2 (PGE2) and IL-1 in human monocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	3553	NP_000567.1	interleukin-1 beta proprotein	1918997,15481145	2007-11-07 17:31	HIV-1 gp120 stimulates monocytes to release TNF-alpha, IL-1 beta, IL-6, and granulocyte-macrophage-CSF, and this effect can be blocked with soluble CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3553	NP_000567.1	interleukin-1 beta proprotein	7511078,7815507,8764000,9108403,9225992,9658081,12089333,15481145,16160188	2007-11-07 17:31	Cytokines induced in vitro by HIV-1 gp120 in normal peripheral blood mononuclear cells (PBMC) include interferon-alpha (IFN-alpha) and IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-10, IL-1 alpha and IL-1 beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3553	NP_000567.1	interleukin-1 beta proprotein	11500085	2007-11-07 17:31	CD23 protein membrane expression is upregulated by HIV-1 gp120 and this upregulation induces the production of nitric oxide (NO) and IL-1beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	3553	NP_000567.1	interleukin-1 beta proprotein	11704656	2007-11-07 17:30	HIV-1 coat protein gp120 stimulates the release of interleukin-1beta from human neuroblastoma cells and causes cell death
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3553	NP_000567.1	interleukin-1 beta proprotein	1548758,1905933,7511078,7561697,7706435,8537091,9288832,10964543,15288392	2007-11-07 17:30	HIV-1 gp41 or gp120 synthetic peptides induce the production of interleukin (IL)-1 and tumor necrosis factor (TNF); in contrast, gp41 or gp120 synthetic peptides are able to depress the production of interferon (IFN)-alpha, IFN-gamma, and IL-2
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3553	NP_000567.1	interleukin-1 beta proprotein	10964543	2007-11-07 17:31	HIV-1 gp41 stimulates microglial cell production of cytokines (TNF-alpha, IL-1beta, and IL-6) and chemokines (RANTES and MIP-1alpha)
11676	156110	NP_057857.2	Nef	upregulates	9606	3553	NP_000567.1	interleukin-1 beta proprotein	12574335,15638726,17077296	2007-11-07 17:27	Treatment of human monocyte-derived macrophages with soluble recombinant HIV-1 Nef (rNef) upregulates the transcription of genes for several inflammatory factors, including IL-1beta, which is released upon rNef treatment
11676	156110	NP_057857.2	Nef	upregulates	9606	3553	NP_000567.1	interleukin-1 beta proprotein	15518810	2007-11-07 17:28	Expression of Nef from the brain-derived HIV-1 isolate YU-2 in astrocytes significantly upregulates IL-1beta expression
11676	155871	NP_057853.1	Tat	upregulates	9606	3554	NP_000868.1	interleukin-1 receptor type 1 precursor	7818827	2007-11-07 17:29	HIV-1 Tat upregulates the expression of IL-1RA in uninfected mononuclear cells
11676	155871	NP_057853.1	Tat	upregulates	9606	3557	NP_776213.1	interleukin-1 receptor antagonist protein isoform 2	8852605	2007-11-07 17:27	HIV-1 Tat upregulates the expression of IL-1 receptor antagonist through binding to and inhibiting CD26
11676	155030	NP_579876.2	matrix	enhances	9606	3558	NP_000577.2	interleukin-2 precursor	9517986,12105273,12542496	2007-11-07 17:28	HIV-1 Matrix enhances lymphocyte proliferation and IL-2 induced production of interferon gamma and TNF-alpha
11676	155030	NP_579876.2	matrix	upregulates	9606	3558	NP_000577.2	interleukin-2 precursor	12542496	2007-11-07 17:28	HIV-1 Matrix upregulates levels of IL-2, IL-12 and IL-15 in natural killer cells and induces natural killer cell proliferation
11676	155807	NP_057852.2	Vpr	downregulates	9606	3558	NP_000577.2	interleukin-2 precursor	9334723	2007-11-07 17:27	HIV-1 Vpr suppresses expression of IL-2 through suppression of NF-kappa B activity via the induction of I kappa B alpha
11676	155871	NP_057853.1	Tat	downregulates	9606	3558	NP_000577.2	interleukin-2 precursor	1394441,7734194,7983746,11254713	2007-11-07 17:29	HIV-1 Tat downregulates IL-2 expression in Jurkat T-cells stably transfected with Tat, H9 T-cells, as well as other T-cells, through an effect on the rel/AP1 complex and IL-2 promoter, resulting in functional unresponsiveness in T-cells
11676	155871	NP_057853.1	Tat	upregulates	9606	3558	NP_000577.2	interleukin-2 precursor	7695626,7999066,8207793,9045614,10207088,11114167,11385624	2007-11-07 17:29	HIV-1 Tat upregulates IL-2 expression in activated T-cells and Jurkat T-cells through activation of the IL-2 promoter, an effect involving NF-kappa B, NFAT, and cyclic nucleoside phosphodiesterase 4
11676	155871	NP_057853.1	Tat	downregulates	9606	3558	NP_000577.2	interleukin-2 precursor	8095514	2007-11-07 17:27	HIV-1 Tat downregulates IL-2 expression in T-cells by inhibiting CD26 which interferes with the delivery or amplification of a signal necessary for IL-2 production
11676	155871	NP_057853.1	Tat	activated by	9606	3558	NP_000577.2	interleukin-2 precursor	11689614	2007-11-07 17:28	Treatment of T lymphocytes with IL-2, IL-6 and TNFalpha increases CDK9 and cyclin T1 protein levels, suggesting a mechanism for activation of HIV-1 Tat function and reactivation of HIV-1 in CD4+ T lymphocytes harboring a latent provirus
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	downregulates	9606	3558	NP_000577.2	interleukin-2 precursor	7523014,7642615,9045910,9712080	2007-11-07 17:27	Pretreatment of CD4+ cells with HIV-1 gp160 significantly reduces PHA-induced secretion of IFN-gamma and IL-2 but augments IL-4 production
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3558	NP_000577.2	interleukin-2 precursor	1346976,1888898,1905933,2315327,7957556,9007200,11350667,17177332	2007-11-07 17:29	HIV-1 gp120 exerts a dose-dependent reduction of IL-2 mRNA expression, IL-2 production, and surface IL-2 receptor expression in CD4+ lymphocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	enhanced by	9606	3558	NP_000577.2	interleukin-2 precursor	2552026	2007-11-07 17:29	HIV-1 gp120-specific cell mediated cytotoxicity (CMC) is enhanced by IL-2 or the combination of IL-2 and IFN-alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3558	NP_000577.2	interleukin-2 precursor	2842093	2007-11-07 17:29	Proliferative responses of lymphocytes to cytomegalovirus are inhibited by relatively high concentrations (greater than or equal to 10 micrograms/ml) of recombinant HIV-1 envelope glycoprotein and this immunosuppression is completely overcome by IL2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3558	NP_000577.2	interleukin-2 precursor	7589092	2007-11-07 17:27	Molecular interactions of CD2 with LFA-3 and CD28 with B7-1 in conjunction with TCR occupancy prevent T cells from programmed apoptosis mediated by binding of CD4 to HIV-1 gp120, resulting in increased levels of IL-2 and IL-4 secretion from the T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3558	NP_000577.2	interleukin-2 precursor	7957556	2007-11-07 17:29	HIV-1 gp120 and anti-CD4 antibodies induce a specific, significant decrease in the binding activity of NF-AT, NF-kappa B and AP-1, which leads to an inhibition of IL-2 production and cell proliferation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3558	NP_000577.2	interleukin-2 precursor	8706326	2007-11-07 17:30	In the presence of HIV-1 gp120, stimulation through the CD28 pathway partially restores IL-2 and IFN-gamma production by T cell lines in response to anti-CD3 antibodies
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3558	NP_000577.2	interleukin-2 precursor	8706326	2007-11-07 17:30	Secretion of IL-2 and IFN-gamma stimulated with anti-CD3 antibodies is inhibited by HIV-1 gp120 in T cell lines
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3558	NP_000577.2	interleukin-2 precursor	9226175	2007-11-07 17:27	Binding of HIV-1 gp120 to CD4 downregulates Bcl-2 protein in CD4+ T lymphocytes and facilitates Fas/Fas-ligand triggered apoptosis; addition of IL-2 rescues CD4+ T cells from CD4/gp120-induced Bcl-2 downmodulation and apoptosis induction
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3558	NP_000577.2	interleukin-2 precursor	12605694	2007-11-07 17:30	IL-2-induced activation of JAK/STAT5 in human CD4+ T cells is inhibited by HIV-1 gp120 and anti-CD4 antibodies
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3558	NP_000577.2	interleukin-2 precursor	16393999	2007-11-07 17:31	CCR5- and CXCR4-tropic HIV-1 gp120 proteins suppress the ability of NK cells to proliferate in the presence of IL-2
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	downregulates	9606	3558	NP_000577.2	interleukin-2 precursor	1832084,9534962	2007-11-07 17:31	An HIV-1 gp41 peptide (amino acid residues 581-597) inhibits both protein kinase C (PKC)-dependent interleukin 2 (IL 2) production and the [Ca2+]i influx-dependent but PKC-independent induction of IL 2 receptor expression
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	downregulates	9606	3558	NP_000577.2	interleukin-2 precursor	1832084,1905933,7697734	2007-11-07 17:30	HIV-1 gp41 or gp120 synthetic peptides induce the production of interleukin (IL)-1 and tumor necrosis factor (TNF); in contrast, gp41 or gp120 synthetic peptides are able to depress the production of interferon (IFN)-alpha, IFN-gamma, and IL-2
11676	156110	NP_057857.2	Nef	Inhibits	9606	3558	NP_000577.2	interleukin-2 precursor	1527859,2052609	2007-11-07 17:27	HIV-1 Nef inhibits the induction of interleukin 2-directed gene expression
11676	156110	NP_057857.2	Nef	inhibits	9606	3558	NP_000577.2	interleukin-2 precursor	8102828	2007-11-07 17:27	HIV-1 Nef suppresses the IL-2-dependent proliferation of CD4+ cells; this suppression is due to the enhanced production of several lymphokines, including interferon-gamma
11676	156110	NP_057857.2	Nef	downregulates	9606	3558	NP_000577.2	interleukin-2 precursor	8598486,8765022,15638726	2007-11-07 17:27	Upon TcR triggering with antigens, HIV-1 Nef specifically downregulates IL-2 and interferon-gamma production in human T cells
11676	156110	NP_057857.2	Nef	upregulates	9606	3558	NP_000577.2	interleukin-2 precursor	8769094,10618429,10985305	2007-11-07 17:27	HIV-1 Nef induces the production of IL-2 and interferon-gamma in human T cells
11676	156110	NP_057857.2	Nef	interacts with	9606	3558	NP_000577.2	interleukin-2 precursor	10196292	2007-11-07 17:27	HIV-1 Nef can facilitate HIV-1 replication in human lymphoid tissue ex vivo by increasing the numbers of productively infected cells and by increasing the responsiveness to IL-2 stimulation
11676	156110	NP_057857.2	Nef	upregulates	9606	3558	NP_000577.2	interleukin-2 precursor	10393966,16354571	2007-11-07 17:28	HIV-1 Nef increases IL-2 secretion when Jurkat and primary human CD4 T cells are stimulated through the T cell receptor and the co-stimulus receptor (CD28); this effect depends on Nef myristoylation
11676	155871	NP_057853.1	Tat	downregulates	9606	3559	NP_000408.1	interleukin-2 receptor subunit alpha precursor	1394441,7734194	2007-11-07 17:29	HIV-1 Tat downregulates IL-2R in Jurkat and H9 T-cell lines, an effect that may contribute to the immunosuppressive effects of HIV-1 Tat
11676	155871	NP_057853.1	Tat	upregulates	9606	3559	NP_000408.1	interleukin-2 receptor subunit alpha precursor	9223324	2007-11-07 17:28	HIV-1 Tat upregulates IL-2Ralpha (CD25) in PBMCs and purified T cells through integrins alpha-3 and alpha-5
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3559	NP_000408.1	interleukin-2 receptor subunit alpha precursor	2315327,2843775,9341758,9637477	2007-11-07 17:29	HIV-1 gp120 exerts a dose-dependent reduction of IL-2 mRNA expression, IL-2 production, and surface IL-2 receptor expression in CD4+ lymphocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3559	NP_000408.1	interleukin-2 receptor subunit alpha precursor	9637477	2007-11-07 17:30	The inhibition of IL-2R expression and proliferation induced by the interaction of CD4 with HIV-1 envelope glycoprotein gp120 is correlated with the inhibition of expression and activation of Janus kinase JAK3
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3559	NP_000408.1	interleukin-2 receptor subunit alpha precursor	15784911	2007-11-07 17:31	CD4+ T cells infected with CCR5-tropic HIV-1 have significantly higher levels of activation-marker expression (e.g. CD25, CD71 and HLA-DR) than CD4+ T lymphocytes infected with CXCR4-tropic HIV-1
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	downregulates	9606	3559	NP_000408.1	interleukin-2 receptor subunit alpha precursor	1832084	2007-11-07 17:31	An HIV-1 gp41 peptide (amino acid residues 581-597) inhibits both protein kinase C (PKC)-dependent interleukin 2 (IL 2) production and the [Ca2+]i influx-dependent but PKC-independent induction of IL 2 receptor expression
11676	156110	NP_057857.2	Nef	downregulates	9606	3559	NP_000408.1	interleukin-2 receptor subunit alpha precursor	7853525,7903128	2007-11-07 17:27	HIV-1 Nef expression in the CD4+ T-cell line MT2 and in PHA-activated PBMCs downregulates the expression of IL-2R from the cell surface
11676	155871	NP_057853.1	Tat	downregulates	9606	3560	NP_000869.1	interleukin-2 receptor subunit beta precursor	1394441,7734194	2007-11-07 17:29	HIV-1 Tat downregulates IL-2R in Jurkat and H9 T-cell lines, an effect that may contribute to the immunosuppressive effects of HIV-1 Tat
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3560	NP_000869.1	interleukin-2 receptor subunit beta precursor	2315327,2843775,9341758,9637477	2007-11-07 17:29	HIV-1 gp120 exerts a dose-dependent reduction of IL-2 mRNA expression, IL-2 production, and surface IL-2 receptor expression in CD4+ lymphocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3560	NP_000869.1	interleukin-2 receptor subunit beta precursor	9637477	2007-11-07 17:30	The inhibition of IL-2R expression and proliferation induced by the interaction of CD4 with HIV-1 envelope glycoprotein gp120 is correlated with the inhibition of expression and activation of Janus kinase JAK3
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3561	NP_000197.1	cytokine receptor common subunit gamma precursor	2315327,2843775,9341758,9637477	2007-11-07 17:29	HIV-1 gp120 exerts a dose-dependent reduction of IL-2 mRNA expression, IL-2 production, and surface IL-2 receptor expression in CD4+ lymphocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3561	NP_000197.1	cytokine receptor common subunit gamma precursor	9637477	2007-11-07 17:31	The inhibition of IL-2R expression and proliferation induced by the interaction of CD4 with HIV-1 envelope glycoprotein gp120 is correlated with the inhibition of expression and activation of Janus kinase JAK3
11676	155871	NP_057853.1	Tat	upregulates	9606	3562	NP_000579.2	interleukin-3 precursor	11994280	2007-11-07 17:28	HIV-1 Tat upregulates IL-3 expression in vincristine-treated Kaposi's sarcoma cells, an effect involved in the activation of AKT kinase and that contributes to the anti-apoptotic effect of Tat
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulates	9606	3562	NP_000579.2	interleukin-3 precursor	7642615,8018916	2007-11-07 17:30	The aberrant activation of AP-1 by HIV-1 gp160 in CD4+ T cells is hypothesized to upregulate cytokines containing AP-1 sites (e.g. IL-3 and colony stimulating factor) and lead to T cell unresponsiveness by inhibiting interleukin-2 secretion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulates	9606	3562	NP_000579.2	interleukin-3 precursor	12089333	2007-11-07 17:31	HIV-1 gp120 modulates expression of the cytokines IL1beta, IL3, IL6, IL10, IL13, IL15, IFNbeta2A, IFNgamma, IFNomega, TNFalpha, VEGF, VEGF B, and LIF in PBMCs and MDMs
11676	155030	NP_579876.2	matrix	inhibits	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	12105273,12542496	2007-11-07 17:28	HIV-1 Matrix blocks IL-4 downregulation of interferon gamma and TNF-alpha
11676	155030	NP_579876.2	matrix	inhibits	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	16427155	2007-11-07 17:29	HIV-1 Matrix slightly enhances TNF-alpha and IFN-gamma secretion induced by IL-15 monocyte stimulation and counteracts IL-4 mediated inhibition of the production of these cytokines
11676	155807	NP_057852.2	Vpr	downregulates	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	9334723	2007-11-07 17:27	HIV-1 Vpr suppresses expression of IL-4 through suppression of NF-kappa B activity via the induction of I kappa B alpha
11676	155871	NP_057853.1	Tat	upregulates	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	7695626,16375755	2007-11-07 17:29	HIV-1 Tat upregulates IL-4 expression in Jurkat T-cells
11676	155871	NP_057853.1	Tat	induces release of	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	11149986,11396683,16375755	2007-11-07 17:29	HIV-1 Tat induces IL-4 and IL-13 release from basophils, leading to dysregulation of the IgE/Fc epsilon RI network
11676	155871	NP_057853.1	Tat	interacts with	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	17151125	2007-11-07 17:31	Activation of IL-4/STAT6 signaling partially contributes to HIV-1 Tat-induced Kaposi's sarcoma-associated herpesvirus (KSHV) replication
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulates	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	7523014,10710213	2007-11-07 17:27	Pretreatment of CD4+ cells with HIV-1 gp160 significantly reduces PHA-induced secretion of IFN-gamma and IL-2 but augments IL-4 production
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	1346976,8764000,15215692	2007-11-07 17:30	Antigen-induced interleukin 4 secretion is markedly reduced in HIV-1 gp120-treated T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	7589092	2007-11-07 17:29	Molecular interactions of CD2 with LFA-3 and CD28 with B7-1 in conjunction with TCR occupancy prevent T cells from programmed apoptosis mediated by binding of CD4 to HIV-1 gp120, resulting in increased levels of IL-2 and IL-4 secretion from the T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	10623799,10710213,10853974,11149986,15215692	2007-11-07 17:31	HIV-1 gp120 upregulates IL-4-induced IgE production through the regulation of the nitric oxide pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cooperates with	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	16547227	2007-11-07 17:31	HIV-1 gp120 cooperates with BAFF and cytokines IL-4 and IL-10 to activate mannose C-type lectin receptors-expressing B cells
11676	156110	NP_057857.2	Nef	inhibits	9606	3565	NP_000580.1	interleukin-4 isoform 1 precursor	16429138	2007-11-07 17:31	HIV-1 Nef suppresses immunoglobulin class-switch DNA recombination by inducing IkappaBalpha and SOCS proteins, which block CD154, IL-4 and IL-10 cytokine signaling via NF-kappaB and STAT transcription factors
11676	155871	NP_057853.1	Tat	upregulates	9606	3566	NP_000409.1	interleukin-4 receptor subunit alpha isoform a precursor	1617647,8891114	2007-11-07 17:29	HIV-1 Tat upregulates IL-4R in the Raji B-lymphoblastoid cell line, suggesting the possibility that the immunosuppressive effects of HIV-1 are mediated at least in part through IL-4 receptors
11676	155030	NP_579876.2	matrix	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	8938574	2007-11-07 17:28	HIV-1 Matrix upregulates IL-6 production in placental mononuclear cells
11676	155807	NP_057852.2	Vpr	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	10775602	2007-11-07 17:27	HIV-1 Vpr upregulates IL-6 expression in primary macrophages and in A549 cells
11676	155871	NP_057853.1	Tat	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	7494249,7523444,7526541,7693046,7803268,7986583,8113688,8179923,8510564,9169458,9378998,9671211,9792375,10358063,10964543,16375755,17197385	2007-11-07 17:29	HIV-1 Tat upregulates IL-6 expression in monocytes, astrocytes, microglial cells, human brain endothelial cells, THP-1 and Jurkat T-cells, MC3 B-cells, HeLa, and cells from Kaposi's sarcoma lesions
11676	155871	NP_057853.1	Tat	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	8113688,9169458	2007-11-07 17:29	HIV-1 Tat upregulates IL-6 expression by transactivating the IL-6 promoter, an effect mediated through enhancement of CAAT enhancer-binding protein (C/EBP; nuclear factor-IL-6) DNA binding activity
11676	155871	NP_057853.1	Tat	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	9671211	2007-11-07 17:29	Upregulation of IL-6 by HIV-1 Tat in human brain endothelial cells is mediated through activation of protein kinase C (PK-C) and cAMP-dependent protein kinase (PK-A)
11676	155871	NP_057853.1	Tat	activated by	9606	3569	NP_000591.1	interleukin-6 precursor	11689614	2007-11-07 17:28	Treatment of T lymphocytes with IL-2, IL-6 and TNFalpha increases CDK9 and cyclin T1 protein levels, suggesting a mechanism for activation of HIV-1 Tat function and reactivation of HIV-1 in CD4+ T lymphocytes harboring a latent provirus
11676	155871	NP_057853.1	Tat	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	15630704,16206161	2007-11-07 17:29	Astrocyte cultures treated with morphine and HIV-1 Tat show exaggerated increases in chemokine release, including monocyte chemoattractant protein-1 (MCP-1), RANTES, and IL-6
11676	155871	NP_057853.1	Tat	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	15857508	2007-11-07 17:28	IL-6 and IL-6 receptor are upregulated in human epithelial cells by HIV-1 Tat treatment
11676	155871	NP_057853.1	Tat	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	16273337,17197385	2007-11-07 17:29	HIV-1 Tat protein upregulates expression of IL-6 and IL-8 in human breast cancer cells by an NF-kappaB-dependent pathway
11676	155871	NP_057853.1	Tat	activated by	9606	3569	NP_000591.1	interleukin-6 precursor	17150965	2007-11-07 17:31	Hydroxyurea and IL-6 synergistically enhance HIV-1 Tat activation of HIV-1 LTR-driven transcription via the Sp1 binding site
11676	155871	NP_057853.1	Tat	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	17151125	2007-11-07 17:31	Ectopic expression of HIV-1 Tat induces the production of human IL-6 (huIL-6) and its receptor (huIL-6Ra) and activates STAT3 signaling; these effects are involved in Tat-mediated activation of Kaposi's sarcoma-associated herpesvirus (KSHV) replication
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	1656094,8018916,8938574	2007-11-07 17:30	HIV-1 gp160 induces interleukin-6 production in CD4+ T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	3569	NP_000591.1	interleukin-6 precursor	1346976,1656094,1918997,7511078,7536422,7704970,8806809,12089333,15288392,15481145	2007-11-07 17:30	HIV-1 gp120 stimulates monocytes to release TNF-alpha, IL-1 beta, IL-6, and granulocyte-macrophage-CSF, and this effect can be blocked with soluble CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	7511078,7815507,8764000,9108403,9225992,9658081,12089333,15481145,16160188	2007-11-07 17:31	Cytokines induced in vitro by HIV-1 gp120 in normal peripheral blood mononuclear cells (PBMC) include interferon-alpha (IFN-alpha) and IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-10, IL-1 alpha and IL-1 beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	11517385	2007-11-07 17:31	HIV-1 gp120 activates human brain microvascular endothelial cells (HBMEC) via CD4 in upregulating ICAM-1 and VCAM-1 expression, IL-6 secretion and increased monocyte transmigration across monolayers
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	7553888,10964543	2007-11-07 17:31	HIV-1 gp41 induces significant IL-6 production by human monocytic cells; IL-10 inhibits gp41-induced IL-6 production and reduces the expression of IL-6 mRNA
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	3569	NP_000591.1	interleukin-6 precursor	8247028	2007-11-07 17:31	PWM, LPS, IFN-gamma and IL-6 can increase HIV-1 gp41 binding to human B cells
11676	156110	NP_057857.2	Nef	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	8086129,10388525	2007-11-07 17:27	Treatment of human PBMC and PBL with soluble HIV-1 Nef upregulates IL-6 production
11676	156110	NP_057857.2	Nef	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	10415019	2007-11-07 17:27	Intracisternal HIV-1 Nef injection upregulates levels of IL-6, TNF-alpha, and IFN-gamma in rat cerebrospinal fluid
11676	156110	NP_057857.2	Nef	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	12370346,12396456	2007-11-07 17:27	HIV-1 Nef expression by immature human and macaque dendritic cells (DCs) upregulates IL-6, IL-12, TNF-alpha, CXCL8, CCL3, and CCL4 release, but without upregulating co-stimulatory and other molecules characteristic of mature DCs
11676	156110	NP_057857.2	Nef	upregulates	9606	3569	NP_000591.1	interleukin-6 precursor	12574335,12960275	2007-11-07 17:28	The expression of HIV-1 Nef in primary human monocyte-derived macrophages (MDM) induces a significant increase in the concentration of IL-6
11676	155871	NP_057853.1	Tat	upregulates	9606	3570	NP_000556.1	interleukin-6 receptor subunit alpha isoform 1 precursor	15857508	2007-11-07 17:28	IL-6 and IL-6 receptor are upregulated in human epithelial cells by HIV-1 Tat treatment
11676	155871	NP_057853.1	Tat	upregulates	9606	3570	NP_000556.1	interleukin-6 receptor subunit alpha isoform 1 precursor	17151125	2007-11-07 17:31	Ectopic expression of HIV-1 Tat induces the production of human IL-6 (huIL-6) and its receptor (huIL-6Ra) and activates STAT3 signaling; these effects are involved in Tat-mediated activation of Kaposi's sarcoma-associated herpesvirus (KSHV) replication
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulates	9606	3570	NP_000556.1	interleukin-6 receptor subunit alpha isoform 1 precursor	8450224	2007-11-07 17:30	Antibodies against cell surface molecules LFA-1, ICAM-1, HLA-DR, and CD28 inhibit the HIV-1 gp160-induced B cell differentiation response; gp160 also induces IL-6R and CD23 molecule expression on B cells
11676	155871	NP_057853.1	Tat	inhibits	9606	3574	NP_000871.1	interleukin-7 precursor	16967044	2007-11-07 17:31	HIV-1 Tat inhibits the effects of IL-7 on activation of CD8 T-cells signaling via IL-7R
11676	155871	NP_057853.1	Tat	inhibits	9606	3574	NP_000871.1	interleukin-7 precursor	16967044	2007-11-07 17:31	Upregulation of intracellular perforin accumulation by IL-7 in CD8 T-cells is inhibited by HIV-1 Tat
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3574	NP_000871.1	interleukin-7 precursor	9158092	2007-11-07 17:31	IL-7 and IL-12 significantly augment proliferative responses to HIV-1 gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3574	NP_000871.1	interleukin-7 precursor	15630452,16162475	2007-11-07 17:30	HIV-1 gp120-induced neuronal apoptosis is augmented by IL-7
11676	155871	NP_057853.1	Tat	upregulates	9606	3575	NP_002176.2	interleukin-7 receptor subunit alpha precursor	16614257	2007-11-07 17:31	HIV-1 Tat upregulates the expression of IL-7R in human macrophages, which leads to the enhancement of HIV-1 replication
11676	155871	NP_057853.1	Tat	downregulates	9606	3575	NP_002176.2	interleukin-7 receptor subunit alpha precursor	16967044	2007-11-07 17:31	HIV-1 Tat downregulates cell surface expression of IL-7R on human CD8 T-cells in a dose- and time-dependent manner
11676	155871	NP_057853.1	Tat	inhibits	9606	3575	NP_002176.2	interleukin-7 receptor subunit alpha precursor	16967044	2007-11-07 17:31	HIV-1 Tat inhibits the effects of IL-7 on activation of CD8 T-cells signaling via IL-7R
11676	155807	NP_057852.2	Vpr	regulates	9606	3576	NP_000575.1	interleukin-8 precursor	10775602,10985253	2007-11-07 17:27	HIV-1 Vpr regulates interleukin 8 (IL-8) expression, with reports showing both up- and downregulation of IL-8
11676	155871	NP_057853.1	Tat	downregulates	9606	3576	NP_000575.1	interleukin-8 precursor	7695626	2007-11-07 17:29	HIV-1 Tat downregulates IL-8 expression in the Raji B-cell line, however in the presence of PMA+PHA Tat induced IL-8 expression
11676	155871	NP_057853.1	Tat	upregulates	9606	3576	NP_000575.1	interleukin-8 precursor	7695626,9378998,9510190,10376933,10982368,11160671,12388718,16375755,16697675	2007-11-07 17:29	HIV-1 Tat upregulates IL-8 expression in astrocytes, monocytes, monocyte derived macrophages, Jurkat T-cells, HeLa cells, and human brain endothelial cells, an effect that likely contributes to the immune dysregulation observed during HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	3576	NP_000575.1	interleukin-8 precursor	9510190,11160671	2007-11-07 17:29	HIV-1 Tat upregulation of IL-8 is linked to the cell cycle and involves NF-kappa B, RelA, c-rel, and CREB-binding protein
11676	155871	NP_057853.1	Tat	upregulates	9606	3576	NP_000575.1	interleukin-8 precursor	10982368	2007-11-07 17:29	Upregulation of IL-8 by HIV-1 Tat in astrocytes is inhibited by the MEK1/2 inhibitor UO126, indicating a role for MEK1/2 in Tat-mediated chemokine induction
11676	155871	NP_057853.1	Tat	upregulates	9606	3576	NP_000575.1	interleukin-8 precursor	11069235	2007-11-07 17:27	HIV-1 Tat upregulates IL-8 and VEGF production and release from polymorphonuclear leukocytes (PMNL), indicating that PMNL recruitment by Tat is linked to angiogenesis
11676	155871	NP_057853.1	Tat	upregulates	9606	3576	NP_000575.1	interleukin-8 precursor	12388718	2007-11-07 17:29	Upregulation of IL-8 by HIV-1 Tat is implicated in the pathogenesis of Kaposi's sarcoma
11676	155871	NP_057853.1	Tat	upregulates	9606	3576	NP_000575.1	interleukin-8 precursor	16273337,17197385	2007-11-07 17:29	HIV-1 Tat protein upregulates expression of IL-6 and IL-8 in human breast cancer cells by an NF-kappaB-dependent pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3576	NP_000575.1	interleukin-8 precursor	8995686,12021366,12089333,15481145	2007-11-07 17:27	Interleukin 8 (IL-8) gene expression is enhanced in monocytes treated with HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3576	NP_000575.1	interleukin-8 precursor	16934308	2007-11-07 17:31	In endometrial epithelium-derived cells, gp120 from CCR5-tropic HIV-1 increases the release of monocytes/chemokines-attracting chemokines (IL-8 and GRO) and proinflammatory cytokines (TNF-beta and IL-1alpha)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibited by	9606	3576	NP_000575.1	interleukin-8 precursor	11226151	2007-11-07 17:30	The interaction between HIV-1 gp41 fusion peptide and lymphocyte membrane is blocked by interleukin-8 and abolished by pre-treating the cells with heparin sulfate (HS)
11676	156110	NP_057857.2	Nef	upregulates	9606	3576	NP_000575.1	interleukin-8 precursor	12370346,17077296	2007-11-07 17:27	HIV-1 Nef expression by immature human and macaque dendritic cells (DCs) upregulates IL-6, IL-12, TNF-alpha, CXCL8, CCL3, and CCL4 release, but without upregulating co-stimulatory and other molecules characteristic of mature DCs
11676	155030	NP_579880.1	capsid	induces release of	9606	3586	NP_000563.1	interleukin-10 precursor	9743208	2007-11-07 17:29	Immunosuppressive peptides corresponding to HIV-1 Capsid amino acids 218-238 upregulate prostaglandin E2 production and induce IL-10 secretion
11676	155348	NP_705927.1	reverse transcriptase	inhibited by	9606	3586	NP_000563.1	interleukin-10 precursor	7527834	2007-11-07 17:29	IL-10 inhibits HIV-1 replication in primary tissue culture-derived macrophages in a dose-dependent manner, decreases HIV-1 reverse transcription upon macrophage infection, and subsequently mediates viral latency in vitro
11676	155807	NP_057852.2	Vpr	modulates	9606	3586	NP_000563.1	interleukin-10 precursor	9334723,10775602,10985253,12444143	2007-11-07 17:27	HIV-1 Vpr modulates expression of interleukin 10 (IL-10), increasing or suppressing IL-10 expression through varying effects on NF-kappa B activity in different cell lines
11676	155807	NP_057852.2	Vpr	upregulates	9606	3586	NP_000563.1	interleukin-10 precursor	15956545	2007-11-07 17:28	HIV-1 Vpr upregulates the production of interleukin 10 (IL-10) in dendritic cells
11676	155871	NP_057853.1	Tat	upregulates	9606	3586	NP_000563.1	interleukin-10 precursor	7695626,8037735,8898665,11044099,11833470,11919157,15857508,15907845,16375755,16920714	2007-11-07 17:29	HIV-1 Tat upregulates expression of IL-10 in peripheral blood monocytes and T-cell lines through a protein kinase C dependent mechanism involving NF-kappa B, ERK1, and ERK2
11676	155871	NP_057853.1	Tat	upregulates	9606	3586	NP_000563.1	interleukin-10 precursor	15488737,16920714	2007-11-07 17:28	HIV-1 Tat induces production of IL-10 through the activation of PKC beta(II) and delta isozymes in human monocytes
11676	155871	NP_057853.1	Tat	inhibited by	9606	3586	NP_000563.1	interleukin-10 precursor	16781761	2007-11-07 17:31	IL-10 inhibits HIV-1 gene expression in an HIV-1 Tat-dependent manner by downregulating cyclin T1 expression through the induction of proteasome-mediated proteolysis in human macrophages
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3586	NP_000563.1	interleukin-10 precursor	7511078,7815507,8764000,9108403,9225992,9658081,12089333,15481145,16160188	2007-11-07 17:27	Cytokines induced in vitro by HIV-1 gp120 in normal peripheral blood mononuclear cells (PBMC) include interferon-alpha (IFN-alpha) and IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-10, IL-1 alpha and IL-1 beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3586	NP_000563.1	interleukin-10 precursor	11087201,15603899	2007-11-07 17:30	HIV-1 gp120-induced reduction of IL-12 parallels IL-10 induction and inhibits translocation of CD40 to the surface of monocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cooperates with	9606	3586	NP_000563.1	interleukin-10 precursor	16547227	2007-11-07 17:31	HIV-1 gp120 cooperates with BAFF and cytokines IL-4 and IL-10 to activate mannose C-type lectin receptors-expressing B cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3586	NP_000563.1	interleukin-10 precursor	7553888,9143942,9534962,10089566,10807185	2007-11-07 17:31	HIV-1 gp41 induces IL-10 expression in human monocytes and gp41-induced IL-10 expression leads to reduced IL-2 and interferon-gamma production
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	3586	NP_000563.1	interleukin-10 precursor	7553888	2007-11-07 17:31	IL-10 inhibits gp41-induced IL-6 production and reduces the expression of IL-6 mRNA
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	3586	NP_000563.1	interleukin-10 precursor	10089566,10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	156110	NP_057857.2	Nef	upregulates	9606	3586	NP_000563.1	interleukin-10 precursor	9096366,11137132	2007-11-07 17:27	Extracellular HIV-1 Nef induces interleukin (IL)-10 mRNA expression in human PBMCs as well as in H9 T and U937 promonocytic human cell lines; release of IL-10 into supernatants from PBMCs stimulated with Nef is dose-dependent
11676	156110	NP_057857.2	Nef	upregulates	9606	3586	NP_000563.1	interleukin-10 precursor	11023665,12270545	2007-11-07 17:27	HIV-1 Nef significantly upregulates IL-10 protein and mRNA expression in monocytes but not in T or B lymphocytes; by contrast, SEA induced IL-10 protein and mRNA expression in T lymphocytes but not in monocytes or B lymphocytes
11676	156110	NP_057857.2	Nef	upregulates	9606	3586	NP_000563.1	interleukin-10 precursor	11137132	2007-11-07 17:27	Herbimycin A significantly blocks HIV-1 Nef-induced production of IL-10 at both the protein and the mRNA level, demonstrating the involvement of a herbimycin A-sensitive Protein tyrosine kinase in the signal transduction pathway for exogenous HIV-1 Nef
11676	156110	NP_057857.2	Nef	inhibits	9606	3586	NP_000563.1	interleukin-10 precursor	16429138	2007-11-07 17:31	HIV-1 Nef suppresses immunoglobulin class-switch DNA recombination by inducing IkappaBalpha and SOCS proteins, which block CD154, IL-4 and IL-10 cytokine signaling via NF-kappaB and STAT transcription factors
11676	155030	NP_579876.2	matrix	upregulates	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	12542496	2007-11-07 17:28	HIV-1 Matrix upregulates levels of IL-2, IL-12 and IL-15 in natural killer cells and induces natural killer cell proliferation
11676	155807	NP_057852.2	Vpr	downregulates	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	9334723,12444143,15142381,15780175,15817944	2007-11-07 17:27	HIV-1 Vpr suppresses expression and secretion of IL-12 subunit p35 and IL-12 holo-protein, but not IL-12 subunit p40
11676	155807	NP_057852.2	Vpr	downregulates	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	15956545	2007-11-07 17:28	HIV-1 Vpr downregulates the production of interleukin 12 (IL-12) in dendritic cells
11676	155871	NP_057853.1	Tat	upregulates	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	7695626,11751963	2007-11-07 17:29	HIV-1 Tat upregulates IL-12 expression in Jurkat T-cells, Raji B-cells, and monocyte-derived dendritic cells
11676	155871	NP_057853.1	Tat	downregulates	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	9516412	2007-11-07 17:30	HIV-1 Tat downregulates IL-12 production by human dendritic cells by blocking extracellular calcium influx
11676	155871	NP_057853.1	Tat	downregulates	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	9671213	2007-11-07 17:29	HIV-1 Tat downregulates IL-12 production by human peripheral blood mononuclear cells (PBMCs)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	9158092,9712080,10352291	2007-11-07 17:31	IL-7 and IL-12 significantly augment proliferative responses to HIV-1 gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	7867080,12719551,15331709	2007-11-07 17:30	Apoptosis of CD4+ lymphocytes induced by HIV-1 gp120 cross-linking to CD4 is inhibited by IL-12
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	8648753,9225992	2007-11-07 17:30	Secretion of IL-12 is found in macrophages primed with gamma interferon (IFN-gamma) and subsequently treated with gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	9108403	2007-11-07 17:27	HIV-gp120 induces a significant IL-10 synthesis, which in turn inhibits IL-12 subunits mRNA accumulation and protein secretion after Staphylococcus aureus strain cowan I (SAC)-activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	11087201,14764743,15331709	2007-11-07 17:30	HIV-1 gp120 inhibits early and late production of interleukin (IL)-12 by peripheral blood mononuclear cells (PBMC)
11676	156110	NP_057857.2	Nef	upregulates	9606	3592	NP_000873.2	interleukin-12 subunit alpha precursor	12370346,14597672,17077296	2007-11-07 17:27	HIV-1 Nef upregulates IL-12 release in immature human and macaque dendritic cells
11676	155030	NP_579876.2	matrix	upregulates	9606	3593	NP_002178.2	interleukin-12 subunit beta precursor	12542496	2007-11-07 17:28	HIV-1 Matrix upregulates levels of IL-2, IL-12 and IL-15 in natural killer cells and induces natural killer cell proliferation
11676	155871	NP_057853.1	Tat	upregulates	9606	3593	NP_002178.2	interleukin-12 subunit beta precursor	7695626,11751963	2007-11-07 17:29	HIV-1 Tat upregulates IL-12 expression in Jurkat T-cells, Raji B-cells, and monocyte-derived dendritic cells
11676	155871	NP_057853.1	Tat	downregulates	9606	3593	NP_002178.2	interleukin-12 subunit beta precursor	9516412	2007-11-07 17:30	HIV-1 Tat downregulates IL-12 production by human dendritic cells by blocking extracellular calcium influx
11676	155871	NP_057853.1	Tat	downregulates	9606	3593	NP_002178.2	interleukin-12 subunit beta precursor	9671213	2007-11-07 17:29	HIV-1 Tat downregulates IL-12 production by human peripheral blood mononuclear cells (PBMCs)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3593	NP_002178.2	interleukin-12 subunit beta precursor	9158092,9712080,10352291	2007-11-07 17:31	IL-7 and IL-12 significantly augment proliferative responses to HIV-1 gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	3593	NP_002178.2	interleukin-12 subunit beta precursor	7867080,12719551,15331709	2007-11-07 17:30	Apoptosis of CD4+ lymphocytes induced by HIV-1 gp120 cross-linking to CD4 is inhibited by IL-12
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3593	NP_002178.2	interleukin-12 subunit beta precursor	8648753,9225992	2007-11-07 17:30	Secretion of IL-12 is found in macrophages primed with gamma interferon (IFN-gamma) and subsequently treated with gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3593	NP_002178.2	interleukin-12 subunit beta precursor	9108403	2007-11-07 17:27	HIV-gp120 induces a significant IL-10 synthesis, which in turn inhibits IL-12 subunits mRNA accumulation and protein secretion after Staphylococcus aureus strain cowan I (SAC)-activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3593	NP_002178.2	interleukin-12 subunit beta precursor	11087201,14764743,15331709	2007-11-07 17:30	HIV-1 gp120 inhibits early and late production of interleukin (IL)-12 by peripheral blood mononuclear cells (PBMC)
11676	155348	NP_705927.1	reverse transcriptase	inhibited by	9606	3596	NP_002179.2	interleukin-13 precursor	9226003	2007-11-07 17:29	IL-13 can act on macrophages both before and after HIV-1 infection to interfere with virus replication by blocking the completion of reverse transcription, decreasing virus production, and reducing the infectivity of the progeny virions
11676	155871	NP_057853.1	Tat	induces release of	9606	3596	NP_002179.2	interleukin-13 precursor	11149986,11396683,16375755	2007-11-07 17:29	HIV-1 Tat induces IL-4 and IL-13 release from basophils, leading to dysregulation of the IgE/Fc epsilon RI network
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	3596	NP_002179.2	interleukin-13 precursor	10623799,11149986	2007-11-07 17:31	HIV-1 gp120 induces IL-4 and IL-13 releases from human basophils through its interaction with the VH3 region of IgE
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulates	9606	3596	NP_002179.2	interleukin-13 precursor	12089333	2007-11-07 17:31	HIV-1 gp120 modulates expression of the cytokines IL1beta, IL3, IL6, IL10, IL13, IL15, IFNbeta2A, IFNgamma, IFNomega, TNFalpha, VEGF, VEGF B, and LIF in PBMCs and MDMs
11676	155030	NP_579876.2	matrix	upregulates	9606	3600	NP_000576.1	interleukin-15 preproprotein	12542496	2007-11-07 17:28	HIV-1 Matrix upregulates levels of IL-2, IL-12 and IL-15 in natural killer cells and induces natural killer cell proliferation
11676	155030	NP_579876.2	matrix	inhibits	9606	3600	NP_000576.1	interleukin-15 preproprotein	16427155	2007-11-07 17:29	HIV-1 Matrix is able to reduce MIP-1alpha secretion from IL-15-stimulated monocyte cells
11676	155030	NP_579876.2	matrix	enhances	9606	3600	NP_000576.1	interleukin-15 preproprotein	16427155	2007-11-07 17:29	HIV-1 Matrix slightly enhances TNF-alpha and IFN-gamma secretion induced by IL-15 monocyte stimulation and counteracts IL-4 mediated inhibition of the production of these cytokines
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulates	9606	3600	NP_000576.1	interleukin-15 preproprotein	12089333	2007-11-07 17:31	HIV-1 gp120 modulates expression of the cytokines IL1beta, IL3, IL6, IL10, IL13, IL15, IFNbeta2A, IFNgamma, IFNomega, TNFalpha, VEGF, VEGF B, and LIF in PBMCs and MDMs
11676	156110	NP_057857.2	Nef	upregulates	9606	3600	NP_751914.1	interleukin-15 preproprotein	10388525,11122241,17077296	2007-11-07 17:27	Exogenous HIV-1 Nef protein induces the proliferation of unstimulated and suboptimally stimulated normal human PBMC through upregulation of IL-15 synthesis in the monocyte/macrophage population
11676	155871	NP_057853.1	Tat	inhibited by	9606	3603	NP_004504.3	pro-interleukin-16 isoform 1	8977168,16375755	2007-11-07 17:29	Recombinant IL-16 inhibits HIV-1 Tat activation of the HIV-1 LTR promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3603	NP_004504.3	pro-interleukin-16 isoform 1	8599832	2007-11-07 17:27	IL-16 induces rapid translocation of PKC from the cytosol to the membrane in CD4+ cells; PKC inhibitors completely block IL-16-induced lymphocyte migration as well as the motile response induced by HIV-1 gp120 and anti-CD4 antibody binding to CD4
11676	155908	NP_057854.1	Rev	inhibited by	9606	3609	NP_036350.2	interleukin enhancer-binding factor 3 isoform a	17125513	2007-11-07 17:31	NF90 inhibits HIV-1 Rev-dependent activity by interfering with the RNA export function of Rev
11676	155908	NP_057854.1	Rev	interacts with	9606	3609	NP_036350.2	interleukin enhancer-binding factor 3 isoform a	17125513	2007-11-07 17:31	The C-terminal 67 amino acids (604-671) of NF90 interact with HIV-1 Rev
11676	155807	NP_057852.2	Vpr	downregulates	9606	3620	NP_002155.1	indoleamine 2,3-dioxygenase 1	12444143	2007-11-07 17:27	HIV-1 Vpr potentiates the suppression of indoleamine 2,3-dioxygenase by glucocorticoids via the glucocorticoid receptor pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	3620	NP_002155.1	indoleamine 2,3-dioxygenase 1	17158233	2007-11-07 17:31	CCR5- or CXCR4-tropic HIV-1 induce the release of Indoleamine 2,3-dioxygenase (IDO) in plasmacytoid dendritic cells and this induction is inhibited by the blockade of HIV-1 gp120 interaction with CD4 by anti-CD4-Ab
11676	155871	NP_057853.1	Tat	upregulates	9606	3627	NP_001556.1	small inducible cytokine B10 precursor	10982368,12539042,16697675	2007-11-07 17:29	HIV-1 Tat upregulates IP-10 expression through a MAPK dependent mechanism in astrocytes and also induces IP-10 expression in immature dendritic cells, an effect that may facilitate expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	inhibits	9606	3627	NP_001556.1	small inducible cytokine B10 precursor	14630801	2007-11-07 17:28	HIV-1 Tat can downregulate CXCR3-mediated functions by inhibiting the chemotactic activity of IP-10/CXCL10, an effect mediated by Tat amino acids 25-31
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3627	NP_001556.1	small inducible cytokine B10 precursor	11878903,12089333	2007-11-07 17:30	CXCR4-tropic HIV-1 gp120 augments the expression of RANTES, IP-10, MCP-1, and LTN in peripheral blood mononuclear cells (PBMCs), while CCR5-tropic HIV-1 gp120 also induces an increase in both IP-10 and MCP-1 production
11676	156110	NP_057857.2	Nef	upregulates	9606	3627	NP_001556.1	small inducible cytokine B10 precursor	15518810	2007-11-07 17:28	Nef from the brain-derived HIV-1 isolate YU-2 remarkably upregulates IP-10 expression, which leads to neural cell death
11676	155807	NP_057852.2	Vpr	inhibits	9606	3630	NP_000198.1	insulin preproprotein	15265780,15616007	2007-11-07 17:28	HIV-1 Vpr inhibits insulin-induced association of 14-3-3 and Foxo3a in HeLa cells
11676	155807	NP_057852.2	Vpr	inhibits	9606	3630	NP_000198.1	insulin preproprotein	15265780,15616007	2007-11-07 17:28	HIV-1 Vpr inhibits insulin-induced cytoplasmic translocation of Foxo3a, a subtype of the forkhead transcription factors
11676	155807	NP_057852.2	Vpr	inhibits	9606	3630	NP_000198.1	insulin preproprotein	15616007	2007-11-07 17:28	HIV-1 Vpr antagonizes insulin's effect on the expression of glucose 6-phosphatase, manganese superoxide dismutase, and sterol carrier protein 2 genes in HepG2 cells
11676	155807	NP_057852.2	Vpr	upregulates	9606	3655	NP_000201.2	integrin alpha-6 isoform b precursor	10713718	2007-11-07 17:27	HIV-1 Vpr-expressing Jurkat T cell clones showed upregulated expression of integrin alpha 6, suggesting a role of Vpr in modulating the cell adhesion process
11676	155871	NP_057853.1	Tat	binds	9606	3659	NP_002189.1	interferon regulatory factor 1	16512786,16703666	2007-11-07 17:31	HIV-1 Tat represses transcription of the LMP2 gene by competing with STAT1 (signal transducer and activator of transcription 1) for binding to IRF-1 (interferon-regulatory factor-1) at the LMP2 promoter
11676	156110	NP_057857.2	Nef	upregulates	9606	3659	NP_002189.1	interferon regulatory factor 1	11675348	2007-11-07 17:28	HIV-1 Nef-induced signal transducer and activator of transcription 1 (STAT1) activation results in increased expression of interferon regulatory factor-1 (IRF-1) in recombinant Nef-treated human monocyte-derived macrophages (MDMs)
11676	156110	NP_057857.2	Nef	upregulates	9606	3660	NP_002190.1	interferon regulatory factor 2	11420046	2007-11-07 17:28	HIV-1 Nef upregulates interferon regulatory factor 2 (IRF-2) in human T cells
11676	156110	NP_057857.2	Nef	activates	9606	3661	NP_001562.1	interferon regulatory factor 3	17182689	2007-11-07 17:31	HIV-1 Nef myristoylation is required for the activation of IRF-3, leading to the synthesis of IFNbeta in monocytes-derived-macrophages
11676	155871	NP_057853.1	Tat	upregulates	9606	3665	NP_001563.2	interferon regulatory factor 7 isoform a	12539042	2007-11-07 17:29	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including IFN regulatory factor 7A (IRF7), in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	3669	NP_002192.2	interferon-stimulated gene 20 kDa protein	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including HEM45, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155348	NP_705926.1	retropepsin	cleaves	9606	3675	NP_002195.1	integrin alpha-3 isoform a precursor	12119179	2007-11-07 17:29	Beta4 integrin and alpha3 integrin are cleaved by the HIV-1 protease in human embryonic fibroblasts
11676	155871	NP_057853.1	Tat	activates	9606	3675	NP_002195.1	integrin alpha-3 isoform a precursor	9223324	2007-11-07 17:28	Activation of primary T cells by HIV-1 Tat involves integrin receptors and monoclonal antibodies to integrin alpha 3 inhibit Tat-induced upregulation of CD25
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3675	NP_002195.1	integrin alpha-3 isoform a precursor	12775419	2007-11-07 17:31	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3676	NP_000876.3	integrin alpha-4 precursor	9263011	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155807	NP_057852.2	Vpr	upregulates	9606	3678	NP_002196.2	integrin alpha-5 precursor	10713718	2007-11-07 17:27	HIV-1 Vpr-expressing Jurkat T cell clones showed upregulated expression of integrin alpha 5, suggesting a role of Vpr in modulating the cell adhesion process
11676	155871	NP_057853.1	Tat	binds	9606	3678	NP_002196.2	integrin alpha-5 precursor	2202737,7539135,7690138,10397733	2007-11-07 17:28	The arginine-glycine-aspartic acid (RGD) sequence present at the carboxy-terminal of HIV-1 Tat mediates vascular cell and monocyte migration and invasion by binding to the alpha-5-beta-1 and alpha-v-beta-3 integrins
11676	155871	NP_057853.1	Tat	interacts with	9606	3678	NP_002196.2	integrin alpha-5 precursor	7539135,7690138,10397733	2007-11-07 17:28	HIV-1 Tat induces angiogenesis and cooperates in the development of AIDS-associated Kaposi sarcoma as a result of interactions with integrins alpha-5-beta-1 and alpha-v-beta 3
11676	155871	NP_057853.1	Tat	upregulates	9606	3678	NP_002196.2	integrin alpha-5 precursor	8599839	2007-11-07 17:30	HIV-1 Tat upregulates VLA-5 (integrin alpha 5) cell surface receptor levels in thymic epithelial cells
11676	155871	NP_057853.1	Tat	activates	9606	3678	NP_002196.2	integrin alpha-5 precursor	8757349,9223324	2007-11-07 17:28	Activation of primary T cells by HIV-1 Tat involves integrin receptors and monoclonal antibodies to integrin alpha 5 inhibit Tat-induced upregulation of CD25
11676	155871	NP_057853.1	Tat	interacts with	9606	3678	NP_002196.2	integrin alpha-5 precursor	9916748	2007-11-07 17:29	IFN-gamma interacts with HIV-1 Tat to induce endothelial cells to proliferate and invade the extracellular matrix by upregulating the receptors for Tat (integrins alpha-5-beta-1 and alpha-v-beta-3), suggesting Tat and IFN-gamma play major roles in AIDS-KS
11676	155871	NP_057853.1	Tat	inhibits	9606	3683	NP_002200.1	integrin alpha L precursor	9743356	2007-11-07 17:30	HIV-1 Tat inhibits the rise in intracellular free calcium concentration in Natural Killer (NK) cells upon cross-linking of the adhesion molecule CD11a and the activation molecule CD16, indicating Tat is involved in the impairment of NK cell function
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3683	NP_002200.1	integrin alpha L precursor	7917519	2007-11-07 17:31	ICAM-1 promotes HIV-1 gp160-mediated syncytium formation, and the ICAM-1 contrareceptor LFA-1 attenuates the syncytium-inhibiting activity of virus-neutralizing monoclonal antibodies and soluble CD4
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3683	NP_002200.1	integrin alpha L precursor	8450224	2007-11-07 17:30	Antibodies against cell surface molecules LFA-1, ICAM-1, HLA-DR, and CD28 inhibit the HIV-1 gp160-induced B cell differentiation response; gp160 also induces IL-6R and CD23 molecule expression on B cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	downregulates	9606	3683	NP_002200.1	integrin alpha L precursor	9341793	2007-11-07 17:31	HIV-1 gp160 downregulates lymphocyte function-associated antigen-1 (LFA-1)-dependent adhesion between CD4+ T cells and B cells; this downregulation is shown to be p56lck-dependent
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	3683	NP_002200.1	integrin alpha L precursor	9341793	2007-11-07 17:30	PI3-kinase activation induced by HIV-1 gp160 leads to downregulation of LFA-1-mediated T cell adhesion to B cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3683	NP_002200.1	integrin alpha L precursor	1757107,1967280,2543075	2007-11-07 17:29	Anti-CD18 monoclonal antibodies completely block cell fusion between HIV-1 infected U-937 cells and MT-4 T cells, indicating participation of CD18, or of the protein complex CD11a-c/CD18, in addition to CD4, in the infection and cytopathic effect of HIV-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3683	NP_002200.1	integrin alpha L precursor	7904170	2007-11-07 17:29	Cells treated with monoclonal antibodies to ICAM-1 and LFA-1 adhesion molecules show an impaired release of IFN after HIV-1 gp120 stimulation, suggesting a crucial role of cell-to-cell interactions in the process leading to IFN production
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3683	NP_002200.1	integrin alpha L precursor	9263011	2007-11-07 17:28	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3683	NP_002200.1	integrin alpha L precursor	15183063	2007-11-07 17:31	Infectivity of an HIV-1 Matrix mutant that carries a suboptimal amount of HIV-1 gp120/41 is restored to a certain degree by the presence of ICAM-1 when infection is performed in cells expressing an activated form of its natural counter-ligand, LFA-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	3683	NP_002200.1	integrin alpha L precursor	17078873	2007-11-07 17:31	HIV-1 replication is delayed in LFA-1 negative T cells after Dendritic cell (DC)-mediated transmission; activation of LFA-1 is crucial for efficient DC-mediated HIV-1 transmission, suggesting an interaction between LFA-1 and HIV-1 gp120
11676	156110	NP_057857.2	Nef	interacts with	9606	3683	NP_002200.1	integrin alpha L precursor	8086129	2007-11-07 17:27	Monoclonal antibodies to the cell surface molecule leukocyte function-associated molecule (LFA)-1 alpha inhibit the Nef-induced B-cell differentiation response, suggesting an interaction between Nef and LFA-1alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3684	NP_000623.2	integrin alpha-M isoform 2 precursor	1967280	2007-11-07 17:29	Anti-CD18 monoclonal antibodies completely block cell fusion between HIV-1 infected U-937 cells and MT-4 T cells, indicating participation of CD18, or of the protein complex CD11a-c/CD18, in addition to CD4, in the infection and cytopathic effect of HIV-1
11676	156110	NP_057857.2	Nef	interacts with	9606	3684	NP_000623.2	integrin alpha-M isoform 2 precursor	12682255	2007-11-07 17:28	HIV-1 Nef interacts with complement receptor 3 (CR3) in a manner that allows CR3 redistribution toward bacterial-induced pseudopods in macrophages
11676	155871	NP_057853.1	Tat	binds	9606	3685	NP_002201.1	integrin alpha-V isoform 1 precursor	2202737,7539135,7682219,7690138,9517988,10397733	2007-11-07 17:29	The arginine-glycine-aspartic acid (RGD) sequence present at the carboxy-terminal of HIV-1 Tat mediates vascular cell and monocyte migration and invasion by binding to the alpha-5-beta-1 and alpha-v-beta-3 integrins
11676	155871	NP_057853.1	Tat	interacts with	9606	3685	NP_002201.1	integrin alpha-V isoform 1 precursor	7539135,7690138,9626063,10397733,10438928	2007-11-07 17:29	HIV-1 Tat induces angiogenesis and cooperates in the development of AIDS-associated Kaposi sarcoma as a result of interactions with integrins alpha-5-beta-1 and alpha-v-beta 3
11676	155871	NP_057853.1	Tat	interacts with	9606	3685	NP_002201.1	integrin alpha-V isoform 1 precursor	8757349	2007-11-07 17:29	Interaction of HIV-1 Tat with alpha 5, beta 1, and alpha v subunits of surface integrin receptors mediates activation of CD4+ T cells
11676	155871	NP_057853.1	Tat	interacts with	9606	3685	NP_002201.1	integrin alpha-V isoform 1 precursor	9256940	2007-11-07 17:29	The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells through an interaction with integrin alpha v beta 3
11676	155871	NP_057853.1	Tat	interacts with	9606	3685	NP_002201.1	integrin alpha-V isoform 1 precursor	9916748	2007-11-07 17:29	IFN-gamma interacts with HIV-1 Tat to induce endothelial cells to proliferate and invade the extracellular matrix by upregulating the receptors for Tat (integrins alpha-5-beta-1 and alpha-v-beta-3), suggesting Tat and IFN-gamma play major roles in AIDS-KS
11676	155871	NP_057853.1	Tat	interacts with	9606	3685	NP_002201.1	integrin alpha-V isoform 1 precursor	16105876,16166568	2007-11-07 17:29	HIV-1 Tat exerts several pleiotropic effects by interacting with different cellular receptors, including integrin alpha(v)beta3, which triggers the activation of focal adhesion kinase, RhoA and pp60src
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3685	NP_002201.1	integrin alpha-V isoform 1 precursor	12083833	2007-11-07 17:31	HIV-1 gp120 interacts with CD4 and alphavbeta3 in peripheral blood monocyte-derived macrophages; neutralizing antibodies against the alphavbeta3 integrin interfere with the coprecipitation of alphavbeta3 with an anti-gp120 antibody
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3687	NP_000878.2	integrin alpha-X precursor	1967280	2007-11-07 17:29	Anti-CD18 monoclonal antibodies completely block cell fusion between HIV-1 infected U-937 cells and MT-4 T cells, indicating participation of CD18, or of the protein complex CD11a-c/CD18, in addition to CD4, in the infection and cytopathic effect of HIV-1
11676	155871	NP_057853.1	Tat	binds	9606	3688	NP_002202.2	integrin beta-1 isoform 1A precursor	2202737,7539135,7690138,9517988,10397733	2007-11-07 17:29	The arginine-glycine-aspartic acid (RGD) sequence present at the carboxy-terminal of HIV-1 Tat mediates vascular cell and monocyte migration and invasion by binding to the alpha-5-beta-1 and alpha-v-beta-3 integrins
11676	155871	NP_057853.1	Tat	interacts with	9606	3688	NP_002202.2	integrin beta-1 isoform 1A precursor	7539135,7690138,10397733	2007-11-07 17:29	HIV-1 Tat induces angiogenesis and cooperates in the development of AIDS-associated Kaposi sarcoma as a result of interactions with integrins alpha-5-beta-1 and alpha-v-beta 3
11676	155871	NP_057853.1	Tat	interacts with	9606	3688	NP_002202.2	integrin beta-1 isoform 1A precursor	8757349	2007-11-07 17:29	Interaction of HIV-1 Tat with alpha 5, beta 1, and alpha v subunits of surface integrin receptors mediates activation of CD4+ T cells
11676	155871	NP_057853.1	Tat	interacts with	9606	3688	NP_002202.2	integrin beta-1 isoform 1A precursor	8757599	2007-11-07 17:27	HIV-1 Tat induced monocyte invasion is inhibited by anti-beta integrin Ab or tissue inhibitor of metalloproteinase (TIMP), indicating an interaction with beta integrins and TIMP
11676	155871	NP_057853.1	Tat	interacts with	9606	3688	NP_002202.2	integrin beta-1 isoform 1A precursor	9916748	2007-11-07 17:29	IFN-gamma interacts with HIV-1 Tat to induce endothelial cells to proliferate and invade the extracellular matrix by upregulating the receptors for Tat (integrins alpha-5-beta-1 and alpha-v-beta-3), suggesting Tat and IFN-gamma play major roles in AIDS-KS
11676	155871	NP_057853.1	Tat	upregulates	9606	3689	NP_000202.2	integrin beta-2 precursor	8568270	2007-11-07 17:28	HIV-1 Tat treatment of monocytes upregulates beta 2 integrins and anti-beta 2 Abs inhibits Tat induced adhesion of monocytes to endothelial monolayers, suggesting a mechanism where monocytes could be inappropriately activated by HIV-1 Tat
11676	155871	NP_057853.1	Tat	interacts with	9606	3689	NP_000202.2	integrin beta-2 precursor	8757599	2007-11-07 17:27	HIV-1 Tat induced monocyte invasion is inhibited by anti-beta integrin Ab or tissue inhibitor of metalloproteinase (TIMP), indicating an interaction with beta integrins and TIMP
11676	155871	NP_057853.1	Tat	inhibits	9606	3689	NP_000202.2	integrin beta-2 precursor	11751951	2007-11-07 17:28	HIV-1 Tat inhibits calcium influx and impairs CAMKII activation elicited via LFA-1 (beta 2 integrin) in NK cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3689	NP_000202.2	integrin beta-2 precursor	1967280	2007-11-07 17:29	Anti-CD18 monoclonal antibodies completely block cell fusion between HIV-1 infected U-937 cells and MT-4 T cells, indicating participation of CD18, or of the protein complex CD11a-c/CD18, in addition to CD4, in the infection and cytopathic effect of HIV-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3689	NP_000202.2	integrin beta-2 precursor	8558011	2007-11-07 17:30	HIV-1 gp120-mediated ICAM-1 expression has functional significance, as it enhances the ability of monocytic cells to bind to gp120-stimulated human astrocytes in an ICAM-1/beta 2 integrin-dependent fashion
11676	155871	NP_057853.1	Tat	binds	9606	3690	NP_000203.2	integrin beta-3 precursor	2202737,7539135,7682219,7690138,9517988,10397733	2007-11-07 17:29	The arginine-glycine-aspartic acid (RGD) sequence present at the carboxy-terminal of HIV-1 Tat mediates vascular cell and monocyte migration and invasion by binding to the alpha-5-beta-1 and alpha-v-beta-3 integrins
11676	155871	NP_057853.1	Tat	interacts with	9606	3690	NP_000203.2	integrin beta-3 precursor	7539135,7690138,10397733,10438928	2007-11-07 17:29	HIV-1 Tat induces angiogenesis and cooperates in the development of AIDS-associated Kaposi sarcoma as a result of interactions with integrins alpha-5-beta-1 and alpha-v-beta 3
11676	155871	NP_057853.1	Tat	interacts with	9606	3690	NP_000203.2	integrin beta-3 precursor	8757599	2007-11-07 17:27	HIV-1 Tat induced monocyte invasion is inhibited by anti-beta integrin Ab or tissue inhibitor of metalloproteinase (TIMP), indicating an interaction with beta integrins and TIMP
11676	155871	NP_057853.1	Tat	interacts with	9606	3690	NP_000203.2	integrin beta-3 precursor	9256940,11867691	2007-11-07 17:29	The RGD-containing domain of exogenous HIV-1 Tat inhibits the engulfment of apoptotic bodies by dendritic cells through an interaction with integrin alpha v beta 3
11676	155871	NP_057853.1	Tat	interacts with	9606	3690	NP_000203.2	integrin beta-3 precursor	9916748	2007-11-07 17:29	IFN-gamma interacts with HIV-1 Tat to induce endothelial cells to proliferate and invade the extracellular matrix by upregulating the receptors for Tat (integrins alpha-5-beta-1 and alpha-v-beta-3), suggesting Tat and IFN-gamma play major roles in AIDS-KS
11676	155871	NP_057853.1	Tat	interacts with	9606	3690	NP_000203.2	integrin beta-3 precursor	16105876,16166568	2007-11-07 17:29	HIV-1 Tat exerts several pleiotropic effects by interacting with different cellular receptors, including integrin alpha(v)beta3, which triggers the activation of focal adhesion kinase, RhoA and pp60src
11676	155871	NP_057853.1	Tat	upregulates	9606	3690	NP_000203.2	integrin beta-3 precursor	16339753	2007-11-07 17:29	HIV-1 Tat upregulates the levels of CD61 in phorbol myristate acetate (PMA)-stimulated K562 hematopoietic progenitor cells
11676	155348	NP_705926.1	retropepsin	cleaves	9606	3691	NP_000204.3	integrin beta-4 isoform 1 precursor	12119179	2007-11-07 17:29	Beta4 integrin and alpha3 integrin are cleaved by the HIV-1 protease in human embryonic fibroblasts
11676	155871	NP_057853.1	Tat	interacts with	9606	3691	NP_000204.3	integrin beta-4 isoform 1 precursor	8444901	2007-11-07 17:29	A monoclonal antibody to beta 4 integrin inhibited cellular attachment of HIV-1 Tat by over 90%, suggesting an interaction between Tat and the beta 4 integrin subunit in cell attachment to Tat
11676	155871	NP_057853.1	Tat	binds	9606	3693	NP_002204.2	integrin beta-5 precursor	7682219,10438928	2007-11-07 17:29	The vitronectin-binding integrin, alpha v beta 5, is the cell surface protein that binds to the basic RGD domain (amino acids 65-85) of HIV-1 Tat
11676	155871	NP_057853.1	Tat	interacts with	9606	3693	NP_002204.2	integrin beta-5 precursor	8757599	2007-11-07 17:27	HIV-1 Tat induced monocyte invasion is inhibited by anti-beta integrin Ab or tissue inhibitor of metalloproteinase (TIMP), indicating an interaction with beta integrins and TIMP
11676	155908	NP_057854.1	Rev	inhibits	9606	3704	NP_258412.1	inosine triphosphate pyrophosphatase isoform a	1667585	2007-11-07 17:27	putative interaction based on report showing inhibition of nucleoside triphosphatase by Rev in mouse cells
11676	155871	NP_057853.1	Tat	interacts with	9606	3708	NP_002213.1	inositol 1,4,5-triphosphate receptor, type 1	10843712	2007-11-07 17:29	HIV-1 Tat induces release of calcium from inositol 1,4,5-triphosphate receptor-regulated stores in neurons and astrocytes, an effect that plays an important role in Tat-induced TNF-alpha production
11676	156110	NP_057857.2	Nef	Interacts with	9606	3708	NP_002213.1	inositol 1,4,5-triphosphate receptor, type 1	11956293,16454711	2007-11-07 17:28	HIV-1 Nef interacts with inositol 1,4,5-triphosphate receptor (IP3R) to trigger the activation of plasma membrane calcium influx channels
11676	155871	NP_057853.1	Tat	interacts with	9606	3709	NP_002214.2	inositol 1,4,5-trisphosphate receptor type 2	10843712	2007-11-07 17:28	HIV-1 Tat induces release of calcium from inositol 1,4,5-triphosphate receptor-regulated stores in neurons and astrocytes, an effect that plays an important role in Tat-induced TNF-alpha production
11676	155871	NP_057853.1	Tat	interacts with	9606	3710	NP_002215.1	inositol 1,4,5-triphosphate receptor, type 3	10843712	2007-11-07 17:28	HIV-1 Tat induces release of calcium from inositol 1,4,5-triphosphate receptor-regulated stores in neurons and astrocytes, an effect that plays an important role in Tat-induced TNF-alpha production
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3716	NP_002218.2	tyrosine-protein kinase JAK1	12089333,12775419	2007-11-07 17:30	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3718	NP_000206.2	tyrosine-protein kinase JAK3	9637477,11485409,12605694	2007-11-07 17:31	The inhibition of IL-2R expression and proliferation induced by the interaction of CD4 with HIV-1 envelope glycoprotein gp120 is correlated with the inhibition of expression and activation of Janus kinase JAK3
11676	155807	NP_057852.2	Vpr	activates	9606	3725	NP_002219.1	transcription factor AP-1	16243842	2007-11-07 17:29	Synthetic HIV-1 Vpr protein activates AP-1 (Jun/Fos), c-Jun N-terminal kinase (JNK), NF-kappaB, and MKK7 in both U937 cells and primary macrophages.
11676	155871	NP_057853.1	Tat	binds	9606	3725	NP_002219.1	transcription factor AP-1	7690421	2007-11-07 17:28	Crosslinking experiments suggest a direct binding interaction between HIV-1 Tat and AP1 that is relatively inefficient and that correlates with the ability of AP1 to support Tat transactivation
11676	155871	NP_057853.1	Tat	activates	9606	3725	NP_002219.1	transcription factor AP-1	9129988,9223324,9621077,9670954,10509564,10799874,11260070,11448159,15258149	2007-11-07 17:28	HIV-1 Tat activates c-jun (Activator Protein-1; AP-1) through the activation of JNK, an effect mediated through the activation of p56lck
11676	155871	NP_057853.1	Tat	activates	9606	3725	NP_002219.1	transcription factor AP-1	10644332,12485413	2007-11-07 17:28	HIV-1 Tat-induced expression of MCP-1 is partially mediated through the activation of c-jun (Activator Protein-1; AP-1) binding to, and transactivation of the MCP-1 promoter by Tat
11676	155871	NP_057853.1	Tat	downregulates	9606	3725	NP_002219.1	transcription factor AP-1	11254713	2007-11-07 17:28	HIV-1 Tat interacts with the cooperative rel/AP1 complex, downregulating its transactivation activity and leading to a decrease in IL-2 gene transcription
11676	155871	NP_057853.1	Tat	enhances	9606	3725	NP_002219.1	transcription factor AP-1	16690925	2007-11-07 17:31	HIV-1 Tat expression in Jurkat T cells enhances cooperative NFAT/AP-1- but not AP-1-dependent transcription independent of its ability to transactivate the HIV-1 LTR
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	3725	NP_002219.1	transcription factor AP-1	7642615	2007-11-07 17:30	HIV-1 gp160 induces activation of transcription factor, activated protein-1 (AP-1), comprised of Fos and Jun proteins, in CD4 positive T cell lines
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3725	NP_002219.1	transcription factor AP-1	7957556	2007-11-07 17:29	HIV-1 gp120 and anti-CD4 antibodies induce a specific, significant decrease in the binding activity of NF-AT, NF-kappa B and AP-1, which leads to an inhibition of IL-2 production and cell proliferation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	3725	NP_002219.1	transcription factor AP-1	8621941	2007-11-07 17:30	Binding of heat-inactivated HIV-1 (iHIV-1) or HIV-1 gp120 to infected resting PBMCs is sufficient to activate NF-kappa B and AP-1, to induce cell surface expression of CD25, and to commit cells to produce virus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3725	NP_002219.1	transcription factor AP-1	10027715,10581001,12089333,12775419	2007-11-07 17:31	Treatment of cells with HIV-1 gp120 induces increased levels of endogenous c-fos and c-jun mRNA and proteins, an activation of both c-fos and c-jun promoters, and a very rapid stimulation of the MAPK/ERK pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	3725	NP_002219.1	transcription factor AP-1	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3725	NP_002219.1	transcription factor AP-1	16001969	2007-11-07 17:31	HIV-1 envelope protein gp120 is able to induce COX-2 mRNA and protein in human neuroblastoma cell lines that express CXCR4 and CCR5 but not CD4; gp120 induces COX-2 promoter transcription through NF-kappaB and activating protein-1 (AP-1) sites
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	3725	NP_002219.1	transcription factor AP-1	16179804	2007-11-07 17:31	HIV-1 gp120 and p300 synergistically increase TGF-beta, ATF-2 and activating protein-1 (AP-1) expression leading to tubular cell apoptosis; in addition, HIV-1 gp120 treatment causes phosphorylation of Smad2 and downregulation of c-Jun
11676	156110	NP_057857.2	Nef	downregulates	9606	3725	NP_002219.1	transcription factor AP-1	8480425	2007-11-07 17:28	HIV-1 Nef inhibits c-jun transcription in mitogen-stimulated human T cells
11676	156110	NP_057857.2	Nef	activates	9606	3725	NP_002219.1	transcription factor AP-1	10388555,12419805	2007-11-07 17:28	HIV-1 Nef expression in human (THP-1) monocyte-macrophages induces both DNA binding and transcriptional activities of the activator protein-1 (AP-1) transcription factor, c-fos and c-jun; this induction requires the proline-rich PxxP motif of Nef
11676	155030	NP_057850.1	Pr55(Gag)	co-localizes with	9606	3732	NP_002222.1	CD82 antigen isoform 1	16735575	2007-11-07 17:31	HIV-1 Gag proteins co-localize with tetraspanins CD9, CD81, and CD82 in CD63-enriched microdomains
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	3735	NP_005539.1	lysyl-tRNA synthetase isoform 2	11333884,12756246,15078180,15183344,15220430	2007-11-07 17:29	Lysyl-tRNA synthetase is incorporated into HIV-1 virions through an interaction with HIV-1 Gag
11676	155030	NP_057850.1	Pr55(Gag)	interacts with	9606	3735	NP_005539.1	lysyl-tRNA synthetase isoform 2	12756246,15220430,16702215	2007-11-07 17:30	The interaction of Lysyl-tRNA synthetase with HIV-1 Gag is dependent upon Gag amino acids 310-363 (last 54 amino acids of the capsid domain) and amino acids 208-259 of Lysyl-tRNA synthetase
11676	155030	NP_579880.1	capsid	interacts with	9606	3735	NP_005539.1	lysyl-tRNA synthetase isoform 2	16702215	2007-11-07 17:31	The Capsid domain of HIV-1 Gag is sufficient for the interaction of Gag with lysyl-tRNA synthetase in an in vitro pull-down assay
11676	155348	NP_705926.1	retropepsin	inhibited by	9606	3735	NP_005539.1	lysyl-tRNA synthetase isoform 2	15888436	2007-11-07 17:29	Using a bioluminescence resonance energy transfer assay to directly measure HIV-1 protease activity in vivo indicates that the overexpression of lysyl tRNA synthetase (LysRS) in the cell reduces viral protease activity
11676	155807	NP_057852.2	Vpr	inhibits	9606	3735	NP_005539.1	lysyl-tRNA synthetase isoform 2	9525626,15142377,16120388	2007-11-07 17:28	HIV-1 Vpr binds to Lysyl-tRNA synthetase (LysRS) and inhibits LysRS-mediated aminoacylation of tRNA-Lys, an effect that may influence the initiation of HIV-1 reverse transcription
11676	155945	NP_057855.1	Vpu	interacts with	9606	3777	NP_002237.1	potassium channel subfamily K member 3	15099514,15099524	2007-11-07 17:29	HIV-1 Vpu interacts with TASK-1, a mammalian background K(+) channel, which in turn suppresses TASK-1 current in HEK-293 cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3778	NP_002238.2	calcium-activated potassium channel subunit alpha-1 isoform b	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3780	NP_002239.2	small conductance calcium-activated potassium channel protein 1	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3781	NP_067627.2	small conductance calcium-activated potassium channel protein 2 isoform a	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3782	NP_002240.3	small conductance calcium-activated potassium channel protein 3 isoform a	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3783	NP_002241.1	intermediate conductance calcium-activated potassium channel protein 4	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155871	NP_057853.1	Tat	activates	9606	3791	NP_002244.1	vascular endothelial growth factor receptor 2 precursor	8946838,9621077,10590123,10873597,11145723,11688957,14602571	2007-11-07 17:27	HIV-1 Tat, through its basic region (amino acids 49-57), binds and activates VEGFR-2, an effect associated with Tat-mediated pathogenesis and induction of angiogenesis in AIDS-associated Kaposi's sarcoma
11676	155871	NP_057853.1	Tat	activates	9606	3791	NP_002244.1	vascular endothelial growth factor receptor 2 precursor	9621077,11409852,16697675	2007-11-07 17:28	The interaction of HIV-1 Tat with KDR/VEGFR2 is implicated in the activation of ERK1 and ERK2 signaling pathways
11676	155871	NP_057853.1	Tat	interacts with	9606	3791	NP_002244.1	vascular endothelial growth factor receptor 2 precursor	11994280	2007-11-07 17:28	The activation of AKT and the protection of Kaposi's sarcoma cells from apoptosis mediated by HIV-1 Tat involves the interaction of Tat with VEGFR2
11676	155871	NP_057853.1	Tat	interacts with	9606	3791	NP_002244.1	vascular endothelial growth factor receptor 2 precursor	15528360	2007-11-07 17:28	The phosphorylation of vascular endothelial growth factor receptor type 2 (Flk-1/KDR) induces the ability of Tat to stimulate focal adhesion assembly and the migration of human brain microvascular endothelial cells (HBMECs)
11676	155871	NP_057853.1	Tat	upregulated by	9606	3791	NP_002244.1	vascular endothelial growth factor receptor 2 precursor	15857508	2007-11-07 17:28	VEGFR2 is upregulated by HIV-1 Tat treatment in human epithelial cells
11676	156110	NP_057857.2	Nef	upregulates	9606	3815	NP_000213.1	mast/stem cell growth factor receptor isoform 1 precursor	9108086	2007-11-07 17:28	The mechanism of HIV-1 induced apoptosis in astrocytes involves the upregulation of the receptor tyrosine kinase protooncogene c-Kit by the HIV-1 Nef protein
11676	155908	NP_057854.1	Rev	binds	9606	3835	NP_015556.1	kinesin-like protein KIF22	12805422	2007-11-07 17:30	KID is hypothesized to be a human breast cancer variant of Rev/Rex effector binding protein (REBP), a nuclear protein that binds HIV-1 Rev, co-localizes with Rev in the nucleoplasm and nuclear periphery of cells, and enhances Rev-dependent mRNA expression
11676	155030	NP_579876.2	matrix	imported by	9606	3836	NP_002255.2	karyopherin alpha 1	2064827,7494303,7745752,8041734,8041786,8105392,8529100,8551560,8659115,8876228,9275210,9303297,9366553,9463369,9548947,9557700,9562972,9593140,9603322,9918876,10525473,10860744,10964507,11904219	2007-11-07 17:28	The role of HIV-1 Matrix during nuclear import of the HIV-1 preintegration complex has been controversial, however recent understanding indicates HIV-1 Matrix and Vpr proteins act in concert to facilitate nuclear import by binding to karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	3836	NP_002255.2	karyopherin alpha 1	7585960,7859280,8552640,9008157	2007-11-07 17:28	Nuclear import of HIV-1 preintegration complexes by karyopherin alpha is governed by phosphorylation of HIV-1 Matrix on tyrosine and serine, however the exact role of phosphorylation of the C-terminal tyrosine of Matrix has been debated
11676	155030	NP_579876.2	matrix	imported by	9606	3836	NP_002255.2	karyopherin alpha 1	8105392,10860744	2007-11-07 17:28	HIV-1 Matrix contains two nuclear localization signals (NLS) spanning amino acids 24-33 and 110-114 that are recognized by karyopherin alpha and mediate the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	3836	NP_002255.2	karyopherin alpha 1	8659115,9366553,9463369,9557700,9562972,10525473	2007-11-07 17:28	HIV-1 Vpr increases the affinity of karyopherin alpha to the HIV-1 Matrix nuclear localization signal, thereby mediating the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	3836	NP_002255.2	karyopherin alpha 1	9282826	2007-11-07 17:28	HIV-1 Matrix increases intracellular ATP content, an effect hypothesized to support the ATP-dependent nuclear import of HIV-1 preintegration complexes by karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	3836	NP_002255.2	karyopherin alpha 1	10964507	2007-11-07 17:28	Hsp70 stimulates the binding of HIV-1 matrix to karyopherin alpha
11676	155348	NP_705928.1	integrase	imported by	9606	3836	NP_002255.2	karyopherin alpha 1	1631159,9275210,9366553,10366569,10525473,10888652,11035935,11278458,11389849,12368302,12414950	2007-11-07 17:29	Some reports indicate a possible role for the interactions between karyopherin alpha and beta with HIV-1 integrase in the nuclear import of HIV-1 preintegration complexes (PIC), while other reports indicate integrase is not involved in PIC nuclear import
11676	155348	NP_705928.1	integrase	imported by	9606	3836	NP_002255.2	karyopherin alpha 1	9275210,11035935,11278458	2007-11-07 17:29	Karyopherin alpha and beta are reported to interact with HIV-1 integrase (IN) to facilitate nuclear import of IN, however a conflicting report indicates nuclear accumulation of IN does not involve karyopherin alpha, beta 1, or beta 2 mediated pathways
11676	155348	NP_705928.1	integrase	binds	9606	3836	NP_002255.2	karyopherin alpha 1	9275210,15037073	2007-11-07 17:29	Karyopherin alpha binds to a bipartite nuclear localization signal in HIV-1 integrase (amino acids 186-189 and 211-219)
11676	155807	NP_057852.2	Vpr	binds	9606	3836	NP_002255.2	karyopherin alpha 1	9261351,9436978,9463369,9582382,9817747,10772949,10888660,10964507,11152524,12504543,15142377,15731250	2007-11-07 17:28	HIV-1 Vpr interacts with both karyopherin alpha 1 and alpha 2 to facilitate nuclear import of the HIV-1 preintegration complex, however conflicting reports indicate it may also be imported by other mechanisms independently of karyopherin alpha 1 and 2
11676	155807	NP_057852.2	Vpr	interacts with	9606	3836	NP_002255.2	karyopherin alpha 1	15731250	2007-11-07 17:28	HIV-1 Vpr interacts with importin-alpha through alphaH1 (residues 17-34) and alphaH2 (residues 46-74); the interaction via alphaH1 is indispensable for the nuclear entry of Vpr, and residues 393-462 of importin-alpha promote entry of Vpr into the nucleus
11676	155030	NP_579876.2	matrix	imported by	9606	3837	NP_002256.2	importin subunit beta-1	8105392,9562972,10860744	2007-11-07 17:28	Karyopherin beta mediates the nuclear import of HIV-1 preintegration complexes through karyopherin alpha, which binds directly to nuclear localization signals in HIV-1 Matrix
11676	155348	NP_705928.1	integrase	imported by	9606	3837	NP_002256.2	importin subunit beta-1	1631159,9275210,9366553,10366569,10525473,10888652,11035935,11278458,11389849,12368302,12414950	2007-11-07 17:29	Some reports indicate a possible role for the interactions between karyopherin alpha and beta with HIV-1 integrase in the nuclear import of HIV-1 preintegration complexes (PIC), while other reports indicate integrase is not involved in PIC nuclear import
11676	155348	NP_705928.1	integrase	imported by	9606	3837	NP_002256.2	importin subunit beta-1	9275210,11035935,11278458	2007-11-07 17:29	Karyopherin alpha and beta are reported to interact with HIV-1 integrase (IN) to facilitate nuclear import of IN, however a conflicting report indicates nuclear accumulation of IN does not involve karyopherin alpha, beta 1, or beta 2 mediated pathways
11676	155348	NP_705928.1	integrase	binds	9606	3837	NP_002256.2	importin subunit beta-1	9275210	2007-11-07 17:29	Karyopherin beta binds to complexes between HIV-1 integrase (integrase/GST fusion protein) and karyopherin alpha, but not to integrase alone
11676	155807	NP_057852.2	Vpr	regulates	9606	3837	NP_002256.2	importin subunit beta-1	9436978,9463369,9582382,9621063,9817747,10772949	2007-11-07 17:28	HIV-1 Vpr co-localizes with karyopherin beta and regulates karyopherin beta-mediated docking of the HIV-1 preintegration complex at the nuclear envelope, however multiple reports indicate the two proteins do not directly interact
11676	155871	NP_057853.1	Tat	imported by	9606	3837	NP_002256.2	importin subunit beta-1	9430704,9891055	2007-11-07 17:30	Importin beta binds to the HIV-1 Tat protein nuclear localization signal (NLS; amino acids 49-57) and mediates the nuclear import of Tat through a novel import pathway
11676	155871	NP_057853.1	Tat	binds	9606	3837	NP_002256.2	importin subunit beta-1	9891055	2007-11-07 17:30	The binding of HIV-1 Tat with importin beta is inhibited by RanGTP
11676	155908	NP_057854.1	Rev	binds	9606	3837	NP_002256.2	importin subunit beta-1	9405152,9891055,12614157,16354571	2007-11-07 17:27	importin beta specifically binds to the Rev nuclear localization signal (NLS, amino acids 35-50) and mediates the nuclear import of Rev
11676	155908	NP_057854.1	Rev	inhibited by	9606	3837	NP_002256.2	importin subunit beta-1	9891055	2007-11-07 17:30	importin beta can inhibit the interaction of HIV-1 Rev with HIV-1 RRE RNA
11676	155030	NP_579876.2	matrix	imported by	9606	3838	NP_002257.1	importin subunit alpha-2	2064827,7494303,7745752,8041734,8041786,8105392,8529100,8551560,8659115,8876228,9275210,9303297,9366553,9463369,9548947,9557700,9562972,9593140,9603322,9918876,10525473,10860744,10964507,11904219	2007-11-07 17:29	The role of HIV-1 Matrix during nuclear import of the HIV-1 preintegration complex has been controversial, however recent understanding indicates HIV-1 Matrix and Vpr proteins act in concert to facilitate nuclear import by binding to karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	3838	NP_002257.1	importin subunit alpha-2	7585960,7859280,8552640,9008157	2007-11-07 17:28	Nuclear import of HIV-1 preintegration complexes by karyopherin alpha is governed by phosphorylation of HIV-1 Matrix on tyrosine and serine, however the exact role of phosphorylation of the C-terminal tyrosine of Matrix has been debated
11676	155030	NP_579876.2	matrix	imported by	9606	3838	NP_002257.1	importin subunit alpha-2	8105392,10860744	2007-11-07 17:28	HIV-1 Matrix contains two nuclear localization signals (NLS) spanning amino acids 24-33 and 110-114 that are recognized by karyopherin alpha and mediate the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	3838	NP_002257.1	importin subunit alpha-2	8659115,9366553,9463369,9557700,9562972,10525473	2007-11-07 17:28	HIV-1 Vpr increases the affinity of karyopherin alpha to the HIV-1 Matrix nuclear localization signal, thereby mediating the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	3838	NP_002257.1	importin subunit alpha-2	9282826	2007-11-07 17:28	HIV-1 Matrix increases intracellular ATP content, an effect hypothesized to support the ATP-dependent nuclear import of HIV-1 preintegration complexes by karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	3838	NP_002257.1	importin subunit alpha-2	10964507	2007-11-07 17:28	Hsp70 stimulates the binding of HIV-1 matrix to karyopherin alpha
11676	155348	NP_705928.1	integrase	imported by	9606	3838	NP_002257.1	importin subunit alpha-2	1631159,9275210,9366553,10366569,10525473,10888652,11035935,11278458,11389849,12368302,12414950	2007-11-07 17:29	Some reports indicate a possible role for the interactions between karyopherin alpha and beta with HIV-1 integrase in the nuclear import of HIV-1 preintegration complexes (PIC), while other reports indicate integrase is not involved in PIC nuclear import
11676	155348	NP_705928.1	integrase	imported by	9606	3838	NP_002257.1	importin subunit alpha-2	9275210,11035935,11278458	2007-11-07 17:29	Karyopherin alpha and beta are reported to interact with HIV-1 integrase (IN) to facilitate nuclear import of IN, however a conflicting report indicates nuclear accumulation of IN does not involve karyopherin alpha, beta 1, or beta 2 mediated pathways
11676	155348	NP_705928.1	integrase	binds	9606	3838	NP_002257.1	importin subunit alpha-2	9275210,15037073	2007-11-07 17:29	Karyopherin alpha binds to a bipartite nuclear localization signal in HIV-1 integrase (amino acids 186-189 and 211-219)
11676	155807	NP_057852.2	Vpr	binds	9606	3838	NP_002257.1	importin subunit alpha-2	9261351,9436978,9463369,9582382,9817747,10772949,10888660,10964507,11152524,12504543,15142377,15731250	2007-11-07 17:28	HIV-1 Vpr interacts with both karyopherin alpha 1 and alpha 2 to facilitate nuclear import of the HIV-1 preintegration complex, however conflicting reports indicate it may also be imported by other mechanisms independently of karyopherin alpha 1 and 2
11676	155807	NP_057852.2	Vpr	interacts with	9606	3838	NP_002257.1	importin subunit alpha-2	15731250	2007-11-07 17:28	HIV-1 Vpr interacts with importin-alpha through alphaH1 (residues 17-34) and alphaH2 (residues 46-74); the interaction via alphaH1 is indispensable for the nuclear entry of Vpr, and residues 393-462 of importin-alpha promote entry of Vpr into the nucleus
11676	155030	NP_579876.2	matrix	imported by	9606	3839	NP_002258.2	importin subunit alpha-3	2064827,7494303,7745752,8041734,8041786,8105392,8529100,8551560,8659115,8876228,9275210,9303297,9366553,9463369,9548947,9557700,9562972,9593140,9603322,9918876,10525473,10860744,10964507,11904219	2007-11-07 17:28	The role of HIV-1 Matrix during nuclear import of the HIV-1 preintegration complex has been controversial, however recent understanding indicates HIV-1 Matrix and Vpr proteins act in concert to facilitate nuclear import by binding to karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	3839	NP_002258.2	importin subunit alpha-3	7585960,7859280,8552640,9008157	2007-11-07 17:28	Nuclear import of HIV-1 preintegration complexes by karyopherin alpha is governed by phosphorylation of HIV-1 Matrix on tyrosine and serine, however the exact role of phosphorylation of the C-terminal tyrosine of Matrix has been debated
11676	155030	NP_579876.2	matrix	imported by	9606	3839	NP_002258.2	importin subunit alpha-3	8105392,10860744	2007-11-07 17:28	HIV-1 Matrix contains two nuclear localization signals (NLS) spanning amino acids 24-33 and 110-114 that are recognized by karyopherin alpha and mediate the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	3839	NP_002258.2	importin subunit alpha-3	8659115,9366553,9463369,9557700,9562972,10525473	2007-11-07 17:28	HIV-1 Vpr increases the affinity of karyopherin alpha to the HIV-1 Matrix nuclear localization signal, thereby mediating the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	3839	NP_002258.2	importin subunit alpha-3	9282826	2007-11-07 17:28	HIV-1 Matrix increases intracellular ATP content, an effect hypothesized to support the ATP-dependent nuclear import of HIV-1 preintegration complexes by karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	3839	NP_002258.2	importin subunit alpha-3	10964507	2007-11-07 17:28	Hsp70 stimulates the binding of HIV-1 matrix to karyopherin alpha
11676	155348	NP_705928.1	integrase	imported by	9606	3839	NP_002258.2	importin subunit alpha-3	1631159,9275210,9366553,10366569,10525473,10888652,11035935,11278458,11389849,12368302,12414950	2007-11-07 17:29	Some reports indicate a possible role for the interactions between karyopherin alpha and beta with HIV-1 integrase in the nuclear import of HIV-1 preintegration complexes (PIC), while other reports indicate integrase is not involved in PIC nuclear import
11676	155348	NP_705928.1	integrase	imported by	9606	3839	NP_002258.2	importin subunit alpha-3	9275210,11035935,11278458	2007-11-07 17:29	Karyopherin alpha and beta are reported to interact with HIV-1 integrase (IN) to facilitate nuclear import of IN, however a conflicting report indicates nuclear accumulation of IN does not involve karyopherin alpha, beta 1, or beta 2 mediated pathways
11676	155348	NP_705928.1	integrase	binds	9606	3839	NP_002258.2	importin subunit alpha-3	9275210,15037073	2007-11-07 17:29	Karyopherin alpha binds to a bipartite nuclear localization signal in HIV-1 integrase (amino acids 186-189 and 211-219)
11676	155030	NP_579876.2	matrix	imported by	9606	3840	NP_002259.1	importin subunit alpha-4	2064827,7494303,7745752,8041734,8041786,8105392,8529100,8551560,8659115,8876228,9275210,9303297,9366553,9463369,9548947,9557700,9562972,9593140,9603322,9918876,10525473,10860744,10964507,11904219	2007-11-07 17:28	The role of HIV-1 Matrix during nuclear import of the HIV-1 preintegration complex has been controversial, however recent understanding indicates HIV-1 Matrix and Vpr proteins act in concert to facilitate nuclear import by binding to karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	3840	NP_002259.1	importin subunit alpha-4	7585960,7859280,8552640,9008157	2007-11-07 17:28	Nuclear import of HIV-1 preintegration complexes by karyopherin alpha is governed by phosphorylation of HIV-1 Matrix on tyrosine and serine, however the exact role of phosphorylation of the C-terminal tyrosine of Matrix has been debated
11676	155030	NP_579876.2	matrix	imported by	9606	3840	NP_002259.1	importin subunit alpha-4	8105392,10860744	2007-11-07 17:28	HIV-1 Matrix contains two nuclear localization signals (NLS) spanning amino acids 24-33 and 110-114 that are recognized by karyopherin alpha and mediate the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	3840	NP_002259.1	importin subunit alpha-4	8659115,9366553,9463369,9557700,9562972,10525473	2007-11-07 17:28	HIV-1 Vpr increases the affinity of karyopherin alpha to the HIV-1 Matrix nuclear localization signal, thereby mediating the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	3840	NP_002259.1	importin subunit alpha-4	9282826	2007-11-07 17:28	HIV-1 Matrix increases intracellular ATP content, an effect hypothesized to support the ATP-dependent nuclear import of HIV-1 preintegration complexes by karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	3840	NP_002259.1	importin subunit alpha-4	10964507	2007-11-07 17:28	Hsp70 stimulates the binding of HIV-1 matrix to karyopherin alpha
11676	155348	NP_705928.1	integrase	imported by	9606	3840	NP_002259.1	importin subunit alpha-4	1631159,9275210,9366553,10366569,10525473,10888652,11035935,11278458,11389849,12368302,12414950	2007-11-07 17:29	Some reports indicate a possible role for the interactions between karyopherin alpha and beta with HIV-1 integrase in the nuclear import of HIV-1 preintegration complexes (PIC), while other reports indicate integrase is not involved in PIC nuclear import
11676	155348	NP_705928.1	integrase	imported by	9606	3840	NP_002259.1	importin subunit alpha-4	9275210,11035935,11278458	2007-11-07 17:29	Karyopherin alpha and beta are reported to interact with HIV-1 integrase (IN) to facilitate nuclear import of IN, however a conflicting report indicates nuclear accumulation of IN does not involve karyopherin alpha, beta 1, or beta 2 mediated pathways
11676	155348	NP_705928.1	integrase	binds	9606	3840	NP_002259.1	importin subunit alpha-4	9275210,15037073	2007-11-07 17:29	Karyopherin alpha binds to a bipartite nuclear localization signal in HIV-1 integrase (amino acids 186-189 and 211-219)
11676	155030	NP_579876.2	matrix	imported by	9606	3841	NP_002260.2	importin subunit alpha-6	2064827,7494303,7745752,8041734,8041786,8105392,8529100,8551560,8659115,8876228,9275210,9303297,9366553,9463369,9548947,9557700,9562972,9593140,9603322,9918876,10525473,10860744,10964507,11904219	2007-11-07 17:29	The role of HIV-1 Matrix during nuclear import of the HIV-1 preintegration complex has been controversial, however recent understanding indicates HIV-1 Matrix and Vpr proteins act in concert to facilitate nuclear import by binding to karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	3841	NP_002260.2	importin subunit alpha-6	7585960,7859280,8552640,9008157	2007-11-07 17:28	Nuclear import of HIV-1 preintegration complexes by karyopherin alpha is governed by phosphorylation of HIV-1 Matrix on tyrosine and serine, however the exact role of phosphorylation of the C-terminal tyrosine of Matrix has been debated
11676	155030	NP_579876.2	matrix	imported by	9606	3841	NP_002260.2	importin subunit alpha-6	8105392,10860744	2007-11-07 17:28	HIV-1 Matrix contains two nuclear localization signals (NLS) spanning amino acids 24-33 and 110-114 that are recognized by karyopherin alpha and mediate the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	3841	NP_002260.2	importin subunit alpha-6	8659115,9366553,9463369,9557700,9562972,10525473	2007-11-07 17:28	HIV-1 Vpr increases the affinity of karyopherin alpha to the HIV-1 Matrix nuclear localization signal, thereby mediating the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	3841	NP_002260.2	importin subunit alpha-6	9282826	2007-11-07 17:28	HIV-1 Matrix increases intracellular ATP content, an effect hypothesized to support the ATP-dependent nuclear import of HIV-1 preintegration complexes by karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	3841	NP_002260.2	importin subunit alpha-6	10964507	2007-11-07 17:28	Hsp70 stimulates the binding of HIV-1 matrix to karyopherin alpha
11676	155348	NP_705928.1	integrase	imported by	9606	3841	NP_002260.2	importin subunit alpha-6	1631159,9275210,9366553,10366569,10525473,10888652,11035935,11278458,11389849,12368302,12414950	2007-11-07 17:29	Some reports indicate a possible role for the interactions between karyopherin alpha and beta with HIV-1 integrase in the nuclear import of HIV-1 preintegration complexes (PIC), while other reports indicate integrase is not involved in PIC nuclear import
11676	155348	NP_705928.1	integrase	imported by	9606	3841	NP_002260.2	importin subunit alpha-6	9275210,11035935,11278458	2007-11-07 17:29	Karyopherin alpha and beta are reported to interact with HIV-1 integrase (IN) to facilitate nuclear import of IN, however a conflicting report indicates nuclear accumulation of IN does not involve karyopherin alpha, beta 1, or beta 2 mediated pathways
11676	155348	NP_705928.1	integrase	binds	9606	3841	NP_002260.2	importin subunit alpha-6	9275210,15037073	2007-11-07 17:29	Karyopherin alpha binds to a bipartite nuclear localization signal in HIV-1 integrase (amino acids 186-189 and 211-219)
11676	155030	NP_579876.2	matrix	imported by	9606	3842	NP_002261.2	transportin 1	8105392,9562972,10860744	2007-11-07 17:28	Karyopherin beta mediates the nuclear import of HIV-1 preintegration complexes through karyopherin alpha, which binds directly to nuclear localization signals in HIV-1 Matrix
11676	155348	NP_705928.1	integrase	imported by	9606	3842	NP_002261.2	transportin 1	1631159,9275210,9366553,10366569,10525473,10888652,11035935,11278458,11389849,12368302,12414950	2007-11-07 17:29	Some reports indicate a possible role for the interactions between karyopherin alpha and beta with HIV-1 integrase in the nuclear import of HIV-1 preintegration complexes (PIC), while other reports indicate integrase is not involved in PIC nuclear import
11676	155348	NP_705928.1	integrase	imported by	9606	3842	NP_002261.2	transportin 1	9275210,11035935,11278458	2007-11-07 17:29	Karyopherin alpha and beta are reported to interact with HIV-1 integrase (IN) to facilitate nuclear import of IN, however a conflicting report indicates nuclear accumulation of IN does not involve karyopherin alpha, beta 1, or beta 2 mediated pathways
11676	155348	NP_705928.1	integrase	binds	9606	3842	NP_002261.2	transportin 1	9275210	2007-11-07 17:29	Karyopherin beta binds to complexes between HIV-1 integrase (integrase/GST fusion protein) and karyopherin alpha, but not to integrase alone
11676	155807	NP_057852.2	Vpr	regulates	9606	3842	NP_002261.2	transportin 1	9436978,9463369,9582382,9621063,9817747,10772949	2007-11-07 17:29	HIV-1 Vpr co-localizes with karyopherin beta and regulates karyopherin beta-mediated docking of the HIV-1 preintegration complex at the nuclear envelope, however multiple reports indicate the two proteins do not directly interact
11676	155871	NP_057853.1	Tat	imported by	9606	3842	NP_002261.2	transportin 1	9430704,9891055	2007-11-07 17:30	Importin beta binds to the HIV-1 Tat protein nuclear localization signal (NLS; amino acids 49-57) and mediates the nuclear import of Tat through a novel import pathway
11676	155871	NP_057853.1	Tat	binds	9606	3842	NP_002261.2	transportin 1	9891055	2007-11-07 17:30	The binding of HIV-1 Tat with importin beta is inhibited by RanGTP
11676	155908	NP_057854.1	Rev	binds	9606	3842	NP_002261.2	transportin 1	9405152,9891055,12614157	2007-11-07 17:28	importin beta specifically binds to the Rev nuclear localization signal (NLS, amino acids 35-50) and mediates the nuclear import of Rev
11676	155908	NP_057854.1	Rev	inhibited by	9606	3842	NP_002261.2	transportin 1	9891055	2007-11-07 17:30	importin beta can inhibit the interaction of HIV-1 Rev with HIV-1 RRE RNA
11676	155030	NP_579876.2	matrix	imported by	9606	3843	NP_002262.3	importin-5	8105392,9562972,10860744	2007-11-07 17:28	Karyopherin beta mediates the nuclear import of HIV-1 preintegration complexes through karyopherin alpha, which binds directly to nuclear localization signals in HIV-1 Matrix
11676	155348	NP_705928.1	integrase	imported by	9606	3843	NP_002262.3	importin-5	1631159,9275210,9366553,10366569,10525473,10888652,11035935,11278458,11389849,12368302,12414950	2007-11-07 17:29	Some reports indicate a possible role for the interactions between karyopherin alpha and beta with HIV-1 integrase in the nuclear import of HIV-1 preintegration complexes (PIC), while other reports indicate integrase is not involved in PIC nuclear import
11676	155348	NP_705928.1	integrase	imported by	9606	3843	NP_002262.3	importin-5	9275210,11035935,11278458	2007-11-07 17:29	Karyopherin alpha and beta are reported to interact with HIV-1 integrase (IN) to facilitate nuclear import of IN, however a conflicting report indicates nuclear accumulation of IN does not involve karyopherin alpha, beta 1, or beta 2 mediated pathways
11676	155348	NP_705928.1	integrase	binds	9606	3843	NP_002262.3	importin-5	9275210	2007-11-07 17:29	Karyopherin beta binds to complexes between HIV-1 integrase (integrase/GST fusion protein) and karyopherin alpha, but not to integrase alone
11676	155807	NP_057852.2	Vpr	regulates	9606	3843	NP_002262.3	importin-5	9436978,9463369,9582382,9621063,9817747,10772949	2007-11-07 17:28	HIV-1 Vpr co-localizes with karyopherin beta and regulates karyopherin beta-mediated docking of the HIV-1 preintegration complex at the nuclear envelope, however multiple reports indicate the two proteins do not directly interact
11676	155871	NP_057853.1	Tat	imported by	9606	3843	NP_002262.3	importin-5	9430704,9891055	2007-11-07 17:30	Importin beta binds to the HIV-1 Tat protein nuclear localization signal (NLS; amino acids 49-57) and mediates the nuclear import of Tat through a novel import pathway
11676	155871	NP_057853.1	Tat	binds	9606	3843	NP_002262.3	importin-5	9891055	2007-11-07 17:30	The binding of HIV-1 Tat with importin beta is inhibited by RanGTP
11676	155908	NP_057854.1	Rev	binds	9606	3843	NP_002262.3	importin-5	9405152,9891055,12614157	2007-11-07 17:28	importin beta specifically binds to the Rev nuclear localization signal (NLS, amino acids 35-50) and mediates the nuclear import of Rev
11676	155908	NP_057854.1	Rev	inhibited by	9606	3843	NP_002262.3	importin-5	9891055	2007-11-07 17:30	importin beta can inhibit the interaction of HIV-1 Rev with HIV-1 RRE RNA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	3845	NP_203524.1	GTPase KRas isoform a precursor	9269777,9344703	2007-11-07 17:30	HIV-1 gp160 alone or CD4/gp160 cross-linking induces tyrosine phosphorylation of intracellular substrates p59fyn, zap 70, and p95vav and also leads to ras activation
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inactivates	9606	3845	NP_203524.1	GTPase KRas isoform a precursor	9344703	2007-11-07 17:31	Pretreatment of cells with HIV-1 gp160 results in marked inhibition of tyrosine phosphorylation of p59(fyn), PLC-gamma1, ras activation, and TNF-alpha secretion in anti-CD3 mAb activated CD4+ T cells
11676	155871	NP_057853.1	Tat	upregulates	9606	3908	NP_000417.2	laminin subunit alpha-2 isoform a precursor	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3908	NP_000417.2	laminin subunit alpha-2 isoform a precursor	9597096	2007-11-07 17:27	HIV-1 gp120 inhibits CD3-triggered T cell co-stimulation by the extracellular matrix (ECM) proteins, which includes laminins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	3908	NP_000417.2	laminin subunit alpha-2 isoform a precursor	9597096	2007-11-07 17:27	HIV-1 gp41 inhibits CD3-triggered T cell co-stimulation by the extracellular matrix (ECM) proteins, which includes laminins
11676	155871	NP_057853.1	Tat	upregulates	9606	3909	NP_000218.2	laminin subunit alpha-3 isoform 2	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3909	NP_000218.2	laminin subunit alpha-3 isoform 2	9597096	2007-11-07 17:27	HIV-1 gp120 inhibits CD3-triggered T cell co-stimulation by the extracellular matrix (ECM) proteins, which includes laminins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	3909	NP_000218.2	laminin subunit alpha-3 isoform 2	9597096	2007-11-07 17:27	HIV-1 gp41 inhibits CD3-triggered T cell co-stimulation by the extracellular matrix (ECM) proteins, which includes laminins
11676	155871	NP_057853.1	Tat	upregulates	9606	3910	NP_002281.1	laminin, alpha 4 precursor	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3910	NP_002281.1	laminin, alpha 4 precursor	9597096	2007-11-07 17:27	HIV-1 gp120 inhibits CD3-triggered T cell co-stimulation by the extracellular matrix (ECM) proteins, which includes laminins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	3910	NP_002281.1	laminin, alpha 4 precursor	9597096	2007-11-07 17:27	HIV-1 gp41 inhibits CD3-triggered T cell co-stimulation by the extracellular matrix (ECM) proteins, which includes laminins
11676	155871	NP_057853.1	Tat	upregulates	9606	3911	NP_005551.3	laminin subunit alpha-5 precursor	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3911	NP_005551.3	laminin subunit alpha-5 precursor	9597096	2007-11-07 17:27	HIV-1 gp120 inhibits CD3-triggered T cell co-stimulation by the extracellular matrix (ECM) proteins, which includes laminins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	3911	NP_005551.3	laminin subunit alpha-5 precursor	9597096	2007-11-07 17:27	HIV-1 gp41 inhibits CD3-triggered T cell co-stimulation by the extracellular matrix (ECM) proteins, which includes laminins
11676	155871	NP_057853.1	Tat	upregulates	9606	3912	NP_002282.1	laminin, beta 1 precursor	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155871	NP_057853.1	Tat	upregulates	9606	3913	NP_002283.3	laminin subunit beta-2 precursor	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155871	NP_057853.1	Tat	upregulates	9606	3914	NP_000219.2	laminin subunit beta-3 precursor	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155871	NP_057853.1	Tat	upregulates	9606	3915	NP_002284.2	laminin, gamma 1 precursor	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155030	NP_579880.1	capsid	co-localizes with	9606	3916	NP_005552.3	lysosome-associated membrane glycoprotein 1 precursor	12230470	2007-11-07 17:29	In human macrophages, HIV-1 Capsid (p24) co-localizes with MHC II (HLA-DR), CD63, and Lamp1 in MHC II compartments
11676	155871	NP_057853.1	Tat	upregulates	9606	3918	NP_005553.1	laminin, gamma 2 isoform a precursor	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155871	NP_057853.1	Tat	activates	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	10799874	2007-11-07 17:28	HIV-1 Tat activates p56lck in Jurkat cells leading to the degradation of IkappaBalpha and activation of NFkappaB, AP-1, JNK, MAPKK, caspases, and apoptosis
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	1535787,1548763,9989602	2007-11-07 17:31	Interaction of HIV-1 gp160 with CD4 increases p56lck autophosphorylation and kinase activity
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	9341793	2007-11-07 17:28	HIV-1 gp160 downregulates lymphocyte function-associated antigen-1 (LFA-1)-dependent adhesion between CD4+ T cells and B cells; this downregulation is shown to be p56lck-dependent
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	1491632,1535086,1622897,2040625,7774645,8887682,12628756	2007-11-07 17:30	HIV-1 gp120 induces the dissociation of p56lck from CD4 and the downregulation of CD4 from the cellular surface
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	1622897,7680610,8648738,8671590,8883579	2007-11-07 17:30	p56lck-positive cells are markedly more susceptible to syncytium formation than p56lck-negative cells, implying a regulatory role for p56lck in the syncytium formation mediated by HIV-1 gp120 envelope interaction with CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	7494315	2007-11-07 17:30	Activation of the CD4-p56lck receptor signal transduction pathway by HIV-1 gp120 does not increase prostaglandin formation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	7522245,8671590,9036944,9043947,9123823	2007-11-07 17:30	Binding of HIV-1 gp120 to CD4 induces p56lck activation and zeta-chain (TCR) associated protein kinase 70kDa desensitization independent of TCR tyrosine phosphorylation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	7539724,7774645,9043947	2007-11-07 17:30	HIV-1 gp120 inhibits CD3-induced Lck activation and cellular tyrosine phosphorylation, particularly of phosphoinositide-specific phospholipase C-gamma-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	8671590,8883579,9043947,9269777,9344703	2007-11-07 17:31	Interaction of HIV-1 gp120 with CD4 leads to increased levels of phosphorylation of the src-family Lck and Fyn protein tyrosine kinases and enhancement of their activities
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	8870842	2007-11-07 17:30	The protein tyrosine kinase p56lck plays an active role in transmitting an HIV-1 gp120-mediated signal that increases the oxidative state of cells and as a consequence amplifies TNF-mediated NF-kappa B DNA binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	8887682	2007-11-07 17:30	Binding of HIV-1 gp120 to CD4 molecules results in the association of Lck and Raf-1, which is abolished by preincubation of the virus with soluble CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	9123823,10358157,10422873	2007-11-07 17:28	HIV-1 gp120 induces an increase in tyrosine phosphorylation of two proteins, p56lck and phosphatidylinositol 3-kinase (PI 3-kinase) p85 alpha, that are physically complexed to the CD4 molecule
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	requires	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	9621091	2007-11-07 17:30	CD4-p56Lck interaction is required for HIV-1 gp120-induced nuclear translocation of NF-kappaB in HeLa cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	8671590	2007-11-07 17:31	HIV-1 gp120 and gp41-induced cell killing is accompanied by tyrosine phosphorylation and activation of the CD4-associated p56(Lck) kinase, and by activation of a second member of the scr family of protein tyrosine kinases, p59(fyn) kinase
11676	156110	NP_057857.2	Nef	interacts with	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	7831289,7871751,8871625,10208934	2007-11-07 17:27	Amino acid residues 402-419 of the cytoplasmic tail of CD4 are required for association with Lck and also for the downregulation of CD4 induced by HIV-1 Nef, suggesting a potential interaction between Nef and Lck
11676	156110	NP_057857.2	Nef	inactivates	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	7853525	2007-11-07 17:27	HIV-1 Nef interferes with the activation of Lck and as a consequence of signaling via the IL-2 receptor
11676	156110	NP_057857.2	Nef	binds	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	7859737,8626429,9705913	2007-11-07 17:28	Cooperation of the Lck SH2 and SH3 domains is required for HIV-1 Nef binding to Lck to a level similar to Nef binding to the Hck SH3 domain
11676	156110	NP_057857.2	Nef	binds	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	8794306,10544125,10642173,14965316,15078178,15638726,15976924	2007-11-07 17:28	A highly conserved proline-rich repeat sequence in Nef between amino acids 69-78 directly binds to the SH2 and SH3 domains of Lck
11676	156110	NP_057857.2	Nef	binds	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	9075929,10364375	2007-11-07 17:27	HIV-1 and SIV Nef can bind Lck SH2 domains, and their N-terminal 50 amino acid residues are sufficient for Src kinase binding and activation
11676	156110	NP_057857.2	Nef	Interacts with	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	11525746	2007-11-07 17:28	HIV-1 Nef efficiently interacts with Lck by coimmunoprecipitation and in vitro kinase assays; this interaction is reduced by an R71T mutation in the proline-rich motif of Nef
11676	156110	NP_057857.2	Nef	upregulates	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	15186530	2007-11-07 17:28	HIV-1 Nef increases the association of the src family tyrosine kinase, Lck, and TCRzeta with rafts in human T cells, suggesting Nef primes resting T cells for activation by upregulating the levels of signaling molecules within rafts
11676	156110	NP_057857.2	Nef	interacts with	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	15371598	2007-11-07 17:28	Assays with phage-displayed Nef from HIV-1 NL4-3 have been used to identify a series of guanidine alkaloid-based inhibitors of Nef interactions with p53, actin, and p56(lck)
11676	156110	NP_057857.2	Nef	requires	9606	3932	NP_005347.3	tyrosine-protein kinase Lck precursor	15892963	2007-11-07 17:28	HIV-1 Nef enhances the phosphorylation of c-Cbl in CD4+ T cells, an effect that requires the Src tyrosine kinase Lck
11676	155348	NP_705926.1	retropepsin	cleaves	9606	3936	NP_002289.1	L-plastin	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	cleaved by	9606	3936	NP_002289.1	L-plastin	9923600	2007-11-07 17:31	Plasmin cleaves HIV-1 gp160 precisely at the C-terminal arginine residue 510 of gp120, yielding the mature gp120 and gp41 proteins
11676	155871	NP_057853.1	Tat	downregulates	9606	3939	NP_005557.1	L-lactate dehydrogenase A chain isoform 1	15710247	2007-11-07 17:28	Upregulation of actin, heat shock protein 90 and mitochondrial single-stranded DNA binding protein, and downregulation of lactate dehydrogenase are identified in human astrocytes expressing Tat
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	3939	NP_005557.1	L-lactate dehydrogenase A chain isoform 1	11125887	2007-11-07 17:31	HIV-1 gp120/41 (SFVenvBX08)-expressing microglia exhibit a 170% increase in lactate dehydrogenase (LDH) release
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	induces release of	9606	3939	NP_005557.1	L-lactate dehydrogenase A chain isoform 1	11582518	2007-11-07 17:31	A lentivirus lytic peptide 1 (LLP-1) corresponding to the carboxyl terminus of HIV-1 gp41 induces a significant lactate dehydrogenase (LDH, a marker of cell death) release from human neuronal and glial cell lines
11676	155871	NP_057853.1	Tat	downregulates	9606	3945	NP_002291.1	L-lactate dehydrogenase B chain	15710247	2007-11-07 17:28	Upregulation of actin, heat shock protein 90 and mitochondrial single-stranded DNA binding protein, and downregulation of lactate dehydrogenase are identified in human astrocytes expressing Tat
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	3945	NP_002291.1	L-lactate dehydrogenase B chain	11125887	2007-11-07 17:31	HIV-1 gp120/41 (SFVenvBX08)-expressing microglia exhibit a 170% increase in lactate dehydrogenase (LDH) release
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	induces release of	9606	3945	NP_002291.1	L-lactate dehydrogenase B chain	11582518	2007-11-07 17:31	A lentivirus lytic peptide 1 (LLP-1) corresponding to the carboxyl terminus of HIV-1 gp41 induces a significant lactate dehydrogenase (LDH, a marker of cell death) release from human neuronal and glial cell lines
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	3948	NP_002292.1	L-lactate dehydrogenase C chain	11125887	2007-11-07 17:31	HIV-1 gp120/41 (SFVenvBX08)-expressing microglia exhibit a 170% increase in lactate dehydrogenase (LDH) release
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	induces release of	9606	3948	NP_002292.1	L-lactate dehydrogenase C chain	11582518	2007-11-07 17:31	A lentivirus lytic peptide 1 (LLP-1) corresponding to the carboxyl terminus of HIV-1 gp41 induces a significant lactate dehydrogenase (LDH, a marker of cell death) release from human neuronal and glial cell lines
11676	156110	NP_057857.2	Nef	upregulates	9606	3949	NP_000518.1	low-density lipoprotein receptor precursor	16014965	2007-11-07 17:28	HIV-1 Nef expression in Jurkat cells upregulates LDLR, which is involved in cholesterol uptake
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	3956	NP_002296.1	galectin-1	15778371	2007-11-07 17:30	Galectin-1, a dimeric beta-galactoside-binding protein, promotes infection with CCR5-tropic, CXCR4-tropic, and CCR5/CXCR4 dual-tropic HIV-1 variants by facilitating attachment of HIV-1 gp120 to CD4 at the cell surface
11676	155871	NP_057853.1	Tat	upregulates	9606	3958	NP_002297.2	galectin-3 isoform 1	7600101,10089212	2007-11-07 17:29	HIV-1 Tat upregulates galectin-3 (carbohydrate-binding protein 35; CBP35) expression in an Sp-1 dependent manner
11676	155908	NP_057854.1	Rev	inhibits	9606	3958	NP_002297.2	galectin-3 isoform 1	8581828	2007-11-07 17:27	CBP35 was identified as part of a complex of ribonucleoproteins that bind to RRE RNA, an interaction that is abolished by Rev
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulates	9606	3976	NP_002300.1	leukemia inhibitory factor precursor	12089333	2007-11-07 17:30	HIV-1 gp120 modulates expression of the cytokines IL1beta, IL3, IL6, IL10, IL13, IL15, IFNbeta2A, IFNgamma, IFNomega, TNFalpha, VEGF, VEGF B, and LIF in PBMCs and MDMs
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	3998	NP_005561.1	protein ERGIC-53 precursor	8267903,8666845,10725420,12487819	2007-11-07 17:31	Activation of the classical complement pathway by HIV-1 gp120 is initiated by the binding of MBP to carbohydrate side chains of gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	3998	NP_005561.1	protein ERGIC-53 precursor	12487819	2007-11-07 17:31	Treatment of HIV-1 gp120 with endoglycosidase H (eH) or endoglycosidase F1 (eF1) abrogates binding of MBL
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	3998	NP_005561.1	protein ERGIC-53 precursor	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	3998	NP_005561.1	protein ERGIC-53 precursor	12941144,15572157	2007-11-07 17:30	DC-SIGN and MBL bind primarily to glycans on HIV-1 gp120/gp41; preincubation of CXCR4-, CCR5- or dual-tropic HIV-1 strains with MBL prevents DC-SIGN-mediated trans infection of T cells
11676	155908	NP_057854.1	Rev	binds	9606	4000	NP_005563.1	lamin-A/C isoform 2	1667585	2007-11-07 17:27	putative interaction based on report of Rev binding to nuclear scaffold and lamin C from mouse cells
11676	155807	NP_057852.2	Vpr	co-localizes with	9606	4000	NP_733821.1	lamin-A/C isoform 1 precursor	9436978,11691994	2007-11-07 17:28	HIV-1 Vpr co-localizes with lamin A/C and induces localized disruptions in the normal nuclear lamin architecture, contributing to the formation of nuclear envelope herniations
11676	155871	NP_057853.1	Tat	binds	9606	4000	NP_733821.1	lamin-A/C isoform 1 precursor	2406262,2544227	2007-11-07 17:27	Purified HIV-1 Tat has been shown to bind with high affinity to the nuclear matrix from H9 cells and to link viral RNAs to the nuclear matrix
11676	155807	NP_057852.2	Vpr	co-localizes with	9606	4001	NP_005564.1	lamin-B1	9436978,11691994	2007-11-07 17:28	HIV-1 Vpr co-localizes with lamin B and induces localized disruptions in the normal nuclear lamin architecture, contributing to the formation of nuclear envelope herniations
11676	155871	NP_057853.1	Tat	binds	9606	4001	NP_005564.1	lamin-B1	2406262,2544227	2007-11-07 17:27	Purified HIV-1 Tat has been shown to bind with high affinity to the nuclear matrix from H9 cells and to link viral RNAs to the nuclear matrix
11676	155871	NP_057853.1	Tat	inhibits	9606	4035	NP_002323.1	low density lipoprotein-related protein 1	11100124,16697675	2007-11-07 17:30	Binding of HIV-1 Tat to LRP inhibits neuronal binding, uptake and degradation of physiological ligands for LRP, including alpha2-macroglobulin, apolipoprotein E4, amyloid precursor and amyloid beta-protein
11676	155871	NP_057853.1	Tat	binds	9606	4035	NP_002323.1	low density lipoprotein-related protein 1	11100124,15264223	2007-11-07 17:30	LRP binds to the core domain of HIV-1 Tat (amino acids 37-48) and promotes the efficient uptake of Tat into neurons, suggesting Tat may mediate HIV-1 induced neuropathology through disruption of LRP ligands and activation of neuronal genes
11676	155871	NP_057853.1	Tat	upregulates	9606	4049	NP_000586.2	lymphotoxin-alpha precursor	1279199,2243081,7695626,7818827,8139045,16375755	2007-11-07 17:29	HIV-1 Tat upregulates TNF-beta expression through binding to a TAR-like RNA structure in the TNF-beta promoter
11676	155871	NP_057853.1	Tat	downregulates	9606	4049	NP_000586.2	lymphotoxin-alpha precursor	9282784,16375755	2007-11-07 17:29	HIV-1 Tat downregulates TNF-beta expression in central nervous system-derived glial cells, suggesting a novel mechanism whereby HIV-1 is able to establish latent infection of glial cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	4049	NP_000586.2	lymphotoxin-alpha precursor	16934308	2007-11-07 17:31	In endometrial epithelium-derived cells, gp120 from CCR5-tropic HIV-1 increases the release of monocytes/chemokines-attracting chemokines (IL-8 and GRO) and proinflammatory cytokines (TNF-beta and IL-1alpha)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	4057	NP_002334.2	lactotransferrin precursor	9781360,15709021,16928883	2007-11-07 17:31	Native lactoferrin (LF) and acylated LF from milk strongly bind to the V3 domain of the HIV-1 envelope protein gp120, resulting in inhibition of the virus-cell fusion and entry of the virus in CD4+ cells
11676	155871	NP_057853.1	Tat	downregulates	9606	4064	NP_005573.1	CD180 molecule	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat downregulates the expression of many proteins, including RP105, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	4067	NP_002341.1	tyrosine-protein kinase Lyn isoform A	16621960	2007-11-07 17:31	Stimulation of human monocyte-derived macrophages with HIV-1 gp120 results in the CCR5-mediated activation of Lyn and the concomitant Lyn-dependent activation of the mitogen-activated protein (MAP) kinase ERK-1/2, which leads to production of TNF-alpha
11676	156110	NP_057857.2	Nef	interacts with	9606	4067	NP_002341.1	tyrosine-protein kinase Lyn isoform A	10544125,10642173,12734410,15078178,15638726,16454711	2007-11-07 17:27	The interaction of HIV-1 Nef with Lyn does not induce Lyn kinase activation
11676	156110	NP_057857.2	Nef	activates	9606	4067	NP_002341.1	tyrosine-protein kinase Lyn isoform A	16849330	2007-11-07 17:31	Interaction of HIV-1 Nef with the SH3 domain of Lyn regulates its effects on Lyn tyrosine kinase activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	4087	NP_005892.1	mothers against decapentaplegic homolog 2 isoform 1	16179804	2007-11-07 17:31	HIV-1 gp120 and p300 synergistically increase TGF-beta, ATF-2 and activating protein-1 (AP-1) expression leading to tubular cell apoptosis; in addition, HIV-1 gp120 treatment causes phosphorylation of Smad2 and downregulation of c-Jun
11676	155871	NP_057853.1	Tat	stimulated by	9606	4088	NP_005893.1	mothers against decapentaplegic homolog 3 isoform 1	12202226,12758167	2007-11-07 17:29	Smad-3 stimulates HIV-1 Tat mediated transcription from the HIV-1 LTR promoter and the MCP promoter through a direct association with Tat amino acids 1-40
11676	155871	NP_057853.1	Tat	inhibited by	9606	4088	NP_005893.1	mothers against decapentaplegic homolog 3 isoform 1	16750572	2007-11-07 17:31	The C-terminal MH2 domain of Smad3 can decrease the levels of HIV-1 Tat-induced activation of MCP-1 in astrocytic cells
11676	155871	NP_057853.1	Tat	inhibited by	9606	4089	NP_005350.1	mothers against decapentaplegic homolog 4	12202226,12758167	2007-11-07 17:29	Smad-4 inhibits Smad-3 and HIV-1 Tat-induced transcription from the HIV-1 LTR promoter and the MCP promoter through a direct association with amino acids 1-40 of Tat
11676	155871	NP_057853.1	Tat	downregulates	9606	4091	NP_005576.3	mothers against decapentaplegic homolog 6 isoform 1	16282533	2007-11-07 17:29	SMAD6 expression and its phosphorylation, in response to bone morphogenetic protein-2 (BMP2) treatment, is downregulated by HIV-1 Tat treatment in the macrophage cell line U937
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	4092	NP_005895.1	mothers against decapentaplegic homolog 7	16179804	2007-11-07 17:31	HIV-1 gp120-induced apoptosis in human proximal renal tubular cells is significantly enhanced by p300, and Smad7 and an anti-TGF-beta antibody inhibit this effect of p300
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	4099	NP_002352.1	myelin-associated glycoprotein isoform a precursor	1282933	2007-11-07 17:30	HIV-1 gp120 binds to myelin associated glycoprotein (MAG), an autoantigen in demyelinating neuropathy
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	4121	NP_005898.2	mannosyl-oligosaccharide 1,2-alpha-mannosidase IA	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4121	NP_005898.2	mannosyl-oligosaccharide 1,2-alpha-mannosidase IA	2283726,2355006,2406237,2542563,2649653,2829950,8218172,8892864	2007-11-07 17:29	HIV-1 gp120 N-linked oligosaccharides are processed by manosidase I and II in the Golgi complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4121	NP_005898.2	mannosyl-oligosaccharide 1,2-alpha-mannosidase IA	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	4121	NP_005898.2	mannosyl-oligosaccharide 1,2-alpha-mannosidase IA	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	4122	NP_006113.2	alpha-mannosidase 2x	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4122	NP_006113.2	alpha-mannosidase 2x	2283726,2355006,2542563,2649653,2829950,8218172,8892864	2007-11-07 17:29	HIV-1 gp120 N-linked oligosaccharides are processed by manosidase I and II in the Golgi complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4122	NP_006113.2	alpha-mannosidase 2x	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	4122	NP_006113.2	alpha-mannosidase 2x	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	4123	NP_006706.2	alpha-mannosidase 2C1	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4123	NP_006706.2	alpha-mannosidase 2C1	2283726,2355006,2542563,2649653,2829950,8218172,8892864	2007-11-07 17:29	HIV-1 gp120 N-linked oligosaccharides are processed by manosidase I and II in the Golgi complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4123	NP_006706.2	alpha-mannosidase 2C1	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	4123	NP_006706.2	alpha-mannosidase 2C1	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	4124	NP_002363.2	alpha-mannosidase 2	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4124	NP_002363.2	alpha-mannosidase 2	2283726,2355006,2542563,2649653,2829950,8218172,8892864	2007-11-07 17:29	HIV-1 gp120 N-linked oligosaccharides are processed by manosidase I and II in the Golgi complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4124	NP_002363.2	alpha-mannosidase 2	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	4124	NP_002363.2	alpha-mannosidase 2	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	4125	NP_000519.2	lysosomal alpha-mannosidase isoform 1 precursor	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4125	NP_000519.2	lysosomal alpha-mannosidase isoform 1 precursor	2283726,2355006,2542563,2649653,2829950,8218172,8892864	2007-11-07 17:29	HIV-1 gp120 N-linked oligosaccharides are processed by manosidase I and II in the Golgi complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4125	NP_000519.2	lysosomal alpha-mannosidase isoform 1 precursor	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	4125	NP_000519.2	lysosomal alpha-mannosidase isoform 1 precursor	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	4126	NP_005899.3	beta-mannosidase precursor	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4126	NP_005899.3	beta-mannosidase precursor	2283726,2355006,2542563,2649653,2829950,8218172,8892864	2007-11-07 17:31	HIV-1 gp120 N-linked oligosaccharides are processed by manosidase I and II in the Golgi complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4126	NP_005899.3	beta-mannosidase precursor	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	4126	NP_005899.3	beta-mannosidase precursor	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155348	NP_705926.1	retropepsin	cleaves	9606	4130	NP_002364.5	microtubule-associated protein 1A	2212989,8997639	2007-11-07 17:29	HIV-1 protease extensively cleaves microtubule-associated proteins 1 and 2 and completely inhibits microtubule assembly
11676	155348	NP_705926.1	retropepsin	cleaves	9606	4133	NP_002365.3	microtubule-associated protein 2 isoform 1	1494913,2212989,8997639	2007-11-07 17:29	HIV-1 protease extensively cleaves microtubule-associated proteins 1 and 2 and completely inhibits microtubule assembly
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	4133	NP_002365.3	microtubule-associated protein 2 isoform 1	15285794,15285795	2007-11-07 17:30	Ascorbate supplementation prevents the deleterious upregulation of iNOS and associated neuronal (MAP2) and astrocytic (GFAP) protein expression and structural changes caused by gp120 in human brain cell cultures
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	4149	NP_002373.3	protein max isoform a	11208609	2007-11-07 17:30	HIV-1 gp120 downregulates expression of c-Myc, Max, and 14-3-3epsilon proteins, and decreases phosphorylation of ATP-dependent tyrosine kinases (Akt) at Ser-473 in human mesangial cells (HMC)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	4153	NP_000233.1	mannose-binding protein C precursor	8267903,8666845,10725420,12487819,15488604	2007-11-07 17:29	Activation of the classical complement pathway by HIV-1 gp120 is initiated by the binding of MBP to carbohydrate side chains of gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	4153	NP_000233.1	mannose-binding protein C precursor	12487819,15488604	2007-11-07 17:31	Treatment of HIV-1 gp120 with endoglycosidase H (eH) or endoglycosidase F1 (eF1) abrogates binding of MBL
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	4153	NP_000233.1	mannose-binding protein C precursor	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	4153	NP_000233.1	mannose-binding protein C precursor	12941144,15117456,15488604,15572157,16094691	2007-11-07 17:30	DC-SIGN and MBL bind primarily to glycans on HIV-1 gp120/gp41; preincubation of CXCR4-, CCR5- or dual-tropic HIV-1 strains with MBL prevents DC-SIGN-mediated trans infection of T cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	4166	NP_067628.1	carbohydrate sulfotransferase 6	1433500,8419650	2007-11-07 17:30	Sulfate is linked to the carbohydrate chains of HIV-1 glycoproteins gp160, gp120, and gp41 during the endoplasmic reticulum to Golgi transport of the glycoproteins
11676	155871	NP_057853.1	Tat	ubiquitinated by	9606	4193	NP_002383.2	E3 ubiquitin-protein ligase Mdm2 isoform MDM2	12883554	2007-11-07 17:29	Hdm2 interacts directly with HIV-1 Tat and ubiquitinates Tat on amino acid residue Lys71
11676	155871	NP_057853.1	Tat	regulated by	9606	4193	NP_002383.2	E3 ubiquitin-protein ligase Mdm2 isoform MDM2	12883554	2007-11-07 17:29	Ubiquitination of HIV-1 Tat by Hdm2 is required for efficient replication of HIV-1, indicating Hdm2 regulates Tat function and is a Tat co-activator
11676	156110	NP_057857.2	Nef	binds	9606	4217	NP_005914.1	mitogen-activated protein kinase kinase kinase 5	11298454,11323689	2007-11-07 17:27	HIV-1 Nef binds to ASK1 as demonstrated by GST-pull down and coimmunoprecipitation experiments
11676	156110	NP_057857.2	Nef	inhibits	9606	4217	NP_005914.1	mitogen-activated protein kinase kinase kinase 5	11298454,11323689	2007-11-07 17:27	HIV-1 Nef inhibits ASK1 catalytic activity by impairing stimulus-coupled release of its normal negative regulator, thioredoxin
11676	156110	NP_057857.2	Nef	inhibits	9606	4217	NP_005914.1	mitogen-activated protein kinase kinase kinase 5	11298454,11323689	2007-11-07 17:27	Inhibition of ASK1 by HIV-1 Nef leads to the inhibition of both Fas- and TNFalpha-mediated apoptosis, as well as the inhibition of the activation of the downstream c-Jun amino-terminal kinase
11676	155871	NP_057853.1	Tat	downregulates	9606	4234	NP_005362.2	methyltransferase-like protein 1 isoform a	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat downregulates the expression of many proteins, including D1075-like gene product, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4246	NP_002398.1	mammaglobin-B precursor	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the expression of many proteins, including Mammaglobin, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	4247	NP_002399.1	alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4247	NP_002399.1	alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	2283726,2355006,2542563,2649653,2829950,8218172,8892864	2007-11-07 17:31	HIV-1 gp120 N-linked oligosaccharides are processed by manosidase I and II in the Golgi complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4247	NP_002399.1	alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	4247	NP_002399.1	alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155871	NP_057853.1	Tat	upregulates	9606	4250	NP_002402.1	mammaglobin-A precursor	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the expression of many proteins, including Mammaglobin, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	inhibits	9606	4261	NP_000237.1	class II transactivator	10661406,11118314	2007-11-07 17:27	HIV-1 Tat downregulates expression of MHC class II genes in antigen-presenting cells (APC) by inhibiting the transactivator of MHC class II genes, CIITA
11676	155871	NP_057853.1	Tat	inhibits	9606	4261	NP_000237.1	class II transactivator	10661406	2007-11-07 17:28	HIV-1 Tat inhibits CIITA by competing with CIITA for binding to P-TEFb
11676	155871	NP_057853.1	Tat	inhibited by	9606	4261	NP_000237.1	class II transactivator	11118314,12355430	2007-11-07 17:27	The HLA class II transcriptional activator, CIITA, inhibits HIV-1 Tat and virus replication
11676	155871	NP_057853.1	Tat	upregulates	9606	4283	NP_002407.1	C-X-C motif chemokine 9 precursor	12539042	2007-11-07 17:29	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including HuMIG, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	156110	NP_057857.2	Nef	upregulates	9606	4288	NP_002408.3	antigen KI-67 isoform 1	16260903	2007-11-07 17:29	Podocyte-specific expression of HIV-1 Nef induces loss of synaptopodin and WT1, and expression of Ki-67 in podocytes, which is essential for the dedifferentiation and proliferation of podocytes in HIV-associated nephropathy
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	4296	NP_002410.1	mitogen-activated protein kinase kinase kinase 11	12190962,12354290	2007-11-07 17:31	Treatment of neurons with HIV-1 gp120 in culture produces apoptotic neuronal death through the mixed lineage kinase 3 (MLK3) signaling pathway
11676	155871	NP_057853.1	Tat	inhibited by	9606	4311	NP_000893.2	neprilysin	8003005,16877296	2007-11-07 17:30	CD10/Nep inhibits HIV-1 Tat dimerization in Jurkat T-cells
11676	155871	NP_057853.1	Tat	inhibits	9606	4311	NP_000893.2	neprilysin	15668537	2007-11-07 17:28	HIV-1 Tat, which is found in the brains of patients with HIV-1 infection, inhibits the amyloid beta (Abeta)-degrading enzyme, neprilysin (NEP)
11676	155871	NP_057853.1	Tat	activates	9606	4312	NP_002412.1	interstitial collagenase isoform 1 preproprotein	11598182	2007-11-07 17:29	Through the activation of membrane-type-1-matrix-metalloproteinase (MMP-1) and the induction of tissue inhibitor of metalloproteinase-2 (TIMP-2), HIV-1 Tat and bFGF synergize to upregulate MMP-2 secretion and activation in endothelial cells
11676	155871	NP_057853.1	Tat	induces release of	9606	4312	NP_002412.1	interstitial collagenase isoform 1 preproprotein	14982725	2007-11-07 17:28	HIV-1 Tat and methamphetamine enhance the release of MMP-1, MMP-2, and uPA from human brain cells
11676	155871	NP_057853.1	Tat	degraded by	9606	4312	NP_002412.1	interstitial collagenase isoform 1 preproprotein	16807369	2007-11-07 17:31	MMP-1 can degrade HIV-1 Tat and this effect is blocked by MMP-1 inhibitors.
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	4312	NP_002412.1	interstitial collagenase isoform 1 preproprotein	15972662	2007-11-07 17:30	CXCR4-tropic and CXCR4/CCR5 dual-tropic HIV-1 gp120 induce the cleavage of CD62 ligand by a mechanism dependent on matrix metalloproteinases 1 and 3, CD4, CXCR4, Galpha(i), and p38 MAPK, whereas CCR5-tropic gp120 does not
11676	155871	NP_057853.1	Tat	upregulates	9606	4313	NP_004521.1	72 kDa type IV collagenase isoform a preproprotein	7935812,11598182	2007-11-07 17:29	HIV-1 Tat and bFGF synergize to upregulate MMP-2 (type-IV collagenase) secretion and activation in endothelial cells and also synergize in inducing angiogenic Kaposi's sarcoma-like lesions in mice as a result of enhanced MMP-2 expression
11676	155871	NP_057853.1	Tat	upregulates	9606	4313	NP_004521.1	72 kDa type IV collagenase isoform a preproprotein	11220743	2007-11-07 17:29	HIV-1 Tat from AIDS patients with HIV-associated dementia upregulates MMP-2 and MMP-7 release and activation, leading to neurotoxicity
11676	155871	NP_057853.1	Tat	induces release of	9606	4313	NP_004521.1	72 kDa type IV collagenase isoform a preproprotein	14982725	2007-11-07 17:28	HIV-1 Tat and methamphetamine enhance the release of MMP-1, MMP-2, and uPA from human brain cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	4313	NP_004521.1	72 kDa type IV collagenase isoform a preproprotein	15955449	2007-11-07 17:30	HIV-1 gp120 interaction with human mannose receptor (hMR) results in increased production of matrix metalloproteinase-2 (MMP-2) in astrocytes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	4313	NP_004521.1	72 kDa type IV collagenase isoform a preproprotein	9699154	2007-11-07 17:31	Treatment of human glial and neuronal cells with an HIV-1 gp41 peptide (amino acids 583-599) markedly increases the activity of matrix metalloproteinase 2 (MMP-2)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	4314	NP_002413.1	stromelysin-1 preproprotein	15972662	2007-11-07 17:30	CXCR4-tropic and CXCR4/CCR5 dual-tropic HIV-1 gp120 induce the cleavage of CD62 ligand by a mechanism dependent on matrix metalloproteinases 1 and 3, CD4, CXCR4, Galpha(i), and p38 MAPK, whereas CCR5-tropic gp120 does not
11676	155871	NP_057853.1	Tat	upregulates	9606	4316	NP_002414.1	matrilysin preproprotein	11220743	2007-11-07 17:29	HIV-1 Tat from AIDS patients with HIV-associated dementia upregulates MMP-2 and MMP-7 release and activation, leading to neurotoxicity
11676	155871	NP_057853.1	Tat	upregulates	9606	4318	NP_004985.2	matrix metalloproteinase-9 preproprotein	8568270,9378998,10580107	2007-11-07 17:29	HIV-1 Tat upregulates the expression of MMP-9 in monocytes in an IL-1beta, TNF-alpha, and tyrosine phosphatase dependent manner
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	4318	NP_004985.2	matrix metalloproteinase-9 preproprotein	11468147,15288392	2007-11-07 17:31	T- and M-tropic HIV-1 gp120 proteins are able to induce the secretion of matrix metalloproteinase 9 (MMP-9) by T cells or glioma cells; MMP-9 is an extracellular metalloproteinase present in cerebrospinal fluid of patients with HIV-1
11676	156110	NP_057857.2	Nef	activates	9606	4318	NP_004985.2	matrix metalloproteinase-9 preproprotein	10636480	2007-11-07 17:28	MMP-9 activity in the cerebrospinal fluid (CSF) samples from rats is induced by injecting the rats intracisternally with recombinant HIV-1 Nef protein, but not after injection of heat-treated Nef, HIV-1 gp120, HIV-1 gp160 or PBS
11676	155807	NP_057852.2	Vpr	enhanced by	9606	4331	NP_002422.1	CDK-activating kinase assembly factor MAT1 isoform 1	12379213	2007-11-07 17:28	As a component of the TFIIH transcription complex, MAT1 enhances the synergistic activation of glucocorticoid receptor by HIV-1 Vpr and p300
11676	155807	NP_057852.2	Vpr	inhibited by	9606	4331	NP_002422.1	CDK-activating kinase assembly factor MAT1 isoform 1	12379213	2007-11-07 17:28	As a component of the TFIIH transcription complex, MAT1 inhibits HIV-1 Vpr cell cycle-arresting function
11676	155871	NP_057853.1	Tat	binds	9606	4331	NP_002422.1	CDK-activating kinase assembly factor MAT1 isoform 1	8628270,8934526,9184228,9334327,9765201	2007-11-07 17:28	Amino acids 1-48 of HIV-1 Tat, which includes the Tat activation domain, mediate the binding of Tat to CAK and the TFIIH complex through a direct interaction with CDK7 and possibly other TFIIH subunits, including p62 and ERCC3
11676	155871	NP_057853.1	Tat	interacts with	9606	4331	NP_002422.1	CDK-activating kinase assembly factor MAT1 isoform 1	8849451,8934526,9054383,9121429	2007-11-07 17:28	HIV-1 Tat interacts with the RNA polymerase II holoenzyme and transcription preinitiation complexes, which include TFIIH, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	requires	9606	4331	NP_002422.1	CDK-activating kinase assembly factor MAT1 isoform 1	8934526,9184228,9334327	2007-11-07 17:28	CAK/TFIIH is required for HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	4331	NP_002422.1	CDK-activating kinase assembly factor MAT1 isoform 1	8934526,9184228,9311822,9334327,9570510,9651670,10438593,10866664,14569024	2007-11-07 17:28	Interaction of HIV-1 Tat with TFIIH stimulates phosphorylation of Ser-5 of the RNA polymerase II C-terminal domain (CTD), which in turn also stimulates co-transcriptional capping of HIV-1 mRNA
11676	155871	NP_057853.1	Tat	synergizes with	9606	4331	NP_002422.1	CDK-activating kinase assembly factor MAT1 isoform 1	8934526	2007-11-07 17:28	TFIIH synergizes with HIV-1 Tat to induce transcription elongation from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	4331	NP_002422.1	CDK-activating kinase assembly factor MAT1 isoform 1	9651670,10066804,10082552,10866664,14569024	2007-11-07 17:28	TFIIH interacts with HIV-1 Tat as a component of the HIV-1 transcription preinitiation complex, but is released from the elongation complex which includes P-TEFb
11676	155871	NP_057853.1	Tat	downregulates	9606	4360	NP_002429.1	macrophage mannose receptor 1 precursor	11120831	2007-11-07 17:30	HIV-1 Tat represses transcription from the rat mannose receptor promoter, thereby downregulating expression of mannose receptor
11676	155871	NP_057853.1	Tat	downregulates	9606	4360	NP_002429.1	macrophage mannose receptor 1 precursor	16615932	2007-11-07 17:31	HIV-1 Tat interaction with cyclin T1 is required for the repression of mannose receptor (MR) and bone morphogenetic protein receptor-2 (BMPR2) promoters
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	4360	NP_002429.1	macrophage mannose receptor 1 precursor	15047828,15955449,16672549	2007-11-07 17:30	HIV-1 gp120 interaction with human mannose receptor (hMR) results in increased production of matrix metalloproteinase-2 (MMP-2) in astrocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	4360	NP_002429.1	macrophage mannose receptor 1 precursor	16547227,16672549,17077296	2007-11-07 17:31	HIV-1 gp120 binds to B cells through mannose C-type lectin receptors (MCLRs), such as DC-SIGN, mannose receptor, and langerin
11676	156110	NP_057857.2	Nef	downregulates	9606	4360	NP_002429.1	macrophage mannose receptor 1 precursor	15637102	2007-11-07 17:28	HIV-1 Nef downregulates mannose receptor (MR) on the surface of macrophages and dendritic cells (DC); both NTLY and SDXXXL motifs in the cytoplasmic tail of MR are critical for the cell surface reduction of MR
11676	155871	NP_057853.1	Tat	upregulates	9606	4363	NP_004987.1	ATP-binding cassette, sub-family C, member 1 isoform 1	16395283	2007-11-07 17:29	HIV-1 Tat specifically upregulates MRP1 messenger ribonucleic acid and protein expression both in brain microvascular endothelial cells (BMEC) and astrocytes
11676	155871	NP_057853.1	Tat	upregulates	9606	4363	NP_004987.1	ATP-binding cassette, sub-family C, member 1 isoform 1	16395283	2007-11-07 17:29	HIV-1 Tat upregulates expression of MRP1 through activation of the mitogen-activated protein kinase signaling cascade
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	4478	NP_002435.1	moesin	8892894	2007-11-07 17:29	The cytoskeletal proteins ezrin, moesin, and cofilin are incorporated into HIV-1 particles, presumably through their interaction with actin which binds to the nucleocapsid domain of HIV-1 Gag
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	4478	NP_002435.1	moesin	9213396,15818415	2007-11-07 17:27	Ezrin and moesin are structural proteins that bind to the cellular membrane and interact with HIV-1 gp120/gp160 in CD4- and Gal-C-negative brain cells; ezrin and moesin play a role as gp120/gp160 binding proteins during the uptake of HIV
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	relocalizes	9606	4478	NP_002435.1	moesin	15818415	2007-11-07 17:31	Treatment of CD4+ T cells with HIV-1 gp120 induces CD95-mediated apoptosis, CD95/ERM protein (ezrin, radixin, moesin) colocalization and stable ezrin phosphorylation
11676	155871	NP_057853.1	Tat	upregulates	9606	4489	NP_005937.2	metallothionein-1A	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4490	NP_005938.1	metallothionein-1B	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4493	NP_783316.2	metallothionein-1E	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4494	NP_005940.1	metallothionein-1F	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4495	NP_005941.1	metallothionein-1G	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4496	NP_005942.1	metallothionein-1H	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4499	NP_789846.1	metallothionein-1M	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4501	NP_005943.1	metallothionein-1X	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4502	NP_005944.1	metallothionein-2	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4504	NP_005945.1	metallothionein-3	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4599	NP_002453.1	myxovirus resistance protein 1	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including MX1, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	4609	NP_002458.2	myc proto-oncogene protein	1318011,9129988,11311202	2007-11-07 17:30	HIV-1 Tat upregulates c-myc transcription in certain B-cell lines, salivary gland cell lines, and A549 human broncoalveolar carcinoma cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	4609	NP_002458.2	myc proto-oncogene protein	11208609	2007-11-07 17:30	HIV-1 gp120 downregulates expression of c-Myc, Max, and 14-3-3epsilon proteins, and decreases phosphorylation of ATP-dependent tyrosine kinases (Akt) at Ser-473 in human mesangial cells (HMC)
11676	155348	NP_705926.1	retropepsin	cleaves	9606	4624	NP_002462.1	myosin heavy chain 6	8424456	2007-11-07 17:29	HIV-1 protease cleaves human myosin heavy chain in vitro
11676	155348	NP_705926.1	retropepsin	cleaves	9606	4625	NP_000248.2	myosin-7	8424456	2007-11-07 17:29	HIV-1 protease cleaves human myosin heavy chain in vitro
11676	155348	NP_705926.1	retropepsin	cleaves	9606	4627	NP_002464.1	myosin-9	8424456	2007-11-07 17:29	HIV-1 protease cleaves human myosin heavy chain in vitro
11676	155348	NP_705926.1	retropepsin	cleaves	9606	4628	NP_005955.1	myosin-10	8424456	2007-11-07 17:29	HIV-1 protease cleaves human myosin heavy chain in vitro
11676	155348	NP_705926.1	retropepsin	cleaves	9606	4629	NP_002465.1	myosin-11 isoform SM1A	8424456	2007-11-07 17:29	HIV-1 protease cleaves human myosin heavy chain in vitro
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulates	9606	4676	NP_005960.1	nucleosome assembly protein 1-like 4	12089333	2007-11-07 17:30	HIV-1 gp120 modulates expression of the chemokines, GRO-alpha (CXCL1), GRO-gamma, NAP2, IL-8, IP-10, MIP-1beta, MIP-1alpha, RANTES, and MIP-3alpha, in PBMCs and MDMs
11676	155030	NP_579876.2	matrix	fractionates with	9606	4691	NP_005372.2	nucleolin	12027446,14978336	2007-11-07 17:28	Nucleolin is incorporated into HIV-1 particles during budding of HIV-1 from lipid rafts and following virus entry into cells is recovered in fractions containing HIV-1 DNA, Matrix and Reverse Transcriptase proteins
11676	155348	NP_705927.1	reverse transcriptase	fractionates with	9606	4691	NP_005372.2	nucleolin	12027446	2007-11-07 17:29	After HIV entry into cells, equilibrium density fractionation of cellular extracts revealed cell surface nucleolin is recovered in fractions containing actin, HIV DNA, viral matrix, and reverse transcriptase, suggesting nucleolin accompanies viral entry
11676	155030	NP_579883.1	p6	ubiquitinated by	9606	4734	NP_006145.2	E3 ubiquitin-protein ligase NEDD4 isoform 1	9525617,11087859,11087860,11112487,11991975	2007-11-07 17:29	The L domain (P(T/S)APP; amino acids 7-11) of HIV-1 p6-Gag interacts with a ubiquitin ligase complex resulting in the monoubiquitination of p6
11676	155030	NP_579883.1	p6	ubiquitinated by	9606	4734	NP_006145.2	E3 ubiquitin-protein ligase NEDD4 isoform 1	11087859,12610113	2007-11-07 17:29	Ubiquitination of HIV-1 p6-Gag may be important for proper virus release from cells
11676	155030	NP_579883.1	p6	ubiquitinated by	9606	4734	NP_006145.2	E3 ubiquitin-protein ligase NEDD4 isoform 1	11087860	2007-11-07 17:29	Nedd4 is one possible ubiquitin ligase implicated to interact with the L domain of HIV-1 p6-Gag resulting in monoubiquitination of p6
11676	155459	NP_057851.1	Vif	binds	9606	4734	NP_006145.2	E3 ubiquitin-protein ligase NEDD4 isoform 1	15013426	2007-11-07 17:28	HIV-1 Vif, through amino acids 20-128, binds to the WW domains of hNedd4 and AIP4, two HECT E3 ubiquitin ligases
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4758	NP_000425.1	sialidase-1 precursor	8892864,12487819	2007-11-07 17:27	The desialylation of HIV-1 gp120 with neuraminidase greatly augments the initial virus-cell interaction, leading to remarkably enhanced viral replication and cytopathogenicity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4758	NP_000425.1	sialidase-1 precursor	12487819	2007-11-07 17:31	Removal of sialic acids from HIV-1 gp120 with neuraminidase (NA) enhances mannose-binding lectin (MBL) binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4759	NP_005374.1	sialidase 2	8892864,12487819	2007-11-07 17:27	The desialylation of HIV-1 gp120 with neuraminidase greatly augments the initial virus-cell interaction, leading to remarkably enhanced viral replication and cytopathogenicity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	4759	NP_005374.1	sialidase 2	12487819	2007-11-07 17:31	Removal of sialic acids from HIV-1 gp120 with neuraminidase (NA) enhances mannose-binding lectin (MBL) binding
11676	156110	NP_057857.2	Nef	induces phosphorylation of	9606	4771	NP_000259.1	merlin isoform 1	16282498	2007-11-07 17:29	HIV-1 Nef-induced activation of p21-activated kinase 2 (PAK2) enhances merlin phosphorylation, a cellular substrate of PAK2
11676	155348	NP_705927.1	reverse transcriptase	enhanced by	9606	4772	NP_765978.1	nuclear factor of activated T-cells, cytoplasmic 1 isoform A	9845362	2007-11-07 17:29	NFATc facilitates HIV-1 RT reverse transcription activity and enhances HIV-1 infectivity in human T cells
11676	155807	NP_057852.2	Vpr	upregulates	9606	4772	NP_765978.1	nuclear factor of activated T-cells, cytoplasmic 1 isoform A	12788643	2007-11-07 17:30	HIV-1 Vpr upregulates NFAT-directed gene expression
11676	155871	NP_057853.1	Tat	activates	9606	4772	NP_765978.1	nuclear factor of activated T-cells, cytoplasmic 1 isoform A	7999066	2007-11-07 17:29	HIV-1 Tat enhances IL-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif
11676	155871	NP_057853.1	Tat	synergizes with	9606	4772	NP_765978.1	nuclear factor of activated T-cells, cytoplasmic 1 isoform A	9075924	2007-11-07 17:29	NF-ATc synergizes with NF-kappa B and HIV-1 Tat in transcriptional activation of the HIV-1 LTR promoter and enhances HIV-1 replication in T cells
11676	155871	NP_057853.1	Tat	decreases phosphorylation of	9606	4772	NP_765978.1	nuclear factor of activated T-cells, cytoplasmic 1 isoform A	12482669	2007-11-07 17:28	Induction of TNF-alpha by HIV-1 Tat is inhibited by cyclosporin A, an inhibitor of calcineurin that acts by preventing the dephosphorylation of NF-AT
11676	155871	NP_057853.1	Tat	enhances	9606	4772	NP_765978.1	nuclear factor of activated T-cells, cytoplasmic 1 isoform A	16690925	2007-11-07 17:31	HIV-1 Tat expression in Jurkat T cells enhances cooperative NFAT/AP-1- but not AP-1-dependent transcription independent of its ability to transactivate the HIV-1 LTR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	4772	NP_765978.1	nuclear factor of activated T-cells, cytoplasmic 1 isoform A	7957556,16260021	2007-11-07 17:29	HIV-1 gp120 and anti-CD4 antibodies induce a specific, significant decrease in the binding activity of NF-AT, NF-kappa B and AP-1, which leads to an inhibition of IL-2 production and cell proliferation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	4772	NP_765978.1	nuclear factor of activated T-cells, cytoplasmic 1 isoform A	8814265,16260021	2007-11-07 17:27	Using either anti-CD4 monoclonal antibodies or HIV-1 gp120 binding to CD4 reveals a common epitope-specific activation of both the HIV-1 LTR and of the transcription factors NF-kappa B and NF-AT
11676	156110	NP_057857.2	Nef	inhibits	9606	4772	NP_765978.1	nuclear factor of activated T-cells, cytoplasmic 1 isoform A	10618429,10748182,11222731,11448168,11956293,12788643,12884293,15078178	2007-11-07 17:27	HIV-1 Nef expression significantly downregulates the level of plasma membrane GM1 in unstimulated T cells, which inhibits the activation of nuclear factor of activated T-cells (NF-AT)
11676	156110	NP_057857.2	Nef	activates	9606	4772	NP_765978.1	nuclear factor of activated T-cells, cytoplasmic 1 isoform A	10618429,10748182,11222731,11448168,11956293,12788643	2007-11-07 17:29	Nef-mediated super-induction of IL-2 reflects the activation of both NFAT and NFkappaB in response to CD3 or CD28 stimulation
11676	156110	NP_057857.2	Nef	upregulates	9606	4772	NP_765978.1	nuclear factor of activated T-cells, cytoplasmic 1 isoform A	16237100	2007-11-07 17:29	HIV-1 Nef-induced priming of TCR signaling pathways increases the number of cells expressing the transcription factors NF-kappaB and NFAT after TCR stimulation
11676	155348	NP_705927.1	reverse transcriptase	enhanced by	9606	4773	NP_036472.2	nuclear factor of activated T-cells, cytoplasmic 2 isoform B	9845362	2007-11-07 17:29	NFATc facilitates HIV-1 RT reverse transcription activity and enhances HIV-1 infectivity in human T cells
11676	155807	NP_057852.2	Vpr	upregulates	9606	4773	NP_036472.2	nuclear factor of activated T-cells, cytoplasmic 2 isoform B	12788643	2007-11-07 17:30	HIV-1 Vpr upregulates NFAT-directed gene expression
11676	155871	NP_057853.1	Tat	enhances	9606	4773	NP_036472.2	nuclear factor of activated T-cells, cytoplasmic 2 isoform B	7999066,10207088	2007-11-07 17:29	HIV-1 Tat upregulation of the IL-2 promoter maps to the NFAT motif of the IL-2 enhancer, suggesting Tat-mediated enhancement of NFAT1 transactivation may explain the upregulation of IL-2 that occurs during HIV-1 infection
11676	155871	NP_057853.1	Tat	inhibited by	9606	4773	NP_036472.2	nuclear factor of activated T-cells, cytoplasmic 2 isoform B	8834464,10207088	2007-11-07 17:29	NFAT1 inhibits Tat-mediated transactivation of the HIV-1 LTR promoter through a direct binding interaction between the two proteins
11676	155871	NP_057853.1	Tat	binds	9606	4773	NP_036472.2	nuclear factor of activated T-cells, cytoplasmic 2 isoform B	10207088	2007-11-07 17:29	HIV-1 Tat binds to NFAT1, an interaction mediated by the N-terminus of Tat (amino acids 1-26) and the transactivation domain of NFAT1 (amino acids 1-96)
11676	155871	NP_057853.1	Tat	enhances	9606	4773	NP_036472.2	nuclear factor of activated T-cells, cytoplasmic 2 isoform B	10207088	2007-11-07 17:29	HIV-1 Tat enhances NFAT1-driven transcription in Jurkat T cells through a direct protein-protein interaction between the two proteins
11676	155871	NP_057853.1	Tat	decreases phosphorylation of	9606	4773	NP_036472.2	nuclear factor of activated T-cells, cytoplasmic 2 isoform B	12482669	2007-11-07 17:28	Induction of TNF-alpha by HIV-1 Tat is inhibited by cyclosporin A, an inhibitor of calcineurin that acts by preventing the dephosphorylation of NF-AT
11676	155871	NP_057853.1	Tat	enhances	9606	4773	NP_036472.2	nuclear factor of activated T-cells, cytoplasmic 2 isoform B	16690925	2007-11-07 17:31	HIV-1 Tat expression in Jurkat T cells enhances cooperative NFAT/AP-1- but not AP-1-dependent transcription independent of its ability to transactivate the HIV-1 LTR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	4773	NP_036472.2	nuclear factor of activated T-cells, cytoplasmic 2 isoform B	7957556,16260021	2007-11-07 17:29	HIV-1 gp120 and anti-CD4 antibodies induce a specific, significant decrease in the binding activity of NF-AT, NF-kappa B and AP-1, which leads to an inhibition of IL-2 production and cell proliferation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	4773	NP_036472.2	nuclear factor of activated T-cells, cytoplasmic 2 isoform B	8814265,16260021	2007-11-07 17:27	Using either anti-CD4 monoclonal antibodies or HIV-1 gp120 binding to CD4 reveals a common epitope-specific activation of both the HIV-1 LTR and of the transcription factors NF-kappa B and NF-AT
11676	155807	NP_057852.2	Vpr	upregulates	9606	4775	NP_775188.1	nuclear factor of activated T-cells, cytoplasmic 3 isoform 1	12788643	2007-11-07 17:30	HIV-1 Vpr upregulates NFAT-directed gene expression
11676	155871	NP_057853.1	Tat	activates	9606	4775	NP_775188.1	nuclear factor of activated T-cells, cytoplasmic 3 isoform 1	7999066	2007-11-07 17:29	HIV-1 Tat enhances IL-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif
11676	155871	NP_057853.1	Tat	decreases phosphorylation of	9606	4775	NP_775188.1	nuclear factor of activated T-cells, cytoplasmic 3 isoform 1	12482669	2007-11-07 17:28	Induction of TNF-alpha by HIV-1 Tat is inhibited by cyclosporin A, an inhibitor of calcineurin that acts by preventing the dephosphorylation of NF-AT
11676	155871	NP_057853.1	Tat	enhances	9606	4775	NP_775188.1	nuclear factor of activated T-cells, cytoplasmic 3 isoform 1	16690925	2007-11-07 17:31	HIV-1 Tat expression in Jurkat T cells enhances cooperative NFAT/AP-1- but not AP-1-dependent transcription independent of its ability to transactivate the HIV-1 LTR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	4775	NP_775188.1	nuclear factor of activated T-cells, cytoplasmic 3 isoform 1	7957556,16260021	2007-11-07 17:30	HIV-1 gp120 and anti-CD4 antibodies induce a specific, significant decrease in the binding activity of NF-AT, NF-kappa B and AP-1, which leads to an inhibition of IL-2 production and cell proliferation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	4775	NP_775188.1	nuclear factor of activated T-cells, cytoplasmic 3 isoform 1	8814265,16260021	2007-11-07 17:30	Using either anti-CD4 monoclonal antibodies or HIV-1 gp120 binding to CD4 reveals a common epitope-specific activation of both the HIV-1 LTR and of the transcription factors NF-kappa B and NF-AT
11676	155807	NP_057852.2	Vpr	upregulates	9606	4776	NP_004545.2	nuclear factor of activated T-cells, cytoplasmic 4 isoform 2	12788643	2007-11-07 17:30	HIV-1 Vpr upregulates NFAT-directed gene expression
11676	155871	NP_057853.1	Tat	activates	9606	4776	NP_004545.2	nuclear factor of activated T-cells, cytoplasmic 4 isoform 2	7999066	2007-11-07 17:29	HIV-1 Tat enhances IL-2 promoter activity through synergism with phorbol ester and calcium-mediated activation of the NF-AT cis-regulatory motif
11676	155871	NP_057853.1	Tat	decreases phosphorylation of	9606	4776	NP_004545.2	nuclear factor of activated T-cells, cytoplasmic 4 isoform 2	12482669	2007-11-07 17:28	Induction of TNF-alpha by HIV-1 Tat is inhibited by cyclosporin A, an inhibitor of calcineurin that acts by preventing the dephosphorylation of NF-AT
11676	155871	NP_057853.1	Tat	enhances	9606	4776	NP_004545.2	nuclear factor of activated T-cells, cytoplasmic 4 isoform 2	16690925	2007-11-07 17:31	HIV-1 Tat expression in Jurkat T cells enhances cooperative NFAT/AP-1- but not AP-1-dependent transcription independent of its ability to transactivate the HIV-1 LTR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	4776	NP_004545.2	nuclear factor of activated T-cells, cytoplasmic 4 isoform 2	7957556,16260021	2007-11-07 17:29	HIV-1 gp120 and anti-CD4 antibodies induce a specific, significant decrease in the binding activity of NF-AT, NF-kappa B and AP-1, which leads to an inhibition of IL-2 production and cell proliferation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	4776	NP_004545.2	nuclear factor of activated T-cells, cytoplasmic 4 isoform 2	8814265,16260021	2007-11-07 17:27	Using either anti-CD4 monoclonal antibodies or HIV-1 gp120 binding to CD4 reveals a common epitope-specific activation of both the HIV-1 LTR and of the transcription factors NF-kappa B and NF-AT
11676	155871	NP_057853.1	Tat	synergizes with	9606	4782	NP_005588.2	nuclear factor 1 C-type isoform 1	8628270,12221105	2007-11-07 17:28	HIV-1 Tat synergizes with CTF to activate transcription and enhance transcript elongation and exon skipping
11676	155030	NP_579881.1	nucleocapsid	enhances	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	10704334	2007-11-07 17:29	HIV-1 Nucleocapsid has been shown to bind to the HIV-1 LTR promoter and enhance NF-kappaB, Sp1, and TFIIB-induced HIV-1 LTR-directed RNA transcription
11676	155348	NP_705926.1	retropepsin	cleaves	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	2017258,7742037,8790371,8997639	2007-11-07 17:29	HIV-1 protease can cleave p105 into a p45 maturation product and increases levels of active nuclear NF-kappa B complex
11676	155807	NP_057852.2	Vpr	regulates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	9334723,9560267,10775602,12444143,15142381,15725353,15780175,15817944,16305395	2007-11-07 17:27	HIV-1 Vpr regulates NF-kappa B, activating it in certain circumstances while suppressing it in others
11676	155807	NP_057852.2	Vpr	inhibits	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	9334723,15725353,15780175,15817944	2007-11-07 17:27	Regulation of apoptosis by HIV-1 Vpr is linked to Vpr suppression of NF-kappa B activity via the induction of I kappa B and is mapped to the first alpha-helical domain (amino acids 17-34) of Vpr
11676	155807	NP_057852.2	Vpr	downregulates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	9334723,15142381,16429131	2007-11-07 17:27	Vpr suppresses expression of IL-2, IL-10, IL-12, TNFalpha and IL-4, all of which are NF-kappa B-dependent
11676	155807	NP_057852.2	Vpr	interacts with	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	9560267,16243842	2007-11-07 17:27	Data suggests that p300, through its interactions with NF-kappa B, basal transcriptional components, and Cdks, is modulated by HIV-1 Vpr and regulates HIV replication
11676	155807	NP_057852.2	Vpr	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	9560267,16305395	2007-11-07 17:27	NF-kappa B contributes to HIV-1 transactivation by HIV-1 Vpr but is not completely responsible for this effect
11676	155807	NP_057852.2	Vpr	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	10775602	2007-11-07 17:27	HIV-1 Vpr increases IL-8 expression and IL-8 promoter activity by activating transcription factors NF-kappa B and NF-IL-6 and also increases transcription of NF-kappa B and NF-IL-6 enhancer containing viral promoters
11676	155807	NP_057852.2	Vpr	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	10775602	2007-11-07 17:27	Upregulation of IL-6, IL-10, TNFalpha, and gamma interferon is linked to HIV-1 Vpr activation of NF-kappa B
11676	155807	NP_057852.2	Vpr	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	12444143	2007-11-07 17:27	HIV-1 Vpr activation of NF-kappa B regulated promoters is linked to Vpr regulation of IL-12, CD44, Toll-like receptor 4, indolamine 2,3-dioxygenase, macrophage receptor with collagenous structure, and thrombospondin 1
11676	155807	NP_057852.2	Vpr	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	12444143,16305395,16429131	2007-11-07 17:27	HIV-1 Vpr potentiates the trans-activation, but not the trans-repression, properties of the glucocorticoid receptor on NF-kappa B-regulated simple promoters
11676	155807	NP_057852.2	Vpr	inhibits	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	16429131	2007-11-07 17:29	Recruitment of PARP-1 by HIV-1 Vpr-glucocorticoid receptor (GR) complex prevents its nuclear localization, which is necessary for Vpr to suppress NF-kappaB
11676	155871	NP_057853.1	Tat	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	1505523,1583734,7494249,7729429,7800480,8615004,8676466,8709193,9525916,9566873,10384093,10644726,11511100,11704662	2007-11-07 17:28	HIV-1 Tat-mediated transcriptional activation of the HIV-1 LTR promoter requires NFkappaB binding sites in the promoter and involves the activation of NFkappaB by Tat
11676	155871	NP_057853.1	Tat	binds	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	7690421,7838536,10225209	2007-11-07 17:27	HIV-1 Tat has been shown to bind NFkappaB in vitro in gel shift, GST-pull down and affinity matrix assays
11676	155871	NP_057853.1	Tat	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	7859743,9110146	2007-11-07 17:27	HIV-1 Tat enhances tumor necrosis factor-induced activation of NFkappaB by downregulating manganese-dependent superoxide dismutase (MnSOD)
11676	155871	NP_057853.1	Tat	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	8113688,8207793,8627654,8724035,9278385,9510190,9730685,9792375,10384093,10446807,10480634,10580107,10644332,10671224,11044099,11160671,11241736,11385624,11522182,11579140,11827962,11833470,12167619,12427593,12473373,12482669,12485413,15258149	2007-11-07 17:28	HIV-1 Tat activates NFkappaB, causing the induction of CD95 ligand, CD69, iNOS, MCP-1, IL-2, IL-6, IL-8, IL-10, TNF-alpha, VCAM-1, ICAM-1, E-selectin, and MMP-9, as well as monocyte adhesion, cellular activation and angiogenesis
11676	155871	NP_057853.1	Tat	interacts with	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	8834464,10207088	2007-11-07 17:27	NFAT-1 negatively regulates HIV-1 Tat-mediated transactivation of the HIV-1 LTR by competing with NFkappaB for its binding to the LTR, thereby blocking the interaction of NFkappaB with Tat
11676	155871	NP_057853.1	Tat	recruits	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	9566873,14657027,16697675	2007-11-07 17:27	HIV-1 Tat recruits P/CAF to the integrated HIV-1 LTR promoter causing the acetylation of histones, which in turn leads to the recruitment the p65 subunit of NFkappaB to the promoter
11676	155871	NP_057853.1	Tat	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	10393859	2007-11-07 17:28	Activation of NFkappaB by HIV-1 Tat is inhibited by Nitric Oxide
11676	155871	NP_057853.1	Tat	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	10400814	2007-11-07 17:27	HIV-1 Tat activates NFkappaB through the cellular interferon-inducible, double-stranded RNA dependent protein kinase, PKR
11676	155871	NP_057853.1	Tat	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	10799874	2007-11-07 17:28	p56-lck plays a critical role in the activation of NFkappaB by HIV-1 Tat
11676	155871	NP_057853.1	Tat	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	11299302	2007-11-07 17:28	Activation of NFkappaB by HIV-1 Tat leads to a reduction in adenylyl cyclase activity and an inhibition of cAMP synthesis
11676	155871	NP_057853.1	Tat	regulated by	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	11704662	2007-11-07 17:27	NFkappaB tethers the p160 nuclear receptor co-activator GRIP1 to the HIV-1 LTR promoter, thereby regulating the full activation of this promoter by HIV-1 Tat
11676	155871	NP_057853.1	Tat	acetylates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	11739381	2007-11-07 17:27	HIV-1 Tat induces the acetylation of the NFkappaB p50 subunit as well as the p50/p65 complex by p300, causing an increase in NFkappaB DNA binding activity and in the rate of transcription
11676	155871	NP_057853.1	Tat	interacts with	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	17197380	2007-11-07 17:31	In HIV-1 Tat-expressing and HIV-infected astrocytes, endothelin-1 (ET-1) is significantly elevated through NF-kappaB (NF-kappaB)-responsive sites in the ET-1 promoter
11676	155945	NP_057855.1	Vpu	inhibits	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	11278695,11696595,12973300,14561767	2007-11-07 17:27	HIV-1 Vpu inhibits NF-kappa B activation by interfering with beta-TrCP-mediated degradation of IkappaB-alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	7957556	2007-11-07 17:29	HIV-1 gp120 and anti-CD4 antibodies induce a specific, significant decrease in the binding activity of NF-AT, NF-kappa B and AP-1, which leads to an inhibition of IL-2 production and cell proliferation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	8621941,8814265,9235945,10235509	2007-11-07 17:30	Binding of heat-inactivated HIV-1 (iHIV-1) or HIV-1 gp120 to infected resting PBMCs is sufficient to activate NF-kappa B and AP-1, to induce cell surface expression of CD25, and to commit cells to produce virus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	8870842	2007-11-07 17:30	In CD4-positive Jurkat cells, gp120 enhances TNF-induced NF-kappa B activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	8870842	2007-11-07 17:30	The protein tyrosine kinase p56lck plays an active role in transmitting an HIV-1 gp120-mediated signal that increases the oxidative state of cells and as a consequence amplifies TNF-mediated NF-kappa B DNA binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	9621091	2007-11-07 17:30	CD4-p56Lck interaction is required for HIV-1 gp120-induced nuclear translocation of NF-kappaB in HeLa cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	11959143,15103018	2007-11-07 17:31	HIV-1 gp120/CD4 interaction-induced NF-kappaB activation stimulates the hyperphosphorylation of IkappaB-alpha by IkappaB kinases (IKKs)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	15103018	2007-11-07 17:31	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	16001969	2007-11-07 17:31	HIV-1 envelope protein gp120 is able to induce COX-2 mRNA and protein in human neuroblastoma cell lines that express CXCR4 and CCR5 but not CD4; gp120 induces COX-2 promoter transcription through NF-kappaB and activating protein-1 (AP-1) sites
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	16554660	2007-11-07 17:31	HIV-1 gp120 induces NF-kappaB activation and increases p21(cip1/waf1) and p27(kip1) protein levels in human mesangial cells
11676	156110	NP_057857.2	Nef	inhibits	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	1527859	2007-11-07 17:27	HIV-1 Nef inhibits the induction of HIV-1- and interleukin 2-directed gene expression, and the effect on HIV-1 transcription depends on an intact NF-kappa B-binding site
11676	156110	NP_057857.2	Nef	inhibits	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	1527859,15638726	2007-11-07 17:28	HIV-1 Nef inhibits the induction of NF-kappa B DNA-binding activity by T-cell mitogens, however Nef does not affect the DNA-binding activity of other transcription factors implicated in HIV-1 regulation, including SP-1, USF, URS, and NF-AT
11676	156110	NP_057857.2	Nef	downregulates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	8151786,8178481	2007-11-07 17:28	Stimulation of T cells by mitogens or antibodies to the T-cell receptor (TCR)-CD3 complex results in the downregulation of transcriptional factors NF-kappa B and AP-1 in cells expressing HIV-1 Nef
11676	156110	NP_057857.2	Nef	activates	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	12396456,12419805,12574335,14597672,15258149,16237100	2007-11-07 17:28	HIV-1 Nef activates nuclear transcription factor NF-kappaB in human monocyte/macrophages, promonoctyes, and dendritic cells, and to a lesser extent in immature dendritic cells
11676	156110	NP_057857.2	Nef	inhibits	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	15827086	2007-11-07 17:28	HIV-1 Nef expression in Drosophila inhibits NF-kappa-B activation
11676	156110	NP_057857.2	Nef	inhibits	9606	4790	NP_003989.2	nuclear factor NF-kappa-B p105 subunit isoform 1	16429138	2007-11-07 17:31	HIV-1 Nef suppresses immunoglobulin class-switch DNA recombination by inducing IkappaBalpha and SOCS proteins, which block CD154, IL-4 and IL-10 cytokine signaling via NF-kappaB and STAT transcription factors
11676	155871	NP_057853.1	Tat	activates	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	1505523,1583734,7494249,7729429,7800480,8615004,8676466,8709193,9525916,9566873,10384093,10644726,11511100,11704662,15258149	2007-11-07 17:27	HIV-1 Tat-mediated transcriptional activation of the HIV-1 LTR promoter requires NFkappaB binding sites in the promoter and involves the activation of NFkappaB by Tat
11676	155871	NP_057853.1	Tat	binds	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	7690421,7838536,10225209	2007-11-07 17:27	HIV-1 Tat has been shown to bind NFkappaB in vitro in gel shift, GST-pull down and affinity matrix assays
11676	155871	NP_057853.1	Tat	activates	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	7859743,9110146	2007-11-07 17:27	HIV-1 Tat enhances tumor necrosis factor-induced activation of NFkappaB by downregulating manganese-dependent superoxide dismutase (MnSOD)
11676	155871	NP_057853.1	Tat	activates	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	8113688,8207793,8627654,8724035,9278385,9510190,9730685,9792375,10384093,10446807,10480634,10580107,10644332,10671224,11044099,11160671,11241736,11385624,11522182,11579140,11827962,11833470,12167619,12427593,12473373,12482669,12485413,15258149	2007-11-07 17:27	HIV-1 Tat activates NFkappaB, causing the induction of CD95 ligand, CD69, iNOS, MCP-1, IL-2, IL-6, IL-8, IL-10, TNF-alpha, VCAM-1, ICAM-1, E-selectin, and MMP-9, as well as monocyte adhesion, cellular activation and angiogenesis
11676	155871	NP_057853.1	Tat	interacts with	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	8834464,10207088	2007-11-07 17:27	NFAT-1 negatively regulates HIV-1 Tat-mediated transactivation of the HIV-1 LTR by competing with NFkappaB for its binding to the LTR, thereby blocking the interaction of NFkappaB with Tat
11676	155871	NP_057853.1	Tat	activates	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	10393859	2007-11-07 17:27	Activation of NFkappaB by HIV-1 Tat is inhibited by Nitric Oxide
11676	155871	NP_057853.1	Tat	activates	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	10400814	2007-11-07 17:27	HIV-1 Tat activates NFkappaB through the cellular interferon-inducible, double-stranded RNA dependent protein kinase, PKR
11676	155871	NP_057853.1	Tat	activates	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	10799874	2007-11-07 17:27	p56-lck plays a critical role in the activation of NFkappaB by HIV-1 Tat
11676	155871	NP_057853.1	Tat	activates	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	11299302	2007-11-07 17:27	Activation of NFkappaB by HIV-1 Tat leads to a reduction in adenylyl cyclase activity and an inhibition of cAMP synthesis
11676	155871	NP_057853.1	Tat	regulated by	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	11704662	2007-11-07 17:27	NFkappaB tethers the p160 nuclear receptor co-activator GRIP1 to the HIV-1 LTR promoter, thereby regulating the full activation of this promoter by HIV-1 Tat
11676	155871	NP_057853.1	Tat	interacts with	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	17197385	2007-11-07 17:31	In HIV-1 Tat-expressing and HIV-infected astrocytes, endothelin-1 (ET-1) is significantly elevated through NF-kappaB (NF-kappaB)-responsive sites in the ET-1 promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	4791	NP_002493.3	nuclear factor NF-kappa-B p100 subunit isoform b	15103018	2007-11-07 17:31	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155807	NP_057852.2	Vpr	upregulates	9606	4792	NP_065390.1	NF-kappa-B inhibitor alpha	9334723,15142381,15725353,15817944	2007-11-07 17:27	HIV-1 Vpr induced an increase in I kappa B alpha message in PBMCs, supporting the notion that Vpr diminishes NF-kappa B activity by upregulating I kappa B alpha transcription, an effect that is linked to Vpr regulation of apoptosis
11676	155871	NP_057853.1	Tat	degrades	9606	4792	NP_065390.1	NF-kappa-B inhibitor alpha	7565415,10393859,10480634,10580107,11511100	2007-11-07 17:27	HIV-1 Tat induces the phosphorylation and degradation of IkappaB leading to the activation of NF-kappa B, an effect that appears to be regulated by Tat induced expression of NOS-2 and NOS-3
11676	155871	NP_057853.1	Tat	inhibited by	9606	4792	NP_065390.1	NF-kappa-B inhibitor alpha	8615004,8709193	2007-11-07 17:27	I kappa B potently inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155908	NP_057854.1	Rev	inhibited by	9606	4792	NP_065390.1	NF-kappa-B inhibitor alpha	7878004,9060679	2007-11-07 17:27	I kappa B alpha inhibits Rev function, most likely through a cellular factor involved in Rev transactivation
11676	155945	NP_057855.1	Vpu	stabilizes	9606	4792	NP_065390.1	NF-kappa-B inhibitor alpha	11278695,11696595,12973300,14561767	2007-11-07 17:27	HIV-1 Vpu inhibits beta-TrCP mediated degradation of phosphorylated IkappaB-alpha
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	downregulated by	9606	4792	NP_065390.1	NF-kappa-B inhibitor alpha	7878004	2007-11-07 17:31	I kappa B alpha inhibits HIV replication and gp160 expression by negatively regulating Rev function, most likely acting through a cellular factor involved in Rev transactivation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	4792	NP_065390.1	NF-kappa-B inhibitor alpha	11959143	2007-11-07 17:31	HIV-1 gp120/CD4 interaction-induced NF-kappaB activation stimulates the hyperphosphorylation of IkappaB-alpha by IkappaB kinases (IKKs)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	4792	NP_065390.1	NF-kappa-B inhibitor alpha	15103018	2007-11-07 17:31	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	4792	NP_065390.1	NF-kappa-B inhibitor alpha	16001969	2007-11-07 17:31	Overexpression of NF-kappaB inhibitory subunit, IkappaBalpha, completely abrogates gp120-induced COX-2 activity
11676	156110	NP_057857.2	Nef	degrades	9606	4792	NP_065390.1	NF-kappa-B inhibitor alpha	12419805	2007-11-07 17:28	The degradation of I-kappaB alpha in promonocytic cells treated with exogenous HIV-1 Nef results in the activation of NF-kappaB
11676	156110	NP_057857.2	Nef	upregulates	9606	4792	NP_065390.1	NF-kappa-B inhibitor alpha	16429138	2007-11-07 17:31	HIV-1 Nef suppresses immunoglobulin class-switch DNA recombination by inducing IkappaBalpha and SOCS proteins, which block CD154, IL-4 and IL-10 cytokine signaling via NF-kappaB and STAT transcription factors
11676	155871	NP_057853.1	Tat	inhibited by	9606	4793	NP_002494.2	NF-kappa-B inhibitor beta isoform a	8615004,8709193	2007-11-07 17:27	I kappa B potently inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	degrades	9606	4793	NP_002494.2	NF-kappa-B inhibitor beta isoform a	10480634,10580107,10799874,11511100	2007-11-07 17:27	HIV-1 Tat induces the phosphorylation and degradation of IkappaB through a p56lck dependent mechanism, leading to the activation of NF-kappa B
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	4793	NP_002494.2	NF-kappa-B inhibitor beta isoform a	15103018	2007-11-07 17:31	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155871	NP_057853.1	Tat	synergizes with	9606	4803	NP_002497.2	beta-nerve growth factor precursor	8178451	2007-11-07 17:30	Nerve growth factor synergizes with HIV-1 Tat to induce HIV-1 gene expression in neuronal and glial cell lines
11676	155871	NP_057853.1	Tat	inhibits	9606	4803	NP_002497.2	beta-nerve growth factor precursor	15361847	2007-11-07 17:28	HIV-1 Tat shows the ability to inhibit the nerve growth factor (NGF)-induced neuronal differentiation of PC12 cells
11676	155871	NP_057853.1	Tat	inhibits	9606	4803	NP_002497.2	beta-nerve growth factor precursor	16741963	2007-11-07 17:31	Expression of HIV-1 Tat in human SK-N-MC cells inhibits the NGF-signaling pathway leading to suppression of MAPK and reduction of Puralpha binding to the Egr-1 promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	4826	NP_005377.1	neuronatin isoform alpha	12775420	2007-11-07 17:31	Downregulation of guanine nucleotide-releasing protein, CD151/PETA-3, neuronatin, neuroendocrine differentiation factor, mitochondria 16s rRNA, and signal recognition particle is observed in HIV-1 infected and HIV-1 gp120-treated astrocytes
11676	155030	NP_579876.2	matrix	myristoylated by	9606	4836	NP_066565.1	glycylpeptide N-tetradecanoyltransferase 1	2194551,2405382,2692561,2737204,2788277,7521919,8139035,8576268,8970978,9261380,9299393,9971769,10074105,10196310,11302743,12244217,12767222,14699046,14707265,15280532,16183191,16216583,16306631	2007-11-07 17:28	HIV-1 Matrix is myristoylated on its N-terminal glycine residue by N-myristoyltransferase, a chemical modification important for membrane targeting of Gag/Matrix, for facilitating Matrix multimerization, and for virus particle formation and budding
11676	156110	NP_057857.2	Nef	myristoylated by	9606	4836	NP_066565.1	glycylpeptide N-tetradecanoyltransferase 1	10339411,11463741,16475823	2007-11-07 17:28	The N-terminal methionine of HIV-1 Nef is myristoylated by N-myristoyltransferase
11676	156110	NP_057857.2	Nef	interacts with	9606	4836	NP_066565.1	glycylpeptide N-tetradecanoyltransferase 1	15613341	2007-11-07 17:28	p65 N-myristoyltransferase isoform 1 coimmunoprecipitates with HIV-1 Nef in experiments using antibodies to Nef, and this interaction requires an intact myristoylation signal in Nef
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	4842	NP_000611.1	nitric oxide synthase, brain	7521167,8581564	2007-11-07 17:29	Preincubation of human astrocytoma cells with HIV-1 gp120 produces a significant increase of nitrite and PGE2 in cell supernatants; the effect of gp120 on both nitrite and PGE2 production is inhibited by antagonists of NO synthase or cyclooxygenase
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	4842	NP_000611.1	nitric oxide synthase, brain	7561697,8943206,9870939,10068656,10203575,10443886	2007-11-07 17:31	The amino terminus of HIV-1 gp41 induces nitric oxide synthase in human glial and astrocyte cultures and that causes the dysregulation of nitric oxide production
11676	155871	NP_057853.1	Tat	upregulates	9606	4843	NP_000616.3	nitric oxide synthase, inducible	7526541	2007-11-07 17:29	HIV-1 Tat induces iNOS in rat brain injected with Tat through upregulation of TNF-alpha, suggesting a mechanism for Tat-induced CNS damage
11676	155871	NP_057853.1	Tat	inhibits	9606	4843	NP_000616.3	nitric oxide synthase, inducible	8760410	2007-11-07 17:30	HIV-1 Tat inhibits interferon-induced iNOS activity in a murine macrophage cell line
11676	155871	NP_057853.1	Tat	upregulates	9606	4843	NP_000616.3	nitric oxide synthase, inducible	10393859	2007-11-07 17:28	HIV-1 Tat induces the expression of NOS-2 and NOS-3 which appears to be a mechanism for regulating Tat-mediated degradation of IkappaBalpha and activation of NFkappaB
11676	155871	NP_057853.1	Tat	upregulates	9606	4843	NP_000616.3	nitric oxide synthase, inducible	10446807,11579140,12167619	2007-11-07 17:30	HIV-1 Tat induces iNOS in human astroglia and microglia through the activation of NF-kappaB and C/EBPbeta, an effect that may participate in the pathogenesis of HIV-associated dementia
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	4843	NP_000616.3	nitric oxide synthase, inducible	15285794	2007-11-07 17:30	Ascorbate supplementation prevents the deleterious upregulation of iNOS and associated neuronal (MAP2) and astrocytic (GFAP) protein expression and structural changes caused by gp120 in human brain cell cultures
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	4843	NP_000616.3	nitric oxide synthase, inducible	7561697,8943206,9870939,10068656,10203575,10443886	2007-11-07 17:31	The amino terminus of HIV-1 gp41 induces nitric oxide synthase in human glial and astrocyte cultures and that causes the dysregulation of nitric oxide production
11676	155871	NP_057853.1	Tat	upregulates	9606	4846	NP_000594.2	nitric oxide synthase, endothelial isoform 1	10393859	2007-11-07 17:28	HIV-1 Tat induces the expression of NOS-2 and NOS-3 which appears to be a mechanism for regulating Tat-mediated degradation of IkappaBalpha and activation of NFkappaB
11676	155871	NP_057853.1	Tat	downregulates	9606	4846	NP_000594.2	nitric oxide synthase, endothelial isoform 1	12947275	2007-11-07 17:29	HIV-1 Tat protein significantly decreased endothelium-dependent vasorelaxation and eNOS mRNA and protein expression in endothelial cells of porcine coronary arteries, suggesting a role for Tat in coronary heart disease in HIV-infected patients
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	4846	NP_000594.2	nitric oxide synthase, endothelial isoform 1	7561697,8943206,9870939,10068656,10203575,10443886	2007-11-07 17:31	The amino terminus of HIV-1 gp41 induces nitric oxide synthase in human glial and astrocyte cultures and that causes the dysregulation of nitric oxide production
11676	155871	NP_057853.1	Tat	interacts with	9606	4853	NP_077719.2	neurogenic locus notch homolog protein 2 preproprotein	14609630	2007-11-07 17:30	HIV-1 Tat interacts with the EGF-like repeats 1-6 (amino acids 26-256) of Human Notch2, suggesting Tat might modulate Notch2 function, thus affecting various AIDS-associated pathologies
11676	155871	NP_057853.1	Tat	binds	9606	4869	NP_002511.1	nucleophosmin isoform 1	7826206,9094689	2007-11-07 17:30	The nucleolar shuttle protein B23 binds to HIV-1 Tat and data indicates B23 is necessary for the nucleolar localization of Tat
11676	155908	NP_057854.1	Rev	binds	9606	4869	NP_002511.1	nucleophosmin isoform 1	2017166,12511551,16354571	2007-11-07 17:27	during nuclear import B23 forms a specific binding complex with Rev which is dissociated by RRE RNA and phosphorylation by casein kinase II (CK2)
11676	155908	NP_057854.1	Rev	associates with	9606	4869	NP_002511.1	nucleophosmin isoform 1	2109912,7593322	2007-11-07 17:27	B23 is associated with the nucleolar localization of Rev
11676	155908	NP_057854.1	Rev	binds	9606	4869	NP_002511.1	nucleophosmin isoform 1	2109912,2404140	2007-11-07 17:27	amino acids 38-52 of Rev have been implicated in the association with B32
11676	155908	NP_057854.1	Rev	interacts with	9606	4869	NP_002511.1	nucleophosmin isoform 1	7628555,8224012,9150888	2007-11-07 17:27	interaction of B23 with Rev has been implicated in the cytotoxic activity of Rev
11676	155908	NP_057854.1	Rev	stimulated by	9606	4869	NP_002511.1	nucleophosmin isoform 1	7794916,9092824	2007-11-07 17:27	B23 stimulates the nuclear import of Rev, an effect that is increased when B23 is phosphorylated by casein kinase II (CK2)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	4893	NP_002515.1	GTPase NRas precursor	9269777,9344703	2007-11-07 17:30	HIV-1 gp160 alone or CD4/gp160 cross-linking induces tyrosine phosphorylation of intracellular substrates p59fyn, zap 70, and p95vav and also leads to ras activation
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inactivates	9606	4893	NP_002515.1	GTPase NRas precursor	9344703	2007-11-07 17:31	Pretreatment of cells with HIV-1 gp160 results in marked inhibition of tyrosine phosphorylation of p59(fyn), PLC-gamma1, ras activation, and TNF-alpha secretion in anti-CD3 mAb activated CD4+ T cells
11676	155871	NP_057853.1	Tat	enhanced by	9606	4904	NP_004550.2	nuclease-sensitive element-binding protein 1	8254772,9472608,10573156	2007-11-07 17:30	YB-1 interacts with HIV-1 Tat and enhances Tat-induced activation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	binds	9606	4904	NP_004550.2	nuclease-sensitive element-binding protein 1	10573156	2007-11-07 17:30	Binding of YB-1 to HIV-1 Tat is mediated through the C-terminal region of Tat (amino acids 48-72) and through amino acids 75-203 of YB-1
11676	155908	NP_057854.1	Rev	interacts with	9606	4928	NP_005378.4	nuclear pore complex protein Nup98-Nup96 isoform 3	8943370,14554087	2007-11-07 17:27	the FG repeat region of nup98 interacts directly with the nuclear export sequence of HIV-1 Rev, suggesting a physiological role for nup98 in modulating Rev-dependent RNA export during HIV infection
11676	155908	NP_057854.1	Rev	recruits	9606	4928	NP_005378.4	nuclear pore complex protein Nup98-Nup96 isoform 3	9847314	2007-11-07 17:27	Rev can recruit nup98 to the nucleolus
11676	155908	NP_057854.1	Rev	inhibited by	9606	4928	NP_005378.4	nuclear pore complex protein Nup98-Nup96 isoform 3	9847314	2007-11-07 17:27	the FG-containing repeat domain of Nup98 can inhibit Rev-mediated expression of viral proteins
11676	155908	NP_057854.1	Rev	interacts with	9606	4928	NP_005378.4	nuclear pore complex protein Nup98-Nup96 isoform 3	11238447	2007-11-07 17:27	nup98 is involved in Rev-mediated nuclear export of HIV-1 mRNA through an interaction with eukaryotic initiation factor 5A (eIF-5A) which binds to Rev
11676	155871	NP_057853.1	Tat	interacts with	9606	4938	NP_002525.2	2'-5'-oligoadenylate synthase 1 isoform 2	1708818	2007-11-07 17:27	HIV-1 Tat interacts with interferon-inducible enzymes 2-5A synthetase and dsRNA-dependent protein kinase to influence the rate of translation and protein synthesis in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	4939	NP_058197.2	2'-5'-oligoadenylate synthase 2 isoform 1	1708818	2007-11-07 17:27	HIV-1 Tat interacts with interferon-inducible enzymes 2-5A synthetase and dsRNA-dependent protein kinase to influence the rate of translation and protein synthesis in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	4940	NP_006178.2	2'-5'-oligoadenylate synthase 3	1708818	2007-11-07 17:27	HIV-1 Tat interacts with interferon-inducible enzymes 2-5A synthetase and dsRNA-dependent protein kinase to influence the rate of translation and protein synthesis in vitro
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	4950	NP_002529.1	occludin	15977641	2007-11-07 17:30	Treatment of cultured human brain endothelial cells with HIV-1 gp120 results in increased permeability of the endothelial monolayer and causes disruption and downregulation of the tight junction proteins ZO-1, ZO-2, and occludin in these cells
11676	155871	NP_057853.1	Tat	upregulates	9606	4968	NP_002533.1	N-glycosylase/DNA lyase isoform 1a	15929986	2007-11-07 17:28	HIV-1 Tat appears to upregulate OGG1 expression by sequestrating AP-4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	4986	NP_000903.2	kappa-type opioid receptor	11931835	2007-11-07 17:31	Kappa-opioid receptor (KOR) agonist treatment of CD4(+) lymphocytes inhibits HIV-1 envelope gp120/41-mediated membrane fusion via downregulation of CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	4988	NP_000905.3	mu-type opioid receptor isoform MOR-1	11445868	2007-11-07 17:30	HIV-1 gp120 upregulates mu opiate receptor expression in human vascular endothelium; in contrast, morphine decreases mu opioid receptor expression
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	4988	NP_000905.3	mu-type opioid receptor isoform MOR-1	16846840	2007-11-07 17:31	HIV-1 gp120 upregulates mu opioid receptor (MOR) expression in TPA-differentiated HL-60 cells; treatment with TNF-alpha neutralizing antibody as well as anti-TNF-alpha receptor type II (TNFR-II) antibody, inhibits gp120-induced upregulation of MOR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	5004	NP_000598.1	orosomucoid 1 precursor	7795416,11336643	2007-11-07 17:29	Recombinant precursor gp160 (rgp160) or surface unit gp120 (rgp120) of HIV-1 and alpha 1-acid glycoprotein (AGP) show a specific low-affinity binding via N-linked glycans
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	5004	NP_000598.1	orosomucoid 1 precursor	11336643	2007-11-07 17:31	AGP inhibits the binding of the HIV-1 gp120 consensus V3 domain (V3Cs) and macrophage inflammatory protein-1beta (MIP-1beta) to CCR5 on human monocyte-derived macrophages (MDM)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	5005	NP_000599.1	alpha-1-acid glycoprotein 2 precursor	7795416,11336643	2007-11-07 17:29	Recombinant precursor gp160 (rgp160) or surface unit gp120 (rgp120) of HIV-1 and alpha 1-acid glycoprotein (AGP) show a specific low-affinity binding via N-linked glycans
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	5005	NP_000599.1	alpha-1-acid glycoprotein 2 precursor	11336643	2007-11-07 17:31	AGP inhibits the binding of the HIV-1 gp120 consensus V3 domain (V3Cs) and macrophage inflammatory protein-1beta (MIP-1beta) to CCR5 on human monocyte-derived macrophages (MDM)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaved by	9606	5034	NP_000909.2	protein disulfide-isomerase precursor	12218051,12218052	2007-11-07 17:30	Protein-disulfide isomerase (PDI) cleaves disulfide bonds in recombinant HIV-1 envelope glycoprotein gp120, and gp120 bound to the surface receptor CD4 undergoes a disulfide reduction that is prevented by PDI inhibitors
11676	155871	NP_057853.1	Tat	cleaved by	9606	5045	NP_002560.1	furin preproprotein	15135058	2007-11-07 17:28	Furin cleaves HIV-1 Tat at amino acid residue 56, resulting in greatly reduced Tat transactivation activity
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	cleaved by	9606	5045	NP_002560.1	furin preproprotein	1360148,7639757,7774724,8163529,8189547,8670066,8940009,8995623,9094426,9521771,10225274,10452538,11861826,11921231,12071862,12354117,15371436,16600625	2007-11-07 17:30	Furin, a subtilisin-like eukaryotic endoprotease, is able to process HIV-1 gp160/gp140 to the cleavage products gp120 and gp41 at the cleavage site with the consensus amino acid sequence Arg-X-Lys/Arg-Arg
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	cleaved by	9606	5046	NP_002561.1	proprotein convertase subtilisin/kexin type 6 isoform a preproprotein	8670066,8940009,8995442,9521771,11063880	2007-11-07 17:30	Kexin/subtilisin-related convertases such as furin, PACE4, PC1, PC2, PC5 and its isoform PC5/6-B can process HIV-1 gp160 to gp120/gp41
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	5047	NP_002562.2	glycodelin precursor	9274854	2007-11-07 17:28	3-hydroxyphthalic anhydride (3HP) modified glycodelin GdA and GdS proteins inhibit HIV-1 gp120-CD4 binding and induce anti-HIV activity
11676	155871	NP_057853.1	Tat	interacts with	9606	5048	NP_000421.1	platelet-activating factor acetylhydrolase IB subunit alpha	15698475,17018134	2007-11-07 17:31	HIV-1 Tat interacts with LIS1 in vitro and in vivo, and this interaction might contribute to the effect of Tat on microtubule formation
11676	155871	NP_057853.1	Tat	interacts with	9606	5048	NP_000421.1	platelet-activating factor acetylhydrolase IB subunit alpha	17018134	2007-11-07 17:31	Inhibition of PP2A by LIS1 increases Tat mediated HIV-1 transcription
11676	155871	NP_057853.1	Tat	upregulates	9606	5054	NP_000593.1	plasminogen activator inhibitor 1 isoform 1 precursor	7523444	2007-11-07 17:30	HIV-1 Tat has been shown to activate central nervous system-derived endothelial cells by the upregulation of E-selectin, IL-6 and PAI-1
11676	155871	NP_057853.1	Tat	modulates	9606	5054	NP_000593.1	plasminogen activator inhibitor 1 isoform 1 precursor	9143604	2007-11-07 17:28	HIV-1 Tat affects the fibrinolytic activity of tumor cell lines derived from BKV/tat-transgenic mice by upregulating/modulating the production of both urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor 1 (PAI-1)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5055	NP_002566.1	plasminogen activator inhibitor 2 precursor	16923810	2007-11-07 17:31	HIV-1 infection and HIV-1 gp120 treatment of human peripheral blood mononuclear cells result in induction of SerpinB2 and this induction enhances transcription from the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	5058	NP_002567.3	serine/threonine-protein kinase PAK 1 isoform 2	14694110	2007-11-07 17:28	HIV-1 Tat induces actin cytoskeletal rearrangements through p21-activated kinase 1 (PAK1) and downstream activation of the endothelial NADPH oxidase, an effect that is lost by introduction of mutations into the Tat cysteine-rich or basic domains
11676	156110	NP_057857.2	Nef	activates	9606	5058	NP_002567.3	serine/threonine-protein kinase PAK 1 isoform 2	7797518,9792838,10713183,16091223	2007-11-07 17:28	The activation of Nef-associated kinase (NAK; also known as p21-activated kinase 1 or PAK1) by HIV-1 Nef is via the small GTPases Cdc42 and Rac1, suggesting an interaction between Nef and these GTPases
11676	156110	NP_057857.2	Nef	associates with	9606	5058	NP_002567.3	serine/threonine-protein kinase PAK 1 isoform 2	8108442,8709241,9070423,12734410	2007-11-07 17:28	A cellular serine kinase is found to specifically associate with HIV-1 Nef; proteins of 62 kDa and 72 kDa, which coimmunoprecipitated with Nef, are phosphorylated in in vitro kinase assays
11676	156110	NP_057857.2	Nef	associates with	9606	5058	NP_002567.3	serine/threonine-protein kinase PAK 1 isoform 2	8709288,8862424,9070423,9371615,15638726,16091223	2007-11-07 17:28	The association of HIV-1 Nef with the cellular serine kinase PAK enhances efficient proviral DNA synthesis and virion infectivity
11676	156110	NP_057857.2	Nef	activates	9606	5058	NP_002567.3	serine/threonine-protein kinase PAK 1 isoform 2	8939608	2007-11-07 17:28	HIV-1 Nef-mediated activation of a PAK-related kinase correlates with the induction of high virus loads and the development of AIDS in infected rhesus macaques
11676	156110	NP_057857.2	Nef	activates	9606	5058	NP_002567.3	serine/threonine-protein kinase PAK 1 isoform 2	10559302,11463741	2007-11-07 17:28	HIV-1 Nef binding and activation of the PAK-related kinase and phosphorylation of its substrate (a complex composed of PIX and p95) are readily detected in both infected primary T lymphocytes and macrophages
11676	156110	NP_057857.2	Nef	activates	9606	5058	NP_002567.3	serine/threonine-protein kinase PAK 1 isoform 2	11689886,12009866	2007-11-07 17:28	HIV-1 Nef-mediated p21-activated kinase (PAK) activation involves the binding of Nef and phosphatidylinositol 3-kinase (PI3K)
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5062	NP_002568.2	serine/threonine-protein kinase PAK 2	9151826	2007-11-07 17:28	hPAK65 has been demonstrated to phosphorylate HIV-1 Matrix on serine residues in vitro
11676	156110	NP_057857.2	Nef	binds	9606	5062	NP_002568.2	serine/threonine-protein kinase PAK 2	9075929,11160719,11463741,12734410,14965316,15638726,16501114,16687395,16912329,16916529,17077296	2007-11-07 17:28	HIV-1 Nef binds to p21-activated kinase 2 (PAK2); this interaction is mediated through the N-terminal domain of Nef and the C-terminal part of the regulatory domain of PAK2
11676	156110	NP_057857.2	Nef	activates	9606	5062	NP_002568.2	serine/threonine-protein kinase PAK 2	10607567,11070003,15847608,16282498,16979207	2007-11-07 17:28	HIV-1 Nef-mediated PAK2 activation is found in multiple human cell lines of myeloid, lymphoid, and non hematopoietic origin
11676	156110	NP_057857.2	Nef	binds	9606	5062	NP_002568.2	serine/threonine-protein kinase PAK 2	11448168	2007-11-07 17:28	Hck-derived SH3 domains efficiently associate with HIV-1 Nef in cells and thereby potently inhibit SH3-dependent Nef functions, such as binding p21-activated kinase-2 (PAK2)
11676	156110	NP_057857.2	Nef	activates	9606	5062	NP_002568.2	serine/threonine-protein kinase PAK 2	12855553,16272310	2007-11-07 17:28	The activation of PAK2 by HIV-1 Nef is critical for human intrathymic T-cell development
11676	156110	NP_057857.2	Nef	co-localizes with	9606	5062	NP_002568.2	serine/threonine-protein kinase PAK 2	15047825,16916529	2007-11-07 17:28	HIV-1 Nef co-localizes with PAK-2 in lipid rafts; a palmitoylated Nef is highly enriched in lipid rafts and associates with higher levels of PAK-2 activity than wild type Nef
11676	156110	NP_057857.2	Nef	interacts with	9606	5062	NP_002568.2	serine/threonine-protein kinase PAK 2	15194762,16912329,16916529	2007-11-07 17:28	HIV-1 group N and group O nef alleles interact with PAK-2, albeit with different efficiencies
11676	156110	NP_057857.2	Nef	associates with	9606	5062	NP_002568.2	serine/threonine-protein kinase PAK 2	16501114,16912329	2007-11-07 17:31	Mutation of HIV-1 Nef amino acid residues at positions 85, 89, 187, 188, and 191 dramatically alters association with Pak2 without affecting Nef expression levels or CD4 and MHC-I downregulation
11676	155871	NP_057853.1	Tat	upregulates	9606	5074	NP_002574.2	PRKC apoptosis WT1 regulator protein	10393834	2007-11-07 17:30	Par-4 expression is upregulated by HIV-1 Tat in hippocampal neurons and participates at an early stage of Tat-induced neuronal apoptosis, suggesting Par-4 may be a mediator of neuronal apoptosis in HIV encephalitis
11676	155348	NP_705928.1	integrase	binds	9606	5105	NP_002582.2	cytosolic phosphoenolpyruvate carboxykinase 1	11689615	2007-11-07 17:29	Interaction of human PCK1 with HIV-1 integrase is presumed based on a reported binding interaction between yeast PCK1 and integrase
11676	155871	NP_057853.1	Tat	interacts with	9606	5111	NP_002583.1	proliferating cell nuclear antigen	15050687	2007-11-07 17:28	When expressed in astrocytes, neurons, and non-glial 293T cells, HIV-1 Tat interacts with a number of cell cycle-related proteins including cyclin A, cyclin B, cyclin D3, Cdk2, Cdk4, Cdk1/Cdc2, cdc6, p27, p53, p63, hdlg, and PCNA
11676	155807	NP_057852.2	Vpr	induces accumulation of	9606	5116	NP_006022.3	pericentrin	14767062	2007-11-07 17:28	HIV-1 Vpr-expressing HeLa cells stained with centriole markers pericentrin, gamma-tubulin, and Cen2 contain multiple pairs of centrioles scattered in the perinuclear region, indicating Vpr causes the accumulation of multiple centrosome-like structures
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	cleaved by	9606	5122	NP_000430.3	neuroendocrine convertase 1 isoform 1 preproprotein	7639757,8163529,8940009,8995623	2007-11-07 17:30	PC1, one of the subtilisin/kexin family convertases, cleaves HIV-1 gp160 into gp120 and gp41 at amino acids 511-512
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	cleaved by	9606	5125	NP_006191.2	proprotein convertase subtilisin/kexin type 5 preproprotein	8670066,9521771,11063880	2007-11-07 17:30	Kexin/subtilisin-related convertases such as furin, PACE4, PC1, PC2, PC5 and its isoform PC5/6-B can process HIV-1 gp160 to gp120/gp41
11676	155871	NP_057853.1	Tat	activates	9606	5136	NP_005010.2	calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A isoform 1	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	activates	9606	5137	NP_005011.1	calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	activates	9606	5138	NP_002590.1	cGMP-dependent 3',5'-cyclic phosphodiesterase isoform 1	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	activates	9606	5139	NP_000912.3	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	activates	9606	5140	NP_000913.2	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	recruits	9606	5141	NP_006193.1	cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4	11114167	2007-11-07 17:30	HIV-1 Tat protein, in combination with anti-CD3/CD28 mAbs, promotes IL-2 production and proliferation of primary CD4+ T lymphocytes by recruiting cyclic nucleoside phosphodiesterase 4, resulting in increased susceptibility to HIV-1 infection
11676	155871	NP_057853.1	Tat	activates	9606	5141	NP_006193.1	cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform 4	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	recruits	9606	5142	NP_002591.2	cAMP-specific 3',5'-cyclic phosphodiesterase 4B isoform 1	11114167	2007-11-07 17:30	HIV-1 Tat protein, in combination with anti-CD3/CD28 mAbs, promotes IL-2 production and proliferation of primary CD4+ T lymphocytes by recruiting cyclic nucleoside phosphodiesterase 4, resulting in increased susceptibility to HIV-1 infection
11676	155871	NP_057853.1	Tat	activates	9606	5142	NP_002591.2	cAMP-specific 3',5'-cyclic phosphodiesterase 4B isoform 1	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	activates	9606	5143	NP_000914.2	cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform PDE4C-1	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	activates	9606	5144	NP_006194.2	cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform 2	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	activates	9606	5150	NP_002594.1	high affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A isoform a	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	activates	9606	5151	NP_002596.1	high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform 1	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	activates	9606	5153	NP_000915.1	calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B isoform 1	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	5199	NP_002612.1	properdin precursor	7911492	2007-11-07 17:27	Complement proteins C4, C3d, C5b-9, and properdin bind to HIV-1 gp120-coated CD4+ T cells of healthy individuals when incubated in autologous serum
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	5199	NP_002612.1	properdin precursor	8630395	2007-11-07 17:30	A synthetic peptide covering positions 233-251 of the HIV-1 gp120 protein binds to complement proteins C3, C4, C5, C9, and properdin
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	5199	NP_002612.1	properdin precursor	7590866,7893437	2007-11-07 17:27	Preincubation of HIV-1 gp41 with either factor H or properdin, and of HIV-1 gp120 with C3b or C4b affect the interaction between HIV-1 gp41 and gp120
11676	155871	NP_057853.1	Tat	downregulates	9606	5243	NP_000918.2	multidrug resistance protein 1	7621073	2007-11-07 17:27	HIV-1 Tat represses transcription of the Sp1-dependent MDR1 promoter, suggesting Tat downregulates MDR1 expression
11676	155871	NP_057853.1	Tat	upregulates	9606	5243	NP_000918.2	multidrug resistance protein 1	15934943	2007-11-07 17:31	HIV-1 Tat upregulates expression of P-glycoprotein (P-gp) in brain microvascular endothelial cells (BMEC)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5243	NP_000918.2	multidrug resistance protein 1	9542318	2007-11-07 17:30	Treatment of CD4+ and CD8+ T cells with HIV-1 gp120 increases the intracellular expression of P-glycoprotein (P-gp)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5244	NP_000434.1	multidrug resistance protein 3 isoform A	9542318	2007-11-07 17:30	Treatment of CD4+ and CD8+ T cells with HIV-1 gp120 increases the intracellular expression of P-glycoprotein (P-gp)
11676	155348	NP_705926.1	retropepsin	cleaves	9606	5255	NP_002628.1	phosphorylase kinase, alpha 1 (muscle)	1872871	2007-11-07 17:29	The alpha subunit of phosphorylase kinase is preferentially cleaved at arg748-val749 by HIV-1 protease
11676	155348	NP_705926.1	retropepsin	cleaves	9606	5256	NP_000283.1	phosphorylase b kinase regulatory subunit alpha, liver isoform	1872871	2007-11-07 17:29	The alpha subunit of phosphorylase kinase is preferentially cleaved at arg748-val749 by HIV-1 protease
11676	155348	NP_705926.1	retropepsin	cleaves	9606	5257	NP_000284.1	phosphorylase b kinase regulatory subunit beta isoform a	1872871	2007-11-07 17:29	The beta subunit of phosphorylase kinase is cleaved at leu678-pro679 by HIV-1 protease
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	5265	NP_000286.3	alpha-1-antitrypsin precursor	8227051,12621451,12878320	2007-11-07 17:31	Alpha1-Antitrypsin (alpha(1)AT) is cleaved by serine proteases, causing a conformational change in alpha(1)AT that sequesters HIV-1 protease, blocks both gp160 and p55 processing, and is a powerful inhibitor of HIV replication
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	10641798	2007-11-07 17:29	HIV-1 RT heterodimer expressed in bacteria can be phosphorylated in vitro by several purified mammalian protein kinases including auto-activated protein kinase (PK), CKII, cytosolic protamine kinase (CPK), myelin basic protein kinase 1 (MBPK1), and PRKC
11676	155871	NP_057853.1	Tat	activates	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	8798481,9394803,9708406,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates phosphatidylinositol 3-kinase (PI3K), leading to the activation of Akt/PKB, decreased levels of cAMP and CREB phosphorylation, and the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	interacts with	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	9446795	2007-11-07 17:28	Activation of protein kinase C-epsilon by HIV-1 Tat involves an interaction with PI 3-kinase
11676	155871	NP_057853.1	Tat	interacts with	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	11154208	2007-11-07 17:28	HIV-1 Tat induced release of MCP-1 from human lung microvascular endothelial cells involves an interaction between Tat and PI3 kinase
11676	155871	NP_057853.1	Tat	inhibited by	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	12077252	2007-11-07 17:28	Phosphatidylinositol 3-kinase inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter by affecting the formation of the Tat-associated kinase transactivating complex
11676	155871	NP_057853.1	Tat	interacts with	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	14602571	2007-11-07 17:28	HIV-1 Tat-mediated cytopathic changes in human brain microvascular endothelial cells involves its interaction with phosphatidylinositol 3-kinase (PI3K)
11676	155871	NP_057853.1	Tat	activates	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	9341793	2007-11-07 17:30	PI3-kinase activation induced by HIV-1 gp160 leads to downregulation of LFA-1-mediated T cell adhesion to B cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	9808187	2007-11-07 17:31	HIV-1 gp160 disrupts the association between phospholipase C gamma-1 and phosphoinositide 3 kinase (PI3-kinase), and this effect is dependent on PI3-kinase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	12551992,12960231	2007-11-07 17:30	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	16081599	2007-11-07 17:30	HIV-1 gp120-induced TNF-alpha production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	5286	NP_002636.1	phosphoinositide-3-kinase, class 2, alpha polypeptide	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155871	NP_057853.1	Tat	activates	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	8798481,9394803,9708406,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates phosphatidylinositol 3-kinase (PI3K), leading to the activation of Akt/PKB, decreased levels of cAMP and CREB phosphorylation, and the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	interacts with	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	9446795	2007-11-07 17:28	Activation of protein kinase C-epsilon by HIV-1 Tat involves an interaction with PI 3-kinase
11676	155871	NP_057853.1	Tat	interacts with	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	11154208	2007-11-07 17:28	HIV-1 Tat induced release of MCP-1 from human lung microvascular endothelial cells involves an interaction between Tat and PI3 kinase
11676	155871	NP_057853.1	Tat	inhibited by	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	12077252	2007-11-07 17:28	Phosphatidylinositol 3-kinase inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter by affecting the formation of the Tat-associated kinase transactivating complex
11676	155871	NP_057853.1	Tat	interacts with	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	14602571	2007-11-07 17:28	HIV-1 Tat-mediated cytopathic changes in human brain microvascular endothelial cells involves its interaction with phosphatidylinositol 3-kinase (PI3K)
11676	155871	NP_057853.1	Tat	activates	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	9341793	2007-11-07 17:30	PI3-kinase activation induced by HIV-1 gp160 leads to downregulation of LFA-1-mediated T cell adhesion to B cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	9808187	2007-11-07 17:31	HIV-1 gp160 disrupts the association between phospholipase C gamma-1 and phosphoinositide 3 kinase (PI3-kinase), and this effect is dependent on PI3-kinase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	12551992,12960231	2007-11-07 17:31	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	16081599	2007-11-07 17:30	HIV-1 gp120-induced TNF-alpha production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	5287	NP_002637.2	phosphoinositide-3-kinase, class 2, beta polypeptide	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155871	NP_057853.1	Tat	activates	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	8798481,9394803,9708406,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates phosphatidylinositol 3-kinase (PI3K), leading to the activation of Akt/PKB, decreased levels of cAMP and CREB phosphorylation, and the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	interacts with	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	9446795	2007-11-07 17:28	Activation of protein kinase C-epsilon by HIV-1 Tat involves an interaction with PI 3-kinase
11676	155871	NP_057853.1	Tat	interacts with	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	11154208	2007-11-07 17:28	HIV-1 Tat induced release of MCP-1 from human lung microvascular endothelial cells involves an interaction between Tat and PI3 kinase
11676	155871	NP_057853.1	Tat	inhibited by	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	12077252	2007-11-07 17:28	Phosphatidylinositol 3-kinase inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter by affecting the formation of the Tat-associated kinase transactivating complex
11676	155871	NP_057853.1	Tat	interacts with	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	14602571	2007-11-07 17:28	HIV-1 Tat-mediated cytopathic changes in human brain microvascular endothelial cells involves its interaction with phosphatidylinositol 3-kinase (PI3K)
11676	155871	NP_057853.1	Tat	activates	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	9341793	2007-11-07 17:30	PI3-kinase activation induced by HIV-1 gp160 leads to downregulation of LFA-1-mediated T cell adhesion to B cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	9808187	2007-11-07 17:31	HIV-1 gp160 disrupts the association between phospholipase C gamma-1 and phosphoinositide 3 kinase (PI3-kinase), and this effect is dependent on PI3-kinase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	12551992,12960231	2007-11-07 17:31	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	16081599	2007-11-07 17:31	HIV-1 gp120-induced TNF-alpha production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	5288	NP_004561.2	phosphoinositide-3-kinase, class 2, gamma polypeptide	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155871	NP_057853.1	Tat	activates	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	8798481,9394803,9708406,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates phosphatidylinositol 3-kinase (PI3K), leading to the activation of Akt/PKB, decreased levels of cAMP and CREB phosphorylation, and the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	interacts with	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	9446795	2007-11-07 17:28	Activation of protein kinase C-epsilon by HIV-1 Tat involves an interaction with PI 3-kinase
11676	155871	NP_057853.1	Tat	interacts with	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	11154208	2007-11-07 17:28	HIV-1 Tat induced release of MCP-1 from human lung microvascular endothelial cells involves an interaction between Tat and PI3 kinase
11676	155871	NP_057853.1	Tat	inhibited by	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	12077252	2007-11-07 17:28	Phosphatidylinositol 3-kinase inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter by affecting the formation of the Tat-associated kinase transactivating complex
11676	155871	NP_057853.1	Tat	interacts with	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	14602571	2007-11-07 17:28	HIV-1 Tat-mediated cytopathic changes in human brain microvascular endothelial cells involves its interaction with phosphatidylinositol 3-kinase (PI3K)
11676	155871	NP_057853.1	Tat	activates	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	9341793	2007-11-07 17:30	PI3-kinase activation induced by HIV-1 gp160 leads to downregulation of LFA-1-mediated T cell adhesion to B cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	9808187	2007-11-07 17:31	HIV-1 gp160 disrupts the association between phospholipase C gamma-1 and phosphoinositide 3 kinase (PI3-kinase), and this effect is dependent on PI3-kinase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	12551992,12960231	2007-11-07 17:31	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	16081599	2007-11-07 17:31	HIV-1 gp120-induced TNF-alpha production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	5289	NP_002638.2	phosphatidylinositol 3-kinase catalytic subunit type 3	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155871	NP_057853.1	Tat	activates	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	8798481,9394803,9708406,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates phosphatidylinositol 3-kinase (PI3K), leading to the activation of Akt/PKB, decreased levels of cAMP and CREB phosphorylation, and the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	interacts with	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	9446795	2007-11-07 17:28	Activation of protein kinase C-epsilon by HIV-1 Tat involves an interaction with PI 3-kinase
11676	155871	NP_057853.1	Tat	interacts with	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	11154208	2007-11-07 17:28	HIV-1 Tat induced release of MCP-1 from human lung microvascular endothelial cells involves an interaction between Tat and PI3 kinase
11676	155871	NP_057853.1	Tat	inhibited by	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	12077252	2007-11-07 17:28	Phosphatidylinositol 3-kinase inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter by affecting the formation of the Tat-associated kinase transactivating complex
11676	155871	NP_057853.1	Tat	interacts with	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	14602571	2007-11-07 17:29	HIV-1 Tat-mediated cytopathic changes in human brain microvascular endothelial cells involves its interaction with phosphatidylinositol 3-kinase (PI3K)
11676	155871	NP_057853.1	Tat	activates	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	9341793	2007-11-07 17:28	PI3-kinase activation induced by HIV-1 gp160 leads to downregulation of LFA-1-mediated T cell adhesion to B cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	9808187	2007-11-07 17:31	HIV-1 gp160 disrupts the association between phospholipase C gamma-1 and phosphoinositide 3 kinase (PI3-kinase), and this effect is dependent on PI3-kinase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	12551992,12960231	2007-11-07 17:30	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	16081599	2007-11-07 17:30	HIV-1 gp120-induced TNF-alpha production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	156110	NP_057857.2	Nef	downregulates	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	8636073,9247029,10208934	2007-11-07 17:27	The association of phosphatidylinositol (PI) 3-kinase with platelet-derived growth factor (PDGF) activated receptor was downregulated by HIV-1 nef expression
11676	156110	NP_057857.2	Nef	upregulates	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	10985305	2007-11-07 17:27	The presence of HIV-1 Nef in Jurkat cells stimulated with a combination of PMA and anti-CD28 upregulates the levels of PI3K production
11676	156110	NP_057857.2	Nef	interacts with	9606	5290	NP_006209.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	11289809,12526811,12584329	2007-11-07 17:27	Downregulation of cell surface major histocompatibility complex class I (MHC-I) protein expression by HIV-1 Nef depends on a phosphoinositide 3-kinase (PI3K)-regulated signaling pathway, suggesting an interaction between Nef and PI3K
11676	155871	NP_057853.1	Tat	activates	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	8798481,9394803,9708406,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates phosphatidylinositol 3-kinase (PI3K), leading to the activation of Akt/PKB, decreased levels of cAMP and CREB phosphorylation, and the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	interacts with	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	9446795	2007-11-07 17:28	Activation of protein kinase C-epsilon by HIV-1 Tat involves an interaction with PI 3-kinase
11676	155871	NP_057853.1	Tat	interacts with	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	11154208	2007-11-07 17:28	HIV-1 Tat induced release of MCP-1 from human lung microvascular endothelial cells involves an interaction between Tat and PI3 kinase
11676	155871	NP_057853.1	Tat	inhibited by	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	12077252	2007-11-07 17:28	Phosphatidylinositol 3-kinase inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter by affecting the formation of the Tat-associated kinase transactivating complex
11676	155871	NP_057853.1	Tat	interacts with	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	14602571	2007-11-07 17:28	HIV-1 Tat-mediated cytopathic changes in human brain microvascular endothelial cells involves its interaction with phosphatidylinositol 3-kinase (PI3K)
11676	155871	NP_057853.1	Tat	activates	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	9341793	2007-11-07 17:28	PI3-kinase activation induced by HIV-1 gp160 leads to downregulation of LFA-1-mediated T cell adhesion to B cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	9808187	2007-11-07 17:31	HIV-1 gp160 disrupts the association between phospholipase C gamma-1 and phosphoinositide 3 kinase (PI3-kinase), and this effect is dependent on PI3-kinase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	12551992,12960231	2007-11-07 17:30	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	16081599	2007-11-07 17:30	HIV-1 gp120-induced TNF-alpha production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	5291	NP_006210.1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155871	NP_057853.1	Tat	activates	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	8798481,9394803,9708406,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates phosphatidylinositol 3-kinase (PI3K), leading to the activation of Akt/PKB, decreased levels of cAMP and CREB phosphorylation, and the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	interacts with	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	9446795	2007-11-07 17:28	Activation of protein kinase C-epsilon by HIV-1 Tat involves an interaction with PI 3-kinase
11676	155871	NP_057853.1	Tat	interacts with	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	11154208	2007-11-07 17:28	HIV-1 Tat induced release of MCP-1 from human lung microvascular endothelial cells involves an interaction between Tat and PI3 kinase
11676	155871	NP_057853.1	Tat	inhibited by	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	12077252	2007-11-07 17:28	Phosphatidylinositol 3-kinase inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter by affecting the formation of the Tat-associated kinase transactivating complex
11676	155871	NP_057853.1	Tat	interacts with	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	14602571	2007-11-07 17:28	HIV-1 Tat-mediated cytopathic changes in human brain microvascular endothelial cells involves its interaction with phosphatidylinositol 3-kinase (PI3K)
11676	155871	NP_057853.1	Tat	activates	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	9341793	2007-11-07 17:30	PI3-kinase activation induced by HIV-1 gp160 leads to downregulation of LFA-1-mediated T cell adhesion to B cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	9808187	2007-11-07 17:31	HIV-1 gp160 disrupts the association between phospholipase C gamma-1 and phosphoinositide 3 kinase (PI3-kinase), and this effect is dependent on PI3-kinase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	12551992,12960231	2007-11-07 17:31	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	16081599	2007-11-07 17:30	HIV-1 gp120-induced TNF-alpha production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	5293	NP_005017.2	phosphoinositide-3-kinase, catalytic, delta polypeptide	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155871	NP_057853.1	Tat	activates	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	8798481,9394803,9708406,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates phosphatidylinositol 3-kinase (PI3K), leading to the activation of Akt/PKB, decreased levels of cAMP and CREB phosphorylation, and the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	interacts with	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	9446795	2007-11-07 17:28	Activation of protein kinase C-epsilon by HIV-1 Tat involves an interaction with PI 3-kinase
11676	155871	NP_057853.1	Tat	interacts with	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	11154208	2007-11-07 17:28	HIV-1 Tat induced release of MCP-1 from human lung microvascular endothelial cells involves an interaction between Tat and PI3 kinase
11676	155871	NP_057853.1	Tat	inhibited by	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	12077252	2007-11-07 17:28	Phosphatidylinositol 3-kinase inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter by affecting the formation of the Tat-associated kinase transactivating complex
11676	155871	NP_057853.1	Tat	interacts with	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	14602571	2007-11-07 17:28	HIV-1 Tat-mediated cytopathic changes in human brain microvascular endothelial cells involves its interaction with phosphatidylinositol 3-kinase (PI3K)
11676	155871	NP_057853.1	Tat	activates	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	9341793	2007-11-07 17:28	PI3-kinase activation induced by HIV-1 gp160 leads to downregulation of LFA-1-mediated T cell adhesion to B cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	9808187	2007-11-07 17:31	HIV-1 gp160 disrupts the association between phospholipase C gamma-1 and phosphoinositide 3 kinase (PI3-kinase), and this effect is dependent on PI3-kinase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	12551992,12960231	2007-11-07 17:30	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	16081599	2007-11-07 17:30	HIV-1 gp120-induced TNF-alpha production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	5294	NP_002640.2	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155871	NP_057853.1	Tat	activates	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	8798481,9394803,9708406,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates phosphatidylinositol 3-kinase (PI3K), leading to the activation of Akt/PKB, decreased levels of cAMP and CREB phosphorylation, and the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	interacts with	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	9446795	2007-11-07 17:28	Activation of protein kinase C-epsilon by HIV-1 Tat involves an interaction with PI 3-kinase
11676	155871	NP_057853.1	Tat	interacts with	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	11154208	2007-11-07 17:28	HIV-1 Tat induced release of MCP-1 from human lung microvascular endothelial cells involves an interaction between Tat and PI3 kinase
11676	155871	NP_057853.1	Tat	inhibited by	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	12077252	2007-11-07 17:28	Phosphatidylinositol 3-kinase inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter by affecting the formation of the Tat-associated kinase transactivating complex
11676	155871	NP_057853.1	Tat	interacts with	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	14602571	2007-11-07 17:28	HIV-1 Tat-mediated cytopathic changes in human brain microvascular endothelial cells involves its interaction with phosphatidylinositol 3-kinase (PI3K)
11676	155871	NP_057853.1	Tat	activates	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	9341793	2007-11-07 17:28	PI3-kinase activation induced by HIV-1 gp160 leads to downregulation of LFA-1-mediated T cell adhesion to B cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	9808187	2007-11-07 17:30	HIV-1 gp160 disrupts the association between phospholipase C gamma-1 and phosphoinositide 3 kinase (PI3-kinase), and this effect is dependent on PI3-kinase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	9123823,10358157,10422873	2007-11-07 17:30	HIV-1 gp120 induces an increase in tyrosine phosphorylation of two proteins, p56lck and phosphatidylinositol 3-kinase (PI 3-kinase) p85 alpha, that are physically complexed to the CD4 molecule
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	12551992,12960231	2007-11-07 17:30	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	16081599	2007-11-07 17:30	HIV-1 gp120-induced TNF-alpha production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	156110	NP_057857.2	Nef	binds	9606	5295	NP_852664.1	phosphatidylinositol 3-kinase regulatory subunit alpha isoform 1	11689886,12009866,12734410,14965316,15638726	2007-11-07 17:27	HIV-1 Nef binds to the regulatory subunit (p85) of phosphatidylinositol-3-kinase (PI3K) in a manner that depends on the C-terminus of p85 and Nef
11676	155871	NP_057853.1	Tat	activates	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	8798481,9394803,9708406,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates phosphatidylinositol 3-kinase (PI3K), leading to the activation of Akt/PKB, decreased levels of cAMP and CREB phosphorylation, and the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	interacts with	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	9446795	2007-11-07 17:28	Activation of protein kinase C-epsilon by HIV-1 Tat involves an interaction with PI 3-kinase
11676	155871	NP_057853.1	Tat	interacts with	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	11154208	2007-11-07 17:28	HIV-1 Tat induced release of MCP-1 from human lung microvascular endothelial cells involves an interaction between Tat and PI3 kinase
11676	155871	NP_057853.1	Tat	inhibited by	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	12077252	2007-11-07 17:28	Phosphatidylinositol 3-kinase inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter by affecting the formation of the Tat-associated kinase transactivating complex
11676	155871	NP_057853.1	Tat	interacts with	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	14602571	2007-11-07 17:28	HIV-1 Tat-mediated cytopathic changes in human brain microvascular endothelial cells involves its interaction with phosphatidylinositol 3-kinase (PI3K)
11676	155871	NP_057853.1	Tat	activates	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	9341793	2007-11-07 17:30	PI3-kinase activation induced by HIV-1 gp160 leads to downregulation of LFA-1-mediated T cell adhesion to B cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	9808187	2007-11-07 17:31	HIV-1 gp160 disrupts the association between phospholipase C gamma-1 and phosphoinositide 3 kinase (PI3-kinase), and this effect is dependent on PI3-kinase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	9123823,10358157,10422873	2007-11-07 17:31	HIV-1 gp120 induces an increase in tyrosine phosphorylation of two proteins, p56lck and phosphatidylinositol 3-kinase (PI 3-kinase) p85 alpha, that are physically complexed to the CD4 molecule
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	12551992,12960231	2007-11-07 17:31	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	16081599	2007-11-07 17:30	HIV-1 gp120-induced TNF-alpha production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	5296	NP_005018.1	phosphatidylinositol 3-kinase regulatory subunit beta	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	5304	NP_002643.1	prolactin-inducible protein precursor	9724097,10072505	2007-11-07 17:31	Gross cystic disease fluid protein-15 (GCDFP-15) binds to CD4, a T-cell co-receptor involved in antigen recognition, thereby inhibiting the ability of the receptor to interact with the HIV-1 envelope protein gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	5304	NP_002643.1	prolactin-inducible protein precursor	10072505	2007-11-07 17:31	Binding of HIV-1 envelope protein gp120 to CD4 downregulates Bcl-2 expression; this effect is inhibited by gp17/GCDFP-15, which blocks the ability of CD4 to interact with gp120, leading to moderate up-regulation of Bcl-2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5319	NP_000919.1	phospholipase A2 precursor	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5319	NP_000919.1	phospholipase A2 precursor	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5320	NP_000291.1	phospholipase A2, membrane associated precursor	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5320	NP_000291.1	phospholipase A2, membrane associated precursor	9745929	2007-11-07 17:31	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5321	NP_077734.1	cytosolic phospholipase A2	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5321	NP_077734.1	cytosolic phospholipase A2	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5322	NP_000920.1	calcium-dependent phospholipase A2 precursor	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5322	NP_000920.1	calcium-dependent phospholipase A2 precursor	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155030	NP_057850.1	Pr55(Gag)	inhibits	9606	5328	NP_002649.1	urokinase-type plasminogen activator isoform 1 preproprotein	11394884	2007-11-07 17:29	The amino-terminal fragment of urokinase-type plasminogen activator is hypothesized to inhibit the assembly of HIV-1 Gag and the budding of HIV-1 from infected cells
11676	155871	NP_057853.1	Tat	upregulates	9606	5328	NP_002649.1	urokinase-type plasminogen activator isoform 1 preproprotein	9143604	2007-11-07 17:28	HIV-1 Tat affects the fibrinolytic activity of tumor cell lines derived from BKV/tat-transgenic mice by upregulating/modulating the production of both urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor 1 (PAI-1)
11676	155871	NP_057853.1	Tat	induces release of	9606	5328	NP_002649.1	urokinase-type plasminogen activator isoform 1 preproprotein	14982725	2007-11-07 17:28	HIV-1 Tat and methamphetamine enhance the release of MMP-1, MMP-2, and uPA from human brain cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaved by	9606	5328	NP_002649.1	urokinase-type plasminogen activator isoform 1 preproprotein	8676469	2007-11-07 17:27	Urokinase-type plasminogen activator (uPA), a proteinase that activates plasminogen, cleaves HIV-1 gp120 within the V3 loop
11676	155030	NP_579880.1	capsid	interacts with	9606	5329	NP_002650.1	urokinase plasminogen activator surface receptor isoform 1 precursor	10722370	2007-11-07 17:29	A peptide (Ch7) derived from HIV-1 Capsid (amino acids 232-238) has been shown to have immunosuppressive effects through a possible interaction with the Plasminogen Receptor, indicating a role for Capsid in the immunosuppressive effects of HIV-1
11676	155871	NP_057853.1	Tat	activates	9606	5330	NP_004564.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2	7589147,9278385,9730685,10501179,10843712,12482669	2007-11-07 17:28	HIV-1 Tat induces release of calcium and TNF-alpha production, an effect mediated at least in part by activation of phospholipase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	5330	NP_004564.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-2	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155871	NP_057853.1	Tat	activates	9606	5331	NP_000923.1	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-3 isoform 1	7589147,9278385,9730685,10501179,10843712,12482669	2007-11-07 17:28	HIV-1 Tat induces release of calcium and TNF-alpha production, an effect mediated at least in part by activation of phospholipase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	5331	NP_000923.1	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-3 isoform 1	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155871	NP_057853.1	Tat	activates	9606	5332	NP_000924.2	phospholipase C beta 4 isoform a	7589147,9278385,9730685,10501179,10843712,12482669	2007-11-07 17:28	HIV-1 Tat induces release of calcium and TNF-alpha production, an effect mediated at least in part by activation of phospholipase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	5332	NP_000924.2	phospholipase C beta 4 isoform a	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155871	NP_057853.1	Tat	activates	9606	5333	NP_006216.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1 isoform 2	7589147,9278385,9730685,10501179,10843712,12482669	2007-11-07 17:28	HIV-1 Tat induces release of calcium and TNF-alpha production, an effect mediated at least in part by activation of phospholipase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	5333	NP_006216.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1 isoform 2	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155871	NP_057853.1	Tat	activates	9606	5335	NP_002651.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 isoform a	7589147,9278385,9730685,10501179,10843712,12482669	2007-11-07 17:28	HIV-1 Tat induces release of calcium and TNF-alpha production, an effect mediated at least in part by activation of phospholipase C
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5335	NP_002651.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 isoform a	9344703	2007-11-07 17:31	Pretreatment of cells with HIV-1 gp160 results in marked inhibition of tyrosine phosphorylation of p59(fyn), PLC-gamma1, ras activation, and TNF-alpha secretion in anti-CD3 mAb activated CD4+ T cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5335	NP_002651.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 isoform a	9808187	2007-11-07 17:30	HIV-1 gp160 disrupts the association between phospholipase C gamma-1 and phosphoinositide 3 kinase (PI3-kinase), and this effect is dependent on PI3-kinase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	5335	NP_002651.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 isoform a	1979339,7774645	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155871	NP_057853.1	Tat	activates	9606	5336	NP_002652.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2	7589147,9278385,9730685,10501179,10843712,12482669	2007-11-07 17:28	HIV-1 Tat induces release of calcium and TNF-alpha production, an effect mediated at least in part by activation of phospholipase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	5336	NP_002652.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2	1979339	2007-11-07 17:30	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155459	NP_057851.1	Vif	relocalizes	9606	5339	NP_000436.2	plectin isoform 1c	11172097	2007-11-07 17:27	Variants of HIV-1 Vif have been shown to form perinuclear aggregates and relocalize plectin to these structures
11676	155348	NP_705926.1	retropepsin	cleaves	9606	5357	NP_002661.1	plastin 1	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155348	NP_705926.1	retropepsin	cleaves	9606	5358	NP_005023.2	plastin-3 isoform 1	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155348	NP_705928.1	integrase	interacts with	9606	5371	NP_150241.2	probable transcription factor PML isoform 1	11430827	2007-11-07 17:29	HIV-1 preintegration complexes containing HIV-1 integrase induce the cytoplasmic recruitment of integrase interactor 1 (INI1, hSNF5) and PML and associate with these cellular proteins before migrating to the nucleus
11676	155871	NP_057853.1	Tat	regulated by	9606	5371	NP_150241.2	probable transcription factor PML isoform 1	12727882	2007-11-07 17:30	Data suggests that PML proteins regulate Tat-mediated transcriptional activation by modulating the availability of cyclin T1 and other essential cofactors to the transcription machinery
11676	155871	NP_057853.1	Tat	downregulates	9606	5396	NP_008833.1	paired mesoderm homeobox protein 1 isoform pmx-1a	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat downregulates the expression of many proteins, including PHOX1, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	upregulates	9606	5423	NP_002681.1	DNA polymerase beta	11242139	2007-11-07 17:30	HIV-1 Tat is a potent inducer of the human DNA repair enzyme beta-polymerase, suggesting Tat may alter DNA stability in AIDS-related lymphomas
11676	155871	NP_057853.1	Tat	interacts with	9606	5426	NP_006222.2	DNA polymerase epsilon catalytic subunit A	9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme, which includes DNA polymerase epsilon, during Tat-mediated transactivation of the HIV-1 LTR
11676	155807	NP_057852.2	Vpr	activates	9606	5430	NP_000928.1	DNA-directed RNA polymerase II subunit RPB1	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	stimulates	9606	5430	NP_000928.1	DNA-directed RNA polymerase II subunit RPB1	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:27	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155871	NP_057853.1	Tat	interacts with	9606	5430	NP_000928.1	DNA-directed RNA polymerase II subunit RPB1	8700889	2007-11-07 17:27	HIV-1 Tat, through its basic domain (amino acids 52-57) specifically interacts with the largest subunit of RNA polymerase II (amino acids 1325-1630)
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5430	NP_000928.1	DNA-directed RNA polymerase II subunit RPB1	16289656	2007-11-07 17:29	HIV-1 Tat 41/44 peptide TAALS from the core domain of Tat inhibits Tat-mediated HIV-1 gene expression and replication by binding the Cdk2/Cyclin E complex and inhibiting the phosphorylation of serine 5 of RNAPII
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5430	NP_000928.1	DNA-directed RNA polymerase II subunit RPB1	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	activates	9606	5431	NP_000929.1	DNA-directed RNA polymerase II subunit RPB2	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	stimulates	9606	5431	NP_000929.1	DNA-directed RNA polymerase II subunit RPB2	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:27	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5431	NP_000929.1	DNA-directed RNA polymerase II subunit RPB2	16289656	2007-11-07 17:29	HIV-1 Tat 41/44 peptide TAALS from the core domain of Tat inhibits Tat-mediated HIV-1 gene expression and replication by binding the Cdk2/Cyclin E complex and inhibiting the phosphorylation of serine 5 of RNAPII
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5431	NP_000929.1	DNA-directed RNA polymerase II subunit RPB2	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	activates	9606	5432	NP_116558.1	DNA-directed RNA polymerase II subunit RPB3	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	stimulates	9606	5432	NP_116558.1	DNA-directed RNA polymerase II subunit RPB3	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:27	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5432	NP_116558.1	DNA-directed RNA polymerase II subunit RPB3	16289656	2007-11-07 17:29	HIV-1 Tat 41/44 peptide TAALS from the core domain of Tat inhibits Tat-mediated HIV-1 gene expression and replication by binding the Cdk2/Cyclin E complex and inhibiting the phosphorylation of serine 5 of RNAPII
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5432	NP_116558.1	DNA-directed RNA polymerase II subunit RPB3	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	activates	9606	5433	NP_004796.1	DNA-directed RNA polymerase II subunit RPB4	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	stimulates	9606	5433	NP_004796.1	DNA-directed RNA polymerase II subunit RPB4	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:27	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5433	NP_004796.1	DNA-directed RNA polymerase II subunit RPB4	16289656	2007-11-07 17:29	HIV-1 Tat 41/44 peptide TAALS from the core domain of Tat inhibits Tat-mediated HIV-1 gene expression and replication by binding the Cdk2/Cyclin E complex and inhibiting the phosphorylation of serine 5 of RNAPII
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5433	NP_004796.1	DNA-directed RNA polymerase II subunit RPB4	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	activates	9606	5434	NP_002686.2	DNA-directed RNA polymerases I, II, and III subunit RPABC1	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	stimulates	9606	5434	NP_002686.2	DNA-directed RNA polymerases I, II, and III subunit RPABC1	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:27	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5434	NP_002686.2	DNA-directed RNA polymerases I, II, and III subunit RPABC1	16289656	2007-11-07 17:29	HIV-1 Tat 41/44 peptide TAALS from the core domain of Tat inhibits Tat-mediated HIV-1 gene expression and replication by binding the Cdk2/Cyclin E complex and inhibiting the phosphorylation of serine 5 of RNAPII
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5434	NP_002686.2	DNA-directed RNA polymerases I, II, and III subunit RPABC1	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	activates	9606	5435	NP_068809.1	DNA-directed RNA polymerases I, II, and III subunit RPABC2	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	stimulates	9606	5435	NP_068809.1	DNA-directed RNA polymerases I, II, and III subunit RPABC2	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:28	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5435	NP_068809.1	DNA-directed RNA polymerases I, II, and III subunit RPABC2	16289656	2007-11-07 17:29	HIV-1 Tat 41/44 peptide TAALS from the core domain of Tat inhibits Tat-mediated HIV-1 gene expression and replication by binding the Cdk2/Cyclin E complex and inhibiting the phosphorylation of serine 5 of RNAPII
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5435	NP_068809.1	DNA-directed RNA polymerases I, II, and III subunit RPABC2	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	activates	9606	5436	NP_002687.1	DNA-directed RNA polymerase II subunit RPB7	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	stimulates	9606	5436	NP_002687.1	DNA-directed RNA polymerase II subunit RPB7	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:28	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5436	NP_002687.1	DNA-directed RNA polymerase II subunit RPB7	16289656	2007-11-07 17:29	HIV-1 Tat 41/44 peptide TAALS from the core domain of Tat inhibits Tat-mediated HIV-1 gene expression and replication by binding the Cdk2/Cyclin E complex and inhibiting the phosphorylation of serine 5 of RNAPII
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5436	NP_002687.1	DNA-directed RNA polymerase II subunit RPB7	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	activates	9606	5437	NP_006223.2	DNA-directed RNA polymerases I, II, and III subunit RPABC3	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	activates	9606	5437	NP_006223.2	DNA-directed RNA polymerases I, II, and III subunit RPABC3	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	stimulates	9606	5437	NP_006223.2	DNA-directed RNA polymerases I, II, and III subunit RPABC3	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:28	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5437	NP_006223.2	DNA-directed RNA polymerases I, II, and III subunit RPABC3	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	activates	9606	5438	NP_006224.1	DNA-directed RNA polymerase II subunit RPB9	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	stimulates	9606	5438	NP_006224.1	DNA-directed RNA polymerase II subunit RPB9	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:28	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5438	NP_006224.1	DNA-directed RNA polymerase II subunit RPB9	16289656	2007-11-07 17:29	HIV-1 Tat 41/44 peptide TAALS from the core domain of Tat inhibits Tat-mediated HIV-1 gene expression and replication by binding the Cdk2/Cyclin E complex and inhibiting the phosphorylation of serine 5 of RNAPII
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5438	NP_006224.1	DNA-directed RNA polymerase II subunit RPB9	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	activates	9606	5439	NP_006225.1	DNA-directed RNA polymerase II subunit RPB11-a	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	stimulates	9606	5439	NP_006225.1	DNA-directed RNA polymerase II subunit RPB11-a	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:28	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5439	NP_006225.1	DNA-directed RNA polymerase II subunit RPB11-a	16289656	2007-11-07 17:29	HIV-1 Tat 41/44 peptide TAALS from the core domain of Tat inhibits Tat-mediated HIV-1 gene expression and replication by binding the Cdk2/Cyclin E complex and inhibiting the phosphorylation of serine 5 of RNAPII
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5439	NP_006225.1	DNA-directed RNA polymerase II subunit RPB11-a	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	activates	9606	5440	NP_005025.1	DNA-directed RNA polymerases I, II, and III subunit RPABC4	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	activates	9606	5440	NP_005025.1	DNA-directed RNA polymerases I, II, and III subunit RPABC4	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	stimulates	9606	5440	NP_005025.1	DNA-directed RNA polymerases I, II, and III subunit RPABC4	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:28	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5440	NP_005025.1	DNA-directed RNA polymerases I, II, and III subunit RPABC4	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155807	NP_057852.2	Vpr	activates	9606	5441	NP_066951.1	DNA-directed RNA polymerases I, II, and III subunit RPABC5	8800208,9874563,10359081,10931842,12379213,12634356,12642036	2007-11-07 17:27	HIV-1 Vpr interacts with basal transcription complexes such as P-TEFb, TFIIH, TFIID (TBP) and TFIIB which activate RNA polymerase II gene transcription
11676	155871	NP_057853.1	Tat	activates	9606	5441	NP_066951.1	DNA-directed RNA polymerases I, II, and III subunit RPABC5	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	stimulates	9606	5441	NP_066951.1	DNA-directed RNA polymerases I, II, and III subunit RPABC5	1559613,2190099,7638159,7853496,8637904,8676484,8849451,8876177,8910388,8934526,9054383,9121429,9184228,9311822,9315662,9334327,9491887,9570510,9651670,9696809,9765201,10066804,10069959,10329125,10364292,10373521,10393184,10438593,10536359,10545121,10617616,10698937,10704353,10757782,10866664,10958691,11080476,11112772,11547919,11809800,12049628,12052871,12114499,12126615,12221105,12887902,14569024,16838299,17168834	2007-11-07 17:28	HIV-1 Tat complexes with RNA polymerase II and cellular transcription factors as part of the HIV-1 transcription preinitiation and elongation complexes and stimulates RNA polymerase II processivity by inducing the phosphorylation of its C-terminal Domain
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5441	NP_066951.1	DNA-directed RNA polymerases I, II, and III subunit RPABC5	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5443	NP_000930.1	pro-opiomelanocortin preproprotein	9851780	2007-11-07 17:28	UV-inactivated HIV and the viral envelope protein, gp120, are able to induce ACTH production in cultured T lymphocytes
11676	155871	NP_057853.1	Tat	binds	9606	5451	NP_002688.2	POU domain, class 2, transcription factor 1	7690421	2007-11-07 17:28	Oct binds to HIV-1 Tat affinity matrices and also confers Tat responsiveness on a basal HIV-1 promoter
11676	155871	NP_057853.1	Tat	inhibited by	9606	5451	NP_002688.2	POU domain, class 2, transcription factor 1	15207707	2007-11-07 17:28	Combination of LBP-1 and Oct1 cellular transcription activators represses transcription initiation at the HIV-1 LTR promoter by HIV-1 Tat
11676	156110	NP_057857.2	Nef	downregulates	9606	5468	NP_619725.2	peroxisome proliferator-activated receptor gamma isoform 1	15075535	2007-11-07 17:28	HIV-1 Nef suppresses PPAR-gamma expression in human T and macrophage cell lines, and the effects of PPAR-gamma on viral replication is reduced by co-expression of Nef in MT4 T cells
11676	155348	NP_705926.1	retropepsin	cleaves	9606	5473	NP_002695.1	platelet basic protein preproprotein	10419831	2007-11-07 17:29	Connective tissue-activating peptide (CTAPIII) and neutrophil-activating peptide 2 (NAP/2) are generated by digestion of a ubiquitin-CTAPIII conjugate with yeast ubiquitin C-terminal hydrolase (YUH1) and HIV protease, respectively
11676	155030	NP_057850.1	Pr55(Gag)	binds	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	8676452,16785541	2007-11-07 17:29	Binding of HIV-1 Gag to cyclophilin A requires a region within the nucleocapsid domain of Gag which is important for Gag self-association
11676	155030	NP_057850.1	Pr55(Gag)	modulated by	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	9305737,9636359	2007-11-07 17:29	Cyclophilin A modulates processing of HIV-1 Gag by the viral protease
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	16275650,16815734,17038183	2007-11-07 17:29	H219Q and H219P substitutions in the viral CypA binding loop of HIV-1 Gag reduces CypA incorporation into HIV-1 and potentiates viral replication in CypA-rich MT-2 and H9 cells
11676	155030	NP_579876.2	matrix	binds	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	8659916,10096576	2007-11-07 17:29	Cyclophilin A binds to HIV-1 Matrix
11676	155030	NP_579876.2	matrix	binds	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	8659916,10096576	2007-11-07 17:28	The 12 carboxy-terminal amino acids of HIV-1 Matrix (p17; amino acids 121-132) are important for optimal binding of cyclophilin to HIV-1 Gag and Capsid (p24)
11676	155030	NP_579880.1	capsid	binds	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	7543589,7572395,7969494,7969495,8513493,8648689,8659916,8662505,8676442,8676452,8709190,8764025,8980222,8980234,9016720,9032343,9223641,9261419,9261445,9337866,9380739,9385632,9557731,9573245,9658084,9875332,10026140,10096576,10208938,10208939,10794694,11250896,11312344,11379967,11581426,11836403,11929983,12009870,12032547,12181673,12208976,12210402,12477877,12547912,12634401,12932580,16275650,17038183	2007-11-07 17:29	HIV-1 Capsid and Gag proteins bind to cyclophilin A, resulting in the incorporation of cyclophilin A into virions, which is important for the completion of early steps in HIV-1 replication following entry of the virus into cells
11676	155030	NP_579880.1	capsid	interacts with	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	7969495,8648687,8764025,8806510,9129655,9380739	2007-11-07 17:29	The interaction of HIV-1 Capsid to cyclophilin A can be inhibited by cyclosporin A leading to inhibition of virus replication
11676	155030	NP_579880.1	capsid	isomerized by	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	8662505,9261419,11312344,11836403,11929983	2007-11-07 17:29	Cyclophilin A catalyzes efficiently the cis/trans isomerization of the Gly-89-Pro-90 peptide bond of HIV-1 Capsid
11676	155030	NP_579880.1	capsid	binds	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	8662505,9032343,9223641,9420228,10026140,10208939,11929983,17038183	2007-11-07 17:29	Proline-90 and Glycine-89 of HIV-1 Capsid are required for the binding of cyclophilin A to Capsid
11676	155030	NP_579880.1	capsid	binds	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	8662505,8676452,8830660,8980234,9016720,9032343,9223641,9261419,9261445,9337866,9380739,9385632,9557731,10026140,10704338,10794694,12210402,12730686	2007-11-07 17:29	The active site hydrophobic binding pocket of cyclophilin A (amino acids 54-126) binds to the N-Terminal and central portion of HIV-1 Capsid, most importantly to Capsid amino acids 85-93
11676	155030	NP_579880.1	capsid	binds	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	8676452,9223641	2007-11-07 17:29	Binding of HIV-1 Capsid to cyclophilin A requires HIV-1 Gag dimerization
11676	155030	NP_579880.1	capsid	interacts with	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	8709190,12477877	2007-11-07 17:29	The HIV-1 p2 peptide (spacer peptide in the HIV-1 Gag polyprotein between Capsid and Nucleocapsid; SP1) is involved in the interaction between HIV-1 Capsid and cyclophilin A
11676	155030	NP_579880.1	capsid	binds	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	10096576	2007-11-07 17:29	Cyclophilin A has a higher affinity for HIV-1 Gag than for the mature HIV-1 Capsid protein, as a result of additional interactions with the 12 C-terminal amino acids of HIV-1 Matrix
11676	155030	NP_579880.1	capsid	stabilizes	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	12788626	2007-11-07 17:30	Cyclophilin A decreases the degree of capsid protein processing by the HIV-1 protease
11676	155030	NP_579880.1	capsid	modulates	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	12897779,15596813,16815734	2007-11-07 17:30	Cyclophilin A binding to HIV-1 Capsid modulates the sensitivity of HIV-1 to host restriction factors
11676	155030	NP_579880.1	capsid	interacts with	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	16199531,16203999,16643975,16815734	2007-11-07 17:29	TRIM5 alpha-mediated resistance to HIV-1 in Old World monkey cells is modulated by the HIV-1 Capsid and cyclophilin A interaction
11676	155030	NP_579880.1	capsid	binds	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	16275650	2007-11-07 17:29	H219Q and H219P substitutions in the cyclophilin A binding loop of HIV-1 CA enhance HIV-1 replication by reducing viral cyclophilin A content in resulting virions as produced in cyclophilin A-rich cells
11676	155459	NP_057851.1	Vif	binds	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	7884893	2007-11-07 17:27	Vif has been demonstrated to bind to cyclophilin A using a biochemical binding assay
11676	155807	NP_057852.2	Vpr	isomerized by	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	12881522,12881523,16120388,16571786	2007-11-07 17:30	Cyclophilin A interacts directly with HIV-1 Vpr to mediate the cis/trans-proline isomerization of Vpr, which is important for Vpr synthesis and function
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	9546659,12181673	2007-11-07 17:28	Macrophage- and T-cell-tropic V3 loop peptides of HIV-1 gp120 bind specifically to the active site of the immunophilins FK506-binding protein (FKBP12), and cyclophilins A and B, and inhibit their peptidyl-prolyl cis-trans isomerase (PPIase) activities
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	requires	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	10581250	2007-11-07 17:31	The interaction between exposed cyclophilin A (CypA) and cell surface heparans represents the initial step of HIV-1 attachment and is a necessary step for HIV-1 gp120 binding to CD4
11676	156110	NP_057857.2	Nef	binds	9606	5478	NP_066953.1	peptidyl-prolyl cis-trans isomerase A	7884893	2007-11-07 17:28	Cyclophilin A has been demonstrated to bind to HIV-1 Nef using a biochemical binding assay, however the biological significance of this interaction is currently not known
11676	155030	NP_579880.1	capsid	binds	9606	5479	NP_000933.1	peptidyl-prolyl cis-trans isomerase B precursor	8513493,9032343,10026140,10096576	2007-11-07 17:29	Cyclophilin B binds to several Gly-Pro amino acid motifs in HIV-1 Capsid (amino acids 89-90, 156-157, and 223-224
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	5479	NP_000933.1	peptidyl-prolyl cis-trans isomerase B precursor	9546659,12181673	2007-11-07 17:28	Macrophage- and T-cell-tropic V3 loop peptides of HIV-1 gp120 bind specifically to the active site of the immunophilins FK506-binding protein (FKBP12), and cyclophilins A and B, and inhibit their peptidyl-prolyl cis-trans isomerase (PPIase) activities
11676	155871	NP_057853.1	Tat	stimulated by	9606	5499	NP_002699.1	serine/threonine-protein phosphatase PP1-alpha catalytic subunit isoform 1	12036313,12788939	2007-11-07 17:30	Protein phosphatase 1 (PP1) associates with HIV-1 Tat and stimulates Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	regulated by	9606	5499	NP_002699.1	serine/threonine-protein phosphatase PP1-alpha catalytic subunit isoform 1	12788939	2007-11-07 17:30	Stimulation of HIV-1 Tat transactivation by protein phosphatase 1 (PP1) is inhibited by nuclear inhibitor of PP1 (NIPP1), indicating Tat function is regulated by PP1/NIPP1
11676	155871	NP_057853.1	Tat	regulated by	9606	5499	NP_002699.1	serine/threonine-protein phosphatase PP1-alpha catalytic subunit isoform 1	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155871	NP_057853.1	Tat	binds	9606	5499	NP_002699.1	serine/threonine-protein phosphatase PP1-alpha catalytic subunit isoform 1	16131488	2007-11-07 17:29	PP1 interacts with Tat in part through the binding of Val(36) and Phe(38) of Tat to PP1, and Tat is involved in the nuclear and subnuclear targeting of PP1
11676	155871	NP_057853.1	Tat	stimulated by	9606	5500	NP_002700.1	serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform 1	12036313,12788939	2007-11-07 17:30	Protein phosphatase 1 (PP1) associates with HIV-1 Tat and stimulates Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	regulated by	9606	5500	NP_002700.1	serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform 1	12788939	2007-11-07 17:30	Stimulation of HIV-1 Tat transactivation by protein phosphatase 1 (PP1) is inhibited by nuclear inhibitor of PP1 (NIPP1), indicating Tat function is regulated by PP1/NIPP1
11676	155871	NP_057853.1	Tat	regulated by	9606	5500	NP_002700.1	serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform 1	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155871	NP_057853.1	Tat	interacts with	9606	5500	NP_002700.1	serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform 1	16131488	2007-11-07 17:29	PP1 interacts with Tat in part through the binding of Val(36) and Phe(38) of Tat to PP1, and Tat is involved in the nuclear and subnuclear targeting of PP1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5500	NP_002700.1	serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform 1	12775419	2007-11-07 17:31	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155871	NP_057853.1	Tat	stimulated by	9606	5501	NP_002701.1	serine/threonine-protein phosphatase PP1-gamma catalytic subunit	12036313,12788939	2007-11-07 17:30	Protein phosphatase 1 (PP1) associates with HIV-1 Tat and stimulates Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	regulated by	9606	5501	NP_002701.1	serine/threonine-protein phosphatase PP1-gamma catalytic subunit	12788939	2007-11-07 17:30	Stimulation of HIV-1 Tat transactivation by protein phosphatase 1 (PP1) is inhibited by nuclear inhibitor of PP1 (NIPP1), indicating Tat function is regulated by PP1/NIPP1
11676	155871	NP_057853.1	Tat	regulated by	9606	5501	NP_002701.1	serine/threonine-protein phosphatase PP1-gamma catalytic subunit	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155871	NP_057853.1	Tat	binds	9606	5501	NP_002701.1	serine/threonine-protein phosphatase PP1-gamma catalytic subunit	16131488	2007-11-07 17:29	PP1 interacts with Tat in part through the binding of Val(36) and Phe(38) of Tat to PP1, and Tat is involved in the nuclear and subnuclear targeting of PP1
11676	155871	NP_057853.1	Tat	inhibited by	9606	5511	NP_054829.2	nuclear inhibitor of protein phosphatase 1 isoform alpha	12788939,16048649	2007-11-07 17:30	Nuclear inhibitor of PP1 (NIPP1) inhibits HIV-1 Tat-induced transcription, an effect that can be reversed by co-expression of PP1, indicating Tat function is regulated by PP1/NIPP1
11676	155871	NP_057853.1	Tat	binds	9606	5511	NP_054829.2	nuclear inhibitor of protein phosphatase 1 isoform alpha	16131488	2007-11-07 17:29	PP1 interacts with Tat in part through the binding of Val(36) and Phe(38) of Tat to PP1, and Tat is involved in the nuclear and subnuclear targeting of PP1
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5515	NP_002706.1	serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	9013886	2007-11-07 17:28	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5515	NP_002706.1	serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	9013886	2007-11-07 17:28	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5515	NP_002706.1	serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	11531413	2007-11-07 17:28	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155871	NP_057853.1	Tat	modulated by	9606	5515	NP_002706.1	serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5516	NP_004147.1	serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	9013886	2007-11-07 17:28	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5516	NP_004147.1	serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	9013886	2007-11-07 17:28	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5516	NP_004147.1	serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	11531413	2007-11-07 17:28	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155871	NP_057853.1	Tat	modulated by	9606	5516	NP_004147.1	serine/threonine-protein phosphatase 2A catalytic subunit beta isoform	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5518	NP_055040.2	serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	9013886	2007-11-07 17:28	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5518	NP_055040.2	serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	9013886	2007-11-07 17:28	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5518	NP_055040.2	serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	11531413	2007-11-07 17:28	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155871	NP_057853.1	Tat	modulated by	9606	5518	NP_055040.2	serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5519	NP_002707.3	serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform isoform a	9013886	2007-11-07 17:28	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5519	NP_002707.3	serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform isoform a	9013886	2007-11-07 17:28	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5519	NP_002707.3	serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform isoform a	11531413	2007-11-07 17:28	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155871	NP_057853.1	Tat	modulated by	9606	5519	NP_002707.3	serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform isoform a	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5520	NP_002708.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform 1	9013886	2007-11-07 17:29	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5520	NP_002708.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform 1	9013886	2007-11-07 17:27	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5520	NP_002708.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform 1	11531413,15725353	2007-11-07 17:27	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155807	NP_057852.2	Vpr	activates	9606	5520	NP_002708.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform 1	15142377,15578586,15638722	2007-11-07 17:29	HIV-1 Vpr cell death causing peptide (amino acid residues 71-96) can activate the expression of PP2A when applied extracellularly to CD4+ T cells as well as cause the activation of PP2A from brain, liver, and adipose tissues
11676	155807	NP_057852.2	Vpr	complexes with	9606	5520	NP_002708.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform 1	15142377,15725353	2007-11-07 17:28	HIV-1 Vpr was reported to mediate G2 arrest by forming a complex with PP2A through binding to the B55 regulatory subunit, thereby targeting the complex to the nucleus and enhancing cdc25 dephosphorylation, however the paper was subsequently retracted
11676	155871	NP_057853.1	Tat	modulated by	9606	5520	NP_002708.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform 1	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	regulated by	9606	5520	NP_002708.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform isoform 1	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5521	NP_004567.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform a	9013886	2007-11-07 17:29	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5521	NP_004567.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform a	9013886	2007-11-07 17:27	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5521	NP_004567.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform a	11531413	2007-11-07 17:27	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155807	NP_057852.2	Vpr	activates	9606	5521	NP_004567.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform a	15578586,15638722,15780175,15817944	2007-11-07 17:28	HIV-1 Vpr cell death causing peptide (amino acid residues 71-96) can activate the expression of PP2A when applied extracellularly to CD4+ T cells as well as cause the activation of PP2A from brain, liver, and adipose tissues
11676	155807	NP_057852.2	Vpr	complexes with	9606	5521	NP_004567.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform a	15725353,15780175	2007-11-07 17:27	HIV-1 Vpr was reported to mediate G2 arrest by forming a complex with PP2A through binding to the B55 regulatory subunit, thereby targeting the complex to the nucleus and enhancing cdc25 dephosphorylation, however the paper was subsequently retracted
11676	155871	NP_057853.1	Tat	modulated by	9606	5521	NP_004567.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform a	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	regulated by	9606	5521	NP_004567.1	serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform a	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5522	NP_065149.2	protein phosphatase 2, regulatory subunit B, gamma isoform a	9013886	2007-11-07 17:29	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5522	NP_065149.2	protein phosphatase 2, regulatory subunit B, gamma isoform a	9013886	2007-11-07 17:27	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5522	NP_065149.2	protein phosphatase 2, regulatory subunit B, gamma isoform a	11531413	2007-11-07 17:27	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155807	NP_057852.2	Vpr	activates	9606	5522	NP_065149.2	protein phosphatase 2, regulatory subunit B, gamma isoform a	15578586,15638722	2007-11-07 17:28	HIV-1 Vpr cell death causing peptide (amino acid residues 71-96) can activate the expression of PP2A when applied extracellularly to CD4+ T cells as well as cause the activation of PP2A from brain, liver, and adipose tissues
11676	155807	NP_057852.2	Vpr	complexes with	9606	5522	NP_065149.2	protein phosphatase 2, regulatory subunit B, gamma isoform a	15725353,15780175,15817944	2007-11-07 17:27	HIV-1 Vpr was reported to mediate G2 arrest by forming a complex with PP2A through binding to the B55 regulatory subunit, thereby targeting the complex to the nucleus and enhancing cdc25 dephosphorylation, however the paper was subsequently retracted
11676	155871	NP_057853.1	Tat	modulated by	9606	5522	NP_065149.2	protein phosphatase 2, regulatory subunit B, gamma isoform a	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	regulated by	9606	5522	NP_065149.2	protein phosphatase 2, regulatory subunit B, gamma isoform a	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5523	NP_002709.2	serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha isoform 1	9013886	2007-11-07 17:29	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5523	NP_002709.2	serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha isoform 1	9013886	2007-11-07 17:27	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5523	NP_002709.2	serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha isoform 1	11531413	2007-11-07 17:27	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155807	NP_057852.2	Vpr	activates	9606	5523	NP_002709.2	serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha isoform 1	15578586,15780175	2007-11-07 17:28	HIV-1 Vpr cell death causing peptide (amino acid residues 71-96) can activate the expression of PP2A when applied extracellularly to CD4+ T cells as well as cause the activation of PP2A from brain, liver, and adipose tissues
11676	155807	NP_057852.2	Vpr	complexes with	9606	5523	NP_002709.2	serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha isoform 1	15638722,15725353,15780175,15817944	2007-11-07 17:27	HIV-1 Vpr was reported to mediate G2 arrest by forming a complex with PP2A through binding to the B55 regulatory subunit, thereby targeting the complex to the nucleus and enhancing cdc25 dephosphorylation, however the paper was subsequently retracted
11676	155871	NP_057853.1	Tat	modulated by	9606	5523	NP_002709.2	serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha isoform 1	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	regulated by	9606	5523	NP_002709.2	serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha isoform 1	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5524	NP_066954.2	serine/threonine-protein phosphatase 2A activator isoform b	9013886	2007-11-07 17:29	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5524	NP_066954.2	serine/threonine-protein phosphatase 2A activator isoform b	9013886	2007-11-07 17:27	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5524	NP_066954.2	serine/threonine-protein phosphatase 2A activator isoform b	11531413	2007-11-07 17:27	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155807	NP_057852.2	Vpr	activates	9606	5524	NP_066954.2	serine/threonine-protein phosphatase 2A activator isoform b	15578586,15638722	2007-11-07 17:28	HIV-1 Vpr cell death causing peptide (amino acid residues 71-96) can activate the expression of PP2A when applied extracellularly to CD4+ T cells as well as cause the activation of PP2A from brain, liver, and adipose tissues
11676	155807	NP_057852.2	Vpr	complexes with	9606	5524	NP_066954.2	serine/threonine-protein phosphatase 2A activator isoform b	15638722,15725353,15780175,15817944	2007-11-07 17:27	HIV-1 Vpr was reported to mediate G2 arrest by forming a complex with PP2A through binding to the B55 regulatory subunit, thereby targeting the complex to the nucleus and enhancing cdc25 dephosphorylation, however the paper was subsequently retracted
11676	155871	NP_057853.1	Tat	modulated by	9606	5524	NP_066954.2	serine/threonine-protein phosphatase 2A activator isoform b	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	regulated by	9606	5524	NP_066954.2	serine/threonine-protein phosphatase 2A activator isoform b	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5525	NP_006234.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	9013886	2007-11-07 17:29	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5525	NP_006234.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	9013886	2007-11-07 17:27	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5525	NP_006234.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	11531413	2007-11-07 17:27	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155807	NP_057852.2	Vpr	complexes with	9606	5525	NP_006234.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	15638722,15725353,15780175,15817944	2007-11-07 17:27	HIV-1 Vpr was reported to mediate G2 arrest by forming a complex with PP2A through binding to the B55 regulatory subunit, thereby targeting the complex to the nucleus and enhancing cdc25 dephosphorylation, however the paper was subsequently retracted
11676	155871	NP_057853.1	Tat	modulated by	9606	5525	NP_006234.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	regulated by	9606	5525	NP_006234.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5526	NP_006235.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	9013886	2007-11-07 17:29	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5526	NP_006235.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	9013886	2007-11-07 17:27	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5526	NP_006235.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	11531413	2007-11-07 17:27	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155807	NP_057852.2	Vpr	complexes with	9606	5526	NP_006235.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	15725353,15780175,15817944	2007-11-07 17:27	HIV-1 Vpr was reported to mediate G2 arrest by forming a complex with PP2A through binding to the B55 regulatory subunit, thereby targeting the complex to the nucleus and enhancing cdc25 dephosphorylation, however the paper was subsequently retracted
11676	155871	NP_057853.1	Tat	modulated by	9606	5526	NP_006235.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	regulated by	9606	5526	NP_006235.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5526	NP_006235.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform	12775419	2007-11-07 17:31	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5527	NP_002710.2	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform a	9013886	2007-11-07 17:29	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5527	NP_002710.2	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform a	9013886	2007-11-07 17:27	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5527	NP_002710.2	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform a	11531413	2007-11-07 17:27	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155807	NP_057852.2	Vpr	complexes with	9606	5527	NP_002710.2	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform a	15725353,15780175,15817944	2007-11-07 17:27	HIV-1 Vpr was reported to mediate G2 arrest by forming a complex with PP2A through binding to the B55 regulatory subunit, thereby targeting the complex to the nucleus and enhancing cdc25 dephosphorylation, however the paper was subsequently retracted
11676	155871	NP_057853.1	Tat	modulated by	9606	5527	NP_002710.2	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform a	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	regulated by	9606	5527	NP_002710.2	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform isoform a	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5528	NP_006236.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform isoform 1	9013886	2007-11-07 17:29	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5528	NP_006236.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform isoform 1	9013886	2007-11-07 17:27	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5528	NP_006236.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform isoform 1	11531413	2007-11-07 17:27	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155807	NP_057852.2	Vpr	complexes with	9606	5528	NP_006236.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform isoform 1	15725353,15780175,15817944	2007-11-07 17:28	HIV-1 Vpr was reported to mediate G2 arrest by forming a complex with PP2A through binding to the B55 regulatory subunit, thereby targeting the complex to the nucleus and enhancing cdc25 dephosphorylation, however the paper was subsequently retracted
11676	155871	NP_057853.1	Tat	modulated by	9606	5528	NP_006236.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform isoform 1	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	regulated by	9606	5528	NP_006236.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform isoform 1	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155030	NP_579881.1	nucleocapsid	activates	9606	5529	NP_006237.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform	9013886	2007-11-07 17:29	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	activates	9606	5529	NP_006237.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform	9013886	2007-11-07 17:28	HIV-1 Vpr forms a complex with HIV-1 nucleocapsid that directly activates PP2A
11676	155807	NP_057852.2	Vpr	upregulates	9606	5529	NP_006237.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform	11531413	2007-11-07 17:28	HIV-1 Vpr was found to upregulate PP2A in fission yeast
11676	155807	NP_057852.2	Vpr	complexes with	9606	5529	NP_006237.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform	15725353,15780175,15817944	2007-11-07 17:28	HIV-1 Vpr was reported to mediate G2 arrest by forming a complex with PP2A through binding to the B55 regulatory subunit, thereby targeting the complex to the nucleus and enhancing cdc25 dephosphorylation, however the paper was subsequently retracted
11676	155871	NP_057853.1	Tat	modulated by	9606	5529	NP_006237.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform	9400615	2007-11-07 17:28	An increase in the amount of PP2A core enzyme with a concomitant decrease in the amount of PP2A holoenzyme inhibits HIV-1 Tat-stimulated transcription from the HIV-1 LTR promoter, indicating a role for PP2A in the modulation of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	regulated by	9606	5529	NP_006237.1	serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform	16048649	2007-11-07 17:28	Protein phosphatase-2A (PP2A) and protein phosphatase-1 (PP1) regulate HIV-1 Tat-activated transcription through dephosphorylation of CDK9
11676	155871	NP_057853.1	Tat	activates	9606	5530	NP_000935.1	serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform 1	12482669	2007-11-07 17:28	Induction of TNF-alpha by HIV-1 Tat is inhibited by cyclosporin A, an inhibitor of calcineurin that acts by preventing the dephosphorylation of NF-AT, suggesting Tat activates calcineurin
11676	155871	NP_057853.1	Tat	activates	9606	5532	NP_066955.1	serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform b	12482669	2007-11-07 17:28	Induction of TNF-alpha by HIV-1 Tat is inhibited by cyclosporin A, an inhibitor of calcineurin that acts by preventing the dephosphorylation of NF-AT, suggesting Tat activates calcineurin
11676	155871	NP_057853.1	Tat	activates	9606	5533	NP_005596.2	serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform	12482669	2007-11-07 17:28	Induction of TNF-alpha by HIV-1 Tat is inhibited by cyclosporin A, an inhibitor of calcineurin that acts by preventing the dephosphorylation of NF-AT, suggesting Tat activates calcineurin
11676	155871	NP_057853.1	Tat	activates	9606	5534	NP_000936.1	calcineurin subunit B type 1	12482669	2007-11-07 17:28	Induction of TNF-alpha by HIV-1 Tat is inhibited by cyclosporin A, an inhibitor of calcineurin that acts by preventing the dephosphorylation of NF-AT, suggesting Tat activates calcineurin
11676	155871	NP_057853.1	Tat	activates	9606	5535	NP_671709.1	calcineurin subunit B type 2	12482669	2007-11-07 17:28	Induction of TNF-alpha by HIV-1 Tat is inhibited by cyclosporin A, an inhibitor of calcineurin that acts by preventing the dephosphorylation of NF-AT, suggesting Tat activates calcineurin
11676	155871	NP_057853.1	Tat	downregulates	9606	5551	NP_005032.2	perforin-1 precursor	16967044	2007-11-07 17:31	Upregulation of intracellular perforin accumulation by IL-7 in CD8 T-cells is inhibited by HIV-1 Tat
11676	155030	NP_579876.2	matrix	activates	9606	5566	NP_002721.1	cAMP-dependent protein kinase catalytic subunit alpha isoform 1	1978848,7688126,7946090	2007-11-07 17:28	HIV-1 Matrix impairs proliferation of normal lymphocytes in vitro by inducing the activity of the inhibitory protein kinase A (PKA)
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5566	NP_002721.1	cAMP-dependent protein kinase catalytic subunit alpha isoform 1	9151826	2007-11-07 17:28	Protein kinase A (PKA) has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155030	NP_579880.1	capsid	phosphorylated by	9606	5566	NP_002721.1	cAMP-dependent protein kinase catalytic subunit alpha isoform 1	12842892	2007-11-07 17:30	cAMP-dependent protein kinase is incorporated into HIV-1 virions, interacts with and phosphorylates the HIV-1 Capsid protein, and regulates HIV-1 infectivity
11676	155871	NP_057853.1	Tat	activates	9606	5566	NP_002721.1	cAMP-dependent protein kinase catalytic subunit alpha isoform 1	9278385,9671211,9730685	2007-11-07 17:28	HIV-1 Tat induces IL-6 and TNF-alpha expression through the activation of cAMP-dependent protein kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	5566	NP_002721.1	cAMP-dependent protein kinase catalytic subunit alpha isoform 1	9540970	2007-11-07 17:30	Treatment of normal human fibroblasts with HIV-1 gp120 protein results in a significant decrease in the levels of 8-azido-[32P]cAMP binding to RI and RII domains of protein kinase A (PKA) and in PKA activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5566	NP_002721.1	cAMP-dependent protein kinase catalytic subunit alpha isoform 1	12972513	2007-11-07 17:31	The exposure of CD4+ T cells to HIV gp120 results in a long-lasting hyporesponsiveness to antigen stimulation through protein kinase A-mediated signaling
11676	156110	NP_057857.2	Nef	phosphorylated by	9606	5566	NP_002721.1	cAMP-dependent protein kinase catalytic subunit alpha isoform 1	15629779	2007-11-07 17:28	Serine residues Ser6 and Ser9 of HIV-1 Nef are phosphorylated by PKA in a cell-free system; intracellularly, only Ser9 of HIV-1 NL4-3 Nef is phosphorylated by PKA in resting peripheral blood mononuclear cells
11676	155030	NP_579876.2	matrix	activates	9606	5567	NP_002722.1	cAMP-dependent protein kinase catalytic subunit beta isoform 2	1978848,7688126,7946090	2007-11-07 17:28	HIV-1 Matrix impairs proliferation of normal lymphocytes in vitro by inducing the activity of the inhibitory protein kinase A (PKA)
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5567	NP_002722.1	cAMP-dependent protein kinase catalytic subunit beta isoform 2	9151826	2007-11-07 17:28	Protein kinase A (PKA) has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155030	NP_579880.1	capsid	phosphorylated by	9606	5567	NP_002722.1	cAMP-dependent protein kinase catalytic subunit beta isoform 2	12842892	2007-11-07 17:30	cAMP-dependent protein kinase is incorporated into HIV-1 virions, interacts with and phosphorylates the HIV-1 Capsid protein, and regulates HIV-1 infectivity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	5567	NP_002722.1	cAMP-dependent protein kinase catalytic subunit beta isoform 2	9540970	2007-11-07 17:30	Treatment of normal human fibroblasts with HIV-1 gp120 protein results in a significant decrease in the levels of 8-azido-[32P]cAMP binding to RI and RII domains of protein kinase A (PKA) and in PKA activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5567	NP_002722.1	cAMP-dependent protein kinase catalytic subunit beta isoform 2	12972513	2007-11-07 17:31	The exposure of CD4+ T cells to HIV gp120 results in a long-lasting hyporesponsiveness to antigen stimulation through protein kinase A-mediated signaling
11676	155871	NP_057853.1	Tat	activates	9606	5567	NP_891993.1	cAMP-dependent protein kinase catalytic subunit beta isoform 1	9278385,9671211,9730685	2007-11-07 17:28	HIV-1 Tat induces IL-6 and TNF-alpha expression through the activation of cAMP-dependent protein kinase pathways
11676	155030	NP_579876.2	matrix	activates	9606	5568	NP_002723.2	cAMP-dependent protein kinase catalytic subunit gamma	1978848,7688126,7946090	2007-11-07 17:28	HIV-1 Matrix impairs proliferation of normal lymphocytes in vitro by inducing the activity of the inhibitory protein kinase A (PKA)
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5568	NP_002723.2	cAMP-dependent protein kinase catalytic subunit gamma	9151826	2007-11-07 17:28	Protein kinase A (PKA) has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155030	NP_579880.1	capsid	phosphorylated by	9606	5568	NP_002723.2	cAMP-dependent protein kinase catalytic subunit gamma	12842892	2007-11-07 17:30	cAMP-dependent protein kinase is incorporated into HIV-1 virions, interacts with and phosphorylates the HIV-1 Capsid protein, and regulates HIV-1 infectivity
11676	155871	NP_057853.1	Tat	activates	9606	5568	NP_002723.2	cAMP-dependent protein kinase catalytic subunit gamma	9278385,9671211,9730685	2007-11-07 17:28	HIV-1 Tat induces IL-6 and TNF-alpha expression through the activation of cAMP-dependent protein kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	5568	NP_002723.2	cAMP-dependent protein kinase catalytic subunit gamma	9540970	2007-11-07 17:30	Treatment of normal human fibroblasts with HIV-1 gp120 protein results in a significant decrease in the levels of 8-azido-[32P]cAMP binding to RI and RII domains of protein kinase A (PKA) and in PKA activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5568	NP_002723.2	cAMP-dependent protein kinase catalytic subunit gamma	12972513	2007-11-07 17:31	The exposure of CD4+ T cells to HIV gp120 results in a long-lasting hyporesponsiveness to antigen stimulation through protein kinase A-mediated signaling
11676	155030	NP_579876.2	matrix	activates	9606	5571	NP_002724.1	5'-AMP-activated protein kinase subunit gamma-1 isoform 1	1978848,7688126,7946090	2007-11-07 17:28	HIV-1 Matrix impairs proliferation of normal lymphocytes in vitro by inducing the activity of the inhibitory protein kinase A (PKA)
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5571	NP_002724.1	5'-AMP-activated protein kinase subunit gamma-1 isoform 1	9151826	2007-11-07 17:28	Protein kinase A (PKA) has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155871	NP_057853.1	Tat	activates	9606	5571	NP_002724.1	5'-AMP-activated protein kinase subunit gamma-1 isoform 1	9278385,9671211,9730685	2007-11-07 17:28	HIV-1 Tat induces IL-6 and TNF-alpha expression through the activation of cAMP-dependent protein kinase pathways
11676	155030	NP_579876.2	matrix	activates	9606	5573	NP_002725.1	cAMP-dependent protein kinase type I-alpha regulatory subunit	1978848,7688126,7946090	2007-11-07 17:28	HIV-1 Matrix impairs proliferation of normal lymphocytes in vitro by inducing the activity of the inhibitory protein kinase A (PKA)
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5573	NP_002725.1	cAMP-dependent protein kinase type I-alpha regulatory subunit	9151826	2007-11-07 17:28	Protein kinase A (PKA) has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155871	NP_057853.1	Tat	activates	9606	5573	NP_002725.1	cAMP-dependent protein kinase type I-alpha regulatory subunit	9278385,9671211,9730685,17168834	2007-11-07 17:28	HIV-1 Tat induces IL-6 and TNF-alpha expression through the activation of cAMP-dependent protein kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	5573	NP_002725.1	cAMP-dependent protein kinase type I-alpha regulatory subunit	9540970	2007-11-07 17:30	Treatment of normal human fibroblasts with HIV-1 gp120 protein results in a significant decrease in the levels of 8-azido-[32P]cAMP binding to RI and RII domains of protein kinase A (PKA) and in PKA activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5573	NP_002725.1	cAMP-dependent protein kinase type I-alpha regulatory subunit	12972513	2007-11-07 17:31	The exposure of CD4+ T cells to HIV gp120 results in a long-lasting hyporesponsiveness to antigen stimulation through protein kinase A-mediated signaling
11676	155030	NP_579876.2	matrix	activates	9606	5575	NP_002726.1	cAMP-dependent protein kinase type I-beta regulatory subunit	1978848,7688126,7946090	2007-11-07 17:28	HIV-1 Matrix impairs proliferation of normal lymphocytes in vitro by inducing the activity of the inhibitory protein kinase A (PKA)
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5575	NP_002726.1	cAMP-dependent protein kinase type I-beta regulatory subunit	9151826	2007-11-07 17:28	Protein kinase A (PKA) has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155871	NP_057853.1	Tat	activates	9606	5575	NP_002726.1	cAMP-dependent protein kinase type I-beta regulatory subunit	9278385,9671211,9730685,17168834	2007-11-07 17:28	HIV-1 Tat induces IL-6 and TNF-alpha expression through the activation of cAMP-dependent protein kinase pathways
11676	155030	NP_579876.2	matrix	activates	9606	5576	NP_004148.1	cAMP-dependent protein kinase type II-alpha regulatory subunit	1978848,7688126,7946090	2007-11-07 17:29	HIV-1 Matrix impairs proliferation of normal lymphocytes in vitro by inducing the activity of the inhibitory protein kinase A (PKA)
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5576	NP_004148.1	cAMP-dependent protein kinase type II-alpha regulatory subunit	9151826	2007-11-07 17:28	Protein kinase A (PKA) has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155871	NP_057853.1	Tat	activates	9606	5576	NP_004148.1	cAMP-dependent protein kinase type II-alpha regulatory subunit	9278385,9671211,9730685,17168834	2007-11-07 17:28	HIV-1 Tat induces IL-6 and TNF-alpha expression through the activation of cAMP-dependent protein kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	5576	NP_004148.1	cAMP-dependent protein kinase type II-alpha regulatory subunit	9540970	2007-11-07 17:30	Treatment of normal human fibroblasts with HIV-1 gp120 protein results in a significant decrease in the levels of 8-azido-[32P]cAMP binding to RI and RII domains of protein kinase A (PKA) and in PKA activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5576	NP_004148.1	cAMP-dependent protein kinase type II-alpha regulatory subunit	12972513	2007-11-07 17:31	The exposure of CD4+ T cells to HIV gp120 results in a long-lasting hyporesponsiveness to antigen stimulation through protein kinase A-mediated signaling
11676	155030	NP_579876.2	matrix	activates	9606	5577	NP_002727.2	cAMP-dependent protein kinase type II-beta regulatory subunit	1978848,7688126,7946090	2007-11-07 17:28	HIV-1 Matrix impairs proliferation of normal lymphocytes in vitro by inducing the activity of the inhibitory protein kinase A (PKA)
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5577	NP_002727.2	cAMP-dependent protein kinase type II-beta regulatory subunit	9151826	2007-11-07 17:28	Protein kinase A (PKA) has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155871	NP_057853.1	Tat	activates	9606	5577	NP_002727.2	cAMP-dependent protein kinase type II-beta regulatory subunit	9278385,9671211,9730685,17168834	2007-11-07 17:28	HIV-1 Tat induces IL-6 and TNF-alpha expression through the activation of cAMP-dependent protein kinase pathways
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5578	NP_002728.1	protein kinase C alpha type	7876252,8473314,9151826	2007-11-07 17:28	Protein kinase C (PKC) phosphorylates HIV-1 Gag and Matrix on serine residue 111 resulting in a shift in localization of Matrix from the cytosol to the cellular membrane, suggesting a myristoyl-protein switch regulated by PKC phosphorylation
11676	155348	NP_705926.1	retropepsin	inhibited by	9606	5578	NP_002728.1	protein kinase C alpha type	10491200	2007-11-07 17:29	Phosphorylation of human recombinant vimentin by PKC inhibits the proteolytic processing of the vimentin head domain by HIV-1 protease
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	5578	NP_002728.1	protein kinase C alpha type	10641798	2007-11-07 17:29	HIV-1 RT heterodimer expressed in bacteria can be phosphorylated in vitro by several purified mammalian protein kinases including auto-activated protein kinase (PK), CKII, cytosolic protamine kinase (CPK), myelin basic protein kinase 1 (MBPK1), and PRKC
11676	155871	NP_057853.1	Tat	regulated by	9606	5578	NP_002728.1	protein kinase C alpha type	2182321	2007-11-07 17:27	Protein kinase C is required for HIV-1 Tat-mediated transactivation of the viral LTR promoter, indicating protein kinase C regulates the process of HIV-1 transactivation and may play a role in the transition of HIV from latency to productive growth
11676	155871	NP_057853.1	Tat	activates	9606	5578	NP_002728.1	protein kinase C alpha type	8627654,9446795,9671211,10843712,11044099,11154208,11833470,11919157,12482669,15488737	2007-11-07 17:27	HIV-1 Tat activates protein kinase C, resulting in the induction of TNF-alpha, IL-6 and IL-10 expression and the secretion of MCP-1
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5578	NP_002728.1	protein kinase C alpha type	8914829	2007-11-07 17:27	Protein kinase C phosphorylates HIV-1 Tat on serine residue 46
11676	155908	NP_057854.1	Rev	phosphorylated by	9606	5578	NP_002728.1	protein kinase C alpha type	9341215	2007-11-07 17:27	PKC has been shown to phosphorylate Rev in vitro, an effect associated with accelerated formation of an efficient RNA-binding conformation for Rev
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	5578	NP_002728.1	protein kinase C alpha type	7642615	2007-11-07 17:30	HIV-1 gp160-induced AP-1 complex formation is dependent upon protein tyrosine phosphorylation and is abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blockers or cyclosporine A
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	relocalizes	9606	5578	NP_002728.1	protein kinase C alpha type	11744714	2007-11-07 17:31	HIV-1 gp160-induced Ca(2+) influx reduction is antagonized by an inhibitor acting especially on PKC alpha and PKC beta I; Western blotting analyses show that the cellular distribution of PKC alpha and -beta I are significantly modified by gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5578	NP_002728.1	protein kinase C alpha type	1970444	2007-11-07 17:29	Downmodulation of the interaction between HIV-1 gp120 and CD4 by TPA is blocked by protein kinase C (PKC) inhibitors, suggesting PKC may play an important role in HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5578	NP_002728.1	protein kinase C alpha type	3259291	2007-11-07 17:29	A specific interaction between CD4 and HIV-1 gp120 is required for phosphorylation of CD4, which could involve protein kinase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5578	NP_002728.1	protein kinase C alpha type	8206685	2007-11-07 17:29	HIV-1 gp120 increases the levels of calcium-dependent and -independent PKC isozymes; the most striking change is observed in PKC-zeta isozyme levels
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5578	NP_002728.1	protein kinase C alpha type	8599832	2007-11-07 17:27	IL-16 induces rapid translocation of PKC from the cytosol to the membrane in CD4+ cells; PKC inhibitors completely block IL-16-induced lymphocyte migration as well as the motile response induced by HIV-1 gp120 and anti-CD4 antibody binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5578	NP_002728.1	protein kinase C alpha type	11141237,11504923	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5578	NP_002728.1	protein kinase C alpha type	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5578	NP_002728.1	protein kinase C alpha type	1832084,2139676	2007-11-07 17:30	A synthetic peptide containing residues 581-597 from HIV-1 gp41 inhibits protein kinase C (pkC)-mediated phosphorylation of the CD3 gamma-chain in intact cells and directly inhibits partially purified pkC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5578	NP_002728.1	protein kinase C alpha type	7850771	2007-11-07 17:31	A synthetic peptide corresponding to cytoplasmic domain residues 828-848 of HIV-1 gp41 inhibits pKC-catalysed phosphorylation of a protein substrate
11676	156110	NP_057857.2	Nef	phosphorylated by	9606	5578	NP_002728.1	protein kinase C alpha type	7540194,8178481,9049329	2007-11-07 17:27	Protein kinase C phosphorylates HIV-1 Nef at threonine 15
11676	156110	NP_057857.2	Nef	phosphorylated by	9606	5578	NP_002728.1	protein kinase C alpha type	9032396,9139671,11312657	2007-11-07 17:27	Treatment of cells with protein kinase C (PKC) inhibitors reduces HIV-1 Nef phosphorylation in vivo, and phosphorylation of Nef increases 8- to 12-fold after treatment with phorbol myristate acetate; these data indicate PKC phosphorylates Nef
11676	155348	NP_705926.1	retropepsin	inhibited by	9606	5579	NP_002729.2	protein kinase C beta type isoform 2	10491200	2007-11-07 17:29	Phosphorylation of human recombinant vimentin by PKC inhibits the proteolytic processing of the vimentin head domain by HIV-1 protease
11676	155871	NP_057853.1	Tat	regulated by	9606	5579	NP_002729.2	protein kinase C beta type isoform 2	2182321	2007-11-07 17:27	Protein kinase C is required for HIV-1 Tat-mediated transactivation of the viral LTR promoter, indicating protein kinase C regulates the process of HIV-1 transactivation and may play a role in the transition of HIV from latency to productive growth
11676	155871	NP_057853.1	Tat	activates	9606	5579	NP_002729.2	protein kinase C beta type isoform 2	8627654,9446795,9671211,10843712,11044099,11154208,11833470,11919157,12482669,15488737	2007-11-07 17:27	HIV-1 Tat activates protein kinase C, resulting in the induction of TNF-alpha, IL-6 and IL-10 expression and the secretion of MCP-1
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5579	NP_002729.2	protein kinase C beta type isoform 2	8914829	2007-11-07 17:27	Protein kinase C phosphorylates HIV-1 Tat on serine residue 46
11676	156110	NP_057857.2	Nef	downregulates	9606	5579	NP_002729.2	protein kinase C beta type isoform 2	10417813	2007-11-07 17:27	HIV-1 Nef selectively downregulates beta II and epsilon PKC isoforms in human astrocytoma cells
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	5579	NP_997700.1	protein kinase C beta type isoform 1	10641798	2007-11-07 17:29	HIV-1 RT heterodimer expressed in bacteria can be phosphorylated in vitro by several purified mammalian protein kinases including auto-activated protein kinase (PK), CKII, cytosolic protamine kinase (CPK), myelin basic protein kinase 1 (MBPK1), and PRKC
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	5579	NP_997700.1	protein kinase C beta type isoform 1	7642615	2007-11-07 17:30	HIV-1 gp160-induced AP-1 complex formation is dependent upon protein tyrosine phosphorylation and is abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blockers or cyclosporine A
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	relocalizes	9606	5579	NP_997700.1	protein kinase C beta type isoform 1	11744714	2007-11-07 17:31	HIV-1 gp160-induced Ca(2+) influx reduction is antagonized by an inhibitor acting especially on PKC alpha and PKC beta I; Western blotting analyses show that the cellular distribution of PKC alpha and -beta I are significantly modified by gp160
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5579	NP_997700.1	protein kinase C beta type isoform 1	1970444	2007-11-07 17:29	Downmodulation of the interaction between HIV-1 gp120 and CD4 by TPA is blocked by protein kinase C (PKC) inhibitors, suggesting PKC may play an important role in HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5579	NP_997700.1	protein kinase C beta type isoform 1	3259291	2007-11-07 17:30	A specific interaction between CD4 and HIV-1 gp120 is required for phosphorylation of CD4, which could involve protein kinase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5579	NP_997700.1	protein kinase C beta type isoform 1	8206685	2007-11-07 17:29	HIV-1 gp120 increases the levels of calcium-dependent and -independent PKC isozymes; the most striking change is observed in PKC-zeta isozyme levels
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5579	NP_997700.1	protein kinase C beta type isoform 1	8599832	2007-11-07 17:27	IL-16 induces rapid translocation of PKC from the cytosol to the membrane in CD4+ cells; PKC inhibitors completely block IL-16-induced lymphocyte migration as well as the motile response induced by HIV-1 gp120 and anti-CD4 antibody binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5579	NP_997700.1	protein kinase C beta type isoform 1	11141237,11504923	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5579	NP_997700.1	protein kinase C beta type isoform 1	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5579	NP_997700.1	protein kinase C beta type isoform 1	1832084,2139676	2007-11-07 17:30	A synthetic peptide containing residues 581-597 from HIV-1 gp41 inhibits protein kinase C (pkC)-mediated phosphorylation of the CD3 gamma-chain in intact cells and directly inhibits partially purified pkC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5579	NP_997700.1	protein kinase C beta type isoform 1	7850771	2007-11-07 17:31	A synthetic peptide corresponding to cytoplasmic domain residues 828-848 of HIV-1 gp41 inhibits pKC-catalysed phosphorylation of a protein substrate
11676	155348	NP_705926.1	retropepsin	inhibited by	9606	5580	NP_006245.2	protein kinase C delta type	10491200	2007-11-07 17:29	Phosphorylation of human recombinant vimentin by PKC inhibits the proteolytic processing of the vimentin head domain by HIV-1 protease
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	5580	NP_006245.2	protein kinase C delta type	10641798	2007-11-07 17:29	HIV-1 RT heterodimer expressed in bacteria can be phosphorylated in vitro by several purified mammalian protein kinases including auto-activated protein kinase (PK), CKII, cytosolic protamine kinase (CPK), myelin basic protein kinase 1 (MBPK1), and PRKC
11676	155871	NP_057853.1	Tat	regulated by	9606	5580	NP_006245.2	protein kinase C delta type	2182321	2007-11-07 17:27	Protein kinase C is required for HIV-1 Tat-mediated transactivation of the viral LTR promoter, indicating protein kinase C regulates the process of HIV-1 transactivation and may play a role in the transition of HIV from latency to productive growth
11676	155871	NP_057853.1	Tat	activates	9606	5580	NP_006245.2	protein kinase C delta type	8627654,9446795,9671211,10843712,11044099,11154208,11833470,11919157,12482669,15488737	2007-11-07 17:27	HIV-1 Tat activates protein kinase C, resulting in the induction of TNF-alpha, IL-6 and IL-10 expression and the secretion of MCP-1
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5580	NP_006245.2	protein kinase C delta type	8914829	2007-11-07 17:27	Protein kinase C phosphorylates HIV-1 Tat on serine residue 46
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	5580	NP_006245.2	protein kinase C delta type	7642615	2007-11-07 17:30	HIV-1 gp160-induced AP-1 complex formation is dependent upon protein tyrosine phosphorylation and is abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blockers or cyclosporine A
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5580	NP_006245.2	protein kinase C delta type	1970444	2007-11-07 17:29	Downmodulation of the interaction between HIV-1 gp120 and CD4 by TPA is blocked by protein kinase C (PKC) inhibitors, suggesting PKC may play an important role in HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5580	NP_006245.2	protein kinase C delta type	3259291	2007-11-07 17:29	A specific interaction between CD4 and HIV-1 gp120 is required for phosphorylation of CD4, which could involve protein kinase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5580	NP_006245.2	protein kinase C delta type	8206685	2007-11-07 17:29	HIV-1 gp120 increases the levels of calcium-dependent and -independent PKC isozymes; the most striking change is observed in PKC-zeta isozyme levels
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5580	NP_006245.2	protein kinase C delta type	8599832	2007-11-07 17:27	IL-16 induces rapid translocation of PKC from the cytosol to the membrane in CD4+ cells; PKC inhibitors completely block IL-16-induced lymphocyte migration as well as the motile response induced by HIV-1 gp120 and anti-CD4 antibody binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5580	NP_006245.2	protein kinase C delta type	11141237,11504923	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5580	NP_006245.2	protein kinase C delta type	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5580	NP_006245.2	protein kinase C delta type	1832084,2139676	2007-11-07 17:30	A synthetic peptide containing residues 581-597 from HIV-1 gp41 inhibits protein kinase C (pkC)-mediated phosphorylation of the CD3 gamma-chain in intact cells and directly inhibits partially purified pkC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5580	NP_006245.2	protein kinase C delta type	7850771	2007-11-07 17:31	A synthetic peptide corresponding to cytoplasmic domain residues 828-848 of HIV-1 gp41 inhibits pKC-catalysed phosphorylation of a protein substrate
11676	155348	NP_705926.1	retropepsin	inhibited by	9606	5581	NP_005391.1	protein kinase C epsilon type	10491200	2007-11-07 17:29	Phosphorylation of human recombinant vimentin by PKC inhibits the proteolytic processing of the vimentin head domain by HIV-1 protease
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	5581	NP_005391.1	protein kinase C epsilon type	10641798	2007-11-07 17:29	HIV-1 RT heterodimer expressed in bacteria can be phosphorylated in vitro by several purified mammalian protein kinases including auto-activated protein kinase (PK), CKII, cytosolic protamine kinase (CPK), myelin basic protein kinase 1 (MBPK1), and PRKC
11676	155871	NP_057853.1	Tat	regulated by	9606	5581	NP_005391.1	protein kinase C epsilon type	2182321	2007-11-07 17:27	Protein kinase C is required for HIV-1 Tat-mediated transactivation of the viral LTR promoter, indicating protein kinase C regulates the process of HIV-1 transactivation and may play a role in the transition of HIV from latency to productive growth
11676	155871	NP_057853.1	Tat	activates	9606	5581	NP_005391.1	protein kinase C epsilon type	8627654,9446795,9671211,10843712,11044099,11154208,11833470,11919157,12482669,15488737	2007-11-07 17:27	HIV-1 Tat activates protein kinase C, resulting in the induction of TNF-alpha, IL-6 and IL-10 expression and the secretion of MCP-1
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5581	NP_005391.1	protein kinase C epsilon type	8914829	2007-11-07 17:27	Protein kinase C phosphorylates HIV-1 Tat on serine residue 46
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	5581	NP_005391.1	protein kinase C epsilon type	7642615	2007-11-07 17:30	HIV-1 gp160-induced AP-1 complex formation is dependent upon protein tyrosine phosphorylation and is abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blockers or cyclosporine A
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5581	NP_005391.1	protein kinase C epsilon type	1970444	2007-11-07 17:29	Downmodulation of the interaction between HIV-1 gp120 and CD4 by TPA is blocked by protein kinase C (PKC) inhibitors, suggesting PKC may play an important role in HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5581	NP_005391.1	protein kinase C epsilon type	3259291	2007-11-07 17:29	A specific interaction between CD4 and HIV-1 gp120 is required for phosphorylation of CD4, which could involve protein kinase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5581	NP_005391.1	protein kinase C epsilon type	8206685	2007-11-07 17:29	HIV-1 gp120 increases the levels of calcium-dependent and -independent PKC isozymes; the most striking change is observed in PKC-zeta isozyme levels
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5581	NP_005391.1	protein kinase C epsilon type	8599832	2007-11-07 17:27	IL-16 induces rapid translocation of PKC from the cytosol to the membrane in CD4+ cells; PKC inhibitors completely block IL-16-induced lymphocyte migration as well as the motile response induced by HIV-1 gp120 and anti-CD4 antibody binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5581	NP_005391.1	protein kinase C epsilon type	11141237,11504923	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5581	NP_005391.1	protein kinase C epsilon type	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5581	NP_005391.1	protein kinase C epsilon type	1832084,2139676	2007-11-07 17:30	A synthetic peptide containing residues 581-597 from HIV-1 gp41 inhibits protein kinase C (pkC)-mediated phosphorylation of the CD3 gamma-chain in intact cells and directly inhibits partially purified pkC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5581	NP_005391.1	protein kinase C epsilon type	7850771	2007-11-07 17:31	A synthetic peptide corresponding to cytoplasmic domain residues 828-848 of HIV-1 gp41 inhibits pKC-catalysed phosphorylation of a protein substrate
11676	156110	NP_057857.2	Nef	downregulates	9606	5581	NP_005391.1	protein kinase C epsilon type	10417813,15078178	2007-11-07 17:27	HIV-1 Nef downregulates the expression of PKC epsilon in human astrocytoma cells
11676	155348	NP_705926.1	retropepsin	inhibited by	9606	5582	NP_002730.1	protein kinase C gamma type	10491200	2007-11-07 17:29	Phosphorylation of human recombinant vimentin by PKC inhibits the proteolytic processing of the vimentin head domain by HIV-1 protease
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	5582	NP_002730.1	protein kinase C gamma type	10641798	2007-11-07 17:29	HIV-1 RT heterodimer expressed in bacteria can be phosphorylated in vitro by several purified mammalian protein kinases including auto-activated protein kinase (PK), CKII, cytosolic protamine kinase (CPK), myelin basic protein kinase 1 (MBPK1), and PRKC
11676	155871	NP_057853.1	Tat	regulated by	9606	5582	NP_002730.1	protein kinase C gamma type	2182321	2007-11-07 17:28	Protein kinase C is required for HIV-1 Tat-mediated transactivation of the viral LTR promoter, indicating protein kinase C regulates the process of HIV-1 transactivation and may play a role in the transition of HIV from latency to productive growth
11676	155871	NP_057853.1	Tat	activates	9606	5582	NP_002730.1	protein kinase C gamma type	8627654,9446795,9671211,10843712,11044099,11154208,11833470,11919157,12482669	2007-11-07 17:27	HIV-1 Tat activates protein kinase C, resulting in the induction of TNF-alpha, IL-6 and IL-10 expression and the secretion of MCP-1
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5582	NP_002730.1	protein kinase C gamma type	8914829	2007-11-07 17:28	Protein kinase C phosphorylates HIV-1 Tat on serine residue 46
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	5582	NP_002730.1	protein kinase C gamma type	7642615	2007-11-07 17:30	HIV-1 gp160-induced AP-1 complex formation is dependent upon protein tyrosine phosphorylation and is abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blockers or cyclosporine A
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5582	NP_002730.1	protein kinase C gamma type	1970444	2007-11-07 17:29	Downmodulation of the interaction between HIV-1 gp120 and CD4 by TPA is blocked by protein kinase C (PKC) inhibitors, suggesting PKC may play an important role in HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5582	NP_002730.1	protein kinase C gamma type	3259291	2007-11-07 17:29	A specific interaction between CD4 and HIV-1 gp120 is required for phosphorylation of CD4, which could involve protein kinase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5582	NP_002730.1	protein kinase C gamma type	8206685	2007-11-07 17:31	HIV-1 gp120 increases the levels of calcium-dependent and -independent PKC isozymes; the most striking change is observed in PKC-zeta isozyme levels
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5582	NP_002730.1	protein kinase C gamma type	8599832	2007-11-07 17:27	IL-16 induces rapid translocation of PKC from the cytosol to the membrane in CD4+ cells; PKC inhibitors completely block IL-16-induced lymphocyte migration as well as the motile response induced by HIV-1 gp120 and anti-CD4 antibody binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5582	NP_002730.1	protein kinase C gamma type	11141237,11504923	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5582	NP_002730.1	protein kinase C gamma type	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5582	NP_002730.1	protein kinase C gamma type	1832084,2139676	2007-11-07 17:30	A synthetic peptide containing residues 581-597 from HIV-1 gp41 inhibits protein kinase C (pkC)-mediated phosphorylation of the CD3 gamma-chain in intact cells and directly inhibits partially purified pkC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5582	NP_002730.1	protein kinase C gamma type	7850771	2007-11-07 17:31	A synthetic peptide corresponding to cytoplasmic domain residues 828-848 of HIV-1 gp41 inhibits pKC-catalysed phosphorylation of a protein substrate
11676	155348	NP_705926.1	retropepsin	inhibited by	9606	5583	NP_006246.2	protein kinase C eta type	10491200	2007-11-07 17:29	Phosphorylation of human recombinant vimentin by PKC inhibits the proteolytic processing of the vimentin head domain by HIV-1 protease
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	5583	NP_006246.2	protein kinase C eta type	10641798	2007-11-07 17:29	HIV-1 RT heterodimer expressed in bacteria can be phosphorylated in vitro by several purified mammalian protein kinases including auto-activated protein kinase (PK), CKII, cytosolic protamine kinase (CPK), myelin basic protein kinase 1 (MBPK1), and PRKC
11676	155871	NP_057853.1	Tat	regulated by	9606	5583	NP_006246.2	protein kinase C eta type	2182321	2007-11-07 17:28	Protein kinase C is required for HIV-1 Tat-mediated transactivation of the viral LTR promoter, indicating protein kinase C regulates the process of HIV-1 transactivation and may play a role in the transition of HIV from latency to productive growth
11676	155871	NP_057853.1	Tat	activates	9606	5583	NP_006246.2	protein kinase C eta type	8627654,9446795,9671211,10843712,11044099,11154208,11833470,11919157,12482669	2007-11-07 17:28	HIV-1 Tat activates protein kinase C, resulting in the induction of TNF-alpha, IL-6 and IL-10 expression and the secretion of MCP-1
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5583	NP_006246.2	protein kinase C eta type	8914829	2007-11-07 17:28	Protein kinase C phosphorylates HIV-1 Tat on serine residue 46
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	5583	NP_006246.2	protein kinase C eta type	7642615	2007-11-07 17:30	HIV-1 gp160-induced AP-1 complex formation is dependent upon protein tyrosine phosphorylation and is abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blockers or cyclosporine A
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5583	NP_006246.2	protein kinase C eta type	1970444	2007-11-07 17:29	Downmodulation of the interaction between HIV-1 gp120 and CD4 by TPA is blocked by protein kinase C (PKC) inhibitors, suggesting PKC may play an important role in HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5583	NP_006246.2	protein kinase C eta type	3259291	2007-11-07 17:29	A specific interaction between CD4 and HIV-1 gp120 is required for phosphorylation of CD4, which could involve protein kinase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5583	NP_006246.2	protein kinase C eta type	8206685	2007-11-07 17:29	HIV-1 gp120 increases the levels of calcium-dependent and -independent PKC isozymes; the most striking change is observed in PKC-zeta isozyme levels
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5583	NP_006246.2	protein kinase C eta type	8599832	2007-11-07 17:27	IL-16 induces rapid translocation of PKC from the cytosol to the membrane in CD4+ cells; PKC inhibitors completely block IL-16-induced lymphocyte migration as well as the motile response induced by HIV-1 gp120 and anti-CD4 antibody binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5583	NP_006246.2	protein kinase C eta type	11141237,11504923	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5583	NP_006246.2	protein kinase C eta type	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5583	NP_006246.2	protein kinase C eta type	1832084,2139676	2007-11-07 17:30	A synthetic peptide containing residues 581-597 from HIV-1 gp41 inhibits protein kinase C (pkC)-mediated phosphorylation of the CD3 gamma-chain in intact cells and directly inhibits partially purified pkC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5583	NP_006246.2	protein kinase C eta type	7850771	2007-11-07 17:31	A synthetic peptide corresponding to cytoplasmic domain residues 828-848 of HIV-1 gp41 inhibits pKC-catalysed phosphorylation of a protein substrate
11676	155348	NP_705926.1	retropepsin	inhibited by	9606	5584	NP_002731.3	protein kinase C, iota	10491200	2007-11-07 17:29	Phosphorylation of human recombinant vimentin by PKC inhibits the proteolytic processing of the vimentin head domain by HIV-1 protease
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	5584	NP_002731.3	protein kinase C, iota	10641798	2007-11-07 17:29	HIV-1 RT heterodimer expressed in bacteria can be phosphorylated in vitro by several purified mammalian protein kinases including auto-activated protein kinase (PK), CKII, cytosolic protamine kinase (CPK), myelin basic protein kinase 1 (MBPK1), and PRKC
11676	155871	NP_057853.1	Tat	regulated by	9606	5584	NP_002731.3	protein kinase C, iota	2182321	2007-11-07 17:28	Protein kinase C is required for HIV-1 Tat-mediated transactivation of the viral LTR promoter, indicating protein kinase C regulates the process of HIV-1 transactivation and may play a role in the transition of HIV from latency to productive growth
11676	155871	NP_057853.1	Tat	activates	9606	5584	NP_002731.3	protein kinase C, iota	8627654,9446795,9671211,10843712,11044099,11154208,11833470,11919157,12482669	2007-11-07 17:28	HIV-1 Tat activates protein kinase C, resulting in the induction of TNF-alpha, IL-6 and IL-10 expression and the secretion of MCP-1
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5584	NP_002731.3	protein kinase C, iota	8914829	2007-11-07 17:28	Protein kinase C phosphorylates HIV-1 Tat on serine residue 46
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	5584	NP_002731.3	protein kinase C, iota	7642615	2007-11-07 17:30	HIV-1 gp160-induced AP-1 complex formation is dependent upon protein tyrosine phosphorylation and is abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blockers or cyclosporine A
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5584	NP_002731.3	protein kinase C, iota	1970444	2007-11-07 17:29	Downmodulation of the interaction between HIV-1 gp120 and CD4 by TPA is blocked by protein kinase C (PKC) inhibitors, suggesting PKC may play an important role in HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5584	NP_002731.3	protein kinase C, iota	3259291	2007-11-07 17:30	A specific interaction between CD4 and HIV-1 gp120 is required for phosphorylation of CD4, which could involve protein kinase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5584	NP_002731.3	protein kinase C, iota	8206685	2007-11-07 17:29	HIV-1 gp120 increases the levels of calcium-dependent and -independent PKC isozymes; the most striking change is observed in PKC-zeta isozyme levels
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5584	NP_002731.3	protein kinase C, iota	8599832	2007-11-07 17:27	IL-16 induces rapid translocation of PKC from the cytosol to the membrane in CD4+ cells; PKC inhibitors completely block IL-16-induced lymphocyte migration as well as the motile response induced by HIV-1 gp120 and anti-CD4 antibody binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5584	NP_002731.3	protein kinase C, iota	11141237,11504923	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5584	NP_002731.3	protein kinase C, iota	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5584	NP_002731.3	protein kinase C, iota	1832084,2139676	2007-11-07 17:30	A synthetic peptide containing residues 581-597 from HIV-1 gp41 inhibits protein kinase C (pkC)-mediated phosphorylation of the CD3 gamma-chain in intact cells and directly inhibits partially purified pkC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5584	NP_002731.3	protein kinase C, iota	7850771	2007-11-07 17:31	A synthetic peptide corresponding to cytoplasmic domain residues 828-848 of HIV-1 gp41 inhibits pKC-catalysed phosphorylation of a protein substrate
11676	155871	NP_057853.1	Tat	regulated by	9606	5587	NP_002733.2	serine/threonine-protein kinase D1	2182321	2007-11-07 17:28	Protein kinase C is required for HIV-1 Tat-mediated transactivation of the viral LTR promoter, indicating protein kinase C regulates the process of HIV-1 transactivation and may play a role in the transition of HIV from latency to productive growth
11676	155871	NP_057853.1	Tat	activates	9606	5587	NP_002733.2	serine/threonine-protein kinase D1	8627654,9446795,9671211,10843712,11044099,11154208,11833470,11919157,12482669	2007-11-07 17:28	HIV-1 Tat activates protein kinase C, resulting in the induction of TNF-alpha, IL-6 and IL-10 expression and the secretion of MCP-1
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5587	NP_002733.2	serine/threonine-protein kinase D1	8914829	2007-11-07 17:28	Protein kinase C phosphorylates HIV-1 Tat on serine residue 46
11676	155348	NP_705926.1	retropepsin	inhibited by	9606	5588	NP_006248.1	protein kinase C theta type	10491200	2007-11-07 17:29	Phosphorylation of human recombinant vimentin by PKC inhibits the proteolytic processing of the vimentin head domain by HIV-1 protease
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	5588	NP_006248.1	protein kinase C theta type	10641798	2007-11-07 17:29	HIV-1 RT heterodimer expressed in bacteria can be phosphorylated in vitro by several purified mammalian protein kinases including auto-activated protein kinase (PK), CKII, cytosolic protamine kinase (CPK), myelin basic protein kinase 1 (MBPK1), and PRKC
11676	155871	NP_057853.1	Tat	regulated by	9606	5588	NP_006248.1	protein kinase C theta type	2182321	2007-11-07 17:28	Protein kinase C is required for HIV-1 Tat-mediated transactivation of the viral LTR promoter, indicating protein kinase C regulates the process of HIV-1 transactivation and may play a role in the transition of HIV from latency to productive growth
11676	155871	NP_057853.1	Tat	activates	9606	5588	NP_006248.1	protein kinase C theta type	8627654,9446795,9671211,10843712,11044099,11154208,11833470,11919157,12482669	2007-11-07 17:28	HIV-1 Tat activates protein kinase C, resulting in the induction of TNF-alpha, IL-6 and IL-10 expression and the secretion of MCP-1
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5588	NP_006248.1	protein kinase C theta type	8914829	2007-11-07 17:28	Protein kinase C phosphorylates HIV-1 Tat on serine residue 46
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	5588	NP_006248.1	protein kinase C theta type	7642615	2007-11-07 17:30	HIV-1 gp160-induced AP-1 complex formation is dependent upon protein tyrosine phosphorylation and is abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blockers or cyclosporine A
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5588	NP_006248.1	protein kinase C theta type	1970444	2007-11-07 17:29	Downmodulation of the interaction between HIV-1 gp120 and CD4 by TPA is blocked by protein kinase C (PKC) inhibitors, suggesting PKC may play an important role in HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5588	NP_006248.1	protein kinase C theta type	3259291	2007-11-07 17:29	A specific interaction between CD4 and HIV-1 gp120 is required for phosphorylation of CD4, which could involve protein kinase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5588	NP_006248.1	protein kinase C theta type	8206685	2007-11-07 17:29	HIV-1 gp120 increases the levels of calcium-dependent and -independent PKC isozymes; the most striking change is observed in PKC-zeta isozyme levels
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5588	NP_006248.1	protein kinase C theta type	8599832	2007-11-07 17:27	IL-16 induces rapid translocation of PKC from the cytosol to the membrane in CD4+ cells; PKC inhibitors completely block IL-16-induced lymphocyte migration as well as the motile response induced by HIV-1 gp120 and anti-CD4 antibody binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5588	NP_006248.1	protein kinase C theta type	11141237,11504923	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5588	NP_006248.1	protein kinase C theta type	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5588	NP_006248.1	protein kinase C theta type	1832084,2139676	2007-11-07 17:30	A synthetic peptide containing residues 581-597 from HIV-1 gp41 inhibits protein kinase C (pkC)-mediated phosphorylation of the CD3 gamma-chain in intact cells and directly inhibits partially purified pkC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5588	NP_006248.1	protein kinase C theta type	7850771	2007-11-07 17:31	A synthetic peptide corresponding to cytoplasmic domain residues 828-848 of HIV-1 gp41 inhibits pKC-catalysed phosphorylation of a protein substrate
11676	156110	NP_057857.2	Nef	interacts with	9606	5588	NP_006248.1	protein kinase C theta type	8663223,9617893,11222731,12734410	2007-11-07 17:27	Interactions between HIV-1 Nef and PKC isozymes in Jurkat cells show that Nef interacts preferentially with PKCtheta; the interaction of Nef and PKCtheta is independent of calcium, but enhanced by phospholipid activators of PKC
11676	155348	NP_705926.1	retropepsin	inhibited by	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	10491200	2007-11-07 17:29	Phosphorylation of human recombinant vimentin by PKC inhibits the proteolytic processing of the vimentin head domain by HIV-1 protease
11676	155348	NP_705927.1	reverse transcriptase	phosphorylated by	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	10641798	2007-11-07 17:29	HIV-1 RT heterodimer expressed in bacteria can be phosphorylated in vitro by several purified mammalian protein kinases including auto-activated protein kinase (PK), CKII, cytosolic protamine kinase (CPK), myelin basic protein kinase 1 (MBPK1), and PRKC
11676	155871	NP_057853.1	Tat	regulated by	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	2182321	2007-11-07 17:28	Protein kinase C is required for HIV-1 Tat-mediated transactivation of the viral LTR promoter, indicating protein kinase C regulates the process of HIV-1 transactivation and may play a role in the transition of HIV from latency to productive growth
11676	155871	NP_057853.1	Tat	activates	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	8627654,9446795,9671211,10843712,11044099,11154208,11833470,11919157,12482669	2007-11-07 17:28	HIV-1 Tat activates protein kinase C, resulting in the induction of TNF-alpha, IL-6 and IL-10 expression and the secretion of MCP-1
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	8914829	2007-11-07 17:28	Protein kinase C phosphorylates HIV-1 Tat on serine residue 46
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	7642615	2007-11-07 17:30	HIV-1 gp160-induced AP-1 complex formation is dependent upon protein tyrosine phosphorylation and is abolished by inhibitors of protein kinase C, but it is unaffected by calcium channel blockers or cyclosporine A
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	1970444	2007-11-07 17:29	Downmodulation of the interaction between HIV-1 gp120 and CD4 by TPA is blocked by protein kinase C (PKC) inhibitors, suggesting PKC may play an important role in HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	3259291	2007-11-07 17:29	A specific interaction between CD4 and HIV-1 gp120 is required for phosphorylation of CD4, which could involve protein kinase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	8206685	2007-11-07 17:29	HIV-1 gp120 increases the levels of calcium-dependent and -independent PKC isozymes; the most striking change is observed in PKC-zeta isozyme levels
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	8599832	2007-11-07 17:27	IL-16 induces rapid translocation of PKC from the cytosol to the membrane in CD4+ cells; PKC inhibitors completely block IL-16-induced lymphocyte migration as well as the motile response induced by HIV-1 gp120 and anti-CD4 antibody binding to CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	11141237,11504923	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	15689238	2007-11-07 17:31	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	1832084,2139676	2007-11-07 17:30	A synthetic peptide containing residues 581-597 from HIV-1 gp41 inhibits protein kinase C (pkC)-mediated phosphorylation of the CD3 gamma-chain in intact cells and directly inhibits partially purified pkC
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	5590	NP_002735.3	protein kinase C zeta type isoform 1	7850771	2007-11-07 17:31	A synthetic peptide corresponding to cytoplasmic domain residues 828-848 of HIV-1 gp41 inhibits pKC-catalysed phosphorylation of a protein substrate
11676	155348	NP_705928.1	integrase	interacts with	9606	5591	NP_008835.5	DNA-dependent protein kinase catalytic subunit isoform 1	10213687,11070027,11158303,11406603,15875659,16075307	2007-11-07 17:29	DNA-PK is proposed to play a role in retroviral DNA integration and protects cells against toxicity induced by HIV-1 Integrase or integration
11676	155871	NP_057853.1	Tat	binds	9606	5591	NP_008835.5	DNA-dependent protein kinase catalytic subunit isoform 1	9525578	2007-11-07 17:28	Amino acids 56-101 of HIV-1 Tat mediate Tat binding to DNA-PK, an effect that augments DNA-PK-mediated phosphorylation of Sp1 during Tat transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	downregulates	9606	5591	NP_008835.5	DNA-dependent protein kinase catalytic subunit isoform 1	16751065	2007-11-07 17:31	The DNA repair gene DNA-PKcs and cell cycle-related genes Cdc20, Cdc25C, KIF2C and CTS1 are downregulated in HIV-1 Tat-expressing human rhabdomyosarcoma cells
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	8552640	2007-11-07 17:28	Phosphorylation of HIV-1 Matrix on tyrosine and serine prior to and during virus infection facilitates dissociation of Matrix from the cellular membrane, thus allowing it to translocate to the nucleus and participate in HIV-1 nuclear import
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	10074203	2007-11-07 17:28	Recombinant MAPK phosphorylates HIV-1 Matrix on serine and threonine residues, whereas immunoprecipitated MAPK predominantly phosphorylates HIV-1 Matrix on serine residues
11676	155030	NP_579883.1	p6	phosphorylated by	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	11773377,15155723	2007-11-07 17:29	HIV-1 p6-Gag is phosphorylated by cellular kinases with ERK1 and ERK2 being the most likely kinases involved in p6 phosphorylation
11676	155348	NP_705927.1	reverse transcriptase	interacts with	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	9564043	2007-11-07 17:29	MEK1 in HIV-1 producer cells is able to activate virion-associated MAPK in trans, and the activated MAPK facilitates efficient disengagement of the HIV-1 reverse transcription complex from the cell membrane and subsequent nuclear translocation
11676	155459	NP_057851.1	Vif	phosphorylated by	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	8626571,9792705,10074203	2007-11-07 17:27	MAPK phosphorylates HIV-1 Vif on Thr96 and Ser165 and is important in the regulation of HIV-1 infectivity by Vif
11676	155807	NP_057852.2	Vpr	activates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	17158886	2007-11-07 17:31	Treatment of cells with HIV-1 Vpr 52-96 or Vpr 1-45 peptides induces strong activation of p38, ERK and JNK MAPKs and results in phosphorylation of ERK and JNK MAPKs
11676	155871	NP_057853.1	Tat	activates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	9223324,9325171,9558095,9621077,10509564,10780709,10799874,10982368,11044099,11260070,11409852,11579140,12167619,12482669,12491158,16920714	2007-11-07 17:28	HIV-1 Tat activates ERK1 and ERK2 through the activation of MEK1 and MEK2, leading to induction of IL-8, IL-10, IP-10, iNOS, superoxide and TNF-alpha, as well as suppression of p35 activator of cdk5, activation of CREB and increased albumin permeability
11676	155871	NP_057853.1	Tat	activates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	9621077,11409852	2007-11-07 17:28	The interaction of HIV-1 Tat with KDR/VEGFR2 is implicated in the activation of ERK1 and ERK2 signaling pathways
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	10074203	2007-11-07 17:28	HIV-1 Tat is phosphorylated by MAPK in vitro
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	16395283	2007-11-07 17:29	Treatment with HIV-1 Tat induces phosphorylation of ERK1/2 and JNK in brain microvascular endothelial cells (BMEC) and astrocytes, which mediates Tat-induced multidrug resistance-associated protein 1 (MRP1) expression
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	16436505	2007-11-07 17:29	HIV-1 Tat induces ERK phosphorylation by the activation of the small GTPase Ras, but not the small GTPase Rac, in human endothelial cells
11676	155871	NP_057853.1	Tat	inactivates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	16741963	2007-11-07 17:31	Expression of HIV-1 Tat in human SK-N-MC cells inhibits the NGF-signaling pathway leading to suppression of MAPK and reduction of Puralpha binding to the Egr-1 promoter
11676	155908	NP_057854.1	Rev	phosphorylated by	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	8806671,10074203	2007-11-07 17:27	MAPK has been shown to phosphorylate Rev in vitro
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	9045910	2007-11-07 17:31	Pre-incubation of CD4+ T lymphocytes with anti-CD4 mAb or HIV-1 gp160 inhibits the activation of c-Jun N-terminal kinases (JNK) and extracellular signal-regulated protein kinase 2 (ERK2) in response to phorbol 12-myristate 13-acetate and ionomycin
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	15603708	2007-11-07 17:31	The activation of mitogen-activated protein kinases (MAPKs, including ERK, JNK, and p38MAPK) is induced by incubation of HIV-1 gp160 with CD4+complement receptor type 2 (CR2)+ cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	9403476,9658081,11504923,11532249,15371627,16621960	2007-11-07 17:28	HIV-1 gp120 activates c-Jun N-terminal kinase (JNK) and p42 extracellular-regulated kinase (ERK) in macrophages and primary human central nervous system (CNS) cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	10027715,10581001,12089333,12239168,12775419	2007-11-07 17:31	Treatment of cells with HIV-1 gp120 induces increased levels of endogenous c-fos and c-jun mRNA and proteins, an activation of both c-fos and c-jun promoters, and a very rapid stimulation of the MAPK/ERK pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	decreases phosphorylation of	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	12714584	2007-11-07 17:30	Pretreatment of CD4+ T cells with HIV-1 gp120 followed by stimulation with jacalin results in marked inhibition of phosphorylation of ERK2 as well as JNK
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	15689238	2007-11-07 17:30	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	16621960	2007-11-07 17:31	Stimulation of human monocyte-derived macrophages with HIV-1 gp120 results in the CCR5-mediated activation of Lyn and the concomitant Lyn-dependent activation of the mitogen-activated protein (MAP) kinase ERK-1/2, which leads to production of TNF-alpha
11676	156110	NP_057857.2	Nef	binds	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	8794306	2007-11-07 17:27	A proline-rich repeat sequence [(Pxx)4] in HIV-1 Nef occurring between amino acid residues 69 to 78 binds to MAPK and significantly decreases its kinase activity in vitro
11676	156110	NP_057857.2	Nef	Inhibits	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	9453574	2007-11-07 17:27	HIV-1 Nef expression in a human astrocytic cell line inhibits the endothelin-1 mediated activation of ERK1 and ERK2 activity
11676	156110	NP_057857.2	Nef	inhibits	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	9453574	2007-11-07 17:29	The activation of extracellular signal-regulated kinase 2 (ERK2) by endothelin-1 (ET-1) is inhibited by HIV-1 Nef in human astrocytes; a similar inhibitory action of Nef on ERK2 activation was observed after direct stimulation of G proteins
11676	156110	NP_057857.2	Nef	upregulates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	10074203,11726657,12354773	2007-11-07 17:27	HIV-1 Nef expression in primary CD4 T cells upregulates ERK, MEK, and Elk induction in a T cell receptor stimulation dependent manner, leading to enhanced viral replication and infectivity
11676	156110	NP_057857.2	Nef	activates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	10388555,17182689	2007-11-07 17:27	In human and murine monocyte-macrophages, HIV-1 Nef induces both DNA binding and transcriptional activities of the activator protein-1 (AP-1) through an association with ERK1 and 2 signaling pathways
11676	156110	NP_057857.2	Nef	activates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	10748182,11153078,11958689,12734410	2007-11-07 17:28	MAPK and JNK activities are activated in the presence of HIV-1 Nef after TNF-alpha treatment in human glial cells
11676	156110	NP_057857.2	Nef	activates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	15343382,17182689	2007-11-07 17:28	HIV-1 Nef, through its PxxP and RR106 motifs, upregulates Src kinase activity and signal transducer and activator of transcription 3 (Stat3) phosphorylation, and activates the Ras-c-Raf-MAPK1,2 pathway in podocytes
11676	156110	NP_057857.2	Nef	activates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	15343382	2007-11-07 17:28	Phospho-MAPK1,2 and phospho-Stat3 staining increase in podocytes of kidneys from HIV-associated nephropathy patients, suggesting HIV-1 Nef-induced activation of these pathways is responsible for podocyte proliferation and dedifferentiation
11676	156110	NP_057857.2	Nef	activates	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	15459189	2007-11-07 17:28	HIV-1 Nef induces ERK/MAPK signaling, which is essential for Nef-mediated Bcl-XL upregulation and cell survival in TF-1 macrophages cells
11676	156110	NP_057857.2	Nef	regulated by	9606	5594	NP_002736.3	mitogen-activated protein kinase 1	15928037	2007-11-07 17:28	HIV-1 Nef-induced Fas ligand transcription is regulated by p38 MAPK-mediated activator protein-1 (AP-1) activation
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	8552640	2007-11-07 17:28	Phosphorylation of HIV-1 Matrix on tyrosine and serine prior to and during virus infection facilitates dissociation of Matrix from the cellular membrane, thus allowing it to translocate to the nucleus and participate in HIV-1 nuclear import
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	10074203	2007-11-07 17:28	Recombinant MAPK phosphorylates HIV-1 Matrix on serine and threonine residues, whereas immunoprecipitated MAPK predominantly phosphorylates HIV-1 Matrix on serine residues
11676	155030	NP_579883.1	p6	phosphorylated by	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	11773377	2007-11-07 17:29	HIV-1 p6-Gag is phosphorylated by cellular kinases with ERK1 and ERK2 being the most likely kinases involved in p6 phosphorylation
11676	155348	NP_705927.1	reverse transcriptase	interacts with	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	9564043	2007-11-07 17:29	MEK1 in HIV-1 producer cells is able to activate virion-associated MAPK in trans, and the activated MAPK facilitates efficient disengagement of the HIV-1 reverse transcription complex from the cell membrane and subsequent nuclear translocation
11676	155459	NP_057851.1	Vif	phosphorylated by	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	8626571,9792705,10074203	2007-11-07 17:28	MAPK phosphorylates HIV-1 Vif on Thr96 and Ser165 and is important in the regulation of HIV-1 infectivity by Vif
11676	155871	NP_057853.1	Tat	activates	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	9223324,9325171,9558095,9621077,10509564,10780709,10799874,10982368,11044099,11260070,11409852,11579140,12167619,12482669,12491158,16920714	2007-11-07 17:28	HIV-1 Tat activates ERK1 and ERK2 through the activation of MEK1 and MEK2, leading to induction of IL-8, IL-10, IP-10, iNOS, superoxide and TNF-alpha, as well as suppression of p35 activator of cdk5, activation of CREB and increased albumin permeability
11676	155871	NP_057853.1	Tat	activates	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	9621077,11409852	2007-11-07 17:28	The interaction of HIV-1 Tat with KDR/VEGFR2 is implicated in the activation of ERK1 and ERK2 signaling pathways
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	10074203	2007-11-07 17:28	HIV-1 Tat is phosphorylated by MAPK in vitro
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	16395283	2007-11-07 17:29	Treatment with HIV-1 Tat induces phosphorylation of ERK1/2 and JNK in brain microvascular endothelial cells (BMEC) and astrocytes, which mediates Tat-induced multidrug resistance-associated protein 1 (MRP1) expression
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	16436505	2007-11-07 17:29	HIV-1 Tat induces ERK phosphorylation by the activation of the small GTPase Ras, but not the small GTPase Rac, in human endothelial cells
11676	155871	NP_057853.1	Tat	inactivates	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	16741963	2007-11-07 17:31	Expression of HIV-1 Tat in human SK-N-MC cells inhibits the NGF-signaling pathway leading to suppression of MAPK and reduction of Puralpha binding to the Egr-1 promoter
11676	155908	NP_057854.1	Rev	phosphorylated by	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	8806671,10074203	2007-11-07 17:28	MAPK has been shown to phosphorylate Rev in vitro
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	15603708	2007-11-07 17:31	The activation of mitogen-activated protein kinases (MAPKs, including ERK, JNK, and p38MAPK) is induced by incubation of HIV-1 gp160 with CD4+complement receptor type 2 (CR2)+ cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	9403476,9658081,11504923,11532249,15371627,16621960	2007-11-07 17:28	HIV-1 gp120 activates c-Jun N-terminal kinase (JNK) and p42 extracellular-regulated kinase (ERK) in macrophages and primary human central nervous system (CNS) cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	10027715,10581001,12089333,12239168,12775419	2007-11-07 17:31	Treatment of cells with HIV-1 gp120 induces increased levels of endogenous c-fos and c-jun mRNA and proteins, an activation of both c-fos and c-jun promoters, and a very rapid stimulation of the MAPK/ERK pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	15689238	2007-11-07 17:30	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	16621960	2007-11-07 17:31	Stimulation of human monocyte-derived macrophages with HIV-1 gp120 results in the CCR5-mediated activation of Lyn and the concomitant Lyn-dependent activation of the mitogen-activated protein (MAP) kinase ERK-1/2, which leads to production of TNF-alpha
11676	156110	NP_057857.2	Nef	activates	9606	5595	NP_002737.2	mitogen-activated protein kinase 3 isoform 1	17182689	2007-11-07 17:31	HIV-1 Nef myristoylation is required for the rapid and transient phosphorylation of the alpha- and beta- subunits of the Ikappa-B kinase complex and activation of JNK, ERK1/2 and p38 MAPK family members
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5596	NP_002738.2	mitogen-activated protein kinase 4	12239168	2007-11-07 17:31	HIV-1 gp120 binding to CD4 results in activation of the mitogen-activated protein kinase (MAPK) in CD4(+) lymphocytes prestimulated through their T-cell receptor (TCR)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5597	NP_002739.1	mitogen-activated protein kinase 6	12239168	2007-11-07 17:31	HIV-1 gp120 binding to CD4 results in activation of the mitogen-activated protein kinase (MAPK) in CD4(+) lymphocytes prestimulated through their T-cell receptor (TCR)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5598	NP_002740.2	mitogen-activated protein kinase 7 isoform 1	12239168	2007-11-07 17:31	HIV-1 gp120 binding to CD4 results in activation of the mitogen-activated protein kinase (MAPK) in CD4(+) lymphocytes prestimulated through their T-cell receptor (TCR)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5599	NP_002741.1	mitogen-activated protein kinase 8 isoform JNK1 alpha1	9045910	2007-11-07 17:30	Pre-incubation of CD4+ T lymphocytes with anti-CD4 mAb or HIV-1 gp160 inhibits the activation of c-Jun N-terminal kinases (JNK) and extracellular signal-regulated protein kinase 2 (ERK2) in response to phorbol 12-myristate 13-acetate and ionomycin
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5599	NP_002741.1	mitogen-activated protein kinase 8 isoform JNK1 alpha1	15603708	2007-11-07 17:31	The activation of mitogen-activated protein kinases (MAPKs, including ERK, JNK, and p38MAPK) is induced by incubation of HIV-1 gp160 with CD4+complement receptor type 2 (CR2)+ cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5599	NP_002741.1	mitogen-activated protein kinase 8 isoform JNK1 alpha1	9403476,11504923,12089333,12775419,15246824	2007-11-07 17:30	HIV-1 gp120 activates c-Jun N-terminal kinase (JNK) and p42 extracellular-regulated kinase (ERK) in primary human central nervous system (CNS) cells with an early peak of activation at 2 to 5 minutes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5599	NP_002741.1	mitogen-activated protein kinase 8 isoform JNK1 alpha1	11468147,11698270,12239168,12857973,12960231	2007-11-07 17:31	CCR5 and CXCR4 coreceptor engagement by HIV-1 gp120 in primary macrophages activates 2 members of the mitogen-activated protein kinase (MAPK) superfamily, c-Jun amino-terminal kinase and p38 MAPK
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5599	NP_002741.1	mitogen-activated protein kinase 8 isoform JNK1 alpha1	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	decreases phosphorylation of	9606	5599	NP_002741.1	mitogen-activated protein kinase 8 isoform JNK1 alpha1	12714584	2007-11-07 17:30	Pretreatment of CD4+ T cells with HIV-1 gp120 followed by stimulation with jacalin results in marked inhibition of phosphorylation of ERK2 as well as JNK
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	5599	NP_002741.1	mitogen-activated protein kinase 8 isoform JNK1 alpha1	16481105	2007-11-07 17:31	HIV-1 gp120 activates NMDA receptor directly and phosphorylates JNK through a gp120-mediated apoptotic pathway in human neuroblastoma cells
11676	155807	NP_057852.2	Vpr	activates	9606	5599	NP_620637.1	mitogen-activated protein kinase 8 isoform JNK1 alpha2	16243842,17158886	2007-11-07 17:29	Synthetic HIV-1 Vpr protein activates AP-1 (Jun/Fos), c-Jun N-terminal kinase (JNK), NF-kappaB, and MKK7 in both U937 cells and primary macrophages.
11676	155871	NP_057853.1	Tat	activates	9606	5599	NP_620637.1	mitogen-activated protein kinase 8 isoform JNK1 alpha2	9129988,9223324,9621077,9670954,10509564,10799874,11260070,11448159	2007-11-07 17:28	HIV-1 Tat activates c-jun (Activator Protein-1; AP-1) through the activation of JNK, an effect mediated through the activation of p56lck
11676	155871	NP_057853.1	Tat	activates	9606	5599	NP_620637.1	mitogen-activated protein kinase 8 isoform JNK1 alpha2	12023963	2007-11-07 17:28	Activation of JNK by HIV-1 Tat is mediated by TRAF4
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5599	NP_620637.1	mitogen-activated protein kinase 8 isoform JNK1 alpha2	16395283	2007-11-07 17:29	Treatment with HIV-1 Tat induces phosphorylation of ERK1/2 and JNK in brain microvascular endothelial cells (BMEC) and astrocytes, which mediates Tat-induced multidrug resistance-associated protein 1 (MRP1) expression
11676	156110	NP_057857.2	Nef	activates	9606	5599	NP_620637.1	mitogen-activated protein kinase 8 isoform JNK1 alpha2	10394361,11153078	2007-11-07 17:28	HIV-1 Nef activates c-jun nuclear kinase (JNK) in human glial cells and the resulting activation promotes cell proliferation
11676	156110	NP_057857.2	Nef	activates	9606	5599	NP_620637.1	mitogen-activated protein kinase 8 isoform JNK1 alpha2	10394361,14597672	2007-11-07 17:29	The interaction between HIV-1 Nef and Vav leads to the activation of c-Jun N-terminal kinase (JNK)
11676	156110	NP_057857.2	Nef	activates	9606	5599	NP_620637.1	mitogen-activated protein kinase 8 isoform JNK1 alpha2	15827086	2007-11-07 17:28	Using genetic and immunohistochemical studies in Drosophila transgenic lines, wild-type HIV-1 Nef demonstrates induction of JNK activation and apoptotic activities
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5600	NP_002742.3	mitogen-activated protein kinase 11	12239168	2007-11-07 17:31	HIV-1 gp120 binding to CD4 results in activation of the mitogen-activated protein kinase (MAPK) in CD4(+) lymphocytes prestimulated through their T-cell receptor (TCR)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5601	NP_002743.3	mitogen-activated protein kinase 9 isoform JNK2 alpha2	9045910	2007-11-07 17:31	Pre-incubation of CD4+ T lymphocytes with anti-CD4 mAb or HIV-1 gp160 inhibits the activation of c-Jun N-terminal kinases (JNK) and extracellular signal-regulated protein kinase 2 (ERK2) in response to phorbol 12-myristate 13-acetate and ionomycin
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5601	NP_002743.3	mitogen-activated protein kinase 9 isoform JNK2 alpha2	15603708	2007-11-07 17:31	The activation of mitogen-activated protein kinases (MAPKs, including ERK, JNK, and p38MAPK) is induced by incubation of HIV-1 gp160 with CD4+complement receptor type 2 (CR2)+ cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5601	NP_002743.3	mitogen-activated protein kinase 9 isoform JNK2 alpha2	9403476,11504923,12089333,12775419,15246824	2007-11-07 17:30	HIV-1 gp120 activates c-Jun N-terminal kinase (JNK) and p42 extracellular-regulated kinase (ERK) in primary human central nervous system (CNS) cells with an early peak of activation at 2 to 5 minutes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5601	NP_002743.3	mitogen-activated protein kinase 9 isoform JNK2 alpha2	11468147,11698270,12239168,12857973,12960231	2007-11-07 17:31	CCR5 and CXCR4 coreceptor engagement by HIV-1 gp120 in primary macrophages activates 2 members of the mitogen-activated protein kinase (MAPK) superfamily, c-Jun amino-terminal kinase and p38 MAPK
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	decreases phosphorylation of	9606	5601	NP_002743.3	mitogen-activated protein kinase 9 isoform JNK2 alpha2	12714584	2007-11-07 17:30	Pretreatment of CD4+ T cells with HIV-1 gp120 followed by stimulation with jacalin results in marked inhibition of phosphorylation of ERK2 as well as JNK
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	5601	NP_002743.3	mitogen-activated protein kinase 9 isoform JNK2 alpha2	16481105	2007-11-07 17:31	HIV-1 gp120 activates NMDA receptor directly and phosphorylates JNK through a gp120-mediated apoptotic pathway in human neuroblastoma cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibits	9606	5602	NP_002744.1	mitogen-activated protein kinase 10 isoform 1	9045910	2007-11-07 17:31	Pre-incubation of CD4+ T lymphocytes with anti-CD4 mAb or HIV-1 gp160 inhibits the activation of c-Jun N-terminal kinases (JNK) and extracellular signal-regulated protein kinase 2 (ERK2) in response to phorbol 12-myristate 13-acetate and ionomycin
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	activates	9606	5602	NP_002744.1	mitogen-activated protein kinase 10 isoform 1	15603708	2007-11-07 17:31	The activation of mitogen-activated protein kinases (MAPKs, including ERK, JNK, and p38MAPK) is induced by incubation of HIV-1 gp160 with CD4+complement receptor type 2 (CR2)+ cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5602	NP_002744.1	mitogen-activated protein kinase 10 isoform 1	9403476,11504923,12089333,12775419,15246824	2007-11-07 17:29	HIV-1 gp120 activates c-Jun N-terminal kinase (JNK) and p42 extracellular-regulated kinase (ERK) in primary human central nervous system (CNS) cells with an early peak of activation at 2 to 5 minutes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5602	NP_002744.1	mitogen-activated protein kinase 10 isoform 1	11468147,11698270,12239168,12857973,12960231	2007-11-07 17:31	CCR5 and CXCR4 coreceptor engagement by HIV-1 gp120 in primary macrophages activates 2 members of the mitogen-activated protein kinase (MAPK) superfamily, c-Jun amino-terminal kinase and p38 MAPK
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	decreases phosphorylation of	9606	5602	NP_002744.1	mitogen-activated protein kinase 10 isoform 1	12714584	2007-11-07 17:30	Pretreatment of CD4+ T cells with HIV-1 gp120 followed by stimulation with jacalin results in marked inhibition of phosphorylation of ERK2 as well as JNK
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	5602	NP_002744.1	mitogen-activated protein kinase 10 isoform 1	16481105	2007-11-07 17:31	HIV-1 gp120 activates NMDA receptor directly and phosphorylates JNK through a gp120-mediated apoptotic pathway in human neuroblastoma cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5603	NP_002745.1	mitogen-activated protein kinase 13	12239168	2007-11-07 17:31	HIV-1 gp120 binding to CD4 results in activation of the mitogen-activated protein kinase (MAPK) in CD4(+) lymphocytes prestimulated through their T-cell receptor (TCR)
11676	155348	NP_705927.1	reverse transcriptase	interacts with	9606	5604	NP_002746.1	dual specificity mitogen-activated protein kinase kinase 1	9564043	2007-11-07 17:29	MEK1 in HIV-1 producer cells is able to activate virion-associated MAPK in trans, and the activated MAPK facilitates efficient disengagement of the HIV-1 reverse transcription complex from the cell membrane and subsequent nuclear translocation
11676	155871	NP_057853.1	Tat	activates	9606	5604	NP_002746.1	dual specificity mitogen-activated protein kinase kinase 1	9223324,9325171,9558095,9621077,10509564,10780709,10799874,10982368,11044099,11260070,11409852,11579140,12167619,12482669	2007-11-07 17:28	HIV-1 Tat activates mitogen-activated protein kinases ERK1 and ERK2 through the activation of MEK1 and MEK2, leading to induction of IL-8, IL-10, IP-10, iNOS, superoxide and TNF-alpha, as well as the activation of CREB and increased albumin permeability
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5604	NP_002746.1	dual specificity mitogen-activated protein kinase kinase 1	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	156110	NP_057857.2	Nef	upregulates	9606	5604	NP_002746.1	dual specificity mitogen-activated protein kinase kinase 1	11726657,15638726,16454711	2007-11-07 17:28	HIV-1 Nef expression in primary T cells upregulates MEK1/2 activities, which induces the increased phosphorylation of ERK1/2
11676	155807	NP_057852.2	Vpr	downregulates	9606	5605	NP_109587.1	dual specificity mitogen-activated protein kinase kinase 2	16103188	2007-11-07 17:28	HIV-1 Vpr downregulates expression of genes involved in the MEK2-ERK pathway, including MAP2K2 (MEK2) and MKNK2
11676	155807	NP_057852.2	Vpr	decreases phosphorylation of	9606	5605	NP_109587.1	dual specificity mitogen-activated protein kinase kinase 2	16103188	2007-11-07 17:31	Overexpression of HIV-1 Vpr decreases phosphorylation of MEK2
11676	155871	NP_057853.1	Tat	activates	9606	5605	NP_109587.1	dual specificity mitogen-activated protein kinase kinase 2	9223324,9325171,9558095,9621077,10509564,10780709,10799874,10982368,11044099,11260070,11409852,11579140,12167619,12482669	2007-11-07 17:28	HIV-1 Tat activates mitogen-activated protein kinases ERK1 and ERK2 through the activation of MEK1 and MEK2, leading to induction of IL-8, IL-10, IP-10, iNOS, superoxide and TNF-alpha, as well as the activation of CREB and increased albumin permeability
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5605	NP_109587.1	dual specificity mitogen-activated protein kinase kinase 2	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	156110	NP_057857.2	Nef	upregulates	9606	5605	NP_109587.1	dual specificity mitogen-activated protein kinase kinase 2	11726657,15638726,16454711	2007-11-07 17:29	HIV-1 Nef expression in primary T cells upregulates MEK1/2 activities, which induces the increased phosphorylation of ERK1/2
11676	155807	NP_057852.2	Vpr	activates	9606	5609	NP_660186.1	dual specificity mitogen-activated protein kinase kinase 7	16243842	2007-11-07 17:29	Synthetic HIV-1 Vpr protein activates AP-1 (Jun/Fos), c-Jun N-terminal kinase (JNK), NF-kappaB, and MKK7 in both U937 cells and primary macrophages.
11676	155871	NP_057853.1	Tat	interacts with	9606	5610	NP_002750.1	interferon-induced, double-stranded RNA-activated protein kinase isoform a	1708818	2007-11-07 17:28	HIV-1 Tat interacts with interferon-inducible enzymes 2-5A synthetase and dsRNA-dependent protein kinase to influence the rate of translation and protein synthesis in vitro
11676	155871	NP_057853.1	Tat	downregulates	9606	5610	NP_002750.1	interferon-induced, double-stranded RNA-activated protein kinase isoform a	2180064	2007-11-07 17:28	HIV-1 Tat downregulates the steady-state amount of p68 kinase (PKR) in interferon-treated HeLa cells stably expressing Tat
11676	155871	NP_057853.1	Tat	binds	9606	5610	NP_002750.1	interferon-induced, double-stranded RNA-activated protein kinase isoform a	7491766,9079663,10620360	2007-11-07 17:28	Binding of HIV-1 Tat to PKR has been mapped to residues 40-58 of Tat, overlapping the hydrophobic core and basic region of Tat
11676	155871	NP_057853.1	Tat	inhibits	9606	5610	NP_002750.1	interferon-induced, double-stranded RNA-activated protein kinase isoform a	7491766,9079663,10620360	2007-11-07 17:28	HIV-1 Tat inhibits the activation, activity and autophosphorylation of PKR, suggesting a potential mechanism by which HIV could suppress the interferon system
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5610	NP_002750.1	interferon-induced, double-stranded RNA-activated protein kinase isoform a	7491766,9079663,9735304,15737233	2007-11-07 17:28	HIV-1 Tat is phosphorylated by PKR on serine 62, threonine 64 and serine 68
11676	155871	NP_057853.1	Tat	enhanced by	9606	5610	NP_002750.1	interferon-induced, double-stranded RNA-activated protein kinase isoform a	10400814	2007-11-07 17:28	PKR enhances HIV-1 Tat-mediated activation of NF-kappaB activation and transcriptional induction of the HIV-1 LTR promoter in the murine HL3T1 cell line
11676	155871	NP_057853.1	Tat	upregulates	9606	5610	NP_002750.1	interferon-induced, double-stranded RNA-activated protein kinase isoform a	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including PKR, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	5610	NP_002750.1	interferon-induced, double-stranded RNA-activated protein kinase isoform a	15737233	2007-11-07 17:28	Mutations in HIV-1 Tat that prevent Tat phosphorylation by PKR result in an up to 4-fold decrease in HIV-1 LTR transactivation by Tat
11676	155871	NP_057853.1	Tat	activates	9606	5610	NP_002750.1	interferon-induced, double-stranded RNA-activated protein kinase isoform a	15907845	2007-11-07 17:28	HIV-1 Tat-induction of IL-10 dysregulation is associated with PKR activation in primary blood monocytes
11676	155871	NP_057853.1	Tat	upregulates	9606	5621	NP_000302.1	major prion protein preproprotein	1351748	2007-11-07 17:30	HIV-1 Tat binds to a stem-loop structure in the mRNA of prion protein (PrP) that is similar to HIV-1 TAR RNA and infection of astrocytes with HIV-1 results in an increased level of PrP mRNA, suggesting Tat upregulates PrP expression
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaved by	9606	5644	NP_002760.1	trypsin-1 preproprotein	1763044	2007-11-07 17:30	Cleavage of HIV-1 gp120 with trypsin at residue 432 destroys CD4 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaved by	9606	5645	NP_002761.1	trypsin-2 preproprotein	1763044	2007-11-07 17:30	Cleavage of HIV-1 gp120 with trypsin at residue 432 destroys CD4 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5645	NP_002761.1	trypsin-2 preproprotein	12775419	2007-11-07 17:30	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155348	NP_705928.1	integrase	degraded by	9606	5682	NP_002777.1	proteasome subunit alpha type-1 isoform 2	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5682	NP_002777.1	proteasome subunit alpha type-1 isoform 2	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5682	NP_002777.1	proteasome subunit alpha type-1 isoform 2	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5682	NP_002777.1	proteasome subunit alpha type-1 isoform 2	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5682	NP_002777.1	proteasome subunit alpha type-1 isoform 2	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5682	NP_002777.1	proteasome subunit alpha type-1 isoform 2	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5683	NP_002778.1	proteasome subunit alpha type-2	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5683	NP_002778.1	proteasome subunit alpha type-2	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5683	NP_002778.1	proteasome subunit alpha type-2	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5683	NP_002778.1	proteasome subunit alpha type-2	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5683	NP_002778.1	proteasome subunit alpha type-2	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5683	NP_002778.1	proteasome subunit alpha type-2	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5684	NP_002779.1	proteasome subunit alpha type-3 isoform 1	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5684	NP_002779.1	proteasome subunit alpha type-3 isoform 1	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5684	NP_002779.1	proteasome subunit alpha type-3 isoform 1	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5684	NP_002779.1	proteasome subunit alpha type-3 isoform 1	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5684	NP_002779.1	proteasome subunit alpha type-3 isoform 1	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5684	NP_002779.1	proteasome subunit alpha type-3 isoform 1	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5685	NP_002780.1	proteasome subunit alpha type-4 isoform 1	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5685	NP_002780.1	proteasome subunit alpha type-4 isoform 1	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5685	NP_002780.1	proteasome subunit alpha type-4 isoform 1	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5685	NP_002780.1	proteasome subunit alpha type-4 isoform 1	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5685	NP_002780.1	proteasome subunit alpha type-4 isoform 1	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5685	NP_002780.1	proteasome subunit alpha type-4 isoform 1	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5686	NP_002781.2	proteasome subunit alpha type-5	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5686	NP_002781.2	proteasome subunit alpha type-5	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5686	NP_002781.2	proteasome subunit alpha type-5	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5686	NP_002781.2	proteasome subunit alpha type-5	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5686	NP_002781.2	proteasome subunit alpha type-5	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5686	NP_002781.2	proteasome subunit alpha type-5	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5687	NP_002782.1	proteasome subunit alpha type-6	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5687	NP_002782.1	proteasome subunit alpha type-6	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5687	NP_002782.1	proteasome subunit alpha type-6	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5687	NP_002782.1	proteasome subunit alpha type-6	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5687	NP_002782.1	proteasome subunit alpha type-6	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5687	NP_002782.1	proteasome subunit alpha type-6	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5688	NP_002783.1	proteasome subunit alpha type-7	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5688	NP_002783.1	proteasome subunit alpha type-7	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5688	NP_002783.1	proteasome subunit alpha type-7	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5688	NP_002783.1	proteasome subunit alpha type-7	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5688	NP_002783.1	proteasome subunit alpha type-7	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5688	NP_002783.1	proteasome subunit alpha type-7	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5689	NP_002784.1	proteasome subunit beta type-1 precursor	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5689	NP_002784.1	proteasome subunit beta type-1 precursor	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5689	NP_002784.1	proteasome subunit beta type-1 precursor	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5689	NP_002784.1	proteasome subunit beta type-1 precursor	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5689	NP_002784.1	proteasome subunit beta type-1 precursor	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5689	NP_002784.1	proteasome subunit beta type-1 precursor	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5690	NP_002785.1	proteasome subunit beta type-2	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5690	NP_002785.1	proteasome subunit beta type-2	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5690	NP_002785.1	proteasome subunit beta type-2	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5690	NP_002785.1	proteasome subunit beta type-2	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5690	NP_002785.1	proteasome subunit beta type-2	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5690	NP_002785.1	proteasome subunit beta type-2	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5691	NP_002786.2	proteasome subunit beta type-3	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5691	NP_002786.2	proteasome subunit beta type-3	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5691	NP_002786.2	proteasome subunit beta type-3	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5691	NP_002786.2	proteasome subunit beta type-3	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5691	NP_002786.2	proteasome subunit beta type-3	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5691	NP_002786.2	proteasome subunit beta type-3	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5692	NP_002787.2	proteasome subunit beta type-4	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5692	NP_002787.2	proteasome subunit beta type-4	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5692	NP_002787.2	proteasome subunit beta type-4	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5692	NP_002787.2	proteasome subunit beta type-4	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5692	NP_002787.2	proteasome subunit beta type-4	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5692	NP_002787.2	proteasome subunit beta type-4	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	156110	NP_057857.2	Nef	binds	9606	5692	NP_002787.2	proteasome subunit beta type-4	9344905	2007-11-07 17:28	Amino acids 34-143 of HIV-1 Nef mediate its binding to amino acids 73-249 of the HsN3 proteasomal subunit
11676	156110	NP_057857.2	Nef	downregulates	9606	5692	NP_002787.2	proteasome subunit beta type-4	9344905	2007-11-07 17:28	HIV-1 Nef was found to markedly downregulate intracellular levels of both a co-expressed HsN3 and the endogenous simian homologue, suggesting Nef may alter proteasome function in infected cells
11676	155348	NP_705928.1	integrase	degraded by	9606	5693	NP_002788.1	proteasome subunit beta type-5 isoform 1	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5693	NP_002788.1	proteasome subunit beta type-5 isoform 1	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5693	NP_002788.1	proteasome subunit beta type-5 isoform 1	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5693	NP_002788.1	proteasome subunit beta type-5 isoform 1	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5693	NP_002788.1	proteasome subunit beta type-5 isoform 1	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5693	NP_002788.1	proteasome subunit beta type-5 isoform 1	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5694	NP_002789.1	proteasome subunit beta type-6 precursor	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5694	NP_002789.1	proteasome subunit beta type-6 precursor	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5694	NP_002789.1	proteasome subunit beta type-6 precursor	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5694	NP_002789.1	proteasome subunit beta type-6 precursor	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5694	NP_002789.1	proteasome subunit beta type-6 precursor	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5694	NP_002789.1	proteasome subunit beta type-6 precursor	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5695	NP_002790.1	proteasome subunit beta type-7 proprotein	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5695	NP_002790.1	proteasome subunit beta type-7 proprotein	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5695	NP_002790.1	proteasome subunit beta type-7 proprotein	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5695	NP_002790.1	proteasome subunit beta type-7 proprotein	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5695	NP_002790.1	proteasome subunit beta type-7 proprotein	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5695	NP_002790.1	proteasome subunit beta type-7 proprotein	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705927.1	reverse transcriptase	degraded by	9606	5696	NP_004150.1	proteasome subunit beta type-8 isoform E1 proprotein	10358150	2007-11-07 17:29	Up-regulation of LMP7 by IFN-gamma enhances proteasomal degradation of HIV-1 RT and presentation of the VIYQYMDDL epitope derived from HIV-1 RT
11676	155348	NP_705928.1	integrase	degraded by	9606	5696	NP_004150.1	proteasome subunit beta type-8 isoform E1 proprotein	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5696	NP_004150.1	proteasome subunit beta type-8 isoform E1 proprotein	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5696	NP_004150.1	proteasome subunit beta type-8 isoform E1 proprotein	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5696	NP_004150.1	proteasome subunit beta type-8 isoform E1 proprotein	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5696	NP_004150.1	proteasome subunit beta type-8 isoform E1 proprotein	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5696	NP_004150.1	proteasome subunit beta type-8 isoform E1 proprotein	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155871	NP_057853.1	Tat	upregulates	9606	5696	NP_004150.1	proteasome subunit beta type-8 isoform E1 proprotein	15356131	2007-11-07 17:28	HIV-1 Tat upregulates LMP7 and MECL1 catalytic subunits of the proteasome resulting in a more efficient generation and presentation of subdominant MHC-I-binding CTL epitopes of heterologous Ags
11676	155348	NP_705928.1	integrase	degraded by	9606	5698	NP_002791.1	proteasome subunit beta type-9 proprotein	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5698	NP_002791.1	proteasome subunit beta type-9 proprotein	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5698	NP_002791.1	proteasome subunit beta type-9 proprotein	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5698	NP_002791.1	proteasome subunit beta type-9 proprotein	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5698	NP_002791.1	proteasome subunit beta type-9 proprotein	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5698	NP_002791.1	proteasome subunit beta type-9 proprotein	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155871	NP_057853.1	Tat	downregulates	9606	5698	NP_002791.1	proteasome subunit beta type-9 proprotein	16512786,16703666	2007-11-07 17:31	HIV-1 Tat represses transcription of the LMP2 gene by competing with STAT1 (signal transducer and activator of transcription 1) for binding to IRF-1 (interferon-regulatory factor-1) at the LMP2 promoter
11676	155348	NP_705928.1	integrase	degraded by	9606	5699	NP_002792.1	proteasome subunit beta type-10 proprotein	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5699	NP_002792.1	proteasome subunit beta type-10 proprotein	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5699	NP_002792.1	proteasome subunit beta type-10 proprotein	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5699	NP_002792.1	proteasome subunit beta type-10 proprotein	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5699	NP_002792.1	proteasome subunit beta type-10 proprotein	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	binds	9606	5699	NP_002792.1	proteasome subunit beta type-10 proprotein	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155871	NP_057853.1	Tat	upregulates	9606	5699	NP_002792.1	proteasome subunit beta type-10 proprotein	15356131	2007-11-07 17:28	HIV-1 Tat upregulates LMP7 and MECL1 catalytic subunits of the proteasome resulting in a more efficient generation and presentation of subdominant MHC-I-binding CTL epitopes of heterologous Ags
11676	155348	NP_705928.1	integrase	degraded by	9606	5700	NP_002793.2	26S protease regulatory subunit 4	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5700	NP_002793.2	26S protease regulatory subunit 4	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5700	NP_002793.2	26S protease regulatory subunit 4	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5700	NP_002793.2	26S protease regulatory subunit 4	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5700	NP_002793.2	26S protease regulatory subunit 4	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5700	NP_002793.2	26S protease regulatory subunit 4	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5701	NP_002794.1	26S protease regulatory subunit 7	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5701	NP_002794.1	26S protease regulatory subunit 7	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	stimulated by	9606	5701	NP_002794.1	26S protease regulatory subunit 7	1377363,7711076,8500623	2007-11-07 17:30	The MSS1 protein has been shown to stimulate HIV-1 Tat transactivation of the HIV-1 LTR promoter and based on sequence homology has been identified as subunit 7 of the 26S protease
11676	155871	NP_057853.1	Tat	inhibits	9606	5701	NP_002794.1	26S protease regulatory subunit 7	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5701	NP_002794.1	26S protease regulatory subunit 7	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5701	NP_002794.1	26S protease regulatory subunit 7	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5701	NP_002794.1	26S protease regulatory subunit 7	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5702	NP_002795.2	26S protease regulatory subunit 6A	10893419	2007-11-07 17:29	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5702	NP_002795.2	26S protease regulatory subunit 6A	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibited by	9606	5702	NP_002795.2	26S protease regulatory subunit 6A	2194290,8323548,8419915,8500623,9714759,11463857	2007-11-07 17:30	TBP1 is a member of the ATPase family and a component of the 26S proteasome, and is a transcriptional activator that interacts directly with HIV-1 Tat to specifically inhibit Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	inhibits	9606	5702	NP_002795.2	26S protease regulatory subunit 6A	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5702	NP_002795.2	26S protease regulatory subunit 6A	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	inhibited by	9606	5702	NP_002795.2	26S protease regulatory subunit 6A	9345291,10806355	2007-11-07 17:30	Inhibition of HIV-1 Tat function by TBP1 is enhanced by TBP1 interacting protein (TBPIP)
11676	155871	NP_057853.1	Tat	interacts with	9606	5702	NP_002795.2	26S protease regulatory subunit 6A	12419264	2007-11-07 17:28	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5702	NP_002795.2	26S protease regulatory subunit 6A	14550573	2007-11-07 17:28	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5704	NP_006494.1	26S protease regulatory subunit 6B isoform 1	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5704	NP_006494.1	26S protease regulatory subunit 6B isoform 1	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	interacts with	9606	5704	NP_006494.1	26S protease regulatory subunit 6B isoform 1	2194290,8323548,8419915,8500623,9714759,11463857	2007-11-07 17:30	TBP7 is a homolog of TBP1, a component of the 26S proteasome and a transcriptional activator that interacts with HIV-1 Tat to specifically inhibit Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	inhibits	9606	5704	NP_006494.1	26S protease regulatory subunit 6B isoform 1	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5704	NP_006494.1	26S protease regulatory subunit 6B isoform 1	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5704	NP_006494.1	26S protease regulatory subunit 6B isoform 1	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5704	NP_006494.1	26S protease regulatory subunit 6B isoform 1	14550573	2007-11-07 17:28	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5705	NP_002796.4	26S protease regulatory subunit 8	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5705	NP_002796.4	26S protease regulatory subunit 8	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	interacts with	9606	5705	NP_002796.4	26S protease regulatory subunit 8	2194290,8323548,8419915,8500623,9714759,11463857	2007-11-07 17:30	TBP10 (SUG1) is a homolog of TBP1, a component of the 26S proteasome and a transcriptional activator that interacts with HIV-1 Tat to specifically inhibit Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	inhibits	9606	5705	NP_002796.4	26S protease regulatory subunit 8	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5705	NP_002796.4	26S protease regulatory subunit 8	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5705	NP_002796.4	26S protease regulatory subunit 8	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5705	NP_002796.4	26S protease regulatory subunit 8	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5706	NP_002797.2	proteasome 26S ATPase subunit 6	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5706	NP_002797.2	proteasome 26S ATPase subunit 6	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5706	NP_002797.2	proteasome 26S ATPase subunit 6	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5706	NP_002797.2	proteasome 26S ATPase subunit 6	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5706	NP_002797.2	proteasome 26S ATPase subunit 6	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5706	NP_002797.2	proteasome 26S ATPase subunit 6	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5707	NP_002798.2	26S proteasome non-ATPase regulatory subunit 1	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5707	NP_002798.2	26S proteasome non-ATPase regulatory subunit 1	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5707	NP_002798.2	26S proteasome non-ATPase regulatory subunit 1	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5707	NP_002798.2	26S proteasome non-ATPase regulatory subunit 1	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5707	NP_002798.2	26S proteasome non-ATPase regulatory subunit 1	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5707	NP_002798.2	26S proteasome non-ATPase regulatory subunit 1	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5708	NP_002799.3	26S proteasome non-ATPase regulatory subunit 2	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5708	NP_002799.3	26S proteasome non-ATPase regulatory subunit 2	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5708	NP_002799.3	26S proteasome non-ATPase regulatory subunit 2	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5708	NP_002799.3	26S proteasome non-ATPase regulatory subunit 2	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5708	NP_002799.3	26S proteasome non-ATPase regulatory subunit 2	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5708	NP_002799.3	26S proteasome non-ATPase regulatory subunit 2	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5709	NP_002800.2	26S proteasome non-ATPase regulatory subunit 3	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5709	NP_002800.2	26S proteasome non-ATPase regulatory subunit 3	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5709	NP_002800.2	26S proteasome non-ATPase regulatory subunit 3	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5709	NP_002800.2	26S proteasome non-ATPase regulatory subunit 3	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5709	NP_002800.2	26S proteasome non-ATPase regulatory subunit 3	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5709	NP_002800.2	26S proteasome non-ATPase regulatory subunit 3	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5710	NP_002801.1	26S proteasome non-ATPase regulatory subunit 4	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5710	NP_002801.1	26S proteasome non-ATPase regulatory subunit 4	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:29	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5710	NP_002801.1	26S proteasome non-ATPase regulatory subunit 4	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5710	NP_002801.1	26S proteasome non-ATPase regulatory subunit 4	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5710	NP_002801.1	26S proteasome non-ATPase regulatory subunit 4	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5710	NP_002801.1	26S proteasome non-ATPase regulatory subunit 4	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5711	NP_005038.1	26S proteasome non-ATPase regulatory subunit 5	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5711	NP_005038.1	26S proteasome non-ATPase regulatory subunit 5	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:29	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5711	NP_005038.1	26S proteasome non-ATPase regulatory subunit 5	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5711	NP_005038.1	26S proteasome non-ATPase regulatory subunit 5	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5711	NP_005038.1	26S proteasome non-ATPase regulatory subunit 5	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5711	NP_005038.1	26S proteasome non-ATPase regulatory subunit 5	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5713	NP_002802.2	26S proteasome non-ATPase regulatory subunit 7	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5713	NP_002802.2	26S proteasome non-ATPase regulatory subunit 7	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:29	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5713	NP_002802.2	26S proteasome non-ATPase regulatory subunit 7	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5713	NP_002802.2	26S proteasome non-ATPase regulatory subunit 7	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5713	NP_002802.2	26S proteasome non-ATPase regulatory subunit 7	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5713	NP_002802.2	26S proteasome non-ATPase regulatory subunit 7	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5714	NP_002803.1	proteasome 26S non-ATPase subunit 8	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5714	NP_002803.1	proteasome 26S non-ATPase subunit 8	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:29	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5714	NP_002803.1	proteasome 26S non-ATPase subunit 8	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5714	NP_002803.1	proteasome 26S non-ATPase subunit 8	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5714	NP_002803.1	proteasome 26S non-ATPase subunit 8	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5714	NP_002803.1	proteasome 26S non-ATPase subunit 8	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5715	NP_002804.2	26S proteasome non-ATPase regulatory subunit 9	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5715	NP_002804.2	26S proteasome non-ATPase regulatory subunit 9	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:29	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5715	NP_002804.2	26S proteasome non-ATPase regulatory subunit 9	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5715	NP_002804.2	26S proteasome non-ATPase regulatory subunit 9	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5715	NP_002804.2	26S proteasome non-ATPase regulatory subunit 9	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5715	NP_002804.2	26S proteasome non-ATPase regulatory subunit 9	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5716	NP_002805.1	26S proteasome non-ATPase regulatory subunit 10 isoform 1	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5716	NP_002805.1	26S proteasome non-ATPase regulatory subunit 10 isoform 1	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:29	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5716	NP_002805.1	26S proteasome non-ATPase regulatory subunit 10 isoform 1	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5716	NP_002805.1	26S proteasome non-ATPase regulatory subunit 10 isoform 1	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5716	NP_002805.1	26S proteasome non-ATPase regulatory subunit 10 isoform 1	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5716	NP_002805.1	26S proteasome non-ATPase regulatory subunit 10 isoform 1	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5717	NP_002806.2	26S proteasome non-ATPase regulatory subunit 11	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5717	NP_002806.2	26S proteasome non-ATPase regulatory subunit 11	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:29	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5717	NP_002806.2	26S proteasome non-ATPase regulatory subunit 11	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5717	NP_002806.2	26S proteasome non-ATPase regulatory subunit 11	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5717	NP_002806.2	26S proteasome non-ATPase regulatory subunit 11	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5717	NP_002806.2	26S proteasome non-ATPase regulatory subunit 11	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5718	NP_002807.1	26S proteasome non-ATPase regulatory subunit 12 isoform 1	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5718	NP_002807.1	26S proteasome non-ATPase regulatory subunit 12 isoform 1	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:29	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5718	NP_002807.1	26S proteasome non-ATPase regulatory subunit 12 isoform 1	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5718	NP_002807.1	26S proteasome non-ATPase regulatory subunit 12 isoform 1	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5718	NP_002807.1	26S proteasome non-ATPase regulatory subunit 12 isoform 1	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5718	NP_002807.1	26S proteasome non-ATPase regulatory subunit 12 isoform 1	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5719	NP_002808.2	proteasome 26S non-ATPase subunit 13 isoform 1	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5719	NP_002808.2	proteasome 26S non-ATPase subunit 13 isoform 1	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5719	NP_002808.2	proteasome 26S non-ATPase subunit 13 isoform 1	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5719	NP_002808.2	proteasome 26S non-ATPase subunit 13 isoform 1	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5719	NP_002808.2	proteasome 26S non-ATPase subunit 13 isoform 1	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5719	NP_002808.2	proteasome 26S non-ATPase subunit 13 isoform 1	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5720	NP_006254.1	proteasome activator complex subunit 1 isoform 1	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5720	NP_006254.1	proteasome activator complex subunit 1 isoform 1	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5720	NP_006254.1	proteasome activator complex subunit 1 isoform 1	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5720	NP_006254.1	proteasome activator complex subunit 1 isoform 1	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5720	NP_006254.1	proteasome activator complex subunit 1 isoform 1	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5720	NP_006254.1	proteasome activator complex subunit 1 isoform 1	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155348	NP_705928.1	integrase	degraded by	9606	5721	NP_002809.2	proteasome activator complex subunit 2	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	5721	NP_002809.2	proteasome activator complex subunit 2	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	5721	NP_002809.2	proteasome activator complex subunit 2	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	5721	NP_002809.2	proteasome activator complex subunit 2	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	5721	NP_002809.2	proteasome activator complex subunit 2	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	5721	NP_002809.2	proteasome activator complex subunit 2	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155871	NP_057853.1	Tat	interacts with	9606	5725	NP_002810.1	polypyrimidine tract-binding protein 1 isoform a	8626763	2007-11-07 17:30	Polypyrimidine tract-binding protein (PTB) stimulates the binding of RNA Polymerase II and TRP-185 to HIV-1 TAR RNA, suggesting an interaction between PTB and HIV-1 Tat
11676	155908	NP_057854.1	Rev	interacts with	9606	5725	NP_002810.1	polypyrimidine tract-binding protein 1 isoform a	8883365	2007-11-07 17:27	hnRNP I binds to cis-acting repressive (CRS) sequences in HIV-1 RNA suggesting a role for this binding in influencing Rev function
11676	155871	NP_057853.1	Tat	enhanced by	9606	5728	NP_000305.3	phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	12077252	2007-11-07 17:28	Inhibiting phosphatidylinositol 3-kinase by overexpressing PTEN phosphatase enhances HIV-1 Tat transactivation of the viral LTR promoter
11676	155871	NP_057853.1	Tat	downregulates	9606	5728	NP_000305.3	phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5742	NP_000953.2	prostaglandin G/H synthase 1 isoform 1 precursor	7521167,8581564,9639560,12354292	2007-11-07 17:30	Preincubation of human astrocytoma cells with HIV-1 gp120 produces a significant increase of nitrite and PGE2 in cell supernatants; the effect of gp120 on both nitrite and PGE2 production is inhibited by antagonists of NO synthase or cyclooxygenase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5742	NP_000953.2	prostaglandin G/H synthase 1 isoform 1 precursor	9639560,12354292	2007-11-07 17:31	HIV-1 gp120 increases the intracellular concentrations of prostaglandin E2 and leukotriene B4 by upregulating the activity and expression of the arachidonate-metabolizing enzymes prostaglandin H synthase and 5-lipoxygenase, respectively
11676	155871	NP_057853.1	Tat	upregulates	9606	5743	NP_000954.1	prostaglandin G/H synthase 2 precursor	16941353	2007-11-07 17:31	HIV-1 Tat-induced cyclooxygenase (COX)-2 expression and prostaglandin E2 (PGE2) synthesis increase Leishmania growth in HIV-1-infected macrophages
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5743	NP_000954.1	prostaglandin G/H synthase 2 precursor	7521167,8581564,9639560,12354292	2007-11-07 17:30	Preincubation of human astrocytoma cells with HIV-1 gp120 produces a significant increase of nitrite and PGE2 in cell supernatants; the effect of gp120 on both nitrite and PGE2 production is inhibited by antagonists of NO synthase or cyclooxygenase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5743	NP_000954.1	prostaglandin G/H synthase 2 precursor	9639560,12354292	2007-11-07 17:31	HIV-1 gp120 increases the intracellular concentrations of prostaglandin E2 and leukotriene B4 by upregulating the activity and expression of the arachidonate-metabolizing enzymes prostaglandin H synthase and 5-lipoxygenase, respectively
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5743	NP_000954.1	prostaglandin G/H synthase 2 precursor	16001969	2007-11-07 17:31	HIV-1 envelope protein gp120 is able to induce COX-2 mRNA and protein in human neuroblastoma cell lines that express CXCR4 and CCR5 but not CD4; gp120 induces COX-2 promoter transcription through NF-kappaB and activating protein-1 (AP-1) sites
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5743	NP_000954.1	prostaglandin G/H synthase 2 precursor	16001969	2007-11-07 17:31	Overexpression of NF-kappaB inhibitory subunit, IkappaBalpha, completely abrogates gp120-induced COX-2 activity
11676	155871	NP_057853.1	Tat	upregulates	9606	5747	NP_722560.1	focal adhesion kinase 1 isoform a	9708406	2007-11-07 17:28	HIV-1 Tat upregulates p125FAK and induces the tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 neuronal cells
11676	155871	NP_057853.1	Tat	phosphorylates	9606	5747	NP_722560.1	focal adhesion kinase 1 isoform a	15528360	2007-11-07 17:28	Focal adhesion kinase (FAK) is tyrosine-phosphorylated by Tat, and inhibition of FAK by the dominant interfering mutant form, FAK-related nonkinase, significantly blocks HBMEC migration and disrupted focal adhesions upon Tat activation
11676	155871	NP_057853.1	Tat	activates	9606	5747	NP_722560.1	focal adhesion kinase 1 isoform a	16105876	2007-11-07 17:29	HIV-1 Tat exerts several pleiotropic effects by interacting with different cellular receptors, including integrin alpha(v)beta3, which triggers the activation of focal adhesion kinase, RhoA and pp60src
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5756	NP_002813.2	twinfilin-1	12775419	2007-11-07 17:31	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155908	NP_057854.1	Rev	binds	9606	5757	NP_002814.2	prothymosin, alpha (gene sequence 28)	7588773	2007-11-07 17:27	prothymosin alpha has been identified through the use of a Rev affinity column as specifically binding to the activation domain of Rev (amino acids 75-83)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	5781	NP_002825.3	tyrosine-protein phosphatase non-receptor type 11	12824191	2007-11-07 17:31	HCV-E2 and HIV-gp120 act collaboratively to trigger a specific set of downstream signaling pathways that include activation of p38 mitogen-activated protein (MAP) kinase and the tyrosine phosphatase, SHP2, in hepatocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5786	NP_002827.1	receptor-type tyrosine-protein phosphatase alpha isoform 1 precursor	9263011	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5787	NP_002828.2	protein tyrosine phosphatase, receptor type, B precursor	9263011	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5788	NP_002829.2	receptor-type tyrosine-protein phosphatase C isoform 1 precursor	7539755	2007-11-07 17:27	Treatment of CD4+ T cells with HIV-1 gp120 significantly increases CD4 association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreases that with CD45RC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5788	NP_002829.2	receptor-type tyrosine-protein phosphatase C isoform 1 precursor	11804554	2007-11-07 17:31	CD4(+)CD45RO(+) cells display high HIV-1 gp120-binding capacity, whereas CD4(+)CD45RO(-) cells show undetectable HIV-1 gp120 binding
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	5788	NP_002829.2	receptor-type tyrosine-protein phosphatase C isoform 1 precursor	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	5788	NP_002829.2	receptor-type tyrosine-protein phosphatase C isoform 1 precursor	16524887	2007-11-07 17:31	HIV-1 gp120-induced apoptosis is regulated by CD45 through inducing CD45 association with the HIV coreceptor CXCR4 in T cell lines and peripheral blood mononuclear cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5800	NP_109592.1	receptor-type tyrosine-protein phosphatase O isoform a precursor	9263011	2007-11-07 17:27	HIV-1 gp120 induces CD4 association with lymphocyte surface molecules CD3, CD11a, CD27, CD45RA, CD45RB, CD45RO, CD49d, CD38, CD26, CD59, CD95 and class I MHC molecules
11676	155871	NP_057853.1	Tat	regulated by	9606	5813	NP_005850.1	transcriptional activator protein Pur-alpha	8943069,9383706,10500218,10679817,10954586,11413364,11730934	2007-11-07 17:29	Puralpha interacts with HIV-1 Tat to regulate the effect of Tat transactivating the HIV-1 LTR promoter, as well as the JCV promoter and other cellular promoters
11676	155871	NP_057853.1	Tat	inhibits	9606	5813	NP_005850.1	transcriptional activator protein Pur-alpha	10412036	2007-11-07 17:29	Puralpha self-associates in an RNA dependent manner, an effect that is inhibited by HIV-1 Tat
11676	155871	NP_057853.1	Tat	binds	9606	5813	NP_005850.1	transcriptional activator protein Pur-alpha	10500218,10679817	2007-11-07 17:29	Binding of HIV-1 Tat to Puralpha is mediated through amino acids 49-72 of Tat and 100-121 of Puralpha, and is enhanced by RNA
11676	155871	NP_057853.1	Tat	inhibits	9606	5813	NP_005850.1	transcriptional activator protein Pur-alpha	11596104	2007-11-07 17:29	Puralpha-mediated inhibition of protein translation can be inhibited by HIV-1 Tat
11676	155871	NP_057853.1	Tat	cooperates with	9606	5813	NP_005850.1	transcriptional activator protein Pur-alpha	11730934	2007-11-07 17:29	HIV-1 Tat cooperates with Puralpha, cyclin T1, and CDK9 to activate the TNFalpha promoter and upregulate TNFalpha expression
11676	155871	NP_057853.1	Tat	binds	9606	5813	NP_005850.1	transcriptional activator protein Pur-alpha	12491158	2007-11-07 17:29	HIV-1 Tat downregulates the expression of p35, a neuron-specific activator of cdk5, and also binds to Puralpha, which associates with cdk5, leading to deregulation of neuronal differentiation and survival
11676	155871	NP_057853.1	Tat	inhibits	9606	5813	NP_005850.1	transcriptional activator protein Pur-alpha	16741963	2007-11-07 17:31	Expression of HIV-1 Tat in human SK-N-MC cells inhibits the NGF-signaling pathway leading to suppression of MAPK and reduction of Puralpha binding to the Egr-1 promoter
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5829	NP_002850.1	paxillin	9621077	2007-11-07 17:27	HIV-1 Tat stimulates the phosphorylation of paxillin and its association with RAFTK, an effect linked to Tat-induced angiogenesis and AIDS-related Kaposi's sarcoma
11676	155871	NP_057853.1	Tat	activates	9606	5879	NP_008839.2	ras-related C3 botulinum toxin substrate 1 isoform Rac1	16436505	2007-11-07 17:29	HIV-1 Tat activates the small GTPases Ras and Rac and the mitogen-activated protein kinase ERK when expressed in human endothelial cells; this effect is mediated through the arginine-glycine-aspartic (RGD) region of Tat
11676	155871	NP_057853.1	Tat	downregulates	9606	5879	NP_008839.2	ras-related C3 botulinum toxin substrate 1 isoform Rac1	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	156110	NP_057857.2	Nef	interacts with	9606	5879	NP_008839.2	ras-related C3 botulinum toxin substrate 1 isoform Rac1	8994833,16687395,17077296	2007-11-07 17:28	HIV-1 Nef binds and activates Nef-associated kinase via interactions with the small GTPases CDC42 and Rac1, which are required for optimal levels of Nef-dependent viral replication in vivo
11676	156110	NP_057857.2	Nef	activates	9606	5879	NP_008839.2	ras-related C3 botulinum toxin substrate 1 isoform Rac1	10394361,14597672	2007-11-07 17:28	HIV-1 Nef-mediated activation of Vav induces an increase of active Rac1 levels
11676	156110	NP_057857.2	Nef	Interacts with	9606	5879	NP_008839.2	ras-related C3 botulinum toxin substrate 1 isoform Rac1	14737186	2007-11-07 17:28	HIV-1 Nef interacts with Rac1 in a protein complex including DOCK2 and ELMO1
11676	155871	NP_057853.1	Tat	activates	9606	5880	NP_002863.1	ras-related C3 botulinum toxin substrate 2 precursor	16436505	2007-11-07 17:29	HIV-1 Tat activates the small GTPases Ras and Rac and the mitogen-activated protein kinase ERK when expressed in human endothelial cells; this effect is mediated through the arginine-glycine-aspartic (RGD) region of Tat
11676	155871	NP_057853.1	Tat	downregulates	9606	5880	NP_002863.1	ras-related C3 botulinum toxin substrate 2 precursor	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	156110	NP_057857.2	Nef	Interacts with	9606	5880	NP_002863.1	ras-related C3 botulinum toxin substrate 2 precursor	14737186	2007-11-07 17:28	Interaction of HIV-1 Nef with a protein complex, which includes Rac2, DOCK2, and ELMO1, activates Rac activity in T cells
11676	155807	NP_057852.2	Vpr	requires	9606	5884	NP_002864.1	cell cycle checkpoint protein RAD17 isoform 1	15485898,16354571	2007-11-07 17:28	Rad17 is required for HIV-1 Vpr-mediated G2 arrest in Rad17-specific siRNA-transfected cells
11676	155807	NP_057852.2	Vpr	binds	9606	5886	NP_005044.1	UV excision repair protein RAD23 homolog A	9371639,9636371,9846873,11087358,11259200,12079361,16120388	2007-11-07 17:28	Binding of HIV-1 Vpr (amino acids 25-77) to the UBA(2) domain of HHR23A (amino acids 319-363) affects the cell cycle arrest induced by Vpr
11676	155807	NP_057852.2	Vpr	inhibited by	9606	5886	NP_005044.1	UV excision repair protein RAD23 homolog A	9371639,9636371,11259200	2007-11-07 17:28	Two reports indicate overexpression of HHR23A can inhibit HIV-1 Vpr-induced cell cycle arrest, while a third report indicates Vpr binding to HHR23A does not correlate with the ability of Vpr to induce cell cycle arrest
11676	155807	NP_057852.2	Vpr	inhibits	9606	5886	NP_005044.1	UV excision repair protein RAD23 homolog A	11196199	2007-11-07 17:28	Co-expression of HIV-1 Vpr with HHR23A neutralizes inhibitory effects of HHR23A on p53 transcriptional activity
11676	155807	NP_057852.2	Vpr	binds	9606	5886	NP_005044.1	UV excision repair protein RAD23 homolog A	11426943	2007-11-07 17:28	Overexpression of HHR23A causes apoptosis of cells, suggesting that Vpr binding to HHR23A may be involved in Vpr-induced apoptosis
11676	155348	NP_705928.1	integrase	inhibited by	9606	5888	NP_002866.2	DNA repair protein RAD51 homolog 1 isoform 1	17090598	2007-11-07 17:31	RAD51 protein inhibits the integration catalyzed by HIV-1 integrase both in vitro and in yeast expressing integrase
11676	155807	NP_057852.2	Vpr	inhibits	9606	5888	NP_002866.2	DNA repair protein RAD51 homolog 1 isoform 1	16983346	2007-11-07 17:31	HIV-1 Vpr inhibits the interaction of p53 and Rad51 in chromatin fractions, as observed under irradiation-induced DNA double-strand breaks
11676	155807	NP_057852.2	Vpr	stimulates	9606	5888	NP_002866.2	DNA repair protein RAD51 homolog 1 isoform 1	16983346	2007-11-07 17:31	HIV-1 Vpr stimulates the focus formation of Rad51 and BRCA1, which are involved in repair of DNA double-strand breaks (DSBs) by homologous recombination (HR)
11676	155871	NP_057853.1	Tat	interacts with	9606	5888	NP_002866.2	DNA repair protein RAD51 homolog 1 isoform 1	9121429,16511829	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme, which includes HRAD51, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	upregulates	9606	5888	NP_002866.2	DNA repair protein RAD51 homolog 1 isoform 1	14755242	2007-11-07 17:28	In PC12 cells treated with genotoxic agents, HIV-1 Tat reduces DNA breakage and increases repair of DNA double-strand breaks through a mechanism involving the upregulation of Rad51, a key regulator of homologous recombination in cells
11676	155871	NP_057853.1	Tat	enhanced by	9606	5888	NP_002866.2	DNA repair protein RAD51 homolog 1 isoform 1	16511829	2007-11-07 17:31	Expression of Rad51 enhances basal- and HIV-1 Tat-induced transcription of the HIV-1 LTR promoter; this event requires cooperativity from the C/EBP family of transcription factors including C/EBPbeta and C/EBPbeta homologous protein (CHOP)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	5894	NP_002871.1	RAF proto-oncogene serine/threonine-protein kinase	8887682,9658081	2007-11-07 17:30	Binding of HIV-1 gp120 to CD4 molecules results in the association of Lck and Raf-1, which is abolished by preincubation of the virus with soluble CD4
11676	156110	NP_057857.2	Nef	binds	9606	5894	NP_002871.1	RAF proto-oncogene serine/threonine-protein kinase	9624170,11463741,12734410	2007-11-07 17:27	A conserved acidic sequence motif in HIV-1 Nef at positions 174-179 binds to c-Raf1; the interaction of Nef with c-Raf1 leads to a downstream transduction of cell signaling through the c-Raf1-MAP kinase pathway in vivo
11676	155030	NP_579876.2	matrix	regulated by	9606	5901	NP_006316.1	GTP-binding nuclear protein Ran	9562972	2007-11-07 17:28	Ran terminates the nuclear import of HIV-1 Matrix by directly binding to karyopherin beta and disassembling the import complex
11676	155908	NP_057854.1	Rev	binds	9606	5901	NP_006316.1	GTP-binding nuclear protein Ran	9837918	2007-11-07 17:27	binding of the GTP bound form of Ran (RanGTP) to a preformed Rev-CRM1 complex is linked to an interaction of RanGTP with the nuclear export signal (NES) of Rev (amino acids 75-83)
11676	155908	NP_057854.1	Rev	binds	9606	5901	NP_006316.1	GTP-binding nuclear protein Ran	9837918,10518602	2007-11-07 17:27	the GTP bound form of Ran (RanGTP) binds to a preformed Rev-CRM1 (exportin 1) complex to mediate nuclear export of HIV-1 mRNA
11676	155908	NP_057854.1	Rev	enhanced by	9606	5901	NP_006316.1	GTP-binding nuclear protein Ran	12134013	2007-11-07 17:27	Rev-Rev interactions (multimerization) are enhanced by RanGTP
11676	155908	NP_057854.1	Rev	competes with	9606	5902	NP_002873.1	ran-specific GTPase-activating protein	9111043	2007-11-07 17:27	RanBP1 competes with Rev for the same nuclear export pathway and as a result can affect Rev-mediated nuclear export of HIV-1 mRNA
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	5923	NP_002882.3	ras-specific guanine nucleotide-releasing factor 1 isoform 1	12775420	2007-11-07 17:31	Downregulation of guanine nucleotide-releasing protein, CD151/PETA-3, neuronatin, neuroendocrine differentiation factor, mitochondria 16s rRNA, and signal recognition particle is observed in HIV-1 infected and HIV-1 gp120-treated astrocytes
11676	155871	NP_057853.1	Tat	inhibited by	9606	5925	NP_000312.2	retinoblastoma-associated protein	8490568	2007-11-07 17:30	Co-expression of the human retinoblastoma gene in HeLa cells with HIV-1 Tat inhibits the Tat mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	decreases phosphorylation of	9606	5925	NP_000312.2	retinoblastoma-associated protein	9525916	2007-11-07 17:28	HIV-1 Tat induces a G1 arrest in cells of glial origin, leading to a downregulation of cyclin E-Cdk2 kinase activity and phosphorylation of Rb
11676	155871	NP_057853.1	Tat	activated by	9606	5925	NP_000312.2	retinoblastoma-associated protein	9525916	2007-11-07 17:28	The under-phosphorylated form of Rb that is prevalent in HIV-1 Tat treated glial cells activates HIV-1 transcription by a mechanism involving the NFkappaB enhancer in the viral LTR promoter, likely through promoting the interaction of Rb with E2F-1
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	5925	NP_000312.2	retinoblastoma-associated protein	15093750	2007-11-07 17:28	Tat-expressing EBV-positive B cells show downregulation of Bcl-2, and in serum starvation conditions display the Retinoblastoma (Rb) hyper-phosphorylated form, progress throughout the cell cycle, and retain the ability to grow in small clumps
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	decreases phosphorylation of	9606	5925	NP_000312.2	retinoblastoma-associated protein	9453249	2007-11-07 17:28	The V3 loop of HIV-1 gp120 induces G1 arrest in IL-2-dependent cell cycle progression by reducing cyclin E expression and phosphorylation of retinoblastoma protein (pRb)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5925	NP_000312.2	retinoblastoma-associated protein	15103018	2007-11-07 17:30	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	156110	NP_057857.2	Nef	upregulates	9606	5925	NP_000312.2	retinoblastoma-associated protein	12241561	2007-11-07 17:27	HIV-1 Nef is implicated in the upregulation of Cyclin D1, and subsequently phospho-pRb (Ser780), in infected podocytes and may be involved in the pathogenesis of HIV-associated nephropathy
11676	155871	NP_057853.1	Tat	binds	9606	5934	NP_005602.2	retinoblastoma-like 2 (p130)	12196924,13679860	2007-11-07 17:30	HIV-1 Tat protein specifically binds to pRb2/p130 and data suggest this interaction results in the deregulation of the control exerted by pRb2/p130 on the cell cycle, indicating a potential role in AIDS-related oncogenesis
11676	155871	NP_057853.1	Tat	inhibits	9606	5934	NP_005602.2	retinoblastoma-like 2 (p130)	13679860	2007-11-07 17:30	HIV-1 Tat can inhibit the growth control activity exerted by pRb2/p130 in the T98G cell line, and results show that pRb2/p130 mRNA levels increase in the presence of Tat, whereas no change in the phosphorylation status of pRb2/p130 is observed
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	5934	NP_005602.2	retinoblastoma-like 2 (p130)	15103018	2007-11-07 17:30	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	relocalizes	9606	5962	NP_002897.1	radixin	15818415	2007-11-07 17:31	Treatment of CD4+ T cells with HIV-1 gp120 induces CD95-mediated apoptosis, CD95/ERM protein (ezrin, radixin, moesin) colocalization and stable ezrin phosphorylation
11676	155871	NP_057853.1	Tat	interacts with	9606	5966	NP_002899.1	proto-oncogene c-Rel	1727488	2007-11-07 17:30	The c-rel protein is a strong activator of HIV-1 gene expression suggesting a possible interaction with HIV-1 Tat, however results from co-expression experiments did not detect synergy with Tat activation
11676	155871	NP_057853.1	Tat	upregulates	9606	5966	NP_002899.1	proto-oncogene c-Rel	9510190	2007-11-07 17:28	HIV-1 Tat upregulates c-rel and RelA transcription factor binding to the CD28-responsive element in the IL-8 promoter, leading to super-induction of IL-8
11676	155871	NP_057853.1	Tat	downregulates	9606	5966	NP_002899.1	proto-oncogene c-Rel	11254713	2007-11-07 17:28	HIV-1 Tat interacts with the cooperative rel/AP1 complex, downregulating its transactivation activity and leading to a decrease in IL-2 gene transcription
11676	155807	NP_057852.2	Vpr	activates	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	9560267	2007-11-07 17:27	Data suggests that HIV-1 Vpr acts in concert with Rel A and p300 to activate HIV transcription, possibly by Vpr effects on Cdc2 kinase activity
11676	155807	NP_057852.2	Vpr	inhibits	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	17023015	2007-11-07 17:31	HIV-1 Vpr inhibits the nuclear translocation of Rel A in infected T cells
11676	155871	NP_057853.1	Tat	activates	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	1505523,1583734,7494249,7729429,7800480,8615004,8676466,8709193,9525916,9566873,10384093,10644726,11511100,11704662,17031851	2007-11-07 17:28	HIV-1 Tat-mediated transcriptional activation of the HIV-1 LTR promoter requires NFkappaB binding sites in the promoter and involves the activation of NFkappaB by Tat
11676	155871	NP_057853.1	Tat	binds	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	7690421,7838536,10225209	2007-11-07 17:28	HIV-1 Tat has been shown to bind NFkappaB in vitro in gel shift, GST-pull down and affinity matrix assays
11676	155871	NP_057853.1	Tat	activates	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	7859743,9110146	2007-11-07 17:28	HIV-1 Tat enhances tumor necrosis factor-induced activation of NFkappaB by downregulating manganese-dependent superoxide dismutase (MnSOD)
11676	155871	NP_057853.1	Tat	activates	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	8113688,8207793,8627654,8724035,9278385,9510190,9730685,9792375,10384093,10446807,10480634,10580107,10644332,10671224,11044099,11160671,11241736,11385624,11522182,11579140,11827962,11833470,12167619,12427593,12473373,12482669,12485413	2007-11-07 17:28	HIV-1 Tat activates NFkappaB, causing the induction of CD95 ligand, CD69, iNOS, MCP-1, IL-2, IL-6, IL-8, IL-10, TNF-alpha, VCAM-1, ICAM-1, E-selectin, and MMP-9, as well as monocyte adhesion, cellular activation and angiogenesis
11676	155871	NP_057853.1	Tat	interacts with	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	8615004	2007-11-07 17:28	Inhibition of HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter by NFkappaB/Rel inhibitors correlates with their inhibitory activities on the RelA subunit of the NFkappaB complex, indicating an interaction of Tat with RelA
11676	155871	NP_057853.1	Tat	interacts with	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	8834464,10207088	2007-11-07 17:28	NFAT-1 negatively regulates HIV-1 Tat-mediated transactivation of the HIV-1 LTR by competing with NFkappaB for its binding to the LTR, thereby blocking the interaction of NFkappaB with Tat
11676	155871	NP_057853.1	Tat	upregulates	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	9510190	2007-11-07 17:28	HIV-1 Tat upregulates c-rel and RelA transcription factor binding to the CD28-responsive element in the IL-8 promoter, leading to super-induction of IL-8
11676	155871	NP_057853.1	Tat	recruits	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	9566873,14657027	2007-11-07 17:28	HIV-1 Tat recruits P/CAF to the integrated HIV-1 LTR promoter causing the acetylation of histones, which in turn leads to the recruitment the p65 subunit of NFkappaB to the promoter
11676	155871	NP_057853.1	Tat	activates	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	10393859	2007-11-07 17:28	Activation of NFkappaB by HIV-1 Tat is inhibited by Nitric Oxide
11676	155871	NP_057853.1	Tat	activates	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	10400814	2007-11-07 17:28	HIV-1 Tat activates NFkappaB through the cellular interferon-inducible, double-stranded RNA dependent protein kinase, PKR
11676	155871	NP_057853.1	Tat	activates	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	10799874	2007-11-07 17:28	p56-lck plays a critical role in the activation of NFkappaB by HIV-1 Tat
11676	155871	NP_057853.1	Tat	activates	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	11299302	2007-11-07 17:28	Activation of NFkappaB by HIV-1 Tat leads to a reduction in adenylyl cyclase activity and an inhibition of cAMP synthesis
11676	155871	NP_057853.1	Tat	regulated by	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	11704662	2007-11-07 17:28	NFkappaB tethers the p160 nuclear receptor co-activator GRIP1 to the HIV-1 LTR promoter, thereby regulating the full activation of this promoter by HIV-1 Tat
11676	155871	NP_057853.1	Tat	acetylates	9606	5970	NP_068810.2	v-rel reticuloendotheliosis viral oncogene homolog A	11739381,17031851	2007-11-07 17:28	HIV-1 Tat induces the acetylation of the NFkappaB p50 subunit as well as the p50/p65 complex by p300, causing an increase in NFkappaB DNA binding activity and in the rate of transcription
11676	155871	NP_057853.1	Tat	activates	9606	5971	NP_006500.2	transcription factor RelB	1505523,1583734,7494249,7729429,7800480,8615004,8676466,8709193,9525916,9566873,10384093,10644726,11511100,11704662	2007-11-07 17:27	HIV-1 Tat-mediated transcriptional activation of the HIV-1 LTR promoter requires NFkappaB binding sites in the promoter and involves the activation of NFkappaB by Tat
11676	155871	NP_057853.1	Tat	binds	9606	5971	NP_006500.2	transcription factor RelB	7690421,7838536,10225209	2007-11-07 17:28	HIV-1 Tat has been shown to bind NFkappaB in vitro in gel shift, GST-pull down and affinity matrix assays
11676	155871	NP_057853.1	Tat	activates	9606	5971	NP_006500.2	transcription factor RelB	7859743,9110146	2007-11-07 17:28	HIV-1 Tat enhances tumor necrosis factor-induced activation of NFkappaB by downregulating manganese-dependent superoxide dismutase (MnSOD)
11676	155871	NP_057853.1	Tat	activates	9606	5971	NP_006500.2	transcription factor RelB	8113688,8207793,8627654,8724035,9278385,9510190,9730685,9792375,10384093,10446807,10480634,10580107,10644332,10671224,11044099,11160671,11241736,11385624,11522182,11579140,11827962,11833470,12167619,12427593,12473373,12482669,12485413	2007-11-07 17:29	HIV-1 Tat activates NFkappaB, causing the induction of CD95 ligand, CD69, iNOS, MCP-1, IL-2, IL-6, IL-8, IL-10, TNF-alpha, VCAM-1, ICAM-1, E-selectin, and MMP-9, as well as monocyte adhesion, cellular activation and angiogenesis
11676	155871	NP_057853.1	Tat	interacts with	9606	5971	NP_006500.2	transcription factor RelB	8834464,10207088	2007-11-07 17:28	NFAT-1 negatively regulates HIV-1 Tat-mediated transactivation of the HIV-1 LTR by competing with NFkappaB for its binding to the LTR, thereby blocking the interaction of NFkappaB with Tat
11676	155871	NP_057853.1	Tat	activates	9606	5971	NP_006500.2	transcription factor RelB	10393859	2007-11-07 17:28	Activation of NFkappaB by HIV-1 Tat is inhibited by Nitric Oxide
11676	155871	NP_057853.1	Tat	activates	9606	5971	NP_006500.2	transcription factor RelB	10400814	2007-11-07 17:28	HIV-1 Tat activates NFkappaB through the cellular interferon-inducible, double-stranded RNA dependent protein kinase, PKR
11676	155871	NP_057853.1	Tat	activates	9606	5971	NP_006500.2	transcription factor RelB	10799874	2007-11-07 17:28	p56-lck plays a critical role in the activation of NFkappaB by HIV-1 Tat
11676	155871	NP_057853.1	Tat	activates	9606	5971	NP_006500.2	transcription factor RelB	11299302	2007-11-07 17:28	Activation of NFkappaB by HIV-1 Tat leads to a reduction in adenylyl cyclase activity and an inhibition of cAMP synthesis
11676	155871	NP_057853.1	Tat	regulated by	9606	5971	NP_006500.2	transcription factor RelB	11704662	2007-11-07 17:28	NFkappaB tethers the p160 nuclear receptor co-activator GRIP1 to the HIV-1 LTR promoter, thereby regulating the full activation of this promoter by HIV-1 Tat
11676	155871	NP_057853.1	Tat	interacts with	9606	5981	NP_002904.3	replication factor C subunit 1	9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme, which includes RFC, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	5982	NP_852136.1	replication factor C subunit 2 isoform 1	9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme, which includes RFC, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	5983	NP_002906.1	replication factor C subunit 3 isoform 1	9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme, which includes RFC, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	5984	NP_002907.1	replication factor C subunit 4	9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme, which includes RFC, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	5985	NP_031396.1	replication factor C subunit 5 isoform 1	9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme, which includes RFC, during Tat-mediated transactivation of the HIV-1 LTR
11676	155030	NP_057850.1	Pr55(Gag)	associates with	9606	6059	NP_002931.2	ATP-binding cassette sub-family E member 1	11780123,16275648	2007-11-07 17:29	HP68 associates post-translationally with HIV-1 Gag and Vif, an interaction that requires the Nucleocapsid domain of Gag and that is essential for assembly of immature HIV-1 capsids
11676	155030	NP_057850.1	Pr55(Gag)	interacts with	9606	6059	NP_002931.2	ATP-binding cassette sub-family E member 1	16275648	2007-11-07 17:29	The nucleocapsid (NC) domain of Gag is critical for interaction with endogenous ABCE1 in primate cells; basic residues in NC are critical for the Gag-ABCE1 interaction, while the cysteine and histidine residues in the zinc fingers are dispensable
11676	155459	NP_057851.1	Vif	associates with	9606	6059	NP_002931.2	ATP-binding cassette sub-family E member 1	11780123,12600646	2007-11-07 17:27	HuHP68 is essential for HIV-1 capsid assembly and associates with HIV-1 Vif in the form of an HuHP68 complex with HIV-1 Gag
11676	155348	NP_705927.1	reverse transcriptase	inhibited by	9606	6117	NP_002936.1	replication protein A 70 kDa DNA-binding subunit	9084803	2007-11-07 17:29	Replication protein A and HIV-1 nucleocapsid protein interfere with the strand displacement DNA synthesis of HIV-1 reverse transcriptase by binding to the displaced strand and keeping it away from the newly synthesized strand
11676	155807	NP_057852.2	Vpr	interacts with	9606	6117	NP_002936.1	replication protein A 70 kDa DNA-binding subunit	16306615	2007-11-07 17:29	HIV-1 Vpr-induced activation of ATR increases the chromatin binding of replication protein A (RPA)
11676	155871	NP_057853.1	Tat	interacts with	9606	6117	NP_002936.1	replication protein A 70 kDa DNA-binding subunit	9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme, which includes RPA, during Tat-mediated transactivation of the HIV-1 LTR
11676	155348	NP_705927.1	reverse transcriptase	inhibited by	9606	6118	NP_002937.1	replication protein A 32 kDa subunit	9084803	2007-11-07 17:29	Replication protein A and HIV-1 nucleocapsid protein interfere with the strand displacement DNA synthesis of HIV-1 reverse transcriptase by binding to the displaced strand and keeping it away from the newly synthesized strand
11676	155807	NP_057852.2	Vpr	induces phosphorylation of	9606	6118	NP_002937.1	replication protein A 32 kDa subunit	16956949	2007-11-07 17:31	HIV-1 Vpr induces phosphorylation of replication protein A (RPA2) at serine 4 and 8 in an ATR-dependent manner
11676	155348	NP_705927.1	reverse transcriptase	inhibited by	9606	6119	NP_002938.1	replication protein A 14 kDa subunit	9084803	2007-11-07 17:29	Replication protein A and HIV-1 nucleocapsid protein interfere with the strand displacement DNA synthesis of HIV-1 reverse transcriptase by binding to the displaced strand and keeping it away from the newly synthesized strand
11676	155871	NP_057853.1	Tat	interacts with	9606	6122	NP_000958.1	60S ribosomal protein L3 isoform a	7576925	2007-11-07 17:30	TARBP-b binds to HIV-1 TAR RNA and data suggests that TARBP-b interacts with HIV-1 Tat to mediate transactivation of the HIV-1 LTR promoter
11676	155908	NP_057854.1	Rev	interacts with	9606	6125	NP_000960.2	60S ribosomal protein L5	9465063	2007-11-07 17:27	ribosomal protein L5 interacts with eukaryotic initiation factor 5A (eIF-5A) as a cofactor for the Rev nuclear export activity of eIF-5A
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	6198	NP_003152.1	ribosomal protein S6 kinase beta-1	10089566,10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	155348	NP_705927.1	reverse transcriptase	interacts with	9606	6300	NP_002960.2	mitogen-activated protein kinase 12	9564043	2007-11-07 17:29	MEK1 in HIV-1 producer cells is able to activate virion-associated MAPK in trans, and the activated MAPK facilitates efficient disengagement of the HIV-1 reverse transcription complex from the cell membrane and subsequent nuclear translocation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	6300	NP_002960.2	mitogen-activated protein kinase 12	12239168	2007-11-07 17:31	HIV-1 gp120 binding to CD4 results in activation of the mitogen-activated protein kinase (MAPK) in CD4(+) lymphocytes prestimulated through their T-cell receptor (TCR)
11676	155459	NP_057851.1	Vif	binds	9606	6303	NP_002961.1	diamine acetyltransferase 1	12600646	2007-11-07 17:28	Binding of HIV-1 Vif to SSAT was identified using a yeast two-hybrid screen and confirmed by co-immunoprecipitation
11676	155459	NP_057851.1	Vif	modulates	9606	6303	NP_002961.1	diamine acetyltransferase 1	12600646	2007-11-07 17:28	It is postulated that HIV-1 Vif modulates SSAT activity, affecting levels of cellular polyamines leading to possible affects on the properties of viral RNA
11676	155871	NP_057853.1	Tat	upregulates	9606	6303	NP_002961.1	diamine acetyltransferase 1	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Spermidine N1-acetyltransferase, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155807	NP_057852.2	Vpr	downregulates	9606	6346	NP_002972.1	C-C motif chemokine 1 precursor	10985253	2007-11-07 17:27	HIV-1 Vpr downregulates the monocyte chemoattractant I-309)
11676	155871	NP_057853.1	Tat	inhibits	9606	6346	NP_002972.1	C-C motif chemokine 1 precursor	14630801	2007-11-07 17:28	HIV-1 Tat inhibits I-309 (CCL1) driven cell migration as demonstrated using Tat peptides containing CXC or CC-like sequences (Tat amino acids 25-27 and 30-31, respectively)
11676	155871	NP_057853.1	Tat	upregulates	9606	6347	NP_002973.1	C-C motif chemokine 2 precursor	9501225,9792375,10068657,10453044,10644332,10751368,10982368,11145723,11154208,12473373,12485413,12758167,14550782,15194470,16697675	2007-11-07 17:29	HIV-1 Tat upregulates MCP-1 expression, an effect that may contribute to the pathogenesis of Tat associated with AIDS dementia
11676	155871	NP_057853.1	Tat	inhibits	9606	6347	NP_002973.1	C-C motif chemokine 2 precursor	9789057	2007-11-07 17:29	HIV-1 Tat is a competitive inhibitor of MCP-1 binding to CCR2
11676	155871	NP_057853.1	Tat	upregulates	9606	6347	NP_002973.1	C-C motif chemokine 2 precursor	9792375,10644332,11154208,12473373,12485413,16697675	2007-11-07 17:29	Upregulation of MCP-1 by HIV-1 Tat is mediated at the transcriptional level and is regulated, at least in part, by NF-kappa B, AP1, Sp1, protein kinase C and PI3 kinase
11676	155871	NP_057853.1	Tat	upregulates	9606	6347	NP_002973.1	C-C motif chemokine 2 precursor	10982368	2007-11-07 17:29	Upregulation of MCP-1 by HIV-1 Tat in astrocytes is inhibited by the MEK1/2 inhibitor UO126, indicating a role for MEK1/2 in Tat-mediated chemokine induction
11676	155871	NP_057853.1	Tat	inhibited by	9606	6347	NP_002973.1	C-C motif chemokine 2 precursor	12753088	2007-11-07 17:29	MCP-1 and RANTES have been shown to inhibit Tat-induced apoptosis of mixed cultures of human neurons and astrocytes
11676	155871	NP_057853.1	Tat	upregulates	9606	6347	NP_002973.1	C-C motif chemokine 2 precursor	12758167	2007-11-07 17:29	Tat-mediated upregulation of MCP-1 transcription is stimulated by Smad-3 and decreased by Smad-4
11676	155871	NP_057853.1	Tat	upregulates	9606	6347	NP_002973.1	C-C motif chemokine 2 precursor	15630704,16206161	2007-11-07 17:29	Astrocyte cultures treated with morphine and Tat show exaggerated increases in chemokine release, including monocyte chemoattractant protein-1 (MCP-1), RANTES, and IL-6
11676	155871	NP_057853.1	Tat	activates	9606	6347	NP_002973.1	C-C motif chemokine 2 precursor	16750572	2007-11-07 17:31	The C-terminal MH2 domain of Smad3 can decrease the levels of HIV-1 Tat-induced activation of MCP-1 in astrocytic cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	enhances	9606	6347	NP_002973.1	C-C motif chemokine 2 precursor	11313374,11878903,15481145,16160188	2007-11-07 17:31	Treatment of macrophages (MDM) with recombinant gp120-IIIB results in a specific and dose-dependent enhancement of secretion of monocyte chemoattractant protein-1, macrophage inflammatory protein-1beta, and RANTES
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	6347	NP_002973.1	C-C motif chemokine 2 precursor	11878903,12089333	2007-11-07 17:31	CXCR4-tropic HIV-1 gp120 augments the expression of RANTES, IP-10, MCP-1, and LTN in peripheral blood mononuclear cells (PBMCs), while CCR5-tropic HIV-1 gp120 also induces an increase in both IP-10 and MCP-1 production
11676	156110	NP_057857.2	Nef	upregulates	9606	6347	NP_002973.1	C-C motif chemokine 2 precursor	17046994	2007-11-07 17:31	HIV-1 Nef upregulates CCL-2/MCP-1 expression in astrocytes and this upregulation by Nef depends on the myristoylation moiety (residues 2-3) of Nef and requires functional calmodulin
11676	155030	NP_579876.2	matrix	downregulates	9606	6348	NP_002974.1	C-C motif chemokine 3	16427155	2007-11-07 17:29	HIV-1 Matrix is able to reduce MIP-1alpha secretion from IL-15-stimulated monocyte cells
11676	155807	NP_057852.2	Vpr	downregulates	9606	6348	NP_002974.1	C-C motif chemokine 3	10985253,15142381,15780175,15817944,16354571	2007-11-07 17:27	HIV-1 Vpr downregulates the expression of beta chemokines in primary lymphocytes and macrophage, including MIP-1 alpha, MIP-1 beta, and RANTES
11676	155871	NP_057853.1	Tat	upregulates	9606	6348	NP_002974.1	C-C motif chemokine 3	7695626,9520456,10602409,10751368,10964543,11751963,16697675	2007-11-07 17:29	HIV-1 Tat upregulates MIP-1alpha expression in microglia, MDDC, and T and B cell lines, an effect that suggests Tat plays an important role in the pathogenesis of HIV encephalitis and AIDS associated progressive multifocal leukoencephalopathy (PML)
11676	155871	NP_057853.1	Tat	downregulates	9606	6348	NP_002974.1	C-C motif chemokine 3	8687429,9207199	2007-11-07 17:29	HIV-1 Tat downregulates MIP-1alpha expression in Jurkat T-cells by inducing MNP-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	6348	NP_002974.1	C-C motif chemokine 3	8898753,8906795,9359702,9420238,9576751,9658081,10644351,10820198	2007-11-07 17:27	The CCR5 chemokine receptor is required for the entry of macrophage-tropic HIV-1 into target cells; the HIV-1 gp120-CD4 complex binds CCR5, which inhibits the binding of the natural CCR5 ligands macrophage inflammatory protein (MIP)-1alpha and MIP-1beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	6348	NP_002974.1	C-C motif chemokine 3	9653130,10644351	2007-11-07 17:31	HIV-1 gp120 from a T-cell-tropic virus causes CD4-dependent antagonism of CXCR4 response to SDF-1alpha, whereas gp120 from macrophage-tropic viruses causes CD4-dependent antagonism of CCR5 response to MIP-1alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	6348	NP_002974.1	C-C motif chemokine 3	10089882	2007-11-07 17:31	The chemokine receptor CCR5 is posttranslationally modified by sulfation of its N-terminal tyrosines; sulfated tyrosines contribute to the binding of CCR5 to MIP-1 alpha, MIP-1 beta, and HIV-1 gp120/CD4 complexes and to the ability of HIV-1 to enter cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	6348	NP_002974.1	C-C motif chemokine 3	10446313	2007-11-07 17:31	The neuroprotective action of VIP on gp120-induced neuronal cell death is attenuated by co-treatment with anti-MIP-1alpha, suggesting that the neuroprotective action of VIP is linked in part to its release of MIP-1alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	6348	NP_002974.1	C-C motif chemokine 3	11023526	2007-11-07 17:31	N-formyl-methionyl-leucylphenyl-alanine binding to formyl peptide receptor (FPR) results in significant attenuation of cell responses to CCR5 ligands and in inhibition of HIV-1 gp120-mediated fusion and infection of cells expressing CD4, CCR5, and FPR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	6348	NP_002974.1	C-C motif chemokine 3	11602715,12089333,15481145,16160188	2007-11-07 17:31	Exposure of macrophages to purified CCR5- or CXCR4-tropic HIV-1 envelope glycoprotein gp120 induces secretion of high levels of macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, RANTES, and tumor necrosis factor alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	6348	NP_002974.1	C-C motif chemokine 3	16393999	2007-11-07 17:31	NK cells exposed to CXCR4-tropic HIV-1 gp120 produce lower levels of CC chemokines RANTES, MIP-1alpha, and MIP-1beta compared with that produced from untreated NK cells
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	6348	NP_002974.1	C-C motif chemokine 3	10964543	2007-11-07 17:31	HIV-1 gp41 stimulates microglial cell production of cytokines (TNF-alpha, IL-1beta, and IL-6) and chemokines (RANTES and MIP-1alpha)
11676	156110	NP_057857.2	Nef	upregulates	9606	6348	NP_002974.1	C-C motif chemokine 3	10470075,12574335,12960275	2007-11-07 17:28	The expression of HIV-1 Nef in primary human monocyte-derived macrophages (MDM) increases the concentration of MIP-1alpha
11676	156110	NP_057857.2	Nef	upregulates	9606	6348	NP_002974.1	C-C motif chemokine 3	12370346,15638726	2007-11-07 17:29	HIV-1 Nef expression by immature human and macaque dendritic cells (DCs) upregulates IL-6, IL-12, TNF-alpha, CXCL8, CCL3, and CCL4 release, but without upregulating co-stimulatory and other molecules characteristic of mature DCs
11676	155807	NP_057852.2	Vpr	downregulates	9606	6351	NP_002975.1	C-C motif chemokine 4 isoform 1 precursor	10985253,15142381,15780175,15817944,16354571	2007-11-07 17:27	HIV-1 Vpr downregulates the expression of beta chemokines in primary lymphocytes and macrophages, including MIP-1 alpha, MIP-1 beta, and RANTES
11676	155871	NP_057853.1	Tat	upregulates	9606	6351	NP_002975.1	C-C motif chemokine 4 isoform 1 precursor	9520456,10751368,11751963,16697675	2007-11-07 17:29	HIV-1 Tat upregulates MIP-1beta expression in microglia, monocyte-derived dendritic cells, and activated APC, an effect that may play a role in HIV encephalitis and immunosuppression of uninfected T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	6351	NP_002975.1	C-C motif chemokine 4 isoform 1 precursor	8898753,8906795,8906796,9359702,9420238,9576751,9658081,10644351,10820198,11313374,11485305	2007-11-07 17:27	The CCR5 chemokine receptor is required for the entry of macrophage-tropic HIV-1 into target cells; the HIV-1 gp120-CD4 complex binds CCR5, which inhibits the binding of the natural CCR5 ligands macrophage inflammatory protein (MIP)-1alpha and MIP-1beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	6351	NP_002975.1	C-C motif chemokine 4 isoform 1 precursor	10089882,10938094	2007-11-07 17:31	The chemokine receptor CCR5 is posttranslationally modified by sulfation of its N-terminal tyrosines; sulfated tyrosines contribute to the binding of CCR5 to MIP-1 alpha, MIP-1 beta, and HIV-1 gp120/CD4 complexes and to the ability of HIV-1 to enter cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	6351	NP_002975.1	C-C motif chemokine 4 isoform 1 precursor	11023526	2007-11-07 17:31	N-formyl-methionyl-leucylphenyl-alanine binding to formyl peptide receptor (FPR) results in significant attenuation of cell responses to CCR5 ligands and in inhibition of HIV-1 gp120-mediated fusion and infection of cells expressing CD4, CCR5, and FPR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	6351	NP_002975.1	C-C motif chemokine 4 isoform 1 precursor	11602715,12089333,15481145,16160188	2007-11-07 17:31	Exposure of macrophages to purified CCR5- or CXCR4-tropic HIV-1 envelope glycoprotein gp120 induces secretion of high levels of macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, RANTES, and tumor necrosis factor alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	6351	NP_002975.1	C-C motif chemokine 4 isoform 1 precursor	16393999	2007-11-07 17:31	NK cells exposed to CXCR4-tropic HIV-1 gp120 produce lower levels of CC chemokines RANTES, MIP-1alpha, and MIP-1beta compared with that produced from untreated NK cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6351	NP_002975.1	C-C motif chemokine 4 isoform 1 precursor	16841089	2007-11-07 17:31	HIV-1 gp120 induced cell death is inhibited by a CCR5-mediated neuroprotective pathway that involves protein kinase Akt/PKB as an essential component and can be triggered by the CCR5 agonists MIP-1beta and RANTES
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibited by	9606	6351	NP_002975.1	C-C motif chemokine 4 isoform 1 precursor	9256481	2007-11-07 17:31	RANTES, MIP-1beta, and anti-CD4 antibodies inhibit CCR5-dependent cell-cell fusion mediated by HIV-1 gp120 and gp41 from macrophage-tropic isolates
11676	156110	NP_057857.2	Nef	upregulates	9606	6351	NP_002975.1	C-C motif chemokine 4 isoform 1 precursor	10470075,12574335,15638726	2007-11-07 17:28	HIV-1 Nef induces the production of two CC-chemokines, macrophage inflammatory proteins 1alpha and 1beta, in HIV-1-infected macrophages
11676	156110	NP_057857.2	Nef	upregulates	9606	6351	NP_002975.1	C-C motif chemokine 4 isoform 1 precursor	12370346	2007-11-07 17:27	HIV-1 Nef expression by immature human and macaque dendritic cells (DCs) upregulates IL-6, IL-12, TNF-alpha, CXCL8, CCL3, and CCL4 release, but without upregulating co-stimulatory and other molecules characteristic of mature DCs
11676	155807	NP_057852.2	Vpr	regulates	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	10985253,12359436,15142381,15780175,15817944,16354571	2007-11-07 17:27	HIV-1 Vpr regulates expression of RANTES, including upregulation in microglial cells and downregulation in primary lymphocytes and macrophages
11676	155871	NP_057853.1	Tat	cooperates with	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	9517988	2007-11-07 17:29	HIV-1 Tat cooperates with RANTES in inducing monocyte migration
11676	155871	NP_057853.1	Tat	upregulates	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	10964543	2007-11-07 17:27	HIV-1 Tat upregulates RANTES expression in human microglial cells, an effect that could contribute to the neuropathogenesis if HIV-1
11676	155871	NP_057853.1	Tat	upregulates	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	11751963	2007-11-07 17:29	HIV-1 Tat upregulates RANTES expression in monocyte-derived dendritic cells (MDDC), thereby driving Th1-type immune responses
11676	155871	NP_057853.1	Tat	inhibited by	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	12753088	2007-11-07 17:29	RANTES inhibits HIV-1 Tat-induced apoptosis, a protective effect mediated by the induction of MCP-1
11676	155871	NP_057853.1	Tat	upregulates	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	15630704,16206161,16697675	2007-11-07 17:29	Astrocyte cultures treated with morphine and Tat show exaggerated increases in chemokine release, including monocyte chemoattractant protein-1 (MCP-1), RANTES, and IL-6
11676	155871	NP_057853.1	Tat	upregulates	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	15857508	2007-11-07 17:28	RANTES is upregulated by HIV-1 Tat treatment in human epithelial cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	8898753,8976200,9359702,9420238,9576751,10644351,10774549,10775626,10820198,10882583	2007-11-07 17:27	The binding of HIV-1 gp120 to CCR5 and entry of macrophage-tropic HIV-1 isolates into cells is blocked by CCR5 antagonists or the chemokine RANTES, which interacts with CCR5
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	9826729	2007-11-07 17:31	Chemokines such as fractalkine, macrophage-derived chemokine (MDC), RANTES, and SDF-1alpha are able to block gp120-induced apoptosis of hippocampal neurons; both fractalkine and MDC activate ERK-1/2, while SDF-1alpha activates CREB
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	10872839	2007-11-07 17:31	A synthetic peptide domain of the V3 region of HIV-1 gp120 activates the FPRL1 receptor in monocytes and neutrophils and causes reduced response to several chemokines that use multiple cell receptors, including SDF-1alpha and RANTES
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	11313374,11602715,11878903,12089333,12953261,15481145	2007-11-07 17:31	Exposure of macrophages to purified CCR5- or CXCR4-tropic HIV-1 envelope glycoprotein gp120 induces secretion of high levels of macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, RANTES, and tumor necrosis factor alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	11878903,12089333	2007-11-07 17:31	CXCR4-tropic HIV-1 gp120 augments the expression of RANTES, IP-10, MCP-1, and LTN in peripheral blood mononuclear cells (PBMCs), while CCR5-tropic HIV-1 gp120 also induces an increase in both IP-10 and MCP-1 production
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	16343773	2007-11-07 17:31	RANTES, stromal derived factor-1alpha (SDF-1alpha), macrophage-derived chemokine (MDC), and their combination attenuate HIV-1 gp120-induced food and water intake decrease in rats
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	16393999	2007-11-07 17:31	NK cells exposed to CXCR4-tropic HIV-1 gp120 produce lower levels of CC chemokines RANTES, MIP-1alpha, and MIP-1beta compared with that produced from untreated NK cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	16841089	2007-11-07 17:31	HIV-1 gp120 induced cell death is inhibited by a CCR5-mediated neuroprotective pathway that involves protein kinase Akt/PKB as an essential component and can be triggered by the CCR5 agonists MIP-1beta and RANTES
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibited by	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	9256481	2007-11-07 17:31	RANTES, MIP-1beta, and anti-CD4 antibodies inhibit CCR5-dependent cell-cell fusion mediated by HIV-1 gp120 and gp41 from macrophage-tropic isolates
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	10964543	2007-11-07 17:31	HIV-1 gp41 stimulates microglial cell production of cytokines (TNF-alpha, IL-1beta, and IL-6) and chemokines (RANTES and MIP-1alpha)
11676	156110	NP_057857.2	Nef	upregulates	9606	6352	NP_002976.2	C-C motif chemokine 5 precursor	12359436	2007-11-07 17:27	HIV-1 Nef upregulates the production of RANTES/CCL5 in microglial cells
11676	155871	NP_057853.1	Tat	inhibits	9606	6354	NP_006264.2	C-C motif chemokine 7 precursor	9789057	2007-11-07 17:29	HIV-1 Tat is a competitive inhibitor of MCP-3 binding to CCR3
11676	155871	NP_057853.1	Tat	upregulates	9606	6354	NP_006264.2	C-C motif chemokine 7 precursor	12539042	2007-11-07 17:29	HIV-1 Tat upregulates expression of MCP-3 in immature dendritic cells, suggesting Tat reprograms host dendritic cell gene expression to facilitate expansion of HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6354	NP_006264.2	C-C motif chemokine 7 precursor	10477718	2007-11-07 17:31	Chemokines such as MCP-3 and MCP-2 that can compete with high affinity for MIP-1beta binding to CCR5 can also compete for monomeric HIV-1 gp120 binding to CCR5, although with variable potencies
11676	155871	NP_057853.1	Tat	upregulates	9606	6355	NP_005614.2	C-C motif chemokine 8 precursor	12539042	2007-11-07 17:29	HIV-1 Tat upregulates expression of MCP-2 in immature dendritic cells, suggesting Tat reprograms host dendritic cell gene expression to facilitate expansion of HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6355	NP_005614.2	C-C motif chemokine 8 precursor	10477718	2007-11-07 17:31	Chemokines such as MCP-3 and MCP-2 that can compete with high affinity for MIP-1beta binding to CCR5 can also compete for monomeric HIV-1 gp120 binding to CCR5, although with variable potencies
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6356	NP_002977.1	eotaxin precursor	8674119	2007-11-07 17:27	HIV-1 gp120 utilization of CCR3 as a coreceptor facilitates infection by a more restricted subset of primary viruses, and binding of the CCR3 ligand, eotaxin, inhibits infection by these isolates
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulates	9606	6364	NP_004582.1	C-C motif chemokine 20 isoform 1	12089333	2007-11-07 17:30	HIV-1 gp120 modulates expression of the chemokines, GRO-alpha (CXCL1), GRO-gamma, NAP2, IL-8 (CXCL8), IP-10 (CXCL10), MIP-1beta, MIP-1alpha, RANTES, and MIP-3alpha, in PBMCs and MDMs
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	6364	NP_004582.1	C-C motif chemokine 20 isoform 1	15972662	2007-11-07 17:30	CXCR4-tropic and CXCR4/CCR5 dual-tropic HIV-1 gp120 proteins inhibit B cell chemotaxis toward CXCL12, CCL20, and CCL21, and gp120-induced p38 MAPK activation is triggered by CCL21 and CCL20
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	6366	NP_002980.1	C-C motif chemokine 21 precursor	15972662	2007-11-07 17:30	CXCR4-tropic and CXCR4/CCR5 dual-tropic HIV-1 gp120 proteins inhibit B cell chemotaxis toward CXCL12, CCL20, and CCL21, and gp120-induced p38 MAPK activation is triggered by CCL21 and CCL20
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6367	NP_002981.2	C-C motif chemokine 22 precursor	9826729	2007-11-07 17:31	Chemokines such as fractalkine, macrophage-derived chemokine (MDC), RANTES, and SDF-1alpha are able to block gp120-induced apoptosis of hippocampal neurons; both fractalkine and MDC activate ERK-1/2, while SDF-1alpha activates CREB
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6367	NP_002981.2	C-C motif chemokine 22 precursor	16343773	2007-11-07 17:31	RANTES, stromal derived factor-1alpha (SDF-1alpha), macrophage-derived chemokine (MDC), and their combination attenuate HIV-1 gp120-induced food and water intake decrease in rats
11676	155871	NP_057853.1	Tat	upregulates	9606	6375	NP_002986.1	lymphotactin	14734774,15857508	2007-11-07 17:28	SCYC1 is upregulated by HIV-1 Tat treatment in human epithelial cells
11676	155871	NP_057853.1	Tat	upregulates	9606	6375	NP_002986.1	lymphotactin	14734774	2007-11-07 17:28	Upregulation of XCL1 expression is induced by HIV-1 Tat in human astrocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	6375	NP_002986.1	lymphotactin	11878903	2007-11-07 17:31	CXCR4-tropic HIV-1 gp120 augments the expression of RANTES, IP-10, MCP-1, and LTN in peripheral blood mononuclear cells (PBMCs), while CCR5-tropic HIV-1 gp120 also induces an increase in both IP-10 and MCP-1 production
11676	155871	NP_057853.1	Tat	inhibited by	9606	6376	NP_002987.1	fractalkine precursor	10640747	2007-11-07 17:29	Fractalkine is neuroprotective to cultured neurons when co-administered with HIV-1 Tat, a viral protein that induces neuronal apoptosis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6376	NP_002987.1	fractalkine precursor	9826729	2007-11-07 17:31	Chemokines such as fractalkine, macrophage-derived chemokine (MDC), RANTES, and SDF-1alpha are able to block gp120-induced apoptosis of hippocampal neurons; both fractalkine and MDC activate ERK-1/2, while SDF-1alpha activates CREB
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6376	NP_002987.1	fractalkine precursor	10869418	2007-11-07 17:31	Fractalkine (CX3CL1) protects hippocampal neurons from the neurotoxicity induced by the HIV-1 envelope protein gp120, and neuronal CX(3)CR1 receptors and Akt activation are responsible for the neuroprotective effects of fractalkine
11676	155871	NP_057853.1	Tat	binds	9606	6382	NP_002988.3	syndecan-1 precursor	7690138,9342064	2007-11-07 17:30	Binding of HIV-1 Tat to heparan sulfate proteoglycans is competed out by the heparin-binding factor bFGF
11676	155871	NP_057853.1	Tat	binds	9606	6382	NP_002988.3	syndecan-1 precursor	8570206,9111037,10497173,11024024,11567105,12885232	2007-11-07 17:30	Cell membrane heparin sulfate proteoglycans bind to the basic region of HIV-1 Tat (amino acids 49-57) and act as receptors for extracellular Tat uptake, an effect that may contribute to the angiogenic properties of Tat in promoting Kaposi's sarcoma
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	6382	NP_002988.3	syndecan-1 precursor	16157597,16817962	2007-11-07 17:31	The V3 region (amino acids 298-329) of HIV-1 gp120 contains the syndecan-binding site for HIV-1 via 6-O sulfated motifs; a single conserved arginine (Arg-298) in the V3 region of gp120 governs HIV-1 binding to syndecans
11676	155871	NP_057853.1	Tat	binds	9606	6383	NP_002989.2	syndecan-2 precursor	7690138,9342064	2007-11-07 17:30	Binding of HIV-1 Tat to heparan sulfate proteoglycans is competed out by the heparin-binding factor bFGF
11676	155871	NP_057853.1	Tat	binds	9606	6383	NP_002989.2	syndecan-2 precursor	8570206,9111037,10497173,11024024,11567105,12885232	2007-11-07 17:30	Cell membrane heparin sulfate proteoglycans bind to the basic region of HIV-1 Tat (amino acids 49-57) and act as receptors for extracellular Tat uptake, an effect that may contribute to the angiogenic properties of Tat in promoting Kaposi's sarcoma
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	6383	NP_002989.2	syndecan-2 precursor	16157597,16817962	2007-11-07 17:30	The V3 region (amino acids 298-329) of HIV-1 gp120 contains the syndecan-binding site for HIV-1 via 6-O sulfated motifs; a single conserved arginine (Arg-298) in the V3 region of gp120 governs HIV-1 binding to syndecans
11676	155871	NP_057853.1	Tat	binds	9606	6385	NP_002990.2	syndecan-4 precursor	7690138,9342064	2007-11-07 17:30	Binding of HIV-1 Tat to heparan sulfate proteoglycans is competed out by the heparin-binding factor bFGF
11676	155871	NP_057853.1	Tat	binds	9606	6385	NP_002990.2	syndecan-4 precursor	8570206,9111037,10497173,11024024,11567105,12885232	2007-11-07 17:30	Cell membrane heparin sulfate proteoglycans bind to the basic region of HIV-1 Tat (amino acids 49-57) and act as receptors for extracellular Tat uptake, an effect that may contribute to the angiogenic properties of Tat in promoting Kaposi's sarcoma
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	6385	NP_002990.2	syndecan-4 precursor	16157597,16817962	2007-11-07 17:30	The V3 region (amino acids 298-329) of HIV-1 gp120 contains the syndecan-binding site for HIV-1 via 6-O sulfated motifs; a single conserved arginine (Arg-298) in the V3 region of gp120 governs HIV-1 binding to syndecans
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	6386	NP_005616.2	syntenin-1 isoform 1	12775419	2007-11-07 17:31	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155871	NP_057853.1	Tat	stimulated by	9606	6387	NP_000600.1	stromal cell-derived factor 1 isoform beta	10196252	2007-11-07 17:28	SDF-1alpha stimulates the ability of HIV-1 Tat to transactivate the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	competes with	9606	6387	NP_000600.1	stromal cell-derived factor 1 isoform beta	10772939,11027346	2007-11-07 17:28	HIV-1 Tat competes with SDF-1alpha for binding to CXCR4
11676	155871	NP_057853.1	Tat	upregulates	9606	6387	NP_000600.1	stromal cell-derived factor 1 isoform beta	12044982	2007-11-07 17:28	HIV-1 Tat induces SDF-1alpha expression in neurons and Tat-mediated neurite outgrowth is blocked by anti-SDF-1alpha antibody, suggesting a role for SDF-1alpha in the neuronal response to HIV in brains of AIDS patients
11676	155871	NP_057853.1	Tat	interacts with	9606	6387	NP_000600.1	stromal cell-derived factor 1 isoform beta	12605695	2007-11-07 17:28	HIV-1 Tat interacts with SDF-1alpha to induce apoptosis in Tat-treated erythroid cells
11676	155871	NP_057853.1	Tat	inhibits	9606	6387	NP_000600.1	stromal cell-derived factor 1 isoform beta	14630801	2007-11-07 17:28	HIV-1 Tat can inhibit CXCR4-mediated functions by interfering with the chemotactic activity of SDF-1/CXCL12, an effect mediated by Tat amino acids 25-31
11676	155871	NP_057853.1	Tat	upregulates	9606	6387	NP_000600.1	stromal cell-derived factor 1 isoform beta	15857508	2007-11-07 17:28	SDF-1 is upregulated by HIV-1 Tat treatment in human epithelial cells
11676	156110	NP_057857.2	Nef	inhibits	9606	6387	NP_000600.1	stromal cell-derived factor 1 isoform beta	12354773	2007-11-07 17:28	An intracellular signaling pathway mediated by the binding of SDF-1alpha and CXCR4 is inhibited by Nef in both Jurkat T cells and primary peripheral CD4+ T lymphocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6387	NP_954637.1	stromal cell-derived factor 1 isoform alpha	8976200,10486323,10582593,10600606,10820198,11162626,12834106,15113900,15710459,15748209,16188969	2007-11-07 17:27	The entry of T cell-tropic HIV-1 isolates into cells is blocked by SDF-1, which interacts with the HIV-1 gp120 coreceptor CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	6387	NP_954637.1	stromal cell-derived factor 1 isoform alpha	9601645,9653130,10430052,10486323,10820198,11162626,11287575	2007-11-07 17:31	HIV-1 gp120 from a T-cell-tropic virus causes CD4-dependent antagonism of CXCR4 response to SDF-1alpha, whereas gp120 from macrophage-tropic viruses causes CD4-dependent antagonism of CCR5 response to MIP-1alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	6387	NP_954637.1	stromal cell-derived factor 1 isoform alpha	9744279	2007-11-07 17:31	Apoptosis of CD8+ T cells is mediated by the interaction between TNF-alpha bound to the membrane of macrophages (mbTNF) and a receptor on CD8+ T cells (TNF-receptor II, or TNFRII), which is upregulated by treatment with recombinant HIV-1 gp120 or SDF-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	6387	NP_954637.1	stromal cell-derived factor 1 isoform alpha	9744279	2007-11-07 17:31	The death rate of CD8+ T cells by apoptosis, which is induced by HIV-1 gp120 from CXCR4-tropic HIV strains or by the ligand of the chemokine receptor CXCR4 (SDF-1), increased markedly during HIV infection of peripheral blood mononuclear cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6387	NP_954637.1	stromal cell-derived factor 1 isoform alpha	9826729	2007-11-07 17:31	Chemokines such as fractalkine, macrophage-derived chemokine (MDC), RANTES, and SDF-1alpha are able to block gp120-induced apoptosis of hippocampal neurons; both fractalkine and MDC activate ERK-1/2, while SDF-1alpha activates CREB
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	6387	NP_954637.1	stromal cell-derived factor 1 isoform alpha	10872839	2007-11-07 17:31	A synthetic peptide domain of the V3 region of HIV-1 gp120 activates the FPRL1 receptor in monocytes and neutrophils and causes reduced response to several chemokines that use multiple cell receptors, including SDF-1alpha and RANTES
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6387	NP_954637.1	stromal cell-derived factor 1 isoform alpha	12482395	2007-11-07 17:31	SDF-1alpha reverses gp120-induced downregulation of CD79b in CD40- and IL-4-activated purified HIV-1 seronegative human peripheral blood B cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6387	NP_954637.1	stromal cell-derived factor 1 isoform alpha	12787886	2007-11-07 17:30	The fusion of insulin-like growth factor I (IGF I) with stromal cell-derived factor I or alpha1 proteinase inhibitor has the capacity to compete with the binding of HIV-1 gp120 to CD4 receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	6387	NP_954637.1	stromal cell-derived factor 1 isoform alpha	15972662	2007-11-07 17:30	CXCR4-tropic and CXCR4/CCR5 dual-tropic HIV-1 gp120 proteins inhibit B cell chemotaxis toward CXCL12, CCL20, and CCL21, and gp120-induced p38 MAPK activation is triggered by CCL21 and CCL20
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6387	NP_954637.1	stromal cell-derived factor 1 isoform alpha	16343773	2007-11-07 17:31	RANTES, stromal derived factor-1alpha (SDF-1alpha), macrophage-derived chemokine (MDC), and their combination attenuate HIV-1 gp120-induced food and water intake decrease in rats
11676	155871	NP_057853.1	Tat	binds	9606	6390	NP_002991.2	succinate dehydrogenase	7778269	2007-11-07 17:30	Using a yeast two-hybrid system, HIV-1 Tat has been shown to bind the human succinate-ubiquinone oxidoreductase iron sulfur subunit, suggesting a role for this protein in mediating the biological activity of Tat during HIV-1 replication
11676	155871	NP_057853.1	Tat	upregulates	9606	6401	NP_000441.1	selectin E precursor	7523444,7693046,9269771,9597096,10477700,11827962,15194470	2007-11-07 17:30	HIV-1 Tat upregulates E-selectin (ELAM-1) in endothelial cells via an NF-kappa B-dependent mechanism
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	6402	NP_000646.1	selectin L precursor	10449768,14576059	2007-11-07 17:31	CD4 ligation by HIV-1 gp120 induces metalloproteinase-dependent L-selectin downregulation in primary resting CD4+ T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	6402	NP_000646.1	selectin L precursor	14576059	2007-11-07 17:31	L-selectin downregulation induced by HIV-1 gp120 is completely reversed by AMD3100 (a CXCR4 antagonist), but not SDF-1 alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces cleavage of	9606	6403	NP_002996.1	selectin P precursor	15972662	2007-11-07 17:30	CXCR4-tropic and CXCR4/CCR5 dual-tropic HIV-1 gp120 induce the cleavage of CD62 ligand by a mechanism dependent on matrix metalloproteinases 1 and 3, CD4, CXCR4, Galpha(i), and p38 MAPK, whereas CCR5-tropic gp120 does not
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	6422	NP_003003.3	secreted frizzled-related protein 1 precursor	7561057,8922468,9403839,12925876	2007-11-07 17:30	Antibodies raised against the human fusion regulatory protein 1 (FRP-1; CD98) molecule suppress cell fusion mediated by HIV-1 gp160
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulates	9606	6422	NP_003003.3	secreted frizzled-related protein 1 precursor	9138296	2007-11-07 17:28	Co-cultivation of PBMC with HIV-1 gp160-expressing HeLa cells results in the increased expression of FRP-1 on T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	6422	NP_003003.3	secreted frizzled-related protein 1 precursor	9138296	2007-11-07 17:28	HIV-1 gp120 has the ability to induce expression of FRP-1 on peripheral blood mononuclear cells (PBMC)
11676	155871	NP_057853.1	Tat	inhibits	9606	6426	NP_008855.1	splicing factor, arginine/serine-rich 1 isoform 1	12221105	2007-11-07 17:28	HIV-1 Tat synergizes with type I activators, such as Sp1 and CTF, to enhance transcript elongation and exon skipping, suggesting Tat function leads to the inhibition of splicing factors SF2/ASF and 9G8
11676	155908	NP_057854.1	Rev	inhibits	9606	6426	NP_008855.1	splicing factor, arginine/serine-rich 1 isoform 1	8189522,8626563,9023367	2007-11-07 17:27	SF2/ASF binds to RRE RNA in a Rev-dependent manner, an interaction that is associated with Rev inhibition of HIV-1 mRNA splicing
11676	155908	NP_057854.1	Rev	interacts with	9606	6426	NP_008855.1	splicing factor, arginine/serine-rich 1 isoform 1	8189522,8626563	2007-11-07 17:27	interaction of Rev with SF2/ASF is apparently mediated by complement component 1, q subcomponent binding protein (C1QBP, p32) which associates with SF2/ASF and binds to Rev
11676	155908	NP_057854.1	Rev	inhibited by	9606	6426	NP_008855.1	splicing factor, arginine/serine-rich 1 isoform 1	11967326	2007-11-07 17:27	SF2/ASF has been shown to inhibit Rev function in a dose-dependent fashion
11676	155908	NP_057854.1	Rev	requires	9606	6426	NP_008855.1	splicing factor, arginine/serine-rich 1 isoform 1	15163745	2007-11-07 17:28	SF2/ASF and SRp40 interact with a purine-rich motif within the HIV-1 exon 5, and this interaction activates splicing at an upstream 3' splice site and binding of the 5' splice site to U1 snRNP, which are required for splicing of HIV-1 rev and nef mRNAs
11676	155908	NP_057854.1	Rev	co-localizes with	9606	6427	NP_003007.2	splicing factor, arginine/serine-rich 2	7546906,9541613,9601515,11090190,12239324	2007-11-07 17:27	The splicing inhibitory function of Rev has been associated with Rev localization to subnuclear compartments containing the splicing factor SC-35
11676	155908	NP_057854.1	Rev	inhibited by	9606	6427	NP_003007.2	splicing factor, arginine/serine-rich 2	11967326	2007-11-07 17:27	SC-35 has been shown to inhibit Rev function in a dose-dependent fashion
11676	155908	NP_057854.1	Rev	requires	9606	6430	NP_008856.2	splicing factor, arginine/serine-rich 5	15163745	2007-11-07 17:28	SF2/ASF and SRp40 interact with a purine-rich motif within the HIV-1 exon 5, and this interaction activates splicing at an upstream 3' splice site and binding of the 5' splice site to U1 snRNP, which are required for splicing of HIV-1 rev and nef mRNAs
11676	155871	NP_057853.1	Tat	inhibits	9606	6432	NP_001026854.1	splicing factor, arginine/serine-rich 7	12221105	2007-11-07 17:28	HIV-1 Tat synergizes with type I activators, such as Sp1 and CTF, to enhance transcript elongation and exon skipping, suggesting Tat function leads to the inhibition of splicing factors SF2/ASF and 9G8
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	6441	NP_003010.4	pulmonary surfactant-associated protein D precursor	16227233	2007-11-07 17:30	Surfactant protein D (SP-D) binds to HIV-1 gp120 and inhibits HIV infectivity; the binding of SP-D to gp120 depends on glycosylation of gp120 and multimerization of SP-D
11676	155030	NP_057850.1	Pr55(Gag)	interacts with	9606	6449	NP_003012.1	small glutamine-rich tetratricopeptide repeat-containing protein alpha	9573291,9766974,11878889	2007-11-07 17:29	The enhancement of HIV-1 particle release and Capsid export resulting from the interaction of HIV-1 Vpu with HIV-1 Gag also involves the interaction of both Vpu and Gag with Vpu-binding protein (Ubp; Vpu interactive protein; VIP; SGT; NP_003012)
11676	155945	NP_057855.1	Vpu	interacts with	9606	6449	NP_003012.1	small glutamine-rich tetratricopeptide repeat-containing protein alpha	7966229,9573291,9766974,11878889	2007-11-07 17:27	Small glutamine-rich tetratricopeptide repeat containing protein, also known as Vpu-binding protein (Ubp) or Vpu interactive protein (VIP), interacts with both HIV-1 Vpu and Gag to play a role in Vpu-mediated enhancement of HIV-1 virion release from cells
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	6464	NP_003020.2	SHC-transforming protein 1 isoform 2	9325171	2007-11-07 17:28	HIV-1 Tat activates the MAPK signaling pathway leading to the phosphorylation of Shc, a protein involved in signal transduction downstream of receptor tyrosine kinase activation
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	6464	NP_003020.2	SHC-transforming protein 1 isoform 2	16436505	2007-11-07 17:29	HIV-1 Tat-induced small GTPase Ras activation is mediated by tyrosine phosphorylation of Shc and recruitment of Grb2 in human endothelial cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	6482	NP_003024.1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	6483	NP_008858.1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	6484	NP_006269.1	CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	6487	NP_006270.1	CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase isoform j	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155871	NP_057853.1	Tat	enhanced by	9606	6502	NP_005974.2	S-phase kinase-associated protein 2 isoform 1	16103164	2007-11-07 17:28	Cdk9, the catalytic subunit of P-TEFb, is ubiquitinated by Skp1/Cul1/F-box protein E3 ubiquitin ligase Skp2, which facilitates the formation of the RNA-protein complex between P-TEFb, Tat, and TAR, thereby enhancing Tat transactivation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	6506	NP_004162.2	excitatory amino acid transporter 2	14982736,15927426	2007-11-07 17:31	Astrocyte elevated gene (AEG)-1 expression is increased in astrocytes infected with HIV-1 or treated with HIV-1 gp120; AEG-1 inhibits excitatory amino acid transporter 2 (EAAT2) promoter activity with the potential to promote glutamate excitotoxicity
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	6520	NP_001012679.1	4F2 cell-surface antigen heavy chain isoform a	7561057,8922468,9403839,12925876	2007-11-07 17:30	Antibodies raised against the human fusion regulatory protein 1 (FRP-1; CD98) molecule suppress cell fusion mediated by HIV-1 gp160
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	regulated by	9606	6520	NP_001012679.1	4F2 cell-surface antigen heavy chain isoform a	7561057,12925876	2007-11-07 17:30	The functional interaction between CD98 and CD147 is involved in the regulation of HIV-1 gp160-mediated cell fusion
11676	155871	NP_057853.1	Tat	inhibits	9606	6523	NP_000334.1	sodium/glucose cotransporter 1	16327313	2007-11-07 17:29	HIV-1 Tat induces Na-D-glucose symporter (SGLT-1) mis-sorting and inhibits glucose uptake in human enterocytes
11676	155871	NP_057853.1	Tat	downregulates	9606	6531	NP_001035.1	sodium-dependent dopamine transporter	16237680	2007-11-07 17:31	HIV-1 gp120 and HIV-1 Tat decrease dopamine uptake into striatal synaptosomes by decreasing the V(max) of the dopamine transporter (DAT); 17beta-Estradiol prevents the oxidative stress and loss of DAT function associated with gp120/Tat neurotoxicity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	6531	NP_001035.1	sodium-dependent dopamine transporter	16237680	2007-11-07 17:31	HIV-1 gp120 and HIV-1 Tat decrease dopamine uptake into striatal synaptosomes by decreasing the V(max) of the dopamine transporter (DAT); 17beta-Estradiol prevents the oxidative stress and loss of DAT function associated with gp120/Tat neurotoxicity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	6545	NP_004164.2	cationic amino acid transporter 4	10700465	2007-11-07 17:31	The CDR1, FR2, and CDR3 regions of the VH3 family gene significantly contribute to its binding to HIV-1 gp120
11676	155871	NP_057853.1	Tat	regulated by	9606	6580	NP_003048.1	solute carrier family 22 member 1 isoform a	1727476,7690421,8902060,9078256	2007-11-07 17:30	Oct proteins have been shown to bind to HIV-1 Tat and both enhance and repress Tat-mediated transactivation of the HIV-1 LTR promoter, suggesting a role for Oct proteins in regulation of Tat function
11676	155871	NP_057853.1	Tat	regulated by	9606	6582	NP_003049.1	solute carrier family 22 member 2	1727476,7690421,8902060,9078256	2007-11-07 17:30	Oct proteins have been shown to bind to HIV-1 Tat and both enhance and repress Tat-mediated transactivation of the HIV-1 LTR promoter, suggesting a role for Oct proteins in regulation of Tat function
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	6590	NP_003055.1	antileukoproteinase precursor	15858026,16928883	2007-11-07 17:30	The expression and production of secretory leukocyte protease inhibitor (SLPI), a 12-kDa mucosal antiviral protein, can be stimulated in oral epithelial cells through interactions with HIV-1 gp120
11676	155871	NP_057853.1	Tat	interacts with	9606	6595	NP_003061.3	probable global transcription activator SNF2L2 isoform a	16601680	2007-11-07 17:31	HIV-1 Tat interacts directly with BRM, a DNA-dependent ATPase subunit of the SWI/SNF chromatin-remodeling complex, to activate the HIV-1 LTR, and this interaction is regulated by Tat lysine 50 acetylation
11676	156110	NP_057857.2	Nef	upregulates	9606	6596	NP_003062.2	helicase-like transcription factor	11810028	2007-11-07 17:28	HIV-1 Nef upregulates the expression of helicase-like transcription factor (HLTF-1) in HeLa cells
11676	155871	NP_057853.1	Tat	regulated by	9606	6597	NP_003063.2	transcription activator BRG1 isoform B	16687403	2007-11-07 17:31	INI-1 and BRG-1 synergize with the p300 acetyltransferase to activate the HIV promoter; this synergism depends on the acetyltransferase activity of p300 and on HIV-1 Tat amino acids Lys(50) and Lys(51), suggesting a regulation of Tat by these proteins
11676	155348	NP_705928.1	integrase	stimulated by	9606	6598	NP_003064.2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 isoform a	7627549,7801128,9448295,16403635	2007-11-07 17:29	Integrase interactor 1 (INI1, hSNF5) binds to HIV-1 integrase and stimulates integrase DNA end joining activity
11676	155348	NP_705928.1	integrase	binds	9606	6598	NP_003064.2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 isoform a	7801128,9448295,16403635	2007-11-07 17:29	Binding of integrase interactor 1 (INI1, hSNF5) to HIV-1 integrase is mediated by amino acids 183-243 of INI1 and the central domain of integrase (amino acids 48-188)
11676	155348	NP_705928.1	integrase	interacts with	9606	6598	NP_003064.2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 isoform a	10773452,16403635	2007-11-07 17:29	Inactivation of ySNF5, the yeast homolog of integrase interactor 1 (INI1, hSNF5) abolishes the lethal phenotype induced by the expression of HIV-1 integrase in yeast, suggesting an important role for INI1 in HIV-1 integration
11676	155348	NP_705928.1	integrase	recruits	9606	6598	NP_003064.2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 isoform a	11430827,16403635	2007-11-07 17:29	HIV-1 preintegration complexes containing HIV-1 integrase induce the cytoplasmic recruitment of integrase interactor 1 (INI1, hSNF5) and PML and associate with these cellular proteins before migrating to the nucleus
11676	155348	NP_705928.1	integrase	inhibited by	9606	6598	NP_003064.2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 isoform a	11479624,16403635	2007-11-07 17:29	A cytoplasmically localized fragment of integrase interactor 1 (INI1, hSNF5; amino acids 183-294) potently inhibits HIV-1 particle production and replication
11676	155348	NP_705928.1	integrase	interacts with	9606	6598	NP_003064.2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 isoform a	11479624,15875659,16075307,16403635,16772295,16945155	2007-11-07 17:29	Integrase interactor 1 (INI1, hSNF5) is incorporated into HIV-1 virions, presumably through its interaction with HIV-1 integrase
11676	155348	NP_705928.1	integrase	interacts with	9606	6598	NP_003064.2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 isoform a	14963118,16403635	2007-11-07 17:29	The specificity in incorporation of INI1/hSNF5 into HIV-1 virions is directly correlated with its ability to exclusively interact with HIV-1 integrase but not with other retroviral integrases such as HIV-2, SIV, HTLV-1, and MuLV IN
11676	155348	NP_705928.1	integrase	interacts with	9606	6598	NP_003064.2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 isoform a	16772295	2007-11-07 17:31	HIV-1 Integrase E69G and K71R mutants are impaired for SNF5/Ini1 interaction, and inhibition of SNF5/Ini1 expression by RNA interference increases HIV-1 replication
11676	155871	NP_057853.1	Tat	regulated by	9606	6598	NP_003064.2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 isoform a	16687403	2007-11-07 17:31	INI-1 and BRG-1 synergize with the p300 acetyltransferase to activate the HIV promoter; this synergism depends on the acetyltransferase activity of p300 and on HIV-1 Tat amino acids Lys(50) and Lys(51), suggesting a regulation of Tat by these proteins
11676	155871	NP_057853.1	Tat	binds	9606	6598	NP_003064.2	SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 isoform a	16889668	2007-11-07 17:31	Integrase interactor 1 (INI1)/hSNF5 binds to HIV-1 Tat and co-activates Tat-mediated transcription; both the repeat (Rpt) 1 and Rpt 2 domains of INI1 are required for efficient co-activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	6609	NP_000534.3	sphingomyelin phosphodiesterase isoform 1 precursor	15509740	2007-11-07 17:30	In human primary neurons, HIV-1 gp120 induces the activation of sphingomyelinases (primarily neutral sphingomyelinase); antisense knockdown of neutral sphingomyelinase markedly inhibits gp120-mediated apoptosis and cell death of primary neurons
11676	156110	NP_057857.2	Nef	modulates	9606	6609	NP_000534.3	sphingomyelin phosphodiesterase isoform 1 precursor	9110068	2007-11-07 17:28	HIV-1 Nef expression in human glial cells modulates the sphingomyelinase signaling pathway triggered by TNF-alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	6610	NP_003071.2	sphingomyelin phosphodiesterase 2	15509740	2007-11-07 17:30	HIV-1 gp120 binding to CXCR4 induces NADPH oxidase-mediated production of superoxide radicals in neurons, which is involved in the activation of neutral sphingomyelinase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	6610	NP_003071.2	sphingomyelin phosphodiesterase 2	15509740	2007-11-07 17:30	In human primary neurons, HIV-1 gp120 induces the activation of sphingomyelinases (primarily neutral sphingomyelinase); antisense knockdown of neutral sphingomyelinase markedly inhibits gp120-mediated apoptosis and cell death of primary neurons
11676	156110	NP_057857.2	Nef	upregulates	9606	6626	NP_004587.1	U1 small nuclear ribonucleoprotein A	11420046	2007-11-07 17:28	Expression of HIV-1 Nef in human T cells upregulates U1 SNRNP, a factor that positively regulates HIV-1
11676	155871	NP_057853.1	Tat	stimulated by	9606	6627	NP_003081.2	U2 small nuclear ribonucleoprotein A'	11780068	2007-11-07 17:30	U2 snRNPs interact with the HIV-1 Tat cofactor TAT-SF1 and stimulate transcription from the HIV-1 LTR promoter
11676	155908	NP_057854.1	Rev	inhibits	9606	6627	NP_003081.2	U2 small nuclear ribonucleoprotein A'	8331728	2007-11-07 17:27	Rev inhibits the binding of U2 small nuclear ribonucleoprotein within the spliceosome
11676	155871	NP_057853.1	Tat	stimulated by	9606	6628	NP_003082.1	small nuclear ribonucleoprotein-associated proteins B and B' isoform B	11780068	2007-11-07 17:30	U2 snRNPs interact with the HIV-1 Tat cofactor TAT-SF1 and stimulate transcription from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulated by	9606	6629	NP_003083.1	U2 small nuclear ribonucleoprotein B''	11780068	2007-11-07 17:30	U2 snRNPs interact with the HIV-1 Tat cofactor TAT-SF1 and stimulate transcription from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulated by	9606	6632	NP_008869.1	small nuclear ribonucleoprotein Sm D1	11780068	2007-11-07 17:30	U2 snRNPs interact with the HIV-1 Tat cofactor TAT-SF1 and stimulate transcription from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulated by	9606	6633	NP_004588.1	small nuclear ribonucleoprotein Sm D2 isoform 1	11780068	2007-11-07 17:30	U2 snRNPs interact with the HIV-1 Tat cofactor TAT-SF1 and stimulate transcription from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulated by	9606	6634	NP_004166.1	small nuclear ribonucleoprotein Sm D3	11780068	2007-11-07 17:30	U2 snRNPs interact with the HIV-1 Tat cofactor TAT-SF1 and stimulate transcription from the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	enhances	9606	6647	NP_000445.1	superoxide dismutase	15223067,16792821	2007-11-07 17:28	The membrane transduction efficiencies and biological activities of the SOD protein are enhanced by fusing with the Tat protein transduction domain (PTD) at both termini
11676	155871	NP_057853.1	Tat	downregulates	9606	6647	NP_000445.1	superoxide dismutase	15869407	2007-11-07 17:29	HIV-1 Tat reduces the expression of MnSOD in several cell types
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibited by	9606	6647	NP_000445.1	superoxide dismutase	14975589	2007-11-07 17:30	Free radical scavengers such as superoxide dismutase (SOD), dimethylthiourea (DMTU) and catalase attenuate morphine and gp160-induced human monocyte apoptosis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	6647	NP_000445.1	superoxide dismutase	16871233	2007-11-07 17:31	Antioxidant enzymes such as Cu/Zn-superoxide dismutase (SOD1) and/or glutathione peroxidase (GPx1) protect neuronal cells from HIV-1 gp120-induced programmed cell death
11676	155871	NP_057853.1	Tat	downregulates	9606	6648	NP_000627.2	superoxide dismutase	7859743,8395050,9110146,9882443	2007-11-07 17:29	HIV-1 Tat downregulates the expression of Mn-SOD, an effect that potentiates TNF-induced NF-kappa B activation and that requires the C-terminus (amino acids 72-86) of Tat
11676	155871	NP_057853.1	Tat	downregulates	9606	6648	NP_000627.2	superoxide dismutase	10393559	2007-11-07 17:30	HIV-1 Tat inhibits Tip60 histone-acetyltransferase activity and abolishes Tip60-dependent transcriptional activity of the Mn-SOD promoter, resulting in downregulation of Mn-SOD
11676	155871	NP_057853.1	Tat	enhances	9606	6648	NP_000627.2	superoxide dismutase	15223067,16792821	2007-11-07 17:28	The membrane transduction efficiencies and biological activities of the SOD protein are enhanced by fusing with the Tat protein transduction domain (PTD) at both termini
11676	155871	NP_057853.1	Tat	downregulates	9606	6648	NP_000627.2	superoxide dismutase	15706661	2007-11-07 17:28	HIV-1 Tat downregulates SOD2 expression by interacting with Sp1 and Sp3 to increase the Sp3-containing complexes on the basal SOD2 promoter
11676	155871	NP_057853.1	Tat	downregulates	9606	6648	NP_000627.2	superoxide dismutase	15869407	2007-11-07 17:28	HIV-1 Tat reduces the expression of MnSOD in several cell types
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibited by	9606	6648	NP_000627.2	superoxide dismutase	14975589	2007-11-07 17:30	Free radical scavengers such as superoxide dismutase (SOD), dimethylthiourea (DMTU) and catalase attenuate morphine and gp160-induced human monocyte apoptosis
11676	155871	NP_057853.1	Tat	enhances	9606	6649	NP_003093.2	extracellular superoxide dismutase precursor	15223067,16792821	2007-11-07 17:28	The membrane transduction efficiencies and biological activities of the SOD protein are enhanced by fusing with the Tat protein transduction domain (PTD) at both termini
11676	155871	NP_057853.1	Tat	downregulates	9606	6649	NP_003093.2	extracellular superoxide dismutase precursor	15869407	2007-11-07 17:28	HIV-1 Tat reduces the expression of MnSOD in several cell types
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	inhibited by	9606	6649	NP_003093.2	extracellular superoxide dismutase precursor	14975589	2007-11-07 17:30	Free radical scavengers such as superoxide dismutase (SOD), dimethylthiourea (DMTU) and catalase attenuate morphine and gp160-induced human monocyte apoptosis
11676	155030	NP_579881.1	nucleocapsid	enhances	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	10704334	2007-11-07 17:29	HIV-1 Nucleocapsid has been shown to bind to the HIV-1 LTR promoter and enhance NF-kappaB, Sp1, and TFIIB-induced HIV-1 LTR-directed RNA transcription
11676	155807	NP_057852.2	Vpr	interacts with	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	7592727,8800208,9685344,12634356,12642036,15142377,15302882,15353294,15725353,16120388	2007-11-07 17:28	HIV-1 Vpr interacts with Sp1 in the context of an Sp1-DNA complex that may also include p53, resulting in the transactivation of the HIV-1 LTR promoter
11676	155807	NP_057852.2	Vpr	cooperates with	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	15302882	2007-11-07 17:28	HIV-1 Vpr activates promoter activity of p21/Cip1/Waf1 through the GC-rich region located between nucleotides -84 and -74 in a manner that requires cooperativity of Sp1, which binds to the DNA sequence spanning -84 to -74
11676	155807	NP_057852.2	Vpr	interacts with	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	15302882	2007-11-07 17:28	Results from GST pull-down assays show the association of Vpr with p53 in extracts containing Sp1, suggesting the physical interaction of Vpr with Sp1 and p53 could modulate transcriptional activity of p21
11676	155871	NP_057853.1	Tat	synergizes with	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	1583736,8628270,9372921,10644726,12221105	2007-11-07 17:28	Sp1 synergizes with HIV-1 Tat to activate HIV-1 transcription
11676	155871	NP_057853.1	Tat	binds	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	1924310,7690421,9121429,9525578,12753906,12811817	2007-11-07 17:28	HIV-1 Tat amino acids 30-55 mediate binding of Tat to Sp1, an effect that some reports indicate is a direct binding interaction, while other reports suggest it is indirect and possibly mediated through interaction with other cellular factors
11676	155871	NP_057853.1	Tat	requires	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	1924310,2657100,7666561,7690421,8230415,8411386,8849451,9566873,12458222,16690926	2007-11-07 17:28	Sp1 and Sp1-binding sites in the HIV-1 LTR promoter are required for HIV-1 Tat-mediated activation of viral transcription elongation
11676	155871	NP_057853.1	Tat	inhibits	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	7621073	2007-11-07 17:27	HIV-1 Tat represses transcription from the MHC class I, MDR1, minimal SV40 and other Sp1-dependent promoters, indicating Tat downregulates expression from these promoters by inhibiting Sp1 function
11676	155871	NP_057853.1	Tat	interacts with	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	8207805	2007-11-07 17:28	The tumor suppressor protein p53 inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter through an interaction with the Sp1 sites in the LTR, suggesting an inhibition of Sp1 effects on Tat function
11676	155871	NP_057853.1	Tat	interacts with	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	9388268,10644726	2007-11-07 17:28	Sp1, COUP-TF and HIV-1 Tat interact and cooperate in the transcriptional activation of the HIV-1 LTR promoter in human microglial cells
11676	155871	NP_057853.1	Tat	regulated by	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	9472608	2007-11-07 17:28	YB-1 and Sp1 exert negative effects on each other's function in enhancing transcription from the HIV-1 promoter, suggesting an interplay between these two proteins during regulation of HIV-1 Tat function
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	9525578	2007-11-07 17:28	HIV-1 Tat binds to DNA-PK and augments DNA-PK-mediated phosphorylation of Sp1 during Tat transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	regulates	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	9882443	2007-11-07 17:27	HIV-1 Tat increases Sp1 binding in HeLa cells, suggesting Tat changes the conformation of Sp1 in order to regulate its function during HIV-1 transcription activation
11676	155871	NP_057853.1	Tat	activates	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	10089212,10393859,10644332	2007-11-07 17:28	HIV-1 Tat upregulates the expression of galectin-3, NOS-3, and monocyte chemoattractant protein 1 (MCP-1) through Sp1 activation
11676	155871	NP_057853.1	Tat	cooperates with	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	12221105	2007-11-07 17:28	HIV-1 Tat cooperates with Sp1 to enhance transcript elongation, leading to exon skipping and effects on splicing
11676	155871	NP_057853.1	Tat	interacts with	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	15706661	2007-11-07 17:28	HIV-1 Tat downregulates SOD2 expression by interacting with Sp1 and Sp3 to increase the Sp3-containing complexes on the basal SOD2 promoter
11676	155871	NP_057853.1	Tat	upregulates	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	15869407	2007-11-07 17:28	In hepatic cells, HIV-1 Tat expression upregulates Sp1 and Sp3, which play different roles in regulating MnSOD transcription (overexpression of Sp1 stimulates, while overexpression of Sp3 represses transcriptional activity)
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	16690926	2007-11-07 17:31	HIV-1 Tat expression inhibits the TCF-4-induced inhibition of Sp1 phosphorylation and Sp1-mediated HIV-1 LTR transcription
11676	155871	NP_057853.1	Tat	interacts with	9606	6667	NP_612482.2	transcription factor Sp1 isoform a	17150965	2007-11-07 17:31	Hydroxyurea and IL-6 synergistically enhance HIV-1 Tat activation of HIV-1 LTR-driven transcription via the Sp1 binding site
11676	155871	NP_057853.1	Tat	inhibited by	9606	6670	NP_003102.1	transcription factor Sp3 isoform 1	7800480,9388268	2007-11-07 17:28	Sp3 represses basal expression from the HIV-1 LTR promoter, and overexpression of Sp3 inhibits HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	6670	NP_003102.1	transcription factor Sp3 isoform 1	15706661	2007-11-07 17:28	HIV-1 Tat downregulates SOD2 expression by interacting with Sp1 and Sp3 to increase the Sp3-containing complexes on the basal SOD2 promoter
11676	155871	NP_057853.1	Tat	upregulates	9606	6670	NP_003102.1	transcription factor Sp3 isoform 1	15869407	2007-11-07 17:28	In hepatic cells, HIV-1 Tat expression upregulates Sp1 and Sp3, which play different roles in regulating MnSOD transcription (overexpression of Sp1 stimulates, while overexpression of Sp3 represses transcriptional activity)
11676	155871	NP_057853.1	Tat	interacts with	9606	6671	NP_003103.2	transcription factor Sp4	7800480	2007-11-07 17:28	Sp4 is an activator of the HIV-1 LTR promoter, suggesting an indirect interaction to enhance HIV-1 Tat-mediated transactivation of the viral promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	6693	NP_003114.1	leukosialin precursor	8554898	2007-11-07 17:30	Elimination of CD43 expression by gene targeting in the CEM T cell line results in its increased homotypic adhesion and binding to HIV-1 gp120
11676	155348	NP_705926.1	retropepsin	cleaves	9606	6708	NP_003117.2	spectrin alpha chain, erythrocyte	1991513,8997639	2007-11-07 17:29	HIV-1 protease cleaves alpha-spectrin in vitro at amino acid positions 1352, 1376, and 1697
11676	155348	NP_705926.1	retropepsin	cleaves	9606	6708	NP_003117.2	spectrin alpha chain, erythrocyte	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155348	NP_705926.1	retropepsin	cleaves	9606	6709	NP_003118.1	spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155348	NP_705926.1	retropepsin	cleaves	9606	6710	NP_000338.3	spectrin beta chain, erythrocyte isoform b	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155348	NP_705926.1	retropepsin	cleaves	9606	6711	NP_003119.2	spectrin beta chain, brain 1 isoform 1	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155348	NP_705926.1	retropepsin	cleaves	9606	6712	NP_008877.1	spectrin beta chain, brain 2	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155871	NP_057853.1	Tat	activates	9606	6714	NP_005408.1	proto-oncogene tyrosine-protein kinase Src	9621077	2007-11-07 17:27	HIV-1 Tat stimulates the tyrosine phosphorylation and activation of c-Src kinase resulting in the activation of the intrinsic kinase activity of c-Src, an effect associated with Tat-induced angiogenesis and Kaposi's sarcoma
11676	155871	NP_057853.1	Tat	activates	9606	6714	NP_005408.1	proto-oncogene tyrosine-protein kinase Src	16105876	2007-11-07 17:29	HIV-1 Tat exerts several pleiotropic effects by interacting with different cellular receptors, including integrin alpha(v)beta3, which triggers the activation of focal adhesion kinase, RhoA and pp60src
11676	156110	NP_057857.2	Nef	binds	9606	6714	NP_005408.1	proto-oncogene tyrosine-protein kinase Src	9778343,12734410,15078178,15638726,16849330	2007-11-07 17:28	The RT loop region (residues 90-108) in the Src SH3 domain binds to HIV-1 Nef, but this binding is looser than that of the Hck SH3 domain to HIV-1 Nef
11676	156110	NP_057857.2	Nef	upregulates	9606	6721	NP_004590.2	sterol regulatory element-binding protein 2	16014965	2007-11-07 17:28	Upregulated expression of SREBF2 in Jurkat cells expressing HIV-1 Nef has been confirmed by real-time RT-PCR
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inactivates	9606	6722	NP_003122.1	serum response factor	10556093	2007-11-07 17:31	The interaction of the long cytoplasmic tail of HIV-1 gp41 with the carboxy-terminal regulatory domain of p115-RhoGEF inhibits p115-mediated actin stress fiber formation and activation of serum response factor (SRF)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	6726	NP_003124.1	signal recognition particle 9 kDa protein isoform 2	12775420	2007-11-07 17:31	Downregulation of guanine nucleotide-releasing protein, CD151/PETA-3, neuronatin, neuroendocrine differentiation factor, mitochondria 16s rRNA, and signal recognition particle is observed in HIV-1 infected and HIV-1 gp120-treated astrocytes
11676	155030	NP_579880.1	capsid	binds	9606	6737	NP_003132.2	52 kDa Ro protein	16775307,16828831	2007-11-07 17:31	The RING domain of TRIM21 can functionally replace the corresponding domain of rhesus monkey TRIM5alpha with respect to inhibition of HIV-1 infection through the binding of the chimeras to HIV-1 capsid complexes
11676	155871	NP_057853.1	Tat	interacts with	9606	6741	NP_003133.1	lupus La protein	7933082	2007-11-07 17:30	The La autoantigen binds to HIV-1 TAR RNA and alleviates translational repression by the HIV-1 leader RNA, suggesting a possible involvement of the La autoantigen in HIV-1 gene expression and Tat transactivation
11676	155871	NP_057853.1	Tat	upregulates	9606	6742	NP_003134.1	single-stranded DNA-binding protein, mitochondrial precursor	15710247	2007-11-07 17:28	Upregulation of actin, heat shock protein 90 and mitochondrial single-stranded DNA binding protein, and downregulation of lactate dehydrogenase are identified in human astrocytes expressing Tat
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	6750	NP_001039.1	somatostatin preproprotein	9878821	2007-11-07 17:31	Co-exposure of human fetal neurons to brain-derived neurotrophic factor (BDNF) and HIV-1 gp120 leads to a dose-dependent increase in BDNF-induced somatostatin (SRIF) production
11676	155871	NP_057853.1	Tat	upregulates	9606	6772	NP_009330.1	signal transducer and activator of transcription 1-alpha/beta isoform alpha	12539042	2007-11-07 17:29	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including STAT-1 (p91 and p84), in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	competes with	9606	6772	NP_009330.1	signal transducer and activator of transcription 1-alpha/beta isoform alpha	16512786,16703666	2007-11-07 17:31	HIV-1 Tat represses transcription of the LMP2 gene by competing with STAT1 (signal transducer and activator of transcription 1) for binding to IRF-1 (interferon-regulatory factor-1) at the LMP2 promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	6772	NP_009330.1	signal transducer and activator of transcription 1-alpha/beta isoform alpha	16897667	2007-11-07 17:31	Signal transducer and activator of transcription factor 1 (STAT1) partially regulates HIV-1 gp120/HCV E2-induced caspase 3 activity
11676	156110	NP_057857.2	Nef	activates	9606	6772	NP_009330.1	signal transducer and activator of transcription 1-alpha/beta isoform alpha	11675348,15638726	2007-11-07 17:28	HIV-1 Nef specifically activates both alpha and beta isoforms of the signal transducer and activator of transcription 1 (STAT1) in human monocyte-derived macrophages (MDMs)
11676	155871	NP_057853.1	Tat	activates	9606	6774	NP_003141.2	signal transducer and activator of transcription 3 isoform 2	17151125	2007-11-07 17:31	Ectopic expression of HIV-1 Tat induces the production of human IL-6 (huIL-6) and its receptor (huIL-6Ra) and activates STAT3 signaling; these effects are involved in Tat-mediated activation of Kaposi's sarcoma-associated herpesvirus (KSHV) replication
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	6774	NP_003141.2	signal transducer and activator of transcription 3 isoform 2	12089333,12775419	2007-11-07 17:30	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	156110	NP_057857.2	Nef	activates	9606	6774	NP_644805.1	signal transducer and activator of transcription 3 isoform 1	11328823	2007-11-07 17:28	HIV-1 Nef activates signal transducer and activator of transcription 3 (STAT3) in the granulocyte-macrophage colony-stimulating factor-independent myeloid cell line, TF-1, and in primary human macrophages
11676	156110	NP_057857.2	Nef	activates	9606	6774	NP_644805.1	signal transducer and activator of transcription 3 isoform 1	12396456	2007-11-07 17:28	The expression of HIV-1 Nef in immature dendritic cells activates STAT3
11676	156110	NP_057857.2	Nef	activates	9606	6774	NP_644805.1	signal transducer and activator of transcription 3 isoform 1	12960275,15638726,17077296	2007-11-07 17:28	HIV-1 Nef specifically activates STAT3 in primary human monocyte-derived macrophages (MDM); Nef-dependent STAT3 activation is mediated by the release of soluble factor(s), including MIP-1alpha and IL-6
11676	156110	NP_057857.2	Nef	activates	9606	6774	NP_644805.1	signal transducer and activator of transcription 3 isoform 1	15343382	2007-11-07 17:28	HIV-1 Nef, through its PxxP and RR106 motifs, upregulates Src kinase activity and signal transducer and activator of transcription 3 (Stat3) phosphorylation, and activates the Ras-c-Raf-MAPK1,2 pathway in podocytes
11676	156110	NP_057857.2	Nef	upregulates	9606	6774	NP_644805.1	signal transducer and activator of transcription 3 isoform 1	16260903	2007-11-07 17:29	HIV-1 Nef activates expression of phospho-Stat3, one of the downstream signaling pathways for cell proliferation
11676	155030	NP_579880.1	capsid	upregulates	9606	6776	NP_003143.2	signal transducer and activator of transcription 5A	16289657	2007-11-07 17:29	STAT5 binds to the HIV-1 LTR during HIV infection, activating LTR transcription and leading to the upregulation of HIV-1 p24 Capsid production and an increase in the number of p24+ cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	6776	NP_003143.2	signal transducer and activator of transcription 5A	11485409,12605694	2007-11-07 17:30	CD4 ligation with HIV gp120 inhibits T cell receptor-induced tyrosine phosphorylation and expression of STAT5 by blocking activation and expression of JAK3
11676	155030	NP_579880.1	capsid	upregulates	9606	6777	NP_036580.2	signal transducer and activator of transcription 5B	16289657	2007-11-07 17:29	STAT5 binds to the HIV-1 LTR during HIV infection, activating LTR transcription and leading to the upregulation of HIV-1 p24 Capsid production and an increase in the number of p24+ cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	6777	NP_036580.2	signal transducer and activator of transcription 5B	11485409,12605694	2007-11-07 17:30	CD4 ligation with HIV gp120 inhibits T cell receptor-induced tyrosine phosphorylation and expression of STAT5 by blocking activation and expression of JAK3
11676	155871	NP_057853.1	Tat	interacts with	9606	6778	NP_003144.3	signal transducer and activator of transcription 6 isoform 1	17151125	2007-11-07 17:31	Activation of IL-4/STAT6 signaling partially contributes to HIV-1 Tat-induced Kaposi's sarcoma-associated herpesvirus (KSHV) replication
11676	155030	NP_057850.1	Pr55(Gag)	interacts with	9606	6780	NP_059346.2	double-stranded RNA-binding protein Staufen homolog 1 isoform a	10823848,15024055	2007-11-07 17:29	Staufen is incorporated into HIV-1 virions through association with HIV-1 genomic RNA and is implicated in HIV-1 genome selection and packaging into assembling virions, a process that is mediated by the Nucleocapsid domain of HIV-1 Gag
11676	155030	NP_057850.1	Pr55(Gag)	interacts with	9606	6780	NP_059346.2	double-stranded RNA-binding protein Staufen homolog 1 isoform a	15024055	2007-11-07 17:29	Interaction of HIV-1 Gag with staufen is mediated by staufen's dsRBD3 domain
11676	155871	NP_057853.1	Tat	activated by	9606	6827	NP_003159.1	transcription elongation factor SPT4	10454543,10757782,11112772	2007-11-07 17:28	The SPT5/SPT4 complex, DSIF, associates with the HIV-1 transcription elongation complex (TEC) and are involved in the activation of transcriptional elongation by HIV-1 Tat
11676	155871	NP_057853.1	Tat	stimulated by	9606	6829	NP_003160.2	transcription elongation factor SPT5 isoform a	9514752,10393184,10454543,10757782	2007-11-07 17:27	SPT5 associates with the HIV-1 Tat cofactor Tat-SF1 and the RNA polymerase II holoenzyme and stimulates Tat-mediated transcriptional activation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	6829	NP_003160.2	transcription elongation factor SPT5 isoform a	10757782,11112772,11809800	2007-11-07 17:28	HIV-1 Tat induces the phosphorylation of the SPT5 CTR1 domain (amino acids 754-817) by CDK9/P-TEFb
11676	155871	NP_057853.1	Tat	cooperates with	9606	6829	NP_003160.2	transcription elongation factor SPT5 isoform a	11112772,11809800	2007-11-07 17:28	The SPT5/SPT4 complex, DSIF, associates with the HIV-1 transcription elongation complex (TEC) and SPT5 cooperates with HIV-1 Tat by preventing premature RNA release from the TEC at terminator sequences and reducing polymerase pausing at arrest sites
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	6863	NP_054702.1	protachykinin-1 isoform alpha precursor	11919172	2007-11-07 17:31	Addition of HIV-1 gp120 to monocyte-derived macrophages (MDM) enhances substance P (SP) expression; this gp120-induced SP expression is abrogated by pretreating the cells with soluble CD4
11676	155871	NP_057853.1	Tat	interacts with	9606	6872	NP_004597.2	transcription initiation factor TFIID subunit 1 isoform 1	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	6872	NP_004597.2	transcription initiation factor TFIID subunit 1 isoform 1	7836461	2007-11-07 17:29	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	6872	NP_004597.2	transcription initiation factor TFIID subunit 1 isoform 1	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	6872	NP_004597.2	transcription initiation factor TFIID subunit 1 isoform 1	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6872	NP_004597.2	transcription initiation factor TFIID subunit 1 isoform 1	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	binds	9606	6872	NP_004597.2	transcription initiation factor TFIID subunit 1 isoform 1	9751712,11257518	2007-11-07 17:27	Amino acids (aa) 67-101 (C-term. domain) of HIV-1 Tat bind to aa 848-1279 of TAFII250, while Tat aa 18-36 (cysteine-rich domain) and 36-56 (includes basic domain) bind to TAFII250 aa 885-984 (AT domain) and 1120-1279 (Rap74 binding domain), respectively
11676	155871	NP_057853.1	Tat	inhibits	9606	6872	NP_004597.2	transcription initiation factor TFIID subunit 1 isoform 1	9751712	2007-11-07 17:27	HIV-1 Tat binding to TAFII250 inhibits TAFII250 histone acetyltransferase activity and TAFII250-dependent transcription of the MHC class I and beta2-microglobulin promoters
11676	155871	NP_057853.1	Tat	stimulates	9606	6872	NP_004597.2	transcription initiation factor TFIID subunit 1 isoform 1	10704353	2007-11-07 17:27	HIV-1 Tat stimulates the phosphorylation of TFIIF by TAFII250 during Tat-mediated transcription of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	6873	NP_003175.1	transcription initiation factor TFIID subunit 2	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	6873	NP_003175.1	transcription initiation factor TFIID subunit 2	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	6873	NP_003175.1	transcription initiation factor TFIID subunit 2	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	6873	NP_003175.1	transcription initiation factor TFIID subunit 2	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6873	NP_003175.1	transcription initiation factor TFIID subunit 2	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	6874	NP_003176.2	transcription initiation factor TFIID subunit 4	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	6874	NP_003176.2	transcription initiation factor TFIID subunit 4	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	6874	NP_003176.2	transcription initiation factor TFIID subunit 4	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	6874	NP_003176.2	transcription initiation factor TFIID subunit 4	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6874	NP_003176.2	transcription initiation factor TFIID subunit 4	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	6877	NP_008882.2	transcription initiation factor TFIID subunit 5	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	6877	NP_008882.2	transcription initiation factor TFIID subunit 5	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	6877	NP_008882.2	transcription initiation factor TFIID subunit 5	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	6877	NP_008882.2	transcription initiation factor TFIID subunit 5	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6877	NP_008882.2	transcription initiation factor TFIID subunit 5	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	6878	NP_005632.1	transcription initiation factor TFIID subunit 6 isoform alpha	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	6878	NP_005632.1	transcription initiation factor TFIID subunit 6 isoform alpha	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	6878	NP_005632.1	transcription initiation factor TFIID subunit 6 isoform alpha	7933101	2007-11-07 17:28	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	6878	NP_005632.1	transcription initiation factor TFIID subunit 6 isoform alpha	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6878	NP_005632.1	transcription initiation factor TFIID subunit 6 isoform alpha	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	6879	NP_005633.2	transcription initiation factor TFIID subunit 7	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	6879	NP_005633.2	transcription initiation factor TFIID subunit 7	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	6879	NP_005633.2	transcription initiation factor TFIID subunit 7	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	6879	NP_005633.2	transcription initiation factor TFIID subunit 7	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6879	NP_005633.2	transcription initiation factor TFIID subunit 7	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	6880	NP_003178.1	adenylate kinase isoenzyme 6 isoform a	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	6880	NP_003178.1	adenylate kinase isoenzyme 6 isoform a	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	6880	NP_003178.1	adenylate kinase isoenzyme 6 isoform a	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	6880	NP_003178.1	adenylate kinase isoenzyme 6 isoform a	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6880	NP_003178.1	adenylate kinase isoenzyme 6 isoform a	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	6881	NP_006275.1	transcription initiation factor TFIID subunit 10	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	6881	NP_006275.1	transcription initiation factor TFIID subunit 10	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	6881	NP_006275.1	transcription initiation factor TFIID subunit 10	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	6881	NP_006275.1	transcription initiation factor TFIID subunit 10	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6881	NP_006275.1	transcription initiation factor TFIID subunit 10	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	6882	NP_005634.1	transcription initiation factor TFIID subunit 11	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	6882	NP_005634.1	transcription initiation factor TFIID subunit 11	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	6882	NP_005634.1	transcription initiation factor TFIID subunit 11	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	6882	NP_005634.1	transcription initiation factor TFIID subunit 11	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6882	NP_005634.1	transcription initiation factor TFIID subunit 11	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	6883	NP_005635.1	transcription initiation factor TFIID subunit 12	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	6883	NP_005635.1	transcription initiation factor TFIID subunit 12	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	6883	NP_005635.1	transcription initiation factor TFIID subunit 12	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	6883	NP_005635.1	transcription initiation factor TFIID subunit 12	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6883	NP_005635.1	transcription initiation factor TFIID subunit 12	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	6884	NP_005636.1	transcription initiation factor TFIID subunit 13	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	6884	NP_005636.1	transcription initiation factor TFIID subunit 13	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	6884	NP_005636.1	transcription initiation factor TFIID subunit 13	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	6884	NP_005636.1	transcription initiation factor TFIID subunit 13	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6884	NP_005636.1	transcription initiation factor TFIID subunit 13	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	upregulates	9606	6890	NP_000584.2	antigen peptide transporter 1	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including RING4, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	regulates	9606	6894	NP_005637.3	probable methyltransferase TARBP1	1752441,1936997,7638159,8626763,8846792	2007-11-07 17:30	HIV-1 Tat regulates the binding of TRP-185 to HIV-1 TAR RNA, which in turn regulates the binding of RNA polymerase II to TAR RNA
11676	155871	NP_057853.1	Tat	synergizes with	9606	6895	NP_599150.1	RISC-loading complex subunit TARBP2 isoform a	2011739,14585207	2007-11-07 17:30	TRBP2 binds to HIV-1 TAR RNA and synergizes with HIV-1 Tat to activate the HIV-1 LTR promoter
11676	155807	NP_057852.2	Vpr	binds	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	9874563	2007-11-07 17:28	HIV-1 Vpr (amino acids 1-35) binds to TFIID, an interaction that is associated with the ability of Vpr to stimulate transcription through the glucocorticoid receptor pathway
11676	155871	NP_057853.1	Tat	binds	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	7608968,8121496,8680883,8764062	2007-11-07 17:27	Binding of HIV-1 Tat to TBP has been mapped to the cysteine rich and core domains (amino acids 20-50) of Tat and the H1 alpha helical and S2 domains (amino acids 163-220) of TBP
11676	155871	NP_057853.1	Tat	interacts with	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	7608968,9054383,9292011,10066804,15719058	2007-11-07 17:27	TBP interacts with HIV-1 Tat as part of the HIV-1 transcription preinitiation complex (PIC) and is necessary for Tat association with the PIC
11676	155871	NP_057853.1	Tat	synergizes with	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	7608968,9372921,9632719,9814863	2007-11-07 17:27	TBP synergizes with HIV-1 Tat during Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	binds	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	7835343,8121496,8764009,8764062	2007-11-07 17:27	HIV-1 Tat binds directly to the basal transcription factor TFIID through the TBP subunit of TFIID
11676	155871	NP_057853.1	Tat	interacts with	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	7933101	2007-11-07 17:27	Interaction of TBP/TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	interacts with	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	8207805	2007-11-07 17:27	Inhibition of HIV-1 Tat by p53 is mediated through the Sp1 and TATA box of the HIV-1 LTR, suggesting p53 interferes with the interaction between Tat and TBP during LTR transactivation
11676	155871	NP_057853.1	Tat	requires	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	8230415,8764009,9372921,15719058	2007-11-07 17:27	TBP is required for HIV-1 Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	8764062	2007-11-07 17:27	Binding of HIV-1 Tat to the TBP subunit of TFIID stabilizes the interaction of TFIID with TFIIA
11676	155871	NP_057853.1	Tat	interacts with	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	8764062	2007-11-07 17:27	HIV-1 Tat competes for Dr1 interaction with TBP
11676	155871	NP_057853.1	Tat	interacts with	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	9121429	2007-11-07 17:27	HIV-1 Tat interacts with the RNA polymerase II holoenzyme complex that supports Tat-mediated transactivation of the HIV-1 LTR in vitro upon addition of TBP and TFIIB
11676	155871	NP_057853.1	Tat	interacts with	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	9372921,9632719,9814863,15719058	2007-11-07 17:27	Recruitment of TBP to the HIV-1 LTR promoter is a limiting step for HIV-1 Tat transactivation, however interaction of Tat with TBP/TFIID occurs after this recruitment
11676	155871	NP_057853.1	Tat	interacts with	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	9765201	2007-11-07 17:27	HIV-1 Tat directly interacts with TBP as demonstrated by Tat-affinity column purification
11676	155871	NP_057853.1	Tat	recruits	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	11080476	2007-11-07 17:27	Binding of HIV-1 Tat to p300 induces a conformational change in the CBP/p300 complex such that it can acquire and bind better to basal transcription factors such as TBP, indicating Tat helps CBP/p300 recruit new partners to the transcription machinery
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	6908	NP_003185.1	TATA-box-binding protein isoform 1	12089333,12775419	2007-11-07 17:31	The transcription factors and kinases c-Jun, JNK, MEK, p38 MAPK, STAT-3, JAK-1, TFII D, TFII F, eIF-4E, and RNA polymerase II are induced by HIV-1 gp120
11676	155871	NP_057853.1	Tat	synergizes with	9606	6917	NP_006747.1	transcription elongation factor A protein 1 isoform 1	1559613	2007-11-07 17:28	TFIIS synergizes with HIV-1 Tat during transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	6917	NP_006747.1	transcription elongation factor A protein 1 isoform 1	9765201	2007-11-07 17:28	HIV-1 Tat directly interacts with SII (TFIIS) as demonstrated by Tat-affinity column purification
11676	155871	NP_057853.1	Tat	synergizes with	9606	6919	NP_003186.1	transcription elongation factor A protein 2 isoform a	1559613	2007-11-07 17:28	TFIIS synergizes with HIV-1 Tat during transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	6919	NP_003186.1	transcription elongation factor A protein 2 isoform a	9765201	2007-11-07 17:28	HIV-1 Tat directly interacts with SII (TFIIS) as demonstrated by Tat-affinity column purification
11676	155871	NP_057853.1	Tat	synergizes with	9606	6920	NP_003187.1	transcription elongation factor A protein 3	1559613	2007-11-07 17:28	TFIIS synergizes with HIV-1 Tat during transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	6920	NP_003187.1	transcription elongation factor A protein 3	9765201	2007-11-07 17:28	HIV-1 Tat directly interacts with SII (TFIIS) as demonstrated by Tat-affinity column purification
11676	155459	NP_057851.1	Vif	complexes with	9606	6921	NP_005639.1	transcription elongation factor B polypeptide 1	14564014,15574592,15574593,16303161	2007-11-07 17:29	HIV-1 Vif (amino acids 144-149; SLQXLA motif) interacts with cellular proteins Cul5, elongins B and C, and Rbx1 to form an Skp1-cullin-F-box (SCF)-like complex that allows Vif to interact with APOBEC3G and induce its ubiquitination and degradation
11676	155459	NP_057851.1	Vif	binds	9606	6921	NP_005639.1	transcription elongation factor B polypeptide 1	15574592	2007-11-07 17:28	HIV-1 Vif binding to ElonginC is negatively regulated by serine phosphorylation in the BC-box of the Vif SOCS-box motif, and mutating amino acid S144 in Vif prevents phosphorylation at this site, significantly impairing Vif function and viral replication
11676	155459	NP_057851.1	Vif	complexes with	9606	6923	NP_009039.1	transcription elongation factor B polypeptide 2 isoform a	14564014,15574592,15574593,16303161	2007-11-07 17:29	HIV-1 Vif (amino acids 144-149; SLQXLA motif) interacts with cellular proteins Cul5, elongins B and C, and Rbx1 to form an Skp1-cullin-F-box (SCF)-like complex that allows Vif to interact with APOBEC3G and induce its ubiquitination and degradation
11676	155871	NP_057853.1	Tat	interacts with	9606	6923	NP_009039.1	transcription elongation factor B polypeptide 2 isoform a	9765201	2007-11-07 17:27	HIV-1 Tat directly interacts with elongin B as demonstrated by Tat-affinity column purification
11676	156110	NP_057857.2	Nef	upregulates	9606	6924	NP_003189.1	elongin A	11810028	2007-11-07 17:28	HIV-1 Nef expression in HeLa cells upregulates transcription elongation factor B (SIII; elongin A) expression
11676	155871	NP_057853.1	Tat	inhibits	9606	6925	NP_003190.1	transcription factor 4 isoform b	16690926	2007-11-07 17:31	HIV-1 Tat expression inhibits the TCF-4-induced inhibition of Sp1 phosphorylation and Sp1-mediated HIV-1 LTR transcription
11676	155871	NP_057853.1	Tat	regulated by	9606	6929	NP_003191.1	transcription factor E2-alpha isoform E12	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	regulated by	9606	6934	NP_110383.1	transcription factor 7-like 2 (T-cell specific, HMG-box)	12368361	2007-11-07 17:28	Expression of TCF-4 in human astrocytic cells decreased HIV-1 Tat-mediated transcription of the HIV-1 LTR, while GST pull-down assays revealed a direct interaction of Tat with TCF-4, suggesting TCF-4 may regulate the level of HIV-1 gene transcription
11676	156110	NP_057857.2	Nef	upregulates	9606	6935	NP_110378.2	zinc finger E-box binding homeobox 1	11810028	2007-11-07 17:28	HIV-1 Nef upregulates the expression of transcription factor 8 in HeLa cells
11676	155871	NP_057853.1	Tat	downregulates	9606	7015	NP_937983.2	telomerase reverse transcriptase isoform 1	15017382	2007-11-07 17:28	HIV-1 Tat downregulates the amount of TERT component in the nucleus, where this subunit is required for telomere elongation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	7015	NP_937983.2	telomerase reverse transcriptase isoform 1	9662195	2007-11-07 17:30	Telomerase activity in normal CD34+ hematopoietic progenitor cells (HPC) exposed to recombinant gp120 is significantly reduced
11676	155871	NP_057853.1	Tat	regulated by	9606	7023	NP_003214.1	transcription factor AP-4	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	inhibited by	9606	7024	NP_005644.2	alpha-globin transcription factor CP2 isoform 1	8289393,9371597,10888618,11940654	2007-11-07 17:30	YY1 and LSF transcription factors cooperatively recruit histone deacetylase 1 (HDAC1) to the HIV-1 LTR promoter, thereby inhibiting transcription and Tat activation of the promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	7025	NP_005645.1	COUP transcription factor 1	2739739,8798567,9388268,10644726	2007-11-07 17:29	Through amino acids 49-148, COUP-TF physically interacts with amino acids 48-72 of HIV-1 Tat, allowing COUP-TF to cooperate with Tat during transactivation of the HIV-1 LTR promoter
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	7037	NP_003225.1	transferrin receptor	9341758	2007-11-07 17:27	Treatment of CD4+ T lymphocytes with HIV-1 gp120 before anti-CD3 stimulation impedes cell cycle progression as measured by reduced CD71 expression
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7037	NP_003225.1	transferrin receptor	15784911	2007-11-07 17:31	CD4+ T cells infected with CCR5-tropic HIV-1 have significantly higher levels of activation-marker expression (e.g. CD25, CD71 and HLA-DR) than CD4+ T lymphocytes infected with CXCR4-tropic HIV-1
11676	156110	NP_057857.2	Nef	downregulates	9606	7037	NP_003225.1	transferrin receptor	10451539	2007-11-07 17:28	Treatment of uninfected and acutely or chronically infected MT-4 and H9 T-cells with exogenous HIV-1 Nef downregulates the expression of CD71
11676	156110	NP_057857.2	Nef	modulates	9606	7037	NP_003225.1	transferrin receptor	15569681	2007-11-07 17:28	HIV-1 Nef modulates the trafficking of transferrin receptor (TfR), the prototypical recycling surface protein, with the dileucine motif (amino acids 164-5) in Nef being required for this alteration of TfR recycling
11676	155871	NP_057853.1	Tat	upregulates	9606	7039	NP_003227.1	protransforming growth factor alpha isoform 1	8123596	2007-11-07 17:29	HIV-1 Tat upregulates transcription of the transforming growth factor alpha gene in an epidermal growth factor-dependent manner
11676	155871	NP_057853.1	Tat	upregulates	9606	7040	NP_000651.3	transforming growth factor beta-1 precursor	1281686,7695626,7803268,8264131,8294518,8336945,9383706,9670843,9987082,10431160,15857508	2007-11-07 17:29	HIV-1 Tat upregulates TGF-beta 1 expression in a manner involving IL-6, an effect mediated by Tat amino acids 1-48 and potentially associated with immunosuppression, nephropathy, hematopoietic suppression and glomerulosclerosis
11676	155871	NP_057853.1	Tat	inhibited by	9606	7040	NP_000651.3	transforming growth factor beta-1 precursor	10376933	2007-11-07 17:29	TGF-beta inhibits/down-modulates HIV-1 Tat-induced IL-8 production
11676	155871	NP_057853.1	Tat	upregulates	9606	7040	NP_000651.3	transforming growth factor beta-1 precursor	12202226,12758167	2007-11-07 17:29	HIV-1 Tat upregulation of TGF-beta 1 is likely involved in the regulation of MCP-1 transcription by Tat and the interactions of Tat with Smad-3 and Smad-4, two transcription factors whose activities are induced by the TGF-beta 1 pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	7040	NP_000651.3	transforming growth factor beta-1 precursor	7495302	2007-11-07 17:31	HIV-1 gp160 and serum-free macrophage supernatant (MSP) enhance synthesis of type IV collagen by mesangial cells; anti-TGF-beta antibodies attenuate this gp160/MSP-induced collagen synthesis
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	upregulates	9606	7040	NP_000651.3	transforming growth factor beta-1 precursor	8811049	2007-11-07 17:31	HIV-1 gp160 induces TGF-beta production in human PBMC
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7040	NP_000651.3	transforming growth factor beta-1 precursor	8551249	2007-11-07 17:27	HIV-1 gp120-mediated suppression of CD34+ cell growth is entirely due to an upregulation of endogenous TGF-beta 1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7040	NP_000651.3	transforming growth factor beta-1 precursor	16179804	2007-11-07 17:31	HIV-1 gp120 and p300 synergistically increase TGF-beta, ATF-2 and activating protein-1 (AP-1) expression leading to tubular cell apoptosis; in addition, HIV-1 gp120 treatment causes phosphorylation of Smad2 and downregulation of c-Jun
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7040	NP_000651.3	transforming growth factor beta-1 precursor	16179804	2007-11-07 17:31	HIV-1 gp120-induced apoptosis in human proximal renal tubular cells is significantly enhanced by p300, and Smad7 and an anti-TGF-beta antibody inhibit this effect of p300
11676	155871	NP_057853.1	Tat	upregulates	9606	7042	NP_003229.1	transforming growth factor beta-2 isoform 2	15857508	2007-11-07 17:28	Transforming growth factor, beta 2 (TGF-beta2) is upregulated by HIV-1 Tat treatment in human epithelial cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7047	NP_003232.1	transglutaminase 4 (prostate)	7906657	2007-11-07 17:29	Cyclosporin (CsA) treatment prevents gp120-dependent induction of apoptosis by blocking the activation of Ca(2+)-dependent effector elements such as transglutaminase (TG) proteins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	modified by	9606	7047	NP_003232.1	transglutaminase 4 (prostate)	7688299	2007-11-07 17:30	The HIV-1 transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro; soluble CD4 can block the transglutaminase-catalyzed incorporation of the polyamine spermidine into HIV-1 gp41
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7051	NP_000350.1	protein-glutamine gamma-glutamyltransferase K	7906657	2007-11-07 17:29	Cyclosporin (CsA) treatment prevents gp120-dependent induction of apoptosis by blocking the activation of Ca(2+)-dependent effector elements such as transglutaminase (TG) proteins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	modified by	9606	7051	NP_000350.1	protein-glutamine gamma-glutamyltransferase K	7688299	2007-11-07 17:30	The HIV-1 transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro; soluble CD4 can block the transglutaminase-catalyzed incorporation of the polyamine spermidine into HIV-1 gp41
11676	155908	NP_057854.1	Rev	inhibited by	9606	7052	NP_004604.2	protein-glutamine gamma-glutamyltransferase 2 isoform a	11762979	2007-11-07 17:27	tissue transglutaminase has been proposed to interfere with HIV replication through a specific interaction with eukaryotic initiation factor 5A (eIF-5A) that inhibits Rev-mediated nuclear export of viral mRNA
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7052	NP_004604.2	protein-glutamine gamma-glutamyltransferase 2 isoform a	7906657	2007-11-07 17:29	Cyclosporin (CsA) treatment prevents gp120-dependent induction of apoptosis by blocking the activation of Ca(2+)-dependent effector elements such as transglutaminase (TG) proteins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	modified by	9606	7052	NP_004604.2	protein-glutamine gamma-glutamyltransferase 2 isoform a	7688299	2007-11-07 17:30	The HIV-1 transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro; soluble CD4 can block the transglutaminase-catalyzed incorporation of the polyamine spermidine into HIV-1 gp41
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7053	NP_003236.2	transglutaminase 3 precursor	7906657	2007-11-07 17:29	Cyclosporin (CsA) treatment prevents gp120-dependent induction of apoptosis by blocking the activation of Ca(2+)-dependent effector elements such as transglutaminase (TG) proteins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	modified by	9606	7053	NP_003236.2	transglutaminase 3 precursor	7688299	2007-11-07 17:30	The HIV-1 transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro; soluble CD4 can block the transglutaminase-catalyzed incorporation of the polyamine spermidine into HIV-1 gp41
11676	155871	NP_057853.1	Tat	downregulates	9606	7054	NP_000351.2	tyrosine 3-monooxygenase isoform b	10660577	2007-11-07 17:28	In vivo injection of HIV-1 Tat into the striatum of rats caused a loss of tyrosine hydroxylase positive neurons, which may contribute to the explanation of the pathogenesis of the motorial abnormalities often reported in HIV-1 seropositive individuals
11676	155871	NP_057853.1	Tat	downregulates	9606	7054	NP_000351.2	tyrosine 3-monooxygenase isoform b	10660577	2007-11-07 17:28	Treatment of dopaminergic rat PC12 cells with HIV-1 Tat downregulates the expression of tyrosine hydroxylase (TH) by upregulating the expression of the inducible cAMP early repressor which in turn abrogates the transcription activity of the TH promoter
11676	155807	NP_057852.2	Vpr	stimulates	9606	7057	NP_003237.2	thrombospondin-1 precursor	12444143	2007-11-07 17:27	HIV-1 Vpr potentiates the stimulation of thrombospondin 1 by glucocorticoids via the glucocorticoid receptor pathway
11676	155871	NP_057853.1	Tat	inhibited by	9606	7057	NP_003237.2	thrombospondin-1 precursor	10398144	2007-11-07 17:28	Thrombospondin-1 (TSP) prevents endothelial cell motility induced by HIV-1 Tat and inhibits angiogenic activity exerted by Tat in the Matrigel sponge model, suggesting downregulation of TSP may be permissive for development of KS-associated angiogenesis
11676	155871	NP_057853.1	Tat	binds	9606	7057	NP_003237.2	thrombospondin-1 precursor	11023976	2007-11-07 17:28	Thrombospondin-1 (TSP) binds to HIV-1 Tat, an interaction that can be inhibited by heparin which can bind to both TSP and Tat
11676	155871	NP_057853.1	Tat	inhibited by	9606	7057	NP_003237.2	thrombospondin-1 precursor	11023976	2007-11-07 17:28	Thrombospondin-1 inhibits cell internalization and HIV-1 LTR transactivating activity of extracellular HIV-1 Tat, cell interaction and mitogenic activity of extracellular Tat, as well as the autocrine loop of stimulation exerted by endogenous Tat
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7057	NP_003237.2	thrombospondin-1 precursor	9419208	2007-11-07 17:30	Interaction of TSP1 with HIV-1 gp120 involves CSVTCG sequences in the type 1 properdin-like repeats of TSP1 and amino acids 281-300, 311-330, and 361-380 in the C2-V3-C3 domains of gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7057	NP_003237.2	thrombospondin-1 precursor	9419208	2007-11-07 17:30	TSP1 inhibits HIV-1 infection of peripheral blood mononuclear cells and transformed T and promonocytic cell lines by its binding to HIV-1 gp120
11676	155871	NP_057853.1	Tat	synergizes with	9606	7067	NP_003241.2	thyroid hormone receptor alpha isoform 2	7609079,8036737,8537364	2007-11-07 17:28	HIV-1 Tat synergizes with thyroid hormone (T3) receptor alpha to activate the HIV-1 LTR promoter in the absence of T3, which is relieved in its presence, suggesting a possible role for T3 in the control of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	binds	9606	7067	NP_003241.2	thyroid hormone receptor alpha isoform 2	7609079	2007-11-07 17:28	Thyroid hormone (T3) receptor alpha (T3Ralpha) binds to HIV-1 Tat, an interaction mediated through the DNA-binding domain of T3Ralpha (amino acids 51-118) and the arginine-rich basic region (amino acids 49-57) and possibly amino acids 58-72 of Tat
11676	155030	NP_579876.2	matrix	co-localizes with	9606	7070	NP_006279.2	thy-1 membrane glycoprotein preproprotein	10708443	2007-11-07 17:28	HIV-1 Matrix co-localizes with Thy-1 in lipid rafts, the site of virus particle budding from cells, and Thy-1 is incorporated into virus particles as a result of this process
11676	155871	NP_057853.1	Tat	interacts with	9606	7076	NP_003245.1	metalloproteinase inhibitor 1 precursor	8757599	2007-11-07 17:27	HIV-1 Tat induced monocyte invasion is inhibited by anti-beta integrin Ab or tissue inhibitor of metalloproteinase (TIMP), indicating an interaction with beta integrins and TIMP
11676	155871	NP_057853.1	Tat	downregulates	9606	7076	NP_003245.1	metalloproteinase inhibitor 1 precursor	11598182	2007-11-07 17:29	HIV-1 Tat downregulates both basal and bFGF-induced secretion of TIMP-1 and TIMP-2, an effect involved in the Tat and bFGF induced increase in MMP-2 secretion
11676	155871	NP_057853.1	Tat	interacts with	9606	7077	NP_003246.1	metalloproteinase inhibitor 2 precursor	8757599	2007-11-07 17:27	HIV-1 Tat induced monocyte invasion is inhibited by anti-beta integrin Ab or tissue inhibitor of metalloproteinase (TIMP), indicating an interaction with beta integrins and TIMP
11676	155871	NP_057853.1	Tat	downregulates	9606	7077	NP_003246.1	metalloproteinase inhibitor 2 precursor	11598182	2007-11-07 17:29	HIV-1 Tat downregulates both basal and bFGF-induced secretion of TIMP-1 and TIMP-2, an effect involved in the Tat and bFGF induced increase in MMP-2 secretion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	7082	NP_003248.3	tight junction protein ZO-1 isoform a	15977641	2007-11-07 17:30	Treatment of cultured human brain endothelial cells with HIV-1 gp120 results in increased permeability of the endothelial monolayer and causes disruption and downregulation of the tight junction proteins ZO-1, ZO-2, and occludin in these cells
11676	155348	NP_705926.1	retropepsin	cleaves	9606	7094	NP_006280.2	talin 1	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155807	NP_057852.2	Vpr	downregulates	9606	7099	NP_612564.1	toll-like receptor 4 precursor	12444143	2007-11-07 17:27	HIV-1 Vpr potentiates the suppression of Toll-like receptor 4 by glucocorticoids via the glucocorticoid receptor pathway
11676	155871	NP_057853.1	Tat	downregulates	9606	7122	NP_003268.1	claudin 5	14515355,16697675	2007-11-07 17:30	Exposure of brain microvascular endothelial cells to HIV-1 Tat results in a decrease of claudin-1, claudin-5, and zonula occludens-2 expression and cellular redistribution of claudin-5, suggesting potential disturbance of the blood-brain barrier by Tat
11676	155030	NP_579876.2	matrix	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	12105273,12542496	2007-11-07 17:28	HIV-1 Matrix enhances the cytokine-induced production of TNF-alpha
11676	155030	NP_579876.2	matrix	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	16427155	2007-11-07 17:29	HIV-1 Matrix slightly enhances TNF-alpha and IFN-gamma secretion induced by IL-15 monocyte stimulation and counteracts IL-4 mediated inhibition in the production of these cytokines
11676	155807	NP_057852.2	Vpr	modulates	9606	7124	NP_000585.2	tumor necrosis factor	9334723,10775602,15142381,15780175,15817944	2007-11-07 17:27	HIV-1 Vpr modulates expression of TNFalpha, increasing or suppressing TNFalpha expression through varying effects on NF-kappa B activity in different cell lines
11676	155807	NP_057852.2	Vpr	inhibits	9606	7124	NP_000585.2	tumor necrosis factor	9449720	2007-11-07 17:27	HIV-1 Vpr inhibits TNFalpha induced apoptosis in Jurkat cells
11676	155807	NP_057852.2	Vpr	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	12457980	2007-11-07 17:27	HIV-1 Vpr enhances HIV-1 reproduction in U1 cells by the induction of TNFalpha
11676	155871	NP_057853.1	Tat	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	1279199,7494249,7526541,7695626,7818827,7859743,8724035,8852605,9110146,9278385,9378998,9651389,9670843,9730685,10843712,10964543,11751963,12482669,14550782,16375755	2007-11-07 17:29	HIV-1 Tat upregulates tumor necrosis factor alpha (TNF-alpha) expression, an effect mediated in U937 cells through the inhibition of CD26
11676	155871	NP_057853.1	Tat	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	7494249,7859743,8724035,9438495	2007-11-07 17:29	Upregulation of TNF-alpha by HIV-1 Tat leads to activation of NF-kappa B, leading to NF-kappa B induced activation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	synergizes with	9606	7124	NP_000585.2	tumor necrosis factor	7523444,7693046	2007-11-07 17:29	HIV-1 Tat synergizes with TNF-alpha to enhance IL-6 secretion and activate human central nervous system-derived endothelial cells
11676	155871	NP_057853.1	Tat	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	7526541,7859743,9639071,9651389,11860474,16697675	2007-11-07 17:29	Upregulation of TNF-alpha by HIV-1 Tat is implicated in the toxic effects of Tat, including neuronal death and astroglial dysfunction
11676	155871	NP_057853.1	Tat	interacts with	9606	7124	NP_000585.2	tumor necrosis factor	7859743,9110146	2007-11-07 17:29	HIV-1 Tat interacts with TNF-alpha to potentiate NF-kappa B activation by downregulation of manganese-dependent superoxide dismutase (MnSOD)
11676	155871	NP_057853.1	Tat	synergizes with	9606	7124	NP_000585.2	tumor necrosis factor	9269771	2007-11-07 17:29	HIV-1 Tat synergizes with TNF-alpha to induce the expression of adhesion molecules ICAM-1, VCAM-1 and ELAM-1
11676	155871	NP_057853.1	Tat	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	9278385,9730685,10843712,11579140,12482669	2007-11-07 17:29	induction of TNF-alpha by HIV-1 Tat requires activation of NF-kappa B and also involves protein kinase A, tyrosine kinase, phospholipase C, protein kinase C, MAPK, and release of calcium from inositol 1,4,5-triphosphate receptor-regulated stores
11676	155871	NP_057853.1	Tat	interacts with	9606	7124	NP_000585.2	tumor necrosis factor	9378998	2007-11-07 17:29	HIV-1 Tat interacts with TNF-alpha to induce monocyte metalloproteinase-9 production
11676	155871	NP_057853.1	Tat	interacts with	9606	7124	NP_000585.2	tumor necrosis factor	10376933,16375755	2007-11-07 17:29	HIV-1 Tat and TNF-alpha interact additively in upregulating IL-8 production
11676	155871	NP_057853.1	Tat	synergizes with	9606	7124	NP_000585.2	tumor necrosis factor	10438928	2007-11-07 17:29	IL-1beta, TNF-alpha, and IFN-gamma synergize with HIV-1 Tat to promote in nude mice the development of angioproliferative Kaposi's sarcoma-like lesions
11676	155871	NP_057853.1	Tat	inhibits	9606	7124	NP_000585.2	tumor necrosis factor	11522182	2007-11-07 17:29	HIV-1 Tat inhibits TNF-alpha-induced repression of tumor necrosis factor receptor p55 and amplifies TNF-alpha activity in stably tat-transfected HeLa cells
11676	155871	NP_057853.1	Tat	activated by	9606	7124	NP_000585.2	tumor necrosis factor	11689614	2007-11-07 17:28	Treatment of T lymphocytes with IL-2, IL-6 and TNFalpha increases CDK9 and cyclin T1 protein levels, suggesting a mechanism for activation of HIV-1 Tat function and reactivation of HIV-1 in CD4+ T lymphocytes harboring a latent provirus
11676	155871	NP_057853.1	Tat	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	11730934	2007-11-07 17:28	HIV-1 Tat cooperates with Puralpha, cyclin T1, and CDK9 to activate the TNFalpha promoter and upregulate TNFalpha expression
11676	155871	NP_057853.1	Tat	synergizes with	9606	7124	NP_000585.2	tumor necrosis factor	15246652	2007-11-07 17:28	HIV-1 Tat and TNF-alpha synergistically activate the adhesion of leukocytes to endothelial cells
11676	155871	NP_057853.1	Tat	regulated by	9606	7124	NP_000585.2	tumor necrosis factor	15661163	2007-11-07 17:28	HIV-1 Tat-induced calcium mobilization and TNF-alpha production in primary human monocytes are entirely regulated by DHP receptors
11676	155871	NP_057853.1	Tat	downregulates	9606	7124	NP_000585.2	tumor necrosis factor	16547255	2007-11-07 17:31	HIV-1 Tat from subtype E virus isolates inhibits TNF gene transcription and protein production in CD4(+) Jurkat T cells, and this repression is associated with the tryptophan at residue 32 of Tat
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	downregulates	9606	7124	NP_000585.2	tumor necrosis factor	1993354,7706435,9269777,9344703	2007-11-07 17:30	Pretreatment of CD4+ T cells with HIV-1 gp160 results in marked inhibition of TNF-alpha secretion
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	induces release of	9606	7124	NP_000585.2	tumor necrosis factor	9226228	2007-11-07 17:31	HIV-1 gp160-induced apoptosis is affected in part by the release of TNF-alpha and is associated with attenuated Bcl-2 mRNA expression
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	downregulates	9606	7124	NP_000585.2	tumor necrosis factor	9344703	2007-11-07 17:31	Pretreatment of cells with HIV-1 gp160 results in marked inhibition of tyrosine phosphorylation of p59(fyn), PLC-gamma1, ras activation, and TNF-alpha secretion in anti-CD3 mAb activated CD4+ T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7124	NP_000585.2	tumor necrosis factor	1380260,12372982	2007-11-07 17:30	Pretreatment of HIV-1 infected cells with TNF alpha augments syncytia formation mediated by the interaction of HIV-1 gp120 with cell surface CD4 molecules
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	7124	NP_000585.2	tumor necrosis factor	1918997,7536422,7561697,7704970,8267288,8482849,8806809,12089333,15288392,15307952,15481145,16313253	2007-11-07 17:30	HIV-1 gp120 stimulates human cells to release TNF-alpha, IL-1 beta, IL-6, and granulocyte-macrophage-CSF, and this effect can be blocked with soluble CD4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	1918999,9223523	2007-11-07 17:30	B cells from peripheral blood and lymph nodes of HIV-infected individuals secrete significant levels of TNF-alpha in the presence of HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	7511078,7815507,8764000,9108403,9225992,9658081,12089333,15481145,16160188	2007-11-07 17:31	Cytokines induced in vitro by HIV-1 gp120 in normal peripheral blood mononuclear cells (PBMC) include interferon-alpha (IFN-alpha) and IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-10, IL-1 alpha and IL-1 beta
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7124	NP_000585.2	tumor necrosis factor	8336118	2007-11-07 17:29	Treatment of HIV-1-infected monocytes with TNF-alpha increases the sensitivity of the interaction of the HIV-1 antigen gp120 with cytotoxic sera from HIV-1 infected individuals
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	7124	NP_000585.2	tumor necrosis factor	8381971	2007-11-07 17:30	HIV-1 gp120 partially inhibits the negative beta-adrenergic modulation of lipopolysaccharide-induced production of tumor necrosis factor alpha in microglial cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	8707350,12372982	2007-11-07 17:27	CD4 downregulation by the treatment of macrophages with HIV-1 gp120 is mediated through the induction of endogenous TNF-alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	enhances	9606	7124	NP_000585.2	tumor necrosis factor	8870842	2007-11-07 17:30	In CD4-positive Jurkat cells, HIV-1 gp120 enhances TNF-induced NF-kappa B activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7124	NP_000585.2	tumor necrosis factor	9744279	2007-11-07 17:31	Apoptosis of CD8+ cells is mediated by the interaction between TNF-alpha bound to the membrane of macrophages (mbTNF) and a receptor on CD8+ T cells (TNF-receptor II, or TNFRII), which is upregulated by treatment with recombinant HIV-1 gp120 or SDF-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	7124	NP_000585.2	tumor necrosis factor	11602715	2007-11-07 17:31	Exposure of macrophages to purified CCR5- or CXCR4-tropic HIV-1 envelope glycoprotein gp120 induces secretion of high levels of macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, RANTES, and tumor necrosis factor alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7124	NP_000585.2	tumor necrosis factor	16313253	2007-11-07 17:30	Enhanced TNF-alpha responses are observed when peripheral blood mononuclear cells (PBMCs) are costimulated with HIV-1 gp120 and mannose-binding lectin (MBL)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	16621960	2007-11-07 17:31	Stimulation of human monocyte-derived macrophages with HIV-1 gp120 results in the CCR5-mediated activation of Lyn and the concomitant Lyn-dependent activation of the mitogen-activated protein (MAP) kinase ERK-1/2, which leads to production of TNF-alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	7124	NP_000585.2	tumor necrosis factor	16846840	2007-11-07 17:31	HIV-1 gp120 stimulates the release of TNF-alpha from TPA-differentiated HL-60 cells; treatment with TNF-alpha neutralizing antibody and anti-TNF-alpha receptor type II (TNFR-II) antibody, inhibits gp120-induced upregulation of mu opioid receptor
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	1548758,1905933,7561697,7706435,10964543	2007-11-07 17:30	HIV-1 gp41 or gp120 synthetic peptides induce the production of interleukin (IL)-1 and tumor necrosis factor (TNF); in contrast, gp41 or gp120 synthetic peptides are able to depress the production of interferon (IFN)-alpha, IFN-gamma, and IL-2
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	10964543	2007-11-07 17:31	HIV-1 gp41 stimulates microglial cell production of cytokines (TNF-alpha, IL-1beta, and IL-6) and chemokines (RANTES and MIP-1alpha)
11676	156110	NP_057857.2	Nef	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	10388525,12574335	2007-11-07 17:27	The activating effect of exogenous HIV-1 Nef on PBMC proliferation and on monocyte-derived macrophages is associated with an upregulation of TNF-alpha and IL-6 production
11676	156110	NP_057857.2	Nef	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	10415019	2007-11-07 17:27	Intracisternal HIV-1 Nef injection upregulates levels of IL-6, TNF-alpha, and IFN-gamma in rat cerebrospinal fluid
11676	156110	NP_057857.2	Nef	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	11000208,16091223,17086054	2007-11-07 17:28	Expression of HIV-1 Nef in a CD4+ human T-cell hybridoma enhances the surface levels of the membrane-bound cytokines tumor necrosis factor (TNF) and LIGHT; the enhancement of TNF and LIGHT depends on the presence of a functional dileucine motif in Nef
11676	156110	NP_057857.2	Nef	inhibits	9606	7124	NP_000585.2	tumor necrosis factor	11153078	2007-11-07 17:28	HIV-1 nef gene expression in human glial cells inhibits tumor necrosis factor alpha-induced apoptosis and promotes cell proliferation through the activation of MAPK and JNK
11676	156110	NP_057857.2	Nef	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	12370346,17077296	2007-11-07 17:27	HIV-1 Nef expression by immature human and macaque dendritic cells (DCs) upregulates IL-6, IL-12, TNF-alpha, CXCL8, CCL3, and CCL4 release, but without upregulating co-stimulatory and other molecules characteristic of mature DCs
11676	156110	NP_057857.2	Nef	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	12504564	2007-11-07 17:29	The presence of recombinant HIV-1 Nef and ethanol upregulates the level of tumor necrosis factor alpha (TNF-alpha) production in primary human brain microvascular endothelial cells
11676	156110	NP_057857.2	Nef	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	15576488,16454711	2007-11-07 17:28	Nef-induced expression of TNF-alpha is observed in rat hippocampus grafted with Nef-transduced macrophages
11676	156110	NP_057857.2	Nef	upregulates	9606	7124	NP_000585.2	tumor necrosis factor	16445909,16454711	2007-11-07 17:29	HIV-1 Nef increases the level of tumor necrosis factor-alpha release from primary human-monocyte-derived macrophages (MDM) infected with HIV-1
11676	155348	NP_705926.1	retropepsin	cleaves	9606	7125	NP_003270.1	troponin C, skeletal muscle	1907279	2007-11-07 17:29	HIV-1 protease hydrolyzes troponin C at amino acid residues 101-102
11676	155871	NP_057853.1	Tat	upregulates	9606	7132	NP_001056.1	tumor necrosis factor receptor superfamily member 1A precursor	11522182	2007-11-07 17:29	HIV-1 Tat protects tumor necrosis factor receptor p55 from TNF-alpha-induced repression and amplifies TNF-alpha activity in stably tat-transfected HeLa cells
11676	155871	NP_057853.1	Tat	downregulates	9606	7133	NP_001057.1	tumor necrosis factor receptor superfamily member 1B precursor	1335762	2007-11-07 17:29	HIV-1 Tat downregulates the cell surface expression of the p80 form of the tumor necrosis factor receptor (TNFR2)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7133	NP_001057.1	tumor necrosis factor receptor superfamily member 1B precursor	9744279	2007-11-07 17:31	Apoptosis of CD8+ cells is mediated by the interaction between TNF-alpha bound to the membrane of macrophages (mbTNF) and a receptor on CD8+ T cells (TNF-receptor II, or TNFRII), which is upregulated by treatment with recombinant HIV-1 gp120 or SDF-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7133	NP_001057.1	tumor necrosis factor receptor superfamily member 1B precursor	16846840	2007-11-07 17:31	HIV-1 gp120 upregulates mu opioid receptor (MOR) expression in TPA-differentiated HL-60 cells; treatment with TNF-alpha neutralizing antibody as well as anti-TNF-alpha receptor type II (TNFR-II) antibody, inhibits gp120-induced upregulation of MOR
11676	155348	NP_705926.1	retropepsin	cleaves	9606	7134	NP_003271.1	troponin C, slow skeletal and cardiac muscles	1907279	2007-11-07 17:29	HIV-1 protease hydrolyzes troponin C at amino acid residues 101-102
11676	155030	NP_579881.1	nucleocapsid	enhances	9606	7150	NP_003277.1	DNA topoisomerase 1	2174357,7539924,9209286,9209315	2007-11-07 17:29	Topoisomerase I activity has been detected in HIV particles and HIV-1 nucleocapsid has been shown to interact with and enhance the activity of cellular topoisomerase I, thereby enhancing HIV-1 reverse transcription
11676	155030	NP_579881.1	nucleocapsid	enhances	9606	7150	NP_003277.1	DNA topoisomerase 1	12829794	2007-11-07 17:30	Expression of human topoisomerase I in African green monkey cells enhances the infectivity of HIV-1 in these cells
11676	155348	NP_705927.1	reverse transcriptase	enhanced by	9606	7150	NP_003277.1	DNA topoisomerase 1	7539924,11001406,12051740	2007-11-07 17:29	Topoisomerase I (topo I) enhances HIV-1 reverse transcriptase activity in vitro and this effect can be inhibited by the topo I-specific inhibitor camptothecin
11676	155348	NP_705927.1	reverse transcriptase	enhanced by	9606	7150	NP_003277.1	DNA topoisomerase 1	12051740	2007-11-07 17:29	Topoisomerase I and adenosine triphosphate (ATP) enhance cDNA synthesis by HIV-1 reverse transcriptase, and Topoisomerase I mutants R488A and K532A, lacking enzymatic activity, attenuate the efficiency of cDNA synthesis
11676	155348	NP_705927.1	reverse transcriptase	interacts with	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	11753641,15286711	2007-11-07 17:29	Tumor suppressor protein p53 displays 3' --> 5' exonuclease activity, and interaction of p53 with HIV-1 reverse transcriptase (RT) can provide a proofreading function for HIV-1 RT
11676	155807	NP_057852.2	Vpr	interacts with	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	9685344,15142382,15353294	2007-11-07 17:28	HIV-1 Vpr interacts with p53 in a complex with the transcription factor Sp1 that modulates viral gene transcription from the HIV-1 LTR promoter
11676	155807	NP_057852.2	Vpr	inhibits	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	9685344,15142382	2007-11-07 17:28	Overexpression of p53 decreases the level of activation of the viral LTR promoter by HIV-1 Vpr
11676	155807	NP_057852.2	Vpr	activates	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	11196199	2007-11-07 17:28	HIV-1 Vpr can neutralize inhibitory effects of the human homologue of yeast Rad23 protein A (hHR23A) on p53, thereby activating p53 transcriptional activity
11676	155807	NP_057852.2	Vpr	regulated by	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	12573582,15302882	2007-11-07 17:28	Activation of p21/Waf1/Cip1 by HIV-1 Vpr appears to be regulated by p53
11676	155807	NP_057852.2	Vpr	interacts with	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	15302882	2007-11-07 17:28	Results from GST pull-down assays show the association of Vpr with p53 in extracts containing Sp1, suggesting the physical interaction of Vpr with Sp1 and p53 could modulate transcriptional activity of p21
11676	155807	NP_057852.2	Vpr	inhibits	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	16983346	2007-11-07 17:31	HIV-1 Vpr inhibits the interaction of p53 and Rad51 in chromatin fractions, as observed under irradiation-induced DNA double-strand breaks
11676	155871	NP_057853.1	Tat	downregulates	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	7777531,9129988,11311202,11554765	2007-11-07 17:27	HIV-1 Tat downregulates the expression of p53, suggesting a mechanism for HIV-1-mediated transformation of infected cells
11676	155871	NP_057853.1	Tat	inhibited by	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	7777531,8207805	2007-11-07 17:27	Wild-type p53 is a potent inhibitor of HIV-1 Tat transactivation of the HIV-1 LTR promoter in Jurkat T cells and Hep3B cells
11676	155871	NP_057853.1	Tat	binds	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	7818536	2007-11-07 17:27	HIV-1 Tat binds to p53, an interaction mediated by the basic region of Tat (amino acids 49-57) and the acidic O2 domain of p53 (amino acids 341-354
11676	155871	NP_057853.1	Tat	cooperates with	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	11554765	2007-11-07 17:27	HIV-1 Tat and p53 cooperate in the activation of HIV-1 gene expression in SaOS2 cells
11676	155871	NP_057853.1	Tat	inhibits	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	12501250	2007-11-07 17:27	HIV-1 Tat inhibits p53-responsive transcription by binding to histone acetyltransferases and repressing the acetylation of p53 on residue Lys-320, alluding to a mechanism whereby Tat may impair p53 functions, thus favoring the establishment of neoplasia
11676	155871	NP_057853.1	Tat	upregulates	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	14595650	2007-11-07 17:27	Supernatants from HIV-1 Tat-transfected monocytoid cells induces p53 expression in neurons, indicating a role for Tat in the neuropathogenesis of HIV-1
11676	155871	NP_057853.1	Tat	interacts with	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	15050687	2007-11-07 17:28	When expressed in astrocytes, neurons, and non-glial 293T cells, HIV-1 Tat interacts with a number of cell cycle-related proteins including cyclin A, cyclin B, cyclin D3, Cdk2, Cdk4, Cdk1/Cdc2, cdc6, p27, p53, p63, hdlg, and PCNA
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	9520163,12404120,14555204,14993250,15155568,15642743,16005638	2007-11-07 17:30	HIV-1 gp120 is potentially cytotoxic to human cells through the induction of p53, which may eventually lead to induction of apoptosis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	11602639,15033690,16005638	2007-11-07 17:31	Syncytial apoptosis mediated by the fusion of cells expressing HIV-1 gp120 with cells expressing the CD4/CXCR4 receptor/coreceptor complex causes phosphorylation of p53 on serine 15 and Bax upregulation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	15642743	2007-11-07 17:31	p38 MAPK-mediated p53 phosphorylation on serine 46 contributes to apoptosis induced by the HIV-1 envelope glycoprotein complex (gp120/gp41)
11676	156110	NP_057857.2	Nef	binds	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	7853525,11861836,12734410,15078178	2007-11-07 17:28	HIV-1 Nef binds directly to tumor suppressor protein p53; an N-terminal 57-residue fragment of Nef (Nef 1-57) contains the p53-binding domain
11676	156110	NP_057857.2	Nef	interacts with	9606	7157	NP_000537.3	cellular tumor antigen p53 isoform a	15371598	2007-11-07 17:28	Assays with phage-displayed Nef from HIV-1 NL4-3 have been used to identify a series of guanidine alkaloid-based inhibitors of Nef interactions with p53, actin, and p56(lck)
11676	155871	NP_057853.1	Tat	binds	9606	7161	NP_005418.1	tumor protein p73 isoform a	16135803,16235026	2007-11-07 17:28	Association of tumor protein p73 with HIV-1 Tat prevents the acetylation of Tat on lysine 28 by PCAF, and requires the cysteine-rich domain (amino acids 30 to 40) of Tat, which binds to the N-terminal region (amino acids 1 to 120) of p73
11676	155348	NP_705926.1	retropepsin	degrades	9606	7168	NP_000357.3	tropomyosin alpha-1 chain isoform 5	1516138	2007-11-07 17:29	Exposure of human skin fibroblasts to HIV-1 protease induces the degradation of the vimentin filament network and the disappearance of the tropomyosin isoforms microfilament network
11676	155348	NP_705926.1	retropepsin	cleaves	9606	7168	NP_000357.3	tropomyosin alpha-1 chain isoform 5	1516138,1991513,8424456	2007-11-07 17:29	HIV-1 protease cleaves tropomyosin in vitro at positions 30, 51, and 87
11676	155348	NP_705926.1	retropepsin	degrades	9606	7169	NP_003280.2	tropomyosin beta chain isoform 1	1516138,8424456	2007-11-07 17:29	Exposure of human skin fibroblasts to HIV-1 protease induces the degradation of the vimentin filament network and the disappearance of the tropomyosin isoforms microfilament network
11676	155348	NP_705926.1	retropepsin	degrades	9606	7170	NP_689476.2	tropomyosin alpha-3 chain isoform 1	1516138,8424456	2007-11-07 17:29	Exposure of human skin fibroblasts to HIV-1 protease induces the degradation of the vimentin filament network and the disappearance of the tropomyosin isoforms microfilament network
11676	155945	NP_057855.1	Vpu	downregulates	9606	7185	NP_005649.1	TNF receptor-associated factor 1	11696595	2007-11-07 17:27	Levels of TRAF1 are reduced in T cells as a result of HIV-1 Vpu-mediated inhibition of NF-kappa B activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7188	NP_004610.1	TNF receptor-associated factor 5	15749123	2007-11-07 17:30	Up-regulation of apoptosis genes such as caspase 1, NALP1, and TNF receptor-associated factor 5 are induced by HIV-gp120/ethanol in human neurons
11676	155030	NP_579883.1	p6	binds	9606	7251	NP_006283.1	tumor susceptibility gene 101 protein	11427703,11595185,11726971,11805336,12006492,12379843,12388682,12598123,12663786,12743307,12915533,14581576,15795524,16138902,16234236,16470130,16571793,16808324,16940516	2007-11-07 17:29	The direct binding of the UEV domain (amino acids 1-145) of TSG101 to the L domain (amino acids 7-10) of HIV-1 p6-Gag is essential for the p6 directed budding of HIV-1 virions from infected cells
11676	155030	NP_579883.1	p6	binds	9606	7251	NP_006283.1	tumor susceptibility gene 101 protein	12900394,16470130,17083721	2007-11-07 17:30	The p6 domain of HIV-1 Gag mimics the Tsg101-recruiting activity of the human Hrs protein
11676	155030	NP_579883.1	p6	binds	9606	7251	NP_006283.1	tumor susceptibility gene 101 protein	14505569,14505570,14519844,16470130	2007-11-07 17:29	AIP1 binds to the LXXLF motif in HIV-1 p6 (amino acids 41-44) and also binds to TSG101 to act as a component of the viral budding machinery
11676	155030	NP_579883.1	p6	binds	9606	7251	NP_006283.1	tumor susceptibility gene 101 protein	16234236	2007-11-07 17:29	A short helix (helix-1; amino acid residues 14-18) in HIV-1 p6 enhances the binding of the p6 PTAP motif (residues 7-10) to TSG101
11676	155871	NP_057853.1	Tat	binds	9606	7277	NP_005991.1	tubulin alpha-4A chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	enhances polymerization of	9606	7277	NP_005991.1	tubulin alpha-4A chain	15691386,15698476	2007-11-07 17:28	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155871	NP_057853.1	Tat	disrupts	9606	7277	NP_005991.1	tubulin alpha-4A chain	16327313	2007-11-07 17:29	HIV-1 Tat causes a dramatic decrease in alpha-tubulin staining, which indicates disruption of the cytoskeleton organization in human intestinal epithelial cells
11676	155908	NP_057854.1	Rev	depolymerizes	9606	7277	NP_005991.1	tubulin alpha-4A chain	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces acetylation of	9606	7277	NP_005991.1	tubulin alpha-4A chain	15103018,16148047	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4+-permissive cells increases the level of acetylated alpha-tubulin in a CD4-dependent manner; overexpression of Histone Deacetylase 6 (HDAC6) inhibits the acetylation of alpha-tubulin and prevents HIV-1-cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7277	NP_005991.1	tubulin alpha-4A chain	15103018	2007-11-07 17:31	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155871	NP_057853.1	Tat	binds	9606	7278	NP_005992.1	tubulin alpha-3C/D chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	enhances polymerization of	9606	7278	NP_005992.1	tubulin alpha-3C/D chain	15691386,15698476	2007-11-07 17:28	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155871	NP_057853.1	Tat	disrupts	9606	7278	NP_005992.1	tubulin alpha-3C/D chain	16327313	2007-11-07 17:29	HIV-1 Tat causes a dramatic decrease in alpha-tubulin staining, which indicates disruption of the cytoskeleton organization in human intestinal epithelial cells
11676	155908	NP_057854.1	Rev	depolymerizes	9606	7278	NP_005992.1	tubulin alpha-3C/D chain	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces acetylation of	9606	7278	NP_005992.1	tubulin alpha-3C/D chain	15103018,16148047	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4+-permissive cells increases the level of acetylated alpha-tubulin in a CD4-dependent manner; overexpression of Histone Deacetylase 6 (HDAC6) inhibits the acetylation of alpha-tubulin and prevents HIV-1-cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7278	NP_005992.1	tubulin alpha-3C/D chain	15103018	2007-11-07 17:31	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155871	NP_057853.1	Tat	binds	9606	7280	NP_001060.1	tubulin beta-2A chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	enhances polymerization of	9606	7280	NP_001060.1	tubulin beta-2A chain	15691386,15698476	2007-11-07 17:28	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155871	NP_057853.1	Tat	downregulates	9606	7280	NP_001060.1	tubulin beta-2A chain	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155908	NP_057854.1	Rev	depolymerizes	9606	7280	NP_001060.1	tubulin beta-2A chain	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155807	NP_057852.2	Vpr	induces accumulation of	9606	7283	NP_001061.2	tubulin gamma-1 chain	14767062	2007-11-07 17:28	HIV-1 Vpr-expressing HeLa cells stained with centriole markers pericentrin, gamma-tubulin, and Cen2 contain multiple pairs of centrioles scattered in the perinuclear region, indicating Vpr causes the accumulation of multiple centrosome-like structures
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modified by	9606	7295	NP_003320.2	thioredoxin	16507315	2007-11-07 17:31	The ability of thioredoxin, a protein disulfide isomerase (PDI), to reduce the disulfide bond in CD4 is enhanced in the presence of HIV-1 gp120 and thioredoxin also reduces disulfide bonds in gp120 directly in the absence of CD4
11676	156110	NP_057857.2	Nef	stabilizes	9606	7295	NP_003320.2	thioredoxin	11298454,11323689	2007-11-07 17:27	HIV-1 Nef stabilizes the association of thioredoxin with ASK1, thereby inhibiting the catalytic activity of ASK1, Fas- and TNFalpha-mediated apoptosis, and activation of c-Jun amino-terminal kinase
11676	155030	NP_579876.2	matrix	ubiquitinated by	9606	7314	NP_061828.1	ubiquitin precursor	15994808,16775314	2007-11-07 17:29	Monoubiquitinated forms of the HIV-1 matrix (MA), capsid (CA), and nucleocapsid (NC) proteins are detected in mature virus particles
11676	155030	NP_579880.1	capsid	ubiquitinated by	9606	7314	NP_061828.1	ubiquitin precursor	15994808,16775314	2007-11-07 17:29	Monoubiquitinated forms of the HIV-1 matrix (MA), capsid (CA), and nucleocapsid (NC) proteins are detected in mature virus particles
11676	155030	NP_579881.1	nucleocapsid	ubiquitinated by	9606	7314	NP_061828.1	ubiquitin precursor	15994808,16775314	2007-11-07 17:29	Monoubiquitinated forms of the HIV-1 matrix (MA), capsid (CA), and nucleocapsid (NC) proteins are detected in mature virus particles
11676	155030	NP_579883.1	p6	ubiquitinated by	9606	7314	NP_061828.1	ubiquitin precursor	9525617,11087859,11087860,11112487,11991975,16775314	2007-11-07 17:29	The L domain (P(T/S)APP; amino acids 7-11) of HIV-1 p6-Gag interacts with a ubiquitin ligase complex resulting in the monoubiquitination of p6
11676	155030	NP_579883.1	p6	ubiquitinated by	9606	7314	NP_061828.1	ubiquitin precursor	11087859,12610113,15994808,16808324	2007-11-07 17:29	Ubiquitination of HIV-1 p6-Gag may be important for proper virus release from cells
11676	155030	NP_787042.1	p1	ubiquitinated by	9606	7314	NP_061828.1	ubiquitin precursor	16775314	2007-11-07 17:31	HIV-1 p1 is mono- or di-ubiquitinated at levels comparable to those of the other HIV-2 Gag domains MA, CA, NC, and p6; cumulative replacement of all lysine residues in NC and p1 or in NC and p6 results in an accumulation of late budding structures
11676	155871	NP_057853.1	Tat	ubiquitinated by	9606	7314	NP_061828.1	ubiquitin precursor	12883554	2007-11-07 17:29	HIV-1 Tat is ubiquitinated on Lys71 by Hdm2 in conjunction with ubiquitin-activating enzyme E1 and ubiquitin-conjugating enzyme E2D 1 (UbcH5)
11676	155908	NP_057854.1	Rev	ubiquitinated by	9606	7314	NP_061828.1	ubiquitin precursor	17067581	2007-11-07 17:31	HIV-1 Rev is modified by polyubiquitination at Lys-33 and Lys-115; Lys-33 is the most efficient residue for branching of ubiquitin chains
11676	155030	NP_579876.2	matrix	ubiquitinated by	9606	7316	NP_066289.2	ubiquitin C	15994808,16775314	2007-11-07 17:29	Monoubiquitinated forms of the HIV-1 matrix (MA), capsid (CA), and nucleocapsid (NC) proteins are detected in mature virus particles
11676	155030	NP_579880.1	capsid	ubiquitinated by	9606	7316	NP_066289.2	ubiquitin C	15994808,16775314	2007-11-07 17:29	Monoubiquitinated forms of the HIV-1 matrix (MA), capsid (CA), and nucleocapsid (NC) proteins are detected in mature virus particles
11676	155030	NP_579881.1	nucleocapsid	ubiquitinated by	9606	7316	NP_066289.2	ubiquitin C	15994808,16775314	2007-11-07 17:29	Monoubiquitinated forms of the HIV-1 matrix (MA), capsid (CA), and nucleocapsid (NC) proteins are detected in mature virus particles
11676	155030	NP_579883.1	p6	ubiquitinated by	9606	7316	NP_066289.2	ubiquitin C	9525617,11087859,11087860,11112487,11991975,16775314	2007-11-07 17:30	The L domain (P(T/S)APP; amino acids 7-11) of HIV-1 p6-Gag interacts with a ubiquitin ligase complex resulting in the monoubiquitination of p6
11676	155030	NP_579883.1	p6	ubiquitinated by	9606	7316	NP_066289.2	ubiquitin C	11087859,12610113,15994808,16808324	2007-11-07 17:30	Ubiquitination of HIV-1 p6-Gag may be important for proper virus release from cells
11676	155030	NP_787042.1	p1	ubiquitinated by	9606	7316	NP_066289.2	ubiquitin C	16775314	2007-11-07 17:31	HIV-1 p1 is mono- or di-ubiquitinated at levels comparable to those of the other HIV-2 Gag domains MA, CA, NC, and p6; cumulative replacement of all lysine residues in NC and p1 or in NC and p6 results in an accumulation of late budding structures
11676	155871	NP_057853.1	Tat	ubiquitinated by	9606	7316	NP_066289.2	ubiquitin C	12883554	2007-11-07 17:29	HIV-1 Tat is ubiquitinated on Lys71 by Hdm2 in conjunction with ubiquitin-activating enzyme E1 and ubiquitin-conjugating enzyme E2D 1 (UbcH5)
11676	155908	NP_057854.1	Rev	ubiquitinated by	9606	7316	NP_066289.2	ubiquitin C	17067581	2007-11-07 17:31	HIV-1 Rev is modified by polyubiquitination at Lys-33 and Lys-115; Lys-33 is the most efficient residue for branching of ubiquitin chains
11676	155871	NP_057853.1	Tat	ubiquitinated by	9606	7317	NP_003325.2	ubiquitin-like modifier-activating enzyme 1	12883554	2007-11-07 17:29	Ubiquitination of HIV-1 Tat by Hdm2 requires ubiquitin-activating enzyme E1
11676	155871	NP_057853.1	Tat	ubiquitinated by	9606	7321	NP_003329.1	ubiquitin-conjugating enzyme E2 D1	12883554	2007-11-07 17:29	Ubiquitination of HIV-1 Tat by Hdm2 requires ubiquitin-conjugating enzyme E2D 1 (UbcH5)
11676	155030	NP_579883.1	p6	interacts with	9606	7329	NP_003336.1	SUMO-conjugating enzyme UBC9	15613319	2007-11-07 17:29	HIV-1 p6 interacts with Ubc9 in a yeast two-hybrid system
11676	156110	NP_057857.2	Nef	relocalizes	9606	7332	NP_003338.1	ubiquitin-conjugating enzyme E2 L3	16356860	2007-11-07 17:29	HIV-1 Nef excludes E2 ubiquitin-conjugating enzyme UbcH7, which acts in conjunction with c-Cbl, from lipid rafts in CD4 T cells; this Nef-mediated exclusion is associated with failure of ubiquitination of activated Vav
11676	156110	NP_057857.2	Nef	relocalizes	9606	7332	NP_003338.1	ubiquitin-conjugating enzyme E2 L3	16356860	2007-11-07 17:29	In the presence of Nef, lipid raft Cdc42 is activated and forms a ternary complex between the c-Cbl-interacting protein p85Cool-1/betaPix and c-Cbl, displacing UbcH7 from rafts
11676	155030	NP_579883.1	p6	interacts with	9606	7341	NP_003343.1	small ubiquitin-related modifier 1 isoform a precursor	15613319	2007-11-07 17:29	HIV-1 p6 interacts with SUMO-1 through a covalent attachment of SUMO-1 to lysine 27 of p6, resulting in the incorporation of SUMO-1 into HIV-1 virions
11676	155871	NP_057853.1	Tat	inhibits	9606	7342	NP_055332.2	upstream binding protein 1 (LBP-1a)	7836461	2007-11-07 17:30	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation, is suppressed by HIV-1 Tat
11676	155871	NP_057853.1	Tat	inhibited by	9606	7342	NP_055332.2	upstream binding protein 1 (LBP-1a)	15207707	2007-11-07 17:28	Combination of LBP-1 and Oct1 cellular transcription activators represses transcription initiation at the HIV-1 LTR promoter by HIV-1 Tat
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7368	NP_003351.2	2-hydroxyacylsphingosine 1-beta-galactosyltransferase precursor	7941321	2007-11-07 17:27	Treatment of human colonic epithelial cells with recombinant gamma-interferon (rlFN gamma) induces a dose-dependent inhibition of Galactosyl ceramide (GalCer) expression on the cell surface; GalCer is a receptor for HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7368	NP_003351.2	2-hydroxyacylsphingosine 1-beta-galactosyltransferase precursor	8457384	2007-11-07 17:29	Galactosyl ceramide (GalCer) or sulfatide (sul) may serve as an alternate receptor for human immunodeficiency virus (HIV) in neural cell; the amino acids of HIV-1 gp120 responsible for GalCer/sul binding reside between amino acids 206 and 275
11676	155348	NP_705928.1	integrase	binds	9606	7374	NP_550433.1	uracil-DNA glycosylase isoform UNG2	9882380,12458223,12667798,15875659,16075307	2007-11-07 17:29	Uracil DNA Glycosylase (UNG2; amino acids 1-51) binds to HIV-1 integrase (amino acids 170-180) and is incorporated into HIV-1 particles by binding to the integrase domain of the HIV-1 Gag-Pol polyprotein
11676	155348	NP_705928.1	integrase	incorporates	9606	7374	NP_550433.1	uracil-DNA glycosylase isoform UNG2	12458223,12670953	2007-11-07 17:29	HIV-1 L172A/K173A mutant virus is deficient for Uracil DNA Glycosylase (UNG2) incorporation into virions and is defective for replication due to a blockage at the stage of proviral DNA integration
11676	155807	NP_057852.2	Vpr	binds	9606	7374	NP_550433.1	uracil-DNA glycosylase isoform UNG2	8551605,9151883,9371639,9525900,10888643,12525642,16103149,16120388,17090531	2007-11-07 17:28	HIV-1 Vpr (amino acids 15-77) binds to the uracil DNA glycosylase DNA repair enzyme (amino acids 222-225) and thereby modulates the HIV-1 mutation rate
11676	155807	NP_057852.2	Vpr	incorporates	9606	7374	NP_550433.1	uracil-DNA glycosylase isoform UNG2	9882380,10888643,15142377,16103149	2007-11-07 17:28	One report indicates incorporation of uracil DNA glycosylase (UNG) into HIV-1 virions is mediated by binding of HIV-1 Vpr to UNG, however another indicates virion incorporation of UNG is independent of Vpr and is mediated by the HIV-1 Integrase protein
11676	155807	NP_057852.2	Vpr	binds	9606	7374	NP_550433.1	uracil-DNA glycosylase isoform UNG2	15096517	2007-11-07 17:31	In a yeast two-hybrid assay, tryptophan in position 54 of HIV-1 Vpr is critical for maintaining the interaction of Vpr with UNG2, and the WXXF motif (residues 231-234) of UNG2 is involved in this binding to Vpr
11676	155807	NP_057852.2	Vpr	incorporates	9606	7374	NP_550433.1	uracil-DNA glycosylase isoform UNG2	15096517	2007-11-07 17:31	The interaction of HIV-1 Vpr with UNG2 leads to virion incorporation of catalytically active UNG2, which is directly involved with Vpr in modulating the HIV-1 mutation rate
11676	155807	NP_057852.2	Vpr	complexes with	9606	7374	NP_550433.1	uracil-DNA glycosylase isoform UNG2	16103149	2007-11-07 17:31	HIV-1 Vpr induces the ubiquitination of UNG and forms a complex with UNG
11676	155807	NP_057852.2	Vpr	downregulates	9606	7374	NP_550433.1	uracil-DNA glycosylase isoform UNG2	16103149	2007-11-07 17:31	HIV-1 Vpr-induced reduction in uracil DNA glycosylase (UNG) is mediated through proteasomal degradation
11676	155807	NP_057852.2	Vpr	binds	9606	7374	NP_550433.1	uracil-DNA glycosylase isoform UNG2	17090531	2007-11-07 17:31	Expression of exogenous HIV-1 Vpr inhibits class switch recombination (CSR) by competing with some endogenous factors for the WXXF site (residues 222-225) of uracil-DNA glycosylase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	induces phosphorylation of	9606	7409	NP_005419.2	proto-oncogene vav	9269777	2007-11-07 17:30	HIV-1 gp160 alone or CD4/gp160 cross-linking induces tyrosine phosphorylation of intracellular substrates p59fyn, zap 70, and p95vav and also leads to ras activation
11676	156110	NP_057857.2	Nef	binds	9606	7409	NP_005419.2	proto-oncogene vav	10394361,11463741,12734410,12884293,14597672,16091223,16356860,16454711	2007-11-07 17:27	The C-terminal SH3 domain of Vav binds to the PXXP motif in HIV-1 Nef and this interaction activates Vav and its downstream effectors, leading to morphological changes, cytoskeletal rearrangements, and the activation of the JNK/SAPK cascade
11676	156110	NP_057857.2	Nef	binds	9606	7409	NP_005419.2	proto-oncogene vav	11525746,16091223	2007-11-07 17:28	The interaction of HIV-1 Nef with Vav is detected by pull-down assays; mutations in the Nef PXXP motif maintain some residual binding capacity to Vav
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	induces phosphorylation of	9606	7410	NP_003362.2	guanine nucleotide exchange factor VAV2 isoform 2	9269777	2007-11-07 17:30	HIV-1 gp160 alone or CD4/gp160 cross-linking induces tyrosine phosphorylation of intracellular substrates p59fyn, zap 70, and p95vav and also leads to ras activation
11676	155871	NP_057853.1	Tat	upregulates	9606	7412	NP_001069.1	vascular cell adhesion protein 1 isoform a precursor	9269771,9792375,10477700,10602408,14550782,15194470,15805138	2007-11-07 17:30	HIV-1 Tat upregulates the expression of VCAM-1 in endothelial cells and astrocytes, an effect that is in part regulated by NF-kappa B and may be associated with AIDS-related Kaposi's sarcoma
11676	155945	NP_057855.1	Vpu	upregulates	9606	7412	NP_001069.1	vascular cell adhesion protein 1 isoform a precursor	15078922	2007-11-07 17:29	HIV-1 Vpu upregulates CD40 expression, which enhances efficient expression of VCAM-1 in endothelial cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7412	NP_001069.1	vascular cell adhesion protein 1 isoform a precursor	11517385,14691297	2007-11-07 17:31	HIV-1 gp120 activates human brain microvascular endothelial cells (HBMEC) via CD4 in upregulating ICAM-1 and VCAM-1 expression, IL-6 secretion and increased monocyte transmigration across monolayers
11676	156110	NP_057857.2	Nef	polarizes	9606	7414	NP_003364.1	vinculin isoform VCL	14597672	2007-11-07 17:28	HIV-1 Nef induces polarization of vinculin, a molecule important for dendritic cell (DC) adhesion, motility, and maturation, at one pole of DCs corresponding to the substrate-adhering portion or leading edge of the cell
11676	155807	NP_057852.2	Vpr	interacts with	9606	7416	NP_003365.1	voltage-dependent anion-selective channel protein 1	10620603,11181702	2007-11-07 17:27	HIV-1 Vpr interacts with a molecular complex of voltage-dependent anion channel (VDAC) and adenine nucleotide translocator (ANT) by directly binding to ANT resulting in the induction of mitochondrial membrane permeabilization
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	deglycosylates	9606	7421	NP_000367.1	vitamin D3 receptor	16545013	2007-11-07 17:31	HIV-1 gp160 and gp120 contain alpha-N-acetylgalactosaminidase (Nagalase) activity, which deglycosylates serum vitamin D3-binding protein (Gc protein)
11676	155871	NP_057853.1	Tat	cooperates with	9606	7422	NP_003367.4	vascular endothelial growth factor A isoform b	10873597	2007-11-07 17:27	VEGF can compete with HIV-1 Tat chemotactic activity in Kaposi's sarcoma (KS) cells, indicating Tat may cooperate with VEGF in activation of VEGFR-2 on KS precursor spindle and endothelial cells and contribute to the aggressiveness of AIDS-KS lesions
11676	155871	NP_057853.1	Tat	induces release of	9606	7422	NP_003367.4	vascular endothelial growth factor A isoform b	11069235	2007-11-07 17:27	The chemokine like region of HIV-1 Tat (amino acids 24-51) induces the release of angiogenic factors, including vascular endothelial growth factor (VEGF), an effect linked to Tat induced angiogenesis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulates	9606	7422	NP_003367.4	vascular endothelial growth factor A isoform b	12089333	2007-11-07 17:31	HIV-1 gp120 modulates expression of the cytokines IL1beta, IL3, IL6, IL10, IL13, IL15, IFNbeta2A, IFNgamma, IFNomega, TNFalpha, VEGF, VEGF B, and LIF in PBMCs and MDMs
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	7430	NP_003370.2	ezrin	8892894	2007-11-07 17:29	The cytoskeletal proteins ezrin, moesin, and cofilin are incorporated into HIV-1 particles, presumably through their interaction with actin which binds to the nucleocapsid domain of HIV-1 Gag
11676	155807	NP_057852.2	Vpr	upregulates	9606	7430	NP_003370.2	ezrin	10713718	2007-11-07 17:27	HIV-1 Vpr-expressing Jurkat T cell clones showed a significant upregulation of ezrin protein expression, indicating a role of Vpr in microfilament system assembly
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7430	NP_003370.2	ezrin	9213396,15818415	2007-11-07 17:27	Ezrin and moesin are structural proteins that bind to the cellular membrane and interact with HIV-1 gp120/gp160 in CD4- and Gal-C-negative brain cells; ezrin and moesin play a role as gp120/gp160 binding proteins during the uptake of HIV
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	7430	NP_003370.2	ezrin	14739941	2007-11-07 17:31	HIV-1 gp120-mediated CD4 engagement is involved in the induction of susceptibility of primary human T lymphocytes to CD95-mediated apoptosis through ezrin phosphorylation and ezrin-to-CD95 association
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	relocalizes	9606	7430	NP_003370.2	ezrin	15818415	2007-11-07 17:31	Treatment of CD4+ T cells with HIV-1 gp120 induces CD95-mediated apoptosis, CD95/ERM protein (ezrin, radixin, moesin) colocalization and stable ezrin phosphorylation
11676	155348	NP_705926.1	retropepsin	degrades	9606	7431	NP_003371.2	vimentin	1516138	2007-11-07 17:29	Exposure of human skin fibroblasts to HIV-1 protease induces the degradation of the vimentin filament network and the disappearance of the tropomyosin isoforms microfilament network
11676	155348	NP_705926.1	retropepsin	cleaves	9606	7431	NP_003371.2	vimentin	1516138,1726101,1812754,1991513,2059552,2201025,2203542,8424456,8997639,10845700	2007-11-07 17:29	HIV-1 protease cleaves the intermediate filament proteins vimentin (both human and murine vimentin are cleaved between leucine-422 and arginine-423), desmin, and glial fibrillary acidic protein in vitro
11676	155348	NP_705926.1	retropepsin	cleaves	9606	7431	NP_003371.2	vimentin	2203542	2007-11-07 17:29	HIV-1 protease cleaves three secondary sites of vimentin at positions 51-52, 60-61, and 92-93.
11676	155348	NP_705926.1	retropepsin	cleaves	9606	7431	NP_003371.2	vimentin	10491200	2007-11-07 17:29	Phosphorylation of human recombinant vimentin by PKC inhibits the cleavage of the vimentin head domain by HIV-1 protease
11676	155348	NP_705926.1	retropepsin	cleaves	9606	7431	NP_003371.2	vimentin	11160829	2007-11-07 17:29	Two regions of the vimentin head domain, residues 17-60 and 68-92, are released as a result of vimentin cleavage by HIV-1 protease, leading to altered chromatin distribution
11676	155459	NP_057851.1	Vif	co-localizes with	9606	7431	NP_003371.2	vimentin	8523563,9188594,10613270,11172097,12600646	2007-11-07 17:27	Vif has been reported to co-localize with vimentin filaments in the cytoplasm and cause the collapse of the intermediate filament network into a perinuclear aggregate, however in other reports this co-localization was not observed
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	decreases phosphorylation of	9606	7431	NP_003371.2	vimentin	7842474,8381971,8822624	2007-11-07 17:30	The phosphorylation of the two major cytoskeletal proteins, vimentin and GFAP, which is normally stimulated by isoproterenol, is partially prevented by HIV-1 gp120 in astrocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	7432	NP_003372.1	VIP peptides isoform 1 preproprotein	1617429,10446313,10933622	2007-11-07 17:30	Vasoactive intestinal peptide (VIP) blocks HIV-1 gp120-induced neurotoxicity in culture
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	7432	NP_003372.1	VIP peptides isoform 1 preproprotein	10527688	2007-11-07 17:31	VIP is more potent at suppressing M-tropic than T-tropic HIV-1 gp120 chemotaxis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	7433	NP_004615.2	vasoactive intestinal polypeptide receptor 1 precursor	11834941	2007-11-07 17:31	HIV-1 gp120 has sequence similarity to the natural ligand for VPAC1 and it can activate this receptor directly
11676	155871	NP_057853.1	Tat	competes with	9606	7448	NP_000629.3	vitronectin precursor	7682219,7690138	2007-11-07 17:30	HIV-1 Tat competes with vitronectin for binding to integrins
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7448	NP_000629.3	vitronectin precursor	7522689	2007-11-07 17:29	Interaction of S-protein (vitronectin) with HIV-1 gp120 and CD4 is mediated by heparin
11676	155030	NP_579880.1	capsid	interacts with	9606	7453	NP_004175.2	tryptophanyl-tRNA synthetase, cytoplasmic isoform a	16702215	2007-11-07 17:31	The Capsid domain of HIV-1 Gag is sufficient for the interaction of Gag with tryptophanyl-tRNA synthetase in an in vitro pull-down assay
11676	155807	NP_057852.2	Vpr	interacts with	9606	7465	NP_003381.1	wee1-like protein kinase isoform 1	11531413	2007-11-07 17:28	HIV-1 Vpr induced cell cycle arrest in the G2 phase is mediated predominately through the Wee1 kinase in fission yeast
11676	155807	NP_057852.2	Vpr	induces release of	9606	7465	NP_003381.1	wee1-like protein kinase isoform 1	11691994,15142377,15265780,15725353,15780175,15817944	2007-11-07 17:28	Rupture of HIV-1 Vpr-induced nuclear envelope herniations produces transient loss of the subcellular compartmentalization of Wee1, Cdc25C, cyclin B1, and presumably other soluble cellular components, resulting in their release into the cytoplasm
11676	155807	NP_057852.2	Vpr	inhibited by	9606	7465	NP_003381.1	wee1-like protein kinase isoform 1	12525641,16429131	2007-11-07 17:28	Overexpression of Wee-1 kinase suppresses HIV-1 Vpr-mediated apoptosis
11676	155807	NP_057852.2	Vpr	downregulates	9606	7465	NP_003381.1	wee1-like protein kinase isoform 1	12525641,16354571,16429131	2007-11-07 17:28	Prolonged cell cycle arrest in the G2 phase induced by HIV-1 Vpr results in the depletion of Wee1 kinase
11676	155807	NP_057852.2	Vpr	upregulates	9606	7465	NP_003381.1	wee1-like protein kinase isoform 1	15254189,16354571,16429131	2007-11-07 17:28	HIV-1 Vpr-induced cell cycle arrest results in increased levels of Wee-1 kinase in synchronized HeLa cells; G2 arrest by Vpr is correlated with delayed degradation of Wee-1, and Cdc2 activity is reduced at G2/M in the presence of Vpr
11676	155871	NP_057853.1	Tat	associates with	9606	7469	NP_005654.2	Wolf-Hirschhorn syndrome candidate 2 protein	11112772,16838299	2007-11-07 17:28	NELF associates with HIV-1 Tat as part of the HIV-1 transcription elongation complex
11676	155871	NP_057853.1	Tat	downregulates	9606	7469	NP_005654.2	Wolf-Hirschhorn syndrome candidate 2 protein	11150502	2007-11-07 17:30	WHSC2 is hypothesized to function as a transcriptional repressor and has been shown to be downregulated by HIV-1 Tat
11676	156110	NP_057857.2	Nef	downregulates	9606	7490	NP_000369.3	Wilms tumor protein isoform A	16260903	2007-11-07 17:29	Podocyte-specific expression of HIV-1 Nef induces loss of synaptopodin and WT1, and expression of Ki-67 in podocytes, which is essential for the dedifferentiation and proliferation of podocytes in HIV-associated nephropathy
11676	155030	NP_579876.2	matrix	exported by	9606	7514	NP_003391.1	exportin-1	10604476	2007-11-07 17:28	HIV-1 Matrix contains a nuclear export signal (amino acids 15-32) which is recognized by exportin 1 (CRM1; XPO1) and is important for nucleocytoplasmic shuttling of HIV-1 Gag and genomic RNA to the cytoplasm by exportin 1
11676	155807	NP_057852.2	Vpr	exported by	9606	7514	NP_003391.1	exportin-1	11152524,12805458	2007-11-07 17:28	HIV-1 Vpr contains a nuclear export signal within amino acids 1-71 that is sensitive to Leptomycin B, suggesting it is recognized by CRM1 (exportin 1)
11676	155807	NP_057852.2	Vpr	exported by	9606	7514	NP_003391.1	exportin-1	12805458	2007-11-07 17:30	Nuclear export of HIV-1 Vpr by exportin-1 is required for efficient HIV replication in tissue macrophages and is important for Vpr incorporation into virions
11676	155908	NP_057854.1	Rev	interacts with	9606	7514	NP_003391.1	exportin-1	1648487	2007-11-07 17:29	during Rev-mediated nuclear export of HIV-1 mRNA, Rev interacts directly with the nucleocytoplasmic mRNA-transport system
11676	155908	NP_057854.1	Rev	binds	9606	7514	NP_003391.1	exportin-1	7543368,7745679	2007-11-07 17:29	nuclear export of Rev is dependent on its activation domain which encodes a nuclear export signal (amino acids 75-83)
11676	155908	NP_057854.1	Rev	binds	9606	7514	NP_003391.1	exportin-1	7634337,7637788,8633082,9070945,9368759,14554087	2007-11-07 17:29	CRM1 is involved in the binding of Rev to yeast Rip1 and hRip/Rab, which is involved in Rev-mediated nuclear export of HIV-1 mRNA
11676	155908	NP_057854.1	Rev	interacts with	9606	7514	NP_003391.1	exportin-1	9111043,9837918,10347184,10518602	2007-11-07 17:29	CRM1-mediated nuclear export of Rev involves interactions of CRM1 with RanGTP, RanBP1 and RanGEF
11676	155908	NP_057854.1	Rev	interacts with	9606	7514	NP_003391.1	exportin-1	9368759,16354571	2007-11-07 17:29	CRM1 interacts with FG-repeat-containing nuclear pore proteins during nuclear export of Rev
11676	155908	NP_057854.1	Rev	binds	9606	7514	NP_003391.1	exportin-1	9368759	2007-11-07 17:29	CRM1 interacts with the nuclear export signal of Rev and acts as a bridge between Rev and nuclear pore proteins
11676	155908	NP_057854.1	Rev	interacts with	9606	7514	NP_003391.1	exportin-1	10347184	2007-11-07 17:29	interaction of CRM1 with nucleoporins Nup42 and Nup159 results in the release of Rev from CRM1
11676	155908	NP_057854.1	Rev	binds	9606	7514	NP_003391.1	exportin-1	10381392,11238447	2007-11-07 17:29	eukaryotic initiation factor 5A (eIF-5A) mediates the binding of CRM1 to Rev
11676	155908	NP_057854.1	Rev	inhibited by	9606	7514	NP_003391.1	exportin-1	10875611	2007-11-07 17:29	excess CRM1 may downregulate Rev-mediated RNA export by sequestering Rev to a subnucleolar structure
11676	155908	NP_057854.1	Rev	recruits	9606	7514	NP_003391.1	exportin-1	11836381,16354571	2007-11-07 17:29	Rev recruitment of CRM1 to HIV-1 mRNA is sufficient to mediate nuclear export of incompletely spliced HIV-1 mRNA
11676	155908	NP_057854.1	Rev	enhanced by	9606	7514	NP_003391.1	exportin-1	12134013	2007-11-07 17:27	Rev-Rev interactions (multimerization) are enhanced by CRM1
11676	155908	NP_057854.1	Rev	interacts with	9606	7514	NP_003391.1	exportin-1	12134013	2007-11-07 17:27	The C-terminal region of Rev (amino acids 86-116) plays a role in enhancing the interaction of Rev with CRM1
11676	155908	NP_057854.1	Rev	modulated by	9606	7514	NP_003391.1	exportin-1	12134041	2007-11-07 17:27	nuclear retention and co-localization of Rev and CRM1 is caused by down-modulation of GAP-associated tyrosine phosphoprotein p62 (Sam68), suggesting Sam68 is directly involved in the CRM1-mediated Rev nuclear export pathway
11676	155908	NP_057854.1	Rev	exported by	9606	7514	NP_003391.1	exportin-1	12239324	2007-11-07 17:27	Studies suggest Rev is necessary and sufficient for the accumulation of incompletely spliced HIV RNAs at nuclear pores while CRM1 is required for translocation across the nuclear pore complex
11676	155908	NP_057854.1	Rev	co-localizes with	9606	7514	NP_003391.1	exportin-1	15189895	2007-11-07 17:28	HIV-1 Rev/CRM1 export complexes are observed in nucleoli by cotransfection with CFP/YFP pairs of the proteins on a large three-dimensional set of fixed cells, with Rev/CRM1 colocalization in nucleoli decreasing exponentially after addition of leptomycin B
11676	155348	NP_705928.1	integrase	interacts with	9606	7520	NP_066964.1	X-ray repair cross-complementing protein 5	10213687,11070027,11158303,11406603	2007-11-07 17:29	DNA-PK, along with Ku70 and Ku80, is proposed to play a role in retroviral DNA integration and protects cells against toxicity induced by HIV-1 Integrase or integration
11676	155348	NP_705928.1	integrase	associates with	9606	7520	NP_066964.1	X-ray repair cross-complementing protein 5	11406603	2007-11-07 17:29	Ku80 associates with viral preintegration complexes containing HIV-1 Integrase
11676	155871	NP_057853.1	Tat	interacts with	9606	7520	NP_066964.1	X-ray repair cross-complementing protein 5	8240370	2007-11-07 17:30	Ku protein binds to HIV-1 TAR RNA and is involved in the stimulation of the elongation property of RNA polymerase II as well as the activation of several transcription factors, suggesting a role in HIV-1 gene expression and Tat transactivation
11676	155871	NP_057853.1	Tat	inhibited by	9606	7528	NP_003394.1	transcriptional repressor protein YY1	8289393,9371597,10888618,11940654	2007-11-07 17:30	YY1 and LSF transcription factors cooperatively recruit histone deacetylase 1 (HDAC1) to the HIV-1 LTR promoter, thereby inhibiting transcription and Tat activation of the promoter
11676	155807	NP_057852.2	Vpr	enhanced by	9606	7529	NP_003395.1	14-3-3 protein beta/alpha	11531413,15142377,15265780,16968670	2007-11-07 17:28	Interaction of HIV-1 Vpr with human 14-3-3 protein is presumed based on homology to yeast DNA damage checkpoint protein rad25 which enhances HIV-1 Vpr-induced G2 arrest in vitro, most likely through the inhibition of Cdc25
11676	155807	NP_057852.2	Vpr	inhibits	9606	7529	NP_003395.1	14-3-3 protein beta/alpha	15265780,15708996	2007-11-07 17:28	HIV-1 Vpr inhibits insulin-induced association of 14-3-3 and Foxo3a in HeLa cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	7529	NP_003395.1	14-3-3 protein beta/alpha	15103018	2007-11-07 17:30	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155807	NP_057852.2	Vpr	enhanced by	9606	7531	NP_006752.1	14-3-3 protein epsilon	11531413,15142377,15265780,16968670	2007-11-07 17:28	Interaction of HIV-1 Vpr with human 14-3-3 protein is presumed based on homology to yeast DNA damage checkpoint protein rad25 which enhances HIV-1 Vpr-induced G2 arrest in vitro, most likely through the inhibition of Cdc25
11676	155807	NP_057852.2	Vpr	inhibits	9606	7531	NP_006752.1	14-3-3 protein epsilon	15265780,15708996	2007-11-07 17:28	HIV-1 Vpr inhibits insulin-induced association of 14-3-3 and Foxo3a in HeLa cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	7531	NP_006752.1	14-3-3 protein epsilon	11208609	2007-11-07 17:30	HIV-1 gp120 downregulates expression of c-Myc, Max, and 14-3-3epsilon proteins, and decreases phosphorylation of ATP-dependent tyrosine kinases (Akt) at Ser-473 in human mesangial cells (HMC)
11676	155807	NP_057852.2	Vpr	enhanced by	9606	7532	NP_036611.2	14-3-3 protein gamma	11531413,15142377,15265780	2007-11-07 17:28	Interaction of HIV-1 Vpr with human 14-3-3 protein is presumed based on homology to yeast DNA damage checkpoint protein rad25 which enhances HIV-1 Vpr-induced G2 arrest in vitro, most likely through the inhibition of Cdc25
11676	155807	NP_057852.2	Vpr	inhibits	9606	7532	NP_036611.2	14-3-3 protein gamma	15265780,15708996	2007-11-07 17:28	HIV-1 Vpr inhibits insulin-induced association of 14-3-3 and Foxo3a in HeLa cells
11676	155807	NP_057852.2	Vpr	enhanced by	9606	7533	NP_003396.1	14-3-3 protein eta	11531413,15142377,15265780	2007-11-07 17:28	Interaction of HIV-1 Vpr with human 14-3-3 protein is presumed based on homology to yeast DNA damage checkpoint protein rad25 which enhances HIV-1 Vpr-induced G2 arrest in vitro, most likely through the inhibition of Cdc25
11676	155807	NP_057852.2	Vpr	complexes with	9606	7533	NP_003396.1	14-3-3 protein eta	15142377,15708996,16968670	2007-11-07 17:28	HIV-1 Vpr forms a triple complex with 14-3-3 eta and Cdc25C and thereby promotes cell cycle arrest at the G(2)/M phase by facilitating association of 14-3-3 and Cdc25C
11676	155807	NP_057852.2	Vpr	inhibits	9606	7533	NP_003396.1	14-3-3 protein eta	15265780,15708996	2007-11-07 17:28	HIV-1 Vpr inhibits insulin-induced association of 14-3-3 and Foxo3a in HeLa cells
11676	155807	NP_057852.2	Vpr	binds	9606	7533	NP_003396.1	14-3-3 protein eta	15708996	2007-11-07 17:28	Yeast two-hybrid assays show that HIV-1 Vpr binds strongly to 14-3-3 eta amino acids 141 to 244; the smallest 14-3-3 eta fragment (residues 190-210) also supports this binding, and amino acid mutation R80A in Vpr abolishes the binding to 14-3-3 eta
11676	155807	NP_057852.2	Vpr	enhanced by	9606	7534	NP_003397.1	14-3-3 protein zeta/delta	11531413,15142377,15265780,16968670	2007-11-07 17:28	Interaction of HIV-1 Vpr with human 14-3-3 protein is presumed based on homology to yeast DNA damage checkpoint protein rad25 which enhances HIV-1 Vpr-induced G2 arrest in vitro, most likely through the inhibition of Cdc25
11676	155807	NP_057852.2	Vpr	inhibits	9606	7534	NP_003397.1	14-3-3 protein zeta/delta	15265780,15708996	2007-11-07 17:28	HIV-1 Vpr inhibits insulin-induced association of 14-3-3 and Foxo3a in HeLa cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	induces phosphorylation of	9606	7535	NP_001070.2	tyrosine-protein kinase ZAP-70 isoform 1	9269777	2007-11-07 17:30	HIV-1 gp160 alone or CD4/gp160 cross-linking induces tyrosine phosphorylation of intracellular substrates p59fyn, zap 70, and p95vav and also leads to ras activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7535	NP_001070.2	tyrosine-protein kinase ZAP-70 isoform 1	7522245	2007-11-07 17:30	Binding of HIV-1 gp120 to CD4 induces p56lck activation and zeta-chain (TCR) associated protein kinase 70kDa desensitization independent of TCR tyrosine phosphorylation
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	7841	NP_006293.1	mannosyl-oligosaccharide glucosidase	1678778,2825177	2007-11-07 17:30	Inhibitors of alpha-glucosidase inhibit syncytium formation induced by the envelope glycoprotein of HIV-1 and reduce processing of the HIV-1 envelope precursor protein gp160 by glucosidase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	7841	NP_006293.1	mannosyl-oligosaccharide glucosidase	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	7841	NP_006293.1	mannosyl-oligosaccharide glucosidase	1704656,2959866,8794361,8794362	2007-11-07 17:29	Glucosidase inhibitors inhibit the syncytium formation between HIV-infected and CD4-expressing cells and interfere with HIV-1 infectivity, indicating processing of HIV-1 gp120 by glucosidase is important for virus replication
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	glycosylated by	9606	7841	NP_006293.1	mannosyl-oligosaccharide glucosidase	2076345,2136376,2283726,2355006,2649653,2959866,8218172,12719582,16547752	2007-11-07 17:29	HIV-1 gp120 is extremely heavily glycosylated (31-36 N-linked glycans per molecule) by glucosidase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	7841	NP_006293.1	mannosyl-oligosaccharide glucosidase	8416962,8794361,8794362	2007-11-07 17:29	Imino sugar N-butyldeoxynojirimycin (NB-DNJ) inhibits HIV envelope glycoprotein gp120 processing mediated by alpha glucosidase I
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	7841	NP_006293.1	mannosyl-oligosaccharide glucosidase	8794361,8794362	2007-11-07 17:30	The alpha-glucosidase inhibitor N-butyldeoxynojirimycin (NB-DNJ) inhibits HIV-1 entry and this inhibition correlates with impaired HIV-1 gp120 shedding and gp41 exposure and with changes in antibody recognition of gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	7841	NP_006293.1	mannosyl-oligosaccharide glucosidase	12560567	2007-11-07 17:30	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	7841	NP_006293.1	mannosyl-oligosaccharide glucosidase	1704656,1736542,2829950,3099781,3264072,8093218	2007-11-07 17:31	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155871	NP_057853.1	Tat	binds	9606	7846	NP_006000.2	tubulin alpha-1A chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	enhances polymerization of	9606	7846	NP_006000.2	tubulin alpha-1A chain	15691386,15698476	2007-11-07 17:28	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155871	NP_057853.1	Tat	disrupts	9606	7846	NP_006000.2	tubulin alpha-1A chain	16327313	2007-11-07 17:29	HIV-1 Tat causes a dramatic decrease in alpha-tubulin staining, which indicates disruption of the cytoskeleton organization in human intestinal epithelial cells
11676	155908	NP_057854.1	Rev	depolymerizes	9606	7846	NP_006000.2	tubulin alpha-1A chain	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces acetylation of	9606	7846	NP_006000.2	tubulin alpha-1A chain	15103018,16148047	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4+-permissive cells increases the level of acetylated alpha-tubulin in a CD4-dependent manner; overexpression of Histone Deacetylase 6 (HDAC6) inhibits the acetylation of alpha-tubulin and prevents HIV-1-cell fusion
11676	155871	NP_057853.1	Tat	upregulates	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	9765440,9973525,12605695,15857508,16179731	2007-11-07 17:28	HIV-1 Tat upregulates CXCR4 expression on lymphocytes, monocytes/macrophages and erythroid cells, indicating a role for Tat in HIV-1 pathogenesis and in promoting the infectivity of HIV-1
11676	155871	NP_057853.1	Tat	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	10772939,11027346,16697675	2007-11-07 17:28	HIV-1 Tat binds to CXCR4, competes with the natural ligand of CXCR4, SDF-1alpha, and selectively inhibits the entry and replication of X4-tropic HIV-1 in peripheral blood mononuclear cells (PBMCs), indicating a role for Tat in selecting against X4 virus
11676	155871	NP_057853.1	Tat	inhibits	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	14630801	2007-11-07 17:28	HIV-1 Tat can inhibit CXCR4-mediated functions by interfering with the chemotactic activity of SDF-1/CXCL12, an effect mediated by Tat amino acids 25-31
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	8629022,8805353,8849450,8898753,8976200,8995603,9020356,9024623,9031325,9151868,9261451,9300725,9302439,9359702,9362541,9499113,9499115,9600268,9601645,9614108,9632631,9653051,9696823,9721247,9736741,9770524,9780207,9882290,10029247,10074122,10089882,10229873,10329539,10339592,10357469,10364484,10370370,10371171,10393974,10430052,10438870,10446313,10449282,10482576,10487781,10505675,10544150,10555208,10559349,10582593,10585143,10590105,10590121,10600606,10602722,10623764,10651866,10669334,10704341,10738970,10816381,10825158,10860877,10864687,10875613,10877489,10903911,10903920,10941932,10942389,11005830,11024154,11069996,11086073,11115360,11118068,11119612,11141237,11162626,11162839,11264367,11265761,11278278,11278567,11313374,11333905,11342415,11356952,11356967,11390582,11397808,11408611,11413305,11414813,11426226,11464139,11468147,11489906,11517394,11529558,11533159,11551942,11591141,11591370,11595336,11602639,11602715,11679153,11689632,11698270,11709091,11752220,11799176,11861874,11876757,11877445,118789	2007-11-07 17:27	CXCR4, a 45kDa cellular membrane protein, interacts with the cell surface HIV-1 gp120-CD4 complex and acts as a coreceptor to preferentially support T cell line-tropic HIV-1 Env-mediated cell fusion and HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	8976200,9031325,9359702,9632631,9653051,9653130,9658081,9770524,10393974,10602722,10651866,11162626,11595336,11877445,12713058,12832058,12834106,12871111,12873764,12873765,12963807,14576059,14990703,15113900,15183061,15279544,15351504,15585836,15710459,15748209,15992849,16005638,16188969,16306611	2007-11-07 17:27	The entry of T cell-tropic HIV-1 isolates is blocked by SDF-1 or CXCR4 antagonists, which bind to CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	9151868,9653051,10074122,10329539,10825158,10860877,11551942,12502809,16188969	2007-11-07 17:28	The first (residues 1-39) and third (residues 176-202) extracellular domains of human CXCR4 are required for the functional interaction with HIV-1 gp120; HIV-1 strains have different requirements for their interaction with CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	9184207,9261451,9600268,9653051,10329539,10357469,10544150,10801487,11069996,11118068,11153675,11278567,12368322,12490404,15890935,16378977	2007-11-07 17:28	The specific amino acids 298-329 in the V3 loop of HIV-1 gp120 that determine cellular tropism also regulate chemokine coreceptor (CCR5 or CXCR4) preference for cell entry by the virus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	9362541,11698270,12857973,12960231	2007-11-07 17:28	Engagement of the CCR5 and CXCR4 receptors by HIV-1 gp120 induces tyrosine phosphorylation of the protein tyrosine kinase Pyk2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	9601645,9653130,9658081,10393974,10446313,10651866,11333905,11413305,11414813,11551942,16784459	2007-11-07 17:31	HIV-1 gp120 from a T-cell-tropic virus causes CD4-dependent antagonism of CXCR4 response to SDF-1alpha, whereas gp120 from macrophage-tropic viruses causes CD4-dependent antagonism of CCR5 response to MIP-1alpha
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	9614108	2007-11-07 17:31	Conversion of Asp-187 to the neutral amino acid Val in the second extracellular loop of CXCR4, which is a coreceptor for dual-tropic and T-tropic strains of HIV-1, unmasked activity with M-tropic gp120 in fusion and infection experiments
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	9696823	2007-11-07 17:31	An HIV-1 gp120 mutant with a deletion of amino acids E61 to S85 in its C1 region exhibits a strong interaction with CXCR4, although CD4 binding is undetectable
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	9721247,10801487,11333905,11356952,16702010,16769099,16966601	2007-11-07 17:31	The interaction of HIV-1 gp120 with CXCR4 is inhibited by neutralizing monoclonal antibodies that prevent the interaction of gp120 with CD4 and by antibodies specific for the gp120 V2 and V3 loops
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	9744279	2007-11-07 17:31	The death rate of CD8+ T cells by apoptosis, which is induced by HIV-1 gp120 from CXCR4-tropic HIV strains or by the ligand of the chemokine receptor CXCR4 (SDF-1), is increased markedly during HIV infection of peripheral blood mononuclear cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	9780207	2007-11-07 17:31	HIV-1 gp120 inhibits monocyte response to chemokines and activation by chemoattractants by interacting with CD4 and downregulating the cell surface receptor CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	10229873,10339592,10438870,10559349,10864687,11333905	2007-11-07 17:31	A gp120 protein derived from the HIV-1 IIIB strain utilizes CXCR4 as a primary receptor in the absence of CD4 on T- and B- lymphoid cell lines
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces phosphorylation of	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	10358157	2007-11-07 17:31	HIV-1 gp120, but not SDF-1alpha, induces rapid tyrosine phosphorylation of src-like kinase p56lck in CD4+ T cells, whereas both gp120 and SDF-1alpha cause phosphorylation of CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	10438703,11342415	2007-11-07 17:31	A synthetic peptide corresponding to amino acid residues 414-434 of HIV-1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	10623764	2007-11-07 17:31	Cathepsin D may induce conformational modification of HIV-1 gp120, allowing direct interaction with the CXCR4 coreceptor and enhancing HIV-1 infectivity and entry into cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	10704341,10942389,11141237,11462036,11602639,15327899,15719026	2007-11-07 17:31	Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	10758170,11698270,12857973,12960231,15710459,16188969	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	10941932	2007-11-07 17:31	T-tropic HIV-1 gp120s are capable of priming phorbol ester (PMA) induced co-down-modulation of gp120 complexes with tailless CD4 by interacting with CXCR4, whereas M-tropic gp120 are not, even in the presence of CCR5
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11069996,11162839,11533159	2007-11-07 17:31	Antibodies to specific epitopes of the CCR5 or CXCR4 chemokine receptors inhibit the entry of M-tropic, T-tropic, or dual-tropic HIV-1 into target cells by blocking the interaction of the receptors with the HIV-1 gp120/CD4 complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11119612	2007-11-07 17:31	A CD4-independent, CXCR4-tropic HIV-1 isolate directly interacts with CXCR4 through its mutated gp120, and downregulates CXCR4 membrane expression in CD4-positive or -negative cells chronically infected with the strain
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	relocalizes	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11278278	2007-11-07 17:31	SDF-1alpha and HIV-1 gp120 induce the appearance of pseudopodia in which CD26 and CXCR4 colocalize
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11278567,11356952,11390601,11529558,11679153,11689632,11709091,11711617,12368322,16188969,16227248,16966601	2007-11-07 17:31	V1, V2, and V3 domains and N-linked glycosylation sites of HIV-1 gp120 confer coreceptor tropism; loss of an N-linked glycosylation site within V3 has a major influence on the virus switching from CCR5 to CXCR4 tropism in a V3 charge-dependent manner
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11390582	2007-11-07 17:31	Production of the C-X-C chemokine growth-regulated oncogene alpha (GRO-alpha) is markedly stimulated by CXCR4-tropic HIV-1; HIV-1 gp120 engagement of CXCR4 initiates the stimulation of GRO-alpha production, which is blocked by antibodies to CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11468147,11698270,12857973,12960231	2007-11-07 17:31	CCR5 and CXCR4 coreceptor engagement by HIV-1 gp120 in primary macrophages activates 2 members of the mitogen-activated protein kinase (MAPK) superfamily, c-Jun amino-terminal kinase and p38 MAPK
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11591370	2007-11-07 17:30	Binding of HIV-1 gp120 to SupT1 lymphoblastoid cells triggers association between CXCR4 and ganglioside GM3
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11602639,12873764,16005638	2007-11-07 17:31	Syncytial apoptosis mediated by the fusion of cells expressing HIV-1 gp120 with cells expressing the CD4/CXCR4 receptor/coreceptor complex causes phosphorylation of p53 on serine 15 and Bax upregulation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11711593	2007-11-07 17:31	The cis expression of DC-SIGN on multiple lymphoid cell lines enables more efficient entry and replication of CXCR4-tropic and CCR5/CXCR4 dual-tropic HIV-1 through its binding to the HIV-1 gp120-CD4-CXCR4 complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	relocalizes	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11799176	2007-11-07 17:31	Adsorption of multivalent gp120-containing HIV-1 virion particles into CD4+ T lymphocytes results in segregation of CD4 and CXCR4 into distinct lipid microdomains
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11877445	2007-11-07 17:31	The proteasome inhibitors, lactacystin and epoxomicin, inhibit SDF-1alpha and gp120 protein-induced down-modulation of CXCR4 in Jurkat cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11931835	2007-11-07 17:31	Kappa-opioid receptor (KOR) agonist treatment of CD4(+) lymphocytes inhibits HIV-1 envelope gp120/41-mediated membrane fusion via downregulation of CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	12551992,12960231,15585836	2007-11-07 17:31	HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	12843275	2007-11-07 17:30	Brain-derived neurotrophic factor (BDNF) prevents HIV-1 gp120-mediated neuronal cell death by reducing the levels of CXC chemokine receptor-4 (CXCR4), a receptor that mediates HIV-1 gp120-induced apoptosis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	15183061	2007-11-07 17:31	N-glycosylation at N11 of CXCR4 inhibits the binding of CXCR4 to CXCR4- and CCR5-tropic HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	15509740	2007-11-07 17:31	HIV-1 gp120 binding to CXCR4 induces NADPH oxidase-mediated production of superoxide radicals in neurons, which is involved in the activation of neutral sphingomyelinase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	15972662	2007-11-07 17:30	HIV-1 gp120 interactions with CXCR4 and CCR5 lead to the cross-desensitization of CCR6 and CCR7; this gp120-induced inhibition is strictly dependent on CXCR4 or CCR5 and lipid rafts but not on CD4 or V(H)3-expressing BCR
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	16005638	2007-11-07 17:31	Stimulation of neurons with HIV-1 gp120 or the endogenous CXCR4 agonist, SDF-1 alpha, results in inducing p53 activity and expression of the p53 pro-apoptotic target Apaf-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	16375941	2007-11-07 17:31	HIV-1 gp120 and gp41-mediated virus-cell fusion is more dependent on viral core maturation for viruses bearing CXCR4-tropic gp120 than for those bearing CCR5-tropic gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	16524887	2007-11-07 17:31	In T cell lines and peripheral blood mononuclear cells, HIV-1 gp120-induced apoptosis is regulated by CD45 through the induction of CD45 association with the HIV-1 coreceptor CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	16631222	2007-11-07 17:31	The coreceptor-binding site in HIV-1 gp120 is centered around an anti-parallel beta-sheet structure "bridging sheet domain"; mutations in and adjacent to this domain have greater impact on CXCR4-mediated fusion than on CCR5-mediated fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	16841089	2007-11-07 17:31	HIV-1 gp120-induced neuronal cell death involves p38 mitogen-activated protein kinase; both HIV-1 coreceptors, CCR5 and CXCR4, can mediate HIV-1 gp120-induced neurotoxicity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	17010165	2007-11-07 17:31	Raji-DC-SIGN cells preferentially enhance CXCR4 usage of dual-tropic HIV-1 with higher V3 charges in gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	17011204	2007-11-07 17:31	Transcription factor E2F1 is necessary for neuronal cell death induced by HIV-1 gp120 via neuronal CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	17121788	2007-11-07 17:31	HIV-1 gp120-induced Ca(2+) fluxing is CD4 dependent and coreceptor specific, and is mediated by the CCR5 and CXCR4 coreceptors
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	8629022,8640552,9710449,12871111,14505910,14640682,14694113,15161081,15258189	2007-11-07 17:31	The interactions between HIV-1 gp120/41, CD4 receptor, and CXCR4 result in cell-virus and cell-cell membrane fusion
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	11591141	2007-11-07 17:31	The engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process results in a quick HIV-1 gp41 six-helix bundle formation
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	complexes with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	12871111,14505910,14694113,15047829,15258189,15308751,15479838	2007-11-07 17:31	HIV-1 gp120 and gp41 form a transitional complex with the CD4 receptor and CCR5/CXCR4 coreceptors during virus-cell and cell-cell membrane fusion
11676	156110	NP_057857.2	Nef	inhibits	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	12354773	2007-11-07 17:28	An intracellular signaling pathway mediated by the binding of SDF-1alpha and CXCR4 is inhibited by Nef in both Jurkat T cells and primary peripheral CD4+ T lymphocytes
11676	156110	NP_057857.2	Nef	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	14990729,15452229	2007-11-07 17:28	The interaction of HIV-1 Nef with the cell surface receptor CXCR4 induces apoptosis in CD4+ T cells, an effect that can be inhibited with CXCR4 antibodies, as well as the endogenous CXCR4 ligand SDF-1alpha
11676	156110	NP_057857.2	Nef	Interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	15452229	2007-11-07 17:28	Specific sequences spanning amino-acids 50 to 60 and 170 to 180 in the HIV-1 Nef protein appear to be necessary for Nef-induced apoptosis as well as for physical interaction with CXCR4 receptors
11676	156110	NP_057857.2	Nef	downregulates	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	16928758	2007-11-07 17:31	HIV-1 Nef downregulates the second major HIV-1 coreceptor, CXCR4, from the surface of HIV-infected primary CD4 T lymphocytes with efficiencies comparable to the natural CXCR4 ligand, stromal cell-derived factor-1 alpha
11676	156110	NP_057857.2	Nef	interacts with	9606	7852	NP_003458.1	C-X-C chemokine receptor type 4 isoform b	16978607	2007-11-07 17:31	HIV-1 Nef-induced increase in monocyte migration may be caused through CXCR4 function
11676	155871	NP_057853.1	Tat	associates with	9606	7936	NP_002895.3	negative elongation factor E	11112772,16838299	2007-11-07 17:28	NELF associates with HIV-1 Tat as part of the HIV-1 transcription elongation complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	7941	NP_005075.2	phospholipase A2, group VII	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	7941	NP_005075.2	phospholipase A2, group VII	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155348	NP_705928.1	integrase	acetylated by	9606	7994	NP_006757.1	MYST histone acetyltransferase (monocytic leukemia) 3	16096645,17182677	2007-11-07 17:31	Cellular acetyltransferase binds HIV-1 integrase both in vitro and in cells and acetylates three specific lysines (K264, K266, K273) in the carboxy-terminus of integrase
11676	155908	NP_057854.1	Rev	interacts with	9606	8021	NP_005076.3	nuclear pore complex protein Nup214	8943370	2007-11-07 17:27	the FG repeat region of nup214 interacts directly with Rev
11676	155908	NP_057854.1	Rev	inhibited by	9606	8021	NP_005076.3	nuclear pore complex protein Nup214	9765402	2007-11-07 17:27	truncated, defective forms of nup214 can inhibit Rev function
11676	155908	NP_057854.1	Rev	recruits	9606	8021	NP_005076.3	nuclear pore complex protein Nup214	9847314	2007-11-07 17:27	Rev can recruit nup214 to the nucleolus
11676	155908	NP_057854.1	Rev	inhibited by	9606	8021	NP_005076.3	nuclear pore complex protein Nup214	9847314	2007-11-07 17:27	the FG-containing repeat domain of Nup214 can inhibit Rev-mediated expression of viral proteins
11676	155908	NP_057854.1	Rev	interacts with	9606	8021	NP_005076.3	nuclear pore complex protein Nup214	11238447	2007-11-07 17:27	nup214 is involved in Rev-mediated nuclear export of HIV-1 mRNA through an interaction with eukaryotic initiation factor 5A (eIF-5A) which binds to Rev
11676	155459	NP_057851.1	Vif	complexes with	9606	8065	NP_003469.2	cullin-5	14564014,15574592,15574593,16303161,16530799,16636053	2007-11-07 17:29	HIV-1 Vif (amino acids 144-149; SLQXLA motif; BC-box) interacts with cellular proteins Cul5, elongins B and C, and Rbx1 to form an Skp1-cullin-F-box (SCF)-like complex that allows Vif to interact with APOBEC3G and induce its ubiquitination and degradation
11676	155459	NP_057851.1	Vif	complexes with	9606	8065	NP_003469.2	cullin-5	15574592	2007-11-07 17:28	HIV-1 Vif ubiquitination is promoted by Cul5 in vitro and in vivo in a manner that requires an intact SOCS-box motif in Vif, and autoubiquitination of Vif occurs within an assembled Vif-Cul5 complex
11676	155459	NP_057851.1	Vif	interacts with	9606	8065	NP_003469.2	cullin-5	15574593	2007-11-07 17:28	The amino acids L163 and L169 located downstream of the SOCS-box motif in HIV-1 Vif are required for Vif function and efficient interaction with Cul5-ElonginB-ElonginC
11676	155459	NP_057851.1	Vif	interacts with	9606	8065	NP_003469.2	cullin-5	15574593	2007-11-07 17:28	Two highly conserved Cys residues (C114 and C133) outside the SOCS box (amino acids 144-169) motif in HIV-1 Vif are required for the interaction of Vif with Cul5 but not ElonginC
11676	155459	NP_057851.1	Vif	interacts with	9606	8065	NP_003469.2	cullin-5	16530799,16636053	2007-11-07 17:31	Deletion of amino acids 120 to 138 in Cul5 significantly reduces its interaction with HIV-1 Vif, but does not affect Cul5 binding to Elongins B/C; the HCCH zinc-binding motif (residues 108-139) in Vif is required for the interaction with Cul5
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	8140	NP_003477.4	large neutral amino acids transporter small subunit 1	7561057,8922468,9403839	2007-11-07 17:30	Antibodies raised against the human fusion regulatory protein 1 (FRP-1; CD98) molecule suppress cell fusion mediated by HIV-1 gp160
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	regulated by	9606	8140	NP_003477.4	large neutral amino acids transporter small subunit 1	7561057,8922468,12925876	2007-11-07 17:30	The functional interaction between CD98 and CD147 is involved in the regulation of HIV-1 gp160-mediated cell fusion
11676	155871	NP_057853.1	Tat	interacts with	9606	8148	NP_631961.1	TATA-binding protein-associated factor 2N isoform 1	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	8148	NP_631961.1	TATA-binding protein-associated factor 2N isoform 1	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	8148	NP_631961.1	TATA-binding protein-associated factor 2N isoform 1	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	8148	NP_631961.1	TATA-binding protein-associated factor 2N isoform 1	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	8148	NP_631961.1	TATA-binding protein-associated factor 2N isoform 1	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	interacts with	9606	8178	NP_006523.1	RNA polymerase II elongation factor ELL	9765201	2007-11-07 17:27	HIV-1 Tat directly interacts with ELL as demonstrated by Tat-affinity column purification
11676	155871	NP_057853.1	Tat	stimulates	9606	8202	NP_858045.1	nuclear receptor coactivator 3 isoform a	11704662	2007-11-07 17:30	HIV-1 Tat may function as an adaptor molecule, efficiently stimulating the processes of transcription initiation and elongation through potentiation of the coupling of p160 co-activators and the P-TEFb complex
11676	155871	NP_057853.1	Tat	enhanced by	9606	8202	NP_858045.1	nuclear receptor coactivator 3 isoform a	11704662	2007-11-07 17:30	p/CIP binds to HIV-1 Tat and enhances Tat-stimulated HIV-1 LTR promoter transactivation
11676	155871	NP_057853.1	Tat	binds	9606	8290	NP_003484.1	histone H3.1t	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	inhibits acetylation of	9606	8290	NP_003484.1	histone H3.1t	15611041	2007-11-07 17:29	Purified recombinant Tat and Tat-derived synthetic peptides derived from the p300- and PCAF-binding sites in Tat inhibit histone H3/H4 acetylation in vitro
11676	155871	NP_057853.1	Tat	binds	9606	8294	NP_003486.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8329	NP_003500.1	histone H2A type 1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8330	NP_003501.1	histone H2A type 1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8331	NP_066544.1	histone cluster 1, H2aj	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8332	NP_003502.1	histone H2A type 1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8334	NP_003503.1	histone H2A type 1-C	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8335	NP_003504.2	histone H2A type 1-B/E	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8336	NP_003505.1	histone H2A type 1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8337	NP_003507.1	histone H2A type 2-A	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8338	NP_003508.1	histone H2A type 2-C	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8339	NP_003509.1	histone H2B type 1-C/E/F/G/I	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8340	NP_003510.1	histone H2B type 1-L	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8341	NP_003511.1	histone H2B type 1-N	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8342	NP_003512.1	histone H2B type 1-M	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8343	NP_003513.1	histone H2B type 1-C/E/F/G/I	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8344	NP_003514.2	histone H2B type 1-C/E/F/G/I	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8345	NP_003515.1	histone H2B type 1-H	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8346	NP_003516.1	histone H2B type 1-C/E/F/G/I	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8347	NP_003517.2	histone H2B type 1-C/E/F/G/I	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8348	NP_003518.2	histone H2B type 1-O	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8349	NP_003519.1	histone H2B type 2-E	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8350	NP_003520.1	histone H3.1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8351	NP_003521.2	histone cluster 1, H3d	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8352	NP_003522.1	histone H3.1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8353	NP_003523.1	histone H3.1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8354	NP_003524.1	histone H3.1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8355	NP_003525.1	histone H3.1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8356	NP_003526.1	histone H3.1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8357	NP_003527.1	histone H3.1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8358	NP_003528.1	histone H3.1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8359	NP_003529.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8360	NP_003530.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8361	NP_003531.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8362	NP_003532.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8363	NP_068803.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8364	NP_003533.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8365	NP_003534.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8366	NP_003535.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8367	NP_003536.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8368	NP_003537.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8369	NP_003538.1	histone H4-like protein type G	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8370	NP_003539.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	8398	NP_003551.2	85 kDa calcium-independent phospholipase A2 isoform a	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	8398	NP_003551.2	85 kDa calcium-independent phospholipase A2 isoform a	9745929	2007-11-07 17:31	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	8399	NP_003552.1	group 10 secretory phospholipase A2 precursor	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	8399	NP_003552.1	group 10 secretory phospholipase A2 precursor	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	degrades	9606	8399	NP_003552.1	group 10 secretory phospholipase A2 precursor	17093191	2007-11-07 17:31	sPLA(2)-X neutralizes human immunodeficiency virus type 1 (HIV-1) through degradation of the viral membrane (gp120) and inhibits the replication of both CCR5- and CXCR4-tropic HIV-1 in human CD4(+) T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	8459	NP_003586.3	protein-tyrosine sulfotransferase 2	10089882,10497246,12169668	2007-11-07 17:31	The chemokine receptor CCR5 is posttranslationally modified by sulfation of its N-terminal tyrosines; sulfated tyrosines contribute to the binding of CCR5 to MIP-1 alpha, MIP-1 beta, and HIV-1 gp120/CD4 complexes and to the ability of HIV-1 to enter cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	8460	NP_003587.1	protein-tyrosine sulfotransferase 1	10089882,10497246,12169668	2007-11-07 17:31	The chemokine receptor CCR5 is posttranslationally modified by sulfation of its N-terminal tyrosines; sulfated tyrosines contribute to the binding of CCR5 to MIP-1 alpha, MIP-1 beta, and HIV-1 gp120/CD4 complexes and to the ability of HIV-1 to enter cells
11676	155348	NP_705928.1	integrase	binds	9606	8487	NP_003607.1	survival of motor neuron protein-interacting protein 1 isoform alpha	16731905	2007-11-07 17:31	Survival motor neuron (SMN)-interacting protein 1 (Gemin2) binds to the C-terminal domain (amino acids 213-288) of HIV-1 Integrase and facilitates efficient viral cDNA synthesis soon after infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	8520	NP_003633.1	histone acetyltransferase type B catalytic subunit	12775419	2007-11-07 17:31	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	8534	NP_003645.1	carbohydrate sulfotransferase 1	1433500,8419650	2007-11-07 17:30	Sulfate is linked to the carbohydrate chains of HIV-1 glycoproteins gp160, gp120, and gp41 during the endoplasmic reticulum to Golgi transport of the glycoproteins
11676	155871	NP_057853.1	Tat	downregulates	9606	8536	NP_003647.1	calcium/calmodulin-dependent protein kinase type 1	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat downregulates the expression of many proteins, including CAMK1, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	8567	NP_003673.2	MAP-kinase activating death domain-containing protein isoform d	15103018	2007-11-07 17:30	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155807	NP_057852.2	Vpr	upregulates	9606	8600	NP_003692.1	tumor necrosis factor ligand superfamily member 11 isoform 1	15449141	2007-11-07 17:28	HIV-1 Vpr upregulates RANKL expression through its glucocorticoid (GC) co-activator motif (amino acid residues 22-26), an effect that is independent of Vpr-mediated G2 cell cycle arrest
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	8600	NP_003692.1	tumor necrosis factor ligand superfamily member 11 isoform 1	12975380,15320903	2007-11-07 17:31	Induction of the receptor activator of cytokine nuclear factor kappa B ligand (RANKL) is mediated by HIV-1 gp120; the gp120-mediated induction of RANKL is blocked by interferon-gamma
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	8605	NP_003697.1	phospholipase A2, group IVC	9377118	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	8605	NP_003697.1	phospholipase A2, group IVC	9745929	2007-11-07 17:31	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155807	NP_057852.2	Vpr	enhances	9606	8648	NP_003734.3	nuclear receptor coactivator 1 isoform 1	9874563,12208951	2007-11-07 17:28	HIV-1 Vpr synergistically enhances SRC-1 ligand activated glucocorticoid receptor activity, however Vpr does not bind to SRC-1
11676	155871	NP_057853.1	Tat	stimulates	9606	8648	NP_003734.3	nuclear receptor coactivator 1 isoform 1	11704662	2007-11-07 17:30	HIV-1 Tat may function as an adaptor molecule, efficiently stimulating the processes of transcription initiation and elongation through potentiation of the coupling of p160 co-activators and the P-TEFb complex
11676	155871	NP_057853.1	Tat	enhanced by	9606	8648	NP_003734.3	nuclear receptor coactivator 1 isoform 1	11704662	2007-11-07 17:30	SRC1a binds to HIV-1 Tat and enhances Tat-stimulated HIV-1 LTR promoter transactivation
11676	155871	NP_057853.1	Tat	regulated by	9606	8648	NP_003734.3	nuclear receptor coactivator 1 isoform 1	15661163	2007-11-07 17:28	HIV-1 Tat-induced calcium mobilization and TNF-alpha production in primary human monocytes are entirely regulated by DHP receptors
11676	156110	NP_057857.2	Nef	upregulates	9606	8651	NP_003736.1	suppressor of cytokine signaling 1	16429138	2007-11-07 17:31	HIV-1 Nef suppresses immunoglobulin class-switch DNA recombination by inducing IkappaBalpha and SOCS proteins, which block CD154, IL-4 and IL-10 cytokine signaling via NF-kappaB and STAT transcription factors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	8681	NP_005081.1	JMJD7-PLA2G4B protein	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	8681	NP_005081.1	JMJD7-PLA2G4B protein	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155807	NP_057852.2	Vpr	stimulates	9606	8685	NP_006761.1	macrophage receptor MARCO	12444143	2007-11-07 17:27	HIV-1 Vpr potentiates the stimulation of macrophage receptor with collagenous structure by glucocorticoids via the glucocorticoid receptor pathway
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	8702	NP_003769.1	beta-1,4-galactosyltransferase 4	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	8703	NP_003770.1	beta-1,4-galactosyltransferase 3	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	8704	NP_003771.1	beta-1,4-galactosyltransferase 2	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	8705	NP_003773.1	beta-1,3-galactosyltransferase 4	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	8706	NP_003772.1	UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	8707	NP_003774.1	beta-1,3-galactosyltransferase 2	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	8708	NP_066191.1	beta-1,3-galactosyltransferase 1	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	8717	NP_003780.1	tumor necrosis factor receptor type 1-associated DEATH domain protein	15103018	2007-11-07 17:30	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155871	NP_057853.1	Tat	downregulates	9606	8721	NP_003783.1	endothelial differentiation-related factor 1 isoform alpha	9813014	2007-11-07 17:29	HIV-1 Tat, which affects endothelial functions, downregulates EDF-1 expression both at the RNA and protein levels
11676	155030	NP_579876.2	matrix	co-localizes with	9606	8726	NP_003788.2	polycomb protein EED isoform a	9880543,14610174	2007-11-07 17:28	HIV-1 Matrix and HEED co-localize in the nucleus along with HIV-1 integrase, suggesting the occurrence of multiprotein complexes involving these three proteins at early steps of the HIV-1 life cycle
11676	155030	NP_579876.2	matrix	binds	9606	8726	NP_003788.2	polycomb protein EED isoform a	9880543	2007-11-07 17:28	The N-terminal region of HIV-1 Matrix (amino acids 1-40) binds to HEED (amino acids 388-403 and 495-535)
11676	155348	NP_705928.1	integrase	interacts with	9606	8726	NP_003788.2	polycomb protein EED isoform a	14610174,15875659,16075307	2007-11-07 17:29	HIV-1 integrase (amino acids 212-264) has been shown to interact with EED (amino acids 96-104 and 224-232) in both yeast and in HIV-1 infected cells
11676	155348	NP_705928.1	integrase	stimulated by	9606	8726	NP_003788.2	polycomb protein EED isoform a	14610174	2007-11-07 17:29	Interaction of EED with HIV-1 integrase stimulates the activity of integrase in vitro
11676	156110	NP_057857.2	Nef	relocalizes	9606	8726	NP_003788.2	polycomb protein EED isoform a	14759364,15638726	2007-11-07 17:28	HIV-1 Nef induces a transient relocalization of EED from nucleus to cytoplasm and the relocalization of EED is required for HIV-1 Tat-mediated transcription
11676	156110	NP_057857.2	Nef	binds	9606	8726	NP_003788.2	polycomb protein EED isoform a	14759364	2007-11-07 17:28	Yeast two-hybrid screening and coimmunoprecipitation experiments have shown that peptides spanning from 1 to 35 and from 138 to 211 in HIV-1 Nef bind to the polycomb group protein EED, which is known as a nuclear factor and repressor of transcription
11676	155871	NP_057853.1	Tat	binds	9606	8732	NP_003791.2	RNA guanylyltransferase and 5'-phosphatase	11278368,12408826	2007-11-07 17:30	HIV-1 Tat binding to mammalian capping enzyme (Mce1) is mediated through the C-terminal domain of Tat (amino acids 49-86) and amino acids 211-597 of Mce1
11676	155871	NP_057853.1	Tat	stimulates	9606	8732	NP_003791.2	RNA guanylyltransferase and 5'-phosphatase	11278368,12408826,14569024	2007-11-07 17:30	HIV-1 Tat interacts with mammalian capping enzyme (Mce1), stimulating its guanylyl-transferase and triphosphatase activities, thereby enhancing cap formation on TAR stem-loop RNA
11676	155348	NP_705926.1	retropepsin	cleaves	9606	8735	NP_003793.2	myosin-13	8424456	2007-11-07 17:29	HIV-1 protease cleaves human myosin heavy chain in vitro
11676	156110	NP_057857.2	Nef	upregulates	9606	8740	NP_003798.2	tumor necrosis factor ligand superfamily member 14 isoform 1 precursor	11000208,12836198,16091223	2007-11-07 17:28	Expression of HIV-1 Nef in a CD4+ human T-cell hybridoma enhances the surface levels of the membrane-bound cytokines tumor necrosis factor (TNF) and LIGHT; the enhancement of TNF and LIGHT depends on the presence of a functional dileucine motif in Nef
11676	155871	NP_057853.1	Tat	inhibits	9606	8743	NP_003801.1	tumor necrosis factor ligand superfamily member 10	11243698	2007-11-07 17:30	HIV-1 Tat inhibits apoptosis mediated by TRAIL in Jurkat T cells
11676	155871	NP_057853.1	Tat	upregulates	9606	8743	NP_003801.1	tumor necrosis factor ligand superfamily member 10	11385301,12767990	2007-11-07 17:30	Upregulation of TRAIL by HIV-1 Tat induces bystander-mediated apoptosis in T cells
11676	155871	NP_057853.1	Tat	upregulates	9606	8743	NP_003801.1	tumor necrosis factor ligand superfamily member 10	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including TRAIL, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	8743	NP_003801.1	tumor necrosis factor ligand superfamily member 10	15990565,16046522,16174727	2007-11-07 17:31	Treatment of CD4+ T cells with HIV-1 gp120 results in the upregulation of TRAIL death receptor expression and acquired sensitivity to TRAIL mediated cell death; this effect of gp120 requires the chemokine coreceptor CXCR4, but not CCR5 or the CD4 receptor
11676	156110	NP_057857.2	Nef	Co-localizes with	9606	8766	NP_004654.1	ras-related protein Rab-11A	15569681	2007-11-07 17:28	HIV-1 Nef co-localization with Rab11A GTPase is revealed by staining in the peripheral and perinuclear compartments
11676	155030	NP_579876.2	matrix	activates	9606	8789	NP_003828.2	fructose-1,6-bisphosphatase isozyme 2	9282826	2007-11-07 17:28	HIV-1 Matrix activates fructose 1,6-bisphosphatase gene expression by induction of a 1alpha-hydroxylase activity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	8793	NP_003831.2	tumor necrosis factor receptor superfamily member 10D precursor	15990565,16046522,16174727	2007-11-07 17:31	Treatment of CD4+ T cells with HIV-1 gp120 results in the upregulation of TRAIL death receptor expression and acquired sensitivity to TRAIL mediated cell death; this effect of gp120 requires the chemokine coreceptor CXCR4, but not CCR5 or the CD4 receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	8794	NP_003832.2	tumor necrosis factor receptor superfamily member 10C precursor	15990565,16046522,16174727	2007-11-07 17:31	Treatment of CD4+ T cells with HIV-1 gp120 results in the upregulation of TRAIL death receptor expression and acquired sensitivity to TRAIL mediated cell death; this effect of gp120 requires the chemokine coreceptor CXCR4, but not CCR5 or the CD4 receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	8795	NP_003833.3	tumor necrosis factor receptor superfamily, member 10b isoform 1 precursor	15990565,16046522,16174727	2007-11-07 17:31	Treatment of CD4+ T cells with HIV-1 gp120 results in the upregulation of TRAIL death receptor expression and acquired sensitivity to TRAIL mediated cell death; this effect of gp120 requires the chemokine coreceptor CXCR4, but not CCR5 or the CD4 receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	8797	NP_003835.2	tumor necrosis factor receptor superfamily, member 10a precursor	15990565,16046522,16174727	2007-11-07 17:31	Treatment of CD4+ T cells with HIV-1 gp120 results in the upregulation of TRAIL death receptor expression and acquired sensitivity to TRAIL mediated cell death; this effect of gp120 requires the chemokine coreceptor CXCR4, but not CCR5 or the CD4 receptor
11676	155030	NP_057850.1	Pr55(Gag)	binds	9606	8815	NP_003851.1	barrier-to-autointegration factor	14645565	2007-11-07 17:29	Barrier-to-autointegration factor binds directly to HIV-1 Gag and is a host component of HIV-1 virions
11676	155030	NP_579876.2	matrix	binds	9606	8815	NP_003851.1	barrier-to-autointegration factor	14645565	2007-11-07 17:29	Barrier-to-autointegration factor binds directly to HIV-1 Matrix and is hypothesized to contribute to the assembly or activity of HIV-1 pre-integration complexes through its interaction with Matrix
11676	155348	NP_705928.1	integrase	interacts with	9606	8815	NP_003851.1	barrier-to-autointegration factor	7937898,9465049,12663813,14645565,15875659,16075307,16403635,16738646	2007-11-07 17:29	The barrier-to-autointegration factor (BAF) is a component of HIV-1 preintegration complexes that functions as an integration cofactor that protects retroviral DNA from autointegration
11676	155348	NP_705928.1	integrase	interacts with	9606	8815	NP_003851.1	barrier-to-autointegration factor	16680152,16738646	2007-11-07 17:31	Barrier-to-autointegration factor (BAF) is required for the association of viral cDNA with emerin and for chromatin engagement by viral cDNA before integration, indicating potential interactions between BAF, emerin and HIV-1 integrase
11676	155871	NP_057853.1	Tat	complexes with	9606	8850	NP_003875.3	histone acetyltransferase KAT2B	9733796	2007-11-07 17:30	HIV-1 Tat forms a ternary complex with p300 and P/CAF
11676	155871	NP_057853.1	Tat	interacts with	9606	8850	NP_003875.3	histone acetyltransferase KAT2B	9733796,11956210,15611041,16838299,17168834	2007-11-07 17:30	HIV-1 Tat interaction with P/CAF and other histone acetyl transferases is preferentially important for Tat-mediated transactivation of integrated, but not unintegrated, HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	regulated by	9606	8850	NP_003875.3	histone acetyltransferase KAT2B	10545121	2007-11-07 17:30	Acetylation of HIV-1 Tat by P/CAF at Lysine 28 enhances Tat binding to CDK9, indicating P/CAF may regulate Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	acetylated by	9606	8850	NP_003875.3	histone acetyltransferase KAT2B	10545121,11547919,11956210	2007-11-07 17:30	HIV-1 Tat is acetylated by P/CAF on Lysine 28
11676	155871	NP_057853.1	Tat	regulated by	9606	8850	NP_003875.3	histone acetyltransferase KAT2B	11931765,11937047,12486002,15171254	2007-11-07 17:30	Acetylation of HIV-1 Tat by P/CAF at Lys28 and binding of P/CAF to Lys50 acetylated Tat regulates Tat binding to cyclin T1 and HIV-1 TAR RNA, as well as Tat-mediated transactivation of the HIV-1 LTR promoter, by allowing Tat to dissociate from TAR RNA
11676	155871	NP_057853.1	Tat	binds	9606	8850	NP_003875.3	histone acetyltransferase KAT2B	11931765,12032084,12486002,16362936	2007-11-07 17:30	The bromodomain (amino acids 712-832) of P/CAF mediates its binding to amino acids 20-40 of non-acetylated HIV-1 Tat, to amino acids 48-57 in the arginine rich motif of Lys50 acetylated Tat, while Lys28 acetylation of Tat abrogates P/CAF binding to Tat
11676	155871	NP_057853.1	Tat	synergizes with	9606	8850	NP_003875.3	histone acetyltransferase KAT2B	12032084,16838299,17168834	2007-11-07 17:30	HIV-1 Tat synergizes with P/CAF to activate the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	inhibits	9606	8850	NP_003875.3	histone acetyltransferase KAT2B	12154097	2007-11-07 17:30	HIV-1 Tat inhibits the transcriptional activation activity of P/CAF
11676	155871	NP_057853.1	Tat	inhibits	9606	8850	NP_003875.3	histone acetyltransferase KAT2B	12501250	2007-11-07 17:30	Binding of HIV-1 Tat to P/CAF inhibits acetylation of p53 on Lysine320 leading to repression of p53-mediated promoter transactivation, suggesting a mechanism whereby Tat may impair tumor suppressor functions and favor neoplasia establishment during AIDS
11676	155871	NP_057853.1	Tat	recruits	9606	8850	NP_003875.3	histone acetyltransferase KAT2B	14657027,15183343,15611041,15719065,16035254,16046164,16146763,17168834	2007-11-07 17:30	HIV-1 Tat recruits P/CAF, as well as other known cellular acetyltransferases, to the HIV-1 LTR promoter, an effect involved in the acetylation of histones H3 and H4, and HIV-1 transcriptional activation
11676	155871	NP_057853.1	Tat	acetylated by	9606	8850	NP_003875.3	histone acetyltransferase KAT2B	16135803	2007-11-07 17:28	Association of tumor protein p73 with HIV-1 Tat prevents the acetylation of Tat on lysine 28 by PCAF
11676	155871	NP_057853.1	Tat	downregulates	9606	8851	NP_003876.1	cyclin-dependent kinase 5 activator 1	12491158	2007-11-07 17:28	HIV-1 Tat downregulates the expression of p35, a neuron-specific activator of cdk5, and also binds to Puralpha, which associates with cdk5, leading to deregulation of neuronal differentiation and survival
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	8862	NP_059109.3	apelin preproprotein	11040134	2007-11-07 17:31	APJ, a seven transmembrane domain G-protein-coupled receptor, functions as a coreceptor for gp120 from some HIV-1 strains; a natural peptide ligand for APJ, apelin-13, efficiently blocks APJ coreceptor activity
11676	156110	NP_057857.2	Nef	induces complex with	9606	8874	NP_003890.1	rho guanine nucleotide exchange factor 7 isoform a	16356860	2007-11-07 17:29	In the presence of Nef, lipid raft Cdc42 is activated and forms a ternary complex between the c-Cbl-interacting protein p85Cool-1/betaPix and c-Cbl, displacing UbcH7 from rafts
11676	155871	NP_057853.1	Tat	competes with	9606	8894	NP_003899.2	eukaryotic translation initiation factor 2 subunit 2	9079663,10620360	2007-11-07 17:28	HIV-1 Tat competes with eukaryotic initiation factor 2, a well characterized substrate of PKR, for phosphorylation by activated PKR
11676	155871	NP_057853.1	Tat	interacts with	9606	8894	NP_003899.2	eukaryotic translation initiation factor 2 subunit 2	10648795	2007-11-07 17:29	Eukaryotic translation initiation factor 2 (eIF2) recognizes and binds the TAR secondary structure in HIV-1 RNA, suggesting a role in Tat transactivation of the viral LTR promoter
11676	155871	NP_057853.1	Tat	interacts with	9606	8900	NP_003905.1	cyclin-A1 isoform a	15050687	2007-11-07 17:28	When expressed in astrocytes, neurons, and non-glial 293T cells, HIV-1 Tat interacts with a number of cell cycle-related proteins including cyclin A, cyclin B, cyclin D3, Cdk2, Cdk4, Cdk1/Cdc2, cdc6, p27, p53, p63, hdlg, and PCNA
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	8905	NP_003907.3	AP-1 complex subunit sigma-2	9882340,11222723	2007-11-07 17:30	The cytoplasmic domain (residues 707-856) of HIV-1 gp41 interacts with whole clathrin-associated AP-1 and AP-2 adaptor complexes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	8905	NP_003907.3	AP-1 complex subunit sigma-2	11222723	2007-11-07 17:31	The highly conserved C-terminal dileucine motif (residues 851-856) in the cytosolic domain of HIV-1 gp41 interacts with clathrin-associated AP-1 adaptor complexes
11676	156110	NP_057857.2	Nef	interacts with	9606	8905	NP_003907.3	AP-1 complex subunit sigma-2	9736718,9811606,9811611,11463741,12486136,12836198,15681409	2007-11-07 17:29	A leucine-based motif near the C-terminus of HIV-1 Nef interacts with AP-1 complexes; residues 164 and 165 in Nef are required for the interaction with AP-1
11676	156110	NP_057857.2	Nef	binds	9606	8905	NP_003907.3	AP-1 complex subunit sigma-2	12486136,15681409,16253302	2007-11-07 17:29	The dileucine motif (residues 164-165) in HIV-1 Nef is required for binding to AP-1 complexes and stabilizing their association with membranes
11676	156110	NP_057857.2	Nef	stabilizes	9606	8905	NP_003907.3	AP-1 complex subunit sigma-2	16253302	2007-11-07 17:29	HIV-1 Nef stabilizes AP-1 complexes on endosomal membranes after ADP-ribosylation factor-1 (ARF1) -dependent attachment
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	8906	NP_003908.1	AP-1 complex subunit gamma-like 2	9882340,11222723	2007-11-07 17:30	The cytoplasmic domain (residues 707-856) of HIV-1 gp41 interacts with whole clathrin-associated AP-1 and AP-2 adaptor complexes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	8906	NP_003908.1	AP-1 complex subunit gamma-like 2	11222723	2007-11-07 17:30	The highly conserved C-terminal dileucine motif (residues 851-856) in the cytosolic domain of HIV-1 gp41 interacts with clathrin-associated AP-1 adaptor complexes
11676	156110	NP_057857.2	Nef	interacts with	9606	8906	NP_003908.1	AP-1 complex subunit gamma-like 2	9736718,9811606,9811611,11463741,12486136,12836198,15681409	2007-11-07 17:29	A leucine-based motif near the C-terminus of HIV-1 Nef interacts with AP-1 complexes; residues 164 and 165 in Nef are required for the interaction with AP-1
11676	156110	NP_057857.2	Nef	binds	9606	8906	NP_003908.1	AP-1 complex subunit gamma-like 2	12486136,15681409,16253302	2007-11-07 17:29	The dileucine motif (residues 164-165) in HIV-1 Nef is required for binding to AP-1 complexes and stabilizing their association with membranes
11676	156110	NP_057857.2	Nef	stabilizes	9606	8906	NP_003908.1	AP-1 complex subunit gamma-like 2	16253302	2007-11-07 17:29	HIV-1 Nef stabilizes AP-1 complexes on endosomal membranes after ADP-ribosylation factor-1 (ARF1) -dependent attachment
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	8907	NP_115882.1	AP-1 complex subunit mu-1 isoform 2	9400603,9882340,11222723	2007-11-07 17:27	Two tyrosine-based endocytic signals (residues 704-710 and 760-766) in the cytosolic tail (gp41) of the HIV-1 envelope glycoprotein (Env) complex interact with members of the adaptor medium chain family, AP-1 mu1, AP-2 mu2 and AP-3 mu3A
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	8907	NP_115882.1	AP-1 complex subunit mu-1 isoform 2	9882340,11222723	2007-11-07 17:31	The cytoplasmic domain (residues 707-856) of HIV-1 gp41 interacts with whole clathrin-associated AP-1 and AP-2 adaptor complexes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	8907	NP_115882.1	AP-1 complex subunit mu-1 isoform 2	11222723	2007-11-07 17:31	The highly conserved C-terminal dileucine motif (residues 851-856) in the cytosolic domain of HIV-1 gp41 interacts with clathrin-associated AP-1 adaptor complexes
11676	156110	NP_057857.2	Nef	binds	9606	8907	NP_115882.1	AP-1 complex subunit mu-1 isoform 2	9052838,9314527,11208076	2007-11-07 17:28	HIV-1 Nef acts in cis to induce the rapid endocytosis of CD8-Nef fusion proteins via binding to the mu 1 chain of the adaptor protein type 1 (AP1) complex
11676	156110	NP_057857.2	Nef	interacts with	9606	8907	NP_115882.1	AP-1 complex subunit mu-1 isoform 2	9564030,9586638	2007-11-07 17:28	HIV-1 Nef downregulates CD4 and MHC I by connecting these receptors with the endocytic machinery through direct interactions between Nef and the mu medium chains of AP complexes, essential components of clathrin-coated pits
11676	156110	NP_057857.2	Nef	Interacts with	9606	8907	NP_115882.1	AP-1 complex subunit mu-1 isoform 2	9736718,9811606,9811611,11463741,12486136,12836198,15681409	2007-11-07 17:28	A leucine-based motif near the C-terminus of HIV-1 Nef interacts with AP-1 complexes; residues 164 and 165 in Nef are required for the interaction with AP-1
11676	156110	NP_057857.2	Nef	Interacts with	9606	8907	NP_115882.1	AP-1 complex subunit mu-1 isoform 2	11208076	2007-11-07 17:28	Two distinct regions in Nef, from amino acids 140-150 and from 180-190, can both interact with the mu subunit of the adaptor protein complex 1 (AP-1)
11676	156110	NP_057857.2	Nef	stabilizes	9606	8907	NP_115882.1	AP-1 complex subunit mu-1 isoform 2	16253302	2007-11-07 17:29	HIV-1 Nef stabilizes AP-1 complexes on endosomal membranes after ADP-ribosylation factor-1 (ARF1) -dependent attachment
11676	155030	NP_579876.2	matrix	interacts with	9606	8943	NP_003929.4	AP-3 complex subunit delta-1 isoform 2	15766529	2007-11-07 17:29	The matrix region of HIV-1 Gag interacts directly with the delta subunit of the AP-3 complex, and this interaction is required for Gag trafficking to multivesicular bodies
11676	156110	NP_057857.2	Nef	co-localizes with	9606	8943	NP_003929.4	AP-3 complex subunit delta-1 isoform 2	10814565,12486136	2007-11-07 17:28	HIV-1 Nef co-localizes with the delta subunit of adaptor protein complex 3 (AP-3) in a juxtanuclear region near the cell center of HeLa cells
11676	156110	NP_057857.2	Nef	binds	9606	8943	NP_003929.4	AP-3 complex subunit delta-1 isoform 2	12486136,15681409	2007-11-07 17:28	The dileucine residues and glutamic acid residue of the EXXXLL motif in HIV-1 Nef (amino acid residues 159-165) are required for Nef binding and stabilization of AP-3
11676	155945	NP_057855.1	Vpu	recruits	9606	8945	NP_003930.1	F-box/WD repeat-containing protein 1A isoform 2	9660940,14561767,16165251,16354571	2007-11-07 17:27	Binding of HIV-1 Vpu to beta-TrCP requires two phosphoserine residues on Vpu (amino acids 52 and 56) and results in recruitment of beta-TrCP to cellular membranes
11676	155945	NP_057855.1	Vpu	binds	9606	8945	NP_003930.1	F-box/WD repeat-containing protein 1A isoform 2	9660940,11278695,11696595,14561767,16354571,17121803	2007-11-07 17:27	Through binding to beta-TrCP, HIV-1 Vpu targets CD4 for degradation in the endoplasmic reticulum and also inhibits IkappaB-alpha degradation as well as NF-kappaB activation
11676	155945	NP_057855.1	Vpu	inhibits	9606	8945	NP_003930.1	F-box/WD repeat-containing protein 1A isoform 2	14561767	2007-11-07 17:29	HIV-1 Vpu is a strong competitive inhibitor of beta-TrCP and impairs the degradation of SCF-beta-TrCP substrates such as IKBalpha, ATF4 and beta-catenin
11676	155871	NP_057853.1	Tat	binds	9606	8968	NP_066298.1	histone H3.1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8969	NP_066408.1	histone H2A type 1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	8970	NP_066402.2	histone H2B type 1-J	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	156110	NP_057857.2	Nef	inhibits	9606	8976	NP_003932.3	neural Wiskott-Aldrich syndrome protein	16687395	2007-11-07 17:31	HIV-1 Nef inhibits the concomitant activation of the actin organizer N-Wasp by interfering with the translocation of N-Wasp to the cell periphery and blocks morphological changes induced by the known N-Wasp regulators Rac1 and Cdc42
11676	155871	NP_057853.1	Tat	enhances	9606	9020	NP_003945.2	mitogen-activated protein kinase kinase kinase 14	11511100	2007-11-07 17:27	HIV-1 Tat enhances the capacity of NF-kappaB-inducing kinase (NIK) to accelerate degradation of IkappaB
11676	155871	NP_057853.1	Tat	interacts with	9606	9044	NP_003963.1	TATA-binding protein-associated factor 172	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	9044	NP_003963.1	TATA-binding protein-associated factor 172	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	9044	NP_003963.1	TATA-binding protein-associated factor 172	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	9044	NP_003963.1	TATA-binding protein-associated factor 172	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	9044	NP_003963.1	TATA-binding protein-associated factor 172	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	155871	NP_057853.1	Tat	downregulates	9606	9076	NP_066924.1	claudin-1	14515355,16697675	2007-11-07 17:30	Exposure of brain microvascular endothelial cells to HIV-1 Tat results in a decrease of claudin-1, claudin-5, and zonula occludens-2 expression and cellular redistribution of claudin-5, suggesting potential disturbance of the blood-brain barrier by Tat
11676	155807	NP_057852.2	Vpr	interacts with	9606	9131	NP_004199.1	apoptosis-inducing factor 1, mitochondrial isoform 1 precursor	12404120,16511342	2007-11-07 17:31	HIV-1 Vpr induces apoptosis through a caspase-independent mitochondrial pathway controlled by AIF
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	relocalizes	9606	9131	NP_004199.1	apoptosis-inducing factor 1, mitochondrial isoform 1 precursor	11193032,15033690	2007-11-07 17:31	Apoptosis induced by HIV-1 gp120/gp41 is involved in the translocation of cytochrome c and apoptosis-inducing factor (AIF) from mitochondria to an extra-mitochondrial localization and in the dissipation of the mitochondrial transmembrane potential
11676	155807	NP_057852.2	Vpr	inactivates	9606	9133	NP_004692.1	G2/mitotic-specific cyclin-B2	7474080,7474100,7494303,7666531,9094673,10958988	2007-11-07 17:29	HIV-1 Vpr inactivates the cdc2-cyclin B kinase complex by inhibiting the dephosphorylation of cdc2 tyrosine 15, leading to arrest in the G2 phase of the cell cycle
11676	155807	NP_057852.2	Vpr	inactivates	9606	9133	NP_004692.1	G2/mitotic-specific cyclin-B2	7474100,11531413	2007-11-07 17:28	HIV-1 Vpr inactivates the cdc2-cyclin B kinase complex by inactivating cdc25C, the phosphatase that dephosphorylates and activates cdc2
11676	155807	NP_057852.2	Vpr	inactivates	9606	9133	NP_004692.1	G2/mitotic-specific cyclin-B2	7494303	2007-11-07 17:28	Inactivation of the cdc2-cyclin B kinase complex and arrest in the G2 phase of the cell cycle has been mapped to the C-terminus of HIV-1 Vpr, including amino acids 73, 80 and 84-96
11676	155807	NP_057852.2	Vpr	inactivates	9606	9133	NP_004692.1	G2/mitotic-specific cyclin-B2	9520381	2007-11-07 17:28	The human Vpr interacting protein (hVIP/MOV34) is a likely cellular cofactor for HIV-1 Vpr inactivation of the cdc2-cyclin B kinase complex and induction of cell cycle arrest
11676	155807	NP_057852.2	Vpr	inhibits	9606	9133	NP_004692.1	G2/mitotic-specific cyclin-B2	9560267	2007-11-07 17:28	Data suggests that HIV-1 Vpr transactivation of the HIV-LTR promoter occurs through the inhibition of p300-associated cdc2-cyclin B kinase complex activity which enhances transcriptional activation by Rel A and p300
11676	155807	NP_057852.2	Vpr	inactivates	9606	9133	NP_004692.1	G2/mitotic-specific cyclin-B2	11878934	2007-11-07 17:28	Inactivation of the cdc2-cyclin B kinase complex by HIV-1 Vpr leads to the activation of Poly(A) polymerase
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	9138	NP_945353.1	rho guanine nucleotide exchange factor 1 isoform 1	10556093	2007-11-07 17:31	The interaction of the long cytoplasmic tail of HIV-1 gp41 with the carboxy-terminal regulatory domain of p115-RhoGEF inhibits p115-mediated actin stress fiber formation and activation of serum response factor (SRF)
11676	155030	NP_057850.1	Pr55(Gag)	inhibited by	9606	9146	NP_004703.1	hepatocyte growth factor-regulated tyrosine kinase substrate	17182674	2007-11-07 17:31	Overexpression of the C-terminal fragment of HRS (residues 391-777) or HRS mutants lacking either the N-terminal FYVE domain (residues 215-290) or the PSAP (residues 348-351) motif efficiently inhibit HIV-1 Gag particle production
11676	155871	NP_057853.1	Tat	inhibits	9606	9150	NP_004706.3	RNA polymerase II subunit A C-terminal domain phosphatase isoform FCP1a	9765293,9822634,10938286,11273209	2007-11-07 17:29	HIV-1 Tat binds to and strongly inhibits the activity of the CTD phosphatase (FCP1), indicating that Tat-dependent suppression of CTD phosphatase is part of the transactivation function of Tat
11676	155871	NP_057853.1	Tat	binds	9606	9150	NP_004706.3	RNA polymerase II subunit A C-terminal domain phosphatase isoform FCP1a	15723517	2007-11-07 17:28	FCP1 is required for Tat-mediated transactivation in vitro and amino acids 562-685 of FCP1 are necessary for binding to Tat in yeast two-hybrid studies
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	cleaved by	9606	9159	NP_004707.2	proprotein convertase subtilisin/kexin type 7 preproprotein	8940009,8995623,9094426,9521771,10452538,11063880,12071862,12354117	2007-11-07 17:30	Kexin/subtilisin-related convertases such as furin, PACE4, PC1, PC2, PC7/LPC, PC5, and its isoform PC5/6-B can process HIV-1 gp160 to gp120/gp41
11676	155871	NP_057853.1	Tat	upregulates	9606	9255	NP_004748.2	aminoacyl tRNA synthase complex-interacting multifunctional protein 1 isoform a precursor	15857508	2007-11-07 17:28	SCYE1 is upregulated by HIV-1 Tat treatment in human epithelial cells
11676	155807	NP_057852.2	Vpr	downregulates	9606	9308	NP_004224.1	CD83 antigen isoform a	15611322	2007-11-07 17:28	HIV-1 Vpr downregulates the expression of several immunologically important molecules including CD40, CD80, CD83, and CD86 co-stimulatory molecules on monocyte-derived macrophage (MDM) and monocyte-derived dendritic cells (MDDC)
11676	155807	NP_057852.2	Vpr	downregulates	9606	9308	NP_004224.1	CD83 antigen isoform a	15956545	2007-11-07 17:28	HIV-1 Vpr inhibits the expression of co-stimulatory molecules including CD80, CD83, and CD86 at the transcriptional level without altering normal cellular transcription during dendritic cell maturation
11676	155871	NP_057853.1	Tat	upregulates	9606	9308	NP_004224.1	CD83 antigen isoform a	11751963	2007-11-07 17:27	HIV-1 Tat upregulates the expression of MHC and co-stimulatory molecules CD40, CD80, CD83 and CD86 in monocyte-derived dendritic cells, thereby driving T cell-mediated immune responses
11676	155871	NP_057853.1	Tat	activates	9606	9328	NP_036219.1	general transcription factor IIIC, polypeptide 5, 63kDa	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	activates	9606	9329	NP_036336.1	general transcription factor IIIC, polypeptide 4, 90kDa	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	activates	9606	9330	NP_036218.1	general transcription factor 3C polypeptide 3	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	9331	NP_004766.1	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase 6	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	9333	NP_963925.2	protein-glutamine gamma-glutamyltransferase 5 isoform 1	7906657	2007-11-07 17:29	Cyclosporin (CsA) treatment prevents gp120-dependent induction of apoptosis by blocking the activation of Ca(2+)-dependent effector elements such as transglutaminase (TG) proteins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	modified by	9606	9333	NP_963925.2	protein-glutamine gamma-glutamyltransferase 5 isoform 1	7688299	2007-11-07 17:30	The HIV-1 transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro; soluble CD4 can block the transglutaminase-catalyzed incorporation of the polyamine spermidine into HIV-1 gp41
11676	155030	NP_579876.2	matrix	myristoylated by	9606	9397	NP_004799.1	glycylpeptide N-tetradecanoyltransferase 2	2194551,2405382,2692561,2737204,2788277,7521919,8139035,8576268,8970978,9261380,9299393,9971769,10074105,10196310,11302743,12244217,12767222,14699046,14707265,15280532,16183191,16216583,16306631	2007-11-07 17:28	HIV-1 Matrix is myristoylated on its N-terminal glycine residue by N-myristoyltransferase, a chemical modification important for membrane targeting of Gag/Matrix, for facilitating Matrix multimerization, and for virus particle formation and budding
11676	155871	NP_057853.1	Tat	interacts with	9606	9412	NP_004255.2	mediator of RNA polymerase II transcription subunit 21	9121429	2007-11-07 17:28	HIV-1 Tat interacts with the RNA polymerase II holoenzyme, which includes SRB7, during Tat-mediated transactivation of the HIV-1 LTR
11676	155871	NP_057853.1	Tat	downregulates	9606	9414	NP_004808.2	tight junction protein ZO-2 isoform 1	14515355,16697675	2007-11-07 17:30	Exposure of brain microvascular endothelial cells to HIV-1 Tat results in a decrease of claudin-1, claudin-5, and zonula occludens-2 expression and cellular redistribution of claudin-5, suggesting potential disturbance of the blood-brain barrier by Tat
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	9414	NP_004808.2	tight junction protein ZO-2 isoform 1	15977641	2007-11-07 17:30	Treatment of cultured human brain endothelial cells with HIV-1 gp120 results in increased permeability of the endothelial monolayer and causes disruption and downregulation of the tight junction proteins ZO-1, ZO-2, and occludin in these cells
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	9435	NP_004258.2	carbohydrate sulfotransferase 2	1433500,8419650	2007-11-07 17:30	Sulfate is linked to the carbohydrate chains of HIV-1 glycoproteins gp160, gp120, and gp41 during the endoplasmic reticulum to Golgi transport of the glycoproteins
11676	156110	NP_057857.2	Nef	induces phosphorylation of	9606	9459	NP_004831.1	rho guanine nucleotide exchange factor 6	10559302	2007-11-07 17:28	HIV-1 Nef binding and activation of p62 PAK induces the interaction and phosphorylation of PIX with the Nef-PAK complex
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	9469	NP_004264.2	carbohydrate sulfotransferase 3	1433500,8419650	2007-11-07 17:30	Sulfate is linked to the carbohydrate chains of HIV-1 glycoproteins gp160, gp120, and gp41 during the endoplasmic reticulum to Golgi transport of the glycoproteins
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	9486	NP_004845.1	carbohydrate sulfotransferase 10	1433500,8419650	2007-11-07 17:30	Sulfate is linked to the carbohydrate chains of HIV-1 glycoproteins gp160, gp120, and gp41 during the endoplasmic reticulum to Golgi transport of the glycoproteins
11676	155348	NP_705928.1	integrase	degraded by	9606	9491	NP_006805.1	proteasome inhibitor subunit 1 isoform 1	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	9491	NP_006805.1	proteasome inhibitor subunit 1 isoform 1	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829,15139295,15183343,15638724,16035254,16046164,16146763	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	9491	NP_006805.1	proteasome inhibitor subunit 1 isoform 1	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	9491	NP_006805.1	proteasome inhibitor subunit 1 isoform 1	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	9491	NP_006805.1	proteasome inhibitor subunit 1 isoform 1	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	9491	NP_006805.1	proteasome inhibitor subunit 1 isoform 1	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155030	NP_579880.1	capsid	upregulates	9606	9536	NP_004869.1	prostaglandin E synthase	9743208	2007-11-07 17:29	Immunosuppressive peptides corresponding to HIV-1 Capsid amino acids 218-238 upregulate prostaglandin E2 production and induce IL-10 secretion
11676	155871	NP_057853.1	Tat	binds	9606	9555	NP_613075.1	core histone macro-H2A.1 isoform 1	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	9564	NP_055382.2	breast cancer anti-estrogen resistance protein 1 isoform 6	9621077	2007-11-07 17:28	HIV-1 Tat enhances the tyrosine phosphorylation of p130Cas, an effect linked to Tat-induced angiogenesis and AIDS-related Kaposi's sarcoma
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	9582	NP_004891.3	probable DNA dC->dU-editing enzyme APOBEC-3B	17020885	2007-11-07 17:31	APOBEC3B may be incorporated into virions by HIV-1 Gag polyprotein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaved by	9606	9601	NP_004902.1	protein disulfide-isomerase A4 precursor	12218051,12218052,15644496,16182193	2007-11-07 17:30	Protein-disulfide isomerase (PDI) cleaves disulfide bonds in recombinant HIV-1 envelope glycoprotein gp120, and gp120 bound to the surface receptor CD4 undergoes a disulfide reduction that is prevented by PDI inhibitors
11676	155871	NP_057853.1	Tat	inhibited by	9606	9618	NP_004286.2	TNF receptor-associated factor 4	12023963	2007-11-07 17:30	Overexpression of the p47-phox binding domain of TRAF4 inhibits endothelial cell JNK activation by HIV-1 Tat, suggesting Tat initiates signals that enter basic signaling cassettes at the level of TRAF4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	9629	NP_004912.2	calcium activated chloride channel 3 precursor	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	9635	NP_006527.1	calcium-activated chloride channel regulator 2 precursor	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155871	NP_057853.1	Tat	upregulates	9606	9636	NP_005092.1	interferon-induced 17 kDa protein precursor	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including ISG15, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	9641	NP_054721.1	IKK-related kinase epsilon	11959143	2007-11-07 17:31	HIV-1 gp120/CD4 interaction-induced NF-kappaB activation stimulates the hyperphosphorylation of IkappaB-alpha by IkappaB kinases (IKKs)
11676	155871	NP_057853.1	Tat	downregulates	9606	9647	NP_055449.1	protein phosphatase 1F	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat downregulates the expression of many proteins, including protein phosphatase 1F (KIAA0015), in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	9651	NP_055453.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase eta-2	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155030	NP_579876.2	matrix	inhibits	9606	9669	NP_056988.3	eukaryotic translation initiation factor 5B	10432305	2007-11-07 17:28	HIV-1 Matrix inhibits hIF2 mediated translation in a reticulocyte lysate assay
11676	155030	NP_579876.2	matrix	binds	9606	9669	NP_056988.3	eukaryotic translation initiation factor 5B	10432305	2007-11-07 17:28	HIV-1 Matrix, as well as the full length HIV-1 Gag protein bind to human translation initiation factor two (hIF2) and these proteins can be immunoprecipitated as a protein complex
11676	155871	NP_057853.1	Tat	binds	9606	9672	NP_055469.2	syndecan 3	7690138,9342064	2007-11-07 17:30	Binding of HIV-1 Tat to heparan sulfate proteoglycans is competed out by the heparin-binding factor bFGF
11676	155871	NP_057853.1	Tat	binds	9606	9672	NP_055469.2	syndecan 3	8570206,9111037,10497173,11024024,11567105,12885232	2007-11-07 17:30	Cell membrane heparin sulfate proteoglycans bind to the basic region of HIV-1 Tat (amino acids 49-57) and act as receptors for extracellular Tat uptake, an effect that may contribute to the angiogenic properties of Tat in promoting Kaposi's sarcoma
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	9672	NP_055469.2	syndecan 3	16157597,16817962	2007-11-07 17:30	The V3 region (amino acids 298-329) of HIV-1 gp120 contains the syndecan-binding site for HIV-1 via 6-O sulfated motifs; a single conserved arginine (Arg-298) in the V3 region of gp120 governs HIV-1 binding to syndecans
11676	155807	NP_057852.2	Vpr	binds	9606	9730	NP_055518.1	protein VPRBP isoform 1	8195203,11223251	2007-11-07 17:28	The leucine/isoleucine-rich domain of HIV-1 Vpr (amino acids 60-81) mediates binding of Vpr to the C-terminal half of VprBP (amino acids 636-1507), resulting in the cytoplasmic retention of Vpr
11676	155871	NP_057853.1	Tat	regulated by	9606	9733	NP_055521.1	squamous cell carcinoma antigen recognized by T-cells 3	11959860	2007-11-07 17:30	Tip110 binds to HIV-1 Tat and regulates Tat transactivation activity, suggesting an important role for Tip110 in HIV-1 gene expression and viral replication
11676	156110	NP_057857.2	Nef	Interacts with	9606	9844	NP_055615.8	engulfment and cell motility protein 1 isoform 1	14737186	2007-11-07 17:28	Interaction of HIV-1 Nef with a protein complex, which includes Rac2, DOCK2, and ELMO1, activates Rac activity in T cells
11676	155348	NP_705928.1	integrase	degraded by	9606	9861	NP_055629.1	26S proteasome non-ATPase regulatory subunit 6	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	9861	NP_055629.1	26S proteasome non-ATPase regulatory subunit 6	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:29	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	9861	NP_055629.1	26S proteasome non-ATPase regulatory subunit 6	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	9861	NP_055629.1	26S proteasome non-ATPase regulatory subunit 6	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	9861	NP_055629.1	26S proteasome non-ATPase regulatory subunit 6	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	9861	NP_055629.1	26S proteasome non-ATPase regulatory subunit 6	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155871	NP_057853.1	Tat	downregulates	9606	9902	NP_006030.2	C-type mannose receptor 2	11120831	2007-11-07 17:30	HIV-1 Tat represses transcription from the rat mannose receptor promoter, thereby downregulating expression of mannose receptor
11676	155871	NP_057853.1	Tat	downregulates	9606	9902	NP_006030.2	C-type mannose receptor 2	16615932	2007-11-07 17:31	HIV-1 Tat interaction with cyclin T1 is required for the repression of mannose receptor (MR) and bone morphogenetic protein receptor-2 (BMPR2) promoters
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	9902	NP_006030.2	C-type mannose receptor 2	15047828,15955449	2007-11-07 17:30	HIV-1 gp120 interaction with human mannose receptor (hMR) results in increased production of matrix metalloproteinase-2 (MMP-2) in astrocytes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	9902	NP_006030.2	C-type mannose receptor 2	16547227	2007-11-07 17:31	HIV-1 gp120 binds to B cells through mannose C-type lectin receptors (MCLRs), such as DC-SIGN, mannose receptor, and langerin
11676	155908	NP_057854.1	Rev	inhibited by	9606	9972	NP_005115.2	nuclear pore complex protein Nup153	10069809	2007-11-07 17:27	antibodies to nup153 can block the nuclear export of Rev as well as Rev-dependent RNA export
11676	155908	NP_057854.1	Rev	interacts with	9606	9972	NP_005115.2	nuclear pore complex protein Nup153	11238447	2007-11-07 17:27	nup153 is involved in Rev-mediated nuclear export of HIV-1 mRNA through an interaction with eukaryotic initiation factor 5A (eIF-5A) which binds to Rev
11676	155459	NP_057851.1	Vif	complexes with	9606	9978	NP_055063.1	RING-box protein 1	14564014	2007-11-07 17:29	HIV-1 Vif (amino acids 144-149; SLQXLA motif) interacts with cellular proteins Cul5, elongins B and C, and Rbx1 to form an Skp1-cullin-F-box (SCF)-like complex that allows Vif to interact with APOBEC3G and induce its ubiquitination and degradation
11676	155807	NP_057852.2	Vpr	inhibits	9606	10000	NP_005456.1	RAC-gamma serine/threonine-protein kinase isoform 1	15616007	2007-11-07 17:28	HIV-1 Vpr inhibits Akt-induced cytoplasmic translocation of Foxo3a, a subtype of the forkhead transcription factors
11676	155871	NP_057853.1	Tat	activates	9606	10000	NP_005456.1	RAC-gamma serine/threonine-protein kinase isoform 1	9394803,11156964,11994280,17157319	2007-11-07 17:28	HIV-1 Tat activates AKT kinase through activation of PI3 kinase, resulting in the protection of cells from apoptosis
11676	155871	NP_057853.1	Tat	activates	9606	10000	NP_005456.1	RAC-gamma serine/threonine-protein kinase isoform 1	11156964	2007-11-07 17:28	HIV-1 Tat downregulates CREB transcription factor expression in PC12 neuronal cells through activation of a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway
11676	155871	NP_057853.1	Tat	activates	9606	10000	NP_005456.1	RAC-gamma serine/threonine-protein kinase isoform 1	17157319	2007-11-07 17:31	Pro-survival effects of intracellular HIV-1 Tat in a microglial cell line is attributed to activation of the PI-3-kinase (PI3K)/Akt pathway via decreasing expression of PTEN, a negative regulator of the PI-3-K pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	10000	NP_005456.1	RAC-gamma serine/threonine-protein kinase isoform 1	10869418	2007-11-07 17:31	Fractalkine (CX3CL1) protects hippocampal neurons from the neurotoxicity induced by the HIV-1 envelope protein gp120, and neuronal CX(3)CR1 receptors and Akt activation are responsible for the neuroprotective effects of fractalkine
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	decreases phosphorylation of	9606	10000	NP_005456.1	RAC-gamma serine/threonine-protein kinase isoform 1	11208609	2007-11-07 17:30	HIV-1 gp120 downregulates expression of c-Myc, Max, and 14-3-3epsilon proteins, and decreases phosphorylation of ATP-dependent tyrosine kinases (Akt) at Ser-473 in human mesangial cells (HMC)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	regulated by	9606	10000	NP_005456.1	RAC-gamma serine/threonine-protein kinase isoform 1	15689238	2007-11-07 17:30	Pre-treatment of endothelial cells with fibroblast growth factor 2 (FGF2) protects cells from HIV-1 gp120 angiotoxicity; this protection is regulated by crosstalk among the ERK, PI3K-AKT and PKC signaling pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	modulated by	9606	10000	NP_005456.1	RAC-gamma serine/threonine-protein kinase isoform 1	16524887	2007-11-07 17:31	CD45 modulates HIV-1 gp120-induced apoptosis by regulating Fas ligand induction and activation of the phosphoinositide 3-kinase/Akt pathway
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	10000	NP_005456.1	RAC-gamma serine/threonine-protein kinase isoform 1	16841089	2007-11-07 17:31	HIV-1 gp120 induced cell death is inhibited by a CCR5-mediated neuroprotective pathway that involves protein kinase Akt/PKB as an essential component and can be triggered by the CCR5 agonists MIP-1beta and RANTES
11676	156110	NP_057857.2	Nef	binds	9606	10005	NP_005460.2	acyl-coenzyme A thioesterase 8 isoform a	9153233,9299485,10799608,10807905	2007-11-07 17:27	Amino acids 108-152 mediate binding of HIV-1 Nef to the human Thioesterase II protein (hTE), an interaction that enhances hTE enzymatic activity
11676	156110	NP_057857.2	Nef	binds	9606	10005	NP_005460.2	acyl-coenzyme A thioesterase 8 isoform a	9153233,10799608,10807905	2007-11-07 17:28	Point mutations in HIV-1 Nef at amino acids Asp108, Leu121, Pro122, and Asp123 abrogate the ability of Nef to bind hTE, downregulate CD4 and MHC class I, and dimerize, indicating a key role for this region of Nef in mediating most of its known functions
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	10013	NP_006035.2	histone deacetylase 6	16148047	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4+-permissive cells increases the level of acetylated alpha-tubulin in a CD4-dependent manner; overexpression of Histone Deacetylase 6 (HDAC6) inhibits the acetylation of alpha-tubulin and prevents HIV-1-cell fusion
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibited by	9606	10013	NP_006035.2	histone deacetylase 6	16148047	2007-11-07 17:31	Overexpression of Histone Deacetylase 6 (HDAC6) inhibits the acetylation of alpha-tubulin and remarkably prevents HIV-1 gp120/41-dependent cell fusion
11676	155030	NP_057850.1	Pr55(Gag)	downregulated by	9606	10015	NP_037506.2	programmed cell death 6-interacting protein isoform 1	17158451	2007-11-07 17:31	Overexpression of AIP1(364-716) leads to a reduction in the cell-associated levels of HIV-1 Gag
11676	155030	NP_057850.1	Pr55(Gag)	interacts with	9606	10015	NP_037506.2	programmed cell death 6-interacting protein isoform 1	17158451	2007-11-07 17:31	Overexpression of AIP1(364-716) severely disrupts Gag processing, resulting in an increase in the ratio of Gag to p25/p24
11676	155030	NP_579883.1	p6	binds	9606	10015	NP_037506.2	programmed cell death 6-interacting protein isoform 1	14505569,14505570,14519844,16234236,16470130	2007-11-07 17:29	AIP1 binds to the LXXLF motif in HIV-1 p6 (amino acids 41-44) and along with TSG101 acts as a component of the viral budding machinery
11676	155030	NP_579883.1	p6	incorporates	9606	10015	NP_037506.2	programmed cell death 6-interacting protein isoform 1	14505569,14505570,16470130,17158451	2007-11-07 17:29	AIP1 is incorporated into HIV-1 virions through its interaction with HIV-1 p6
11676	156110	NP_057857.2	Nef	binds	9606	10015	NP_037506.2	programmed cell death 6-interacting protein isoform 1	16764724	2007-11-07 17:31	Residues 135-138 of HIV-1 Nef bind to AIP1 in vitro and in cells; the binding between Nef and AIP1 is required for formation of multivesicular bodies (MVBs) and contributes to the egress of viral particles from infected cells
11676	155871	NP_057853.1	Tat	interacts with	9606	10018	NP_006529.1	bcl-2-like protein 11 isoform 6	12486001	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	10053	NP_005489.2	AP-1 complex subunit mu-2	9882340	2007-11-07 17:30	A Tyr-based motif YXXO (residues 712-715) in the cytoplasmic domain of HIV-1 gp41 interacts with the micro1 and micro2 subunits of AP complexes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	10053	NP_005489.2	AP-1 complex subunit mu-2	9882340,11222723	2007-11-07 17:30	The cytoplasmic domain (residues 707-856) of HIV-1 gp41 interacts with whole clathrin-associated AP-1 and AP-2 adaptor complexes
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	10053	NP_005489.2	AP-1 complex subunit mu-2	11222723	2007-11-07 17:30	The highly conserved C-terminal dileucine motif (residues 851-856) in the cytosolic domain of HIV-1 gp41 interacts with clathrin-associated AP-1 adaptor complexes
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaved by	9606	10130	NP_005733.1	protein disulfide-isomerase A6 precursor	12218051,12218052,15644496,16182193	2007-11-07 17:30	Protein-disulfide isomerase (PDI) cleaves disulfide bonds in recombinant HIV-1 envelope glycoprotein gp120, and gp120 bound to the surface receptor CD4 undergoes a disulfide reduction that is prevented by PDI inhibitors
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	10164	NP_005760.1	carbohydrate sulfotransferase 4	1433500,8419650	2007-11-07 17:30	Sulfate is linked to the carbohydrate chains of HIV-1 glycoproteins gp160, gp120, and gp41 during the endoplasmic reticulum to Golgi transport of the glycoproteins
11676	155348	NP_705928.1	integrase	degraded by	9606	10197	NP_005780.2	proteasome activator complex subunit 3 isoform 1	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	10197	NP_005780.2	proteasome activator complex subunit 3 isoform 1	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	10197	NP_005780.2	proteasome activator complex subunit 3 isoform 1	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	10197	NP_005780.2	proteasome activator complex subunit 3 isoform 1	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	10197	NP_005780.2	proteasome activator complex subunit 3 isoform 1	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	10197	NP_005780.2	proteasome activator complex subunit 3 isoform 1	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155030	NP_579876.2	matrix	complexes with	9606	10204	NP_005787.1	nuclear transport factor 2	9562972	2007-11-07 17:28	NTF2 coordinates the activity of Ran by binding Ran-GDP into a complex with nucleoporin-docked karyopherins during nuclear import of HIV-1 Matrix
11676	155030	NP_057850.1	Pr55(Gag)	binds	9606	10226	NP_005808.2	mannose 6 phosphate receptor binding protein 1	17003132	2007-11-07 17:31	TIP47 is a connector between HIV-1 Gag and Env and is required for Env incorporation into virions
11676	155030	NP_579876.2	matrix	binds	9606	10226	NP_005808.2	mannose 6 phosphate receptor binding protein 1	17003132	2007-11-07 17:31	HIV-1 Gag binds to TIP47 in a yeast two-hybrid assay; Residues 5-16 of the HIV-1 Gag Matrix domain are required for binding to TIP47
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	10226	NP_005808.2	mannose 6 phosphate receptor binding protein 1	12768012	2007-11-07 17:30	The cytoplasmic domain (residues 801-819) of gp41 binds to TIP47, a protein required for the transport of mannose-6-phosphate receptors from endosomes to the trans-Golgi network (TGN)
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	10226	NP_005808.2	mannose 6 phosphate receptor binding protein 1	17003132	2007-11-07 17:31	TIP47 is a connector between HIV-1 Gag and Env and is required for Env incorporation into virions
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	10242	NP_005823.1	calcium-activated potassium channel subunit beta-2	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155807	NP_057852.2	Vpr	inhibits	9606	10262	NP_005841.1	splicing factor 3B subunit 4	16923959	2007-11-07 17:31	HIV-1 Vpr induces checkpoint activation and G2 arrest by binding to the CUS1 domain of SAP145 and interfering with the functions of the SAP145 and SAP49 proteins, two subunits of the multimeric splicing factor 3b (SF3b)
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	10317	NP_006048.1	beta-1,3-galactosyltransferase 5	2187500,2541446,2542563,2649653,2829950	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155030	NP_579876.2	matrix	binds	9606	10318	NP_006049.3	TNFAIP3-interacting protein 1	11090181	2007-11-07 17:28	The C-terminus (amino acids 468-637) of virion-associated matrix-interacting protein (VAN) binds to HIV-1 Matrix and has been proposed to play a role in the nuclear import of the HIV-1 preintegration complex
11676	155030	NP_579876.2	matrix	incorporates	9606	10318	NP_006049.3	TNFAIP3-interacting protein 1	11090181	2007-11-07 17:28	VAN is efficiently incorporated into HIV-1 virions, presumably as a result of binding to HIV-1 Matrix
11676	156110	NP_057857.2	Nef	binds	9606	10318	NP_006049.3	TNFAIP3-interacting protein 1	9923610	2007-11-07 17:28	Nef-associated factor 1 (Naf1) binds to HIV-1 Nef through amino acids 94-412 of Naf1; overexpression of Naf1 in 293T cells increases CD4 expression, and Nef suppresses this activity of Naf1 to downregulate CD4
11676	155871	NP_057853.1	Tat	upregulates	9606	10319	NP_006050.3	laminin subunit gamma-3 precursor	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	10332	NP_055072.3	C-type lectin domain family 4 member M isoform 1	1518869,1736938	2007-11-07 17:30	HIV-1 gp120 binds to a membrane-associated mannose-binding lectin in a CD4-independent manner
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	10332	NP_055072.3	C-type lectin domain family 4 member M isoform 1	11257134,12152166,15215692,15795245,16365436	2007-11-07 17:31	L-SIGN behaves similarly to DC-SIGN in that it has a high affinity for ICAM-3, captures HIV-1 through gp120 binding, and enhances HIV-1 infection of T cells in trans
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	10332	NP_055072.3	C-type lectin domain family 4 member M isoform 1	11384997,11739956	2007-11-07 17:31	Crystal structures of carbohydrate-recognition domains of DC-SIGN and of DC-SIGNR in combination with binding studies reveal that these receptors selectively recognize endogenous high-mannose oligosaccharides of HIV-1 gp120
11676	155871	NP_057853.1	Tat	inhibited by	9606	10346	NP_006065.2	E3 ubiquitin-protein ligase TRIM22	7797467,16926043	2007-11-07 17:29	Staf-50 downregulates transcription directed by the HIV-1 LTR promoter, suggesting an inhibition of HIV-1 Tat function
11676	155871	NP_057853.1	Tat	upregulates	9606	10346	NP_006065.2	E3 ubiquitin-protein ligase TRIM22	12539042	2007-11-07 17:29	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Staf50, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	inhibited by	9606	10346	NP_006065.2	E3 ubiquitin-protein ligase TRIM22	16926043	2007-11-07 17:31	Overexpression of Staf50, which is known to repress the activity of HIV-1 Tat, inhibits HIV-1 infection between 50% and 90% in 293 T CD4/CCR5 cells as well as in monocyte-derived macrophages (MAC)
11676	155871	NP_057853.1	Tat	binds	9606	10376	NP_006073.2	tubulin alpha-1B chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	enhances polymerization of	9606	10376	NP_006073.2	tubulin alpha-1B chain	15691386,15698476	2007-11-07 17:28	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155908	NP_057854.1	Rev	depolymerizes	9606	10376	NP_006073.2	tubulin alpha-1B chain	10908577	2007-11-07 17:27	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces acetylation of	9606	10376	NP_006073.2	tubulin alpha-1B chain	15103018,16148047	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4+-permissive cells increases the level of acetylated alpha-tubulin in a CD4-dependent manner; overexpression of Histone Deacetylase 6 (HDAC6) inhibits the acetylation of alpha-tubulin and prevents HIV-1-cell fusion
11676	155871	NP_057853.1	Tat	binds	9606	10381	NP_006077.2	tubulin beta-3 chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	enhances polymerization of	9606	10381	NP_006077.2	tubulin beta-3 chain	15691386,15698476	2007-11-07 17:28	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155871	NP_057853.1	Tat	downregulates	9606	10381	NP_006077.2	tubulin beta-3 chain	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155908	NP_057854.1	Rev	depolymerizes	9606	10381	NP_006077.2	tubulin beta-3 chain	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155871	NP_057853.1	Tat	binds	9606	10382	NP_006078.2	tubulin beta-4 chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	enhances polymerization of	9606	10382	NP_006078.2	tubulin beta-4 chain	15691386,15698476	2007-11-07 17:28	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155871	NP_057853.1	Tat	downregulates	9606	10382	NP_006078.2	tubulin beta-4 chain	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155908	NP_057854.1	Rev	depolymerizes	9606	10382	NP_006078.2	tubulin beta-4 chain	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155871	NP_057853.1	Tat	binds	9606	10383	NP_006079.1	tubulin beta-2C chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	enhances polymerization of	9606	10383	NP_006079.1	tubulin beta-2C chain	15691386,15698476	2007-11-07 17:28	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155871	NP_057853.1	Tat	downregulates	9606	10383	NP_006079.1	tubulin beta-2C chain	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155908	NP_057854.1	Rev	depolymerizes	9606	10383	NP_006079.1	tubulin beta-2C chain	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155348	NP_705926.1	retropepsin	cleaves	9606	10397	NP_006087.2	protein NDRG1	15582665	2007-11-07 17:29	Two related serine-threonine kinases, nuclear Dbf2 related 1 (NDR1) and NDR2, are incorporated into HIV-1 particles and are cleaved by the HIV-1 protease (PR), both within virions and within producer cells
11676	156110	NP_057857.2	Nef	binds	9606	10399	NP_006089.1	guanine nucleotide-binding protein subunit beta-2-like 1	11312657	2007-11-07 17:27	The binding of HIV-1 Nef with Rack1 (receptor for activated C kinase 1) is mediated by amino acids 34-143 in Nef; Rack1 acts as a Nef intracellular docking site, bringing Nef and PKCs together
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	induces phosphorylation of	9606	10451	NP_006104.4	guanine nucleotide exchange factor VAV3 isoform 1	9269777	2007-11-07 17:30	HIV-1 gp160 alone or CD4/gp160 cross-linking induces tyrosine phosphorylation of intracellular substrates p59fyn, zap 70, and p95vav and also leads to ras activation
11676	155030	NP_057850.1	Pr55(Gag)	downregulated by	9606	10488	NP_006359.3	cyclic AMP-responsive element-binding protein 3	17054986	2007-11-07 17:31	Overexpression of Luman in cells transfected with HIV-1 provirus decreases the intracellular expression of Gag and Env and leads to a decrease in virion release
11676	155871	NP_057853.1	Tat	inhibited by	9606	10488	NP_006359.3	cyclic AMP-responsive element-binding protein 3	17054986	2007-11-07 17:31	Luman, a transcription factor of the CREB/ATF family, downregulates HIV-1 Tat-mediated transactivation
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	10488	NP_006359.3	cyclic AMP-responsive element-binding protein 3	17054986	2007-11-07 17:31	Interaction between the TMgp41 subunit of HIV-1 Env and Luman affects the stability of the full-length Luman protein
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	downregulated by	9606	10488	NP_006359.3	cyclic AMP-responsive element-binding protein 3	17054986	2007-11-07 17:31	Overexpression of Luman in cells transfected with HIV-1 provirus decreases the intracellular expression of Gag and Env and leads to a decrease in virion release
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	10488	NP_006359.3	cyclic AMP-responsive element-binding protein 3	17054986	2007-11-07 17:31	The central region of luman (residues 100-314) and the residues 751 to 768 of HIV-1 gp41 are required for luman-Env interaction
11676	155871	NP_057853.1	Tat	stimulates	9606	10499	NP_006531.1	nuclear receptor coactivator 2	11704662	2007-11-07 17:30	HIV-1 Tat may function as an adaptor molecule, efficiently stimulating the processes of transcription initiation and elongation through potentiation of the coupling of p160 co-activators and the P-TEFb complex
11676	155871	NP_057853.1	Tat	enhanced by	9606	10499	NP_006531.1	nuclear receptor coactivator 2	11704662	2007-11-07 17:30	The p160 nuclear receptor co-activator GRIP1 binds to the N-terminal region of HIV-1 Tat (amino acids 1-40) through its basic helix-loop-helix domain (amino acids 1-97) and enhances the transactivating activity of Tat
11676	155871	NP_057853.1	Tat	upregulates	9606	10507	NP_006369.2	semaphorin 4D	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the expression of many proteins, including Semaphorin (CD100), in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	enhanced by	9606	10524	NP_874369.1	histone acetyltransferase KAT5 isoform 1	8607265,11275565	2007-11-07 17:30	Tip60 enhances HIV-1 Tat activation of the HIV-1 LTR promoter in HeLa cells
11676	155871	NP_057853.1	Tat	binds	9606	10524	NP_874369.1	histone acetyltransferase KAT5 isoform 1	8607265,9388189,10096020	2007-11-07 17:30	Tip60 is a nuclear histone acetyltransferase that binds to the N-terminal 31 amino acids of HIV-1 Tat
11676	155871	NP_057853.1	Tat	inhibits	9606	10524	NP_874369.1	histone acetyltransferase KAT5 isoform 1	10393559,12154097	2007-11-07 17:30	HIV-1 Tat inhibits Tip60 histone-acetyltransferase activity and abolishes Tip60-dependent transcriptional activity of the Mn-SOD promoter
11676	155871	NP_057853.1	Tat	inhibited by	9606	10524	NP_874369.1	histone acetyltransferase KAT5 isoform 1	11275565	2007-11-07 17:30	Tip60 inhibits HIV-1 Tat activation of the HIV-1 LTR promoter in Jurkat cells
11676	155871	NP_057853.1	Tat	degrades	9606	10524	NP_874369.1	histone acetyltransferase KAT5 isoform 1	16001085	2007-11-07 17:28	HIV-1 Tat induces the polyubiquitination and degradation of Tip60 through p300/CBP-associated E4-type ubiquitin-ligase activity, which results in a dramatic impairment of the Tip60-dependent apoptotic cell response to DNA damage
11676	155030	NP_579876.2	matrix	imported by	9606	10527	NP_006382.1	importin-7	12853482,17020411	2007-11-07 17:29	Importin 7, an import receptor for ribosomal proteins and histone H1, is involved in the active nuclear import of the intracellular HIV-1 reverse transcription complex (RTC) containing HIV-1 RT, IN, NC, MA, and Vpr
11676	155030	NP_579881.1	nucleocapsid	imported by	9606	10527	NP_006382.1	importin-7	12853482,17020411	2007-11-07 17:29	Importin 7, an import receptor for ribosomal proteins and histone H1, is involved in the active nuclear import of the intracellular HIV-1 reverse transcription complex (RTC) containing HIV-1 RT, IN, NC, MA, and Vpr
11676	155348	NP_705927.1	reverse transcriptase	imported by	9606	10527	NP_006382.1	importin-7	12853482,17020411	2007-11-07 17:29	Importin 7, an import receptor for ribosomal proteins and histone H1, is involved in the active nuclear import of the intracellular HIV-1 reverse transcription complex (RTC) containing HIV-1 RT, IN, NC, MA, and Vpr
11676	155348	NP_705928.1	integrase	imported by	9606	10527	NP_006382.1	importin-7	12853482,17020411	2007-11-07 17:29	Importin 7, an import receptor for ribosomal proteins and histone H1, is involved in the active nuclear import of the intracellular HIV-1 reverse transcription complex (RTC) containing HIV-1 RT, IN, NC, MA, and Vpr
11676	155807	NP_057852.2	Vpr	imported by	9606	10527	NP_006382.1	importin-7	12853482,17020411	2007-11-07 17:29	Importin 7, an import receptor for ribosomal proteins and histone H1, is involved in the active nuclear import of the intracellular HIV-1 reverse transcription complex (RTC) containing HIV-1 RT, IN, NC, MA, and Vpr
11676	155030	NP_579876.2	matrix	ubiquitinated by	9606	10537	NP_006389.1	ubiquitin D	15994808,16775314	2007-11-07 17:29	Monoubiquitinated forms of the HIV-1 matrix (MA), capsid (CA), and nucleocapsid (NC) proteins are detected in mature virus particles
11676	155030	NP_579880.1	capsid	ubiquitinated by	9606	10537	NP_006389.1	ubiquitin D	15994808,16775314	2007-11-07 17:29	Monoubiquitinated forms of the HIV-1 matrix (MA), capsid (CA), and nucleocapsid (NC) proteins are detected in mature virus particles
11676	155030	NP_579881.1	nucleocapsid	ubiquitinated by	9606	10537	NP_006389.1	ubiquitin D	15994808,16775314	2007-11-07 17:29	Monoubiquitinated forms of the HIV-1 matrix (MA), capsid (CA), and nucleocapsid (NC) proteins are detected in mature virus particles
11676	155030	NP_579883.1	p6	ubiquitinated by	9606	10537	NP_006389.1	ubiquitin D	9525617,11087859,11087860,11112487,11991975,16775314	2007-11-07 17:30	The L domain (P(T/S)APP; amino acids 7-11) of HIV-1 p6-Gag interacts with a ubiquitin ligase complex resulting in the monoubiquitination of p6
11676	155030	NP_579883.1	p6	ubiquitinated by	9606	10537	NP_006389.1	ubiquitin D	11087859,12610113,15994808,16808324	2007-11-07 17:30	Ubiquitination of HIV-1 p6-Gag may be important for proper virus release from cells
11676	155030	NP_787042.1	p1	ubiquitinated by	9606	10537	NP_006389.1	ubiquitin D	16775314	2007-11-07 17:31	HIV-1 p1 is mono- or di-ubiquitinated at levels comparable to those of the other HIV-2 Gag domains MA, CA, NC, and p6; cumulative replacement of all lysine residues in NC and p1 or in NC and p6 results in an accumulation of late budding structures
11676	155871	NP_057853.1	Tat	ubiquitinated by	9606	10537	NP_006389.1	ubiquitin D	12883554	2007-11-07 17:29	HIV-1 Tat is ubiquitinated on Lys71 by Hdm2 in conjunction with ubiquitin-activating enzyme E1 and ubiquitin-conjugating enzyme E2D 1 (UbcH5)
11676	155908	NP_057854.1	Rev	ubiquitinated by	9606	10537	NP_006389.1	ubiquitin D	17067581	2007-11-07 17:31	HIV-1 Rev is modified by polyubiquitination at Lys-33 and Lys-115; Lys-33 is the most efficient residue for branching of ubiquitin chains
11676	155871	NP_057853.1	Tat	enhanced by	9606	10553	NP_006401.2	HIV-1 Tat interactive protein 2, 30kDa	9482853,10395547,10698937,10892349	2007-11-07 17:30	TIP30 interacts with amino acids 1-48 of HIV-1 Tat, including the Tat activation domain, and enhances Tat activation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stimulates	9606	10553	NP_006401.2	HIV-1 Tat interactive protein 2, 30kDa	10698937	2007-11-07 17:30	HIV-1 Tat stimulates the phosphorylation of the RNA polymerase II C-terminal domain by TIP30
11676	155871	NP_057853.1	Tat	upregulates	9606	10561	NP_006408.2	interferon-induced, hepatitis C-associated microtubular aggregate protein	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including MTAp44, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	binds	9606	10567	NP_006414.1	Rab acceptor 1	11739697,15914857	2007-11-07 17:30	HIV-1 gp41 colocalizes and binds to prenylated Rab acceptor 1 (PRA1)
11676	155348	NP_705928.1	integrase	binds	9606	10575	NP_006421.2	T-complex protein 1 subunit delta	11689615	2007-11-07 17:29	Interaction of human CCT4 with HIV-1 integrase is presumed based on a reported binding interaction between yeast CCT4 and integrase
11676	155871	NP_057853.1	Tat	interacts with	9606	10575	NP_006421.2	T-complex protein 1 subunit delta	8626763	2007-11-07 17:30	Stimulator of TAR RNA-binding proteins (SRB) stimulates the binding of RNA Polymerase II and TRP-185 to HIV-1 TAR RNA, suggesting an interaction between SRB and HIV-1 Tat
11676	155871	NP_057853.1	Tat	competes with	9606	10614	NP_006451.1	protein HEXIM1	12832472	2007-11-07 17:30	MAQ1 complexes with 7SK RNA and cyclin T1 and competes with the binding of Tat to cyclin T1, suggesting the TAR RNA/Tat lentivirus system has evolved to subvert the cellular 7SK RNA/MAQ1 system
11676	155871	NP_057853.1	Tat	competes with	9606	10614	NP_006451.1	protein HEXIM1	15855166	2007-11-07 17:29	HIV-1 Tat competes with Hexim1 (residues 255-359) for cyclin T1 binding, thus releasing P-TEFb from the inactive complex to stimulate the transcription of HIV-1 gene expression
11676	155871	NP_057853.1	Tat	inhibited by	9606	10614	NP_006451.1	protein HEXIM1	15992410	2007-11-07 17:28	HIV-1 Tat transactivation is effectively inhibited by co-expression of HEXIM1 or its paralog HEXIM2; HEXIM1 expression specifically represses transcription mediated by the direct activation of P-TEFb through the recruitment of CycT1
11676	155871	NP_057853.1	Tat	activates	9606	10621	NP_006457.2	DNA-directed RNA polymerase III subunit RPC6	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	activates	9606	10622	NP_006458.2	DNA-directed RNA polymerase III subunit RPC7	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	activates	9606	10623	NP_006459.3	DNA-directed RNA polymerase III subunit RPC3	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155908	NP_057854.1	Rev	inhibited by	9606	10657	NP_006550.1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	10371501,10962565,11483766	2007-11-07 17:27	Sam68 dominant negative mutants inhibit Rev function resulting in sequestration of unspliced HIV-1 mRNA at perinuclear bundles
11676	155908	NP_057854.1	Rev	synergizes with	9606	10657	NP_006550.1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	10962565,11932418,12134041	2007-11-07 17:27	Sam68 promotes Rev-mediated nuclear export of HIV-1 mRNA and synergizes with Rev during this function
11676	155908	NP_057854.1	Rev	binds	9606	10657	NP_006550.1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	11932418	2007-11-07 17:27	amino acids 321-410 of Sam68 are directly involved in the binding of Sam68 to the Rev nuclear export signal (NES, amino acids 75-83)
11676	155908	NP_057854.1	Rev	modulated by	9606	10657	NP_006550.1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	12134041	2007-11-07 17:27	down-modulation of Sam68 causes nuclear retention and co-localization of Rev and CRM1, suggesting Sam68 is directly involved in the CRM1-mediated Rev nuclear export pathway and is required for Rev function
11676	155908	NP_057854.1	Rev	requires	9606	10657	NP_006550.1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	15701759	2007-11-07 17:28	In stable Sam68 knockdown HeLa cells, HIV-1 Rev activation of RRE-mediated gene expression and HIV-1 production are inhibited due to the failure of exporting unspliced HIV-1 mRNAs to the cytoplasm, indicating Rev requires Sam68 for proper function
11676	155908	NP_057854.1	Rev	inhibited by	9606	10657	NP_006550.1	KH domain-containing, RNA-binding, signal transduction-associated protein 1	16236470	2007-11-07 17:29	Amino acid residues 269-321 of Sam68 are required for inhibition of HIV-1 Rev function and viral replication by Sam68 dominant negative mutants lacking the nuclear localization signals
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	10663	NP_006555.1	C-X-C chemokine receptor type 6	9736741,10590105,10877489	2007-11-07 17:28	Macrophage-tropic HIV-1 can use CCR2b, and to a lesser extent CCR3, STRL33, and APJ, to infect cells; the V1/2 region of HIV-1 gp120 plays a more important role in governing the use of CCR2b, CCR3, STRL33, and APJ than for CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	10663	NP_006555.1	C-X-C chemokine receptor type 6	10877489,15053339,15992849,16470129	2007-11-07 17:31	Some HIV-1 isolates are able to use CCR5/Bonzo as HIV-1 gp120 coreceptors for entry into cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	10663	NP_006555.1	C-X-C chemokine receptor type 6	11711593	2007-11-07 17:31	Coexpression of DC-SIGN enables some HIV-1 isolates to use alternate HIV-1 gp120 coreceptors like STRL33 to infect cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cooperates with	9606	10673	NP_006564.1	tumor necrosis factor ligand superfamily member 13B isoform 1	16547227	2007-11-07 17:31	HIV-1 gp120 cooperates with BAFF and cytokines IL-4 and IL-10 to activate mannose C-type lectin receptors-expressing B cells
11676	155807	NP_057852.2	Vpr	interacts with	9606	10728	NP_006592.3	prostaglandin E synthase 3	11531413	2007-11-07 17:28	Interaction of HIV-1 Vpr with human p23 is presumed based on homology to yeast cell cycle regulator p21 protein Wos2 which suppresses HIV-1 Vpr-induced G2 arrest in vitro, most likely through the inhibition of Wee1 or interaction with Cdc2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	10787	NP_038464.1	nck-associated protein 1 isoform 1	15749123	2007-11-07 17:30	Upregulation of apoptosis genes such as NCK-associated protein 1, PTB domain adaptor protein CED-6, and TNF receptor superfamily 5 are induced by HIV-1 gp120 in human neurons
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	10825	NP_006647.3	sialidase-3	8892864,12487819	2007-11-07 17:27	The desialylation of HIV-1 gp120 with neuraminidase greatly augments the initial virus-cell interaction, leading to remarkably enhanced viral replication and cytopathogenicity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	10825	NP_006647.3	sialidase-3	12487819	2007-11-07 17:31	Removal of sialic acids from HIV-1 gp120 with neuraminidase (NA) enhances mannose-binding lectin (MBL) binding
11676	155871	NP_057853.1	Tat	activates	9606	10846	NP_006652.1	cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155871	NP_057853.1	Tat	interacts with	9606	10855	NP_006656.2	heparanase isoform 1 precursor	15264223	2007-11-07 17:28	Treatment of synaptosomes with heparanase and HIV-1 Tat increases Tat-induced oxidative stress, which indicates the requirement of Tat interaction with neuronal membranes to induce oxidative damage
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	10905	NP_006690.1	mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	10905	NP_006690.1	mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	2283726,2355006,2542563,2649653,2829950,8218172,8892864	2007-11-07 17:29	HIV-1 gp120 N-linked oligosaccharides are processed by manosidase I and II in the Golgi complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	10905	NP_006690.1	mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	10905	NP_006690.1	mannosyl-oligosaccharide 1,2-alpha-mannosidase IB	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155807	NP_057852.2	Vpr	decreases phosphorylation of	9606	10914	NP_116021.2	poly(A) polymerase alpha	11878934	2007-11-07 17:28	HIV-1 Vpr dephosphorylates poly(A) polymerase (PAP), presumably through inhibition of the p34cdc2/cyclin B kinase complex, leading to enhanced PAP activity
11676	155871	NP_057853.1	Tat	regulates	9606	10914	NP_116021.2	poly(A) polymerase alpha	8491200	2007-11-07 17:30	The poly(A) site in the HIV-1 5'-LTR is occluded in a Tat-dependent manner, suggesting a role for Tat in regulating this nucleotide signal
11676	155871	NP_057853.1	Tat	associates with	9606	10915	NP_006697.2	transcription elongation regulator 1 isoform 1	9315662,10373521	2007-11-07 17:30	Both CA150 and HIV-1 Tat associate with the RNA polymerase II holoenzyme and are required for Tat transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	binds	9606	10923	NP_006704.2	activated RNA polymerase II transcription cofactor 4	10887206	2007-11-07 17:30	Through amino acids 22-91, PC4 binds to the basic TAR binding domain of HIV-1 Tat (amino acids 49-57) and enhances activation of the HIV-1 LTR promoter in a Tat dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	interacts with	9606	10947	NP_006794.1	AP-3 complex subunit mu-2	9400603	2007-11-07 17:27	Two tyrosine-based endocytic signals (residues 704-710 and 760-766) in the cytosolic tail (gp41) of the HIV-1 envelope glycoprotein (Env) complex interact with members of the adaptor medium chain family, AP-1 mu1, AP-2 mu2 and AP-3 mu3A
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaved by	9606	10954	NP_006801.1	protein disulfide-isomerase A5 precursor	12218051,12218052,15644496,16182193	2007-11-07 17:30	Protein-disulfide isomerase (PDI) cleaves disulfide bonds in recombinant HIV-1 envelope glycoprotein gp120, and gp120 bound to the surface receptor CD4 undergoes a disulfide reduction that is prevented by PDI inhibitors
11676	155807	NP_057852.2	Vpr	inhibits	9606	10971	NP_006817.1	14-3-3 protein theta	15265780,15708996	2007-11-07 17:28	HIV-1 Vpr inhibits insulin-induced association of 14-3-3 and Foxo3a in HeLa cells
11676	155807	NP_057852.2	Vpr	binds	9606	10971	NP_006817.1	14-3-3 protein theta	15708996	2007-11-07 17:28	Yeast two-hybrid assays show that the C-terminal half (residues 141-244) of 14-3-3 tau binds to HIV-1 Vpr; Vpr supports triple complex formation with 14-3-3 tau and Cdc25C
11676	155807	NP_057852.2	Vpr	interacts with	9606	10980	NP_006824.2	COP9 signalosome complex subunit 6	7474080,7474100,7494303,7666531,9094673,9520381,10958988,11531413	2007-11-07 17:29	Interaction of HIV-1 Vpr and hVIP/mov34 is associated with the Vpr mediated inhibition of maturation promoting factor (MPF), a protein kinase complex composed of p34cdc2 and cyclin B
11676	155807	NP_057852.2	Vpr	interacts with	9606	10980	NP_006824.2	COP9 signalosome complex subunit 6	9520381,15832179	2007-11-07 17:28	Interaction of HIV-1 Vpr with hVIP/mov34 is associated with the cell cycle arrest function of Vpr, suggesting hVIP/mov34 is a cellular cofactor for Vpr
11676	155807	NP_057852.2	Vpr	binds	9606	10980	NP_006824.2	COP9 signalosome complex subunit 6	9520381,12237292	2007-11-07 17:28	The C-terminal portion of HIV-1 Vpr directly binds the C-terminal region of hVIP/mov34 (amino acids 251-341)
11676	155807	NP_057852.2	Vpr	interacts with	9606	10980	NP_006824.2	COP9 signalosome complex subunit 6	12237292,15832179	2007-11-07 17:28	Interaction of HIV-1 Vpr and hVIP/mov34 may be involved in the activation of glucocorticoid receptor by Vpr
11676	155807	NP_057852.2	Vpr	binds	9606	10992	NP_006833.2	splicing factor 3B subunit 2	16571786	2007-11-07 17:31	HIV-1 Vpr induces checkpoint activation and G2 arrest by binding to the CUS1 domain of SAP145 and interfering with the functions of the SAP145 and SAP49 proteins, two subunits of the multimeric splicing factor 3b (SF3b)
11676	155807	NP_057852.2	Vpr	interacts with	9606	10992	NP_006833.2	splicing factor 3B subunit 2	16923959	2007-11-07 17:31	HIV-1 Vpr interacts with and co-localizes with SAP145; this interaction is mediated through the C-terminal domain (residues 49-96) of Vpr
11676	155871	NP_057853.1	Tat	downregulates	9606	11004	NP_006836.1	kinesin family member 2C	16751065	2007-11-07 17:31	The DNA repair gene DNA-PKcs and cell cycle-related genes Cdc20, Cdc25C, KIF2C and CTS1 are downregulated in HIV-1 Tat-expressing human rhabdomyosarcoma cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	11034	NP_006861.1	destrin isoform a	12775419	2007-11-07 17:30	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155807	NP_057852.2	Vpr	interacts with	9606	11097	NP_031368.1	nucleoporin-like protein 2	9621063,11691994,12228227,16120388	2007-11-07 17:28	Nucleoporin CG1 (hCG1; nucleoporin-like protein 1; NLP-1) interacts with HIV-1 Vpr to mediate the docking of Vpr at the nuclear envelope which may contribute to the disruption of the nuclear envelope and to the nuclear import of viral DNA by Vpr
11676	155908	NP_057854.1	Rev	interacts with	9606	11097	NP_031368.1	nucleoporin-like protein 2	10358091	2007-11-07 17:27	NLP-1 interacts with CRM-1 (exportin 1), one of the cellular factors that binds to Rev and is required for Rev-mediated nuclear export of HIV-1 mRNA
11676	155908	NP_057854.1	Rev	interacts with	9606	11097	NP_031368.1	nucleoporin-like protein 2	10358091,12228227	2007-11-07 17:27	The central FG repeat-containing region (amino acids 213-380) of NLP-1, also known as hCG1, specifically interacts with the Rev nuclear export signal (amino acids 75-83)
11676	155908	NP_057854.1	Rev	binds	9606	11103	NP_008974.5	KRR1 small subunit processome component homolog	7505766,15832179	2007-11-07 17:28	Information on HIV-1 rev binding protein 2 is the result of a direct sequence submission to NCBI.  Interaction with HIV-1 Rev is assumed based on the name of the protein, however no publications describing this interaction have been identified
11676	155871	NP_057853.1	Tat	activates	9606	11128	NP_008986.2	DNA-directed RNA polymerase III subunit RPC1	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	regulated by	9606	11140	NP_008996.1	hsp90 co-chaperone Cdc37	10617616	2007-11-07 17:29	Hsp70 and Hsp90 and Cdc37 regulate the stabilization and folding of CDK9 as well as the assembly of an active CDK9/cyclin T1 complex responsible for P-TEFb-mediated HIV-1 Tat transactivation
11676	155348	NP_705928.1	integrase	acetylated by	9606	11143	NP_008998.1	histone acetyltransferase MYST2	16096645,17182677	2007-11-07 17:29	Cellular acetyltransferase binds HIV-1 integrase both in vitro and in cells and acetylates three specific lysines (K264, K266, K273) in the carboxy-terminus of integrase
11676	155348	NP_705928.1	integrase	stimulated by	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	12407101,12796494,16403635,17083721,17158150,17172465	2007-11-07 17:29	LEDGF/p75 complexes with HIV-1 integrase and stimulates integrase strand transfer activity in vitro
11676	155348	NP_705928.1	integrase	co-localizes with	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	12407101,12796494,15308744,15788449,16403635,16793062	2007-11-07 17:29	The interaction of HIV-1 integrase with LEDGF/p75 accounts for the karyophilic properties and chromosomal targeting of integrase, which co-localizes with LEDGF/p75 in the nuclei of human cells
11676	155348	NP_705928.1	integrase	interacts with	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	12796494,15875659,16075307,16403635,17137594,17158150	2007-11-07 17:29	The N-terminal zinc binding domain (amino acids 1-52) and the central core domain (amino acids 53-212) of HIV-1 integrase are involved in the interaction with LEDGF/p75, with the core domain harboring the main determinant for interaction
11676	155348	NP_705928.1	integrase	imported by	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	15163664,16314581,16403635	2007-11-07 17:29	The 146-156 amino acid stretch of LEDGF/p75 is critical for nuclear localization and a single amino acid mutation at K150A in LEDGF/p75 renders HIV-1 integrase cytoplasmic
11676	155348	NP_705928.1	integrase	interacts with	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	15475359,16403635,16439544	2007-11-07 17:29	In LEDGF/p75 knock-down cells, there is an increase in ubiquitinated HIV-1 integrase, which is found exclusively in the cytoplasm of these cells, and protection of HIV-1 integrase from the proteasome requires only interaction with LEDGF/p75
11676	155348	NP_705928.1	integrase	interacts with	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	15749713,16403635,17158150	2007-11-07 17:29	Using a pull-down assay, LEDGF/p75 interacts with HIV-1, HIV-2, and FIV integrases and strongly promotes the binding of HIV-1 integrase to DNA in vitro
11676	155348	NP_705928.1	integrase	binds	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	15797927,15895093,16260736,16314581,16337983,16403635,17137594	2007-11-07 17:29	The NMR structure of the integrase-binding domain (IBD) in LEDGF/p75 reveals that residues Ile365, Asp366, or Phe406 in LEDGF/p75 mediate binding to HIV-1 integrase, and amino acids 165-173 of HIV-1 integrase are involved in the binding to LEDGF/p75
11676	155348	NP_705928.1	integrase	interacts with	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	15855167,16314581,16439544,16959283,16987986,17137594,17158150	2007-11-07 17:29	A single mutation at residue Q168 of HIV-1 integrase disrupts its interaction with LEDGF/p75 and results in defective HIV-1 replication
11676	155348	NP_705928.1	integrase	regulated by	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	16311605,16337983,16403635,16439544	2007-11-07 17:29	HIV-1 integration in cells depleted for LEDGF/p75 is less frequent in transcription units, less frequent in genes regulated by LEDGF/p75 and more frequent in GC-rich DNA
11676	155348	NP_705928.1	integrase	binds	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	16793062,16959972	2007-11-07 17:31	LEDGF/p75 binds to HIV-1 integrase (IN) and tethers IN to chromatin; the N-terminal PWWP domain (residues 1-93) in LEDGF/p75, and its beta-barrel substructure (first 63 residues) are required for chromatin binding and IN tethering to chromatin
11676	155348	NP_705928.1	integrase	interacts with	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	16959283	2007-11-07 17:31	A single mutation at residue A128 or H171 of HIV-1 integrase diminishes its interaction with LEDGF/p75
11676	155348	NP_705928.1	integrase	interacts with	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	16959972	2007-11-07 17:31	Intensified RNA interference and dominant-negative protein approaches show that LEDGF/p75 is an essential linkage between HIV-1 integrase and chromatin
11676	155348	NP_705928.1	integrase	interacts with	9606	11168	NP_066967.2	PC4 and SFRS1 interacting protein 1 isoform 1	16987986,17158150	2007-11-07 17:31	Overexpression of the integrase binding domain (IBD) of LEDGF/p75 severely inhibits HIV-1 replication, while no inhibition is observed in cell lines overexpressing the interaction-deficient D366A mutant of integrase
11676	155807	NP_057852.2	Vpr	induces phosphorylation of	9606	11200	NP_009125.1	serine/threonine-protein kinase Chk2 isoform a	16983346	2007-11-07 17:31	HIV-1 Vpr induces expression of gamma-H2AX and phosphorylation of Chk2
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	11253	NP_057303.1	alpha 1,2-mannosidase	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	11253	NP_057303.1	alpha 1,2-mannosidase	2283726,2355006,2406237,2542563,2649653,2829950,8218172,8892864	2007-11-07 17:29	HIV-1 gp120 N-linked oligosaccharides are processed by manosidase I and II in the Golgi complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	11253	NP_057303.1	alpha 1,2-mannosidase	12560567	2007-11-07 17:30	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	11253	NP_057303.1	alpha 1,2-mannosidase	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:31	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155459	NP_057851.1	Vif	interacts with	9606	11262	NP_009168.3	SP140 nuclear body protein isoform 1	12368356	2007-11-07 17:27	HIV-1 Vif may enhance the cytosolic retention of Sp140
11676	155459	NP_057851.1	Vif	binds	9606	11262	NP_009168.3	SP140 nuclear body protein isoform 1	12368356	2007-11-07 17:27	Specific binding of HIV-1 Vif to Sp140 was identified using a yeast two-hybrid screen of a human lymphocyte cDNA library and verified by co-immunoprecipitation
11676	155459	NP_057851.1	Vif	binds	9606	11262	NP_009168.3	SP140 nuclear body protein isoform 1	12368356	2007-11-07 17:27	Wild-type HIV-1 Vif binds to the carboxyl-terminal region of Sp140 between amino acids 527-836, while Vif mutants with deletions of amino acids 12-23, 43-59, 73-87 or 97-112 are strongly inhibited in their binding to Sp140
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	11282	NP_055090.1	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform 1	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	11282	NP_055090.1	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform 1	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	11320	NP_036346.1	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A isoform 1	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	11320	NP_036346.1	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A isoform 1	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	156110	NP_057857.2	Nef	downregulates	9606	11346	NP_009217.3	synaptopodin isoform A	15343382,16260903	2007-11-07 17:28	HIV-1 Nef downregulates expression of synaptopodin, a marker for differentiation in podocytes
11676	155871	NP_057853.1	Tat	upregulates	9606	22798	NP_031382.1	laminin, beta 4	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	22802	NP_036260.1	calcium activated chloride channel 4	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	22861	NP_127497.1	NACHT, LRR and PYD domains-containing protein 1 isoform 1	15749123	2007-11-07 17:30	Upregulation of apoptosis genes such as caspase 1, NALP1, and TNF receptor-associated factor 5 are induced by HIV-gp120/ethanol in human neurons
11676	155871	NP_057853.1	Tat	associates with	9606	22938	NP_036377.1	SNW domain-containing protein 1	15905409	2007-11-07 17:28	SKIP is required for Tat transactivation in vivo and stimulates HIV-1 transcription elongation by associating with CycT1:CDK9 (P-TEFb) and Tat:P-TEFb complexes both in nuclear extracts and in recombinant Tat:P-TEFb:TAR RNA complexes in vitro
11676	155871	NP_057853.1	Tat	binds	9606	22954	NP_036342.1	TAT-interactive protein, 72-KD	7778269	2007-11-07 17:30	HT2A specifically and precisely binds to the activation domain of HIV-1 Tat (amino acids 1-48), suggesting a role for HT2A in mediating the biological activity of Tat during HIV-1 replication
11676	155871	NP_057853.1	Tat	modulated by	9606	22984	NP_055791.1	protein RRP5 homolog	15887232	2007-11-07 17:28	NFBP interacts with the P65 subunit of NF-kappaB and with HIV-1 Tat (amino acids 37-48), co-localizes with Tat in the nucleus and nucleoli, and modulates the synergism between Tat and P65 in activating LTR transcription
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	23007	NP_055811.1	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase eta-1 isoform b	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	23127	NP_055916.1	procollagen galactosyltransferase 2 precursor	2283726,2341393,2649653,8218172	2007-11-07 17:29	Addition of peripheral sugar residues such as galactose, N-acetylglucosamine, and sialic acid to HIV-1 gp120 is processed by specific glycosyltransferase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	23193	NP_938148.1	neutral alpha-glucosidase AB isoform 2	1678778,2825177	2007-11-07 17:30	Inhibitors of alpha-glucosidase inhibit syncytium formation induced by the envelope glycoprotein of HIV-1 and reduce processing of the HIV-1 envelope precursor protein gp160 by glucosidase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	23193	NP_938148.1	neutral alpha-glucosidase AB isoform 2	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	23193	NP_938148.1	neutral alpha-glucosidase AB isoform 2	1704656,2959866	2007-11-07 17:29	Glucosidase inhibitors inhibit the syncytium formation between HIV-infected and CD4-expressing cells and interfere with HIV-1 infectivity, indicating processing of HIV-1 gp120 by glucosidase is important for virus replication
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	glycosylated by	9606	23193	NP_938148.1	neutral alpha-glucosidase AB isoform 2	2076345,2136376,2283726,2355006,2649653,2959866,8218172,12719582,16547752	2007-11-07 17:29	HIV-1 gp120 is extremely heavily glycosylated (31-36 N-linked glycans per molecule) by glucosidase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	23193	NP_938148.1	neutral alpha-glucosidase AB isoform 2	8416962	2007-11-07 17:29	Imino sugar N-butyldeoxynojirimycin (NB-DNJ) inhibits HIV envelope glycoprotein gp120 processing mediated by alpha glucosidase I
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	23193	NP_938148.1	neutral alpha-glucosidase AB isoform 2	8794361,8794362,11752220	2007-11-07 17:30	The alpha-glucosidase inhibitor N-butyldeoxynojirimycin (NB-DNJ) inhibits HIV-1 entry and this inhibition correlates with impaired HIV-1 gp120 shedding and gp41 exposure and with changes in antibody recognition of gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	23193	NP_938148.1	neutral alpha-glucosidase AB isoform 2	12560567	2007-11-07 17:30	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	23193	NP_938148.1	neutral alpha-glucosidase AB isoform 2	1704656,1736542,2829950,3099781,3264072,8093218	2007-11-07 17:31	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155348	NP_705928.1	integrase	degraded by	9606	23198	NP_055429.1	proteasome (prosome, macropain) activator subunit 4	10893419	2007-11-07 17:30	Proteasomal degradation of HIV-1 integrase in mammalian cells occurs by the N-end rule pathway
11676	155459	NP_057851.1	Vif	interacts with	9606	23198	NP_055429.1	proteasome (prosome, macropain) activator subunit 4	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829	2007-11-07 17:30	HIV-1 Vif binds to the cellular cytidine deaminase APOBEC3G and targets it for degradation through an interaction with the proteasome, thereby inhibiting APOBEC3G mediated restriction of HIV-1 replication
11676	155871	NP_057853.1	Tat	inhibits	9606	23198	NP_055429.1	proteasome (prosome, macropain) activator subunit 4	9079628,12419264,14550573	2007-11-07 17:29	HIV-1 Tat inhibits the peptidase activity of the 20 S proteasome and interferes with the formation of the 20 S proteasome-11 S regulator complex
11676	155871	NP_057853.1	Tat	enhances	9606	23198	NP_055429.1	proteasome (prosome, macropain) activator subunit 4	9079628	2007-11-07 17:29	HIV-1 Tat slightly enhances the activity of the purified 26 S proteasome
11676	155871	NP_057853.1	Tat	interacts with	9606	23198	NP_055429.1	proteasome (prosome, macropain) activator subunit 4	12419264	2007-11-07 17:29	Amino acids Lys51, Arg52, and Asp67 of HIV-1 Tat represent the proteasome binding site of Tat, and Tat amino acids 37-72 are necessary for proteasomal interaction and suppression of 11 S regulator-mediated antigen presentation
11676	155871	NP_057853.1	Tat	inhibits	9606	23198	NP_055429.1	proteasome (prosome, macropain) activator subunit 4	14550573	2007-11-07 17:29	HIV-1 Tat binds to the alpha2, alpha4, alpha6, alpha7, beta1, beta2, beta3, beta5, beta6, beta7, LMP7/beta5i, and MECL1/beta2i subunits of the proteasome 20 S core structure and can inhibit cellular proteasome function
11676	155871	NP_057853.1	Tat	activates	9606	23236	NP_056007.1	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-1 isoform a	7589147,9278385,9730685,10501179,10843712,12482669	2007-11-07 17:28	HIV-1 Tat induces release of calcium and TNF-alpha production, an effect mediated at least in part by activation of phospholipase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	23236	NP_056007.1	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-1 isoform a	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	23237	NP_056008.1	activity-regulated cytoskeleton-associated protein	15103018	2007-11-07 17:30	The mRNA expression levels for alpha-tubulin, TRADD, IFN-gamma R2, GAS1, MADD, NF-kappaB, I-kappa B, 14-3-3 protein, APaf1, PARP, IGF-1 receptor, RB1, Rb2/p130, ARC, and caspase 6 are upregulated in human neuronal cells after treatment with HIV-1 gp120
11676	155945	NP_057855.1	Vpu	interacts with	9606	23291	NP_387449.2	F-box/WD repeat-containing protein 11 isoform A	17121803	2007-11-07 17:31	Co-expression of HIV-1 Vpu with beta-TrCP2 induces degradation of total cellular CD4 content; Vpu-mediated CD4 down-modulation is inhibited by double silencing of beta-TrCP1 and beta-TrCP2
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	23324	NP_056089.1	epididymis-specific alpha-mannosidase precursor	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	23324	NP_056089.1	epididymis-specific alpha-mannosidase precursor	2283726,2355006,2542563,2649653,2829950,8218172,8892864	2007-11-07 17:29	HIV-1 gp120 N-linked oligosaccharides are processed by manosidase I and II in the Golgi complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	23324	NP_056089.1	epididymis-specific alpha-mannosidase precursor	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	23324	NP_056089.1	epididymis-specific alpha-mannosidase precursor	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155871	NP_057853.1	Tat	interacts with	9606	23405	NP_803187.1	endoribonuclease Dicer	17181864	2007-11-07 17:31	HIV-1 Tat-Dicer interaction requires RNA; Dicer's helicase domain (residues 246-585) and a portion of Tat amino acids 30-72 are involved in the interaction
11676	155871	NP_057853.1	Tat	regulated by	9606	23411	NP_036370.2	NAD-dependent deacetylase sirtuin-1 isoform a	15719057	2007-11-07 17:28	Deacetylation of HIV-1 Tat by human sirtuin 1 (SIRT1), a nicotinamide adenine dinucleotide-dependent class III protein deacetylase, regulates Tat transactivation of the HIV-1 promoter
11676	155871	NP_057853.1	Tat	inhibited by	9606	23435	NP_031401.1	TAR DNA-binding protein 43	7745706	2007-11-07 17:28	TDP-43 is a cellular protein that binds specifically to pyrimidine-rich motifs in HIV-1 double-stranded TAR DNA and represses transcription from the HIV-1 LTR promoter in both the presence and absence of HIV-1 Tat
11676	155030	NP_579876.2	matrix	binds	9606	23438	NP_036340.1	probable histidyl-tRNA synthetase, mitochondrial precursor	9445076	2007-11-07 17:28	HO3 binds to the HIV-1 Matrix protein (amino acids 26 and 27) resulting in the incorporation of HO3 into virus particles and the enhancement of virus infectivity
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	23443	NP_036375.1	UDP-N-acetylglucosamine transporter	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155871	NP_057853.1	Tat	inactivates	9606	23468	NP_036249.1	chromobox protein homolog 5	12692243	2007-11-07 17:30	HIV-1 Tat is recruited by CTIP2 into a complex with HP1alpha, leading to the relocalization of Tat and inactivation of Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155348	NP_705928.1	integrase	acetylated by	9606	23522	NP_036462.2	histone acetyltransferase MYST4	16096645,17182677	2007-11-07 17:29	Cellular acetyltransferase binds HIV-1 integrase both in vitro and in cells and acetylates three specific lysines (K264, K266, K273) in the carboxy-terminus of integrase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	23563	NP_078809.2	carbohydrate sulfotransferase 5	1433500,8419650	2007-11-07 17:30	Sulfate is linked to the carbohydrate chains of HIV-1 glycoproteins gp160, gp120, and gp41 during the endoplasmic reticulum to Golgi transport of the glycoproteins
11676	155807	NP_057852.2	Vpr	complexes with	9606	23583	NP_055126.1	single-strand-selective monofunctional uracil-DNA glycosylase 1	16103149	2007-11-07 17:28	HIV-1 Vpr induces the ubiquitination of SMUG1 and forms a complex with SMUG1
11676	155807	NP_057852.2	Vpr	downregulates	9606	23583	NP_055126.1	single-strand-selective monofunctional uracil-DNA glycosylase 1	16103149	2007-11-07 17:28	HIV-1 Vpr-induced reduction in single-strand selective monofunctional uracil DNA glycosylase (SMUG1) is mediated through proteasomal degradation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	23613	NP_036540.3	protein kinase C-binding protein 1 isoform b	12775419	2007-11-07 17:31	Genes, including GABRP, ADF, HINT, PRSS2, SDCBP, PTK9, PPP2R5B, ITGA3, PRKCBP1, HMOX2, HAT1, PPP1cB, and ICAM-1, are upregulated after treatment of human astrocytes with HIV-1 gp120
11676	155030	NP_579876.2	matrix	imported by	9606	23633	NP_036448.1	importin subunit alpha-7	2064827,7494303,7745752,8041734,8041786,8105392,8529100,8551560,8659115,8876228,9275210,9303297,9366553,9463369,9548947,9557700,9562972,9593140,9603322,9918876,10525473,10860744,10964507,11904219	2007-11-07 17:28	The role of HIV-1 Matrix during nuclear import of the HIV-1 preintegration complex has been controversial, however recent understanding indicates HIV-1 Matrix and Vpr proteins act in concert to facilitate nuclear import by binding to karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	23633	NP_036448.1	importin subunit alpha-7	7585960,7859280,8552640,9008157	2007-11-07 17:28	Nuclear import of HIV-1 preintegration complexes by karyopherin alpha is governed by phosphorylation of HIV-1 Matrix on tyrosine and serine, however the exact role of phosphorylation of the C-terminal tyrosine of Matrix has been debated
11676	155030	NP_579876.2	matrix	imported by	9606	23633	NP_036448.1	importin subunit alpha-7	8105392,10860744	2007-11-07 17:28	HIV-1 Matrix contains two nuclear localization signals (NLS) spanning amino acids 24-33 and 110-114 that are recognized by karyopherin alpha and mediate the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	23633	NP_036448.1	importin subunit alpha-7	8659115,9366553,9463369,9557700,9562972,10525473	2007-11-07 17:28	HIV-1 Vpr increases the affinity of karyopherin alpha to the HIV-1 Matrix nuclear localization signal, thereby mediating the nuclear import of HIV-1 preintegration complexes
11676	155030	NP_579876.2	matrix	imported by	9606	23633	NP_036448.1	importin subunit alpha-7	9282826	2007-11-07 17:28	HIV-1 Matrix increases intracellular ATP content, an effect hypothesized to support the ATP-dependent nuclear import of HIV-1 preintegration complexes by karyopherin alpha
11676	155030	NP_579876.2	matrix	imported by	9606	23633	NP_036448.1	importin subunit alpha-7	10964507	2007-11-07 17:28	Hsp70 stimulates the binding of HIV-1 matrix to karyopherin alpha
11676	155348	NP_705928.1	integrase	imported by	9606	23633	NP_036448.1	importin subunit alpha-7	1631159,9275210,9366553,10366569,10525473,10888652,11035935,11278458,11389849,12368302,12414950	2007-11-07 17:29	Some reports indicate a possible role for the interactions between karyopherin alpha and beta with HIV-1 integrase in the nuclear import of HIV-1 preintegration complexes (PIC), while other reports indicate integrase is not involved in PIC nuclear import
11676	155348	NP_705928.1	integrase	imported by	9606	23633	NP_036448.1	importin subunit alpha-7	9275210,11035935,11278458	2007-11-07 17:29	Karyopherin alpha and beta are reported to interact with HIV-1 integrase (IN) to facilitate nuclear import of IN, however a conflicting report indicates nuclear accumulation of IN does not involve karyopherin alpha, beta 1, or beta 2 mediated pathways
11676	155348	NP_705928.1	integrase	binds	9606	23633	NP_036448.1	importin subunit alpha-7	9275210,15037073	2007-11-07 17:29	Karyopherin alpha binds to a bipartite nuclear localization signal in HIV-1 integrase (amino acids 186-189 and 211-219)
11676	155908	NP_057854.1	Rev	interacts with	9606	23636	NP_036478.2	nuclear pore glycoprotein p62	11238447	2007-11-07 17:29	nup62 is involved in Rev-mediated nuclear export of HIV-1 mRNA through an interaction with eukaryotic initiation factor 5A (eIF-5A) which binds to Rev
11676	155871	NP_057853.1	Tat	regulated by	9606	23683	NP_005804.1	serine/threonine-protein kinase D3	2182321	2007-11-07 17:28	Protein kinase C is required for HIV-1 Tat-mediated transactivation of the viral LTR promoter, indicating protein kinase C regulates the process of HIV-1 transactivation and may play a role in the transition of HIV from latency to productive growth
11676	155871	NP_057853.1	Tat	activates	9606	23683	NP_005804.1	serine/threonine-protein kinase D3	8627654,9446795,9671211,10843712,11044099,11154208,11833470,11919157,12482669	2007-11-07 17:28	HIV-1 Tat activates protein kinase C, resulting in the induction of TNF-alpha, IL-6 and IL-10 expression and the secretion of MCP-1
11676	155871	NP_057853.1	Tat	phosphorylated by	9606	23683	NP_005804.1	serine/threonine-protein kinase D3	8914829	2007-11-07 17:28	Protein kinase C phosphorylates HIV-1 Tat on serine residue 46
11676	155030	NP_057850.1	Pr55(Gag)	relocalized by	9606	24137	NP_036442.3	chromosome-associated kinesin KIF4A	10559369	2007-11-07 17:29	Binding of HIV-1 Gag to KIF-4 may play a role in HIV-1 Gag polyprotein transport from the cytoplasm to the cell membrane
11676	155030	NP_057850.1	Pr55(Gag)	binds	9606	24137	NP_036442.3	chromosome-associated kinesin KIF4A	10559369	2007-11-07 17:29	Binding of human KIF-4 to HIV-1 Gag is presumed based on homology to murine KIF-4 which binds to an HIV-1 Gag intermediate, consisting of Matrix and Capsid, in a yeast two-hybrid assay and in co-immunoprecipitation assays
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	25834	NP_037376.1	UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IV	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	25834	NP_037376.1	UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IV	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155871	NP_057853.1	Tat	associates with	9606	25920	NP_056271.2	negative elongation factor B	11112772,16838299	2007-11-07 17:28	NELF associates with HIV-1 Tat as part of the HIV-1 transcription elongation complex
11676	155871	NP_057853.1	Tat	upregulates	9606	25930	NP_056281.1	tyrosine-protein phosphatase non-receptor type 23	16408268	2007-11-07 17:29	HIV-1 Tat upregulates the tyrosine phosphatase HD-PTP mRNA in a human endothelial cell line, however Tat-induction of HD-PTP mRNA parallels only with a slight increase of the protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	26279	NP_036532.1	group IID secretory phospholipase A2 precursor	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	26279	NP_036532.1	group IID secretory phospholipase A2 precursor	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	156110	NP_057857.2	Nef	interacts with	9606	26985	NP_036227.1	AP-3 complex subunit mu-1	10814565,11463741,15681409	2007-11-07 17:28	The Nef dileucine motif (amino acids 164-5) is required for the interaction of HIV-1 Nef with the mu subunit of adaptor protein complex 3 (AP-3)
11676	155348	NP_705926.1	retropepsin	cleaves	9606	26986	NP_002559.2	polyadenylate-binding protein 1	16594896,16703665	2007-11-07 17:31	Purified HIV-1 protease cleaves poly(A)-binding protein 1 (PABP1) directly at positions 237 and 477, separating the two first RNA-recognition motifs from the C-terminal domain of PABP
11676	155908	NP_057854.1	Rev	interacts with	9606	26986	NP_002559.2	polyadenylate-binding protein 1	8057425,8657127	2007-11-07 17:27	binding of PAB1 to HIV-1 mRNA requires the presence of Rev and results in polyadenylation of the mRNA which is necessary for the Rev-dependent nucleocytoplasmic transport of HIV-1 mRNA
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	binds	9606	26998	NP_055190.2	fetuin-B precursor	1284814	2007-11-07 17:30	HIV-1 gp160 binds to the natural glycoprotein fetuin
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	27035	NP_008983.1	NADPH oxidase 1 isoform long	9882350	2007-11-07 17:31	HIV-1 gp160 inhibits the cellular immune response and enhances oxidative stress mediated by NADPH oxidase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	27035	NP_008983.1	NADPH oxidase 1 isoform long	15509740	2007-11-07 17:30	HIV-1 gp120 binding to CXCR4 induces NADPH oxidase-mediated production of superoxide radicals in neurons, which is involved in the activation of neutral sphingomyelinase
11676	156110	NP_057857.2	Nef	inhibits	9606	27035	NP_008983.1	NADPH oxidase 1 isoform long	15847608	2007-11-07 17:28	HIV-1 Nef-induced blockade of superoxide release is caused by the inhibition of NADPH oxidase activities in human macrophages; this inhibition is regulated by Nef-mediated increased synthesis and release of IL-10
11676	155030	NP_057850.1	Pr55(Gag)	interacts with	9606	27067	NP_055208.1	staufen homolog 2	15024055	2007-11-07 17:29	Interaction of HIV-1 Gag with staufen is mediated by staufen's dsRBD3 domain
11676	155030	NP_057850.1	Pr55(Gag)	interacts with	9606	27067	NP_055208.1	staufen homolog 2	15024055	2007-11-07 17:29	Staufen is incorporated into HIV-1 virions through association with HIV-1 genomic RNA and is implicated in HIV-1 genome selection and packaging into assembling virions, a process that is mediated by the Nucleocapsid domain of HIV-1 Gag
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	27094	NP_741979.1	calcium-activated potassium channel subunit beta-3 isoform a	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	27113	NP_055232.1	bcl-2-binding component 3 isoform 4	14993250	2007-11-07 17:31	Upregulation of Puma is required for HIV-1 gp120-mediated syncytial apoptosis
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	27113	NP_055232.1	bcl-2-binding component 3 isoform 4	17011204	2007-11-07 17:31	In cultured neurons, HIV-1 gp120 increases transcription factor E2F1 levels in the nucleus, stimulates its transcriptional activity, and enhances the expression of the E2F1 target proteins Cdc2 and Puma
11676	155807	NP_057852.2	Vpr	induces accumulation of	9606	27175	NP_057521.1	tubulin gamma-2 chain	14767062	2007-11-07 17:28	HIV-1 Vpr-expressing HeLa cells stained with centriole markers pericentrin, gamma-tubulin, and Cen2 contain multiple pairs of centrioles scattered in the perinuclear region, indicating Vpr causes the accumulation of multiple centrosome-like structures
11676	155871	NP_057853.1	Tat	stimulated by	9606	27336	NP_055315.2	HIV Tat-specific factor 1	8849451,9649438,9765201,10393184,10454543,10913173,10964778,11780068	2007-11-07 17:30	Tat-SF1 is a required cofactor for HIV-1 Tat activity that stimulates Tat-mediated activation of the HIV-1 LTR promoter
11676	156110	NP_057857.2	Nef	upregulates	9606	27336	NP_055315.2	HIV Tat-specific factor 1	11420046	2007-11-07 17:28	HIV-1 Nef expression in human T cell lines upregulates factors that positively regulate HIV, including Tat-SF1, U1 SNRNP, and IRF-2
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	27345	NP_055320.4	calcium-activated potassium channel subunit beta-4	10758170	2007-11-07 17:31	HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4
11676	155459	NP_057851.1	Vif	binds	9606	27350	NP_055323.2	probable DNA dC->dU-editing enzyme APOBEC-3C	15809227,16414984	2007-11-07 17:31	APOBEC3C restricts HIV-1 replication by causing G to A mutations in viral DNA replication intermediates; HIV-1 Vif binds to and destabilizes APOBEC3C
11676	155030	NP_579883.1	p6	interacts with	9606	29082	NP_054888.2	charged multivesicular body protein 4A	14505569,14505570,14519844	2007-11-07 17:29	HIV-1 p6-Gag interacts with CHMP4A, CHMP4B and CHMP4C proteins through a direct binding interaction with AIP1, a component of the viral budding machinery
11676	155030	NP_579883.1	p6	inhibited by	9606	29082	NP_054888.2	charged multivesicular body protein 4A	14505569,14505570,14519844	2007-11-07 17:29	Overexpression of CHMP4A, CHMP4B or CHMP4C inhibits HIV-1 p6-Gag L-domain function and HIV-1 budding
11676	155871	NP_057853.1	Tat	inhibited by	9606	29893	NP_057640.1	homologous-pairing protein 2 homolog isoform 2	9345291,10806355	2007-11-07 17:30	TBPIP is a cellular protein that interacts with Tat-binding protein-1 (TBP-1) and enhances the inhibitory action of TBP-1 on Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155348	NP_705927.1	reverse transcriptase	inhibited by	9606	29935	NP_037479.1	replication protein A 30 kDa subunit	9084803	2007-11-07 17:29	Replication protein A and HIV-1 nucleocapsid protein interfere with the strand displacement DNA synthesis of HIV-1 reverse transcriptase by binding to the displaced strand and keeping it away from the newly synthesized strand
11676	155871	NP_057853.1	Tat	upregulates	9606	29949	NP_715639.1	interleukin-19 isoform 1 precursor	15857508	2007-11-07 17:28	IL-19 is upregulated in human epithelial cells by HIV-1 Tat treatment
11676	155871	NP_057853.1	Tat	modulated by	9606	29969	NP_951038.1	myoD family inhibitor domain-containing protein isoform p40	10671520,12944466	2007-11-07 17:30	HIC binds both HIV-1 Tat and cyclin T1 through its I-mfa domain (amino acids 165-246) and modulates Tat transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	binds	9606	29969	NP_951038.1	myoD family inhibitor domain-containing protein isoform p40	16260749	2007-11-07 17:29	HIC binds the NLS domain of HIV-1 Tat located between amino acid residues 48 and 60 of Tat
11676	155871	NP_057853.1	Tat	upregulates	9606	30009	NP_037483.1	T-box transcription factor TBX21	15737643	2007-11-07 17:29	HIV-1 Tat acts as a co-stimulatory molecule that affects viral replication by modulating host immune response through induction of T-bet expression and IFN-gamma secretion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	30814	NP_055404.1	group IIE secretory phospholipase A2 precursor	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	30814	NP_055404.1	group IIE secretory phospholipase A2 precursor	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	30835	NP_066978.1	CD209 antigen isoform 1	10721995,10975799,11588046,11711593,11739956,11745695,11799126,11825572,12097593,12176900,12239306,12352970,12438611,12797442,12941144,12960229,14603101,14970226,15043214,15208262,15215692,15385553,15452205,15518824,15545354,15572157,15709021,15752559,16365436,16501104,16611055,16672549,16817962,16940507,17010165,17056872,17077296	2007-11-07 17:31	A dendritic cells (DC)-specific C-type lectin, DC-SIGN, is highly expressed on DC present in mucosal tissues, binds to the HIV-1 envelope glycoprotein gp120, and facilitates infection of HIV-1 permissive cells in trans
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	30835	NP_066978.1	CD209 antigen isoform 1	11384997,11739956	2007-11-07 17:31	Crystal structures of carbohydrate-recognition domains of DC-SIGN and of DC-SIGNR in combination with binding studies reveal that these receptors selectively recognize endogenous high-mannose oligosaccharides of HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	complexes with	9606	30835	NP_066978.1	CD209 antigen isoform 1	11711593,12960229,16611055,16672549	2007-11-07 17:31	The cis expression of DC-SIGN on multiple lymphoid cell lines enables more efficient entry and replication of CXCR4-tropic and CCR5/CXCR4 dual-tropic HIV-1 through its binding to the HIV-1 gp120-CD4-CXCR4 complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	30835	NP_066978.1	CD209 antigen isoform 1	11799126,14970226	2007-11-07 17:31	The HIV-1 gp120 binding site in DC-SIGN is different from that of ICAM-2 and ICAM-3; alanine-scanning mutagenesis of DC-SIGN at N311, R345, V351, G352, E353, S360, G361, and N362 abrogate ICAM-2/3 binding, whereas the HIV-1 gp120 interaction is unaffected
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	30835	NP_066978.1	CD209 antigen isoform 1	12941144,12960229,17010165,17056872	2007-11-07 17:30	DC-SIGN and MBL bind primarily to glycans on HIV-1 gp120/gp41; preincubation of CXCR4-, CCR5- or dual-tropic HIV-1 strains with MBL prevents DC-SIGN-mediated trans infection of T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	30835	NP_066978.1	CD209 antigen isoform 1	14970226	2007-11-07 17:30	Mutagenesis of conserved residues (Gly-346, Glu-347, Asn-349, Glu-354, and Asp-355) of DC-SIGN significantly compromises binding to HIV-1 gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	30835	NP_066978.1	CD209 antigen isoform 1	15208262,15752559,16611055	2007-11-07 17:30	Binding of HIV-1 gp120 to DC-SIGN does not result in increased adhesion levels of LFA-1 to its ligand ICAM-1 in both immature dendritic cells (DC) and Raji-DC-SIGN cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	30835	NP_066978.1	CD209 antigen isoform 1	15385553	2007-11-07 17:30	DC-SIGN tetramers are essential for high affinity interactions with the HIV-1 high mannose glycoprotein gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	30835	NP_066978.1	CD209 antigen isoform 1	15709021	2007-11-07 17:30	Bovine lactoferrin (bLF) binds strongly to DC-SIGN, thus blocking the interaction between DC-SIGN and HIV-1 gp120 and preventing virus capture and subsequent transmission; bLF is a much more efficient inhibitor of transmission than human lactoferrin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	30835	NP_066978.1	CD209 antigen isoform 1	16547227	2007-11-07 17:31	HIV-1 gp120 binds to B cells through mannose C-type lectin receptors (MCLRs), such as DC-SIGN, mannose receptor, and langerin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	30835	NP_066978.1	CD209 antigen isoform 1	17005819	2007-11-07 17:31	Bile salt-stimulated lipase (BSSL) isolated from human milk binds to DC-SIGN, preventing HIV-1 gp120 from interacting with this receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	enhanced by	9606	30835	NP_066978.1	CD209 antigen isoform 1	17010165	2007-11-07 17:31	Raji-DC-SIGN cells preferentially enhance CXCR4 usage of dual-tropic HIV-1 with higher V3 charges in gp120
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	mediated by	9606	30835	NP_066978.1	CD209 antigen isoform 1	17151103	2007-11-07 17:31	Expression of CD4 on Raji B cells strongly inhibits DC-SIGN-mediated HIV-1 (gp120) transmission to T cells; co-expression of CD4 and DC-SIGN in Raji cells promotes internalization and intracellular retention of HIV-1
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	30835	NP_066978.1	CD209 antigen isoform 1	17182696	2007-11-07 17:31	Using an siRNA approach indicates DC-SIGN is not required for efficient trans-enhancement of HIV-1 (gp120) infectivity by dendritic cells (DCs)
11676	156110	NP_057857.2	Nef	upregulates	9606	30835	NP_066978.1	CD209 antigen isoform 1	11825573,12836198,15638726,16454711,17077296,17083721	2007-11-07 17:28	HIV-1 Nef upregulates DC-SIGN in HIV-1 infected dendritic cells by inhibiting DC-SIGN endocytosis, which dramatically increases clustering of dendritic cells with T lymphocytes, thereby enhancing HIV-1 transmission
11676	156110	NP_057857.2	Nef	upregulates	9606	30835	NP_066978.1	CD209 antigen isoform 1	11825573,12836198,16454711	2007-11-07 17:28	Mutation of the dileucine motif at amino acids 165-166 of HIV-1 Nef abolishes the Nef-mediated upregulation of DC-SIGN on the surface of HIV-1 infected dendritic cells
11676	156110	NP_057857.2	Nef	upregulates	9606	30835	NP_066978.1	CD209 antigen isoform 1	16439540	2007-11-07 17:29	Substitution of HIV-1 Nef acidic residue E160 with uncharged residues impairs the ability of Nef to upregulate the expression of DC-SIGN and the invariant chain of MHC class II at the cell surface
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	50487	NP_056530.1	phospholipase A2, group III precursor	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	50487	NP_056530.1	phospholipase A2, group III precursor	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	50489	NP_056532.2	C-type lectin domain family 4 member K	16547227,17077296	2007-11-07 17:31	HIV-1 gp120 binds to B cells through mannose C-type lectin receptors (MCLRs), such as DC-SIGN, mannose receptor, and langerin
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	50507	NP_058627.1	NADPH oxidase 4 isoform a	9882350	2007-11-07 17:31	HIV-1 gp160 inhibits the cellular immune response and enhances oxidative stress mediated by NADPH oxidase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	50507	NP_058627.1	NADPH oxidase 4 isoform a	15509740	2007-11-07 17:30	HIV-1 gp120 binding to CXCR4 induces NADPH oxidase-mediated production of superoxide radicals in neurons, which is involved in the activation of neutral sphingomyelinase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	50508	NP_056533.1	NADPH oxidase 3	9882350	2007-11-07 17:31	HIV-1 gp160 inhibits the cellular immune response and enhances oxidative stress mediated by NADPH oxidase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	50508	NP_056533.1	NADPH oxidase 3	15509740	2007-11-07 17:30	HIV-1 gp120 binding to CXCR4 induces NADPH oxidase-mediated production of superoxide radicals in neurons, which is involved in the activation of neutral sphingomyelinase
11676	155871	NP_057853.1	Tat	upregulates	9606	50604	NP_061194.2	interleukin-20 precursor	15857508	2007-11-07 17:28	IL-20 is upregulated by HIV-1 Tat treatment in human epithelial cells
11676	155030	NP_579876.2	matrix	interacts with	9606	50810	NP_057157.1	hepatoma-derived growth factor-related protein 3	16337983	2007-11-07 17:29	Hepatoma-derived growth factor 2 (HRP2) restores salt-stripped HIV-1 preintegration complex (PIC) activity in vitro
11676	155348	NP_705927.1	reverse transcriptase	interacts with	9606	50810	NP_057157.1	hepatoma-derived growth factor-related protein 3	16337983	2007-11-07 17:29	Hepatoma-derived growth factor 2 (HRP2) restores salt-stripped HIV-1 preintegration complex (PIC) activity in vitro
11676	155348	NP_705928.1	integrase	activated by	9606	50810	NP_057157.1	hepatoma-derived growth factor-related protein 3	16337983	2007-11-07 17:29	Hepatoma-derived growth factor 2 (HRP2) restores salt-stripped HIV-1 preintegration complex (PIC) activity in vitro
11676	155807	NP_057852.2	Vpr	interacts with	9606	50810	NP_057157.1	hepatoma-derived growth factor-related protein 3	16337983	2007-11-07 17:29	Hepatoma-derived growth factor 2 (HRP2) restores salt-stripped HIV-1 preintegration complex (PIC) activity in vitro
11676	155871	NP_057853.1	Tat	activates	9606	50940	NP_058649.3	dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform 4	11156964	2007-11-07 17:28	HIV-1 Tat decreases the intracellular levels of cAMP and CREB ser-133 phosphorylation through a signal transduction pathway involving sequential activation of phosphatidylinositol 3-kinase, AKT, and cyclic nucleoside phosphodiesterases
11676	155348	NP_705926.1	retropepsin	activated by	9606	51022	NP_057150.2	glutaredoxin-2, mitochondrial isoform 1	9325327	2007-11-07 17:29	Treatment of diglutathionylated HIV-1 protease (positions 67 and 95) with thioltransferase (glutaredoxin) restores protease activity and generates an enzyme preparation that has 3- to 5-fold greater specific activity relative to the fully reduced form
11676	155030	NP_057850.1	Pr55(Gag)	regulated by	9606	51160	NP_057292.1	vacuolar protein sorting-associated protein 28 homolog isoform 1	15218037	2007-11-07 17:29	Tsg 101, VPS 28, and VPS 37B form the human endosomal sorting complex required for transport (ESCRT-I), which is required for HIV-1 Gag budding and virus infectivity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	51182	NP_057383.2	heat shock 70 kDa protein 14 isoform 1	7906708	2007-11-07 17:29	The exposure of permissive CD4+ cells to HIV-1 gp120 increases the synthesis and nuclear translocation of 70kDa heat shock protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	51182	NP_057383.2	heat shock 70 kDa protein 14 isoform 1	12832005	2007-11-07 17:30	Over expression of hsp70 with a herpes viral amplicon vector protects cultured hippocampal rat neurons from gp120 neurotoxicity
11676	155871	NP_057853.1	Tat	activates	9606	51196	NP_057425.3	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase epsilon-1 isoform 1	7589147,9278385,9730685,10501179,10843712,12482669	2007-11-07 17:28	HIV-1 Tat induces release of calcium and TNF-alpha production, an effect mediated at least in part by activation of phospholipase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	51196	NP_057425.3	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase epsilon-1 isoform 1	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155348	NP_705926.1	retropepsin	activated by	9606	51218	NP_057501.2	glutaredoxin-related protein 5, mitochondrial precursor	9325327	2007-11-07 17:29	Treatment of diglutathionylated HIV-1 protease (positions 67 and 95) with thioltransferase (glutaredoxin) restores protease activity and generates an enzyme preparation that has 3- to 5-fold greater specific activity relative to the fully reduced form
11676	155348	NP_705926.1	retropepsin	cleaves	9606	51332	NP_057726.1	spectrin, beta, non-erythrocytic 5	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155871	NP_057853.1	Tat	binds	9606	51341	NP_056982.1	zinc finger and BTB domain-containing protein 7A	9973611,11907272	2007-11-07 17:29	Binding of FBI-1 to HIV-1 Tat is mediated by the zinc finger (ZF) domain of FBI-1 (amino acids 377-584) and is diminished by point mutations in Tat at amino acids 18, 30, and 31
11676	155871	NP_057853.1	Tat	stimulated by	9606	51341	NP_056982.1	zinc finger and BTB domain-containing protein 7A	9973611,11907272,12750370	2007-11-07 17:29	FBI-1 is a cellular POZ-domain-containing protein that binds to the HIV-1 LTR and Tat protein and specifically stimulates Tat activity
11676	155030	NP_579876.2	matrix	activates	9606	51422	NP_057287.2	5'-AMP-activated protein kinase subunit gamma-2 isoform a	1978848,7688126,7946090	2007-11-07 17:28	HIV-1 Matrix impairs proliferation of normal lymphocytes in vitro by inducing the activity of the inhibitory protein kinase A (PKA)
11676	155030	NP_579876.2	matrix	phosphorylated by	9606	51422	NP_057287.2	5'-AMP-activated protein kinase subunit gamma-2 isoform a	9151826	2007-11-07 17:28	Protein kinase A (PKA) has been shown to phosphorylate HIV-1 Matrix in vitro
11676	155871	NP_057853.1	Tat	activates	9606	51422	NP_057287.2	5'-AMP-activated protein kinase subunit gamma-2 isoform a	9278385,9671211,9730685	2007-11-07 17:28	HIV-1 Tat induces IL-6 and TNF-alpha expression through the activation of cAMP-dependent protein kinase pathways
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	51454	NP_057399.1	PTB domain-containing engulfment adapter protein 1	15749123	2007-11-07 17:30	Upregulation of apoptosis genes such as NCK-associated protein 1, PTB domain adaptor protein CED-6, and TNF receptor superfamily 5 are induced by HIV-1 gp120 in human neurons
11676	155871	NP_057853.1	Tat	associates with	9606	51497	NP_945327.1	negative elongation factor C/D	11112772,16838299	2007-11-07 17:28	NELF associates with HIV-1 Tat as part of the HIV-1 transcription elongation complex
11676	156110	NP_057857.2	Nef	binds	9606	51606	NP_998784.1	V-type proton ATPase subunit H isoform 2	9620685,11463741,12032142,12058068	2007-11-07 17:27	Vacuolar ATPase subunit H (V1H) binds to the C-terminal flexible loop in HIV-1 Nef; a 15-residue oligopeptide, which is derived from positions 167-181 in Nef, specifically blocks the binding of Nef to V1H
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	downregulates	9606	51652	NP_057163.1	charged multivesicular body protein 3 isoform 1	12775420	2007-11-07 17:31	Downregulation of guanine nucleotide-releasing protein, CD151/PETA-3, neuronatin, neuroendocrine differentiation factor, mitochondria 16s rRNA, and signal recognition particle is observed in HIV-1 infected and HIV-1 gp120-treated astrocytes
11676	155871	NP_057853.1	Tat	upregulates	9606	51692	NP_057291.1	cleavage and polyadenylation specificity factor subunit 3	15194760	2007-11-07 17:28	HIV-1 Tat specifically increases the expression of the cleavage and polyadenylation specificity factor 73-kDa subunit (CPSF3), and this upregulation is an important regulatory step for both viral and cellular gene expression
11676	155871	NP_057853.1	Tat	activates	9606	51728	NP_057394.1	DNA-directed RNA polymerase III subunit RPC10	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	binds	9606	51807	NP_061816.1	tubulin alpha-8 chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	enhances polymerization of	9606	51807	NP_061816.1	tubulin alpha-8 chain	15691386,15698476	2007-11-07 17:28	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155871	NP_057853.1	Tat	disrupts	9606	51807	NP_061816.1	tubulin alpha-8 chain	16327313	2007-11-07 17:29	HIV-1 Tat causes a dramatic decrease in alpha-tubulin staining, which indicates disruption of the cytoskeleton organization in human intestinal epithelial cells
11676	155908	NP_057854.1	Rev	depolymerizes	9606	51807	NP_061816.1	tubulin alpha-8 chain	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces acetylation of	9606	51807	NP_061816.1	tubulin alpha-8 chain	15103018,16148047	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4+-permissive cells increases the level of acetylated alpha-tubulin in a CD4-dependent manner; overexpression of Histone Deacetylase 6 (HDAC6) inhibits the acetylation of alpha-tubulin and prevents HIV-1-cell fusion
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	53358	NP_058544.2	src homology 2 domain containing transforming protein C3	9325171	2007-11-07 17:29	HIV-1 Tat activates the MAPK signaling pathway leading to the phosphorylation of Shc, a protein involved in signal transduction downstream of receptor tyrosine kinase activation
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	53358	NP_058544.2	src homology 2 domain containing transforming protein C3	16436505	2007-11-07 17:29	HIV-1 Tat-induced small GTPase Ras activation is mediated by tyrosine phosphorylation of Shc and recruitment of Grb2 in human endothelial cells
11676	155807	NP_057852.2	Vpr	binds	9606	53371	NP_059122.2	nucleoporin p54	9582382	2007-11-07 17:28	HIV-1 Vpr binds to nucleoporin p54 in vitro during docking of the HIV-1 preintegration complex at the nuclear envelope
11676	155030	NP_579880.1	capsid	binds	9606	53840	NP_067629.2	tripartite motif-containing protein 34 isoform 1	16775307,16828831,17156811	2007-11-07 17:31	The RING, B-box 2, and coiled-coil domains of TRIM34 can functionally replace the corresponding domains of rhesus monkey TRIM5alpha with respect to inhibition of HIV-1 infection through the binding of the chimeras to HIV-1 capsid complexes
11676	155871	NP_057853.1	Tat	binds	9606	54145	NP_059141.1	H2B histone family, member S	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155348	NP_705926.1	retropepsin	induces release of	9606	54205	NP_061820.1	cytochrome c	12404116	2007-11-07 17:29	HIV-1 protease directly cleaves and activates procaspase 8 in T cells, which is associated with cleavage of BID, mitochondrial release of cytochrome c, activation of the downstream caspases 9 and 3, and cleavage of DFF and PARP
11676	155807	NP_057852.2	Vpr	induces release of	9606	54205	NP_061820.1	cytochrome c	16520893	2007-11-07 17:31	Overproduction of EEF2 blocks HIV-1 Vpr-induced cell death both in fission yeast and human cells, suppresses caspase 9 and caspase 3-mediated apoptosis induced by Vpr, and reduces cytochrome c release induced by Vpr
11676	155807	NP_057852.2	Vpr	induces release of	9606	54205	NP_061820.1	cytochrome c	17158886	2007-11-07 17:31	HIV-1 Vpr 52-96 peptide induces apoptosis through cytochrome-c release from mitochondria
11676	155871	NP_057853.1	Tat	induces release of	9606	54205	NP_061820.1	cytochrome c	15691386,15698476	2007-11-07 17:29	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	induces release of	9606	54205	NP_061820.1	cytochrome c	11739707	2007-11-07 17:30	Treatment of CD4+ cells with HIV-1 gp160 causes intracellular calcium increase followed by the release of cytochrome c from mitochondria; association of BAD with Bcl-xL is observed, and a portion of BAD is dephosphorylated after gp160 induction
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	relocalizes	9606	54205	NP_061820.1	cytochrome c	11193032,11462036,15033690	2007-11-07 17:31	Apoptosis induced by HIV-1 gp120/gp41 is involved in the translocation of cytochrome c and apoptosis-inducing factor (AIF) from mitochondria to an extra-mitochondrial localization and in the dissipation of the mitochondrial transmembrane potential
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	54205	NP_061820.1	cytochrome c	12019321,15033690	2007-11-07 17:31	Treatment of cerebrocortical cultures with HIV-1 gp120 results in increased caspase-3 proteolytic activity, mitochondrial release of cytochrome c, and neuronal apoptosis
11676	155459	NP_057851.1	Vif	binds	9606	54476	NP_996994.1	E3 ubiquitin-protein ligase RNF216 isoform a	12600646	2007-11-07 17:28	Binding of HIV-1 Vif to Triad3 was identified using a yeast two-hybrid screen
11676	155459	NP_057851.1	Vif	binds	9606	54476	NP_996994.1	E3 ubiquitin-protein ligase RNF216 isoform a	12600646	2007-11-07 17:28	HIV-1 Vif mutants with amino acid substitutions in residues 105-107 are specifically unable to bind to Triad3
11676	155459	NP_057851.1	Vif	interacts with	9606	54476	NP_996994.1	E3 ubiquitin-protein ligase RNF216 isoform a	12600646	2007-11-07 17:29	Triad3 is proposed to act as a linker protein between HIV-1 Vif and other cellular or viral proteins
11676	155459	NP_057851.1	Vif	binds	9606	54476	NP_996994.1	E3 ubiquitin-protein ligase RNF216 isoform a	15367624	2007-11-07 17:28	Triad 3/ZIN binds to purified HIV-1 Vif in vitro, interacts with HIV-1 Vif in transfected human 293T cells, and can impair viral DNA synthesis by two-fold when overexpressed in cells69
11676	155871	NP_057853.1	Tat	methylated by	9606	55170	NP_060607.1	protein arginine methyltransferase 6	15596808	2007-11-07 17:28	HIV-1 Tat specifically interacts with and is methylated by PRMT6 within cells; overexpression of wild-type PRMT6 decreases Tat transactivation of an HIV-1 long terminal repeat luciferase reporter plasmid in a dose-dependent manner
11676	155908	NP_057854.1	Rev	methylated by	9606	55170	NP_060607.1	protein arginine methyltransferase 6	17176473	2007-11-07 17:31	Arginine 38 methylation of HIV-1 Rev by PRMT6 reduces RRE binding and diminishes export of viral RNA to the cytoplasm
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	methylated by	9606	55170	NP_060607.1	protein arginine methyltransferase 6	17169163	2007-11-07 17:31	HIV-1 Env (gp160) protein methylation mediated by PRMT6 is required to maintain optimal HIV-1 infectivity
11676	155871	NP_057853.1	Tat	binds	9606	55506	NP_061119.1	core histone macro-H2A.2	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	55512	NP_061137.1	sphingomyelin phosphodiesterase 3	15509740	2007-11-07 17:30	HIV-1 gp120 binding to CXCR4 induces NADPH oxidase-mediated production of superoxide radicals in neurons, which is involved in the activation of neutral sphingomyelinase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	55512	NP_061137.1	sphingomyelin phosphodiesterase 3	15509740	2007-11-07 17:30	In human primary neurons, HIV-1 gp120 induces the activation of sphingomyelinases (primarily neutral sphingomyelinase); antisense knockdown of neutral sphingomyelinase markedly inhibits gp120-mediated apoptosis and cell death of primary neurons
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	55627	NP_060221.2	sphingomyelin phosphodiesterase 4 isoform 1	15509740	2007-11-07 17:30	HIV-1 gp120 binding to CXCR4 induces NADPH oxidase-mediated production of superoxide radicals in neurons, which is involved in the activation of neutral sphingomyelinase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	55627	NP_060221.2	sphingomyelin phosphodiesterase 4 isoform 1	15509740	2007-11-07 17:30	In human primary neurons, HIV-1 gp120 induces the activation of sphingomyelinases (primarily neutral sphingomyelinase); antisense knockdown of neutral sphingomyelinase markedly inhibits gp120-mediated apoptosis and cell death of primary neurons
11676	156110	NP_057857.2	Nef	binds	9606	55690	NP_060496.2	phosphofurin acidic cluster sorting protein 1	10707087,11331585,11463741,12526811,12855553,14965316,15638726	2007-11-07 17:28	HIV-1 Nef-induced downregulation of MHC-I expression and MHC-I targeting to the trans-Golgi network (TGN) require the binding of Nef (amino acid residues 62-65) to PACS-1, a molecule that controls the TGN localization of the cellular protein furin
11676	155871	NP_057853.1	Tat	activates	9606	55703	NP_060552.3	DNA-directed RNA polymerase III B	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	activates	9606	55718	NP_060589.1	DNA-directed RNA polymerase III subunit RPC5	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	binds	9606	55766	NP_060737.1	H2A histone family, member J isoform 1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	55830	NP_060916.1	glycosyltransferase 8 domain-containing protein 1	2283726,2341393,2649653,8218172	2007-11-07 17:29	Addition of peripheral sugar residues such as galactose, N-acetylglucosamine, and sialic acid to HIV-1 gp120 is processed by specific glycosyltransferase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	56548	NP_063939.2	carbohydrate sulfotransferase 7	1433500,8419650	2007-11-07 17:30	Sulfate is linked to the carbohydrate chains of HIV-1 glycoproteins gp160, gp120, and gp41 during the endoplasmic reticulum to Golgi transport of the glycoproteins
11676	155871	NP_057853.1	Tat	downregulates	9606	56604	NP_064424.3	putative tubulin beta-4q chain	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155807	NP_057852.2	Vpr	induces release of	9606	56616	NP_063940.1	diablo homolog, mitochondrial isoform 1 precursor	17140287	2007-11-07 17:31	HIV-1 Vpr-induced apoptosis through caspase activation and Smac release from mitochondria is dependent on G2 cell cycle arrest , but is lost in cells synchronized in G1/S
11676	155030	NP_057850.1	Pr55(Gag)	inhibited by	9606	56623	NP_063945.2	72 kDa inositol polyphosphate 5-phosphatase	15465916	2007-11-07 17:29	Overexpression of phosphoinositide 5-phosphatase IV, an enzyme that depletes cellular PI(4,5)P2, severely reduces HIV-1 Gag virus production by retargeting Gag to late endosomes instead of the plasma membrane
11676	155348	NP_705928.1	integrase	interacts with	9606	56852	NP_064550.2	postreplication repair protein hRAD18p	12016221	2007-11-07 17:29	HIV-1 Integrase interacts with (co-immunoprecipitates) and co-localizes with hRad18 suggesting a role for hRad18 in the DNA repair events associated with the HIV-1 integration process
11676	155871	NP_057853.1	Tat	regulates	9606	56903	NP_064529.4	poly(A) polymerase beta	8491200	2007-11-07 17:30	The poly(A) site in the HIV-1 5'-LTR is occluded in a Tat-dependent manner, suggesting a role for Tat in regulating this nucleotide signal
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	57134	NP_065112.1	mannosyl-oligosaccharide 1,2-alpha-mannosidase IC	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	57134	NP_065112.1	mannosyl-oligosaccharide 1,2-alpha-mannosidase IC	2283726,2355006,2406237,2542563,2649653,2829950,8218172,8892864	2007-11-07 17:29	HIV-1 gp120 N-linked oligosaccharides are processed by manosidase I and II in the Golgi complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	57134	NP_065112.1	mannosyl-oligosaccharide 1,2-alpha-mannosidase IC	12560567	2007-11-07 17:31	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	57134	NP_065112.1	mannosyl-oligosaccharide 1,2-alpha-mannosidase IC	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:31	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155459	NP_057851.1	Vif	inhibits	9606	57379	NP_065712.1	activation-induced cytidine deaminase	16580072	2007-11-07 17:31	In E. coli, HIV-1 Vif can block the activity of activation-induced deaminase (AID), a B lymphoid protein necessary for somatic hypermutation; AID inhibition by Vif is mediated by a direct protein-protein interaction via unique amino acid D118
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	57704	NP_065995.1	non-lysosomal glucosylceramidase	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	glycosylated by	9606	57704	NP_065995.1	non-lysosomal glucosylceramidase	2076345,2136376,2283726,2355006,2649653,2959866,8218172,12719582,16547752	2007-11-07 17:29	HIV-1 gp120 is extremely heavily glycosylated (31-36 N-linked glycans per molecule) by glucosidase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	57704	NP_065995.1	non-lysosomal glucosylceramidase	2959866	2007-11-07 17:29	Glucosidase inhibitors inhibit the syncytium formation between HIV-infected and CD4-expressing cells and interfere with HIV-1 infectivity, indicating processing of HIV-1 gp120 by glucosidase is important for virus replication
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	57704	NP_065995.1	non-lysosomal glucosylceramidase	12560567	2007-11-07 17:30	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	57704	NP_065995.1	non-lysosomal glucosylceramidase	1704656,1736542,2829950,3099781,3264072,8093218	2007-11-07 17:31	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155348	NP_705926.1	retropepsin	cleaves	9606	57731	NP_066022.2	spectrin beta chain, brain 3 isoform sigma1	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	57733	NP_066024.1	cytosolic beta-glucosidase isoform a	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	glycosylated by	9606	57733	NP_066024.1	cytosolic beta-glucosidase isoform a	2076345,2136376,2283726,2355006,2649653,2959866,8218172,12719582,16547752	2007-11-07 17:29	HIV-1 gp120 is extremely heavily glycosylated (31-36 N-linked glycans per molecule) by glucosidase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	57733	NP_066024.1	cytosolic beta-glucosidase isoform a	2959866	2007-11-07 17:29	Glucosidase inhibitors inhibit the syncytium formation between HIV-infected and CD4-expressing cells and interfere with HIV-1 infectivity, indicating processing of HIV-1 gp120 by glucosidase is important for virus replication
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	57733	NP_066024.1	cytosolic beta-glucosidase isoform a	12560567	2007-11-07 17:30	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	57733	NP_066024.1	cytosolic beta-glucosidase isoform a	1704656,1736542,2829950,3099781,3264072,8093218	2007-11-07 17:31	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155871	NP_057853.1	Tat	interacts with	9606	58155	NP_067013.1	polypyrimidine tract-binding protein 2	8626763	2007-11-07 17:30	Polypyrimidine tract-binding protein (PTB) stimulates the binding of RNA Polymerase II and TRP-185 to HIV-1 TAR RNA, suggesting an interaction between PTB and HIV-1 Tat
11676	155030	NP_579881.1	nucleocapsid	interacts with	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	15159405,15215254,15358144,15479826,15479846	2007-11-07 17:29	The N-terminus (residues 1-11) of HIV-1 nucleocapsid is critical for HIV-1 Gag and APOBEC3G interaction and virion packaging; the linker region (residues 121-161) of APOBEC3G is also important for efficient packaging into HIV-1 Gag virus like particles
11676	155030	NP_579881.1	nucleocapsid	interacts with	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	15464836,15479826,15479846,17020885	2007-11-07 17:29	Interaction of APOBEC3G with HIV-1 nucleocapsid requires RNA, which may form a bridge between these two proteins
11676	155030	NP_579881.1	nucleocapsid	interacts with	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	15464836	2007-11-07 17:29	Interaction of APOBEC3G with the carboxy-terminal nucleocapsid/p6 domain of the Gag polyprotein precursor is observed by Western analysis
11676	155030	NP_579881.1	nucleocapsid	incorporates	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	17126871	2007-11-07 17:31	Approximately 7 (+/-4) molecules of APOBEC3G are incorporated into HIV-1 Vif-negative virions produced from human PBMCs; this incorporation is mediated by HIV-1 nucleocapsid
11676	155030	NP_579883.1	p6	interacts with	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	15464836	2007-11-07 17:29	Interaction of APOBEC3G with the carboxy-terminal nucleocapsid/p6 domain of the Gag polyprotein precursor is observed by Western analysis
11676	155348	NP_705927.1	reverse transcriptase	inhibited by	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	16971427	2007-11-07 17:31	Vif-negative HIV-1 produced from 293T cells transiently expressing hA3G are impaired in early and late viral DNA production, and in viral infectivity, which are correlated with an inability of tRNA(3)(Lys) to prime reverse transcription
11676	155459	NP_057851.1	Vif	inhibits	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	9811770,9846577,12167863,12719574,12750511,12808465,12808466,12809610,12830140,12840737,12859895,12914693,12920286,12970355,14527406,14528300,14528301,14557625,14564014,14614829,14966139,14978281,14999100,15054139,15080177,15116720,15168739,15177194,15245742,15353294,15373943,15383144,15578976,16250885,16354571,16414984,16501124,16631224,16641889,16678488,16940537,17023652,17067930	2007-11-07 17:27	APOBEC3G, also know as CEM15, is a cellular inhibitor of HIV-1 replication which is suppressed by the viral Vif protein
11676	155459	NP_057851.1	Vif	inhibits	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	12859895,14527406,14528300,14528301,14557625,14614829,14747572,15080177,15116720,15168739,15177194,15245742,15353294,15383144,15578976,16250885,16354571,16414984,16460778,16678488,17020885	2007-11-07 17:29	HIV-1 Vif suppresses the inhibitory effects of APOBEC3G on HIV-1 replication by reducing its intracellular expression and inhibiting its virion encapsidation
11676	155459	NP_057851.1	Vif	degrades	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	14527406,14528300,14528301,14564014,14614829,14672928,15537645,16354571,16460778,16940537	2007-11-07 17:29	HIV-1 Vif binds to amino acids 54-124 of APOBEC3G and causes its degradation through a proteasome dependent pathway
11676	155459	NP_057851.1	Vif	inhibits	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	14564014,14747572,15080177,15116720,15168739,15177194,15245742,15353294,15383144,15578976,16250885,16303161,16678488	2007-11-07 17:29	The ability of HIV-1 Vif to suppress the antiviral activity of APOBEC3G is dependent on the function of a Vif-Cul5-SCF complex involving Cul5, elongins B and C, and Rbx1
11676	155459	NP_057851.1	Vif	binds	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	14672928	2007-11-07 17:28	Co-immunoprecipitation assays show that HIV-1 Vif directly binds APOBEC3G to form a complex in vivo that accelerates the degradation of APOBEC3G via the ubiquitin-proteasome pathway
11676	155459	NP_057851.1	Vif	inhibits	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	14747572	2007-11-07 17:28	Mutation of amino acid S144 in HIV-1 HXB2 Vif significantly reduces the ability of Vif to inhibit the antiviral activity of APOBEC3G
11676	155459	NP_057851.1	Vif	interacts with	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	14966139,14978281,14999100,15054139,15611076,17049578	2007-11-07 17:28	A single amino acid replacement of Asp-128 in human APOBEC3G with the Lys-128 of African green monkey (AGM) APOBEC3G causes the enzyme to switch its interaction, becoming sensitive to SIV(AGM) Vif and resistant to HIV-1 Vif
11676	155459	NP_057851.1	Vif	binds	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	15156567	2007-11-07 17:28	The C-terminal domain (amino acid residues 156-193) of APOBEC3G is required for binding with HIV-1 Vif
11676	155459	NP_057851.1	Vif	binds	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	15537645	2007-11-07 17:28	Binding of APOBEC3G with HIV-1 Vif influences the localization of Vif, and mutation of the isoleucine at Vif amino acid 9 disrupts this interaction
11676	155459	NP_057851.1	Vif	binds	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	15611076	2007-11-07 17:28	The binding of HIV-1 Vif to APOBEC3G is specifically mediated by a strong interacting domain encompassing amino acids 85-99 in APOBEC3G and 169-192 in Vif
11676	155459	NP_057851.1	Vif	inhibits	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	16418394	2007-11-07 17:29	IFN-alpha enhances APOBEC3G expression and inhibits suppression of APOBEC3G by HIV-1 Vif
11676	155459	NP_057851.1	Vif	inhibits	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	16501124,17049578	2007-11-07 17:31	Highly conserved Tryptophan residues in the N-terminal region of HIV-1 Vif are required for the suppression of both APOBEC3G and APOBEC3F
11676	155459	NP_057851.1	Vif	inhibits	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	16699599	2007-11-07 17:31	HIV-1 Vif, which suppresses both APOBEC3G and APOBEC3F antiviral function by inducing their degradation, may selectively remove these proteins from, and/or restrict their localization to, P-bodies
11676	155459	NP_057851.1	Vif	degrades	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	17049578	2007-11-07 17:31	Mutations in the HIV-1 Vif HCCH motif (residues 108-139), BC box (residues 144-146), and Cul5-box (residues 163-169) result in the reduction of Vif-induced APOBEC3G degradation
11676	155459	NP_057851.1	Vif	inhibits	9606	60489	NP_068594.1	DNA dC->dU-editing enzyme APOBEC-3G	17126871	2007-11-07 17:31	Approximately 7 (+/-4) molecules of APOBEC3G are incorporated into HIV-1 Vif-negative virions produced from human PBMCs; HIV-1 Vif inhibits this incorporation
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	64377	NP_071912.2	carbohydrate sulfotransferase 8	1433500,8419650	2007-11-07 17:30	Sulfate is linked to the carbohydrate chains of HIV-1 glycoproteins gp160, gp120, and gp41 during the endoplasmic reticulum to Golgi transport of the glycoproteins
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	64600	NP_073730.2	phospholipase A2, group IIF	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	64600	NP_073730.2	phospholipase A2, group IIF	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	cleaved by	9606	64714	NP_006840.2	protein disulfide-isomerase A2 precursor	12218051,12218052,14592831,16507315	2007-11-07 17:31	Protein-disulfide isomerase (PDI) cleaves disulfide bonds in recombinant HIV-1 envelope glycoprotein gp120, and gp120 bound to the surface receptor CD4 undergoes a disulfide reduction that is prevented by PDI inhibitors
11676	155871	NP_057853.1	Tat	regulates	9606	64895	NP_075045.2	poly(A) polymerase gamma	8491200	2007-11-07 17:30	The poly(A) site in the HIV-1 5'-LTR is occluded in a Tat-dependent manner, suggesting a role for Tat in regulating this nucleotide signal
11676	155871	NP_057853.1	Tat	inactivates	9606	64919	NP_612808.1	B-cell lymphoma/leukemia 11B isoform 1	12692243	2007-11-07 17:30	CTIP2 forms a complex with HIV-1 Tat and HP1alpha resulting in relocalization of Tat and inactivation of Tat-mediated transactivation of the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	binds	9606	64919	NP_612808.1	B-cell lymphoma/leukemia 11B isoform 1	12692243	2007-11-07 17:30	CTIP2 harbors two HIV-1 Tat interaction interfaces (amino acids 145-434 and 717-813) and binds to the N-terminus (amino acids 1-48) of Tat
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	interacts with	9606	79400	NP_078781.2	NADPH oxidase 5	9882350	2007-11-07 17:31	HIV-1 gp160 inhibits the cellular immune response and enhances oxidative stress mediated by NADPH oxidase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	79400	NP_078781.2	NADPH oxidase 5	15509740	2007-11-07 17:30	HIV-1 gp120 binding to CXCR4 induces NADPH oxidase-mediated production of superoxide radicals in neurons, which is involved in the activation of neutral sphingomyelinase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	79694	NP_078917.2	glycoprotein endo-alpha-1,2-mannosidase	2187500,2541446,2542563,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	79694	NP_078917.2	glycoprotein endo-alpha-1,2-mannosidase	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	79694	NP_078917.2	glycoprotein endo-alpha-1,2-mannosidase	12560567	2007-11-07 17:30	Specific alterations of the N-linked carbohydrates on HIV-1 gp120 and gp41 by glucosidases and mannosidase inhibitors can enhance mannose-binding lectin (MBL)-mediated neutralization of virus by strengthening the interaction of HIV-1 with MBL
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	79709	NP_078932.2	procollagen galactosyltransferase 1 precursor	2283726,2341393,2649653,8218172	2007-11-07 17:29	Addition of peripheral sugar residues such as galactose, N-acetylglucosamine, and sialic acid to HIV-1 gp120 is processed by specific glycosyltransferase
11676	155030	NP_057850.1	Pr55(Gag)	regulated by	9606	79720	NP_078943.1	vacuolar protein sorting-associated protein 37B	15218037	2007-11-07 17:29	Tsg 101, VPS 28, and VPS 37B form the human endosomal sorting complex required for transport (ESCRT-I), which is required for HIV-1 Gag budding and virus infectivity
11676	155348	NP_705926.1	retropepsin	cleaves	9606	79784	NP_079005.3	myosin-14 isoform 2	8424456	2007-11-07 17:29	HIV-1 protease cleaves human myosin heavy chain in vitro
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	79868	NP_060936.1	asparagine-linked glycosylation 13 homolog isoform 2	2283726,2341393,2649653,8218172	2008-05-20 05:26	Addition of peripheral sugar residues such as galactose, N-acetylglucosamine, and sialic acid to HIV-1 gp120 is processed by specific glycosyltransferase
11676	155807	NP_057852.2	Vpr	induces accumulation of	9606	79902	NP_079120.1	nuclear pore complex protein Nup85	14767062	2007-11-07 17:28	HIV-1 Vpr-expressing HeLa cells stained with centriole markers pericentrin, gamma-tubulin, and Cen2 contain multiple pairs of centrioles scattered in the perinuclear region, indicating Vpr causes the accumulation of multiple centrosome-like structures
11676	155871	NP_057853.1	Tat	binds	9606	81027	NP_110400.1	tubulin beta-1 chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	enhances polymerization of	9606	81027	NP_110400.1	tubulin beta-1 chain	15691386,15698476	2007-11-07 17:28	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155871	NP_057853.1	Tat	downregulates	9606	81027	NP_110400.1	tubulin beta-1 chain	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155908	NP_057854.1	Rev	depolymerizes	9606	81027	NP_110400.1	tubulin beta-1 chain	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	81579	NP_110448.2	group XIIA secretory phospholipase A2 precursor	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	81579	NP_110448.2	group XIIA secretory phospholipase A2 precursor	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155348	NP_705926.1	retropepsin	cleaves	9606	81631	NP_073729.1	microtubule-associated proteins 1A/1B light chain 3B	2212989,8997639	2007-11-07 17:29	HIV-1 protease extensively cleaves microtubule-associated proteins 1 and 2 and completely inhibits microtubule assembly
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	83468	NP_112592.1	glycosyltransferase 8 domain-containing protein 2	2283726,2341393,2649653,8218172	2007-11-07 17:29	Addition of peripheral sugar residues such as galactose, N-acetylglucosamine, and sialic acid to HIV-1 gp120 is processed by specific glycosyltransferase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	83539	NP_113610.2	carbohydrate sulfotransferase 9	1433500,8419650	2007-11-07 17:30	Sulfate is linked to the carbohydrate chains of HIV-1 glycoproteins gp160, gp120, and gp41 during the endoplasmic reticulum to Golgi transport of the glycoproteins
11676	155348	NP_705926.1	retropepsin	cleaves	9606	83660	NP_055874.1	talin 2	12119179	2007-11-07 17:29	A number of focal adhesion plaque proteins are specifically cleaved by HIV-1 protease, including fimbrin, focal adhesion plaque kinase (FAK), talin, and, to a lesser extent, filamin, spectrin and fibronectin
11676	155459	NP_057851.1	Vif	binds	9606	83737	NP_113671.3	E3 ubiquitin-protein ligase Itchy homolog	15013426	2007-11-07 17:28	HIV-1 Vif, through amino acids 20-128, binds to the WW domains of hNedd4 and AIP4, two HECT E3 ubiquitin ligases
11676	155871	NP_057853.1	Tat	binds	9606	83740	NP_542451.1	histone H2A-Bbd type 2/3	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	83953	NP_114418.2	high affinity immunoglobulin alpha and immunoglobulin mu Fc receptor isoform a	8145026	2007-11-07 17:30	Preincubation of monocytes with HIV-1 gp120 depresses anti-CD3 antibody-induced T cell stimulation and Fc receptor-mediated phagocytosis
11676	155348	NP_705928.1	integrase	acetylated by	9606	84148	NP_115564.1	MYST histone acetyltransferase 1 isoform 1	16096645,17182677	2007-11-07 17:29	Cellular acetyltransferase binds HIV-1 integrase both in vitro and in cells and acetylates three specific lysines (K264, K266, K273) in the carboxy-terminus of integrase
11676	155348	NP_705926.1	retropepsin	cleaves	9606	84557	NP_115903.1	microtubule-associated proteins 1A/1B light chain 3A isoform a	2212989,8997639	2007-11-07 17:29	HIV-1 protease extensively cleaves microtubule-associated proteins 1 and 2 and completely inhibits microtubule assembly
11676	155871	NP_057853.1	Tat	upregulates	9606	84560	NP_116324.1	metallothionein-4	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	binds	9606	84617	NP_115914.1	tubulin beta-6 chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	downregulates	9606	84617	NP_115914.1	tubulin beta-6 chain	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155908	NP_057854.1	Rev	depolymerizes	9606	84617	NP_115914.1	tubulin beta-6 chain	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	84647	NP_115951.2	group XIIB secretory phospholipase A2-like protein precursor	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	84647	NP_115951.2	group XIIB secretory phospholipase A2-like protein precursor	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155348	NP_705928.1	integrase	co-localizes with	9606	84717	NP_116020.1	hepatoma-derived growth factor-related protein 2 isoform 2	15797927	2007-11-07 17:29	Hepatoma-derived growth factor-related protein 2 translocates HIV-1 integrase from the cytoplasm to the nucleus where both proteins co-localize
11676	155871	NP_057853.1	Tat	binds	9606	84790	NP_116093.1	tubulin alpha-1C chain	12486001,15331610	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	enhances polymerization of	9606	84790	NP_116093.1	tubulin alpha-1C chain	15691386,15698476	2007-11-07 17:28	HIV-1 Tat (specifically, amino acids 38-72), enhances tubulin polymerization and triggers the mitochondrial pathway to induce T cell apoptosis as shown in vitro by the release of cytochrome c from isolated mitochondria
11676	155871	NP_057853.1	Tat	disrupts	9606	84790	NP_116093.1	tubulin alpha-1C chain	16327313	2007-11-07 17:29	HIV-1 Tat causes a dramatic decrease in alpha-tubulin staining, which indicates disruption of the cytoskeleton organization in human intestinal epithelial cells
11676	155908	NP_057854.1	Rev	depolymerizes	9606	84790	NP_116093.1	tubulin alpha-1C chain	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces acetylation of	9606	84790	NP_116093.1	tubulin alpha-1C chain	15103018,16148047	2007-11-07 17:30	The binding of HIV-1 gp120 to CD4+-permissive cells increases the level of acetylated alpha-tubulin in a CD4-dependent manner; overexpression of Histone Deacetylase 6 (HDAC6) inhibits the acetylation of alpha-tubulin and prevents HIV-1-cell fusion
11676	155871	NP_057853.1	Tat	activates	9606	84812	NP_116115.1	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-4	7589147,9278385,9730685,10501179,10843712,12482669	2007-11-07 17:28	HIV-1 Tat induces release of calcium and TNF-alpha production, an effect mediated at least in part by activation of phospholipase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	84812	NP_116115.1	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-4	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155807	NP_057852.2	Vpr	co-localizes with	9606	84823	NP_116126.2	lamin-B2	9436978,11691994	2007-11-07 17:27	HIV-1 Vpr co-localizes with lamin B and induces localized disruptions in the normal nuclear lamin architecture, contributing to the formation of nuclear envelope herniations
11676	155871	NP_057853.1	Tat	binds	9606	84823	NP_116126.2	lamin-B2	2406262,2544227	2007-11-07 17:27	Purified HIV-1 Tat has been shown to bind with high affinity to the nuclear matrix from H9 cells and to link viral RNAs to the nuclear matrix
11676	155871	NP_057853.1	Tat	binds	9606	85235	NP_542163.1	histone H2A type 1-H	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	85236	NP_542160.1	histone H2B type 1-K	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155030	NP_579880.1	capsid	inhibited by	9606	85363	NP_149023.1	tripartite motif protein TRIM5 isoform alpha	14985764,15919943,15994791,16828831,17028189,17083721,17087820	2007-11-07 17:31	HIV-1 infection is modestly restricted by human TRIM5alpha, which acts on the incoming HIV-1 capsid
11676	155030	NP_579880.1	capsid	binds	9606	85363	NP_149023.1	tripartite motif protein TRIM5 isoform alpha	15649369,15709033,16809279	2007-11-07 17:31	Removal of a positively charged residue at position 332 of human TRIM5alpha increases its restricting activity by increasing the ability of TRIM5alpha to bind HIV-1 capsid complexes
11676	155030	NP_579880.1	capsid	inhibited by	9606	85363	NP_149023.1	tripartite motif protein TRIM5 isoform alpha	16828831	2007-11-07 17:31	Human TRIM5alpha modestly, but specifically, inhibits an HIV-1 strain carrying a mutation (G89V) in the cyclophilin binding loop in capsid
11676	155030	NP_579880.1	capsid	degraded by	9606	85363	NP_149023.1	tripartite motif protein TRIM5 isoform alpha	17028189,17156811	2007-11-07 17:31	HIV-1 capsid is more rapidly degraded in cells expressing monkey TRIM5alpha than in cells expressing human TRIM5alpha
11676	155030	NP_579880.1	capsid	complexes with	9606	85363	NP_149023.1	tripartite motif protein TRIM5 isoform alpha	17156811	2007-11-07 17:31	TRIM5alpha associates with HIV-1 capsid-nucleocapsid complexes assembled in vitro, and the TRIM5alpha interaction with these complexes is dependent on its B30.2(SPRY) domains
11676	155807	NP_057852.2	Vpr	inactivates	9606	85417	NP_149020.2	G2/mitotic-specific cyclin-B3 isoform 3	7474080,7474100,7494303,7666531,9094673,10958988	2007-11-07 17:28	HIV-1 Vpr inactivates the cdc2-cyclin B kinase complex by inhibiting the dephosphorylation of cdc2 tyrosine 15, leading to arrest in the G2 phase of the cell cycle
11676	155807	NP_057852.2	Vpr	inactivates	9606	85417	NP_149020.2	G2/mitotic-specific cyclin-B3 isoform 3	7474100,11531413	2007-11-07 17:28	HIV-1 Vpr inactivates the cdc2-cyclin B kinase complex by inactivating cdc25C, the phosphatase that dephosphorylates and activates cdc2
11676	155807	NP_057852.2	Vpr	inactivates	9606	85417	NP_149020.2	G2/mitotic-specific cyclin-B3 isoform 3	7494303	2007-11-07 17:28	Inactivation of the cdc2-cyclin B kinase complex and arrest in the G2 phase of the cell cycle has been mapped to the C-terminus of HIV-1 Vpr, including amino acids 73, 80 and 84-96
11676	155807	NP_057852.2	Vpr	inactivates	9606	85417	NP_149020.2	G2/mitotic-specific cyclin-B3 isoform 3	9520381	2007-11-07 17:28	The human Vpr interacting protein (hVIP/MOV34) is a likely cellular cofactor for HIV-1 Vpr inactivation of the cdc2-cyclin B kinase complex and induction of cell cycle arrest
11676	155807	NP_057852.2	Vpr	inhibits	9606	85417	NP_149020.2	G2/mitotic-specific cyclin-B3 isoform 3	9560267	2007-11-07 17:28	Data suggests that HIV-1 Vpr transactivation of the HIV-LTR promoter occurs through the inhibition of p300-associated cdc2-cyclin B kinase complex activity which enhances transcriptional activation by Rel A and p300
11676	155807	NP_057852.2	Vpr	inactivates	9606	85417	NP_149020.2	G2/mitotic-specific cyclin-B3 isoform 3	11878934	2007-11-07 17:28	Inactivation of the cdc2-cyclin B kinase complex by HIV-1 Vpr leads to the activation of Poly(A) polymerase
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	89869	NP_149114.2	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase zeta-1	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155030	NP_057850.1	Pr55(Gag)	regulated by	9606	90678	NP_612370.3	E3 ubiquitin-protein ligase LRSAM1	15256501,16808324	2007-11-07 17:29	TAL, a Tsg101-associated ligase, binds and ubiquitinates Tsg101; TAL-mediated binding and ubiquitination of Tsg101 cooperatively regulate release of HIV-1 Gag
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	92140	NP_848927.1	metadherin	15927426	2007-11-07 17:31	Astrocyte elevated gene (AEG)-1 expression is increased in astrocytes infected with HIV-1 or treated with HIV-1 gp120; AEG-1 inhibits excitatory amino acid transporter 2 (EAAT2) promoter activity with the potential to promote glutamate excitotoxicity
11676	155030	NP_579883.1	p6	interacts with	9606	92421	NP_689497.1	charged multivesicular body protein 4c	14505569,14505570,14519844	2007-11-07 17:29	HIV-1 p6-Gag interacts with CHMP4A, CHMP4B and CHMP4C proteins through a direct binding interaction with AIP1, a component of the viral budding machinery
11676	155030	NP_579883.1	p6	inhibited by	9606	92421	NP_689497.1	charged multivesicular body protein 4c	14505569,14505570,14519844	2007-11-07 17:29	Overexpression of CHMP4A, CHMP4B or CHMP4C inhibits HIV-1 p6-Gag L-domain function and HIV-1 budding
11676	155871	NP_057853.1	Tat	binds	9606	92815	NP_254280.1	histone H2A type 3	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	94239	NP_036544.1	histone H2A.V isoform 1	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	activates	9606	113026	NP_588614.1	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-3	7589147,9278385,9730685,10501179,10843712,12482669	2007-11-07 17:28	HIV-1 Tat induces release of calcium and TNF-alpha production, an effect mediated at least in part by activation of phospholipase C
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	113026	NP_588614.1	1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-3	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	116179	NP_443187.1	protein-glutamine gamma-glutamyltransferase Z	7906657	2007-11-07 17:29	Cyclosporin (CsA) treatment prevents gp120-dependent induction of apoptosis by blocking the activation of Ca(2+)-dependent effector elements such as transglutaminase (TG) proteins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	modified by	9606	116179	NP_443187.1	protein-glutamine gamma-glutamyltransferase Z	7688299	2007-11-07 17:30	The HIV-1 transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro; soluble CD4 can block the transglutaminase-catalyzed incorporation of the polyamine spermidine into HIV-1 gp41
11676	155871	NP_057853.1	Tat	activates	9606	116443	NP_597702.1	glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	7695237,9651389,10197777,11483648,11606043,12414113,12775422,14644469,16489129	2007-11-07 17:27	HIV-1 Tat induces apoptosis of neurons and neurotoxicity through the activation of both NMDA and non-NMDA receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	116443	NP_597702.1	glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	8563977,8581564,8724036,8804048,8821747,8822372,8845955,8955056,10448428,15749123	2007-11-07 17:30	HIV-1 gp120-mediated human cell death involves the NMDA receptor complex; antagonists of the NMDA receptor reverse the gp120-mediated effects
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	116443	NP_597702.1	glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	116443	NP_597702.1	glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	10555109	2007-11-07 17:31	HIV-1 gp120 binds to cells expressing epsilon1/zeta1 or epsilon2/zeta1 combined NMDA receptor subunits, but not to cells expressing a single epsilon1, epsilon2, or zeta1 NMDA receptor subunit
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	116443	NP_597702.1	glutamate receptor, ionotropic, N-methyl-D-aspartate 3A	16481105	2007-11-07 17:31	HIV-1 gp120 activates NMDA receptor directly and phosphorylates JNK through a gp120-mediated apoptotic pathway in human neuroblastoma cells
11676	155871	NP_057853.1	Tat	activates	9606	116444	NP_619635.1	glutamate	7695237,9651389,10197777,11483648,11606043,12414113,12775422,14644469,16489129	2007-11-07 17:27	HIV-1 Tat induces apoptosis of neurons and neurotoxicity through the activation of both NMDA and non-NMDA receptors
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	116444	NP_619635.1	glutamate	8563977,8581564,8724036,8804048,8821747,8822372,8845955,8955056,10448428,15749123	2007-11-07 17:30	HIV-1 gp120-mediated human cell death involves the NMDA receptor complex; antagonists of the NMDA receptor reverse the gp120-mediated effects
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	116444	NP_619635.1	glutamate	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	116444	NP_619635.1	glutamate	10555109	2007-11-07 17:31	HIV-1 gp120 binds to cells expressing epsilon1/zeta1 or epsilon2/zeta1 combined NMDA receptor subunits, but not to cells expressing a single epsilon1, epsilon2, or zeta1 NMDA receptor subunit
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	116444	NP_619635.1	glutamate	16481105	2007-11-07 17:31	HIV-1 gp120 activates NMDA receptor directly and phosphorylates JNK through a gp120-mediated apoptotic pathway in human neuroblastoma cells
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	116835	NP_443202.3	heat shock 70 kDa protein 12B	7906708	2007-11-07 17:29	The exposure of permissive CD4+ cells to HIV-1 gp120 increases the synthesis and nuclear translocation of 70kDa heat shock protein
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibited by	9606	116835	NP_443202.3	heat shock 70 kDa protein 12B	12832005	2007-11-07 17:30	Over expression of hsp70 with a herpes viral amplicon vector protects cultured hippocampal rat neurons from gp120 neurotoxicity
11676	155030	NP_579880.1	capsid	binds	9606	117854	NP_001003818.1	tripartite motif-containing protein 6 isoform 1	16775307,16828831,17156811	2007-11-07 17:31	The RING, B-box 2, and coiled-coil domains of TRIM6 can functionally replace the corresponding domains of rhesus monkey TRIM5alpha with respect to inhibition of HIV-1 infection through the binding of the chimeras to HIV-1 capsid complexes
11676	155871	NP_057853.1	Tat	binds	9606	121504	NP_778224.1	histone H4	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	inhibited by	9606	124790	NP_653209.1	protein HEXIM2	15992410	2007-11-07 17:28	HIV-1 Tat transactivation is effectively inhibited by co-expression of HEXIM1 or its paralog HEXIM2; HEXIM1 expression specifically represses transcription mediated by the direct activation of P-TEFb through the recruitment of CycT1
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	palmitoylated by	9606	126129	NP_689572.1	carnitine O-palmitoyltransferase 1, brain isoform isoform 2	11095714	2007-11-07 17:31	HIV-1 envelope glycoprotein (gp160) contains two palmitoylated cysteine residues C764 and C837; removal of both palmitoylation sites results in the formation of virus with low levels of gp160 incorporation, as well as a decrease in viral infectivity
11676	155871	NP_057853.1	Tat	binds	9606	126961	NP_066403.2	histone H3.2	9566873,11080476,11689053,14657027	2007-11-07 17:30	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	binds	9606	128312	NP_778225.1	histone H2B type 3-B	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155030	NP_579883.1	p6	interacts with	9606	128866	NP_789782.1	charged multivesicular body protein 4b	14505569,14505570,14519844	2007-11-07 17:29	HIV-1 p6-Gag interacts with CHMP4A, CHMP4B and CHMP4C proteins through a direct binding interaction with AIP1, a component of the viral budding machinery
11676	155030	NP_579883.1	p6	inhibited by	9606	128866	NP_789782.1	charged multivesicular body protein 4b	14505569,14505570,14519844	2007-11-07 17:29	Overexpression of CHMP4A, CHMP4B or CHMP4C inhibits HIV-1 p6-Gag L-domain function and HIV-1 budding
11676	155871	NP_057853.1	Tat	interacts with	9606	129685	NP_612639.2	transcription initiation factor TFIID subunit 8	7835343	2007-11-07 17:27	TATA binding protein (TBP)-associated factors (TAFs) in the TFIID complex are required for activation by transcription factors, but are dispensable for HIV-1 Tat LTR transactivation function
11676	155871	NP_057853.1	Tat	recruits	9606	129685	NP_612639.2	transcription initiation factor TFIID subunit 8	7836461	2007-11-07 17:27	A novel function of LBP-1, restricting HIV-1 transcription at the level of elongation by preventing the binding of TFIID to the promoter, is suppressed by HIV-1 Tat, indicating Tat helps recruit TFIID to the HIV-1 LTR
11676	155871	NP_057853.1	Tat	interacts with	9606	129685	NP_612639.2	transcription initiation factor TFIID subunit 8	7933101	2007-11-07 17:27	Interaction of TFIID with the HIV-1 LTR, and therefore presumably HIV-1 Tat protein, is primarily dependent on the LTR TATA element and may also be stabilized or regulated by flanking E box motifs and basic helix-loop-helix proteins such as AP-4 and E47
11676	155871	NP_057853.1	Tat	binds	9606	129685	NP_612639.2	transcription initiation factor TFIID subunit 8	8121496,8680883,8764009,9054383	2007-11-07 17:27	HIV-1 Tat binds, through amino acids 36-50, directly to the TBP subunit of the TFIID holoenzyme complex (which includes at least TFIID subunits p250, p125, p70, TBP, and p30), and increases the interaction of TFIID with the HIV-1 LTR promoter
11676	155871	NP_057853.1	Tat	stabilizes	9606	129685	NP_612639.2	transcription initiation factor TFIID subunit 8	8764062,8849451	2007-11-07 17:27	HIV-1 Tat stabilizes the interaction of TFIIA with TFIID, and TFIIA and TFIID are required to reconstitute Tat-specific and TAR-dependent activation of HIV transcription in vitro
11676	156110	NP_057857.2	Nef	interacts with	9606	130340	NP_001034658.1	AP-1 complex subunit sigma-3	9736718,9811606,9811611,11463741,12486136,12836198,15681409	2007-11-07 17:29	A leucine-based motif near the C-terminus of HIV-1 Nef interacts with AP-1 complexes; residues 164 and 165 in Nef are required for the interaction with AP-1
11676	156110	NP_057857.2	Nef	binds	9606	130340	NP_001034658.1	AP-1 complex subunit sigma-3	12486136,15681409,16253302	2007-11-07 17:29	The dileucine motif (residues 164-165) in HIV-1 Nef is required for binding to AP-1 complexes and stabilizing their association with membranes
11676	156110	NP_057857.2	Nef	stabilizes	9606	130340	NP_001034658.1	AP-1 complex subunit sigma-3	16253302	2007-11-07 17:29	HIV-1 Nef stabilizes AP-1 complexes on endosomal membranes after ADP-ribosylation factor-1 (ARF1) -dependent attachment
11676	155459	NP_057851.1	Vif	inhibits	9606	140564	NP_689639.1	apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D	16920826	2007-11-07 17:31	HIV-1 Vif inhibits human APOBEC3D encapsidation into HIV-1 virions and APOBEC3D-mediated GC-to-AC mutations in viral plus-strand DNA by triggering its proteasomal degradation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	144423	NP_653270.1	glycosyltransferase 1 domain containing 1	2283726,2341393,2649653,8218172	2007-11-07 17:29	Addition of peripheral sugar residues such as galactose, N-acetylglucosamine, and sialic acid to HIV-1 gp120 is processed by specific glycosyltransferase
11676	155971	NP_057856.1	Envelope surface glycoprotein gp160, precursor	processed by	9606	146664	NP_653278.2	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B isoform 1	2187500,2541446,2649653,2829950,8673525,9109416,11530211	2007-11-07 17:30	Oligosaccharide side-chains of HIV-1 gp160 are processed by glycosidase I and II, mannosidase I and II, acetylglucosaminyl transferase I and II, and fucosyl, galactosyl and sialyl transferases in both the endoplasmic reticulum and golgi apparatus
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	processed by	9606	146664	NP_653278.2	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B isoform 1	1736542,2829950,3099781,3264072,8093218	2007-11-07 17:30	Mannose-containing, N-linked oligosaccharide side-chains of HIV-1 gp41 are involved in the initial stage of infection by HIV-1; glycosylation inhibitors block virus-cell and cell-cell fusion and release of the virions
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inactivates	9606	171558	NP_612153.2	pre T-cell antigen receptor alpha precursor	1979339	2007-11-07 17:29	HIV-1 envelope glycoproteins gp120 and gp160 directly and specifically impair the CD3/TcR-mediated activation of phospholipase C (PLC) via the CD4 molecule in uninfected T cells
11676	155871	NP_057853.1	Tat	activates	9606	171568	NP_612211.1	DNA-directed RNA polymerase III subunit RPC8 isoform a	1403646	2007-11-07 17:27	HIV-1 Tat upregulates the transcription by RNA polymerase III of co-transfected or endogenous cellular Alu-repeated sequences by activating transcription factor TFIIIC
11676	155871	NP_057853.1	Tat	inhibits	9606	196883	NP_640340.2	adenylate cyclase type 4	11299302	2007-11-07 17:29	HIV-1 Tat inhibits adenylyl cyclase activity in microglia and astrocyte cultures from neonatal rat brain, suggesting that Tat inhibition of cAMP synthesis may contribute to neuronal degeneration and cell death associated with HIV infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	stimulates	9606	196883	NP_640340.2	adenylate cyclase type 4	10808179	2007-11-07 17:31	The addition of HIV-1 gp120 with TNF-alpha to human B-cells stimulates cAMP production in a dose-dependent manner
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	activates	9606	196883	NP_640340.2	adenylate cyclase type 4	10089566,10807185	2007-11-07 17:30	Secretion of IL-10 is upregulated by HIV-1 gp41 in monocytes through activation of cAMP/adenylate cyclase and p70 (S6)-kinase; up-regulation of IL-10 is paralleled by an enhanced expression of the chemokine receptor CCR5
11676	156110	NP_057857.2	Nef	activates	9606	196883	NP_640340.2	adenylate cyclase type 4	11884542	2007-11-07 17:28	HIV-1 induces the upregulation of complement factor C3 in astrocytes and neurons through signaling pathways that involve protein kinase C and adenylate cyclase activation, which is an effect that may contribute to the pathogenesis of AIDS in the brain
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	induces release of	9606	197257	NP_705690.2	probable D-lactate dehydrogenase, mitochondrial isoform 1 precursor	11125887	2007-11-07 17:31	HIV-1 gp120/41 (SFVenvBX08)-expressing microglia exhibit a 170% increase in lactate dehydrogenase (LDH) release
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	induces release of	9606	197257	NP_705690.2	probable D-lactate dehydrogenase, mitochondrial isoform 1 precursor	11582518	2007-11-07 17:31	A lentivirus lytic peptide 1 (LLP-1) corresponding to the carboxyl terminus of HIV-1 gp41 induces a significant lactate dehydrogenase (LDH, a marker of cell death) release from human neuronal and glial cell lines
11676	155871	NP_057853.1	Tat	upregulates	9606	200315	NP_663745.1	probable DNA dC->dU-editing enzyme APOBEC-3A	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the expression of many proteins, including Phorbolin I, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155030	NP_057850.1	Pr55(Gag)	incorporates	9606	200316	NP_660341.2	DNA dC->dU-editing enzyme APOBEC-3F isoform a	17020885,17038330	2007-11-07 17:31	APOBEC3F may be incorporated into virions by HIV-1 Gag polyprotein
11676	155459	NP_057851.1	Vif	inhibits	9606	200316	NP_660341.2	DNA dC->dU-editing enzyme APOBEC-3F isoform a	15141007,15296757,16460778,16501124,16641889,16699599,16940537,17038330,17067930	2007-11-07 17:28	APOBEC3F, similar to APOBEC3G, induces G to A hypermutations in HIV-1 genomic DNA, and the HIV-1 Vif protein inhibits this activity
11676	155459	NP_057851.1	Vif	binds	9606	200316	NP_660341.2	DNA dC->dU-editing enzyme APOBEC-3F isoform a	15152192,16460778,16940537	2007-11-07 17:28	HIV-1 Vif specifically binds APOBEC3F, and Vif suppresses both the inhibition of virus infectivity caused by APOBEC3F and virion incorporation of APOBEC3F
11676	155459	NP_057851.1	Vif	inhibits	9606	200316	NP_660341.2	DNA dC->dU-editing enzyme APOBEC-3F isoform a	16501124	2007-11-07 17:31	Highly conserved Tryptophan residues in the N-terminal region of HIV-1 Vif are required for the suppression of both APOBEC3G and APOBEC3F
11676	155459	NP_057851.1	Vif	inhibits	9606	200316	NP_660341.2	DNA dC->dU-editing enzyme APOBEC-3F isoform a	16699599	2007-11-07 17:31	HIV-1 Vif, which suppresses both APOBEC3G and APOBEC3F antiviral function by inducing their degradation, may selectively remove these proteins from, and/or restrict their localization to, P-bodies
11676	155871	NP_057853.1	Tat	downregulates	9606	203068	NP_821133.1	tubulin beta chain	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155871	NP_057853.1	Tat	binds	9606	221613	NP_734466.1	histone H2A type 1-A	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	225689	NP_620590.2	mitogen-activated protein kinase 15	12239168	2007-11-07 17:31	HIV-1 gp120 binding to CD4 results in activation of the mitogen-activated protein kinase (MAPK) in CD4(+) lymphocytes prestimulated through their T-cell receptor (TCR)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	255189	NP_998765.2	phospholipase A2, group IVF	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	255189	NP_998765.2	phospholipase A2, group IVF	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155871	NP_057853.1	Tat	binds	9606	255626	NP_733759.1	histone H2B type 1-A	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	modulates	9606	257202	NP_874360.1	glutathione peroxidase 6 precursor	9501919,10652368	2007-11-07 17:30	HIV-1 Tat causes a greater than 50% decrease in intracellular reduced glutathione (GSH), leading to the extracellular appearance of acidic FGF-1, an effect that is partially mediated through modulation of GSH biosynthetic enzymes
11676	155871	NP_057853.1	Tat	downregulates	9606	257202	NP_874360.1	glutathione peroxidase 6 precursor	11368344,15910762	2007-11-07 17:30	Expression of HIV-1 Tat in HeLa cells downregulates cytoplasmic glutathione peroxidase while upregulating phospholipid hydroperoxide glutathione peroxidase, thereby deregulating intracellular oxidant/antioxidant balance and amplifying UV sensitivity
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	283748	NP_828848.3	cytosolic phospholipase A2 delta	9377118,9745929	2007-11-07 17:28	HIV-1 gp120 induces a specific phospholipase A2 (PLA2) activation in lymphocytes through binding to CD4, but this effect is not sufficient to accomplish virus/cell fusion
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	activates	9606	283748	NP_828848.3	cytosolic phospholipase A2 delta	9745929	2007-11-07 17:30	HIV-1 gp120 causes an activation of phospholipase A2, resulting in the increased release of arachidonic acid, which may sensitize the NMDA receptor
11676	155871	NP_057853.1	Tat	upregulates	9606	284217	NP_005550.2	laminin subunit alpha-1 precursor	11311202	2007-11-07 17:30	HIV-1 Tat upregulates the expression of extracellular matrix proteins, including the major basement membrane protein laminin
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	inhibits	9606	284217	NP_005550.2	laminin subunit alpha-1 precursor	9597096	2007-11-07 17:27	HIV-1 gp120 inhibits CD3-triggered T cell co-stimulation by the extracellular matrix (ECM) proteins, which includes laminins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	inhibits	9606	284217	NP_005550.2	laminin subunit alpha-1 precursor	9597096	2007-11-07 17:27	HIV-1 gp41 inhibits CD3-triggered T cell co-stimulation by the extracellular matrix (ECM) proteins, which includes laminins
11676	155871	NP_057853.1	Tat	binds	9606	317772	NP_778235.1	histone H2A type 2-B	9566873,11080476,11689053,14657027	2007-11-07 17:27	HIV-1 Tat peptides bind core histones H2A, H2B, H3 and H4, and Tat protein recruits histone acetyltransferases to the HIV-1 LTR promoter leading to acetylation of histones H3 and H4, derepressing chromatin structure and increasing NFkappaB responsiveness
11676	155871	NP_057853.1	Tat	upregulates	9606	326343	NP_783319.1	metallothionein M	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the interferon-responsive gene expression of many proteins, including Metallothionein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	upregulates	9606	340273	NP_848654.2	ATP-binding cassette, sub-family B, member 5	9542318	2007-11-07 17:30	Treatment of CD4+ and CD8+ T cells with HIV-1 gp120 increases the intracellular expression of P-glycoprotein (P-gp)
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	interacts with	9606	343641	NP_945345.1	transglutaminase 6	7906657	2007-11-07 17:29	Cyclosporin (CsA) treatment prevents gp120-dependent induction of apoptosis by blocking the activation of Ca(2+)-dependent effector elements such as transglutaminase (TG) proteins
11676	155971	NP_579895.1	Envelope transmembrane glycoprotein gp41	modified by	9606	343641	NP_945345.1	transglutaminase 6	7688299	2007-11-07 17:30	The HIV-1 transmembrane glycoprotein gp41 is an amino acceptor and donor substrate for transglutaminase in vitro; soluble CD4 can block the transglutaminase-catalyzed incorporation of the polyamine spermidine into HIV-1 gp41
11676	155871	NP_057853.1	Tat	binds	9606	347688	NP_817124.1	tubulin beta-8 chain isoform 1	12486001	2007-11-07 17:30	HIV-1 Tat (amino acids 36-39) binds tubulin alpha/beta dimers and polymerized microtubules leading to the alteration of microtubule dynamics and activation of a mitochondria-dependent apoptotic pathway that is facilitated by the Bcl-2 relative Bim
11676	155871	NP_057853.1	Tat	downregulates	9606	347688	NP_817124.1	tubulin beta-8 chain isoform 1	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155908	NP_057854.1	Rev	depolymerizes	9606	347688	NP_817124.1	tubulin beta-8 chain isoform 1	10908577	2007-11-07 17:30	Rev acts to depolymerize microtubules that are formed by tubulin, an effect that is observed during HIV-1 infection
11676	155871	NP_057853.1	Tat	downregulates	9606	347733	NP_821080.1	tubulin beta-2B chain	16526095	2007-11-07 17:31	In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	processed by	9606	360203	NP_892019.1	glycosyltransferase 6 domain containing 1	2283726,2341393,2649653,8218172	2007-11-07 17:29	Addition of peripheral sugar residues such as galactose, N-acetylglucosamine, and sialic acid to HIV-1 gp120 is processed by specific glycosyltransferase
11676	155348	NP_705926.1	retropepsin	cleaves	9606	440738	NP_001004343.1	microtubule-associated proteins 1A/1B light chain 3C	2212989,8997639	2007-11-07 17:29	HIV-1 protease extensively cleaves microtubule-associated proteins 1 and 2 and completely inhibits microtubule assembly
11676	155871	NP_057853.1	Tat	interacts with	9606	653361	NP_000256.3	neutrophil cytosol factor 1	12023963	2007-11-07 17:30	p47-phox interacts with TRAF4, and overexpression of the p47-phox binding domain of TRAF4 inhibits endothelial cell JNK activation by HIV-1 Tat, suggesting Tat initiates signals that enter basic signaling cassettes at the level of TRAF4
11676	155871	NP_057853.1	Tat	upregulates	9606	653361	NP_000256.3	neutrophil cytosol factor 1	12539042	2007-11-07 17:30	Microarray analysis indicates HIV-1 Tat upregulates the expression of many proteins, including 47-kD granulomatous disease protein, in immature dendritic cells, an effect that likely facilitates the expansion of HIV-1 infection
11676	155871	NP_057853.1	Tat	induces phosphorylation of	9606	653361	NP_000256.3	neutrophil cytosol factor 1	14694110	2007-11-07 17:28	HIV-1 Tat increases phosphorylation of the NADPH oxidase subunit p47(phox) and causes its rapid redistribution to membrane ruffles in human endothelial cells
11676	155871	NP_057853.1	Tat	binds	9606	729230	NP_000639.1	chemokine (C-C motif) receptor 2 isoform B	9789057	2009-03-31 05:31	HIV-1 Tat binds to CCR2 and displaces MCP-1 from this beta-chemokine receptor, an effect mediated by Tat amino acids 24-51
11676	155871	NP_057853.1	Tat	downregulates	9606	729230	NP_000639.1	chemokine (C-C motif) receptor 2 isoform B	10751368	2009-03-31 05:31	Results from the treatment of microglia with HIV-1 Tat suggest downregulation of CCR2 mRNA expression by HIV-1 Tat, however this was deemed to not be significant
11676	155871	NP_057853.1	Tat	activates	9606	729230	NP_000639.1	chemokine (C-C motif) receptor 2 isoform B	16831471	2009-03-31 05:31	HIV-1 Tat induces CCR2-mediated glial activation
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	binds	9606	729230	NP_000639.1	chemokine (C-C motif) receptor 2 isoform B	9653051,9736741,10486323,10877489,11115360,12192431	2009-03-31 05:31	Macrophage-tropic HIV-1 can use CCR2b, and to a lesser extent CCR3, STRL33, and APJ, to infect cells; the V1/2 region of HIV-1 gp120 plays a more important role in governing the use of CCR2b, CCR3, STRL33, and APJ than for CXCR4
11676	155971	NP_579894.2	Envelope surface glycoprotein gp120	associates with	9606	729230	NP_000639.1	chemokine (C-C motif) receptor 2 isoform B	11804551,15053339,15992849	2009-03-31 05:31	HIV-1 gp120 from CXCR4-tropic subtype E viruses isolated in Thailand associates with and uses at least one of the following coreceptors for virus entry: CCR8, CCR1, CCR2b, or CX3CR1
